APPLICATION_ID,ACTIVITY,ADMINISTERING_IC,APPLICATION_TYPE,ARRA_FUNDED,AWARD_NOTICE_DATE,BUDGET_START,BUDGET_END,CFDA_CODE,CORE_PROJECT_NUM,ED_INST_TYPE,OPPORTUNITY NUMBER,FULL_PROJECT_NUM,FUNDING_ICs,FUNDING_MECHANISM,FY,IC_NAME,NIH_SPENDING_CATS,ORG_CITY,ORG_COUNTRY,ORG_DEPT,ORG_DISTRICT,ORG_DUNS,ORG_FIPS,ORG_IPF_CODE,ORG_NAME,ORG_STATE,ORG_ZIPCODE,PHR,PI_IDS,PI_NAMEs,PROGRAM_OFFICER_NAME,PROJECT_START,PROJECT_END,PROJECT_TERMS,PROJECT_TITLE,SERIAL_NUMBER,STUDY_SECTION,STUDY_SECTION_NAME,SUBPROJECT_ID,SUFFIX,SUPPORT_YEAR,DIRECT_COST_AMT,INDIRECT_COST_AMT,TOTAL_COST,TOTAL_COST_SUB_PROJECT
11188005,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010814,NA,NA,1ZIABC010814-18,NCI:1247909\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,1882058 (contact),"HU, WEI-SHAU  (contact)",NA,NA,NA,5&apos; Untranslated Regions;Adopted;Affect;Binding;Biochemical;Biological Assay;Complex;Cytoplasm;Defect;design;Dimerization;Elements;Epidemic;Evolution;Exhibits;exportin 1 protein;fitness;Genetic Transcription;Genome;Goals;Guanosine;HIV;HIV-1;Image;improved;insight;Integration Host Factors;Knowledge;Length;Light;Methods;Molecular Conformation;mutant;novel;Nucleotides;pathogen;Pathway interactions;pol Gene Products;Polyribosomes;polysome profiling;Primate Lentiviruses;Proteins;Proviruses;Regulation;rev Protein;rev-Responsive Elements;Ribosomes;RNA;RNA Folding;RNA Transport;Role;Site;Structure;Transcript;Transcription Initiation;Transcription Initiation Site;Translating;Translations;Treatment Protocols;Vaccines;Viral;Viral Genome;Viral Proteins;Virion;Virus;Virus Latency;Virus Replication,Elucidating the Regulation of HIV RNA Functions:Translation and Genome Packaging,10814,NA,NA,NA,NA,18,NA,NA,1247909,NA
11188006,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010816,NA,NA,1ZIABC010816-18,NCI:3790575\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6189074 (contact),"HASSAN, RAFFIT  (contact)",NA,NA,NA,Adoptive Cell Transfers;Affinity;Animal Model;Antibodies;antitumor effect;BRCA1 gene;Breast Cancer Early Detection;C-terminal;cancer type;CAR T cell therapy;CCR;Cell Line;Cell surface;Cells;chimeric antigen receptor;chimeric antigen receptor T cells;CLIA certified;Clinic;Clinical;clinical development;Clinical Trials;cohort;Complex;Cutaneous Melanoma;cytotoxicity test;Diagnosis;differential expression;Differentiation Antigens;disease-causing mutation;Distal;DNA Repair;DNA Repair Gene;Early Diagnosis;effective therapy;efficacy study;Eligibility Determination;Enrollment;Epitopes;exhaustion;Family;Family member;gene panel;Gene Proteins;genetic testing;Germ Lines;Germ-Line Mutation;Goals;Human;Immunocompetent;Immunocompromised Host;Immunosuppression;improved;Incidence;Individual;Large Intestine Carcinoma;Longterm Follow-up;Malignant mesothelioma;Malignant neoplasm of lung;Malignant neoplasm of ovary;Malignant neoplasm of pancreas;Malignant neoplasm of urinary bladder;Malignant Neoplasms;manufacture;Mediating;Membrane;Memory;meningioma;Mesothelial Cell;mesothelin;Mesothelioma;Modeling;Monoclonal Antibodies;Mus;Mutation;neoplastic cell;novel therapeutics;Oryctolagus cuniculus;Outcome;overexpression;Pancreatic Adenocarcinoma;Participant;Pathogenicity;patient derived xenograft model;Patients;PD-1/PD-L1;pericardial sac;Peritoneum;Phase;phase 1 study;Phase I Clinical Trials;phase I trial;phase II trial;Pleura;pre-clinical;Pre-Clinical Model;preclinical study;Predisposition;programmed cell death ligand 1;programs;prospective;Proteins;Protocols documentation;receptor;Recording of previous events;Regulation;Renal Carcinoma;Research;Risk;Role;Safety;screening;Screening for cancer;Signal Transduction;Solid Neoplasm;stem cells;Stomach Carcinoma;Surface;Susceptibility Gene;T memory cell;T-Cell Activation;T-Cell Receptor;T-Lymphocyte;Testing;therapy development;Toxic effect;Translating;tumor;Tumor Antigens;tumor microenvironment;United States National Institutes of Health;Uveal Melanoma;Variant;Work,Adoptive cell therapy for malignant mesothelioma and other mesothelin expressing,10816,NA,NA,NA,NA,18,NA,NA,3790575,NA
11188007,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010819,NA,NA,1ZIABC010819-18,NCI:635403\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,1928666 (contact),"MALDARELLI, FRANK  (contact)",NA,NA,NA,Acute;Adult;Africa South of the Sahara;algorithm development;Algorithms;Anti-Retroviral Agents;antiretroviral therapy;assay development;Binding;Bioinformatics;Blood Cells;cathinone;Cells;Chronic;Clinical;Collaborations;Country;Data;Development;Diagnosis;DNA Sequence;driving force;Drug resistance;drug resistance development;drug testing;Early identification;Epidemic;Equilibrium;Genetic;genetic analysis;Genetic Polymorphism;Genetic Population Study;Genetic Recombination;Genetic Transcription;Genetic Variation;Genome;Genotype;Goals;High Prevalence;HIV;HIV drug resistance;HIV Infections;HIV risk;HIV-1;in vivo;Incidence;Individual;Indonesia;Infection;inhibitor;insight;intravenous drug user;invention;Israel;laboratory accident;Length;Link;men;Methods;Molds;Molecular Evolution;Mutation;Nature;Newly Diagnosed;next generation;novel strategies;Patients;Pattern;Peripheral Blood Mononuclear Cell;Plasma;Population;population based;Population Dynamics;Population Heterogeneity;Population Sizes;Positioning Attribute;Prevention approach;Protocols documentation;Proviruses;Public Health;Publications;Reporting;Research;Research Personnel;Resistance;Resistance development;resistance mutation;Risk;Risk Factors;RNA;Sampling;Shapes;Structure;technique development;Technology;United States National Institutes of Health;Universities;Unsafe Sex;Variant;Vertical Transmission;Viral;Viremia;Washington,HIV-1 Genetic Variation in Infected Individuals,10819,NA,NA,NA,NA,18,NA,NA,635403,NA
11188008,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010822,NA,NA,1ZIABC010822-18,NCI:2344675\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9414472 (contact),"BASRAI, MUNIRA  (contact)",NA,NA,NA,Acetylation;Address;Affect;Aneuploidy;anti-cancer research;Area;Basic Science;Biochemical;Biological Assay;cancer cell;cancer therapy;Cell Cycle;Cell Cycle Regulation;Cell Line;Cell model;Cells;Cellular biology;Centromere;centromere protein A;Chromatin;Chromosomal Instability;Chromosomal Stability;chromosome loss;chromosome missegregation;Chromosome Segregation;Chromosomes;Clinic;Clinical Trials;cohesin;cohesion;constitutive expression;daughter cell;DAXX gene;Defect;Diagnosis;Diploidy;DNA;DNA Sequence;dosage;Dose;Drosophila polo protein;established cell line;Euchromatin;Excision;F-Box Proteins;fly;Follow-Up Studies;Future;Gene Dosage;Genes;Genetic;Genome;genome wide screen;genome-wide;Hela Cells;Heterogeneity;Histone Acetylation;Histone Deacetylase Inhibitor;Histone H3;Histone H4;Histones;Homologous Gene;Human;human model;Image;In Vitro;in vivo;Incidence;inducible gene expression;insight;interdisciplinary approach;Kinetochores;Link;Lysine;Malignant Neoplasms;Mediating;Methylation;micronucleus;Microtubules;Mitotic;Molecular;Molecular Chaperones;Molecular Conformation;mouse model;multidisciplinary;Mus;Nuclear;Nucleosomes;overexpression;Pathway interactions;Phenotype;Phosphorylation;Phosphotransferases;Post Translational Modification Analysis;Post-Translational Protein Processing;prevent;Process;Prognosis;Proliferating;Proteins;Proteolysis;Regulation;Research;RNA interference screen;Role;Saccharomyces cerevisiae;Saccharomycetales;Site;Solid Neoplasm;stoichiometry;Sumoylation Pathway;targeted treatment;tool;Topoisomerase II;Translating;transmission process;tumorigenesis;Ubiquitin-mediated Proteolysis Pathway;Ubiquitination;Variant;Xenograft procedure;Yeast Model System;Yeasts,Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation,10822,NA,NA,NA,NA,18,NA,NA,2344675,NA
11188009,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010830,NA,NA,1ZIABC010830-18,NCI:1563961\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9414470 (contact),"GOTTESMAN, MICHAEL  (contact)",NA,NA,NA,3-Dimensional;ABCB1 gene;ABCC1 gene;ABCG2 gene;Affect;Amino Acid Transporter;Animal Model;anti-microbial drug;Antineoplastic Agents;ATAC-seq;Attenuated;Binding;Bioreactors;Blood capillaries;Breast Cancer Cell;cancer cell;Cancer Cell Growth;Cancer cell line;cancer drug resistance;Cataloging;Cell Death;Cell Line;Cell Physiology;Cell Survival;Cells;CHEK1 gene;chemotherapy;Chickens;Cisplatin;Clinical;clinically relevant;Clustered Regularly Interspaced Short Palindromic Repeats;Code;Colon Carcinoma;Complex;CRISPR screen;Cultured Cells;Cutaneous;Cytotoxic agent;Development;Diffusion;Disease;Drug resistance;drug resistance development;efflux pump;Exposure to;FDA approved;Fishes;Future;Gene Expression;Gene Expression Profile;Genes;Genomics;Goals;Growth;Guide RNA;HDAC3 gene;Histone Deacetylase;Histone Deacetylase Inhibitor;Homologous Gene;Hydrogels;In Vitro;in vivo;inhibitor;knock-down;Knock-out;Length;Malignant neoplasm of ovary;Malignant neoplasm of pancreas;Malignant Neoplasms;MCF7 cell;Methylation;Methyltransferase;Microtubule Stabilization;Microtubules;Modeling;Molecular;Multi-Drug Resistance;Multidrug Resistance-Associated Proteins;Mus;neurotoxicity;novel;overexpression;oxaliplatin;Oxygen;Paclitaxel;pancreatic cancer cells;paralogous gene;Pathway interactions;Patients;Pattern;Peripheral;Pharmaceutical Preparations;Phenotype;Physiological;Platinum Compounds;Play;polymerization;Polymers;Precision Run-On Sequencing;prevent;Probability;Protein Isoforms;Proteins;Rattus;Resistance;resistance mechanism;Role;scale up;Silicon;small molecule inhibitor;Solid Neoplasm;Specificity;Specimen;Sulfhydryl Compounds;Suspensions;System;T-Cell Lymphoma;Technology;Testing;Toxic effect;transcriptome sequencing;Transfection;Transgenic Organisms;Tubulin;tumor;uptake;Validation;Verapamil;Vertebrates;Vorinostat;Zebrafish;Zinc,Mechanisms of non-classical multidrug resistance in cancer,10830,NA,NA,NA,NA,18,NA,NA,1563961,NA
11188010,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010832,NA,NA,1ZIABC010832-18,NCI:52986\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8123119 (contact),"NICKLAUS, MARC  (contact)",NA,NA,NA,Active Sites;aqueous;Binding;Binding Proteins;Binding Sites;Chemicals;Complex;Computer Analysis;Computer software;Data;Data Set;Databases;Docking;drug action;Drug Design;Environment;Enzymes;flexibility;Future;Goals;Libraries;Ligands;Linux;Methodology;Modeling;Molecular Conformation;Pharmaceutical Preparations;Process;protein complex;protein data bank;Proteins;Publications;quantum;quantum computing;Quantum Mechanics;Resources;Running;screening;small molecule;Solvents;Structure;theories;Time;United States National Institutes of Health;Vacuum;Visit;Work;X-Ray Crystallography,Fundamentals of Ligand-Protein Interactions,10832,NA,NA,NA,NA,18,NA,NA,52986,NA
11188011,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010844,NA,NA,1ZIABC010844-18,NCI:442710\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9414500 (contact),"ZHURKIN, VICTOR  (contact)",NA,NA,NA,Address;Agreement;Biological Assay;Breast Cancer Cell;Breast Cancer Patient;Cancer Diagnostics;cancer type;cell free DNA;Cell Nucleus;Cell Physiology;Cells;cellular imaging;Chromatin;Chromatin Fiber;Chromatin Structure;Chromophobe Renal Cell Carcinoma;Clear Cell;Clinic;Clinical;cohort;Collaborations;Coupled;Data;density;Diagnostic;Disease;DNA;DNA Binding;DNA Folding;DNA Methylation;DNA Sequence;DNA-Directed RNA Polymerase;Electron Microscope;Epigenetic Process;Equilibrium;Family;Fiber;Foundations;Future;Gel;Gene Expression Regulation;Genes;Genetic Polymorphism;Genetic Transcription;Genome;genome-wide;genome-wide analysis;Genomic DNA;Geometry;Goals;Heterochromatin;Histones;Human;in vivo;Knowledge;Length;Link;Linker DNA;liquid biopsy;Malignant Breast Neoplasm;Malignant Neoplasms;Maps;Medical;Methodology;Molecular Conformation;Monitor;neoplastic cell;Normal tissue morphology;novel;Nucleic Acid Regulatory Sequences;Nucleosomal Repeat Length;Nucleosomes;Nucleotides;Organism;Paper;Patients;Phase;Positioning Attribute;Prevalence;Proteins;Publishing;Regulation;Renal Cell Carcinoma;Research Personnel;Resolution;RNA;Roentgen Rays;Side;Solid;stem;Stratification;Structure;Structure-Activity Relationship;Superhelical DNA;Techniques;Time;Tissues;tomography;transcription factor;Transcription Process;tumor;Tumor Tissue;ultra high resolution;Universities;Urologic Oncology;Variant;Yeasts,DNA Folding in Chromatin at the Supra-nucleosome Level,10844,NA,NA,NA,NA,18,NA,NA,442710,NA
11188012,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010845,NA,NA,1ZIABC010845-18,NCI:442710\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9414500 (contact),"ZHURKIN, VICTOR  (contact)",NA,NA,NA,3-Dimensional;Acetylation;Affect;Affinity;Agreement;Alu Elements;Anisotropy;Apoptosis;Apoptotic;Binding;Binding Sites;Biological Process;cancer cell;Cell Cycle Arrest;cell type;Cells;Chromatin;Combinatorics;Computer Analysis;Coupled;Data;Deoxyribonuclease I;DNA;DNA Binding;DNA Folding;DNA Methylation;DNA-Protein Interaction;Elements;Environment;Epigenetic Process;epigenetic regulation;Exhibits;Family;flexibility;gene induction;Genes;Genetic Transcription;Genomic DNA;Goals;Heterochromatin;Histone Acetylation;Histone H1;Histone H2A;Histone H4;histone modification;Histones;Human;In Vitro;in vitro Model;in vivo;insight;Intuition;Kinetics;Lysine;Malignant Breast Neoplasm;Malignant Neoplasms;Measures;Molecular Conformation;Normal Cell;novel;Nucleosomes;Pattern;Positioning Attribute;Post-Translational Protein Processing;prevent;Probability;Publishing;reconstitution;Repression;Research;response;Response Elements;Roentgen Rays;Shapes;Signal Transduction;Site;Structure;Surface;Tail;Time;TP53 gene;transcription factor;Transcriptional Regulation;transcriptional reprogramming;Tumor Suppressor Proteins;Work;Xenopus,p53-induced Regulation of Transcription in the Chromatin Context,10845,NA,NA,NA,NA,18,NA,NA,442710,NA
11188013,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010850,NA,NA,1ZIABC010850-18,NCI:1901473\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9414510 (contact),"CITRIN, DEBORAH  (contact)",NA,NA,NA,Acceleration;Accidents;Aging;Alveolar;alveolar type II cell;Alveolus;Binding;Biological Markers;Candidate Disease Gene;candidate identification;Cd68;Cell Aging;Cellular Stress;Chest;Chronic;clinical translation;Coculture Techniques;Collaborations;Collagen;Complex;Corn Oil;cytokine;Data;Data Set;Databases;diphenyleneiodonium;Dose;effective therapy;EGF gene;Evaluation;Exhibits;Exons;experience;Exposure to;Family member;Fibroblasts;Fibrosis;fibrotic lung;FRAP1 gene;Gene Expression Profiling;Genes;Goals;Histologic;Human;human tissue;Hydroxyeicosatetraenoic Acids;IGF1 gene;IGF1R gene;immunoregulation;In Vitro;in vivo;Infiltration;Inflammation;Inflammatory;inhibitor;Injury;Insulin-Like Growth Factor I;Interleukin-1 alpha;Interleukin-13;Interleukin-6;Intervention;irradiation;ITGAM gene;Knowledge;Laboratories;Laboratory Finding;Late Radiation Injury;Link;LOX gene;Lung;lung injury;Macrophage;Mediating;member;Methods;Micro Array Data;Modeling;mTOR inhibition;mTOR Signaling Pathway;Mus;NADPH Oxidase;neutralizing antibody;Normal tissue morphology;Oncogenes;Operative Surgical Procedures;Organ;Oxidative Stress;Pathway interactions;Patients;phenotypic biomarker;Phosphorylation;Plasminogen Activator Inhibitor 1;Play;pneumocyte;premature;prevent;Production;protein expression;Proteins;Publications;Pulmonary Fibrosis;Radiation;Radiation exposure;Radiation Fibrosis;Radiation Injuries;radiation mitigation;Radiation Protection;Radiation therapy;radiation-induced lung injury;radioresistant;Recombinants;Resected;Resistance;response;Role;senescence;senescence associated secretory phenotype;senescent cell;Signal Induction;Signal Transduction;Sirolimus;Site;skin fibrosis;stem cells;Structure of parenchyma of lung;success;Superoxides;Tamoxifen;Testing;Therapeutic;Therapeutic Intervention;tissue stem cells;Tissues;Toxic effect;Transforming Growth Factor beta;tumor growth;Vascular Endothelial Growth Factors;Work,Mechanisms of Normal Tissue Toxicity From Irradiation,10850,NA,NA,NA,NA,18,NA,NA,1901473,NA
11188014,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010870,NA,NA,1ZIABC010870-17,NCI:2134849\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692167 (contact),"HICKSTEIN, DENNIS  (contact)",NA,NA,NA,Acute;Adolescence;Allogenic;B-Lymphocytes;Biological;Chimerism;chronic graft versus host disease;Clinical;Clinical Protocols;curative treatments;Disease;Disease-Free Survival;Dysmyelopoietic Syndromes;emerging adult;Engraftment;Flow Cytometry;GATA2 deficiency;Hematology;Hematopoiesis;Hematopoietic Stem Cell Transplantation;immune reconstitution;Immunologic Deficiency Syndromes;Incidence;Individual;Infection;Kinetics;leukemia;Leukocytes;monocyte;Mutation;Mycobacterium avium Complex;Natural Killer Cells;Opportunistic Infections;patient population;Patients;Pattern;peripheral blood;Phenotype;Population;primary endpoint;reconstitution;Recording of previous events;Residual state;Safety;Syndrome;T cell reconstitution;T-Cell Depletion;T-Lymphocyte;Therapeutic;Time;Toxic effect;Transplantation,Hematopoietic Stem Cell Transplant for GATA2 Deficiency,10870,NA,NA,NA,NA,17,NA,NA,2134849,NA
11188015,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010876,NA,NA,1ZIABC010876-17,NCI:930599\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77856862 (contact),"WANG, XIN WEI  (contact)",NA,NA,NA,Address;agricultural pesticide;Agriculture;Architecture;Area;B-Lymphocytes;Behavioral;Biological;Biopsy;carcinogenesis;Caring;CD8-Positive T-Lymphocytes;Cell Communication;cell type;Cells;Chinese;Classification;Clinical;Clonality;cohort;combinatorial;Complex;Country;Data;Death Rate;Detection;Diabetes Mellitus;diagnostic tool;drinking water;early onset;Ecology;Ecosystem;effective therapy;Environmental Exposure;Environmental Risk Factor;Ethnic Origin;Etiology;Evolution;Fasciola hepatica;fitness;Future;Gene Expression;Genes;Genomics;hazard;Heterogeneity;Image;Immune;immune cell infiltrate;Immunofluorescence Immunologic;Incidence;indexing;Infection;Inter-tumoral heterogeneity;International;Intrahepatic Cholangiocarcinoma;Joints;Kenya;Life Style;Linear Models;Link;Liver;liver biopsy;liver cancer patient;Logistic Regressions;longitudinal analysis;Malignant neoplasm of liver;Malignant Neoplasms;Measures;Medical;Medical History;metabolomics;Modality;Modeling;Molecular;Monitor;mortality;multiplexed imaging;Mutation;Neighborhoods;neoplastic cell;Non-linear Models;novel;Outcome;patient prognosis;patient stratification;Patient-Focused Outcomes;Patients;Pattern;pesticide exposure;Phylogeny;Pilot Projects;Population Heterogeneity;Population Study;Predatory Behavior;predict clinical outcome;predictive tools;Prevention;Primary carcinoma of the liver cells;Process;Race;Research;response;Risk;Risk Factors;risk sharing;Role;Sampling;Shapes;Solid;Somatic Mutation;Source;Specimen;Structure;Subgroup;Survivors;survivorship;System;Technology;Thailand;Therapeutic Intervention;Time;TP53 gene;transcriptome;transcriptomics;Treatment Failure;treatment response;Trees;tumor;Tumor Biology;tumor heterogeneity;tumor microenvironment;tumor progression;Variant;Viral hepatitis,Molecular heterogeneity of liver cancer and its clinical impacts,10876,NA,NA,NA,NA,17,NA,NA,930599,NA
11188016,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010877,NA,NA,1ZIABC010877-17,NCI:930599\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77856862 (contact),"WANG, XIN WEI  (contact)",NA,NA,NA,"Affect;Alleles;American;Body fat;Body mass index;Body Regions;cohort;Development;Diet;Diethylnitrosamine;Epidemiology;Etiology;European;Exhibits;Family member;Genetic;genetic risk factor;genetic variant;Genetically Engineered Mouse;genome wide association study;Heat shock proteins;Hepatitis B Virus;Hepatitis C virus;Hepatocyte;Heritability;high risk;Human;Incidence;Individual;Inflammatory Response;Inherited;Link;Lipids;Liver Cirrhosis;Liver diseases;Malignant neoplasm of liver;Malignant Neoplasms;member;Metabolic;Metabolic syndrome;metabolic-associated fatty liver disease;Mitochondria;mitochondrial dysfunction;Molecular;Mus;non-alcoholic fatty liver disease;nonalcoholic steatohepatitis;Obesity;Outcome;Patients;Play;Population;prevent;Primary carcinoma of the liver cells;Prognosis;Prospective, cohort study;Protein Family;Quantitative Trait Loci;Research;Risk;risk variant;Role;Steatohepatitis;trait;trend;Twin Studies;Unhealthy Diet;United States;Variant",Molecular mechanisms of MASHNASH-related hepatocellular carcinoma,10877,NA,NA,NA,NA,17,NA,NA,930599,NA
11188017,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010881,NA,NA,1ZIABC010881-17,NCI:768255\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692189 (contact),"WAKEFIELD, LALAGE  (contact)",NA,NA,NA,Address;Adult;Advanced Malignant Neoplasm;angiogenesis;antagonist;Biology;Breast Cancer Model;cancer stem cell;cancer therapy;Cell Compartmentation;cell motility;cell type;Cells;Chronic;clinical development;clinical material;Clinical Treatment;Collaborations;Complex;Development;early phase clinical trial;Embryonic Development;Epithelium;Genetic;genetic regulatory protein;Goals;high dimensionality;Homeostasis;Human;imaging modality;Immunologic Surveillance;In Situ;in vivo;insight;Knowledge;Light;Maintenance;Malignant Neoplasms;Mammary Neoplasms;Metastatic breast cancer;Modeling;mouse model;Mus;Neoplasm Metastasis;neoplastic cell;novel;novel strategies;Pathway interactions;Patient Selection;Patients;PDL1 inhibitors;pharmacologic;Phenotype;Play;pre-clinical;preclinical study;predictive marker;Prognosis;Proteins;Recovery;Reporter;response;Role;Signal Pathway;Signal Transduction;single-cell RNA sequencing;small cell lung carcinoma;Specific qualifier value;Therapeutic;Therapeutic Agents;Therapeutic Effect;therapeutic target;transcriptomics;Transforming Growth Factor beta;Transforming Growth Factor-Beta Overexpression;Transgenic Organisms;treatment optimization;treatment response;treatment strategy;tumor;tumor microenvironment;tumor progression;Tumor Promotion;Tumor Suppressor Proteins;tumorigenesis;Work,Development of TGF-beta antagonists for cancer therapy,10881,NA,NA,NA,NA,17,NA,NA,768255,NA
11188018,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010885,NA,NA,1ZIABC010885-17,NCI:1373768\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6572342 (contact),"YARCHOAN, ROBERT  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Affect;AIDS related cancer;AIDS therapy;analog;Binding;Biology;Caspase;Cause of Death;CDK4 gene;Cell Line;Cells;Central Nervous System;Clinical Trials;constitutive expression;Cyclin-Dependent Kinases;cytokine;Development;Disease;DNA Viruses;Down-Regulation;effusion;Gene Activation;Genes;Herpesviridae Infections;Highly Active Antiretroviral Therapy;HIV;HIV therapy;Human Herpesvirus 4;Human Herpesvirus 8;Human T-lymphotropic virus 1;Immune;immune function;Immune response;immunoregulation;Infection;Inflammatory;inhibitor;Intercellular adhesion molecule 1;interest;Interleukin-10;Interleukin-6;Kaposi Sarcoma;Laboratory Study;Leptomeninges;Lesion;Lymphoma cell;Lytic;Malignant Neoplasms;Membrane Proteins;Morbidity - disease rate;mortality;Multicentric Angiofollicular Lymphoid Hyperplasia;nano-string;neoplastic cell;novel therapeutics;Oncogenic;Oxidative Stress;Pathogenesis;Pathway interactions;Patients;Persons;Pharmaceutical Preparations;Plasmablast;pomalidomide;prevent;primary effusion lymphoma;Proteins;Regulation;Research;response;Role;Serum;single cell sequencing;Stress;Surface;Symptoms;Syndrome;targeted treatment;Technology;Thalidomide;therapy development;tumor;tumorigenesis;Viral;Viral Load result;Virus;virus host interaction;Work,Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies,10885,NA,NA,NA,NA,17,NA,NA,1373768,NA
11188019,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010887,NA,NA,1ZIABC010887-17,NCI:1188833\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692197 (contact),"AMBS, STEFAN  (contact)",NA,NA,NA,Affect;African;African American;African American Women;African ancestry;African Women;Age;aggressive breast cancer;American;anti-tumor immune response;Architecture;ATAC-seq;Autopsy;Award;Biological;Biology;biomarker identification;Black race;Blood specimen;Body mass index;Breast;Breast Cancer cell line;Breast Cancer Patient;breast cancer progression;Breast Cancer Risk Factor;breast density;Cancer Biology;cancer health disparity;Cancer Research Project;cancer surgery;Cancerous;CCR;Cell Nucleus;cell type;Cells;Characteristics;Chromatin;Chronic;Chronic Disease;Chronic stress;Clinical;Clinical Research;clinically significant;cohort;Collaborations;comorbidity;Contracts;Cross-Sectional Studies;Crowns;Data;data pipeline;Data Set;deprivation;Development;Diabetes Mellitus;Diagnosis;Digestion;digital;digital pathology;Discrimination;Disease;Disease Outcome;Disparate;Division of Cancer Epidemiology and Genetics;DNA copy number;DNA Methylation;Environment;Environmental Exposure;Epigenetic Process;epigenome;Epithelial Cells;Epithelium;ethnic discrimination;Ethnic Origin;European;European ancestry;Excess Mortality;Exhibits;experience;Fibroblasts;Freezing;Gene Expression;Gene Expression Profile;Genes;Genetic;genome sequencing;genome-wide;health disparity;Heterogeneity;Hormonal;Human;Immune;Immune System Diseases;Immunologics;indexing;Inflammation;inflammatory marker;insight;Inter-tumoral heterogeneity;Investigation;Investments;Kenya;Laboratories;Link;Malignant Breast Neoplasm;Malignant Neoplasms;Mammary Gland Parenchyma;Mammary Neoplasms;Manuscripts;Maryland;Measures;metabolome;Methylation;methylation pattern;Minority Groups;Molecular;molecular subtypes;monocyte;multiple omics;Mutation;Myelogenous;Neighborhoods;neoplastic cell;novel;novel marker;Obesity;Operative Surgical Procedures;Oxidation-Reduction;Pathology;Pathway interactions;Patient-Focused Outcomes;Patients;Pattern;perceived stress;Pericytes;Policies;Population;Population Group;Predisposition;Premenopause;Process;Proteome;Protocols documentation;public health intervention;Publications;Publishing;Race;racial discrimination;Reproductive History;Research;Research Design;Research Personnel;Resolution;Resources;Risk Factors;Role;Schedule;Signal Transduction;single cell analysis;single nucleus RNA-sequencing;Social Environment;Social isolation;Social support;socioeconomic disadvantage;Stress;Stressful Event;stressor;Stromal Cells;Structure;Surveys;survival outcome;System;systemic inflammatory response;T-Lymphocyte;targeted treatment;Technology;Tissue Banks;Tissue Sample;Tissues;transcription factor;transcriptome sequencing;transcriptomic profiling;transcriptomics;triple-negative invasive breast carcinoma;tumor;Tumor Biology;Tumor Markers;Tumor Suppressor Genes;Tumor Tissue;tumor-immune system interactions;Validation;Woman,Novel Markers for Disease Outcome in Breast Cancer,10887,NA,NA,NA,NA,17,NA,NA,1188833,NA
11188020,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010888,NA,NA,1ZIABC010888-17,NCI:1675326\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6572342 (contact),"YARCHOAN, ROBERT  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;AIDS related cancer;AIDS-Related Lymphoma;Antibodies;B-Cell Lymphomas;cancer immunotherapy;CDK4 gene;Central Nervous System Lymphoma;chemotherapy;Clinical Research;Clinical Trials;Collaborations;Conduct Clinical Trials;cytokine;Data;Development;Diagnosis;Disease;Disease Progression;Down-Regulation;feasibility trial;follow-up;Ganciclovir;Herpesviridae;HIV;HIV Infections;HIV Seronegativity;HIV therapy;Human Herpesvirus 8;IL7 gene;Immunotherapy;immunotherapy trials;In Vitro;Infection;Inflammatory;inhibitor;Interleukin-12;Kaposi Sarcoma;lenalidomide;Liposomal Doxorubicin;Malignant Neoplasms;Monitor;Monoclonal Antibodies;Multicentric Angiofollicular Lymphoid Hyperplasia;Natural History;Nivolumab;novel therapeutics;Pathogenesis;patient subsets;Patients;PD-1 inhibitors;pembrolizumab;Pharmaceutical Preparations;Phase;pomalidomide;prevent;primary effusion lymphoma;Process;Prodrugs;Protocols documentation;receptor;Relapse;Research Personnel;response;rituximab;Sarcoma;Surface Antigens;Syndrome;Testing;tocilizumab;tool;translational study;tumor;United States Food and Drug Administration;Valganciclovir;Virus;Work;Zidovudine,Clinical Trials of Patients with AIDS-Related Malignancies,10888,NA,NA,NA,NA,17,NA,NA,1675326,NA
11188021,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010891,NA,NA,1ZIABC010891-17,NCI:1761905\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692203 (contact),"HO, MITCHELL  (contact)",NA,NA,NA,Animal Model;anti-cancer research;Antibodies;antibody engineering;anticancer activity;Antigen Targeting;Antigens;Antineoplastic Agents;B lymphoid malignancy;Bioluminescence;Biomedical Engineering;Camels;Cancer Biology;Cancer Family;cancer imaging;cancer immunotherapy;Cancer Patient;cancer therapy;CAR T cell therapy;CCR;CD276 gene;Cell surface;Cell Surface Proteins;Cell Therapy;Cells;chimeric antigen receptor T cells;Clinical;clinical center;Clinical Investigator;Clinical Trials;Collaborations;Combined Modality Therapy;Communication;Cooperative Research and Development Agreement;Coupled;density;design;Development;Disease;Disease remission;Dromedaries;drug development;Engineering;Engraftment;Epitopes;Event;exhaustion;Exhibits;extracellular;Female;Flow Cytometry;Funding;Gene Activation;Generations;Genes;Glypican;GPC3 gene;GPI Membrane Anchors;Heparan Sulfate Proteoglycan;hepatocellular carcinoma cell line;Human;IL7 gene;Immunization;immunogenic;Immunophenotyping;Immunotherapeutic agent;Immunotherapy;improved;in vivo;Infiltration;Integral Membrane Protein;Interleukin 7 Receptor;Interleukin-2;Intramural Research Program;Journals;Laboratories;liver cancer model;Lymphocyte Activation;Malignant Childhood Neoplasm;Malignant mesothelioma;Malignant neoplasm of liver;Malignant neoplasm of ovary;Malignant neoplasm of pancreas;Malignant Neoplasms;Measurement;Mediating;Membrane;Memory;mesothelin;Mesothelioma;Modeling;Molecular Biology;Monitor;Mus;nanobodies;National Cancer Institute;Nature;Neuroblastoma;novel;novel anticancer drug;Paper;Pathway interactions;Patients;Pediatric Neoplasm;Phage Display;Primary carcinoma of the liver cells;programmed cell death protein 1;programs;Proteomics;Publishing;rational design;receptor expression;Research;Resources;Role;Signal Pathway;Signal Transduction;Signal Transduction Pathway;Signaling Molecule;Site;Solid Neoplasm;Stat5 protein;stemness;syndecan;T-Cell Activation;T-Lymphocyte;Technology;Testing;Therapeutic;Therapeutic antibodies;therapeutic target;transcriptome;transcriptome sequencing;tumor;Tumor Antigens;Tumor Volume;tumor xenograft;United States National Institutes of Health;Western Blotting;Work,Development of antibody engineering-based cancer therapies,10891,NA,NA,NA,NA,17,NA,NA,1761905,NA
11188022,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010898,NA,NA,1ZIABC010898-17,NCI:735236\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692213 (contact),"WINK, DAVID  (contact)",NA,NA,NA,4T1;Acute;Alzheimer&apos;s Disease;angiogenesis;Animal Model;Area;Biological;Cancerous;carcinogenesis;Cell Communication;cell type;Cells;Chemicals;Chronic;Clinical;Combined Modality Therapy;conventional therapy;cytokine;Dendritic Cells;Disease;epidemiology study;Generations;Growth;HIF1A gene;Immune;Immune signaling;immunomodulatory therapies;immunoregulation;Immunotherapy;improved;In Situ;Inflammation;Inflammation Process;inhibitor;Interleukin-10;Link;Malignant Breast Neoplasm;Malignant Neoplasms;Microglia;MMP9 gene;Modification;Molecular;Neoplasm Metastasis;NG-Nitroarginine Methyl Ester;Nitric Oxide;Nitric Oxide Synthase;Nitric Oxide Synthetase Inhibitor;novel marker;novel therapeutics;Outcome;Oxidation-Reduction;Peptide Hydrolases;Play;Primary Neoplasm;Process;Prognosis;programmed cell death ligand 1;programs;Proteins;Radiation;Radiation therapy;Regulation;Research;response;restoration;Role;small molecule;Testing;Therapeutic;therapy outcome;Thrombospondin 1;TIMP1 gene;Tissue Inhibitor of Metalloproteinase-1;TNFRSF5 gene;TP53 gene;Transforming Growth Factor beta;Treatment Efficacy;triple-negative invasive breast carcinoma;tumor;wound healing,Redox Mechanism Process of Angiogenesis and Wound Healing,10898,NA,NA,NA,NA,17,NA,NA,735236,NA
11188023,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010899,NA,NA,1ZIABC010899-17,NCI:367619\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692213 (contact),"WINK, DAVID  (contact)",NA,NA,NA,Agonist;Antioxidants;Biological Markers;cancer therapy;cancer type;Cessation of life;chemotherapy;Development;Dithiolthione;Goals;Immunomodulators;Inflammation;Inflammatory;Inflammatory Response;inhibitor;kinase inhibitor;Malignant Breast Neoplasm;Metabolic;Modeling;Myocardial Infarction;Non-Steroidal Anti-Inflammatory Agents;novel;novel therapeutics;Nucleoside Diphosphate Kinase A;Oncogenic;Oxidation-Reduction;Pathway interactions;persulfides;Pharmaceutical Preparations;phosphatase inhibitor;Phosphoric Monoester Hydrolases;prevent;Prevention;Property;Protein Phosphatase 2A Regulatory Subunit PR53;Radiation therapy;Risk;Set protein;side effect;Stroke;Testing;Therapeutic;tumor;Tumor Suppressor Proteins;Ulcer;Work,Inflammation and cancer treatment,10899,NA,NA,NA,NA,17,NA,NA,367619,NA
11188024,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010937,NA,NA,1ZIABC010937-17,NCI:2057118\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10270286 (contact),"PALENA, CLAUDIA  (contact)",NA,NA,NA,Adenocarcinoma;Advanced Malignant Neoplasm;androgen deprivation therapy;androgen independent prostate cancer;Androgen Receptor;antagonist;cancer cell;Cancer Etiology;Carcinoma;Castration;Cell Adhesion;Cell Death Induction;cell motility;Cell Nucleus;Cells;Cessation of life;chemotherapy;Clinical;Cytolysis;Data;Diagnosis;Dimerization;Disease Progression;effector T cell;enzalutamide;Epithelial Cells;Epithelium;Estrogen Receptors;experience;Fulvestrant;Future;Glucocorticoid Receptor;Goals;hormone receptor-positive;Immune;Immunotherapy;In Vitro;in vivo;Invaded;Investigation;Laboratories;Link;Malignant neoplasm of prostate;Malignant Neoplasms;Mediating;men;Mesenchymal;Metastatic breast cancer;Modality;Motility;N-Cadherin;Natural Killer Cells;neoplastic cell;Neuroendocrine Prostate Cancer;novel;novel therapeutic intervention;Nude Mice;overexpression;Patients;pharmacologic;Phenotype;Postmenopause;Predisposition;prevent;prostate cancer cell;prostate cancer model;Prostate Cancer therapy;Radiation;Receptor Signaling;Reducing Agents;Resistance;resistance mechanism;response;Role;targeted treatment;Therapeutic;Time;transcriptome sequencing;tumor;Up-Regulation;Vimentin;Woman;Xenograft procedure,Novel Targets for Immunotherapy,10937,NA,NA,NA,NA,17,NA,NA,2057118,NA
11188025,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010944,NA,NA,1ZIABC010944-17,NCI:4095431\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,2407138 (contact),"SCHLOM, JEFFREY  (contact)",NA,NA,NA,Adenoviruses;Agonist;anti-PD-1;anti-PD-L1;Antibodies;antigen processing;Antigen-Presenting Cells;arm;biomarker signature;Bypass;cancer immunotherapy;Cancer Patient;cancer type;Carcinoma;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;CD8B1 gene;Cells;Cervix Neoplasms;chemokine;Clinical;Clinical Trials;Colon Carcinoma;Combined Modality Therapy;CXCL13 gene;cytokine;Cytolysis;cytotoxic CD8 T cells;Cytotoxic T-Lymphocytes;Data Set;design;Development;docetaxel;Enhancers;Epigenetic Process;Epitopes;Evaluation;Extracellular Matrix;Goals;Gorilla gorilla;Histone Deacetylase Inhibitor;Human;Human papilloma virus infection;Human Papilloma Virus Vaccine;Human Papilloma Virus-Related Malignant Neoplasm;Human Papillomavirus;Human papillomavirus 16;humanized mouse;Immune;immune checkpoint blockade;Immune response;Immune system;immunogenic;Immunotherapeutic agent;Immunotherapy;Impairment;Infiltration;Interferon Type II;Interferons;Interleukin-12;Janus kinase;Ligands;Lung;Macrophage;Major Histocompatibility Complex;Malignant Neoplasms;Mammary Neoplasms;Mediating;Modeling;Monitor;Mus;Mutation;Myelogenous;Necrosis;neoplastic cell;neutrophil;novel therapeutics;Oncoproteins;Pathway interactions;Patients;Pattern;Peptides;Peripheral Blood Mononuclear Cell;Persons;Phase;Phenotype;Play;pre-clinical;Pre-Clinical Model;preclinical study;Predisposition;prevent;Preventive vaccine;programmed cell death ligand 1;programs;Proteome;Recombinants;Refractory;Regulatory T-Lymphocyte;Resistance;response;Role;Sarcoma;Signal Transduction;Solid;Solid Neoplasm;Spleen;STAT protein;success;synergism;T-Lymphocyte;T-Lymphocyte Epitopes;targeted delivery;The Cancer Genome Atlas;Therapeutic;Therapeutic Intervention;transcriptome;transcriptomics;Transforming Growth Factor beta;tumor;Tumor Cell Necrosis;tumor eradication;tumor microenvironment;Tumor Volume;Tumor Weights;United States;Up-Regulation;Vaccines;Viral,Strategies for Cancer Immunotherapy Development: Preclinical Studies,10944,NA,NA,NA,NA,17,NA,NA,4095431,NA
11188026,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010946,NA,NA,1ZIABC010946-17,NCI:752709\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692291 (contact),"MITCHELL, JAMES  (contact)",NA,NA,NA,Acute;Awareness;Biological Markers;cancer risk;carcinogenesis;Chronic;Data;Diet;dosimetry;effective intervention;Evaluation;exposed human population;Exposure to;extend lifespan;External Beam Radiation Therapy;Face;FDA approved;FRAP1 gene;Funding;Government Agencies;Human;Intensity-Modulated Radiotherapy;interest;Journals;Life;life span;Malignant Neoplasms;Mediating;Monitor;Mus;Normal tissue morphology;Nuclear Warfare;Patients;Persons;Pharmaceutical Preparations;Population;Primary carcinoma of the liver cells;Process;Publishing;Radiation;Radiation Dose Unit;Radiation Injuries;Radiation Oncology;Radiation Protection;Radiation therapy;Radiation-Protective Agents;Reagent;Research;Risk;Second Primary Neoplasms;Sirolimus;stem;Survivors;tempol;Time;tumor;tumorigenesis;Weight;Whole-Body Irradiation,Protection against Radiation-Induced Carcinogenesis,10946,NA,NA,NA,NA,17,NA,NA,752709,NA
11188027,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010958,NA,NA,1ZIABC010958-17,NCI:556135\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692315 (contact),"DAAR, IRA  (contact)",NA,NA,NA,Adhesions;Affect;angiogenesis;Apical;autism spectrum disorder;Binding;Biochemical;Biological Models;Breast;Cancer cell line;Cell Adhesion;Cell Fate Control;Cell Line;Cell Lineage;Cell membrane;cell motility;Cell Physiology;Cell-Cell Adhesion;Cells;Cephalic;Colon;Complex;Contact Inhibition;Data;Defect;Development;Developmental Process;Disease;Disseminated Malignant Neoplasm;Distal;E-Cadherin;Embryo;Embryonic Development;Endosomes;Environment;Eph Family Receptors;Ephrins;Epithelial Cells;Event;experimental study;Family;Family member;flotillin;gene product;GTPase-Activating Proteins;Histologic;Human;improved;insight;Intercellular Junctions;interest;Invaded;Investigation;Laboratories;Ligands;Locomotion;loss of function;Lung;Malignant Neoplasms;Maps;Mediating;Melanoma;member;Membrane;Metalloproteases;migration;Morphogenesis;Morphology;Motility;Movement;mutant;Neoplasm Metastasis;neoplastic;Neural Crest;Neural Crest Cell;Neural tube;Neural Tube Closure;Neuroblastoma;novel;Ovarian;Pathway interactions;planar cell polarity;Play;Predisposition;Process;Prosencephalon;Prostate;Proteins;rab11 protein;Rana;receptor;Receptor Protein-Tyrosine Kinases;Recycling;Research;retinal progenitor cell;Role;scaffold;Signal Pathway;Signal Transduction;Signal Transduction Pathway;Signaling Molecule;System;Telencephalon;Tissues;tumorigenesis;Tyrosine Phosphorylation;Visual Fields;Xenopus;Xenopus oocyte,"Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion",10958,NA,NA,NA,NA,17,NA,NA,556135,NA
11188028,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010959,NA,NA,1ZIABC010959-17,NCI:1847578\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6569413 (contact),"NUSSENZWEIG, ANDRE A. (contact)",NA,NA,NA,Age related pathologies;Amino Acids;Ataxia;Ataxia Telangiectasia;ataxia telangiectasia mutated protein;ataxia-telangiectasia like disorder;Bacterial Artificial Chromosomes;Cancer Etiology;cancer predisposition;Characteristics;Chromosomal Instability;Chromosomal translocation;Chromosome Deletion;Complex;Defect;Derivation procedure;Detection;Disease;DNA;DNA Damage;DNA Double Strand Break;DNA Repair;Double Strand Break Repair;Event;Genes;Genome Stability;Genomic Instability;Hereditary Malignant Neoplasm;Human;humanized mouse;Immune System Diseases;immune system function;immunodeficiency;improved;in vivo;Individual;Infertility;Inherited;insight;Meiotic Recombination;mouse model;Mus;Mutate;Mutation;Nijmegen Breakage Syndrome;null mutation;Phenotype;Phosphorylation;Predisposition;Radiation Tolerance;reconstitution;recruit;Research Proposals;response;Series;Signal Transduction;Syndrome;tissue degeneration;Transgenic Mice;transmission process;Tumor Suppression,Relationship between DNA damage detection and signaling,10959,NA,NA,NA,NA,17,NA,NA,1847578,NA
11188029,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010975,NA,NA,1ZIABC010975-17,NCI:908412\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692343 (contact),"HODGE, JAMES  (contact)",NA,NA,NA,Adoptive Cell Transfers;Antitumor Response;cell killing;Cell Line;Cellular Stress;Cervix Carcinoma;Cessation of life;chelation;chemotherapy;Cisplatin;clinically relevant;Colorectal Cancer;Cytolysis;External Beam Radiation Therapy;Gamma Rays;Goals;Head and Neck Squamous Cell Carcinoma;Human;Human Papilloma Virus-Related Malignant Neoplasm;Human Papillomavirus;Human papillomavirus 16;immunogenic;In Vitro;Label;Low Dose Radiation;Malignant neoplasm of lung;Malignant neoplasm of ovary;Malignant Neoplasms;Mediating;Modeling;Monoclonal Antibodies;neoplastic cell;novel;Phenotype;Pre-Clinical Model;preclinical study;Predisposition;Prostate Cancer therapy;Radiation;Radiation Dose Unit;Radio;radio frequency;Radioisotopes;receptor;Reporting;retroviral transduction;Source;Squamous cell carcinoma;standard of care;Surface;System;T-Cell Receptor;T-Lymphocyte;therapeutic HPV vaccine;thermal stress;TNFRSF10B gene;tumor;Vaccine Therapy;Vaccines,Vaccine and radiation for the therapy of human cancers,10975,NA,NA,NA,NA,17,NA,NA,908412,NA
11188030,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010977,NA,NA,1ZIABC010977-17,NCI:796950\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14821366 (contact),"LIPKOWITZ, STANLEY  (contact)",NA,NA,NA,Biochemical;cancer cell;Carcinoma;CBL Protein;Clinical;Collaborations;Complex;Down-Regulation;Epidermal Growth Factor Receptor;Epithelium;ERBB2 gene;Human;inhibitor;Investigation;Laboratories;Malignant Neoplasms;Mammalian Cell;Mediating;member;Mus;mutant;Mutation;overexpression;Pathogenesis;Protein Family;Protein Tyrosine Kinase;Proteins;Receptor Protein-Tyrosine Kinases;Regulation;Research Personnel;Ring Finger Domain;Signal Pathway;Signal Transduction;Structure;trafficking;tumor;ubiquitin-protein ligase;Ubiquitination;Work,Cbl Proteins as Regulators of Tyrosine Kinase Signaling,10977,NA,NA,NA,NA,17,NA,NA,796950,NA
11188031,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010982,NA,NA,1ZIABC010982-17,NCI:623811\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692357 (contact),"APLAN, PETER  (contact)",NA,NA,NA,3&apos; Untranslated Regions;ABCB1 gene;ABL1 gene;Acute leukemia;acute T-cell lymphoblastic leukemia cell;Alleles;Animal Model;Apoptosis;B-Cell Leukemia;B-Lymphocytes;Candidate Disease Gene;Cell Line;cell type;Cells;Chemoresistance;Clinical;Collaborations;Complex;CRISPR screen;Cytarabine;Cytidine;DCK gene;DHFR gene;DNA biosynthesis;DNA replication fork;DNA Resequencing;DNMT3a;Epigenetic Process;Etoposide;exome sequencing;experimental study;Gene Dosage;Gene Expression Profile;Generations;Genes;Genetic;Genetically Engineered Mouse;Genets;Genomic DNA;Growth;helicase;Hematopoietic stem cells;Human;human disease;Immunophenotyping;Impairment;In Vitro;in vivo;Insertional Mutagenesis;Knock-in;Length;leukemia;leukemia/lymphoma;leukemic transformation;Licensing Factor;Ligands;Loss of Heterozygosity;Lymphoblastic Leukemia;Lymphoma;Maintenance;Malignant Neoplasms;Manuscripts;Methotrexate;Modeling;Mouse Strains;Mus;Mutate;Mutation;Myelogenous;NOTCH1 gene;novel;novel strategies;NUP214 gene;NUP98 gene;Pathway interactions;Pattern;Phenotype;Phosphorylation;Phosphotransferases;Prednisone;Preparation;Proliferating;Proteins;PTPN1 gene;Publishing;Recurrence;Reporting;Resistance;retroviral transduction;RNA Splicing;Sampling;small hairpin RNA;stem;stem cell self renewal;T-Cell Leukemia;T-Lymphocyte;TCF3 gene;thymocyte;TOP1 gene;Transgenes;Tumor Suppressor Genes;Vincristine;whole genome,Collaborative Pathways that Lead to Leukemia,10982,NA,NA,NA,NA,17,NA,NA,623811,NA
11188032,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010983,NA,NA,1ZIABC010983-17,NCI:623811\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692357 (contact),"APLAN, PETER  (contact)",NA,NA,NA,Angiogenesis Inhibitors;Apoptosis Inhibitor;Bone Marrow Transplantation;Cell Line;Cell Therapy;Cells;Collaborations;conditioning;Cooperative Research and Development Agreement;Disease;DNA;DNA Methyltransferase Inhibitor;Dysmyelopoietic Syndromes;effective therapy;efficacy evaluation;Engraftment;experimental study;FDA approved;Graft-Versus-Tumor Induction;Hematopoiesis;Hematopoietic;Hematopoietic stem cells;Histocompatibility;Histone Deacetylase Inhibitor;human disease;IL8RA gene;In Vitro;in vivo;Industry;inhibitor;Institution;Ionizing radiation;kinase inhibitor;Licensing;Manuscripts;MCL1 gene;Minor;Modeling;mouse model;Mus;novel;novel therapeutics;NUP98 gene;Pharmacologic Substance;pre-clinical;pre-clinical assessment;Pre-Clinical Model;preclinical efficacy;preclinical study;Prediction of Response to Therapy;Preparation;Proteins;Publishing;Research Personnel;Role;small molecule;Transgenes;Transplantation;Wild Type Mouse;Xenograft Model,Pre-clinical Studies of Therapy for Myelodysplastic Syndrome,10983,NA,NA,NA,NA,17,NA,NA,623811,NA
11188033,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010984,NA,NA,1ZIABC010984-17,NCI:4725194\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692361 (contact),"ROSENBERG, STEVEN  (contact)",NA,NA,NA,Adoptive Cell Transfers;Animal Experiments;Antigens;antitumor effect;Antitumor Response;Autologous;autologous lymphocytes;Autologous Tumor-Infiltrating Lymphocyte;Avidity;bile duct;Bile Duct Carcinoma;Breast;Breast Cancer Patient;Cancer Etiology;cancer immunotherapy;Cancer Patient;cancer regression;cancer therapy;cancer type;Carcinoma;Cell Physiology;Cells;Cervix Uteri;Cessation of life;Clinical Research;Colon;Colorectal;Development;Disease;Disseminated Malignant Neoplasm;Environment;Environmental Monitoring;Esophagus;Evaluation;Exhibits;exome;follow-up;Genes;Human;Immune;immunogenic;Immunologic Tests;Immunotherapy;In Vitro;in vitro testing;in vivo;Infusion procedures;Interleukin-2;KRAS2 gene;Laboratories;Laboratory Research;Laboratory Study;Lymphocyte;Malignant Breast Neoplasm;Malignant neoplasm of cervix uteri;Malignant neoplasm of lung;Malignant neoplasm of ovary;Malignant neoplasm of pancreas;Malignant Neoplasms;malignant stomach neoplasm;Mediating;Melanoma;Melanoma patient;Metastatic breast cancer;Metastatic Melanoma;Mus;Mutation;neoantigens;novel strategies;objective response rate;Operative Surgical Procedures;Patient Selection;Patients;pembrolizumab;Peripheral;personalized immunotherapy;Phenotype;phenotypic biomarker;pilot trial;Population;Production;Protocols documentation;Refractory;Renal Carcinoma;Resected;response;Series;Solid Neoplasm;Somatic Mutation;stem;T-Cell Receptor;T-Lymphocyte;TP53 gene;transcriptome sequencing;Translations;tumor;Tumor Antigens;Tumor-Infiltrating Lymphocytes,Adoptive Cell Transfer Immunotherapy of Cancer,10984,NA,NA,NA,NA,17,NA,NA,4725194,NA
11188034,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010985,NA,NA,1ZIABC010985-17,NCI:4725194\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692361 (contact),"ROSENBERG, STEVEN  (contact)",NA,NA,NA,Adoptive Transfer;Antigens;Autologous;autologous lymphocytes;B lymphoid malignancy;Cancer Patient;cancer regression;cancer therapy;cancer/testis antigen;Carcinoma;CD19 gene;Cells;cellular transduction;chimeric antigen receptor;Clinical;Clinical Research;Clinical Trials;CTAG1 gene;Development;epidermal growth factor receptor VIII;Epitopes;Gene Library;Gene Modified;gene therapy;Gene Transfer;Genes;Genetic Markers;genetic signature;Germ;Glioblastoma;Human;Immunotherapy;improved;In complete remission;Individual;Inpatients;Kanamycin Kinase;KRAS2 gene;KRASG12D;Laboratories;large cell Diffuse non-Hodgkin&apos;s lymphoma;Lymphocyte;MAGEA3 gene;Malignant Neoplasms;Mediating;Melanoma;Melanoma patient;Metastatic Melanoma;MHC antigen;Mutation;neoantigens;novel strategies;Patients;prospective;receptor;Reporting;Resected;response;SILV gene;Solid;Somatic Mutation;stem-like cell;Surface Antigens;synovial sarcoma;T-Cell Receptor;T-Cell Receptor Genes;T-Lymphocyte;TP53 gene;transcriptome;tumor;Tumor Antigens,Gene therapy of cancer,10985,NA,NA,NA,NA,17,NA,NA,4725194,NA
11188035,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010998,NA,NA,1ZIABC010998-17,NCI:689217\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692453 (contact),"KHAN, JAVED  (contact)",NA,NA,NA,Adoptive Cell Transfers;advanced disease;Antigen Targeting;Antigens;BAY 54-9085;Biological Assay;Calcitonin;CAR T cell therapy;CD276 gene;Cell secretion;Cellular Indexing of Transcriptomes and Epitopes by Sequencing;chimeric antigen receptor;chimeric antigen receptor T cells;Clinical Trials;clinically relevant;Clustered Regularly Interspaced Short Palindromic Repeats;cytotoxicity;Disease;Drug resistance;drug resistance development;Epidermal Growth Factor Receptor;Epigenetic Process;European;exhaustion;exome;Gefitinib;Germ Lines;Glypican;Goals;Imatinib;Immunotherapy;Inherited;inhibitor;KDR gene;Knock-out;Malignant Epithelial Cell;Malignant neoplasm of thyroid;Malignant Neoplasms;Medicine;medullary thyroid carcinoma;Methods;Modeling;Mutation;Neoplasm Metastasis;Neuroblastoma;neuroendocrine cancer;next generation sequencing;novel therapeutics;Operative Surgical Procedures;patient subsets;Patients;Pharmacotherapy;Phase III Clinical Trials;Phosphotransferases;prevent;Protein Tyrosine Kinase;Proteins;Proto-Oncogenes;Resistance;Resistance development;resistance mechanism;Rhabdomyosarcoma;side effect;Signal Transduction;single-cell RNA sequencing;small molecule inhibitor;Solid Neoplasm;standard care;Survival Rate;T-Lymphocyte;targeted treatment;Testing;therapy resistant;Thyroidectomy;transcriptome;transcriptome sequencing;Tumor Antigens;Tyrosine Kinase Inhibitor;United States Food and Drug Administration,Therapy Resistance Mechanisms for Cancer,10998,NA,NA,NA,NA,17,NA,NA,689217,NA
11188036,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC010999,NA,NA,1ZIABC010999-17,NCI:1378435\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692453 (contact),"KHAN, JAVED  (contact)",NA,NA,NA,Antibodies;Antibody-drug conjugates;ATAC-seq;Binding;Biological Assay;Biophysics;cancer genomics;CAR T cell therapy;CD276 gene;CD28 gene;CD8B1 gene;Cell Line;Cells;chimeric antigen receptor;chimeric antigen receptor T cells;Clinical Trials Design;Credentialing;cytokine;cytotoxicity;Development;Docking;effective therapy;efficacy testing;Engineering;Epigenetic Process;Exhibits;Face;fibroblast growth factor receptor 4;FOXO1A gene;Generations;Genes;Genetic;Genetic Transcription;Goals;Growth;Histones;Human;improved;In Vitro;in vivo;inhibiting antibody;inhibitor;KDM1A gene;knock-down;Lysine;Malignant Neoplasms;Modeling;Molecular;Monitor;Monoclonal Antibodies;mouse model;murine monoclonal antibody;Mutate;Mutation;Oncogenes;Oncogenic;Pathway interactions;PAX3 gene;pediatric patients;personalized cancer therapy;Phase I Clinical Trials;Phenocopy;Production;Reagent;Receptor Protein-Tyrosine Kinases;Refractory;Relapse;Rhabdomyosarcoma;small molecule inhibitor;Solubility;Specificity;targeted treatment;Testing;Therapeutic;Tissues;transcription factor;transcriptome sequencing;Transmembrane Domain;treatment strategy;tumor;Tumor Cell Line;Xenograft Model,"Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma",10999,NA,NA,NA,NA,17,NA,NA,1378435,NA
11188037,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011002,NA,NA,1ZIABC011002-17,NCI:1148695\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692453 (contact),"KHAN, JAVED  (contact)",NA,NA,NA,Alveolar;Artificial Intelligence;Attention;Behavior;Bioinformatics;Biological;Biology;Cancer Biology;Classification;Clinical;clinical risk;Clinical Trials Cooperative Group;Complex;convolutional neural network;Data;Data Set;deep learning;Diagnosis;diagnostic tool;digital;Disease-Free Survival;DNA analysis;DNA copy number;driver mutation;epigenetic profiling;Event;FOXO1A gene;fusion gene;Future;Genetic;Genetic Transcription;genome wide methylation;Germ Lines;Goals;Hematoxylin and Eosin Staining Method;high risk;Histologic;Image;improved;large language model;Lead;Learning;Link;Machine Learning;Malignant Childhood Neoplasm;Malignant Neoplasms;Maps;mathematical model;Messenger RNA;Methods;Modeling;Molecular;Morphology;multimodality;Mutation;Neural Network Simulation;Outcome;participant enrollment;Pathway interactions;Patients;PAX3 gene;Pediatric Oncology Group;Performance;Phenotype;predictive modeling;Process;Prognosis;prognostic tool;prospective;protein expression;Proteins;Proteomics;Publishing;Receiver Operating Characteristics;Rhabdomyosarcoma;Risk;risk prediction;risk prediction model;risk stratification;Role;Sampling;single-cell RNA sequencing;Slide;Systems Biology;Techniques;Testing;Time;TP53 gene;Training;transcriptomics;tumor;tumor diagnostic;tumor DNA,"Bioinformatics, Machine Learning, Systems Biology of Cancers",11002,NA,NA,NA,NA,17,NA,NA,1148695,NA
11188038,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011006,NA,NA,1ZIABC011006-17,NCI:1454350\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692409 (contact),"STAUDT, LOUIS  (contact)",NA,NA,NA,BCL2 gene;Behavior;biological heterogeneity;Cell Line;Cells;chemotherapy;Classification;Clinical;clinical practice;Clinical Research;Diagnosis;diagnostic platform;Drug Combinations;Drug Targeting;Evaluation;Formalin;Gene Expression;Gene Expression Profile;Genetic;genomic platform;Genomics;Goals;Human;Immuno-Chemotherapy;improved;insight;Investigation;Laboratories;large cell Diffuse non-Hodgkin&apos;s lymphoma;Length;lymphoid neoplasm;Lymphoma;Malignant lymphoid neoplasm;Molecular;Molecular Diagnosis;Molecular Profiling;molecular subtypes;Mutation;Oncogenic;Other Genetics;Outcome;outcome prediction;overexpression;Paraffin Embedding;Pathogenesis;Pathway interactions;Patients;Phenotype;Pre-Clinical Model;predicting response;Predisposition;Progression-Free Survivals;Recurrence;Regimen;response;Signal Transduction;Somatic Mutation;targeted agent;Testing;therapeutic target;Tissue Embedding;Toxic effect;Translating;tumor microenvironment,Molecular diagnosis and outcome prediction in lymphoma,11006,NA,NA,NA,NA,17,NA,NA,1454350,NA
11188039,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011007,NA,NA,1ZIABC011007-17,NCI:1454350\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692409 (contact),"STAUDT, LOUIS  (contact)",NA,NA,NA,Address;Antibody-drug conjugates;Autophagocytosis;Binding;cancer cell;cancer survival;cancer type;CD22 gene;Cell membrane;Chronic;Clinical Trials;Clustered Regularly Interspaced Short Palindromic Repeats;CRISPR screen;CRISPR/Cas technology;Dependence;Dose;Drops;Drug Targeting;Enzymes;Essential Genes;functional genomics;Genes;Genetic;Genetic Screening;Genomic approach;Genomics;Glucocorticoid Receptor;Glucocorticoids;glycosylation;Growth;Head;improved;inhibitor;Laboratories;large cell Diffuse non-Hodgkin&apos;s lymphoma;Libraries;Link;loss of function;Lymphoid;Lymphoma;Malignant Neoplasms;Mediating;Methodology;Modeling;Molecular Abnormality;Molecular Target;molecular targeted therapies;mutant;new therapeutic target;Newly Diagnosed;novel;Oncogenic;Pathway interactions;Pharmaceutical Preparations;Proliferating;Protein Isoforms;Proteomics;Publishing;Regimen;Regulatory Pathway;Reporting;Resistance;Retroviral Vector;RNA Interference;Role;Sialyltransferases;Signal Pathway;Signal Transduction;small hairpin RNA;src-Family Kinases;superresolution microscopy;System;Taxonomy;Testing;Therapeutic;therapy resistant;Toxic effect;whole genome;Xenograft procedure,Functional genomic screens for molecular targets in cancer,11007,NA,NA,NA,NA,17,NA,NA,1454350,NA
11188040,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011008,NA,NA,1ZIABC011008-17,NCI:1454350\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692409 (contact),"STAUDT, LOUIS  (contact)",NA,NA,NA,Address;Antibody-drug conjugates;Autophagocytosis;Binding;cancer cell;Candidate Disease Gene;CD22 gene;Cell membrane;Chronic;Clinical Trials;comparative genomic hybridization;Conduct Clinical Trials;Coupled;Credentialing;CRISPR screen;CRISPR/Cas technology;data integration;DNA Resequencing;Drug Targeting;Enzymes;Epigenetic Process;Gene Expression Profiling;Genes;Genetic;Genetic Screening;Genomics;Glucocorticoid Receptor;Glucocorticoids;glycosylation;Goals;Growth;Head;Human;improved;inhibitor;Knowledge;Laboratories;large cell Diffuse non-Hodgkin&apos;s lymphoma;Link;Lymphoid;Lymphoma;Lymphoma cell;Malignant Neoplasms;Methods;Molecular;Molecular Target;mutant;new therapeutic target;Newly Diagnosed;novel;Oncogenes;Oncogenic;Pharmaceutical Preparations;Proliferating;Protein Isoforms;Proteomics;Publishing;Recurrence;Regimen;Regulatory Pathway;Reporting;Resistance;RNA Interference;Role;Sampling;Sialyltransferases;Signal Transduction;Somatic Mutation;src-Family Kinases;superresolution microscopy;targeted agent;targeted treatment;Testing;Therapeutic;therapeutic development;Tumor Suppressor Proteins;Xenograft procedure,Oncogenic mechanisms and molecular targets in lymphoma,11008,NA,NA,NA,NA,17,NA,NA,1454350,NA
11188041,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011011,NA,NA,1ZIABC011011-17,NCI:1162855\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692465 (contact),"LEVENS, DAVID L. (contact)",NA,NA,NA,base;Base Sequence;Binding Sites;Biochemical;Biological;Biophysics;c-myc Genes;Cell Nucleus;Cells;chemotherapeutic agent;Chromatin;Chromatin Structure;computer infrastructure;Coupling;Development;DNA;DNA Probes;DNA Repair;DNA Structure;DNA-Directed RNA Polymerase;druggable target;electrical potential;Elements;enzyme activity;Exposure to;Fiber;flexibility;Gene Expression Regulation;Genes;Genetic;Genetic Processes;Genetic Recombination;genetic regulatory protein;Genetic Transcription;Genome;Genome Mappings;genome-wide;H-DNA;in vivo;Individual;Knowledge;Left;Literature;Malignant Neoplasms;Maps;Measures;mechanical force;Mechanics;Medical;melting;meter;Methods;Modification;Molecular Conformation;Molecular Machines;nanopore;neural network;novel strategies;Nucleic Acids;Oncogenes;Other Genetics;Pathologic;Pattern;Penetration;permanganate;Physiological;Population;Potassium Permanganate;Predisposition;Process;promoter;Regulatory Element;Relaxation;Resolution;Role;Signal Transduction;single molecule;Single-Stranded DNA;Site;Stress;Stretching;Structure;Topoisomerase;Topoisomerase Inhibitors;Torque;Transcription Process;transmission process;virtual;whole genome;Work;Z-Form DNA,The genome-wide function of supercoiling and alternative DNA conformations,11011,NA,NA,NA,NA,17,NA,NA,1162855,NA
11188042,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011028,NA,NA,1ZIABC011028-17,NCI:1563629\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,2093160 (contact),"LINEHAN, WILLIAM MARSTON (contact)",NA,NA,NA,Adrenal Gland Neoplasms;Adrenal Glands;Affect;American;Bilateral;Blood Tests;Brain Neoplasms;cancer type;Chromosome 17;Chromosome 3;Chromosome 7;Chromosome Arm;Chromosome Mapping;Clear Cell;Clinical;clinical diagnosis;Clinical Management;Clinical Research;Clinical Trials;Complex;Conventional (Clear Cell) Renal Cell Carcinoma;Cytogenetics;Defect;design;Detection;Development;Diagnosis;Disease;Ear Neoplasms;Event;Eye;Family;Family Study;Foundations;Fumarate Hydratase;Gene Mutation;Genes;Genetic;genetic linkage analysis;Genetic study;genetic testing;Genomics;Genotype;Germ Lines;Germ-Line Mutation;Hereditary Leiomyomatosis and Renal Cell Cancer;Hereditary Papillary Renal Carcinoma;Histology;Hybrids;Iceland;improved;Individual;Inherited;Kidney;Kidney Neoplasms;kindred;Laboratories;Labyrinth;Leiomyomatosis;Malignant Neoplasms;member;MET gene;Methods;Methylation;minimally invasive;Molecular Genetics;Mutation;Mutation Detection;New Agents;new therapeutic target;novel;Oncogenes;Oxyphil Cells;Pancreas;pancreatic neoplasm;Papillary;Pathology;Pathway interactions;Patients;Pattern;Phenotype;Pheochromocytoma;preclinical study;Proto-Oncogenes;Renal Carcinoma;Reporting;Research Personnel;Risk;Running;Series;Somatic Mutation;Spinal Neoplasms;Surgical Management;Syndrome;targeted treatment;tumor;Tumor Suppressor Genes;Tyrosine Kinase Domain;United States National Institutes of Health;Vertebral column;VHL gene;VHL mutation;Von Hippel-Lindau Syndrome;Work;working group,Clinical Studies of the Molecular Genetic Basis of Kidney Cancer,11028,NA,NA,NA,NA,17,NA,NA,1563629,NA
11188043,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011032,NA,NA,1ZIABC011032-17,NCI:678223\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692445 (contact),"NECKERS, LEONARD  (contact)",NA,NA,NA,Acetylation;Affect;Antibodies;Appearance;Bypass;C-terminal;cancer cell;CDC37 homolog protein;Cells;Characteristics;Client;Complex;Data;Data Set;Dimerization;Docking;drug efficacy;Enzymes;Eukaryota;Glycolysis;Heat-Shock Proteins 90;Human;in vivo;Lysine;Maps;Mass Spectrum Analysis;Mediating;Metabolic;mimetics;Mitochondria;Modification;Molecular Chaperones;Molecular Conformation;Mutation;N Domain;neoplastic cell;Normal Cell;novel;Nutrient availability;Oncogenic;overexpression;Phosphopeptides;Phosphorylation;Phosphotransferases;Population;Post-Translational Modification Site;Post-Translational Protein Processing;Process;programs;Protein Kinase;Protein Tyrosine Kinase;Proteins;Publishing;recruit;Recycling;Reporting;Shapes;Site;Specificity;src Homology Region 2 Domain;Sumoylation Pathway;System;targeted treatment;Tumor Escape;Tyrosine;Tyrosine Phosphorylation;Yeasts,Post-translational modifications of Hsp90,11032,NA,NA,NA,NA,17,NA,NA,678223,NA
11188044,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011035,NA,NA,1ZIABC011035-17,NCI:92595\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692451 (contact),"ROCHE, PAUL  (contact)",NA,NA,NA,Antigens;CD8-Positive T-Lymphocytes;Cell membrane;Cells;Cross Presentation;Endosomes;Event;Exocytosis;Hematopoietic;Immune;Lysosomes;mast cell;Membrane;Membrane Fusion;Molecular;Mus;Names;Organelles;Phagosomes;Phosphorylation;Process;Proteins;Recycling;Regulation of Exocytosis;Role;Secretory Vesicles;SNAP receptor;SNAP23 gene;Surface;trafficking,Regulation of Exocytosis from Immune Cells,11035,NA,NA,NA,NA,17,NA,NA,92595,NA
11188045,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011038,NA,NA,1ZIABC011038-17,NCI:2759348\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,2093160 (contact),"LINEHAN, WILLIAM MARSTON (contact)",NA,NA,NA,2019-nCoV;Affect;American;beta catenin;Binding;Cancer Etiology;Cancer Model;cancer type;Catalytic Domain;Cell Culture Techniques;Cell Line;Citric Acid Cycle;Clear Cell;Clear cell renal cell carcinoma;Clinical;Clinical Trials;cofactor;Complex;Conventional (Clear Cell) Renal Cell Carcinoma;COVID-19 treatment;Cryoelectron Microscopy;Cutaneous Leiomyoma;Development;Disease;elongin B;elongin C;Enzymes;Family;Foundations;Fumarate Hydratase;Fumarates;Geldanamycin Analogue;Genes;Genetic Transcription;Genome;Germ Lines;Goals;Growth;Heat-Shock Proteins 90;helicase;Hereditary Leiomyomatosis and Renal Cell Cancer;Hereditary Neoplastic Syndromes;Histology;Human;Hypoxia;Hypoxia Inducible Factor;In Vitro;in vitro Model;in vivo;Individual;Inherited;Iron;Kidney Neoplasms;Ligation;Loss of Heterozygosity;Malignant Neoplasms;Mediating;MET gene;Metal Binding Site;Metals;Modeling;Molecular;Mutate;Mutation;New Agents;novel;Oncogenes;oxidation;Papillary;Pathway interactions;Patients;Platelet-Derived Growth Factor;prevent;Process;Procollagen-Proline Dioxygenase;Proteins;receptor;Renal Carcinoma;Renal Cell Carcinoma;Risk;RNA-Directed RNA Polymerase;Role;SARS-CoV-2 antiviral;SARS-CoV-2 inhibitor;Scientist;Site;Small Interfering RNA;Stains;Structure;Sulfur;System;targeted agent;targeted treatment;tempol;Therapeutic;transcription factor;Transforming Growth Factor alpha;Translations;tumor;Tumor Tissue;Ubiquitin;Urologic Oncology;Uterine Fibroids;Vascular Endothelial Growth Factors;VHL gene;VHL protein;Viral;Von Hippel-Lindau Syndrome;Work;Zinc,Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene,11038,NA,NA,NA,NA,17,NA,NA,2759348,NA
11188046,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011043,NA,NA,1ZIABC011043-17,NCI:735826\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,2093160 (contact),"LINEHAN, WILLIAM MARSTON (contact)",NA,NA,NA,Affect;American;Animal Model;Animals;Area;Binding;Binding Proteins;Cancer cell line;Cancer Etiology;cancer type;Cell Surface Receptors;Cells;Clear Cell;Clear cell renal cell carcinoma;Clinical;Code;Cutaneous;Cyst;Cystic kidney;Cytoplasm;Development;Disease;Evaluation;Family;Folliculin;Foundations;Frameshift Mutation;Genes;Germ Lines;Germ-Line Mutation;Growth Factor;Hereditary Neoplastic Syndromes;Hereditary Papillary Renal Carcinoma;HGF gene;Histology;Human;Hybrids;Hyperplasia;In Vitro;in vitro Model;in vivo;Inherited;Kidney;Kidney Neoplasms;kindred;Knockout Mice;loss of function;Loss of Heterozygosity;Lung;MET gene;MET Gene Mutation;MET Oncogene;Modeling;Molecular;Mus;Mutation;New Agents;Nonsense Mutation;novel;Oncogenes;Oxyphil Cells;Papillary;Pathway interactions;patient subsets;Patients;Phenotype;Phosphorylation;Protein Truncation;Proteins;receptor;Renal Carcinoma;Renal Cell Carcinoma;Risk;Role;Sampling;Sirolimus;Somatic Mutation;Specimen;Syndrome;targeted agent;targeted treatment;Testing;Therapeutic;Tissues;tumor;Tumor Suppressor Genes;Tumor Suppressor Proteins;Tyrosine Kinase Domain;VHL gene;Work,Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene,11043,NA,NA,NA,NA,17,NA,NA,735826,NA
11188047,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011055,NA,NA,1ZIABC011055-17,NCI:176281\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201322 (contact),"GILDERSLEEVE, JEFFREY  (contact)",NA,NA,NA,Antibodies;Antigens;Area;Binding;Biological Assay;Biological Markers;cancer biomarkers;cancer diagnosis;cancer therapy;Cancer Vaccines;Carbohydrates;carcinogenesis;COVID-19 patient;Detection;Disease;Goals;Human;Immune response;improved;Malignant Neoplasms;Measures;Monitor;Patients;Play;Polysaccharides;Prognosis;Proteins;Research;response;Role;Serum;Technology;treatment response;vaccine immunogenicity;Vaccines,Serum Antibody Profiling with a Carbohydrate Microarray,11055,NA,NA,NA,NA,17,NA,NA,176281,NA
11188048,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011064,NA,NA,1ZIABC011064-17,NCI:30576\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692507 (contact),"MOCK, BEVERLY  (contact)",NA,NA,NA,Chromosome 1;Distal;Genes;genetic linkage analysis;genome-wide linkage;Human;interest;Interferons;Maps;Mass Spectrum Analysis;Microarray Analysis;Mus;Plasmacytoma;Predisposition;Proteins;Regulation,A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1,11064,NA,NA,NA,NA,17,NA,NA,30576,NA
11188049,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011065,NA,NA,1ZIABC011065-17,NCI:749110\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692507 (contact),"MOCK, BEVERLY  (contact)",NA,NA,NA,Affect;Animal Model;cancer therapy;Cell Cycle;Cell Line;Combined Modality Therapy;Drug Combinations;Drug Synergism;drug testing;FBXW7 gene;FRAP1 gene;Future;Genetic Predisposition to Disease;Goals;head-to-head comparison;Histone Deacetylase;Histone Deacetylase Inhibitor;Histones;Immunocompetent;inhibitor;Malignant Neoplasms;mTOR Inhibitor;Mus;Mutation;MYC Family Protein;Non-Hodgkin&apos;s Lymphoma;Oncogenes;Pathway interactions;Pharmaceutical Preparations;Plasma Cell Neoplasm;preclinical evaluation;preclinical study;Preclinical Testing;Signal Pathway;Signal Transduction Pathway;Sirolimus;targeted treatment;Testing;tissue/cell culture;tumor;Tumor Cell Line;Tumor Suppressor Proteins;Work,"Preclinical Testing of Drug Combinations (HDAC, mTOR, CDK and MYC Inhibitors)",11065,NA,NA,NA,NA,17,NA,NA,749110,NA
11188050,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011070,NA,NA,1ZIABC011070-17,NCI:1048728\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692515 (contact),"JAFFE, ELAINE  (contact)",NA,NA,NA,"Acquired Immunodeficiency Syndrome;Adopted;Adult;age group;Area;Autoimmune Diseases;B-Cell Lymphomas;B-Lymphocytes;Basic Science;Cell Differentiation process;Cell Physiology;Childhood;Classification;Clinical;clinical diagnosis;clinical practice;Clinical Protocols;Clinical Research;Communities;congenital immunodeficiency;Consultations;Dendritic Cells;Development;Diagnosis;Diagnostic;Diagnostic Services;Disease;disease classification;Education;Extranodal;Genes;Goals;Growth;Hematologic Neoplasms;Hematopathology;histiocyte;Histiocytosis;Hodgkin Disease;Human Herpesvirus 4;Human Herpesvirus 8;Hyperplasia;immunodeficiency;Immunohistochemistry;Immunologic Deficiency Syndromes;improved;In Situ Hybridization;in vivo;Institution;International;Ki-1 Large-Cell Lymphoma;Knowledge;Laboratories;Lesion;leukemia/lymphoma;Lymphoblastic Leukemia;Lymphocyte Function;Lymphoid;Lymphoid Cell;lymphoid neoplasm;Lymphoma;Lymphoproliferative Disorders;Malignant lymphoid neoplasm;Mission;Molecular;molecular diagnostics;Multicentric Angiofollicular Lymphoid Hyperplasia;National Heart, Lung, and Blood Institute;National Human Genome Research Institute;National Institute of Allergy and Infectious Disease;Neoplasms;neoplastic;Nodal;novel;Panniculitis;Pathogenesis;Pathologic;Pathologist;Pathology;Patients;Phenotype;Physicians;Physiology;programs;Proliferating;promoter;Publications;Rare Diseases;Reproducibility;Research;Second Opinions;Services;Standardization;subcutaneous;symposium;synergism;T-Cell and NK-Cell Neoplasm;T-Cell Lymphoma;T-Lymphocyte;tool;Training;translational study;Uncertainty;United States National Institutes of Health;Work",Hematopathology Diagnosis,11070,NA,NA,NA,NA,17,NA,NA,1048728,NA
11188051,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011078,NA,NA,1ZIABC011078-17,NCI:646840\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692531 (contact),"DOROSHOW, JAMES  (contact)",NA,NA,NA,Alveolar Soft Part Sarcoma;CCR;clinical development;Clinical Trials;Development;Developmental Therapeutics Program;Disease;Division of Cancer Treatment and Diagnosis;early phase trial;first-in-human;Goals;inhibitor;insight;Kidney;leiomyosarcoma;Molecular;novel anticancer drug;novel therapeutics;Paclitaxel;Pharmacodynamics;pharmacologic;Phase;rapid diagnosis;rare cancer;Solid Neoplasm;System;Systemic Therapy;Therapeutic Agents;Toxic effect;young adult,Phase 0-1 Clinical Trials,11078,NA,NA,NA,NA,17,NA,NA,646840,NA
11188052,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011081,NA,NA,1ZIABC011081-17,NCI:2339854\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692537 (contact),"PINTO, PETER  (contact)",NA,NA,NA,Achievement;Adoption;advanced prostate cancer;Artificial Intelligence;bench to bedside;Biopsy;Caring;CCR;Clinical;Clinical Trials;commercialization;computer aided detection;deep learning;Detection;Development;Diagnosis;Disease;Evidence based practice;Expression Profiling;Gleason Grade for Prostate Cancer;Goals;Image;Image-Guided Surgery;Imaging Device;improved;Journals;Magnetic Resonance Imaging;Malignant neoplasm of prostate;Malignant Neoplasms;Medicine;metabolomics;Methods;multidisciplinary;novel;novel strategies;Pathology;Pathway interactions;Patient Care;Patients;programs;Prostate;Reporting;Research;Screening for Prostate Cancer;System;Techniques;Therapeutic;Tissues;Translations;tumor;United States National Institutes of Health;Urology;Work,Prostate Section,11081,NA,NA,NA,NA,17,NA,NA,2339854,NA
11188053,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011090,NA,NA,1ZIABC011090-17,NCI:772907\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692553 (contact),"BUCK, CHRISTOPHER  (contact)",NA,NA,NA,Adenoviruses;Affect;Animals;Antibodies;Arachnida;Basic Science;Bioinformatics;BK Virus;clinical center;Collaborations;Data Set;deep sequencing;Deposition;Distant;Division of Cancer Epidemiology and Genetics;DNA Viruses;Exanthema;Family;Goals;Human;Human Biology;Immunity;immunosuppressed;Individual;Investigation;JC Virus;Malignant neoplasm of urinary bladder;Malignant Neoplasms;Mission;Molecular Biology;Names;neutralizing monoclonal antibodies;organ transplant recipient;Papillomavirus;Parvovirus;Peer Review;Perception;Play;Polyomavirus;precursor cell;prevent;Process;Proteins;Pruritus;public database;receptor;Recombinants;Recording of previous events;Retroviridae;Risk;Role;Testing;tumor;United States National Institutes of Health;vaccine development;Virion;Virus;Work,Molecular biology of human polyomaviruses,11090,NA,NA,NA,NA,17,NA,NA,772907,NA
11188054,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011091,NA,NA,1ZIABC011091-17,NCI:747717\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,1940613 (contact),"MELTZER, PAUL S. (contact)",NA,NA,NA,Address;Advanced Malignant Neoplasm;analytical method;Animal Model;Base Sequence;Basic Science;Bioinformatics;Biology;Cancer Biology;cancer cell;cancer genome;cancer genomics;Cell Line;Cells;Chromatin;chromatin modification;Chromosomes;Classification;Clinical;Clinical Research;Code;Communities;Complex;computational pipelines;Computing Methodologies;cost effective;Data;Development;DNA;DNA copy number;DNA Methylation;DNA Microarray Chip;DNA Sequence;DNA Sequence Alteration;Epigenetic Process;Fine needle aspiration biopsy;Formalin;Future;Gastrointestinal Stromal Tumors;Gene Expression;Genes;Genetic;Genetic Transcription;Genome;genome-wide analysis;Genomic Instability;genomic profiling;Glioma;Goals;Growth;Harvest;Hematologic Neoplasms;Hospitals;Human;Human Genome;improved;Industrialization;inhibitor;interest;Laboratories;Length;Malignant Breast Neoplasm;Malignant neoplasm of lung;Malignant neoplasm of prostate;Malignant neoplasm of urinary bladder;Malignant Neoplasms;Maps;Measurement;Measures;medullary thyroid carcinoma;Methodology;Methods;Modeling;mouse model;multidisciplinary;multiple omics;Mutation;Mutation Detection;new technology;next generation sequence data;novel;novel strategies;Paraffin Embedding;Pathology;Pathway interactions;pediatric patients;premalignant;Process;Protocols documentation;Repetitive Sequence;Research;Role;Sampling;Scientist;Single Nucleotide Polymorphism;Site;Small RNA;Solid Neoplasm;Sorting;Specialist;Specimen;Structure;Technology;technology development;telomere;Testing;Tissue Sample;Tissues;tool;transcription factor;Transferase;Translational Research;tumor;Untranslated RNA;Variant;whole genome;Work,Cancer Genomics Technology Development,11091,NA,NA,NA,NA,17,NA,NA,747717,NA
11188055,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011107,NA,NA,1ZIABC011107-17,NCI:155546\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692581 (contact),"MORRISON, DEBORAH  (contact)",NA,NA,NA,Adhesiveness;Behavior;Binding;Binding Sites;Biological;Caenorhabditis elegans;Catalytic Domain;cell motility;Cell surface;Cell-Cell Adhesion;Cells;Cellular Structures;CNKSR1 gene;Complex;Cues;Defect;Development;developmental disease;Disease;E-Cadherin;Enhancers;Event;experimental study;extracellular;Family;Family member;gain of function;gastrulation;genetic regulatory protein;Genetic Screening;Germ-Line Mutation;Goals;GTP Binding;Guanosine Triphosphate;Guanosine Triphosphate Phosphohydrolases;Hippocampus;human embryonic development;insight;Insulin Signaling Pathway;Intercellular Junctions;Laboratories;Mediating;member;Molecular;Molecular Conformation;Morphogenesis;MRAS gene;mutant;Neurons;Noonan Syndrome;Pathway interactions;Phosphoric Monoester Hydrolases;Phosphotransferases;Play;Process;Protein Dephosphorylation;Protein Family;Protein phosphatase;Proteins;raf Kinases;ras Proteins;Ras Signaling Pathway;reconstitution;Regulation;Reporting;Research;response;Role;scaffold;Scaffolding Protein;Signal Pathway;Signal Transduction;tumor;Vertebral column;Work;Zebrafish,Role of Protein Scaffolds in RTK-Ras-dependent Signal Transduction,11107,NA,NA,NA,NA,17,NA,NA,155546,NA
11188056,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011112,NA,NA,1ZIABC011112-17,NCI:1027078\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692601 (contact),"SINGER, ALFRED  (contact)",NA,NA,NA,Agonist;Autoimmunity;autoreactive T cell;autoreactivity;CD4 Positive T Lymphocytes;Cells;Clonal Deletion;Development;effector T cell;FOXP3 gene;IL2RA gene;Immune;in vivo;Interleukin-2;prevent;Receptor Signaling;Regulatory T-Lymphocyte;Signal Induction;Signal Transduction;T-Cell Receptor;thymocyte;Thymus Gland;Transforming Growth Factor beta,Development and function of regulatory T cells,11112,NA,NA,NA,NA,17,NA,NA,1027078,NA
11188057,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011115,NA,NA,1ZIABC011115-17,NCI:831661\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6572356 (contact),"SCHRUMP, DAVID  (contact)",NA,NA,NA,Aerodigestive Tract;Affect;Agreement;airway epithelium;Asbestos;Automobile Driving;Bioinformatics;Biological Assay;Biopsy;Blood specimen;cancer cell;Cancer Center;cancer therapy;carcinogenesis;Cell Culture Techniques;Cell Separation;Cells;cigarette smoke;cigarette smoking;Clinical;clinically relevant;Code;cohort;Collaborations;Complementary DNA;crosslink;Development;Digestion;Dilution Techniques;Dimethyl Sulfoxide;DNA;DNA Methylation;DNA Modification Methylases;DNMT3B gene;Dose;Down-Regulation;Enhancers;Environmental Carcinogens;Epigenetic Process;epigenomics;Epithelial Cells;esophageal carcinogenesis;Event;experimental study;Exposure to;exposure to cigarette smoke;EZH2 gene;Family;Fiber;Fibroblasts;FVB Mouse;Gene Chips;Gene Expression;Gene Expression Profile;Gene Silencing;Genes;genetic pedigree;Genomics;Germ Lines;Growth;Hawaii;Human;I-kappa B Proteins;Image;Immunoprecipitation;In Vitro;in vitro Model;in vivo;Invaded;Link;Lung;lung cancer cell;Malignant - descriptor;Malignant neoplasm of esophagus;Malignant neoplasm of lung;Malignant neoplasm of thorax;Malignant Neoplasms;Malignant Pleural Mesothelioma;Manuscripts;Mediating;Mesothelial Cell;Mesothelioma;Mus;Mutation;Neoplasms;NF-kappa B;Normal Cell;Normal tissue morphology;novel;novel strategies;Oncogenes;Patients;Peer Review;pharmacologic;Phenotype;Physical condensation;Pleural;Pleural Mesothelial Cell;Plicamycin;Polycomb;Preparation;Prevention;Primary Neoplasm;promoter;prospective;Proteins;Protocols documentation;Publishing;Quantitative Reverse Transcriptase PCR;RB1 gene;Recording of previous events;Records;recruit;repository;Repression;Resources;RNA;Serum;Signal Transduction;skin biopsy;SP1 gene;Specimen;stemness;Stream;Syndrome;Techniques;Tetanus Helper Peptide;Tissue Sample;Tobacco;treatment strategy;tumor;Tumor Suppressor Proteins;Universities;Untranslated RNA;Up-Regulation;virtual;Western Blotting;Xenograft Model,Epigenetic Mechanisms of Gene Expression in Thoracic Malignancies,11115,NA,NA,NA,NA,17,NA,NA,831661,NA
11188058,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011116,NA,NA,1ZIABC011116-17,NCI:1369437\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692601 (contact),"SINGER, ALFRED  (contact)",NA,NA,NA,Antibodies;Antigen Presentation;Antigens;Detection;Generations;Goals;Major Histocompatibility Complex;Malignant Neoplasms;Mediating;Molecular;molecular shape;Reaction;receptor;receptor binding;T-Cell Receptor;T-Lymphocyte;Thymus Gland,MHC-independent T cells,11116,NA,NA,NA,NA,17,NA,NA,1369437,NA
11188059,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011118,NA,NA,1ZIABC011118-17,NCI:626895\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692609 (contact),"MACKEM, SUSAN  (contact)",NA,NA,NA,Adult;Affect;Anterior;Apoptosis;Apoptotic;autocrine;Autocrine Communication;Basal Cell Nevus Syndrome;Biological Assay;Body System;Brain;Bypass;cancer type;cell behavior;Cell Death;cell motility;Cell Physiology;Cell Proliferation;Cell Survival;Cells;cellular targeting;Cessation of life;Child;Code;Communities;Complement component C5;Complementary DNA;Complex;Coupled;design;Development;Developmental Biology;developmental genetics;Digit structure;Elements;Embryo;Ensure;Enterobacteria phage P1 Cre recombinase;ERG gene;Exons;Family member;Feedback;Fibroblast Growth Factor;Fingers;Gene Deletion;Gene Expression Profile;Gene Expression Regulation;Genes;Genetic;Genetic Diseases;Genetic Transcription;genome-wide;Genomics;Goals;Growth;Holoprosencephaly;Hour;Human;Infant;insight;Intercept;Joints;Learning;Length;Ligands;Limb Bud;Limb Development;Limb structure;Link;Maintenance;Malignant Childhood Neoplasm;Malignant Neoplasms;Mesoderm;Mitogens;model building;Modeling;Morbidity - disease rate;Morphogenesis;morphogens;mortality;mouse model;Mus;mutant;Mutant Strains Mice;Mutate;Mutation;Neoplasm Metastasis;Neoplasms;neoplastic cell;Neural Crest;Normal tissue morphology;novel;Nucleic Acid Regulatory Sequences;Organ;Pancreas;paracrine;Pathologic;Pathology;Pathway interactions;Pattern;Phalanx;Phase;Physiological Processes;Play;Process;Production;progenitor;Proliferating;Prostate;Proteomics;Refractory;Regulation;Reporter;response;Role;selective expression;Shapes;SHH gene;Signal Pathway;Signal Transduction;Skeleton;Skin;smoothened signaling pathway;Sonic Hedgehog Pathway;Specific qualifier value;stem cell population;Stomach;Structure;Study models;System;Systems Biology;Tamoxifen;Testing;Therapeutic Intervention;Thumb structure;Time;tissue regeneration;Tissues;tool;transcription factor;transcriptome;transcriptomic profiling;transcriptomics;Transgenes;Transgenic Mice;tumor;Tumor Biology;tumorigenesis,Role of Shh in developmental patterning and growth of digit skeleton,11118,NA,NA,NA,NA,17,NA,NA,626895,NA
11188060,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011119,NA,NA,1ZIABC011119-17,NCI:835859\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692609 (contact),"MACKEM, SUSAN  (contact)",NA,NA,NA,Adult;Ambystoma;Amphibia;Amputation;Anterior;Appearance;ATAC-seq;beta catenin;Cartilage;Cell Adhesion;cell behavior;Cell Death;cell motility;Cell Physiology;Cells;cellular targeting;Cessation of life;Chick;ChIP-seq;Clustered Regularly Interspaced Short Palindromic Repeats;Complex;Congenital Abnormality;Data;design;Development;Developmental Biology;digit regeneration;Digit structure;Disease;Distal;Elements;Embryo;Ensure;Equilibrium;Erinaceidae;Evolution;Excision;Feedback;Fibroblast Growth Factor;Finger joint structure;Fingers;gastrointestinal epithelium;Gene Dosage;Gene Expression Profiling;Gene Expression Regulation;Gene Targeting;Genes;Genetic;genetic approach;Genetic Transcription;Genomics;GLI3 gene;Goals;Growth;Hindlimb;Homeobox;Homeobox Genes;Homeostasis;Human;in vivo;insight;Intercept;joint formation;Joints;knock-down;Learning;Length;Limb Bud;Limb Development;limb regeneration;Limb structure;Link;Maintenance;Malignant Neoplasms;Mammals;Mesenchyme;Methods;model building;Morphogenesis;Morphology;Mus;mutant;Neoplasm Metastasis;Neoplasms;neoplastic;neoplastic cell;Organ;Organ Culture Techniques;Output;Pathogenesis;Pathologic;Pathology;Pathway interactions;Pattern;Periodicals;Phalanx;Phalanx of hand;Physical condensation;Physiological Processes;Play;Positioning Attribute;postnatal;Process;progenitor;Proliferating;Proteins;Proteomics;Radial;regeneration potential;Regenerative capacity;Regulation;Replication Licensing;Role;Running;Shapes;SHH gene;Signal Induction;Signal Transduction;Site;skeletal;skeletal regeneration;Skeleton;Skin;smoothened signaling pathway;Sonic Hedgehog Pathway;stem cells;Structure;Study models;System;Systems Biology;Testing;Thumb structure;Tissues;transcription factor;transcriptome;Tumor Biology;tumorigenesis;ulna;Vertebrates;Work,Late stage signaling centers and Gli3-Hoxd interaction roles in Hedgehog regulated digit morphogenesis,11119,NA,NA,NA,NA,17,NA,NA,835859,NA
11188061,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011120,NA,NA,1ZIABC011120-17,NCI:522412\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692609 (contact),"MACKEM, SUSAN  (contact)",NA,NA,NA,Adult;Apoptotic;bone morphogenetic protein receptors;Bypass;cell behavior;Cell Death;cell motility;Cell Physiology;Cell Survival;Cells;cellular targeting;Cessation of life;ChIP-seq;chromatin immunoprecipitation;Complex;conditional mutant;derepression;design;Development;Developmental Biology;Digit structure;Ectoderm;Elements;Embryo;Ensure;ERG gene;Erinaceidae;Feedback;Fibroblast Growth Factor;Fingers;Foundations;Gene Expression;Gene Expression Profile;Gene Expression Regulation;Genes;Genetic;genetic approach;Genetic Diseases;Genetic study;Genetic Transcription;genome-wide;Genomics;GLI gene;Goals;Growth;Homeobox Genes;Homeostasis;Human;insight;Intercept;Joints;Knock-out;Learning;Length;Limb Bud;Limb Development;Limb structure;Link;LoxP-flanked allele;Malignant Neoplasms;Mediating;Minor;model building;Modeling;Molecular;Molecular Genetics;Morphogenesis;morphogens;mutant;Mutant Strains Mice;Mutate;Neoplasm Metastasis;Neoplasms;neoplastic cell;Organ;Organogenesis;Pathogenesis;Pathologic;Pathology;Pathway interactions;Pattern;Phalanx;Phase;Physiological Processes;Play;Process;Proliferating;Proteomics;Regulation;response;Role;Secondary to;self-renewal;Shapes;SHH gene;Signal Pathway;Signal Transduction;Skeleton;Skin;Specific qualifier value;Structure;Study models;Supporting Cell;System;Systems Biology;three dimensional structure;Thumb structure;Tissues;transcription factor;transcriptome;transcriptome sequencing;transcriptomic profiling;Tumor Biology;tumorigenesis,Genome-wide target analysis of Shh-activated transcription network in limb bud,11120,NA,NA,NA,NA,17,NA,NA,522412,NA
11188062,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011126,NA,NA,1ZIABC011126-17,NCI:2580801\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692619 (contact),"FRANCHINI, GENOVEFFA  (contact)",NA,NA,NA,5&apos;-Nucleotidase;Accounting;Adenosine;Adjuvant;adolescent woman;Affect;Africa South of the Sahara;aged;Aging;aluminum sulfate;ALVAC;Animal Model;animal old age;Animals;Anti-Inflammatory Agents;Antibodies;antibody-dependent cell cytotoxicity;antigen binding;Antigens;Apoptosis;Apoptotic;Binding;CCL2 gene;CCR5 gene;CD14 gene;CD3 Antigens;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;CD8B1 gene;Cells;Chimeric Proteins;Chromatin;chronic infection;Clinical;cohort;Combined Vaccines;Complex;Contralateral;CREB1 gene;Cryopreservation;Dendritic Cells;design;Development;DNA;Dose;env Gene Products;Enzymes;Epidemic;epigenetic marker;Female Adolescents;first-in-human;Frequencies;Functional impairment;Futility;Gel;HIV;HIV Envelope Protein gp120;HIV Infections;HIV vaccine;HIV Vaccine Trials Network;HIV-1;HIV-infected adolescents;HIV/SIV vaccine;Human;Human Volunteers;Hydroxides;IL17 gene;IL18 gene;Immune;Immunity;Immunization;Immunize;immunogenicity;Incidence;Infection;infection risk;Inflammasome;inhibitor;Insulin-Like Growth Factor I;Interferon Type II;Interleukin-10;Limb structure;Macaca;Macrophage;Mediating;men;MF59;Modality;Modeling;Molecular Conformation;Monoclonal Antibodies;monocyte;monomer;mRNA delivery;Mucosal Immune Responses;Mucosal Immunity;mucosal site;Mucous Membrane;Myelogenous;Myeloid Cells;natural killer cell protein 44-kDa;Natural Killer Cells;NIH Office of AIDS Research;novel vaccines;Nucleocapsid Proteins;Pathogenicity;Pathway interactions;Peripheral Blood Mononuclear Cell;Persons;Phase;phase I trial;Phase III Clinical Trials;Plasma;plasmid DNA;Population;poxvirus vectors;pre-clinical;Predisposition;Proteins;rational design;Recombinants;Regimen;Reproducibility;Research Institute;Resolution;Resources;response;Risk;RNA vaccine;Role;safety testing;Sampling;Shapes;SIV;social;South Africa;South African;spatial relationship;synergism;T cell response;T-Lymphocyte;Testing;Topical application;Transcript;transcriptome;transcriptome sequencing;Translating;Vaccinated;Vaccination;vaccine candidate;vaccine development;vaccine efficacy;vaccine evaluation;vaccine response;vaccine trial;Vaccines;Vaginal Ring;Variant;virucide;Virus;Virus-like particle;Whole Blood;Woman;Work;Zinc;Zinc Fingers,Development of rationally designed HIV vaccines,11126,NA,NA,NA,NA,17,NA,NA,2580801,NA
11188063,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011131,NA,NA,1ZIABC011131-17,NCI:644685\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201459 (contact),"BYRD, ROBERT  (contact)",NA,NA,NA,Bacteria;Biophysics;Cells;Collaborations;Complex;design;Disease;Endoplasmic Reticulum;Enzymes;Evaluation;Family;Genetic;Homeostasis;Human;Infection;interest;Intervention;Investigation;Knowledge;Laboratories;Malignant Neoplasms;member;Membrane;Methods;Molecular Conformation;molecular recognition;multicatalytic endopeptidase complex;multidisciplinary;Neoplasm Metastasis;NMR Spectroscopy;Pathogenicity;Pathway interactions;Process;protein complex;protein degradation;protein protein interaction;Proteins;Protocols documentation;Reaction;receptor;Regulation;Research;Specificity;structural biology;Structure;Substrate Specificity;Therapeutic;tumor;UBE2G2 gene;Ubiquitin;Ubiquitin-Conjugating Enzymes;ubiquitin-protein ligase;Ubiquitination,Investigation of Protein-Protein Interactions in the ERAD Ubiquitylation Pathway,11131,NA,NA,NA,NA,17,NA,NA,644685,NA
11188064,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011132,NA,NA,1ZIABC011132-17,NCI:322342\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201459 (contact),"BYRD, ROBERT  (contact)",NA,NA,NA,Address;Area;Binding;biophysical techniques;Biophysics;Complex;Development;Dissection;Enzymes;Equilibrium;Event;experimental study;Guanosine Triphosphate;Isotope Labeling;Measurement;Membrane;Membrane Proteins;method development;Methodology;Methods;mimetics;Molecular Conformation;molecular dynamics;Molecular Structure;Monitor;Monomeric GTP-Binding Proteins;nanodisk;Neutrons;novel;novel strategies;Pathway interactions;Process;protein complex;Protein Engineering;Protein Family;protein protein interaction;Proteins;Relaxation;Roentgen Rays;side effect;Signal Transduction;small molecule inhibitor;structural biology;Structure;Surface;System;Technology;Therapeutic;therapeutic development;tool;Ubiquitination,Methods Development,11132,NA,NA,NA,NA,17,NA,NA,322342,NA
11188065,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011150,NA,NA,1ZIABC011150-16,NCI:358505\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6569217 (contact),"DURUM, SCOTT  (contact)",NA,NA,NA,Anti-Inflammatory Agents;Antiinflammatory Effect;Bacteria;carcinogenesis;Cells;Chronic;Collaborations;cytokine;Engineering;Food;Goals;gut inflammation;IL17 gene;Immune;Immune response;Immunosuppression;Inflammation;Inflammation Process;Inflammatory;Inflammatory Bowel Diseases;insight;interleukin-22;intestinal epithelium;Intestines;Lactococcus lactis;Mus;Patients;Reporter;Reporting;Therapeutic;Tissues,Chronic Inflammation and Carcinogenesis,11150,NA,NA,NA,NA,16,NA,NA,358505,NA
11188066,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011152,NA,NA,1ZIABC011152-16,NCI:303522\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,2156935 (contact),"TRINCHIERI, GIORGIO  (contact)",NA,NA,NA,adaptive immune response;adaptive immunity;Apoptosis;Area;ATAC-seq;Autoimmune Diseases;Autoimmunity;Biological Response Modifiers;cancer immunotherapy;cancer prevention;Categories;Cell Differentiation process;Cell Physiology;Cells;Classification;Complex;Connective Tissue;cytokine;Data;Data Set;Degenerative Disorder;Dendritic cell activation;Dendritic Cells;Disease;Epithelial Cells;Epithelium;Experimental Models;falls;Family;Gene Expression Profile;Genes;Genetic;Genetic Transcription;Genome;Goals;Helper-Inducer T-Lymphocyte;Homeostasis;Human;human disease;IL17 gene;Immune;Immune response;Immune system;immunopathology;Immunotherapy;Infection;Inflammation;Inflammation Mediators;Inflammatory;Innate Immune Response;Interferon Type I;Interleukin-1 beta;interleukin-23;Lectin Receptors;Ligands;Lymphocyte;Malignant Neoplasms;Mastigophora;Mediating;microbial;microbiome;microorganism;Molecular;Mouth Diseases;Mucous Membrane;Natural Immunity;Nature;neoplastic cell;novel;Oral mucous membrane structure;Pathogenicity;Pathology;Patients;Pattern recognition receptor;Periodontitis;polarized cell;Production;Proliferating;Published Comment;receptor;Regulation;response;Role;Signal Transduction;single-cell RNA sequencing;Surface;synergism;System;T-Cell Activation;T-Lymphocyte Subsets;Time;Tissues;TLR5 gene;Toll-like receptors;Transcriptional Regulation;transcriptome;Vaccines;Work,Regulation of human dendritic cell activation,11152,NA,NA,NA,NA,16,NA,NA,303522,NA
11188067,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011153,NA,NA,1ZIABC011153-16,NCI:2124656\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,2156935 (contact),"TRINCHIERI, GIORGIO  (contact)",NA,NA,NA,Actinobacteria class;Adverse event;Adverse reactions;Affect;Agonist;Animals;anti-PD-1;anti-PD1 therapy;anti-tumor immune response;Antibiotic Therapy;Antibiotics;arm;Bacteria;Bacteroidetes;biological systems;Birth;Cancer Control;cancer immunotherapy;Cancer Patient;cancer type;carcinogenesis;CD4 Positive T Lymphocytes;CD8B1 gene;Cell Proliferation;Cells;chemotherapy;Chemotherapy-Oncologic Procedure;Chronic;Clinical;cohort;commensal bacteria;Communication;Communities;comorbidity;Complex;CPG-oligonucleotide;Crohn&apos;s disease;cytokine;Cytotoxic T-Lymphocytes;Data;data integration;Dendritic Cells;Development;Diet;Dietary Fiber;Disease;Distal;efficacy evaluation;Enterobacteriaceae;Epithelium;Etiology;Eukaryota;Evaluable Disease;Exposure to;Familiarity;Family;fecal microbiota;Fiber;Firmicutes;Fortification;Frequencies;Genes;Genetic;genetic signature;genotoxicity;Germ-Free;Gnotobiotic;Gram-Negative Bacteria;gut microbes;gut microbiome;gut microbiota;Health;Hemorrhage;high risk;Homeostasis;host microbiota;Human;Human body;Human Microbiome;Immune;immune activation;Immune response;Immune system;Immunity;immunodeficiency;Immunotherapy;Impairment;improved;Individual;Infiltration;Inflammation;Inflammatory Response;Intake;Interferons;Invaded;Laboratories;Lung;Macrophage Activation;Maintenance;Malignant Neoplasms;Mediating;Melanoma;Melanoma patient;member;Metabolic Control;Metabolism;Methods;Microbe;microbial;microbiome;microbiome composition;microbiota;microbiota composition;microorganism;migration;Modification;Molecular;monocyte;mouse model;Multiomic Data;multiple omics;Mus;Myelogenous;Myeloid Cells;Myeloid-derived suppressor cells;Necrosis;Neoadjuvant Study;Neoadjuvant Therapy;Nivolumab;Outcome;pathogen;pathogenic microbe;Pathologic;Pathway Analysis;Patients;Pattern;Peripheral;Phagocytosis;Phase;Physiological;Physiology;Platinum;Play;Pre-Clinical Model;preclinical study;Predisposition;Probiotics;Production;programmed cell death protein 1;Progression-Free Survivals;Prokaryotic Cells;Proteobacteria;Protocols documentation;Reactive Oxygen Species;reconstitution;reconstruction;Regulation;Reproducibility;Research Design;Resectable;Resistance;Resistance to infection;response;Role;Sample Size;Science;Services;Signal Transduction;Site;Skin;Statistical Models;stem;Structure;subcutaneous;Supporting Cell;symbiont;System;T-Lymphocyte;Technology;Therapeutic;Time;Tissues;TLR4 gene;treatment response;tumor;Tumor Immunity;tumor microenvironment;tumor-immune system interactions;Tumor-Infiltrating Lymphocytes;United States National Institutes of Health;user-friendly;Work,Role of microbiome in cancer and inflammation,11153,NA,NA,NA,NA,16,NA,NA,2124656,NA
11188068,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011163,NA,NA,1ZIABC011163-16,NCI:988119\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10270581 (contact),"YANG, LI  (contact)",NA,NA,NA,breast cancer metastasis;Breeding;Cancer Biology;Collaborations;Epithelial Cells;Fibroblasts;Genetic;Goals;Growth;Immune response;insight;Knockout Mice;Malignant - descriptor;Mediating;Modeling;Molecular;Mus;Myelogenous;Myeloid Cells;Neoplasm Metastasis;neoplastic cell;Pathway interactions;Phenotype;promoter;receptor;Regulation;Research;Resources;Signal Pathway;Signal Transduction;targeted treatment;Transforming Growth Factor beta;translational potential;tumor;tumor progression;tumor-immune system interactions;Work,Myeloid TGFbeta signaling in breast cancer metastasis,11163,NA,NA,NA,NA,16,NA,NA,988119,NA
11188069,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011165,NA,NA,1ZIABC011165-16,NCI:988119\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10270581 (contact),"YANG, LI  (contact)",NA,NA,NA,cancer therapy;CD4 Positive T Lymphocytes;CD8B1 gene;Cell Proliferation;Cell Survival;Cells;Chromatin;CRISPR/Cas technology;Epigenetic Process;Genetic;Genetic Transcription;genome-wide;growth promoting activity;histone modification;Hypermethylation;IL6 gene;Immune;immune checkpoint;immune checkpoint blockade;Immune response;immunoregulation;in vivo;Inflammatory;Inflammatory Response;JAK3 gene;loss of function;Malignant Neoplasms;Mediator;mouse model;Neoplasm Metastasis;neoplastic cell;NF1 gene;novel;Oncogenes;Pathway interactions;Patients;Play;pre-clinical;programmed cell death ligand 1;promoter;Regulation;Relapse;Reporting;Resistance;response;Role;screening;Signal Transduction;STAT3 gene;Tissues;Transforming Growth Factor beta;triple-negative invasive breast carcinoma;TSC1 gene;tumor;tumor microenvironment;Tumor Suppressor Proteins;tumor-immune system interactions,Roles of tumor suppressors (TSs) in metastatic progression,11165,NA,NA,NA,NA,16,NA,NA,988119,NA
11188070,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011167,NA,NA,1ZIABC011167-16,NCI:576453\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6569146 (contact),"MERLINO, GLENN T. (contact)",NA,NA,NA,Adjuvant;Adjuvant Therapy;Affect;Animal Model;Anterior Pituitary Gland;anti-CTLA4;anti-PD-1;anti-PD-L1;Antibodies;Antineoplastic Agents;Award;Back;Bioinformatics;Biological Markers;Biological Models;Bioluminescence;bone;BRAF gene;Brain;C57BL/6 Mouse;Calendar;Carcinogens;Cause of Death;CCR;CDK4 gene;Cell Culture Techniques;Cell Line;Cells;Cephalic;Cessation of life;chemotherapy;Child;Clinic;Clinical;Clinical Trials;clinically relevant;Clonality;Collaborations;Combined Modality Therapy;COVID-19;CTLA4 gene;Cutaneous Melanoma;Data;Data Set;design;Development;dimethylbenzanthracene;Disease;Disease Progression;Distant;Drug Monitoring;Drug Targeting;effective therapy;efficacy study;Excision;Exclusion;Exhibits;experience;experimental study;Family suidae;Fluorescence;Functional disorder;Funding;fusion gene;Future;Gene Expression;Genetically Engineered Mouse;Goals;Growth;Head;Heterogeneity;Home;host neoplasm interaction;Human;Human Cell Line;human data;Immune;immune checkpoint;Immune checkpoint inhibitor;Immune system;Immune System Diseases;immune system function;Immunocompetent;Immunocompromised Host;Immunotherapeutic agent;Immunotherapy;Impairment;Implant;improved;Inflammatory;inhibitor;insight;Intervention;ipilimumab;Label;Laboratories;Lentivirus;Link;Luciferases;Lung;Malignant Neoplasms;Manuscripts;Melanoma;Melanoma Cell;Melanoma patient;Melanoma Tumor;Memorial Sloan-Kettering Cancer Center;Metastatic malignant neoplasm to brain;Metastatic Melanoma;Metastatic/Recurrent;Modeling;Monitor;mortality;mouse model;Mus;mutant;Mutation;Neoadjuvant Therapy;neoantigens;Neoplasm Metastasis;neoplastic cell;new therapeutic target;NF1 gene;Nivolumab;novel;novel strategies;objective response rate;Oncogenic;Operative Surgical Procedures;Optics;Organ;patient stratification;patient subsets;Patients;Persons;Pharmaceutical Preparations;Pharmacotherapy;Phenotype;Plumbing;posters;pre-clinical;Pre-Clinical Model;pre-clinical research;preclinical trial;predictive marker;Prevalence;prevent;Primary Neoplasm;Prior Therapy;Process;programmed cell death ligand 1;programmed cell death protein 1;programs;promoter;protein expression;Proteins;Rattus;Reagent;Recurrence;Recurrent disease;Reporter;Reporting;Resected;Resistance;resistance mechanism;Resources;response;Role;Running;Signal Transduction;Site;Somatotropin;Source;Study models;success;synergism;T-Lymphocyte;Technology;Testing;Therapeutic;therapeutic biomarker;Tissues;tool;Transgenic Mice;translational potential;tumor;tumor growth;tumor microenvironment;tumorigenic;Ultraviolet Rays;UV Radiation Exposure;Work,Preclinical Mouse Models for Studying Immune Checkpoint Inhibitor Response,11167,NA,NA,NA,NA,16,NA,NA,576453,NA
11188071,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011168,NA,NA,1ZIABC011168-16,NCI:1248960\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8122283 (contact),"ZHANG, YING E (contact)",NA,NA,NA,Adult;Alleles;Cell Cycle Progression;Cell Physiology;clinically relevant;Collagen;Cutaneous;Data;Dedications;Development;DNA Damage;DNA Repair;embryonic stem cell;Enzymes;Epigenetic Process;Family;Fatty Acids;gastrulation;Genes;Genetic;Genetic Transcription;Genome Stability;Glucose Intolerance;high body mass index;histone modification;Homeostasis;Human;Inflammation;Inflammatory Response;Insulin Resistance;Investigation;Knockout Mice;Link;Lipids;Maintenance;Malignant Neoplasms;Mediating;member;Metabolic;Modeling;Modification;Mouse Embryonic Stem Cells;mouse model;multicatalytic endopeptidase complex;Mus;mutant;Mutation;Nodal;non-alcoholic fatty liver disease;Obesity;Pathogenesis;Pathologic;Pathway interactions;Patients;Phosphorylation;Physiological;PPAR gamma;Predisposition;Proteasome Inhibitor;protein degradation;Proteins;Research;response;Role;Signal Induction;Signal Transduction;stem cell differentiation;success;Surgical incisions;System;Therapeutic Uses;Tissues;tool;Transforming Growth Factor beta;tumor;tumor progression;Tumor Suppressor Proteins;tumorigenesis;Ubiquitin;ubiquitin-protein ligase;Ubiquitination;uptake;Weight Gain;wound;wound healing,Physiological and pathological functions of E3 ubiquitin ligases Smurfs,11168,NA,NA,NA,NA,16,NA,NA,1248960,NA
11188072,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011176,NA,NA,1ZIABC011176-16,NCI:769723\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10270608 (contact),"ZIEGELBAUER, JOSEPH  (contact)",NA,NA,NA,Antigen Presentation;Biogenesis;Biological Assay;Cell Communication;Cell division;Cell Physiology;Cell surface;Cellular Immunity;circular RNA;Clinical;comparative;Coupled;Cytomegalovirus;Defect;Disease;DNA;Ectopic Expression;Endoribonucleases;Endosomes;Event;experimental study;Expression Profiling;gain of function;gammaherpesvirus;Gene Expression;Genes;Genetic Transcription;Goals;Herpesviridae;Herpesviridae Infections;Herpesvirus 1;Human;Human Herpesvirus 4;Human Herpesvirus 8;Immune;in silico;Infection;interest;Interferon-beta;Interferons;Light;Location;loss of function;Lysine Degradation Pathway;Lytic;Lytic Phase;Malignant Neoplasms;Mediating;Messenger RNA;MicroRNAs;Molecular;mRNA Decay;Mus;new therapeutic target;Normal Cell;pathogen;Pathogenesis;Pathway interactions;Pattern;Play;Poly I-C;Poly(A) Tail;prevent;Publishing;Recombinant Interferon;Research;Resistance;Ribonucleases;RNA Decay;Role;senescence;Signal Transduction;TLR3 gene;TLR4 gene;Toll-like receptors;Transcript;transcriptome sequencing;Untranslated RNA;Up-Regulation;Viral;Viral Physiology;Virus Diseases;virus host interaction;Work,Functions of KSHV microRNAs and circular RNAs,11176,NA,NA,NA,NA,16,NA,NA,769723,NA
11188073,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011181,NA,NA,1ZIABC011181-16,NCI:789736\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6809564 (contact),"SHARAN, SHYAM  (contact)",NA,NA,NA,Age;Bacterial Artificial Chromosomes;Biological Assay;BRCA1 gene;BRCA2 gene;breast cancer diagnosis;C-terminal;cancer diagnosis;Cancer-Predisposing Gene;Categories;Classification;Clinical;clinically significant;Codon Nucleotides;CRISPR/Cas technology;Development;Disease;DNA;DNA Binding Domain;DNA Repair Gene;ES Cell Line;Exons;Genes;Genetic;genetic information;genetic testing;genetic variant;genome editing;Germ-Line Mutation;Hereditary Breast Carcinoma;High Prevalence;high risk;Human;humanized mouse;Individual;Inherited;Malignant Breast Neoplasm;Malignant Neoplasms;Medicine;Mouse Embryonic Stem Cells;mutant;Mutation;Nature;Nucleotides;Pathogenicity;Persons;Population;repaired;Reporting;Risk;Risk Factors;Role;segregation;Sequence Analysis;Single Nucleotide Polymorphism;Testing;tumorigenesis;United States;Variant;variant of unknown significance;Woman,Functional Analysis of Human Breast Cancer Susceptibility Gene Variants,11181,NA,NA,NA,NA,16,NA,NA,789736,NA
11188074,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011187,NA,NA,1ZIABC011187-16,NCI:1039810\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6802050 (contact),"ACHARYA, JAIRAJ  (contact)",NA,NA,NA,acquired drug resistance;adaptive immune response;Area;Autoimmune Diseases;Biological;Bone Marrow Stem Cell;c-myc Genes;Cell membrane;Cells;Cellular Structures;Ceramides;Colitis;Development;Enzymes;Experimental Autoimmune Encephalomyelitis;FRAP1 gene;Genes;Glucosylceramides;Glycolysis;Helper-Inducer T-Lymphocyte;Human;human disease;hypoxia inducible factor 1;Impairment;Inborn Errors of Metabolism;Lipids;Mammals;Membrane;Metabolic;Metabolism;mouse model;Multienzyme Complexes;Mus;NADP;Niemann-Pick Diseases;Oxidases;Pathway interactions;Play;Process;Proteins;Reactive Oxygen Species;Research;Research Personnel;Role;Second Messenger Systems;Serine;Shapes;Signal Transduction;Specific qualifier value;Sphingolipids;T-Lymphocyte;Transferase;tumor,Sphingolipid Signaling in Mammals,11187,NA,NA,NA,NA,16,NA,NA,1039810,NA
11188075,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011190,NA,NA,1ZIABC011190-16,NCI:183809\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692213 (contact),"WINK, DAVID  (contact)",NA,NA,NA,aerobic glycolysis;anti-cancer;Area;Award;Biological;Biology;blood pressure control;cancer prevention;cancer therapy;Chemicals;Disease;Endothelium;Goals;Heart;Heart failure;hypoxia inducible factor 1;Immune response;in vivo;Legal patent;Malignant Neoplasms;Metabolism;Methods;Modeling;Myocardial Infarction;neurotransmission;Nitric Oxide;Nitric Oxide Synthase;Nitrogen Oxides;Nitrosation;nitroxyl;Oxidation-Reduction;persulfides;Pharmaceutical Preparations;pharmacologic;Pharmacology;Phase III Clinical Trials;prevent;Production;Property;Regulation;Sulfhydryl Compounds;Therapeutic;Tissues;tumor;tumor growth;tumor metabolism,Chemical Biology of Nitroxyl (HNO),11190,NA,NA,NA,NA,16,NA,NA,183809,NA
11188076,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011191,NA,NA,1ZIABC011191-16,NCI:863438\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6569140 (contact),"CHENG, SHEUE-YANN  (contact)",NA,NA,NA,Affect;anaplastic thyroid cancer;Attenuated;attenuation;Biological Assay;Biology;BRAF gene;cancer cell;cancer cell differentiation;Cancer cell line;Cancer Patient;cancer stem cell;Cell Proliferation;Cells;chemotherapy;Combined Modality Therapy;confocal imaging;Cultured Cells;Data;Databases;Development;Diagnosis;Disease;Endocrine Gland Neoplasms;Evaluation;Follicular thyroid carcinoma;Gene Expression;Genes;Genetic Transcription;Genomics;Growth and Development function;Human;Immunohistochemistry;improved;improved outcome;In Vitro;in vivo;Induction of Apoptosis;inhibitor;insight;kinase inhibitor;Malignant neoplasm of thyroid;Malignant Neoplasms;Mediating;MEK inhibition;MEKs;Messenger RNA;Molecular;Molecular Analysis;mouse model;Mutate;Mutation;neoplastic cell;novel;Operative Surgical Procedures;Papillary thyroid carcinoma;Patients;Pharmaceutical Preparations;Phase II Clinical Trials;pre-clinical;programs;Proteins;Proto-Oncogene Proteins B-raf;radioiodine therapy;Recurrence;Reporter;Resistance;RNA Polymerase II;Role;self-renewal;Signal Pathway;Signal Transduction;single-cell RNA sequencing;Solid;stem cell biomarkers;Testing;The Cancer Genome Atlas;Therapeutic;Therapeutic Intervention;therapeutic target;therapy resistant;THRA gene;Thyroid Gland;Thyroid Hormone Receptor;Thyroid hormone receptor alpha;Thyroid Hormones;transcription factor;transcriptomics;tumor;tumor growth;tumor xenograft;Tyrosine Kinase Inhibitor;United States Food and Drug Administration;Variant;Visualization;Xenograft Model;Xenograft procedure,Preclinical Mouse Models of Thyroid Cancer,11191,NA,NA,NA,NA,16,NA,NA,863438,NA
11188077,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011197,NA,NA,1ZIABC011197-16,NCI:910513\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6568841 (contact),"APPELLA, ETTORE  (contact)",NA,NA,NA,Ablation;Active Sites;Aspartic Acid;Binding;Binding Sites;Biochemical;Biological Assay;Biology;Biophysics;C-terminal;cancer cell;Catalysis;Catalytic Domain;Cell Proliferation;Cells;Characteristics;Chemistry;Chemotherapy-Oncologic Procedure;Clear cell carcinoma;Collaborations;Crossbreeding;Databases;Detection;Development;Dimethyl Sulfoxide;DNA Damage;Enterobacteria phage P1 Cre recombinase;Enzymes;experimental study;Family;Fluorescence;France;Genetic Transcription;Genomics;Goals;Growth;high throughput screening;Human;Hydrogen Bonding;Immune;Immune system;improved;inhibitor;insight;Investigation;Ionizing radiation;Ions;Journals;Kinetics;Lewis lung carcinoma cell;Libraries;LoxP-flanked allele;Magnesium;Malignant Breast Neoplasm;Malignant neoplasm of lung;Malignant Neoplasms;malignant stomach neoplasm;MAP Kinase Gene;Mass Spectrum Analysis;Medulloblastoma;Melanoma Tumor;member;Methods;Modeling;Molecular Conformation;molecular dynamics;Mus;Mutate;Myelogenous;National Center for Advancing Translational Sciences;neoplastic cell;Neuroblastoma;neutrophil;Neutrophil Infiltration;Nitrogen;Normal Cell;Outcome;Ovarian Clear Cell Tumor;overexpression;Oxygen;p38 Mitogen Activated Protein Kinase;Pancreatic Adenocarcinoma;phosphatase inhibitor;Phosphoric Monoester Hydrolases;Phosphorylation;Physiological;Polyethylene Glycols;Positioning Attribute;PPM1D gene;promoter;Protein Isoforms;protein phosphatase 2C;Protein Serine/Threonine Phosphatase;Proteins;Publishing;Radiation therapy;Regulation;Research;Resistance;Resolution;Role;Running;screening;small molecule libraries;Stress;Structure;subcutaneous;Sulfur;Testing;TP53 gene;tumor;tumor growth;Tumor Immunity;tumor progression;Tumor Suppressor Proteins;tumorigenesis;Ultraviolet Rays;Universities;virtual screening,Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,11197,NA,NA,NA,NA,16,NA,NA,910513,NA
11188078,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011203,NA,NA,1ZIABC011203-16,NCI:1024388\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,2402881 (contact),"GOTTESMAN, SUSAN  (contact)",NA,NA,NA,Active Sites;Adaptor Signaling Protein;Affect;ATP phosphohydrolase;ATP-Dependent Proteases;ATPase Domain;Bacteria;Bacteria sigma factor KatF protein;Biochemical;Bioinformatics;Biological;biological adaptation to stress;C-terminal;Cell division;cell growth;Cells;Collaborations;Complex;Cues;Cytoplasm;Dissection;DNA Damage;DNA-Directed RNA Polymerase;endopeptidase Clp;Ensure;environmental change;Escherichia coli;Escherichia coli Proteins;Evolution;extreme temperature;falls;Family;Feedback;feeding;flexibility;Gammaproteobacteria;Gene Expression;Gene Expression Regulation;Gene Proteins;Genes;Genetic;Growth;Homeostasis;In Vitro;in vivo;inhibitor;inorganic phosphate;insight;interest;Magnesium;member;misfolded protein;Mitochondria;multicatalytic endopeptidase complex;mutant;Mutation Analysis;N-terminal;Names;novel;Organism;Peptide Hydrolases;Phosphoric Monoester Hydrolases;Play;Polymerase;Polysaccharides;Process;programs;promoter;Protease Domain;protein degradation;Protein Family;protein phosphatase 2C;Proteins;Proteolysis;Pseudomonas;Pseudomonas aeruginosa;Quality Control;reconstitution;Recovery;Regulation;Resistance;response;Role;Route;Shewanella;Sigma Factor;Signal Transduction;small molecule;Small RNA;Starvation;Stress;Structure;System;Testing;Translations;transmission process;Universities;Vibrio;Work,Proteolysis and Regulation of Bacterial Cell Growth Control,11203,NA,NA,NA,NA,16,NA,NA,1024388,NA
11188079,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011204,NA,NA,1ZIABC011204-16,NCI:428728\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9414468 (contact),"STETLER-STEVENSON, WILLIAM  (contact)",NA,NA,NA,Acceleration;Angiogenesis Inhibitors;anti-cancer research;antitumor effect;Biochemical;Biological;Biological Assay;Biological Models;Biological Response Modifier Therapy;bioprocess;Breast;Breast Carcinoma;cancer therapy;cell growth;Cells;chemoradiation;Cloning;Codon Nucleotides;Collaborations;Complementary DNA;Development;Diagnosis;Disease Progression;Drug Delivery Systems;drug development;Elements;enteropeptidase;Enzyme Inhibition;Equilibrium;Extracellular Matrix;Formulation;Glioblastoma;Goals;Growth;Homeostasis;Human;human tissue;improved;In Vitro;in vitro testing;in vivo;in vivo Model;Infiltration;inhibitor;Laboratories;Luciferases;Lung;Lung Carcinoma;Lung Neoplasms;Malignant Breast Neoplasm;Malignant neoplasm of brain;Malignant neoplasm of lung;Malignant neoplasm of pancreas;Malignant Neoplasms;Metalloproteases;method development;Methods;Mission;Modeling;mortality;mouse model;Mus;mutant;Mutation;Myeloid-derived suppressor cells;Neoplasm Metastasis;Non-Small-Cell Lung Carcinoma;Normal tissue morphology;novel;novel therapeutic intervention;novel therapeutics;Pancreas;Pancreatic carcinoma;Patients;Plasmids;Preparation;Primary Neoplasm;Production;Proteins;Protocols documentation;quality assurance;Recombinants;Reporting;Research;Site;Survival Rate;Techniques;Testing;Time;TIMP2 gene;Tissue Inhibitor of Metalloproteinases;Toxic effect;tumor;tumor growth;tumor microenvironment;tumor progression;tumor xenograft;tumorigenic;Wild Type Mouse,Development of TIMP-2 derivatives or strategies as biologic therapies for cancer,11204,NA,NA,NA,NA,16,NA,NA,428728,NA
11188080,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011206,NA,NA,1ZIABC011206-16,NCI:1049760\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8630576 (contact),"DALAL, YAMINI P (contact)",NA,NA,NA,Address;Affect;aged;Aging;Back;Brain;cancer biomarkers;cancer cell;cancer initiation;cell age;Cell Aging;Cell Cycle Arrest;cell growth;Cell Separation;Cells;Centromere;centromere protein A;Chromatin;Chromatin Structure;Chromosomal Instability;Collaborations;Complex;Defect;differential expression;DNA;DNA Methylation;Down-Regulation;Epigenetic Process;Euchromatin;Failure;Fibroblasts;Genetic Transcription;genome-wide;Glioblastoma;Heterochromatin;Histone H3;Histones;Human;Individual;Journals;Kinetochores;knock-down;Link;Location;Malignant Neoplasms;Maps;Mediating;micronucleus;Mitotic;Molecular;new technology;Nuclear Accidents;Nucleoproteins;Organ;Organism;Organoids;Pathway interactions;Pattern;Peer Review;Predisposition;Process;Property;Proteins;Proteomics;Publishing;Research Personnel;Role;Skin;Solid;Specificity;Tissues;TP53 gene;tumor;Tumor Suppressor Proteins;tumorigenesis;Variant;Work,Role of histone variants in aging and cancer,11206,NA,NA,NA,NA,16,NA,NA,1049760,NA
11188081,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011207,NA,NA,1ZIABC011207-16,NCI:839808\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8630576 (contact),"DALAL, YAMINI P (contact)",NA,NA,NA,3-Dimensional;Address;Affect;Aging;aging related;Amino Acid Sequence;Atomic Force Microscopy;Biochemical;Biological Assay;Biology;Biomechanics;Biophysics;bioprinting;cancer cell;Cell Nucleus;Cells;Centromere;chemotherapy;Chromatin;Chromosomes;Complex;Country;Crowding;daughter cell;Disease;Elasticity;Endothelium;Epigenetic Process;epigenome;Eukaryota;field study;fighting;Genetic Transcription;Genome;Genomics;Glioblastoma;Goals;Growth;Histones;Immunofluorescence Immunologic;In Vitro;in vivo;Malignant - descriptor;Malignant Neoplasms;mechanical force;mechanical properties;Mechanics;member;Mitosis;Modeling;Normal Cell;novel therapeutics;Nuclear;Nucleosomes;Oncogenic;Outcome;Paper;Pathway interactions;Pharmaceutical Preparations;Phenotype;Polymers;Postdoctoral Fellow;Process;Property;Publishing;response;segregation;Seminal;sensor;Stains;Stress;Stretching;temozolomide;Therapeutic Agents;therapy development;Time;Tissues;tumor;tumor microenvironment;Variant;Work,Biomechanical properties of chromatin in cancer and normal cells,11207,NA,NA,NA,NA,16,NA,NA,839808,NA
11188082,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011208,NA,NA,1ZIABC011208-16,NCI:1883865\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8777973 (contact),"GREWAL, SHIVINDER S (contact)",NA,NA,NA,Acetylation;Amino Acids;Antineoplastic Agents;Binding;Binding Proteins;Biochemical;Biological Assay;Cancer Biology;cancer therapy;Cell Physiology;cell type;Centromere;centromere autoantigen 80K;centromere protein A;Chromatin;Chromatin Modeling;chromatin remodeling;Chromatin Remodeling Factor;Chromatin Structure;Chromosome Segregation;Chromosome Structures;cohesin;cohesion;Complex;Coupled;Cullin Proteins;Defect;Development;DNA;DNA Binding;DNA biosynthesis;DNA Damage;Elements;Enzymes;Epigenetic Process;Euchromatin;Eukaryota;Eukaryotic Cell;Event;Family;Fission Yeast;Gene Expression Profile;Gene Expression Regulation;Gene Silencing;Genes;Genetic Screening;Genetic Transcription;Genome;genome integrity;Heterochromatin;Higher Order Chromatin Structure;Histone Deacetylase;Histone Deacetylase Inhibitor;Histone Deacetylation;Histone H3;histone methylation;histone methyltransferase;histone modification;Histones;Homologous Gene;Human;human disease;insight;Link;Lysine;Maintenance;Malignant Breast Neoplasm;Malignant Neoplasms;Measures;Mediating;Methylation;methylation pattern;Modification;Molecular;Mutagens;mutant;novel;Nucleosomes;Pathway interactions;Pattern;Phosphorylation;Positioning Attribute;Post-Translational Protein Processing;posttranscriptional;prevent;Process;promoter;Proteins;recruit;Repression;Research;Retrotransposon;RNA Interference;RNA Polymerase I;RNA Polymerase II;Role;scaffold;Sister Chromatid;Site;Structure;Tail;therapeutically effective;Transcript;Transposase;ubiquitin ligase;Variant;Work,Roles of Chromatin-modifying Factors in Epigenetic Control of the Genome,11208,NA,NA,NA,NA,16,NA,NA,1883865,NA
11188083,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011209,NA,NA,1ZIABC011209-16,NCI:209953\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8630576 (contact),"DALAL, YAMINI P (contact)",NA,NA,NA,Binding;Binding Proteins;Biological Models;Birth;Cell Cycle;Cells;Centromere;centromere protein A;Cessation of life;Chromatin;Chromosomes;Complex;Data;daughter cell;DNA;DNA Damage;DNA Repair;Epigenetic Process;Genome;Goals;Human;in vivo;International;Journals;Kinetochores;Life;Life Cycle Stages;Mechanics;Mitotic;nuclear division;Paper;Pathway interactions;Process;protein complex;Proteins;Publishing;restraint;segregation;Structure;tumorigenesis;Work,Formation of Centromeres in vivo,11209,NA,NA,NA,NA,16,NA,NA,209953,NA
11188084,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011211,NA,NA,1ZIABC011211-16,NCI:1785089\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10270676 (contact),"RAMAMURTHI, KUMARAN  (contact)",NA,NA,NA,Antibiotic Resistance;Antibiotics;Antigens;Applied Research;Area;Bacillus subtilis;Bacteria;Bacterial Spores;Basic Science;Breast Cancer Cell;cancer cell;Cell Communication;Cell Differentiation process;Cell division;Cell surface;Cells;Cellular Structures;chemical property;chemotherapeutic agent;Clinic;Clinical;Cytokinesis;Cytoplasm;Development;Disease;Doxorubicin;efficacy testing;Enzymes;ERBB2 gene;Event;Exhibits;Gene Deletion;Genes;Genetic Transcription;Heterogeneity;Immune response;immunogenicity;Infection;interest;Kinetics;Malignant neoplasm of ovary;Malignant Neoplasms;Mediating;Melanoma;Membrane;Microbe;Modeling;Molecular;Molecular Chaperones;Morphogenesis;mouse model;Mus;Names;nanoenvironment;nanoparticle;neoantigens;Nosocomial Infections;novel;Organelles;particle;Pathway interactions;Peptide Vaccines;Peptides;Phenotype;physical property;Population;Process;Proteins;recruit;Reporting;Reproduction spores;resistant strain;Site;small molecule therapeutics;Staphylococcus aureus;Structure;Surface;synthetic construct;System;Technology;therapeutic RNA;Toxic effect;tumor growth;Vaccination;Virulence,Subcellular protein localization in B. subtilis,11211,NA,NA,NA,NA,16,NA,NA,1785089,NA
11188085,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011212,NA,NA,1ZIABC011212-16,NCI:838395\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10270679 (contact),"HU, YINLING  (contact)",NA,NA,NA,Affect;Antibiotics;Bacteria;carcinogenesis;Carcinogens;Cells;Chemicals;Databases;Development;Disease;Environment;Epithelial Cells;Event;Genetic;Genomic Instability;Genomics;gut bacteria;Homeostasis;Human;IKK alpha;Immune system;Impairment;Inflammation;Investigation;Malignant Neoplasms;Microbe;microorganism;Molecular;Mus;Mutant Strains Mice;Mutation;neoplastic cell;Oncogenic;Organ;Pathway interactions;prevent;Reporting;Role;Skin;Skin Cancer;Skin Carcinogenesis;Skin Neoplasms;skin squamous cell carcinoma;Skin tumorigenesis;The Cancer Genome Atlas;Therapeutic;Time;tumor initiation;Tumor Suppressor Proteins;Ultraviolet B Radiation,Functions of IKK alpha in Skin Homeostasis and Skin Tumorigenesis,11212,NA,NA,NA,NA,16,NA,NA,838395,NA
11188086,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011214,NA,NA,1ZIABC011214-16,NCI:1289913\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10270684 (contact),"PARK, JUNG-HYUN  (contact)",NA,NA,NA,Affect;alpha-galactosylceramide;Alternative Splicing;Antibodies;Binding;Cell Physiology;Cell surface;Cell Survival;Cells;Characteristics;chromatin remodeling;conditional knockout;CRISPR/Cas technology;cytokine;Cytokine Receptors;Cytokine Signaling;Data;Development;Family;Generations;Genes;genomic locus;GFI1 gene;Homeostasis;IL17 gene;IL7 gene;Immunity;In Vitro;in vivo;Individual;Inflammatory;interest;Interleukin 2 Receptor Gamma;Interleukin 7 Receptor;Interleukin-15;Interleukin-2;interleukin-21;Interleukin-4;Interleukin-9;Intervention;Investigation;JAK1 gene;JAK3 gene;Knockout Mice;Life;Ligands;Ligation;Link;Maintenance;Mediating;member;Molecular;mouse model;Mus;Mutation;NF-kappa B;novel;nuclear factors of activated T-cells;Nucleic Acid Regulatory Sequences;overexpression;Peripheral;PIK3CG gene;Play;Population;Post-Transcriptional Regulation;Post-Translational Protein Processing;Process;Production;Promoter Regions;protein expression;Proteins;receptor;receptor expression;Receptor Signaling;Regulation;Regulatory Element;Regulatory Pathway;Reporting;Role;RUNX3 gene;Series;Signal Induction;Signal Pathway;Signal Transduction;Stat5 protein;Surface;Systems Analysis;T-Cell Development;T-Lymphocyte;T-Lymphocyte Subsets;Testing;Thymus Gland;Tissues;TNF gene;tool;TRAMP protein;transcription factor;Transcriptional Regulation;Transgenic Mice;Zinc Fingers,Post-Transcriptional Regulation of Interleukin-7 Receptor Expression,11214,NA,NA,NA,NA,16,NA,NA,1289913,NA
11188087,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011215,NA,NA,1ZIABC011215-16,NCI:552819\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10270684 (contact),"PARK, JUNG-HYUN  (contact)",NA,NA,NA,Address;Adverse effects;Animal Model;Binding;CD8-Positive T-Lymphocytes;Cell Lineage;CISH gene;Complementary DNA;cytokine;Cytokine Receptors;Cytokine Signaling;Development;DNA cassette;effector T cell;Elements;embryonic stem cell;Engineering;Family;Feedback;Future;Gene Expression;Generations;Genes;Genetic Transcription;Homeostasis;Human;IL7 gene;Immune;immune activation;Immunology;In Vitro;in vivo;Inflammatory;Interleukin 2 Receptor Gamma;Interleukin 4 Receptor;Interleukin 7 Receptor;Interleukin-4;JAK1 gene;JAK3 gene;Janus kinase;LoxP-flanked allele;Malignant Neoplasms;Mediating;member;Monitor;mouse model;mRNA Expression;Mus;overexpression;Pathway interactions;Peptides;Phosphotransferases;Play;Process;protein degradation;Protein Tyrosine Kinase;receptor;Receptor Inhibition;Receptor Signaling;recruit;Regulation;Reporter;Reporter Genes;Reverse Transcriptase Polymerase Chain Reaction;Role;Signal Pathway;Signal Transduction;Signaling Molecule;Signaling Protein;single-cell RNA sequencing;Stretching;System;T cell differentiation;T memory cell;T-Cell Activation;T-Cell Development;T-Lymphocyte;thymocyte;Thymus Gland;TNFSF5 gene;tool;Transgenes;Transgenic Mice;Tyrosine Phosphorylation;ubiquitin ligase;ubiquitin-protein ligase,Immune Regulatory Roles of Suppressor Of Cytokine Signaling (SOCS) Molecules,11215,NA,NA,NA,NA,16,NA,NA,552819,NA
11188088,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011222,NA,NA,1ZIABC011222-16,NCI:1017460\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10270697 (contact),"SMART, DEEDEE  (contact)",NA,NA,NA,Address;Affect;Animal Model;Astrocytes;Blood - brain barrier anatomy;Brain;Brain Injuries;brain parenchyma;brain tissue;Central Nervous System;Central Nervous System Diseases;Central Nervous System Neoplasms;cerebral microvasculature;clinical efficacy;Clinical Protocols;Cognition;Cranial Irradiation;Development;Disease;hearing impairment;Impaired cognition;improved;In Vitro;interest;Intervention;Ionizing radiation;long-term sequelae;Mediating;Memory impairment;Microglia;Molecular Target;neoplastic cell;Nerve Degeneration;Nervous System Trauma;Neurocognitive;Neurons;novel;Patients;preservation;Process;Radiation;Radiation Dose Unit;radiation mitigator;Radiation therapy;Regimen;side effect;Signal Transduction;Sirtuins;Specimen;Therapeutic;Toxic effect;Vascular Permeabilities,CNS sirtuins in radiation-induced vascular permeability and neurodegeneration,11222,NA,NA,NA,NA,16,NA,NA,1017460,NA
11188089,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011232,NA,NA,1ZIABC011232-16,NCI:353958\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8777873 (contact),"BARCHI, JOSEPH JOHN (contact)",NA,NA,NA,Affect;anti-cancer;Antibodies;Binding;Biological;biophysical techniques;Bladder;Bladder Diseases;Data;design;Epithelial Cells;Epithelium;Glycobiology;Glycopeptides;Goals;Interstitial Cystitis;Lead;Link;Location;methyl group;Molecular Conformation;Morphology;Nature;neoplastic cell;novel;novel anticancer drug;Pain;Patients;Play;receptor;Resolution;Role;scaffold;Serine;sialylation;Threonine;Translating;Tumor Cell Line;Urine;Vaccines;Work,A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead,11232,NA,NA,NA,NA,16,NA,NA,353958,NA
11188090,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011255,NA,NA,1ZIABC011255-15,NCI:2588783\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,1867359 (contact),"HUNTER, KENT WILLIAM (contact)",NA,NA,NA,Adjuvant Chemotherapy;advanced breast cancer;American;Automobile Driving;Bioinformatics;Biology;breast cancer metastasis;burden of illness;Cancer Etiology;Cell Nucleus;Cell Physiology;Cellular Stress;Cessation of life;Clinical;Copy Number Polymorphism;Critical Pathways;Data;Data Set;design;Diagnosis;Discipline;Disease;Distant;driver mutation;epigenomics;Etiology;experience;Future;Gene Proteins;Genes;Genetic;Genetic Transcription;genome-wide;Genomic Instability;genomic locus;Genotype;Goals;Human Genetics;individual response;Inherited;Intervention;Investigation;Localized Disease;Malignant Breast Neoplasm;Malignant Neoplasms;Mammary Neoplasms;Meiosis;member;Messenger RNA;metastatic process;Methods;Modeling;Molecular;Morbidity - disease rate;mortality;mouse genetics;Mouse Mammary Tumor Virus;mouse model;multidisciplinary;Mutation;Neoplasm Metastasis;neoplastic cell;Nuclear;Ontology;Patients;Penetrance;Point Mutation;polyoma middle tumor antigen;precision medicine;Predisposition;prevent;Primary Lesion;Primary Neoplasm;Proteins;Proteomics;Public Health;Recurrence;Relapse;response;RNA;RNA Splicing;Single Nucleotide Polymorphism;Somatic Mutation;Spliceosomes;Survival Rate;Susceptibility Gene;System;Therapeutic;transcriptome sequencing;tumor progression;United States;Variant;Woman,Genetic Modifiers of Initiation and Progression of Mammary Cancer,11255,NA,NA,NA,NA,15,NA,NA,2588783,NA
11188091,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011264,NA,NA,1ZIABC011264-15,NCI:764931\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692263 (contact),"ASHWELL, JONATHAN  (contact)",NA,NA,NA,Ablation;acute T-cell lymphoblastic leukemia cell;Apoptosis;Apoptotic;Biological Process;Cancer cell line;cancer therapy;CD8-Positive T-Lymphocytes;CD8B1 gene;Cell Death;Cell Nucleus;Cell Physiology;Cell Survival;Cells;Cessation of life;Clinical;Clinical Research;CRISPR screen;cytokine;cytotoxic;Data;Deoxycorticosterone;Dexamethasone;Enzymes;Epithelium;Frequencies;Genes;Genetic;Genetic Transcription;Glucocorticoid Receptor;Glucocorticoid-induced apoptosis;Glucocorticoids;Goals;Growth;Half-Life;Hematopoietic;Hematopoietic Neoplasms;histone methyltransferase;Human;Immunosuppressive Agents;Immunotherapy;In Vitro;in vivo;Individual;Infiltration;Investigation;Jurkat Cells;knockout gene;Laboratories;Lymphocyte;Malignant - descriptor;Malignant lymphoid neoplasm;Mature T-Lymphocyte;Mediating;Mus;Mutate;Mutation;Names;overexpression;Parents;PD-1 blockade;pharmacologic;Predisposition;prevent;Process;Regenerative pathway;Regulatory T-Lymphocyte;Reporting;Resistance;T-Cell Activation;T-Cell Development;T-Lymphocyte;Thymus Gland;tumor;tumor growth;tumor progression;Tumor-Derived;Tumor-Infiltrating Lymphocytes;Ubiquitination;Work,Glucocorticoids and T cell development and function,11264,NA,NA,NA,NA,15,NA,NA,764931,NA
11188092,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011267,NA,NA,1ZIABC011267-15,NCI:2272436\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10712491 (contact),"RUDLOFF, UDO  (contact)",NA,NA,NA,Achievement;Address;Amino Acids;analog;Antitumor Response;Binding;Biological;Biological Availability;Blindness;cancer cell;cancer classification;cancer immunotherapy;Cancer Model;Cancer Patient;Canis familiaris;Cell Death Induction;cell killing;Cell Nucleolus;Cell Nucleus;Cells;checkpoint inhibition;Clinical;clinical candidate;clinical translation;Complex;CTLA4 blockade;Data;Dedications;design;Development;Diabetic Retinopathy;Diffuse;Disease;Disseminated Malignant Neoplasm;Dose;drug candidate;Drug Combinations;Drug Design;drug development;drug discovery;Drug Kinetics;effective therapy;efficacy study;Environment;exosome;Eye diseases;Fibrosis;first-in-human;Future;Genome;glycosylation;Goals;Hemorrhage;Human;Immune;immune activation;immune checkpoint;Immune Targeting;Immunologics;Immunooncology;improved;in silico;Inflammatory;inhibitor;innate immune checkpoint;innovation;Interferon Type I;Intramural Research Program;Investigational Therapies;Laboratories;Lesion;Ligation;Liver Fibrosis;Macrophage;Maintenance;Malignant neoplasm of pancreas;Malignant Neoplasms;mannose receptor;manufacture;Maximum Tolerated Dose;Measurement;Measures;Mediating;Medical;Modeling;Modification;molecular marker;Mus;Myeloid Cells;nanobodies;National Center for Advancing Translational Sciences;Neoplasm Metastasis;non-alcoholic fatty liver disease;Non-Insulin-Dependent Diabetes Mellitus;Non-Malignant;novel;novel anticancer drug;Oral;Organ;Pancreas;particle;Patient Selection;Patients;PD-1/PD-L1;PD-L1 blockade;Peptides;Phagocytosis;Pharmaceutical Chemistry;Pharmaceutical Preparations;Phase;phase 1 study;phase 1 testing;phase I trial;Phenotype;Physical condensation;Polymerase;Population;pre-clinical;Pre-Clinical Model;preclinical development;Preclinical Drug Development;preclinical efficacy;preclinical safety;preclinical toxicity;predictive marker;Prevalence;Process;programs;proliferative diabetic retinopathy;Protein Isoforms;Pyrazines;receptor;recruit;Regimen;Reporting;Research;research clinical testing;resistance mechanism;response;Ribonucleoproteins;Ribosomal RNA;Ribosomes;Safety;safety study;Sarcoma;Schedule;screening;Sentinel;Serum;sialylation;Signal Transduction;small molecule;small molecule inhibitor;small molecule libraries;Solid;Solid Neoplasm;T-Cell Activation;Tablets;Therapeutic;therapeutic development;therapy development;Toxic effect;Toxicokinetics;TP53 gene;Translating;tumor;Tumor-associated macrophages;Work,Preclinical drug development in pancreatic cancer,11267,NA,NA,NA,NA,15,NA,NA,2272436,NA
11188093,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011286,NA,NA,1ZIABC011286-15,NCI:802871\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16161791 (contact),"NILUBOL, NARIS  (contact)",NA,NA,NA,3-Dimensional;Adherent Culture;Adrenal Cortex Hormones;Adrenocortical Carcinoma;Agreement;anaplastic thyroid cancer;Apoptosis;Auranofin;Autophagocytosis;biological adaptation to stress;Biological Assay;BRCA1 gene;cancer care;Cancer Patient;Candidate Disease Gene;candidate selection;candidate validation;CASP3 gene;Caspase;CCNB1 gene;CDC2 gene;Cell Cycle Arrest;Cell Death;Cell Line;Cell Proliferation;Cells;CHEK1 gene;Client;Clinical;Clinical Trials;Clustered Regularly Interspaced Short Palindromic Repeats;Coculture Techniques;Combined Modality Therapy;computerized;CTNNB1 gene;Custom;cytotoxic;Data;Databases;Development;differential expression;Disease-Free Survival;DNA Double Strand Break;Dose;Down-Regulation;Drug Combinations;Drug Delivery Systems;efficacy validation;Enzymes;Epithelium;Exclusion;Family;Fibroblasts;Fractionated radiotherapy;FRAP1 gene;Genes;Goals;Heat-Shock Proteins 90;High Pressure Liquid Chromatography;high-throughput drug screening;Hyaluronan;Hydrocortisone;improved;In Vitro;in vivo;Induction of Apoptosis;inhibitor;interstitial;Invaded;Iodine;Label;Libraries;Lipid Peroxidation;LOX gene;malignant endocrine gland neoplasm;Malignant neoplasm of thyroid;Malignant Neoplasms;Manuscripts;Mesenchymal;Messenger RNA;Migration Assay;Mitotic;Molecular;molecular targeted therapies;mRNA Expression;multiple omics;Mus;Mutation;nanoGold;novel;novel anticancer drug;Nuclear Translocation;Operative Surgical Procedures;Organoids;overexpression;Oxidative Stress;Paclitaxel;Pathway interactions;Patients;Penetration;Pharmaceutical Preparations;phosphoproteomics;PIK3CG gene;Play;Preparation;pressure;Prognostic Marker;Protein Isoforms;Proto-Oncogene Proteins c-akt;public database;Quality of life;radiation resistance;Radiation therapy;Radiation Tolerance;Radiation-Sensitizing Agents;Recombinants;Recurrence;repaired;Resistance;Role;Sampling;Scheme;Science;screening;Signal Transduction;SMARCA4 gene;spheroids;Strategic Planning;Survivors;synergism;therapeutic target;thioredoxin reductase;TNF gene;transcriptome sequencing;Transforming Growth Factor beta;treatment effect;Treatment Efficacy;treatment group;tumor;Tumor Burden;Validation;Vascular Endothelial Growth Factors;Vascular Permeabilities;Work;Xenograft procedure,Therapeutic targets and novel anticancer agents for endocrine cancers,11286,NA,NA,NA,NA,15,NA,NA,802871,NA
11188094,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011293,NA,NA,1ZIABC011293-15,NCI:2430584\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8616134 (contact),"OBERDOERFFER, SHALINI  (contact)",NA,NA,NA,"5&apos; Untranslated Regions;Ablation;Acetylation;Acetyltransferase;Address;Behavior;Binding;Biology;cancer cell;Carbon;Cell Cycle;Cell division;Cell Line;Cell Physiology;Cell Proliferation;Cells;Chemicals;Code;cohort;CpG dinucleotide;Cytidine;Cytosine;Development;Disease;DNA;DNA Methylation;DNA-Binding Proteins;Enzymes;Epigenetic Process;epigenome;epitranscriptome;Etiology;Event;Exclusion;Exons;Future;Gene Expression;Genes;Genetic Code;Genetic Transcription;Human;Kinetics;Laboratories;Life;Life Cycle Stages;Location;Malignant Neoplasms;Mammals;Maps;Medicine;Messenger RNA;Methylation;methylome;Modification;Molecular;Mutation;Nature;next generation;novel;novel therapeutic intervention;Nucleic Acids;nucleobase;Nucleotides;Outcome;oxidation;Physiological;Post-Translational Regulation;Protein translocation;Proteins;Proteome;Regulation;Reporter;Research;RNA;RNA metabolism;RNA Polymerase II;RNA Processing;RNA Splicing;RNA, Messenger, Splicing;Role;Shapes;Site;Spliceosome Assembly Pathway;Technology;tool;Transcript;Transcription Initiation;transcriptome;Translation Initiation;Translation Process;Translational Repression;Translations;Variant",Cytidine modifications in mRNA processing and function,11293,NA,NA,NA,NA,15,NA,NA,2430584,NA
11188095,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011303,NA,NA,1ZIABC011303-15,NCI:610483\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10712486 (contact),"LUO, JI  (contact)",NA,NA,NA,Antineoplastic Agents;Autophagocytosis;biological adaptation to stress;Biological Models;Cancer Biology;cancer cell;cancer genome;cancer therapy;Categories;Cells;CHD1 gene;Chromosomal Stability;combinatorial;Dependence;Development;DNA Damage;Drug Targeting;effective therapy;Equilibrium;Evolution;experience;Genes;Genetic;Genetic Screening;Goals;Growth;Immunologic Surveillance;In Vitro;in vivo;Inflammatory;inhibitor;Knowledge;KRAS oncogenesis;KRAS2 gene;Ligase;Malignant Neoplasms;malignant state;Mass Spectrum Analysis;Metabolic stress;Mitotic;Molecular;mutant;Mutate;Neoplasm Metastasis;Normal Cell;novel therapeutics;oncogene addiction;Oncogenes;Oncogenic;Pathway interactions;pharmacologic;Phenotype;Play;Pre-Clinical Model;Proteins;proteotoxicity;Publishing;RAF1 gene;RNA Interference;RNA interference screen;RNA Splicing;Role;Signal Transduction;small molecule;Spliceosomes;Stress;Sumoylation Pathway;targeted treatment;Therapeutic;tumor;Work,Non-oncogene addiction in cancer cells,11303,NA,NA,NA,NA,15,NA,NA,610483,NA
11188096,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011304,NA,NA,1ZIABC011304-15,NCI:244193\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10712486 (contact),"LUO, JI  (contact)",NA,NA,NA,Acceleration;anti-cancer research;cancer cell;cancer genome;Cancer Model;cell behavior;Cells;Collection;combinatorial;Complex;CRISPR library;CRISPR/Cas technology;Dependence;flexibility;gene editing technology;Gene Expression;Gene Mutation;Genes;Genetic;genetic analysis;genetic manipulation;Genetic Screening;genetic testing;genome editing;genome-wide;genomic locus;Genotype;Guide RNA;Human;knock-down;knockout gene;Libraries;Mammalian Cell;Mammalian Genetics;Methods;Modeling;Mus;Mutation;neoplastic cell;paralogous gene;Pattern;preclinical study;Proteins;Publishing;Reagent;RNA Interference;Small Interfering RNA;Somatic Mutation;Technology;tool;tumor;Work,Methods for mammalian genetic analysis,11304,NA,NA,NA,NA,15,NA,NA,244193,NA
11188097,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011306,NA,NA,1ZIABC011306-15,NCI:1060173\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10687117 (contact),"TARASOVA, NADYA  (contact)",NA,NA,NA,Biological Models;CCR;Chemicals;Collaborations;Databases;Development;dimer;Disease;Docking;drug discovery;Drug Targeting;drug-like compound;Equipment and supply inventories;Exclusion;Freedom;Goals;high throughput screening;improved;Industrialization;inhibitor;Knowledge;KRAS2 gene;Libraries;Methodology;Methods;Molecular Weight;mutant;novel;novel strategies;Pathway interactions;Process;programmed cell death ligand 1;protein protein interaction;Proteins;Research;screening;Speed;Ukraine;virtual;virtual library;virtual screening,Inhibitors of protein-protein interactions,11306,NA,NA,NA,NA,15,NA,NA,1060173,NA
11188098,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011311,NA,NA,1ZIABC011311-15,NCI:1421526\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6809564 (contact),"SHARAN, SHYAM  (contact)",NA,NA,NA,Affect;Alleles;Allografting;Apoptosis;Biological;Biological Assay;BRCA deficient;BRCA1 gene;BRCA2 gene;BRCA2 Mutation;Breast;Cell Cycle Arrest;Cell Cycle Checkpoint;Cell Death;Cell division;Cell Line;Cell Survival;cell type;Cells;Chromosome abnormality;Clone Cells;coping;CRISPR/Cas technology;Cytogenetics;Cytoprotection;Data Set;Defect;Development;DNA;DNA Damage;DNA Repair;DNA replication fork;Double Strand Break Repair;Embryo;embryonic stem cell;Epithelium;ESR1 gene;Essential Genes;Estrogen receptor positive;Estrogen Therapy;Estrogens;Fibroblasts;Flap Endonucleases;G2 Phase;Genes;Genetic;Genetic Screening;Genome;Genomic Instability;Germ-Line Mutation;Goals;Growth;homologous recombination;homologous recombination deficiency;Human Cell Line;Immunoprecipitation;in silico;In Vitro;Individual;Knockout Mice;Laboratories;Lower Organism;Malignant Breast Neoplasm;Malignant neoplasm of ovary;Mammary Neoplasms;Mediating;MLH1 gene;Modeling;Mouse Cell Line;mouse model;Mus;mutant;Mutant Strains Mice;Mutation;mutation carrier;Neoplasms;neoplastic cell;new therapeutic target;nuclease;Okazaki fragments;Organoids;Ovarian;overexpression;Pathway interactions;Patient-Focused Outcomes;Phenotype;Physiological;potential biomarker;predictive marker;Process;Proliferating;Promoter Regions;repaired;Resolution;response;Response Elements;restoration;RNA;RNA primers;RNA Processing;Role;S phase;Sequence Analysis;Somatic Cell;Speed;Stress;Structure;Supporting Cell;System;Tamoxifen;The Cancer Genome Atlas;Tissues;TP53 gene;transcriptome sequencing;tumor;tumor growth;tumorigenesis;Variant;Visualization;whole genome,Identification of genetic interactors of Brca2,11311,NA,NA,NA,NA,15,NA,NA,1421526,NA
11188099,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011313,NA,NA,1ZIABC011313-15,NCI:1214358\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11592582 (contact),"SCHNEIDER, JOEL  (contact)",NA,NA,NA,beta pleated sheet;Biocompatible Materials;biological systems;Buffers;Cells;Characteristics;Charge;Chemical Structure;Chemicals;clinical application;covalent bond;crosslink;design;Diffusion;Electrostatics;Encapsulated;Event;experimental study;Face;Family;Future;Gel;Goals;Hydrogels;Hydrogen Bonding;hydrophilicity;Hydrophobicity;Implant;Ionic Strengths;Knowledge;Light;mechanical behavior;Mechanics;Metal Ion Binding;Methods;Microscopy;Molecular;monomer;Morphology;nanoparticle;Nature;novel;Nucleic Acids;peptide structure;Peptides;Pharmaceutical Preparations;Property;Proteins;Protocols documentation;Publishing;Recovery;response;Sampling;self assembly;small molecule;solid state nuclear magnetic resonance;Solvents;stoichiometry;Structure;Surface;Syringes;System;Temperature;Thinness;Time;Tissues;Water,Design and Utility of Novel Proteinaceous Biomaterials,11313,NA,NA,NA,NA,15,NA,NA,1214358,NA
11188100,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011314,NA,NA,1ZIABC011314-15,NCI:505983\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11592582 (contact),"SCHNEIDER, JOEL  (contact)",NA,NA,NA,Adhesions;Adsorption;amphiphilicity;Anti-Bacterial Agents;Antibiotics;aqueous;Binding;Binding Sites;Buffers;cancer cell;Cell membrane;Cell surface;cell type;Cell Wall;Cell-Matrix Junction;Cells;Characteristics;Charge;Chemicals;Chemistry;clinical translation;Coupled;cycloaddition;design;Development;Drug Delivery Systems;Drug Targeting;Electrostatics;Engineering;Environment;Event;Gel;Hemolysis;human induced pluripotent stem cells;Hydrophobic Surfaces;Hydrophobicity;implant material;Injections;Ligation;Lytic;Maintenance;Membrane;Methods;Molecular Conformation;nanocolloid;novel therapeutics;Pathogenesis;Penetration;Peptides;Periodicity;Pharmaceutical Preparations;Phenotype;Polysaccharides;Polystyrenes;Process;protein aminoacid sequence;Quantum Dots;response;self assembly;Sialic Acids;Site;small molecule;Surface;surface coating;Therapeutic;tool;Vitronectin;Wettability,Development of antibacterial agents and materials,11314,NA,NA,NA,NA,15,NA,NA,505983,NA
11188101,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011321,NA,NA,1ZIABC011321-15,NCI:430786\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8123123 (contact),"LEWANDOSKI, MARK B (contact)",NA,NA,NA,Address;angiogenesis;Behavior Control;bone;Cardiac;cell behavior;Cell Communication;Cell Death;Cells;Chromium;Chronic Kidney Failure;Cis-Acting Sequence;Defect;Disease;Embryo;embryo cell;Embryonic Development;FGFR1 gene;FGFR2 gene;Fibroblast Growth Factor;Fibroblast Growth Factor Receptors;Freezing;Gene Expression;Gene Targeting;Genes;Genomics;Genotype;Goals;Growth Factor Gene;innovation;Malignant Neoplasms;Mesoderm;migration;Mus;mutant;neurogenesis;new technology;Pathology;Play;Proliferating;Publications;RNA;RNA Sequences;Role;Signal Pathway;Signal Transduction;Trans-Activators,Identification and characterization of FGF target genes,11321,NA,NA,NA,NA,15,NA,NA,430786,NA
11188102,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011325,NA,NA,1ZIABC011325-15,NCI:503513\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,2432590 (contact),"REIN, ALAN  (contact)",NA,NA,NA,3-Dimensional;Affect;Atomic Force Microscopy;base;Biology;Biophysics;CCR;Cell Nucleus;Cells;Collaborations;Computing Methodologies;design;Dimensions;dimer;Ebola virus;Elements;Embryo;Endogenous Retroviruses;Equine Infectious Anemia Virus;flexibility;HIV-1;Human;Image;interest;Laboratories;Leg;Methodology;Molecular;Molecular Conformation;Murine leukemia virus;Mus;Nature;Nucleic Acids;Population;Property;Proteins;Reagent;Reporting;Resolution;Response Elements;Retroelements;Retroviridae;rev Protein;RNA;RNA Splicing;Roentgen Rays;Role;Shapes;Sorting;structural biology;Structural Models;Structure;Structure-Activity Relationship;Techniques;three dimensional structure;tool;Viral;Viral Proteins;viral RNA;Virus,Retrovirus Biology,11325,NA,NA,NA,NA,15,NA,NA,503513,NA
11188103,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011328,NA,NA,1ZIABC011328-15,NCI:1869292\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,1940613 (contact),"MELTZER, PAUL S. (contact)",NA,NA,NA,Address;Adjuvant Chemotherapy;Adolescent;Adult;Affect;Age;Bioinformatics;Biological Markers;Biology;Bone neoplasms;Breeding;cancer genome;canine model;Canis familiaris;CCR;Cell Cycle;Cells;chemotherapy;Child;chromothripsis;Classification;Clinical;clinical candidate;Clinical Research;clinically relevant;Clonal Evolution;Clonality;Collaborations;comparative genomics;Complex;Data;Data Set;Deposition;Development;Diagnosis;Disease;DNA Methylation;dog genome;Epigenetic Process;Event;Exclusion;extrachromosomal DNA;Frequencies;Future;gain of function;Gene Dosage;Genes;Genetic;Genome;genomic biomarker;genomic data;Genomic Instability;Geography;Goals;Growth;Histology;Human;human disease;Immunotherapy;Individual;Inflammatory;insight;interest;Knowledge;Laboratories;limb amputation;Malignant - descriptor;Malignant Bone Neoplasm;malignant phenotype;Maps;MicroRNAs;Modeling;Molecular;Morbidity - disease rate;mortality;multidisciplinary;Multiomic Data;Mutation;Neoadjuvant Therapy;Neoplasm Metastasis;next generation sequencing;Normal Cell;novel;novel therapeutic intervention;novel therapeutics;Oncogenic;Oncologist;oncology program;Operative Surgical Procedures;Osteosarcoma;Outcome;Pathway interactions;Patients;Pattern;Pediatric Oncology Group;Postoperative Period;pre-clinical research;Precision therapeutics;pressure;Primary Neoplasm;Prior Chemotherapy;Property;public database;Recurrence;Recurrent disease;Reporting;Resistance;Resources;response;RNA methylation;Role;Sampling;Shapes;Signal Transduction;single cell analysis;Surgical Management;System;targeted treatment;Therapeutic;Time;TP53 gene;transcriptome;Transduction Gene;Translational Research;tumor;tumor initiation;tumor-immune system interactions;Work,Characterization of the Osteosarcoma Genome,11328,NA,NA,NA,NA,15,NA,NA,1869292,NA
11188104,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011332,NA,NA,1ZIABC011332-15,NCI:1339057\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10712506 (contact),"KAPLAN, ROSANDRA  (contact)",NA,NA,NA,Acute Lymphocytic Leukemia;Acute Myelocytic Leukemia;Adhesions;Adjuvant;adolescent patient;Adrenocortical Carcinoma;Adult;angiogenesis;anti-cancer research;Area;Biological Markers;Blood Vessels;Bone Marrow;Breast Carcinoma;cancer cell;cancer therapy;cancer type;Cell Communication;Cell Compartmentation;Cell Survival;Cell Therapy;Cells;Cellular Assay;cellular engineering;Cessation of life;Characteristics;Childhood;Childhood Lymphoma;Circulation;Clinical;Clinical Protocols;Clinical Research;clinical translation;Colon Carcinoma;CSF1R gene;Cyclophosphamide;cytokine;Data;Deposition;design;Disease;Distant;Dose;Dysmyelopoietic Syndromes;efficacy evaluation;Endothelial Cells;Engineering;Environment;Event;Ewings sarcoma;Extracellular Matrix;Fibroblasts;first-in-human;FLT3 gene;fludarabine;Gene Expression;Genes;Genetic Engineering;genetic manipulation;Genomics;Giant Cell Tumors;Glioma;Goals;Growth;Hematopoietic;Hematopoietic Stem Cell Mobilization;hematopoietic stem cell niche;Hematopoietic stem cells;Human;human tissue;Immune;immune checkpoint blockade;Immune Evasion;Immunosuppression;Individual;Infiltration;insight;Interleukin-12;Investigation;Lead;Liver;Lung;Lung Carcinoma;Malignant - descriptor;Malignant Breast Neoplasm;Malignant neoplasm of adrenal cortex;Malignant neoplasm of gastrointestinal tract;Malignant neoplasm of lung;Malignant Neoplasms;manufacture;Mediating;Melanoma;Mesenchymal;Metastatic Neoplasm to the Liver;Metastatic Neoplasm to the Lung;metastatic process;Modeling;Modification;Molecular;monocyte;mouse model;Mus;Mutation;Myelogenous;Myeloid Cells;Myeloid-derived suppressor cells;Nature;Neoplasm Metastasis;neoplastic cell;Neuroblastoma;neurofibroma;novel;novel strategies;Osteosarcoma;Patients;Pediatric Neoplasm;pediatric patients;Pericytes;Pharmaceutical Preparations;Phase;phase I trial;Physiological;Play;Population;pre-clinical;Pre-Clinical Model;preclinical efficacy;preclinical study;prevent;Primary Neoplasm;Process;Program Research Project Grants;programs;Proliferating;Proteins;recruit;Recurrence;Refractory;Regulation;Reproducibility;response;Rhabdomyosarcoma;Role;Running;Sampling;Sarcoma;single cell analysis;Site;small molecule inhibitor;Soil;stem cell niche;Stromal Cells;Structure of parenchyma of lung;T cell response;T cell therapy;Therapeutic;therapeutic target;therapy design;therapy development;Tissues;Translating;translational study;trial planning;tumor;tumor growth;Tumor Immunity;tumor microenvironment;tumor progression;Tumor Promotion;tumor-immune system interactions;Tumor-infiltrating immune cells;Work,Tumor Microenvironment in Cancer Progression,11332,NA,NA,NA,NA,15,NA,NA,1339057,NA
11188105,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011333,NA,NA,1ZIABC011333-15,NCI:462482\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10270697 (contact),"SMART, DEEDEE  (contact)",NA,NA,NA,18 year old;Algorithms;Biological Markers;Brain;brain magnetic resonance imaging;Brain Neoplasms;Clinical Trials;cognitive testing;cohort;Communication;Consensus;Cranial Irradiation;Data;Databases;design;Eligibility Determination;Evaluation;follow-up;gender difference;Histology;human subject;image archival system;Intravenous;Longitudinal Studies;Malignant Neoplasms;Measures;Metastatic malignant neoplasm to brain;MRI Scans;Neuropsychological Tests;Neuropsychology;Outcome;Outcome Measure;Pathologic;patient population;Patients;Performance;Primary Brain Neoplasms;Prognosis;prognostic;Protocols documentation;Quality of life;Questionnaires;Radiation;Radiation therapy;Radiation Therapy Oncology Group;radiomics;Radiosurgery;Sorting;Specimen;Standardization;Testing;treatment effect;United States National Institutes of Health,Neuropsychological outcome measures in patients receiving whole brain radiation,11333,NA,NA,NA,NA,15,NA,NA,462482,NA
11188106,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011334,NA,NA,1ZIABC011334-15,NCI:1339057\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10712506 (contact),"KAPLAN, ROSANDRA  (contact)",NA,NA,NA,Adjuvant Therapy;Adult;aging process;Area;Behavior;Biological Assay;Biological Markers;Blood Vessels;bone circulation;Bone Marrow;cancer cell;cancer type;cell behavior;Cell Communication;Cell Compartmentation;Cell Lineage;Cell Therapy;cell type;Cells;chemotherapy;Chemotherapy and/or radiation;Childhood;chimeric antigen receptor T cells;Clinical;clinical translation;Clinical Trials;Collaborations;Complex;conventional therapy;Correlative Study;CXCR3 gene;Cytometry;Data;delivery vehicle;Development;Disease;Disseminated Malignant Neoplasm;Distant;Effectiveness;Endothelial Cells;endothelial stem cell;Endothelium;Engineering;Environment;epigenetic marker;Epigenetic Process;Equilibrium;Event;experimental study;Extracellular Matrix;Fibroblasts;fighting;Flow Cytometry;Gene Expression Profile;Genetic Engineering;Genetic Screening;Genetic Transcription;Growth;Growth and Development function;Heart Diseases;Hematopoietic;Hematopoietic stem cells;high risk;Human;Immune;immune phagocytosis;Immune response;Immune system;immunoregulation;Immunosuppression;Immunotherapy;improved;in vivo;individualized medicine;Inflammatory;insight;Interleukin-12;Investigation;Laboratories;life span;Liver;Longitudinal Studies;Lung;Malignant Neoplasms;Maps;Measures;Mediating;Mediator;Mesenchymal;Metabolic;metastatic process;microvesicles;Modeling;Molecular;Monitor;monocyte;mouse model;Multicellular Process;Mus;Mutation;Myelogenous;Myeloid Cells;Neoplasm Metastasis;neoplastic cell;Neuroblastoma;novel;Organ Transplantation;Osteosarcoma;Patients;Pericytes;Play;Population;potential biomarker;pre-clinical;preclinical study;predictive tools;Primary Neoplasm;Process;progenitor;prognostic tool;programs;receptor;recruit;Recurrent disease;Relapse;repaired;Research;response;Risk;Role;Shapes;Signal Transduction;single cell sequencing;Site;Solid Neoplasm;specific biomarkers;stem cells;Stromal Cells;System;T cell therapy;T-Lymphocyte;Testing;Therapeutic;therapeutic target;therapy design;timeline;tissue regeneration;tissue repair;transcriptomics;Translating;Translational Research;Transplant-Related Disorder;Treatment Efficacy;tumor;Tumor Immunity;Tumor Markers;tumor microenvironment;tumor progression;tumorigenesis;Universities;Vascular Diseases;Vascular Permeabilities;vesicular release;Work,Biomarkers and Therapeutic Targets in Tumor Microenvironment and Metastasis,11334,NA,NA,NA,NA,15,NA,NA,1339057,NA
11188107,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011337,NA,NA,1ZIABC011337-15,NCI:262744\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9414416 (contact),"YANG, JAMES C (contact)",NA,NA,NA,Adoptive Transfer;Antigen Targeting;Antigens;CCR;Cells;Clone Cells;Cloning;Data;engineered T cells;Engineering;Freezing;Generations;Human;Immune;Immunotherapy;Malignant Neoplasms;Melanoma;Mutation;neoantigens;Normal tissue morphology;Patients;Proteins;Reagent;receptor;Renal Carcinoma;Renal Cell Carcinoma;Specificity;Specimen;T cell therapy;T-Cell Receptor;T-Lymphocyte;tool;tumor,Generation of T-cell receptors recognizing antigens on non-melanoma tumors,11337,NA,NA,NA,NA,15,NA,NA,262744,NA
11188108,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011343,NA,NA,1ZIABC011343-15,NCI:591982\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10712484 (contact),"GRETEN, TIM  (contact)",NA,NA,NA,Cell Physiology;clinical center;Clinical Protocols;Conduct Clinical Trials;Correlative Study;experience;Gastrointestinal Neoplasms;hepatobiliary cancer;Immunotherapy;improved;improved outcome;Malignant neoplasm of gastrointestinal tract;Malignant neoplasm of pancreas;Malignant Neoplasms;Metastatic Neoplasm to the Liver;novel therapeutic intervention;Patient-Focused Outcomes;Patients;Pharmaceutical Preparations;Research;Specimen;T-Lymphocyte;Treatment Efficacy;Treatment Protocols;United States National Institutes of Health;Work,Clinical protocols for the treatment of gastrointestinal cancer,11343,NA,NA,NA,NA,15,NA,NA,591982,NA
11188109,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011344,NA,NA,1ZIABC011344-15,NCI:147995\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10712484 (contact),"GRETEN, TIM  (contact)",NA,NA,NA,Affect;Cell Physiology;Cells;clinical center;Conduct Clinical Trials;Correlative Study;Goals;Immune;improved;Liver;Malignant neoplasm of gastrointestinal tract;Metastatic Neoplasm to the Liver;novel;Patient-Focused Outcomes;Patients;Pharmaceutical Preparations;Primary Neoplasm;Research;Sampling;Specimen;T-Lymphocyte;therapy outcome;Treatment Efficacy;tumor;tumor microenvironment;United States National Institutes of Health;Work,Immune suppressor mechanisms in patients with GI cancer,11344,NA,NA,NA,NA,15,NA,NA,147995,NA
11188110,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011345,NA,NA,1ZIABC011345-15,NCI:2219937\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10712484 (contact),"GRETEN, TIM  (contact)",NA,NA,NA,Affect;Cell Physiology;Cells;Cirrhosis;effective therapy;Environment;fatty liver disease;Frequencies;Genetic;Immune;Immunologic Surveillance;Immunologics;Immunosuppressive Agents;Infection;Inflammation;Liver;Liver diseases;Malignant Neoplasms;microbiome;Mucous Membrane;Mus;novel;Phenotype;Regulatory T-Lymphocyte;Research;T-Lymphocyte;Tumor Escape;tumor growth;Tumor Immunity,Analysis of cancer-related immune suppressor mechanisms in mice,11345,NA,NA,NA,NA,15,NA,NA,2219937,NA
11188111,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011351,NA,NA,1ZIABC011351-15,NCI:1191004\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10687150 (contact),"APOLO, ANDREA  (contact)",NA,NA,NA,Adjuvant Study;anti-PD-L1;Area;bladder transitional cell carcinoma;Cancer Etiology;Cessation of life;Clinical;Cystectomy;Disease;first-in-human;High Prevalence;high risk;Human;IgG1;Immune checkpoint inhibitor;Immunotherapy;improved;improved outcome;inhibiting antibody;Ligands;Malignant neoplasm of urinary bladder;Malignant Neoplasms;men;Modality;Muscle;novel therapeutics;Pathway interactions;Patients;PD-1/PD-L1;pembrolizumab;Phase III Clinical Trials;Principal Investigator;programmed cell death ligand 1;programmed cell death protein 1;programs;Randomized;Reporting;Research;response;Somatic Mutation;targeted agent;Testing;Transitional Cell Carcinoma;treatment choice;Treatment outcome;tumor;tumor microenvironment;Tumor-Infiltrating Lymphocytes;United States;United States Food and Drug Administration;Urothelium;Woman,Bladder Cancer Program,11351,NA,NA,NA,NA,15,NA,NA,1191004,NA
11188112,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011354,NA,NA,1ZIABC011354-15,NCI:780978\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6572212 (contact),"WILSON, WYNDHAM H (contact)",NA,NA,NA,Address;Apoptosis;B-Cell Antigen Receptor;B-Cell Lymphomas;BCL2 gene;Cell Line;Clinical;Collaborations;cytotoxic;Dose;Dose Limiting;Dose Rate;Follicular Lymphoma;Genetic;improved outcome;Individual;IRF4 gene;large cell Diffuse non-Hodgkin&apos;s lymphoma;lenalidomide;Malignant lymphoid neoplasm;Mantle Cell Lymphoma;Modeling;neoplastic cell;NF-kappa B;Pathway interactions;Patients;phase 2 study;Randomized;Receptor Signaling;Refractory;Regimen;Regulation;Relapse;resistance mechanism;response;Safety;Schedule;Stratification;targeted agent;targeted treatment;Toxic effect,Targeted treatment of B-cell Lymphoma,11354,NA,NA,NA,NA,15,NA,NA,780978,NA
11188113,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011372,NA,NA,1ZIABC011372-14,NCI:737726\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11142363 (contact),"TOFILON, PHILIP  (contact)",NA,NA,NA,Adherent Culture;Biology;Brain;Cell Line;Cells;Cues;Data;Diagnosis;Disease;DNA Damage;Environment;established cell line;Evolution;fractionated radiation;Funding;Future;Gene Expression;Gene Expression Profile;Genes;genome-wide;Genotype;Glioblastoma;Glioma;Goals;Growth;Human;improved;In Situ;In Vitro;in vivo;insight;Investigation;Laboratories;Leg;Mediating;Molecular;Molecular Target;neglect;neoplastic cell;novel;novel strategies;Patients;Pattern;Phenotype;Pre-Clinical Model;Process;Proteins;Protocols documentation;Radiation;Radiation Protection;radiation resistance;Radiation therapy;Radiation Tolerance;Radiation-Induced Gene Expression;Radiobiology;radioresistant;Radiosensitization;Recurrence;Regulation;Research;response;Role;SLC12A3 gene;Source;stem-like cell;targeted agent;Testing;transcriptome;Translations;treatment response;Tumor Cell Line;tumor heterogeneity;tumor xenograft;Xenograft procedure,Microenvironmental regulation of glioblastoma radiosensitivity,11372,NA,NA,NA,NA,14,NA,NA,737726,NA
11188114,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011373,NA,NA,1ZIABC011373-14,NCI:737726\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11142363 (contact),"TOFILON, PHILIP  (contact)",NA,NA,NA,Affect;Alternative Splicing;Area;Arginine;Binding;Biogenesis;cancer site;Cell Physiology;Cell Survival;cell type;Characteristics;Clinical Trials;clinically relevant;Data;defined contribution;Evaluation;Event;Gene Expression;Gene Expression Profile;Genes;Genetic Transcription;genome-wide;Goals;Histology;Human Genome;inhibitor;Investigation;Ionizing radiation;irradiation;Malignant Breast Neoplasm;Malignant neoplasm of brain;Malignant neoplasm of central nervous system;Malignant Neoplasms;Measures;Mediating;Messenger RNA;Microarray Analysis;MicroRNAs;Modification;mRNA Precursor;mRNA Translation;neoplastic cell;Nervous System;Neurosciences Research;Normal Cell;novel;Phosphotransferases;Polyribosomes;Post-Transcriptional Regulation;posttranscriptional;Predisposition;Process;Proteins;Radiation;radiation effect;Radiation therapy;Radiation Tolerance;Radiation-Induced Change;Radiation-Sensitizing Agents;Radiosensitization;Research;Ribosomal DNA;Ribosomes;RNA Helicase;RNA Polymerase I;RNA Splicing;RNA-Binding Proteins;Role;Serine;small molecule;Source;Specificity;Testing;Translations;translatome;tumor;Tumor Cell Line,Radiation-induced translational control of gene expression,11373,NA,NA,NA,NA,14,NA,NA,737726,NA
11188115,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011378,NA,NA,1ZIABC011378-14,NCI:671217\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11142369 (contact),"BARR, FREDERIC  (contact)",NA,NA,NA,12q13;13q14;1p36;3&apos; Untranslated Regions;Behavior;Binding;Binding Sites;Biological;Biological Assay;Candidate Disease Gene;candidate identification;Cell Culture System;Cell Line;Cells;Chemicals;Childhood;Complementary DNA;CRISPR/Cas technology;design;directed attention;Doxycycline;Event;experimental study;FOXO1A gene;fusion gene;Gene Amplification;Gene Chips;gene interaction;Genes;Genetic Complementation Test;Genetic Heterogeneity;Genetic Transcription;genome-wide;Genomics;Goals;Growth;Human;Immunohistochemistry;Individual;Malignant Neoplasms;Maps;MicroRNAs;Molecular;Monitor;Mus;MYCN gene;Myoblasts;NIH 3T3 Cells;Oncogenic;Oncoproteins;overexpression;Pathogenesis;Pathway interactions;PAX3 gene;PAX7 gene;Phenotype;Population Growth;Porifera;Process;Proteins;Reagent;Recurrence;Reporter Genes;research study;Rhabdomyosarcoma;RNA;RNA Interference;Role;soft tissue;targeted treatment;Testing;Therapeutic Intervention;therapeutic target;Tissue Microarray;transcriptome sequencing;tumor;tumorigenesis;Untranslated RNA;Up-Regulation;Western Blotting;Work,Studies of amplification in rhabdomyosarcoma,11378,NA,NA,NA,NA,14,NA,NA,671217,NA
11188116,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011381,NA,NA,1ZIABC011381-14,NCI:225162\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11199937 (contact),"SINGER, DINAH S. (contact)",NA,NA,NA,3-Dimensional;Acetylation;Adopted;Affinity;Architecture;Binding;Biochemical;biophysical properties;Biophysics;Bromodomain;C-terminal;Cancer Etiology;Cell Cycle Progression;Chromatin;Chromatin Structure;Clinical;Collaborations;Communities;Cryoelectron Microscopy;Data Set;dimer;Dimerization;Disease;DNA Polymerase II;Elements;Enhancers;Epithelium;experimental study;flexibility;Genetic Transcription;Goals;Histones;Immunology;immunoregulation;In Vitro;in vivo;insight;interest;Laboratories;Length;Libraries;Malignant Neoplasms;Mesenchymal;Molecular;Molecular Conformation;MYC Family Protein;N-terminal;Natural Products;Neoplasm Metastasis;Nuclear;Nut carcinoma;Phase;Phosphotransferases;Physical condensation;Play;Post-Translational Protein Processing;Proteins;recruit;Research;Roentgen Rays;Role;Scanning;small molecule;Structure;therapeutic target;three dimensional structure;Transcription Elongation;transcription factor;Transcriptional Regulation;Transferase;Virus Diseases,Brd4 is an atypical kinase that regulates transcription,11381,NA,NA,NA,NA,14,NA,NA,225162,NA
11188117,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011383,NA,NA,1ZIABC011383-14,NCI:1850850\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11142375 (contact),"LARSON, DANIEL  (contact)",NA,NA,NA,3&apos; Splice Site;Alternative Splicing;Behavior;Binding;Binding Sites;Biophysics;Bone Marrow;Cell Nucleus;Cell Physiology;Cells;Complex;Computer Models;Cytoplasm;Disease;Dysmyelopoietic Syndromes;Eukaryotic Cell;Gene Expression;Gene Expression Regulation;Genetic Transcription;Genomic approach;Goals;Health;helicase;Hematopoiesis;Image;In Vitro;in vivo;Individual;Introns;kinetic model;Kinetics;Laboratories;macromolecule;Messenger RNA;Metabolic;Microscopy;Mitochondria;mitochondrial genome;mitochondrial messenger RNA;Mitochondrial Proteins;Modeling;Molecular;Molecular Target;mRNA Precursor;Nuclear;Oncogenic;Outer Mitochondrial Membrane;Patients;Pattern;Point Mutation;Population;Process;progenitor;Proteins;Regulation;Research;RNA;RNA Splicing;RNA-Binding Proteins;Role;Signal Transduction;single molecule;Site;Spliceosomes;Structure;Tissues;transcriptome sequencing;Translational Repression;Translations;Variant;Visualization;Work,Transcription and Splicing Dynamics in Single Cells,11383,NA,NA,NA,NA,14,NA,NA,1850850,NA
11188118,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011387,NA,NA,1ZIABC011387-14,NCI:713169\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11142369 (contact),"BARR, FREDERIC  (contact)",NA,NA,NA,Animals;Biological Assay;Candidate Disease Gene;cDNA Expression;Cell Culture System;Cell Culture Techniques;Cell Line;Cells;Childhood;Chimeric Proteins;Collaborations;CRISPR/Cas technology;Cultured Cells;Dependence;Development;Doxycycline;Event;Excision;experimental study;FOXO1A gene;fusion gene;Fusion Oncogene Proteins;Gene Fusion;Gene Targeting;Genes;genetic analysis;Genetic study;Genetic Transcription;genome-wide;Goals;Growth;Heterogeneity;Human;In Vitro;in vivo;knock-down;Knock-out;Laboratory mice;Maintenance;Malignant Neoplasms;Methodology;Modeling;Molecular;MYC Family Protein;MYCN gene;Myoblasts;N-Myc Protein;Neoplasm Metastasis;neoplastic cell;novel;Oncogenes;Oncogenic;Oncoproteins;Pathogenicity;Pathway interactions;Patients;PAX3 gene;Pharmacology Study;Phenotype;Point Mutation;Population;Primary Neoplasm;protein expression;Proteins;Recurrence;Recurrent tumor;resistance mechanism;Rhabdomyosarcoma;Role;soft tissue;Study models;System;targeted treatment;Testing;transcription factor;tumor;tumor progression;Tumor-Derived;tumorigenesis;tumorigenic;Variant,Studies of gene fusions in rhabdomyosarcoma,11387,NA,NA,NA,NA,14,NA,NA,713169,NA
11188119,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011391,NA,NA,1ZIABC011391-14,NCI:838395\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10270679 (contact),"HU, YINLING  (contact)",NA,NA,NA,Adenocarcinoma;Amphiregulin;anti-PD-1;anti-PD1 antibodies;Antibody Therapy;Cancer Etiology;Cancer Patient;carcinogenesis;CD4 Positive T Lymphocytes;Cessation of life;CSF1R gene;Development;Disease;Epidermal Growth Factor Receptor;Epithelial Cells;Exclusion;Foamy Macrophage;Genes;Human;IKK alpha;IL4R gene;Immunotherapy;improved;Inflammation;Inflammatory;inhibitor;Interleukin-4;KRAS2 gene;Link;lipid metabolism;Lipids;Lung;Lung Adenocarcinoma;Macrophage;Malignant neoplasm of lung;Malignant Neoplasms;Mediating;Metabolic;migration;Modeling;Motility;mouse model;Mus;Mutant Strains Mice;nutrition;Patients;Phosphotransferases;Prevention;Production;programmed cell death protein 1;Reporting;Role;Signal Transduction;Smoker;Squamous Cell Lung Carcinoma;STAT6 gene;Sterol O-Acyltransferase;TP53 gene;United States,Role of IKK alpha in lung cancer development,11391,NA,NA,NA,NA,14,NA,NA,838395,NA
11188120,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011398,NA,NA,1ZIABC011398-14,NCI:1611553\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11142389 (contact),"WESTLAKE, CHRISTOPHER  (contact)",NA,NA,NA,3-Dimensional;Affect;AKT Signaling Pathway;Animal Model;Apical;Architecture;Binding;Biochemistry;Biophysics;Brain;cancer cell;cell assembly;Cell Culture Techniques;Cell Line;Cell membrane;Cell surface;cell type;Cells;cellular imaging;Cellular Membrane;Centrioles;Cilia;ciliopathy;cilium biogenesis;cilium motility;Collaborations;Communicable Diseases;Communication;Complex;CRISPR/Cas technology;Defect;Development;Disease;disease-causing mutation;Docking;Electron Microscopy;Embryo;Endocrine System Diseases;Epithelial Cells;Erinaceidae;extracellular;Extracellular Space;Family;Female;Fibroblasts;Fishes;Fluorescence;fluorescence imaging;Fluorescence Microscopy;Functional disorder;gain of function;Genetic Diseases;Goals;Growth;Health;Homeostasis;Human;human disease;Human Genetics;imaging approach;Impairment;interdisciplinary approach;Investigation;Knock-out;Laboratories;Link;Lung;Malignant Neoplasms;Manuscripts;Membrane;Mesenchymal;Microscopy;Microtubules;Modeling;Molecular;Monomeric GTP-Binding Proteins;Mothers;Motility;Movement;Mus;Nature;Nervous System Disorder;Neurites;notch protein;Organelles;Paper;Pathway interactions;Photoreceptors;Physiological;PIK3CG gene;Platelet-Derived Growth Factor;Play;Postdoctoral Fellow;Preparation;prevent;Process;Proteomics;Publishing;Pythons;Rana;recruit;Regulation;Reporting;Repression;reproductive function;Research;Role;Signal Transduction;Signal Transduction Pathway;Structure;Subcellular structure;Testing;Time;tool;trafficking;tumorigenesis;ultra high resolution;Universities;Variant;Vesicle;Work;Xenograft procedure,Regulation of Ciliogenesis and Ciliary-related signaling,11398,NA,NA,NA,NA,14,NA,NA,1611553,NA
11188121,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011405,NA,NA,1ZIABC011405-14,NCI:230127\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10686755 (contact),"MERINO, MARIA  (contact)",NA,NA,NA,Cell Survival;Clear cell renal cell carcinoma;Clinical;Development;Diagnosis;Disease Outcome;Gene Expression Regulation;Goals;Histologic;Human;human disease;Inherited;Kidney Neoplasms;Link;liquid biopsy;Malignant Neoplasms;MicroRNAs;miRNA expression profiling;Molecular Classification of Tumors;novel marker;Oncogenes;Patients;Phylogenetic Analysis;Play;Post-Transcriptional Regulation;potential biomarker;Proliferating;Regulation;Renal Carcinoma;Role;Small RNA;Testing;tumor;Tumor Suppressor Genes;tumorigenesis;Urine;VHL Gene Inactivation,microRNA Profiling in the Spectrum of Kidney Tumors,11405,NA,NA,NA,NA,14,NA,NA,230127,NA
11188122,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011415,NA,NA,1ZIABC011415-14,NCI:161912\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11142408 (contact),"KOCHENDERFER, JAMES  (contact)",NA,NA,NA,Allogenic;B lymphoid malignancy;B-Cell Leukemia;Blood;CD19 gene;Cell Transplantation;Cells;cellular transduction;chimeric antigen receptor;chimeric antigen receptor T cells;Clinical Oncology;Clinical Trials;Collaborations;Donor person;engineered T cells;experimental study;Extramural Activities;Goals;Hematopoietic Stem Cell Transplantation;HLA Antigens;Homologous Transplantation;Human Biology;in vivo;Infusion procedures;Journals;Learning;leukemia/lymphoma;Malignant Neoplasms;Memory;Molecular;Patients;professor;Proliferating;Proteins;Publications;Publishing;Relapse;Research Personnel;stem;Stem cell transplant;T cell therapy;T memory cell;T-Lymphocyte;Testing;Work,Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor,11415,NA,NA,NA,NA,14,NA,NA,161912,NA
11188123,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011417,NA,NA,1ZIABC011417-14,NCI:647651\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11142408 (contact),"KOCHENDERFER, JAMES  (contact)",NA,NA,NA,Adoptive Transfer;anti-CD20;Antigens;B cell therapy;B lymphoid malignancy;B-Cell Lymphomas;B-Lymphocytes;Biological;CD19 gene;chimeric antigen receptor;chimeric antigen receptor T cells;Chronic Lymphocytic Leukemia;chronic T-cell leukemia;Clinical Trials;curative treatments;cytokine;design;Effectiveness;Enrollment;FDA approved;Gene Modified;genetically modified cells;Human;improved;Infusion procedures;large cell Diffuse non-Hodgkin&apos;s lymphoma;leukemia/lymphoma;Lymphoma;Membrane;Methods;MS4A1 gene;novel therapeutics;Paper;Patients;pre-clinical;Principal Investigator;Production;Publishing;T-Cell Receptor Therapy;T-Lymphocyte;Testing;Toxic effect,Improved Chimeric Antigen Receptor Therapies B-cell Malignancies,11417,NA,NA,NA,NA,14,NA,NA,647651,NA
11188124,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011418,NA,NA,1ZIABC011418-14,NCI:1663324\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6572356 (contact),"SCHRUMP, DAVID  (contact)",NA,NA,NA,airway epithelium;Antibody Specificity;Asbestos;ASCL1 gene;ATAC-seq;Bioinformatics;Bromodomain;Bromodomains and extra-terminal domain inhibitor;cancer cell;Cancer Patient;cancer stem cell;cancer therapy;carcinogenesis;Cells;ChIP-seq;Chromatin;Chromosome 18;Chromosome Mapping;Chromosomes;cigarette smoke;cigarette smoking;Comb animal structure;Complex;Data;deep sequencing;Deoxyribonuclease I;Deoxyribonucleases;Development;digital;Disease;Distant;DNA;DNA Methylation;DNA replication origin;Enhancers;Environmental Carcinogens;Epigenetic Process;epigenomics;Epithelial Cells;Esophageal Adenocarcinoma;esophageal carcinogenesis;Esophageal Squamous Cell;esophageal squamous cell cancer;Esophagus;Event;Exhibits;experimental study;Exposure to;Fiber;Frequencies;G1/S Transition;Gene Expression Profile;Gene Expression Regulation;gene repression;gene synthesis;Genes;genetic signature;genome-wide;Genomics;glucose metabolism;Growth;Human;Hypersensitivity;Impairment;In Vitro;in vitro Model;in vivo;induced pluripotent stem cell;insight;Journals;knock-down;Knock-out;Legal patent;Length;Link;Lung;lung cancer cell;Malignant neoplasm of esophagus;Malignant neoplasm of lung;Malignant neoplasm of thorax;Malignant Neoplasms;Malignant Pleural Mesothelioma;Manuscripts;Maps;Mediating;Mediator;meetings;Metastatic Neoplasm to the Liver;methylome;Modeling;Mus;Neoplasm Metastasis;Neoplasms;new therapeutic target;NFIC gene;Non-Small-Cell Lung Carcinoma;Normal Cell;novel;novel strategies;Oral;Organ;overexpression;Pathway interactions;patient derived xenograft model;Patients;Peer Review;pluripotency;Polycomb;Prevention;Promoter Regions;Protein Family;Proteins;Publishing;Regulatory Element;Reporting;Repression;Reproducibility;Research;Role;S phase;Sampling;sex;Signal Transduction;Site;Specificity;Specimen;Speed;stem;stem cell model;stem cells;stemness;Surgical Oncology;symposium;Testis;therapy resistant;Thoracic Oncology;Thoracic Surgical Procedures;Time;Tobacco;Transcriptional Regulation;transcriptome;treatment strategy;ubiquitin isopeptidase;Up-Regulation;virtual,Modulating Cancer Stem Cell Signaling in Thoracic Malignancies,11418,NA,NA,NA,NA,14,NA,NA,1663324,NA
11188125,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011419,NA,NA,1ZIABC011419-14,NCI:644685\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201459 (contact),"BYRD, ROBERT  (contact)",NA,NA,NA,ADP-Ribosylation Factors;Attention;Basic Science;Biophysics;Clinical Sciences;Collaborations;collaborative approach;Complex;Family;GTP-Binding Proteins;GTPase-Activating Proteins;In Situ;insight;interest;Investigation;Knowledge;Malignant Neoplasms;Membrane;Membrane Proteins;Molecular Biology;molecular dynamics;Monomeric GTP-Binding Proteins;multidisciplinary;Multiprotein Complexes;Mutation;Neutrons;NMR Spectroscopy;novel therapeutic intervention;Pathway interactions;protein complex;Protein Family;Proteins;Publishing;Research;Research Personnel;Signal Transduction;structural biology;Structural Models;Surface;tool;Uveal Melanoma,Structural Biology of GTPase Activating Proteins,11419,NA,NA,NA,NA,14,NA,NA,644685,NA
11188126,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011422,NA,NA,1ZIABC011422-13,NCI:419198\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10270679 (contact),"HU, YINLING  (contact)",NA,NA,NA,Cancer Model;CD4 Positive T Lymphocytes;Cell Count;Cells;Development;FOXP3 gene;Human;IKK alpha;immune cell infiltrate;Immunotherapy;Infiltration;Lung Adenocarcinoma;lymphoid organ;Macrophage;Oncogenic;organ growth;Pathway interactions;Pattern;Play;Regulatory T-Lymphocyte;Role;T-Cell Development;T-Lymphocyte;targeted cancer therapy;tumor;tumor microenvironment;tumorigenesis,Role of IKK alpha in lymphoid organ development,11422,NA,NA,NA,NA,13,NA,NA,419198,NA
11188127,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011423,NA,NA,1ZIABC011423-13,NCI:755121\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11142369 (contact),"BARR, FREDERIC  (contact)",NA,NA,NA,13q;Alveolar;Architecture;bead chip;Biological;Body Regions;Categories;Cells;Childhood;Childhood Rhabdomyosarcoma;Chromatin;chromosome 8 gain;Classification;Clinical;clinically significant;cohort;Collaborations;Data;density;Development;DICER1 gene;DNA Methylation;DNA methylation profiling;Embryonal Rhabdomyosarcoma;Engineering;Epigenetic Process;Etiology;Event;Family;FGFR4 gene;Fibronectins;FOXO1A gene;Freezing;Gene Fusion;Genes;Genetic Transcription;genome wide methylation;genome-wide;genome-wide analysis;Genomic DNA;Goals;Heterogeneity;Histology;Hypermethylation;Malignant Neoplasms;Methylation;methylation pattern;Molecular;mouse model;Mutation;MYCL1 gene;NF1 gene;Oncogenic;Other Genetics;Outcome;Pathologic;Pathway interactions;Pattern;PAX3 gene;PAX7 gene;Point Mutation;Principal Component Analysis;promoter;Promoter Regions;Publishing;RAS Family Gene;Ras Signaling Pathway;Recurrence;Rhabdomyosarcoma;Sampling;Sarcoma;Skeletal Muscle;soft tissue;Tissue-Specific Gene Expression;Tissues;TP53 gene;tumor;Tumor-Derived,Epigenetic studies in rhabdomyosarcoma,11423,NA,NA,NA,NA,13,NA,NA,755121,NA
11188128,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011427,NA,NA,1ZIABC011427-13,NCI:2157534\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11592663 (contact),"MIETTINEN, MARKKU  (contact)",NA,NA,NA,Adenocarcinoma;Affinity;Antigens;beta catenin;Biology;Brachyury protein;Childhood;Choriocarcinoma;Chromosome Mapping;Classification;Clinical;clinical diagnosis;Clinical Markers;clinically significant;Collaborations;Colon Carcinoma;CTNNB1 gene;Development;Diagnostic;diagnostic biomarker;Elements;Epithelium;gastrointestinal;gastrointestinal carcinoma;Gastrointestinal Stromal Tumors;Gene Fusion;Genetic;Genetic Diseases;Genomics;Germ cell tumor;Goals;hemangiopericytoma;Histologic;Hodgkin Disease;Immunotherapy;insight;Ki-1 Large-Cell Lymphoma;Laboratories;Large-Cell Lymphomas;Lymphoma cell;Malignant Childhood Neoplasm;Melanoma;member;Mesenchymal Cell Neoplasm;Methylation;Mismatch Repair Deficiency;Mutation;Myofibroblastomas;Nerve;Neuroendocrine Tumors;neurofibroma;Neurofibromatosis 1;Non-Cutaneous Melanoma;Nose;novel diagnostics;NTRK1 gene;NTRK3 gene;Nuclear;Paraganglioma;Pathology;Patients;Pediatric Oncology;Peripheral Nerve Sheath Neoplasm;Placenta;placental trophoblasts;Probability;Prognostic Marker;programmed cell death ligand 1;Protocols documentation;Research Personnel;Research Support;Retroperitoneal Space;Sarcoma;Schwann Cells;Signs and Symptoms;Site;Soft Tissue Neoplasms;Soft tissue sarcoma;Squamous cell carcinoma;Tissues;Trophoblastic Neoplasms;tumor;Tumor Biology;tumor progression;United States National Institutes of Health,Immunohistochemical and genomic analysis of tumors,11427,NA,NA,NA,NA,13,NA,NA,2157534,NA
11188129,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011431,NA,NA,1ZIABC011431-13,NCI:984541\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11592667 (contact),"LAZAREVIC, VANJA  (contact)",NA,NA,NA,Autoantigens;Autoimmune;Autoimmunity;autoreactivity;Cells;CNS autoimmune disease;Development;Experimental Autoimmune Encephalomyelitis;Gene Expression Profile;Genetic Transcription;IL17 gene;Infiltration;Inflammation;Laboratories;Mediating;Modeling;Mus;neuroinflammation;Organ;Pathogenesis;Pathogenicity;Pathology;Research;Role;Systems Biology;Tissues;transcription factor;Work,Role of T-bet in the pathogenesis of experimental autoimmune encephalomyelitis,11431,NA,NA,NA,NA,13,NA,NA,984541,NA
11188130,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011433,NA,NA,1ZIABC011433-13,NCI:349303\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11592670 (contact),"TANNER, KANDICE  (contact)",NA,NA,NA,3-Dimensional;Adhesions;Adopted;Adult;Animals;Architecture;Biochemical;Biological;Biomimetics;Biophysics;Blood flow;Brain;Breast;cancer cell;Cardiovascular system;Cell Shape;Cells;Complex;Cues;Distant;Distant Metastasis;Ecology;Endothelium;Environment;Exhibits;experience;extracellular;Extracellular Matrix;Extravasation;Gene Expression;Generations;Genetic Variation;Glioblastoma;Habitats;human model;Hydrogels;Impairment;in vivo;insight;Liquid substance;Lung;Malignant Neoplasms;Maps;Measures;mechanical properties;mechanical signal;Mechanics;Neoplasm Metastasis;neoplastic cell;Normal Cell;optic trap;optical traps;Organ;Penetration;Phenotype;physical property;pressure;Primary Neoplasm;Property;Research;response;Rheology;Role;Rotation;Signal Transduction;Site;System;Techniques;Testing;three dimensional cell culture;Tissues;tumor;tumor progression;viscoelasticity;Zebrafish,The Role of Coherent Rotation in Adult Tissue Remodeling,11433,NA,NA,NA,NA,13,NA,NA,349303,NA
11188131,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011436,NA,NA,1ZIABC011436-13,NCI:2686663\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,1882188 (contact),"PATHAK, VINAY K. (contact)",NA,NA,NA,Academy;Atomic Force Microscopy;Binding;Biological Assay;Capsid;Categories;Cell division;Cell Nucleus;Cells;Chromatin;Complex;Consumption;Cytoplasm;DNA;DNA Integration;Docking;ds-DNA;Enzymes;Exhibits;Fluorescent in Situ Hybridization;Genes;Genetic Transcription;Genome;Goals;Green Fluorescent Proteins;HIV-1;Host Defense;Image;In Situ;Infection;insight;Integration Host Factors;integration site;Kinetics;Label;live cell microscopy;Location;Mammalian Cell;Methods;Modeling;Molecular;Movement;Nuclear;Nuclear Envelope;Nuclear Import;Nuclear Pore;Nuclear Pore Complex;Nucleocapsid Proteins;NUP98 gene;Paper;Phase;Physical condensation;Play;Prize;Process;Proteins;Proviruses;Publications;Publishing;quantitative imaging;residence;Retroviridae;Reverse Transcription;RNA;RNA-Directed DNA Polymerase;Role;Science;Site;Structure;Target Populations;Time;Transcriptional Activation;Travel;United States;Viral;viral DNA;Virus Integration;Virus Replication;whole genome;Work,Viral Replication and Interactions with Host Factors,11436,NA,NA,NA,NA,13,NA,NA,2686663,NA
11188132,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011439,NA,NA,1ZIABC011439-13,NCI:647651\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11142408 (contact),"KOCHENDERFER, JAMES  (contact)",NA,NA,NA,antigen binding;Antigen Targeting;Antigens;B-Lymphocytes;Binding;cancer cell;CAR T cell therapy;Cell Maturation;chimeric antigen receptor;chimeric antigen receptor T cells;Clinical;Clinical Trials;Collaborations;design;Development;Family member;follow-up;Genetic Engineering;Goals;Human;Industry;Laboratory Study;Malignant Neoplasms;Medicine;Molecular;Multicenter Trials;Multiple Myeloma;Mus;Nature;novel;Paper;participant enrollment;Patients;phase I trial;Progression-Free Survivals;Publishing;Refractory;Relapse;Remission Induction;response;SLAM protein;T-Lymphocyte;Testing;Time;trial enrollment;Universities,Development of Chimeric Antigen Receptors Targeting Multiple Myeloma,11439,NA,NA,NA,NA,13,NA,NA,647651,NA
11188133,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011459,NA,NA,1ZIABC011459-13,NCI:1252710\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11592694 (contact),"LONCAREK, JADRANKA  (contact)",NA,NA,NA,Affect;Animals;Architecture;Biogenesis;Biology;Cell Cycle;Cell division;cell motility;Cell Physiology;Cells;Centrioles;Centrosome;Cilia;ciliopathy;cilium motility;Continuous Positive Airway Pressure;Defect;Development;Diagnostic;Disease;Electron Microscopy;Ensure;Event;Genetic Diseases;Goals;Homeostasis;Human;Individual;Investigation;Knowledge;Malignant Neoplasms;Manuscripts;Maps;Membrane;Methods;Microcephaly;Microtubules;Mitotic spindle;Molecular;Multiprotein Complexes;nanoscale;Organelles;Pathologic;Phosphotransferases;PLK1 gene;Preparation;Process;Proteins;Publications;Publishing;receptor;Research;Resolution;Sensory;Signal Transduction;Site;Structure;Therapeutic;Tissues;tumor;Tumor Promotion;tumorigenesis;ultra high resolution,Control of centrosome biogenesis,11459,NA,NA,NA,NA,13,NA,NA,1252710,NA
11188134,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011460,NA,NA,1ZIABC011460-13,NCI:772907\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692553 (contact),"BUCK, CHRISTOPHER  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Acute;Adult;Animal Model;Antibodies;Antibody Response;Antigens;BK Virus;Brain Diseases;Capsid Proteins;Chronic;Clinical;Colorectal Cancer;Development;Disease;Genotype;Goals;Human;human monoclonal antibodies;Human Papillomavirus;Humoral Immunities;Immunocompromised Host;Immunosuppressive Agents;India;Individual;Industry;industry partner;Infection;Injection product;invention;JC Virus;Kidney Diseases;Kidney Transplantation;Legal patent;Lesion;Licensing;Link;Malignant neoplasm of prostate;Malignant neoplasm of urinary bladder;Malignant Neoplasms;Mediating;Mus;neutralizing antibody;novel;Oral;Pathology;Patients;Phase I/II Clinical Trial;Play;Polyomavirus;Polyomavirus Infections;pressure;prevent;Preventive vaccine;Progressive Multifocal Leukoencephalopathy;recombinant virus;renal damage;Resistance;Risk;Role;Route;Serotyping;Serum;Symptoms;System;Therapeutic immunosuppression;tool;Transplant Recipients;Urinary tract;Urine;Vaccination;vaccine development;Vaccines;Variant;Viral;Virion;Virus;virus development;Virus-like particle;Viviparous-1 protein;Work,BKV and JCV vaccine development,11460,NA,NA,NA,NA,13,NA,NA,772907,NA
11188135,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011461,NA,NA,1ZIABC011461-13,NCI:340025\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8123034 (contact),"KEWALRAMANI, VINEET N (contact)",NA,NA,NA,Affect;anti-cancer;Anti-viral Therapy;Biology;C-terminal;Capsid;Cells;chimeric antigen receptor T cells;Chimeric Proteins;Chromatin;Cyclophilin A;gene therapy;Gene Transduction Agent;Genome;HIV-1;Human;improved;Infection;Integration Host Factors;Lentivirus Vector;Maps;Mediating;migration;N-terminal;Nuclear;Nuclear Pore Complex;Nuclear Pore Complex Proteins;Play;Process;Protein Analysis;Protein Isoforms;Proteins;Regulation;Role;Surface;TRIM5 gene;Virus;X-Ray Crystallography,The role of POM121 in HIV-1 infection,11461,NA,NA,NA,NA,13,NA,NA,340025,NA
11188136,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011464,NA,NA,1ZIABC011464-13,NCI:953104\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,1928666 (contact),"MALDARELLI, FRANK  (contact)",NA,NA,NA,Adverse effects;Affect;Anatomy;Angiolymphoid hyperplasia;Anti-Inflammatory Agents;Antibiotics;Antigens;Antineoplastic Agents;antiretroviral therapy;Award;Bacterial Translocation;Binding;Biopsy;Blinded;Blood;Blood - brain barrier anatomy;candidate identification;CCR;CD4 Positive T Lymphocytes;Cells;Central Nervous System;chemotherapy;chimeric antigen receptor T cells;Clinical;clinical effect;Clinical Protocols;Clinical Research;Clonal Expansion;co-infection;Collaborations;comorbidity;Comparative Study;Cryptococcal Meningitis;Data;design;Disease;driving force;Event;experience;fluorodeoxyglucose;gastrointestinal;Goals;gut microbiome;HIV;HIV Infections;HIV therapy;HIV vaccine;HIV/AIDS;immune activation;immune reconstitution;Immune response;Immunologics;Immunomodulators;in vivo;Individual;Infection;Inflammatory;Integration Host Factors;Interferon Alfa-2b;interferon therapy;Interferons;Interruption;Intervention;Intervention Studies;Interventional radiology;Kaposi Sarcoma;Location;Long-Term Effects;lymph nodes;Lymphoid Tissue;Lymphoma;Metabolic;microbiome;Minnesota;multidisciplinary;Mycobacterium tuberculosis;National Institute of Allergy and Infectious Disease;Natural Immunity;neoplastic;non-invasive imaging;Peripheral Blood Lymphocyte;Phylogenetic Analysis;Plasma;Population;Positron-Emission Tomography;prevent;Primates;Production;Progressive Multifocal Leukoencephalopathy;Protocols documentation;Randomized;Regimen;Research Personnel;Resistance;response;Retrovirology;rifaximin;Role;Sampling;SARS-CoV-2 infection;Series;Shapes;Site;Source;Squamous cell carcinoma;Structure;Syndrome;Therapeutic;therapeutic vaccine;Time;Tuberculosis;United States National Institutes of Health;uptake;Vaccination;vaccine trial;Vaccines;Viral;Viremia;Virus,Clinical Interventional Studies of HIV Reservoirs,11464,NA,NA,NA,NA,13,NA,NA,953104,NA
11188137,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011465,NA,NA,1ZIABC011465-13,NCI:775237\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692465 (contact),"LEVENS, DAVID L. (contact)",NA,NA,NA,Affect;Amplifiers;Apoptosis;Biochemical;c-myc Genes;cancer cell;carcinogenesis;CCR;Chromatin;Code;Complex;coping;Coupled;CRISPR screen;design;DNA;DNA Damage;Equilibrium;Event;Fiber;Gene Expression;Genes;Genetic;Genetic Transcription;genome integrity;Growth;Human;In Vitro;Intercept;Investigation;Knock-in Mouse;Malignant Neoplasms;Mechanical Stress;Metabolism;Methods;Molecular;Molecular Conformation;Mutation;MYC gene;Normal Cell;novel;Nuclear;Oncogenes;Oncogenic;Output;Pathologic;Pathologic Processes;Pathway interactions;Phase;Physical condensation;Physiological;Physiological Processes;preservation;Process;Proliferating;promoter;protein function;Proteins;Proto-Oncogenes;Regulation;replication stress;System;Tissues;Topoisomerase;TP53 gene;Transcription Coactivator;Transcription Process;Transcriptional Activation;tumor;tumorigenesis;Variant;virtual;Wit;Work;ZIP protein,c-Myc Function,11465,NA,NA,NA,NA,13,NA,NA,775237,NA
11188138,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011466,NA,NA,1ZIABC011466-13,NCI:1588506\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,1928666 (contact),"MALDARELLI, FRANK  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Affect;Anatomy;Anti-Retroviral Agents;antiretroviral therapy;Autopsy;BACH2 gene;Biological Assay;Blood;Bone Marrow Transplantation;Brain;CCR;CD4 Positive T Lymphocytes;Cd68;CD8B1 gene;Cell Line;Cells;Chimerism;Chronic;clinical center;Clinical Protocols;Clonal Expansion;cohort;Collaborations;Colon;Colonoscopy;Complement;Containment;Data;Development;driving force;Evaluation;Event;Evolution;follow-up;Funding;Future;Gammaretrovirus;Gastrointestinal tract structure;Gene Expression;Genes;Genetic;Goals;Grant;HIV;HIV Drug Resistance Program;HIV-1;homologous recombination;ileum;Immune;Immunohistochemistry;In Vitro;in vivo;Individual;Infection;innovation;insight;integration site;Interruption;Investigation;jejunum;Learning;Long-Term Effects;Lung;Lymphocyte;Lymphoid Tissue;Methodology;Methods;Molecular Virology;National Institute of Allergy and Infectious Disease;National Institute of Neurological Disorders and Stroke;next generation sequencing;novel strategies;Pathology;Pathway interactions;Patients;Penetration;Peripheral Blood Mononuclear Cell;Persons;Pharmaceutical Preparations;Plasma;Population;post-transplant;programs;Proliferating;Protocols documentation;Provirus Integration;Proviruses;Pseudoautosomal Region;Reporting;repository;Research Personnel;Sampling;Sampling Studies;Shapes;Site;Sorting;Source;STAT5B gene;Structure;T-Cell Receptor;T-Lymphocyte;Technology;Therapeutic;Tissues;tool;Transplantation;United States National Institutes of Health;Universities;Viral;Viremia;Virus;virus host interaction;Work;X Chromosome,HIV Persistence During Suppressive Antiretroviral Therapy,11466,NA,NA,NA,NA,13,NA,NA,1588506,NA
11188139,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011469,NA,NA,1ZIABC011469-13,NCI:902657\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11592706 (contact),"BEUTLER, JOHN  (contact)",NA,NA,NA,Actinobacteria class;Agreement;analog;Biological Assay;bioweapon;Boston;Cells;Chemicals;Collaborations;Collection;computerized data processing;Data;design;Development;Funding;gang;Goals;improved;Industrialization;Information Systems;International;Kansas;Kazakhstan;Laboratories;Libraries;material transfer agreement;Methodology;Microbiology;Molecular Target;National Institute of General Medical Sciences;Natural Products;Online Systems;Pharmaceutical Chemistry;Plant Extracts;Plant natural product;Plants;Process;programs;Proteins;repository;Research Personnel;Sampling;Scanning;Science;Scientist;screening;screening program;Series;Soil;Source;Specimen;Structure;System;Technology;Testing;Traditional Medicine;Travel;Tube;Universities;US State;virology,Building Libraries with Chemical Diversity for Screening,11469,NA,NA,NA,NA,13,NA,NA,902657,NA
11188140,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011470,NA,NA,1ZIABC011470-13,NCI:902657\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11592706 (contact),"BEUTLER, JOHN  (contact)",NA,NA,NA,Academia;Actins;addiction;Address;African;Algorithms;Allografting;analog;Animal Model;anti-cancer therapeutic;anticancer activity;Antineoplastic Agents;Benzene;Bioinformatics;Biological Assay;Biological Testing;Breast Cancer cell line;Cancer Cell Growth;Cancer cell line;cell growth;Cell Line;Cells;Cellular Assay;cellular imaging;Central Nervous System;Central Nervous System Neoplasms;Child;Collaborations;Collection;Cytoskeleton;Data;Defect;Deoxyglucose;Dependence;Development;drug candidate;Dryness;Electronics;enantiomer;Esters;Euphorbiaceae;Ewings sarcoma;F-Actin;Formulation;Foundations;Fractionation;Glioblastoma;Glucose;Glycolates;Grant;HSF1;in vitro activity;in vivo Model;inhibitor;Investigation;Iowa;Isomerism;Libraries;Link;Location;Macaranga;Malignant Neoplasms;methyl group;Miniature Swine;Modeling;Molecular Target;Natural Compound;Natural Products;Natural Source;Nature;Neurofibromatosis 1;novel;Optical Rotation;oxysterol binding protein;Pathway interactions;Pattern Recognition;Peripheral Nerve Sheath Neoplasm;Pharmacologic Substance;Pharmacotherapy;Phyllanthus;pi bond;Plants;Play;preclinical development;Province;Renal Carcinoma;Renal Cell Carcinoma;renal toxin;Reporting;Role;Sampling;schweinfurthin A;Sesquiterpenes;Small Interfering RNA;Source;Starvation;stem;Sterols;Structure;Synthesis Chemistry;Tanzania;Testing;Toxic effect;Trees;tumor;Tumor Cell Line;Universities;Variant;Xenograft Model,Development of Natural Product Leads as Anticancer Therapeutics,11470,NA,NA,NA,NA,13,NA,NA,902657,NA
11188141,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011471,NA,NA,1ZIABC011471-13,NCI:1450249\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11592709 (contact),"OKEEFE, BARRY  (contact)",NA,NA,NA,2019-nCoV;assay development;Biochemical;Biological Assay;Cells;Crystallization;Enzymes;inhibitor;interest;Libraries;Malignant Neoplasms;Modification;Molecular Biology;nanomolar;Natural Products;Paper;Phosphotransferases;Process;Productivity;Protein Chemistry;protein protein interaction;Publishing;receptor binding;Role;Sampling;Scanning;screening;Technology,Cell-free assay technologies for the identification of active compounds,11471,NA,NA,NA,NA,13,NA,NA,1450249,NA
11188142,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011472,NA,NA,1ZIABC011472-13,NCI:780903\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11592709 (contact),"OKEEFE, BARRY  (contact)",NA,NA,NA,2019-nCoV;Amino Acid Sequence;analog;Animals;anti-cancer;Antibodies;anticancer activity;aqueous;Biological;Biological Response Modifier Therapy;Clinical;clinical development;Communities;Cyanovirin-N;Evaluation;Extramural Activities;Goals;Homologous Protein;Human;Lectin;Legal patent;Libraries;Ligands;marine;member;Methods;Molecular Biology;Molecular Target;Natural Products;Natural Source;novel;oxidation;peptide natural products;Peptides;Phase I Clinical Trials;Protein Chemistry;Proteins;Publications;Reagent;Research;Research Project Grants;Resistance;Resources;Source;three dimensional structure;Viral Cancer;Work,Isolation of bioactive proteins from natural product extracts,11472,NA,NA,NA,NA,13,NA,NA,780903,NA
11188143,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011486,NA,NA,1ZIABC011486-12,NCI:217617\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692585 (contact),"MITSUYA, HIROAKI  (contact)",NA,NA,NA,Amino Acid Sequence;Amino Acid Substitution;analog;anti-hepatitis B;Anti-viral Agents;Anti-viral Therapy;attenuation;Binding;Binding Sites;Cell-Free System;Cells;cellular imaging;Characteristics;Chemicals;Circular DNA;Cirrhosis;clinical application;Combined Modality Therapy;Compensation;Complex;Cryoelectron Microscopy;Cyclopentenes;Data;deoxyguanosine triphosphate;design;Detection;Detergents;Development;DNA;DNA Primers;Drug resistance;drug resistant virus;entecavir;Escherichia coli;Evaluation;flexibility;Fluorescein-5-isothiocyanate;Genes;Hepatitis B Surface Antigens;Hepatitis B Vaccination;Hepatitis B Virus;Hepatocyte;HIV resistance;HIV-1;Human;Hydrophobicity;Immune;improved;In Vitro;in vivo;Incidence;inhibitor;Integration Host Factors;Interferons;Investigational Therapies;Knowledge;Label;Length;Life;Liver;Liver Cirrhosis;Liver diseases;Measures;Mitochondria;Modification;Molecular;Molecular Chaperones;Mus;mutant;novel;Nucleocapsid;Nucleosides;Nucleosome Core Particle;Oral;Patients;Phase;Phenotype;Play;pol genes;Positioning Attribute;Predisposition;prevent;Primary carcinoma of the liver cells;Prognosis;Property;Proteins;Public Health;Radioisotopes;Reading Frames;Recombinants;Reporting;resistance mutation;Reverse Transcriptase Inhibitors;Ribonuclease H;RNA;Roentgen Rays;Role;Safety;senescence;Site;Solubility;Structure;Surface Antigens;Tertiary Protein Structure;Therapeutic;Toxic effect;tripolyphosphate;Viral;Viral Genome;Virus Diseases;Withholding Treatment;X-Ray Crystallography,Development of Novel Agents Active against Hepatitis B Virus,11486,NA,NA,NA,NA,12,NA,NA,217617,NA
11188144,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011488,NA,NA,1ZIABC011488-12,NCI:2478596\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9712359 (contact),"MEIER, JORDAN LESLIE (contact)",NA,NA,NA,Acceleration;Acetyl Coenzyme A;Acetylation;Acetyltransferase;Address;Amino Acids;Archaeal RNA;Area;Benchmarking;Binding;Biochemical;Biological;Biological Assay;Biological Products;biological systems;Biology;Cancer Biology;Cancer Control;cancer diagnosis;cancer therapy;Cells;Cellular Stress;cellular targeting;Chemicals;chemoproteomics;Clinical Trials;Coenzyme A;CREBBP gene;Cryoelectron Microscopy;Cytidine;Dependence;Deposition;design;Detection;Development;Drug Design;drug discovery;Drug resistance;enzyme activity;Enzymes;EP300 gene;Epigenetic Process;epigenetic regulation;epitranscriptomics;Exhibits;Fumarates;Future;Gene Expression Regulation;Genes;Genetic Transcription;Glean;Goals;Head;Hereditary Leiomyomatosis and Renal Cell Cancer;Hereditary Neoplastic Syndromes;histone acetyltransferase;Inborn Errors of Metabolism;Inherited;inhibitor;insight;Knockout Mice;Malignant Neoplasms;Mediating;Messenger RNA;Metabolic;metabolic abnormality assessment;Metabolism;metabolomics;Methods;Modeling;Modification;Molecular;Monitor;mouse model;Neoplasm Metastasis;new technology;novel;novel strategies;Nucleic Acids;Oncogenic;Oncology;Organism;Pathway interactions;Pharmaceutical Preparations;Pharmacologic Substance;Phosphotransferases;Positioning Attribute;Post-Translational Protein Processing;Predisposition;Proteins;Reaction;Regulation;Reporting;Ribosomes;RNA;Role;Signal Pathway;Signal Transduction;small molecule;small molecule inhibitor;Specific qualifier value;Specificity;Stress;Structure;Technology;Technology Development Study;Therapeutic;Toxic effect;Transfer RNA;Translations;tumor;tumor metabolism;tumorigenic;United States National Institutes of Health;unpublished works;urea cycle;Work,Chemical Biology Platforms to Define the Metabolism-Epigenetics Interface,11488,NA,NA,NA,NA,12,NA,NA,2478596,NA
11188145,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011490,NA,NA,1ZIABC011490-12,NCI:2780315\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,12032120 (contact),"WALTERS, KYLIE  (contact)",NA,NA,NA,anticancer activity;Apoptosis;Binding;Cells;Chemicals;Exhibits;Glues;Goals;Hematologic Neoplasms;inhibitor;multicatalytic endopeptidase complex;Multiple Myeloma;Mus;novel strategies;Process;Proteasome Binding;protein degradation;protein expression;Proteins;receptor;recruit;Signaling Protein;Site-Directed Mutagenesis;skills;small molecule;Structure;Surface;tumor growth;UBE3A gene;Ubiquitin;ubiquitin-protein ligase;Ubiquitination;Xenograft Model,Ubiquitin signaling for protein degradation,11490,NA,NA,NA,NA,12,NA,NA,2780315,NA
11188146,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011491,NA,NA,1ZIABC011491-12,NCI:1533291\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,12032122 (contact),"KELLY, ALEXANDER  (contact)",NA,NA,NA,Affect;Aneuploidy;Antineoplastic Agents;aurora B kinase;Binding;borealin;cancer cell;Cell Culture Techniques;Centromere;Chemicals;Chromatin;chromatin modification;Chromosome Condensation;Chromosome Segregation;Chromosome Structures;Chromosomes;Collaborations;Complex;condensin;Cytokinesis;Defect;DNA;Drug Targeting;egg;Embryo;embryo cell;Ensure;Enzymes;Eukaryota;Event;Evolution;Future;Genome;Genomic Instability;helicase;Hi-C;Histones;Human;inner centromere protein;insight;interdisciplinary approach;interest;Kinetics;Kinetochores;Light;Maintenance;Mammals;Mediating;Meiosis;Microtubules;Mitosis;Mitotic;Molecular;Neoplasm Metastasis;Oocytes;Physical condensation;Play;Post-Translational Protein Processing;Process;Proteins;Regulation;Research;Rod;Role;segregation;Signal Transduction;Sister Chromatid;Site;Somatic Cell;Structure;survivin;Therapeutic Intervention;transcription factor TFIIH;Transcription Initiation;translocase;tumor;vertebrate embryos;Vertebrates;Work;Xenopus,Role of kinetochore proteins in chromosome segregation,11491,NA,NA,NA,NA,12,NA,NA,1533291,NA
11188147,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011492,NA,NA,1ZIABC011492-12,NCI:1733722\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692183 (contact),"HARRIS, CURTIS  (contact)",NA,NA,NA,16S ribosomal RNA sequencing;Acceleration;Acids;Adenocarcinoma;Annual Reports;anti-cancer research;Anti-Inflammatory Agents;Antigen Presentation Pathway;Anus;bench to bedside;Bioinformatics;Biological Assay;Biological Factors;Biological Markers;Blood Platelets;Campylobacter;cancer biomarkers;cancer cell;cancer diagnosis;Cancer Patient;Cancer Prognosis;cancer risk;cancer therapy;carcinogenesis;Case/Control Studies;CD4 Positive T Lymphocytes;Cells;Cholestanes;Clinical;cohort;Collaborations;Colorectal Cancer;computational pipelines;computed tomography screening;Contracts;Creatine;cytokine;Data;Data Set;Detection;Development;Diagnosis;Diagnostic;diagnostic value;Disease;Disease Progression;DNA Methylation;dysbiosis;Early Diagnosis;Environmental Exposure;Esophageal carcinoma;Esophagus;Evaluation;Exposure to;Fusobacterium;Glucuronides;Goals;gut microbiome;health disparity;Healthcare;high risk;high risk population;Human;Hydrocortisone;IL8 gene;immune cell infiltrate;Immunotherapy;improved;In Vitro;Individual;individual patient;Infection;Infiltration;Inflammation;Inflammatory;interleukin-23;Intervention;Investigation;KRAS2 gene;Laboratories;Lactobacillus;Large Intestine Carcinoma;Length;Leptotrichia;Life;liquid biopsy;Liquid Chromatography;low dose computed tomography;Lung;Lung Adenocarcinoma;lung cancer screening;lung carcinogenesis;Macrophage;Malignant neoplasm of lung;Malignant Neoplasms;Measures;Medical;Messenger RNA;metabolome;Metagenomics;Microbe;microbial;microbiome;MicroRNAs;Mitochondria;Modality;Modeling;Molecular;Molecular Analysis;Molecular Carcinogenesis;Molecular Genetics;Monitor;mouse model;Mus;Mutation;Myeloid Cells;Neoplasm Metastasis;neoplastic cell;neutrophil;Neutrophil Infiltration;NF-kappa B;non-smoker;novel;Outcome;Pathway interactions;patient subsets;Patients;Phenotype;Plasma;Play;Population;population based;precision medicine;precision oncology;prevent;Prevention;Prevotella;Prognosis;prognostic;prognostic value;programs;Proteome;Publications;Publishing;recruit;Recurrence;Reporting;Research;Residencies;resident commensals;Resources;response;riboside;Risk;Role;Sampling;Science;screening;screening program;Serum;Signal Transduction;single-cell RNA sequencing;Statistical Data Interpretation;Streptococcus;Sulfate;tandem mass spectrometry;targeted treatment;Taxonomy;Testing;The Cancer Genome Atlas;Therapeutic;therapeutic target;therapy outcome;Tissue Sample;Tissues;TLR4 gene;tool;TP53 gene;transcriptome sequencing;tumor;tumor growth;tumor microenvironment;Tumor Promotion;Tumor Tissue;tumorigenesis;tumorigenic;urea cycle;urinary;Urine;validation studies;Veillonella;Work,Precision Medicine of Cancer,11492,NA,NA,NA,NA,12,NA,NA,1733722,NA
11188148,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011496,NA,NA,1ZIABC011496-12,NCI:2600582\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692183 (contact),"HARRIS, CURTIS  (contact)",NA,NA,NA,Adverse effects;Aging;Alzheimer&apos;s disease model;Antibodies;Aorta;Apoptosis;Area;Astrocytes;Biological Assay;Brain;cancer cell;CAR T cell therapy;CD8-Positive T-Lymphocytes;Cell Aging;Cell Death;Cell Surface Proteins;Cells;chimeric antigen receptor T cells;Chronic Lymphocytic Leukemia;chronic traumatic encephalopathy;Clinical;clinical application;Clinical Trials;Coculture Techniques;Collaborations;Cranial Irradiation;Crossbreeding;Data;Development;DNA Repair;drug candidate;drug repurposing;Drug Screening;Encapsulated;Enterobacteria phage P1 Cre recombinase;Expression Profiling;Fibroblasts;Future;Generations;Genetic Transcription;Genome Stability;Glioblastoma;Goals;Heart;high throughput screening;Human;IL13RA1 gene;Impaired cognition;Impairment;improved;In Vitro;in vivo;in vivo Model;inducible gene expression;Injections;Invaded;knock-down;Knock-in Mouse;Knockout Mice;Leukemic Cell;lipid nanoparticle;liver injury;lung cancer cell;Malignant neoplasm of lung;Malignant Neoplasms;Mediating;Metabolic;metabolome;migration;Modeling;Modification;Molecular;mouse model;Mouse Strains;Mus;mutant;Mutation;Natural Products;Nerve Degeneration;Neurodegenerative Disorders;non-oncogenic;Normal Cell;novel;nutrition;Oncogenic;Organ;Pathology;Pathway interactions;Patients;Pennsylvania;Pharmaceutical Preparations;Phenotype;Primates;Progeria;Proliferating;Property;Protein Isoforms;Proteins;Proteome;Protocols documentation;Publications;Radiation therapy;Refractory;Research;RNA Splicing;ROR1 gene;senescence;senescence associated secretory phenotype;Signal Transduction;Site;Skin;Small Interfering RNA;small molecule libraries;Solid Neoplasm;Syndrome;Tamoxifen;Testing;Therapeutic;Therapeutic Effect;Tissues;TP53 gene;Trademark;Transgenic Mice;Translating;Traumatic Brain Injury;tumor;tumor microenvironment;Tumor Suppression;tumorigenesis;Universities;Xenograft procedure,"p53, Aging, and Cancer",11496,NA,NA,NA,NA,12,NA,NA,2600582,NA
11188149,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011501,NA,NA,1ZIABC011501-12,NCI:1696886\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,12032133 (contact),"MILI, STAVROULA  (contact)",NA,NA,NA,3&apos; Untranslated Regions;Antisense Oligonucleotides;Area;cancer cell;cancer type;cell motility;combat;Complex;Data;Disease;Disease Progression;Goals;Mammalian Cell;Messenger RNA;migration;Molecular Motors;Motor;Neoplasm Metastasis;novel;Pathway interactions;Proteins;recruit;Regulation;RNA;RNA-Binding Proteins;therapeutic target;trafficking;Work,Regulation and functional effects of localized RNAs,11501,NA,NA,NA,NA,12,NA,NA,1696886,NA
11188150,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011502,NA,NA,1ZIABC011502-12,NCI:685821\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,12032135 (contact),"JONES, JENNIFER  (contact)",NA,NA,NA,4T1;biophysical properties;CCR;Colon;Computer software;CT26;Detection;DNA Transposable Elements;Elements;Endogenous Retroviruses;exosome;HCT116 Cells;Human;Immune Evasion;Immune response;Kidney;Knowledge acquisition;Malignant lymphoid neoplasm;Malignant Neoplasms;Mammary Neoplasms;MC38;Methods;microvesicles;Modeling;Mouse Mammary Tumor Virus;Mus;nano;nanoparticle;Neoplasm Metastasis;novel;particle;Patients;PC3 cell line;Phenotype;phenotypic biomarker;Plasma;PPBP gene;pre-clinical;programs;Prostate;Protocols documentation;Publications;Reporting;Research;Resolution;RNA;Sampling;Serum;Site Visit;submicron;Surface;Testing;transcriptome sequencing;treatment response;tumor;Tumor Biology;Tumor Cell Line;Tumor-Derived;United States National Institutes of Health;Viral;Work,Biophysical Characterization of EVPs and other Macromolecular Nanoparticles,11502,NA,NA,NA,NA,12,NA,NA,685821,NA
11188151,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011503,NA,NA,1ZIABC011503-12,NCI:857276\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,12032135 (contact),"JONES, JENNIFER  (contact)",NA,NA,NA,4T1;Blood Vessels;CCR;Cells;Cephalic;Cessation of life;Clinical;clinical practice;Clinical Protocols;clinical translation;Collaborations;curative treatments;Data;design;Disease;Disseminated Malignant Neoplasm;Elements;extracellular vesicles;Goals;Immune;immune activation;Immune response;immunoregulation;Immunosuppression;improved;improved outcome;irradiation;Laboratory Research;liquid biopsy;Malignant Neoplasms;Medical Oncology;Modeling;Mus;nanobiology;Neoplasm Metastasis;neoplastic cell;particle;Patient Care;Patient Monitoring;patient population;Patients;Performance;phosphatidylserine receptor;preclinical study;Process;Protocols documentation;Quality of life;Radiation;Radiation Oncology;Radiation therapy;Research;response to injury;Role;Sampling;Stromal Cells;Stromal Neoplasm;Study Section;Surgical Oncology;System;tissue injury;tool;translational goal;Translational Research;treatment response;tumor;Tumor Markers;tumor progression;United States National Institutes of Health;Unresectable;Work,"Discovery of Tumor, Treatment Response, and Systems-based EVP Signatures",11503,NA,NA,NA,NA,12,NA,NA,857276,NA
11188152,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011504,NA,NA,1ZIABC011504-12,NCI:1578811\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10270570 (contact),"HUANG, JING  (contact)",NA,NA,NA,Affinity;anti-cancer research;Autophagocytosis;Biological Markers;Biological Sciences;Breast Cancer Cell;breast cancer metastasis;CBFB gene;Cell Surface Proteins;Cells;Chromatin;Gene Expression Regulation;Genetic Transcription;Goals;Immune Evasion;Immunocompetent;Immunologic Surveillance;inhibition of autophagy;inhibitor;Malignant Breast Neoplasm;Metastatic Neoplasm to the Lung;Molecular;mutant;Mutation;nanobodies;novel therapeutic intervention;Osteosarcoma;Play;preclinical study;Publishing;Role;Runx2 protein;Testing;TP53 gene;transcription factor;Translating;tumor growth;Work,Vulnerabilities in osteosarcoma and breast cancer,11504,NA,NA,NA,NA,12,NA,NA,1578811,NA
11188153,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011506,NA,NA,1ZIABC011506-12,NCI:1578855\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,12032140 (contact),"SCHNERMANN, MARTIN  (contact)",NA,NA,NA,Aniline;Antibodies;Benzoxazoles;bile duct;Biodistribution;Biological;biomedical imaging;Cells;Chemical Structure;Chemistry;chromophore;Complex;cyanine;Cyclization;design;Development;Development Polarity;Exhibits;experience;Fluorescence;fluorescence-guided surgery;fluorophore;functional group;Image;Image-Guided Surgery;Improve Access;improved;in vivo;in vivo optical imaging;insight;Label;Liver;Malignant Neoplasms;Methods;Microscopy;Modification;Molecular;molecular imaging;nanoparticle;New Agents;novel;novel strategies;optical imaging;Optics;Organic Synthesis;Penetration;Permeability;Pharmaceutical Chemistry;Preparation;Property;Reaction;Reagent;Reporting;research clinical testing;scaffold;Signal Transduction;small molecule;Sodium Acetate;Solid Neoplasm;Subcellular structure;Techniques;Tissues;tumor;uptake;Variant,New Synthetic Approaches to Small Molecules for Imaging,11506,NA,NA,NA,NA,12,NA,NA,1578855,NA
11188154,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011512,NA,NA,1ZIABC011512-12,NCI:180905\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,12032143 (contact),"KOBAYASHI, HISATAKA  (contact)",NA,NA,NA,Angiography;Antibodies;Binding;Biodistribution;Biological;cancer imaging;Cells;Clinical;clinical application;Contrast Media;design;Detection;Diagnostic;dimer;Disease;Electron Transport;flexibility;Fluorescence;fluorescence imaging;Fluorescence Resonance Energy Transfer;Gadolinium;Gamma-glutamyl transferase;Homo;imaging modality;imaging probe;in vivo;Indocyanine Green;Iodine;Label;Lesion;Magnetic Resonance Imaging;Malignant Neoplasms;Molecular;molecular imaging;Operative Surgical Procedures;Optics;pharmacologic;Photons;Procedures;Property;Published Comment;Radioisotopes;Radionuclide Imaging;rational design;Sensitivity and Specificity;Signal Transduction;Specificity;Testing;Tissues;X-Ray Computed Tomography,Activatable molecular cancer imaging probe,11512,NA,NA,NA,NA,12,NA,NA,180905,NA
11188155,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011513,NA,NA,1ZIABC011513-12,NCI:1628150\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,12032143 (contact),"KOBAYASHI, HISATAKA  (contact)",NA,NA,NA,Antibodies;Appearance;Area;cancer cell;Cancer Center;cancer therapy;Cell Death;cell injury;cell killing;Cell membrane;Cell surface;cell type;Cells;chemotherapy;Clinical Trials;Collaborations;Development;Diagnosis;effective therapy;Epidermal Growth Factor Receptor;ERBB2 gene;esophageal squamous cell cancer;Exposure to;FOLH1 gene;Goals;GPC3 gene;Head and neck structure;hydrophilicity;IL2RA gene;Image;imaging modality;imaging probe;improved;Light;Liposomes;Malignant Neoplasms;manufacturing scale-up;Membrane;mesothelin;Mucin 1 protein;Names;nanoparticle;nanoparticle delivery;nanosized;Necrosis;non-invasive imaging;Normal Cell;novel;Penetration;photoimmunotherapy;Photosensitizing Agents;Process;Proteins;Reagent;Sensitivity and Specificity;Singapore;Site;Surgeon;targeted cancer therapy;Therapeutic Effect;Tissues;tumor,Cancer-cell specific therapy: photo-immunotherapy,11513,NA,NA,NA,NA,12,NA,NA,1628150,NA
11188156,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011518,NA,NA,1ZIABC011518-12,NCI:1055155\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10202830 (contact),"LEE, KYUNG  (contact)",NA,NA,NA,Aneuploidy;Architecture;Biochemical Process;Biological Process;Cell Cycle;Cell Physiology;Cells;Centrioles;Centrosome;Chromosome Segregation;Client;Complex;Copying Processes;Defect;Development;Ensure;Eukaryotic Cell;Event;genome integrity;Goals;Human;human disease;Imaging technology;interdisciplinary approach;Life;macromolecular assembly;Malignant Neoplasms;Mediating;Mitotic spindle;Modeling;Molecular;Molecular Weight;mutant;novel;Organism;Pericentriolar Regions;Play;PLK1 gene;Procentriole;Process;Protein Dynamics;Proteins;Research;Role;scaffold;self organization;Shapes;single molecule;Site;Structure;Subcellular structure;Work,Molecular basis of centriole duplication,11518,NA,NA,NA,NA,12,NA,NA,1055155,NA
11188157,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011524,NA,NA,1ZIABC011524-12,NCI:1247511\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11592670 (contact),"TANNER, KANDICE  (contact)",NA,NA,NA,acquired factor;Allografting;Antigen Presentation;Architecture;Atypia;B-Lymphocytes;Bacteria;Bacterial Infections;Basement membrane;Benign;Biological Models;biophysical properties;cancer cell;cell motility;cell type;Cellular Morphology;chemical property;Chemicals;Clinical;Complex;Dermis;Disease;Dysplastic Nevus;Epidermis;Evolution;Extracellular Matrix;Fibroblasts;Glycolysis;Histologic;Human;human model;Immune;immune activation;immune cell infiltrate;Immune system;In Vitro;in vivo;in vivo Model;Individual;Invaded;keratinocyte;Lesion;Macrophage;Major Histocompatibility Complex;Measures;mechanical properties;Mechanics;melanocyte;Melanoma;Metabolic;Metastatic Melanoma;Modeling;morphogens;Mus;Natural Killer Cells;Nevus;Organ;Organ Model;Outcome;Oxidative Phosphorylation;Penetration;Precancerous Melanosis;Primary Neoplasm;Radial;Radial Growth Phase;Regulation;sensor;Signal Pathway;Signal Transduction;Skin tumorigenesis;Subcutaneous Tissue;T-Lymphocyte;Testing;three dimensional cell culture;three-dimensional modeling;Tissues;tumor;tumor metabolism;Tumor Suppressor Proteins;Vertebrates;Vertical Growth Phase;Virus;Work;Xenograft procedure;Zebrafish,Mechanical regulation of the microenvironmental niche in skin tumorigenesis,11524,NA,NA,NA,NA,12,NA,NA,1247511,NA
11188158,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011525,NA,NA,1ZIABC011525-12,NCI:1833254\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,12032154 (contact),"LEE, JUNG-MIN  (contact)",NA,NA,NA,Accent;AKT1 gene;anti-PD-L1;Antibody-drug conjugates;arm;bench to bedside;bevacizumab;Binding;Biological Markers;Biology;Biopsy;Biopsy Specimen;Blood;Blood specimen;Canada;Cancer cell line;Cancer Model;Cancer Patient;Cause of Death;CCR;Cell Cycle;Cell Cycle Arrest;Cell Cycle Checkpoint;Cell Death;cell growth;Cell Proliferation;Cessation of life;Characteristics;CHEK1 gene;chemokine;chemotherapy;Clinic;Clinical;clinical development;Clinical Research;clinical trial protocol;Clinical Trials;Collaborations;Collection;Combined Modality Therapy;Complement;Core Facility;Correlative Study;cytokine;cytotoxicity;Data;design;Development;Disease;DNA Damage;DNA Repair;DNA sequencing;Drug Combinations;Drug resistance;Drug Targeting;effective therapy;Effectiveness;Endometrial Carcinoma;Endothelium;Enrollment;exceptional responders;Gene Expression;Gene Mutation;genome integrity;Genomic Instability;Goals;Gynecologic Oncology Group;helicase;high risk;homologous recombination;Immune;immune checkpoint blockade;improved;In Vitro;in vivo;inhibitor;insight;Interferons;Interruption;Intramural Research Program;Investigation;investigator-initiated trial;Japan;KDR gene;Korea;Laboratories;M cell;Malignant Female Reproductive System Neoplasm;Malignant neoplasm of ovary;Malignant Neoplasms;Manuscripts;Mediating;Mediator;Membrane Glycoproteins;Modeling;Molecular;Molecular Profiling;mRNA Expression;Mutation;Mutation Analysis;National Center for Advancing Translational Sciences;NCI Center for Cancer Research;new therapeutic target;next generation;novel;novel drug combination;novel therapeutics;Oncology;Operative Surgical Procedures;Outcome;Ovarian Carcinoma;Pathway interactions;Patient observation;Patients;Phase;phase 2 study;phase II trial;Phosphotransferases;Physicians;PI3K/AKT;Platinum;Poly(ADP-ribose) Polymerase Inhibitor;pre-clinical;Pre-Clinical Model;pre-clinical research;preclinical study;predictive marker;primary endpoint;programmed cell death ligand 1;programs;prospective;Proteins;Proto-Oncogene Proteins c-akt;recombinational repair;recruit;Recurrence;replication stress;Research;Research Personnel;Resistance;Resolution;response;response biomarker;Science;Scientist;Serous;Signal Transduction;Site;standard of care;stem;Subgroup;TACSTD2 gene;Testing;Therapeutic;therapeutic target;Tissue Sample;TP53 gene;transcriptome sequencing;translational approach;Translational Research;translational research program;translational scientist;translational study;tumor;Tumor Debulking;Tyrosine Kinase Inhibitor;United States;United States National Institutes of Health;Up-Regulation;Woman;Women&apos;s study;women&apos;s treatment;Work,Leveraging DNA damage repair pathways as therapeutic targets in womens cancers,11525,NA,NA,NA,NA,12,NA,NA,1833254,NA
11188159,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011552,NA,NA,1ZIABC011552-11,NCI:1901473\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9414510 (contact),"CITRIN, DEBORAH  (contact)",NA,NA,NA,Aftercare;androgen deprivation therapy;Biochemical;Biological;Biological Markers;biomarker identification;Biopsy;Blood;Cancer Patient;Cancer Therapy Evaluation Program;candidate selection;Characteristics;chemoradiation;chemotherapy;Chemotherapy and/or radiation;Clinical;clinical translation;Clinical Trials;Data;Data Set;Development;effective therapy;Evolution;Failure;Gene Expression Profile;Genetic;genetic signature;Goals;human tissue;imaging modality;In Vitro;in vivo;inhibitor;irradiation;Knowledge;Laboratories;Laboratory Study;Local Therapy;Localized Malignant Neoplasm;Longterm Follow-up;Magnetic Resonance Imaging;Malignant neoplasm of prostate;Malignant Neoplasms;MEK inhibition;MEKs;men;Molecular;Neoadjuvant Therapy;novel;Operative Surgical Procedures;Outcome;participant enrollment;Pathway interactions;patient population;Patients;Phase I Clinical Trials;phase I trial;prognostic;programs;prospective;Prostate;Prostate Cancer therapy;Protocols documentation;Publishing;Radiation;radiation resistance;radiation response;Radiation therapy;Radiation-Sensitizing Agents;Radiobiology;radiological imaging;Radiosensitization;Rectal Cancer;Recurrence;Recurrent disease;Recurrent tumor;Research;Resistance;resistance factors;Risk Factors;Sampling;targeted radiotherapeutic;Therapeutic;Time;Tissues;Transforming Growth Factor beta;treatment strategy;tumor;tumor specificity;Tumor Tissue;Work,Targeting mechanisms of radiation resistance,11552,NA,NA,NA,NA,11,NA,NA,1901473,NA
11188160,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011559,NA,NA,1ZIABC011559-11,NCI:873257\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11592670 (contact),"TANNER, KANDICE  (contact)",NA,NA,NA,Adherence;Animals;Architecture;Biological;Biophysical Process;Biophysics;Blood capillaries;Bone Marrow;Brain;Breast Cancer Cell;Cancer Patient;Cardiovascular system;cell behavior;Cell-Cell Adhesion;Cell-Matrix Junction;Cells;Cellular Morphology;Chemicals;Cues;Disseminated Malignant Neoplasm;Distant;Embryo;Environment;environmental change;Extravasation;Fishes;Genetic;Home;Human;human model;in vivo;Infiltration;Integrins;intravital imaging;intravital microscopy;Knowledge;Lesion;Malignant Neoplasms;Maps;Mechanics;Microbial Biofilms;mortality;mouse model;multimodality;Mus;Neoplasm Metastasis;neoplastic cell;Organ;Patients;personalized predictions;Phase;Phenotype;physical property;pressure;Proliferating;refractory cancer;Regulation;Resistance;Resolution;Role;Signal Transduction;Site;Soil;three dimensional cell culture;tissue mapping;tissue tropism;Tissues;trait;Transcriptional Regulation;tumor;tumor progression;viscoelasticity;Visualization;Zebrafish,The role of the tumor biofilm in determining tissue tropism,11559,NA,NA,NA,NA,11,NA,NA,873257,NA
11188161,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011564,NA,NA,1ZIABC011564-11,NCI:676652\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,12032140 (contact),"SCHNERMANN, MARTIN  (contact)",NA,NA,NA,Address;Animal Model;Antibodies;Binding;CCR;Charge;Chemicals;Chemistry;Clinical;Collaborations;cyanine;design;Development;Drug Delivery Systems;fluorophore;Goals;Hydrophobicity;Image;imaging probe;improved;in vivo;insight;Label;Ligands;Light;Monoclonal Antibodies;new therapeutic target;optical imaging;Optics;Pharmaceutical Preparations;physical property;Play;Property;Role;Series;Site;small molecule;Structure;Testing;therapeutic development;Toxic effect;tumor;tumor microenvironment;uptake;Variant;Work,Applying Optical Approaches to the Drug Delivery Problem,11564,NA,NA,NA,NA,11,NA,NA,676652,NA
11188162,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011566,NA,NA,1ZIABC011566-11,NCI:1691575\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,12448167 (contact),"GU, SHUO  (contact)",NA,NA,NA,Address;Area;Biochemical;Biogenesis;Bioinformatics;Biological;Biological Assay;Biological Process;Cancer Biology;cancer therapy;cancer type;Cells;deep sequencing;design;Development;DICER1 gene;Disease;DNA Sequence Alteration;Encyclopedias;Focus Groups;Gene Expression;Genes;Genetic;Genetic study;Glioblastoma;Goals;Health;Human;human disease;improved;in vivo;insight;interdisciplinary approach;Malignant Neoplasms;Mammals;MicroRNAs;Modification;next generation sequencing;novel;Pathway interactions;Play;Production;programs;Protein Isoforms;Proteins;Regulation;Regulator Genes;Research;Resources;RNA-Binding Proteins;Role;Safety;small hairpin RNA;Syndrome;Therapeutic;therapeutic miRNA;therapeutic target;tool;Translating;tumor;tumorigenesis;Untranslated RNA;uridylate;Work,"Mechanism, Regulation and Application of miRNA pathway in cancer",11566,NA,NA,NA,NA,11,NA,NA,1691575,NA
11188163,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011568,NA,NA,1ZIABC011568-11,NCI:1724356\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355366 (contact),"DU, LIN  (contact)",NA,NA,NA,Advanced Development;Age Years;alternative treatment;analog;anti-cancer;assay development;bioactive natural products;Biochemical;Biochemistry;Biological;Biological Assay;Biology;Cancer Biology;cancer cell;cancer type;CCR;Cell Line;Cell Physiology;Cellular biology;Characteristics;Chemicals;Chemistry;Chimeric Proteins;Collaborations;Collection;Complement;Computational Science;Computer Models;coping;cytotoxic;cytotoxicity;Data Analyses;Datura;design;Development;Digit structure;diketopiperazine;Disease;DNA;DNA Topoisomerases;Enzyme-Linked Immunosorbent Assay;Evaluation;Exhibits;experience;Extramural Activities;Fibrolamellar Hepatocellular Carcinoma;Fingerprint;Fractionation;Gene Fusion;Generations;Genes;Genetic;Goals;HCT116 Cells;high throughput screening;HIV;Immune checkpoint inhibitor;Immunology;improved;Individual;Industrialization;Inositol;insight;interdisciplinary approach;Journals;kinase inhibitor;Large Intestine Carcinoma;Legal patent;Libraries;Link;Malignant neoplasm of liver;Malignant Neoplasms;Manuscripts;marine organism;Merkel cell carcinoma;Mesothelioma;Methodology;Microbe;Modification;Molecular;Molecular Biology;Molecular Probes;Molecular Target;nanomolar;Natural product discovery;Natural Products;Natural Products Chemistry;Natural Source;Neurosecretory Systems;New Agents;novel therapeutics;Oncogenic;Organic Synthesis;Paper;Pathway interactions;patient population;Patients;pembrolizumab;Penicillium;Pharmaceutical Chemistry;Pharmaceutical Preparations;pharmacologic;Pharmacology;Phosphotransferases;Plants;Play;Positioning Attribute;preclinical development;Preparation;PRKCA gene;Process;programs;Proliferating;Protein Chemistry;Protein-Serine-Threonine Kinases;Publications;Reporting;Research;Resources;response;RNA;RNA Virus Infections;Role;scaffold;Scientist;screening;secondary metabolite;Secure;Serine;Sesquiterpenes;Skeleton;skills;Skin Cancer;Source;Specificity;structural biology;Structure;Survival Rate;Synthesis Chemistry;Techniques;Technology;therapeutic development;Topoisomerase;translational potential;tumor;tumorigenesis;United States National Institutes of Health,Natural Products Discovery and Characterization Through Network Collaborations,11568,NA,NA,NA,NA,11,NA,NA,1724356,NA
11188164,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011585,NA,NA,1ZIABC011585-11,NCI:1891367\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11592683 (contact),"SCHNEEKLOTH, JOHN  (contact)",NA,NA,NA,Amino Acid Sequence;Binding;Biological Process;biological systems;cancer initiation;Cells;Code;Communicable Diseases;DNA;DNA Structure;Drug Targeting;drug-like compound;Elements;G-Quartets;Genetic Transcription;Genome;Goals;Human;Human Genome;interest;Label;Laboratories;Libraries;Malignant Neoplasms;Molecular;molecular recognition;new technology;novel;Nucleic Acid Binding;Nucleic Acid Folding;Nucleic Acids;Oligonucleotides;Pharmaceutical Preparations;Phenotype;Proteins;Publishing;RNA;small molecule;Structure;Technology;Transcript;transcriptome;tumor progression;Untranslated RNA;Work,Identification of Nucleic Acid Binding Small Molecules,11585,NA,NA,NA,NA,11,NA,NA,1891367,NA
11188165,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011594,NA,NA,1ZIABC011594-11,NCI:446627\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10687150 (contact),"APOLO, ANDREA  (contact)",NA,NA,NA,adaptive immunity;advanced disease;Adverse event;angiogenesis;Angiogenesis Inhibition;Angiogenesis Inhibitors;Anorexia;Avidity;bevacizumab;Binding;Bladder Adenocarcinoma;Blood;Body Weight decreased;Cancer cell line;Cancer Patient;Carboplatin;Carcinoid Tumor;CCR;CD8-Positive T-Lymphocytes;Cell surface;Cells;checkpoint inhibition;chemotherapy;Cisplatin;Clear cell renal cell carcinoma;Clinical;Clinical Treatment;cohort;Data;Data Pooling;Databases;Dehydration;Diarrhea;Dose;Dose Limiting;effector T cell;Endoglin;Endometrial Carcinoma;ENG gene;Enzymes;Equilibrium;Evaluable Disease;exhaust;Fatigue;Flow Cytometry;Functional disorder;gemcitabine;Goals;granulocyte;HGF gene;Human;Immune;Immune checkpoint inhibitor;immunoregulation;Immunotherapeutic agent;improved;Innate Immune Response;International;ipilimumab;Journals;KDR gene;kidney cell;lenalidomide;Literature;Liver;Malignant neoplasm of penis;Malignant neoplasm of urinary bladder;Manuscripts;MAP Kinase Gene;Mediating;Medicine;Melanoma;Metastatic Renal Cell Cancer;Monoclonal Antibodies;monocyte;Mononuclear;mortality risk;Mucositis;Myelogenous;Myeloid-derived suppressor cells;Nausea;neoplastic cell;neuroendocrine differentiation;Neuroendocrine Tumors;New England;Nivolumab;Non-Small-Cell Lung Carcinoma;Pathway interactions;Patients;peripheral blood;Peripheral Blood Mononuclear Cell;Phase;phase 1 study;phase 2 study;phase 3 study;Phase II Clinical Trials;phase III trial;PIK3CG gene;Placebos;Platinum;Population;Primary carcinoma of the liver cells;programmed cell death protein 1;Progressive Disease;Property;Protein Tyrosine Kinase;Proteins;Randomized;rare cancer;Receptor Protein-Tyrosine Kinases;Recommendation;Recurrence;Regulatory T-Lymphocyte;Renal Cell Carcinoma;Reporting;response;Risk;Running;Safety;safety assessment;Sarcomatoid Features;Sarcomatoid Renal Cell Carcinoma;Series;Signal Pathway;Signal Transduction;small molecule inhibitor;Squamous cell carcinoma;standard care;symposium;T-Lymphocyte;targeted agent;Testing;Therapeutic;Therapeutic Trials;Thyroid Gland;Toxic effect;Transitional Cell Carcinoma;treatment response;triple-negative invasive breast carcinoma;Triplet Multiple Birth;tumor;tumor growth;tumor microenvironment;tumor progression;Unresectable;Urine;Urothelium;Uterine Corpus Carcinosarcoma;Vomiting,Targeting the MET Pathway in Urothelial Carcinoma,11594,NA,NA,NA,NA,11,NA,NA,446627,NA
11188166,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011627,NA,NA,1ZIABC011627-10,NCI:695079\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,12032120 (contact),"WALTERS, KYLIE  (contact)",NA,NA,NA,anti-cancer;Antigens;Binding;biophysical techniques;biophysical tools;Cancer Biology;CD19 gene;CD22 gene;CD28 gene;chimeric antigen receptor;chimeric antigen receptor T cells;Complex;Cryo-electron tomography;cytotoxicity;Disease;Elements;Extracellular Space;FDA approved;G-Quartets;Geometry;Goals;Immunotherapy;leukemia/lymphoma;Leukemic Cell;Link;Malignant Neoplasms;Modeling;MYC gene;myosin VI;neoplastic cell;new therapeutic target;novel;Property;Signal Transduction;small molecule;structural biology;Structure;System;Transmembrane Domain;Ubiquitin,Mechanisms of function and targeting for complexes relevant to cancer biology,11627,NA,NA,NA,NA,10,NA,NA,695079,NA
11188167,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011633,NA,NA,1ZIABC011633-10,NCI:2174340\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14280065 (contact),"BHANDOOLA, AVINASH  (contact)",NA,NA,NA,age related;Bone Marrow;Cell Lineage;cell type;Cells;Clustered Regularly Interspaced Short Palindromic Repeats;Defect;Development;Drug Targeting;epigenomics;Epithelial Cells;fetal;Gene Expression Profiling;Genetic Transcription;Growth;Hematopoietic;Immune;insight;interest;Laboratories;Lymphocyte;Lymphoid Cell;Maintenance;Modeling;Molecular;mouse model;Multiple Myeloma;Mutagenesis;Natural regeneration;notch protein;Organ;Osteoblasts;Plasma Cells;progenitor;programs;Purinoceptor;Role;Signal Transduction;single-cell RNA sequencing;System;T cell response;T-Cell Development;T-Lymphocyte;Technology;Thymic epithelial cell;thymic regeneration;Thymus Gland;Tissues;transcription factor;Work,T cell Development and Regeneration,11633,NA,NA,NA,NA,10,NA,NA,2174340,NA
11188168,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011640,NA,NA,1ZIABC011640-10,NCI:353451\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14280069 (contact),"GILBERT, MARK  (contact)",NA,NA,NA,Adult Glioma;Astrocytes;Bioinformatics;Biological Models;Biology;Brain Neoplasms;Cancer cell line;Cell Culture Techniques;Cell Line;Cells;Cellular biology;Characteristics;Ciliary Neurotrophic Factor;Clinic;Clinical;Collaborations;Computer Analysis;Cytostatics;Data;Database Management Systems;Diffuse intrinsic pontine glioma;DNA methylation profiling;Embryo;Equilibrium;exome sequencing;experimental study;Gene Expression;Gene Expression Profiling;gene function;Genes;Genetic;genetic manipulation;genome-wide;Genomics;Genotype;Glioblastoma;Glioma;glioma cell line;Homeostasis;Human;immunoreaction;improved;In Vitro;in vivo;Laboratories;material transfer agreement;meningioma;Messenger RNA;Metabolic;methylome;miRNA expression profiling;Modeling;Molecular;Molecular Profiling;Mouse Cell Line;Mus;mutant;Mutate;neoplastic cell;nerve stem cell;new therapeutic target;Normal tissue morphology;novel therapeutics;Oncogenes;Pathway interactions;Patients;Peripheral Blood Mononuclear Cell;personalized medicine;Phenotype;pre-clinical;preclinical study;Primary Neoplasm;Research;Resources;screening;Serum;Signal Pathway;Signal Transduction;stem cell biology;stem cell self renewal;stem cells;Study models;System;Technical Expertise;Therapeutic;Therapeutic Agents;tool;transcriptome;transcriptome sequencing;translational study;Tretinoin;tumor;tumor initiation;Tumor Stem Cells;Tumor Suppressor Proteins;tumor xenograft;Tumor-Derived;tumorigenesis;Work,Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas,11640,NA,NA,NA,NA,10,NA,NA,353451,NA
11188169,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011643,NA,NA,1ZIABC011643-10,NCI:494832\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14280069 (contact),"GILBERT, MARK  (contact)",NA,NA,NA,Astrocytoma;Caregivers;Caring;Categories;Central Nervous System Neoplasms;Chordoma;Choroid Plexus Carcinoma;Classification;Clinical;clinical infrastructure;Clinical Trials;Collaborations;Consensus;Data Management Resources;Development;Disease;Education;Ependymoma;Evaluation;Fostering;Funding;Gene Amplification;Gene Fusion;Genomic DNA;Genomics;Glioblastoma;Glioma;Gliomatosis cerebri;Goals;Histones;imaging biomarker;Imaging technology;Immune checkpoint inhibitor;Immunologic Monitoring;immunotherapy trials;improved;Incidence;Infrastructure;International;Investigation;Joints;Knowledge;Laboratories;Malignant - descriptor;Malignant neoplasm of central nervous system;Malignant Neoplasms;Medulloblastoma;member;metabolomics;methylome;Molecular;Molecular Analysis;molecular pathology;Monitor;Monograph;mutant;Mutate;Mutation;National Cancer Institute;Natural History;Neoplasms;Nivolumab;Normal tissue morphology;oligodendroglioma;Oncology;outreach;participant enrollment;Pathogenesis;Pathology;Patient advocacy;patient advocacy group;patient engagement;Patient Participation;Patients;Pediatric Oncology;Persons;phase II trial;Phenotype;pineoblastoma;predicting response;predictive marker;Primary Brain Neoplasms;Primary Neoplasm;prognostic;programs;Proteomics;Provider;Publishing;Qualifying;rare cancer;Rare Diseases;Recruitment Activity;Regimen;Research;Research Personnel;Resources;Rhabdoid Tumor;routine imaging;Sampling;Silicon Dioxide;Testing;Therapeutic;Tissue Banks;treatment response;tumor;Tumor Biology;tumor diagnosis;Tumor Tissue;United States;United States National Institutes of Health,Rare Central Nervous System Cancers Initiative,11643,NA,NA,NA,NA,10,NA,NA,494832,NA
11188170,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011646,NA,NA,1ZIABC011646-10,NCI:1819795\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11142391 (contact),"LAL, ASHISH  (contact)",NA,NA,NA,Attention;Biogenesis;Biology;Cell Cycle Arrest;Cell Line;Cell Physiology;Cell Survival;Colorectal;Colorectal Cancer;DNA Damage;epigenetic regulation;Foundations;Future;Gene Expression;gene repression;Genes;Genetic Transcription;Genome;Goals;Human;human disease;Laboratories;Malignant Neoplasms;MicroRNAs;Mitotic spindle;Modeling;mRNA Precursor;mRNA Stability;mRNA Translation;Mutate;novel;Pathway interactions;Play;Post-Transcriptional Regulation;Proliferating;Regulation;Research;response;RNA Splicing;RNA-Binding Proteins;Role;Signal Transduction;TP53 gene;transcription factor;transcriptome;translational potential;Translational Research;Untranslated RNA,Role of long non-coding RNAs and RNA-binding proteins in p53 signaling,11646,NA,NA,NA,NA,10,NA,NA,1819795,NA
11188171,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011647,NA,NA,1ZIABC011647-10,NCI:494832\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14280069 (contact),"GILBERT, MARK  (contact)",NA,NA,NA,10q;11p;11q;12q13;13q;14q13;19q;1p34;1q32;20p;20q;22q;3q26;8q24;Animals;Apoptosis;Area;Astrocytoma;Automobile Driving;Binding Proteins;Bioinformatics;Biological Assay;Biology;Biotechnology;Brain;Brain Neoplasms;Cancer Genome Anatomy Project;Candidate Disease Gene;CDKN2A gene;cDNA Arrays;Cell Line;Cellular biology;Central Nervous System Neoplasms;Chromatin;chromosome 5q loss;Chromosome abnormality;Classification;Clinical;Collaborations;Complex;Data;Data Analyses;Decarboxylation;Deoxyribonuclease I;Deoxyribonucleases;Development;Dioxygenases;Disease;Disparity;DNA;enzyme activity;Enzymes;Epidermal Growth Factor Receptor;Epigenetic Process;Exhibits;experimental study;expression vector;falls;Gene Chips;gene cloning;gene discovery;Gene Expression;Gene Expression Profile;Gene Expression Profiling;Gene Expression Regulation;Gene Silencing;Genes;Genetic;Genetic Transcription;Genome;genome-wide;Genomics;Glioblastoma;Glioma;Gliomagenesis;Goals;Heterogeneity;Human;Human Genome;Human Genome Project;immunosuppressed;In Vitro;in vivo;insight;Isocitrate Dehydrogenase;Laboratories;Learning;Link;Location;Loss of Heterozygosity;Malignant - descriptor;malignant phenotype;Methods;Methylation;Microarray Analysis;Molecular;Molecular Target;Morphology;Mutation;Neuroglia;Neurons;new technology;new therapeutic target;next generation sequencing;novel;Nuclear;Nucleic Acid Regulatory Sequences;Oncogenes;Operative Surgical Procedures;Pathologic;Patients;permissiveness;postmitotic;Process;Proliferating;Protocols documentation;PTEN gene;Receptor Biology and Gene Expression;Recurrence;Reproducibility;Role;Sampling;self-renewal;Signal Transduction Pathway;Site;SNP array;Specimen;stem cells;Structure;Testing;Therapeutic Intervention;Tissues;TP53 gene;transcription factor;transcriptome;Transplantation;tumor;Tumor Biology;Tumor Suppressor Genes;Tumor Suppressor Proteins;Tumor Tissue;tumorigenesis;tumorigenic;Work;Xenograft procedure,Identifying New Glioma-Associated Tumor Suppressors and Oncogenes,11647,NA,NA,NA,NA,10,NA,NA,494832,NA
11188172,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011648,NA,NA,1ZIABC011648-10,NCI:1603147\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14280074 (contact),"SRINIVASAN, RAMAPRASAD  (contact)",NA,NA,NA,Accounting;aerobic glycolysis;Automobile Driving;Awareness;bevacizumab;Biochemical;biological adaptation to stress;Cancer Therapy Evaluation Program;Cessation of life;Citric Acid Cycle;Clear Cell;Clinical;cohort;Constitution;Dasatinib;Data;Dedications;Dependence;design;Development;Disease;disease model;Early Therapeutic-Clinical Trials Network;effective therapy;Enzymes;Erlotinib;Evaluation;forging;Foundations;FRAP1 gene;Fumarate Hydratase;Gene Family;Genes;Genetic;Genomics;Germ Lines;Hereditary Leiomyomatosis and Renal Cell Cancer;Histologic;HSP 90 inhibition;Immune checkpoint inhibitor;Individual;inhibitor;interest;International;Kidney;Laboratories;Lead;Malignant Neoplasms;Manuscripts;meetings;Metabolic;Molecular;molecular marker;Mutation;Oxidative Stress;Paper;Papillary;Pathway interactions;Patient Care;Patients;PD-1 inhibitors;PDL1 inhibitors;pharmacologic;Phase;phase 2 study;Pre-Clinical Model;programs;Publishing;Regimen;Renal Carcinoma;Renal Cell Carcinoma;Research;Research Personnel;response;standard of care;Systemic Therapy;targeted agent;TFE3 gene;Therapeutic;tongue papilla;transcription factor;translational scientist;treatment strategy;Triplet Multiple Birth;tumor;United States;Variant;Vascular Endothelial Growth Factors,Targeting Genetic and Metabolic Alterations in Distinct Subtypes of RCC,11648,NA,NA,NA,NA,10,NA,NA,1603147,NA
11188173,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011650,NA,NA,1ZIABC011650-10,NCI:227701\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14821366 (contact),"LIPKOWITZ, STANLEY  (contact)",NA,NA,NA,African American;Age;alpelisib;Animal Model;biobank;Blood;Blood coagulation;Breast Cancer Patient;Characteristics;Clinical;clinical center;Clinical Trials;Collaborations;Credentialing;Data;Databases;DNA;Dose;Enrollment;Epidermal Growth Factor Receptor;Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Estrogen receptor negative;exome sequencing;Genomics;Germ Lines;Goals;high risk;Hospitals;human old age (65+);In Vitro;inhibitor;Malignant Breast Neoplasm;Mammary Neoplasms;Medical center;medical schools;Metaplastic carcinoma of the breast;Methodist Church;Military Personnel;Molecular;Multivariate Analysis;Nature;older women;Outcome;Paclitaxel;patient population;Patients;Phase;phase 2 study;Phase I/II Clinical Trial;PIK3CA gene;preclinical study;Prognosis;Proteomics;Publications;rare cancer;Recommendation;Research Institute;Sampling;Tissue Banks;transcriptome sequencing;tumor;United States National Institutes of Health;Woman;women&apos;s diagnosis;women&apos;s outcomes;Work;young woman,Genomic characterization of breast cancer in high risk subsets of breast cancer,11650,NA,NA,NA,NA,10,NA,NA,227701,NA
11188174,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011651,NA,NA,1ZIABC011651-10,NCI:525487\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9414416 (contact),"YANG, JAMES C (contact)",NA,NA,NA,anti-PD1 antibodies;Back;Cancer Etiology;Cells;Cessation of life;Clinical;Clinical Research;Development;Disease;Human;Immune response;Immunotherapy;Laboratory Study;Malignant neoplasm of lung;Malignant Neoplasms;Mutate;Mutation;neoantigens;Non-Small-Cell Lung Carcinoma;Operative Surgical Procedures;patient subsets;Patients;Phenotype;Proteins;Publishing;Specimen;T-Lymphocyte;Testing;tumor;Tumor-Infiltrating Lymphocytes,Laboratory and Clinical studies on T-cells recognizing Non-Small Cell Lung Cancer,11651,NA,NA,NA,NA,10,NA,NA,525487,NA
11188175,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011652,NA,NA,1ZIABC011652-10,NCI:475248\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14280079 (contact),"ALEWINE, CHRISTINE  (contact)",NA,NA,NA,Abdominal Cavity;Address;advanced disease;Agonist;Angiogenesis Inhibitors;antagonist;Antibodies;Binding;Blood;Blood Vessels;cancer cell;Cancer Patient;Cell Line;Cell surface;Clinical Trials;Collaborations;Cytotoxin;Data;density;Deposition;design;Disease;Enrollment;Extramural Activities;Goals;Heart;Human;Immune;Immune system;Immunocompetent;Impairment;improved;Integrins;Interleukin-15;Knock-in;KPC model;Lung;Lymphocyte Activation;Macrophage;Malignant neoplasm of pancreas;Manuscripts;Medical;Membrane;mesothelin;Modeling;Mus;Neoplasm Metastasis;Normal Cell;novel;Pancreatic Ductal Adenocarcinoma;pancreatic ductal adenocarcinoma cell;pancreatic ductal adenocarcinoma model;Pathway interactions;Patients;Penetration;Peritoneum;Pharmaceutical Preparations;Phase;Physiology;Precision therapeutics;Property;Proteins;response;Role;targeted treatment;Testing;Therapeutic;therapy resistant;Toxic effect;Transforming Growth Factor beta;tumor;Tumor Antigens;Work;wound healing,Precision Therapy to Target Pancreatic Ductal Adenocarcinoma,11652,NA,NA,NA,NA,10,NA,NA,475248,NA
11188176,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011657,NA,NA,1ZIABC011657-10,NCI:2631114\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14280083 (contact),"HOANG, CHUONG  (contact)",NA,NA,NA,3-Dimensional;anti-cancer;Antineoplastic Agents;Bioinformatics;Biology;biomarker discovery;bioprinting;Biopsy;cancer cell;cancer type;Cell model;cell type;Cells;Characteristics;Chemicals;Chemistry;Chest;Clinical;Collaborations;combinatorial;Complex;design;Development;Diagnosis;Drug Targeting;Epigenetic Process;Evaluation;Film;functional genomics;Future;Genes;Goals;Human;human tissue;Hydrogels;in vivo;Induction of Apoptosis;innovation;insight;Interdisciplinary Study;interest;Investigation;Knowledge;Legal patent;Lesion;Malignant neoplasm of thorax;Malignant Neoplasms;Malignant Pleural Mesothelioma;manufacture;manufacturing scale-up;materials science;Membrane;Mesothelial Cell;Mesothelioma;method development;Methods;MicroRNAs;Modeling;Molecular;nanoparticle;nanoscale;neoplastic cell;next generation;Non-Small-Cell Lung Carcinoma;novel;novel drug class;Nucleic Acids;Organ;Outcome;Pathogenicity;Pathway interactions;Patients;Peptides;Performance;Pharmaceutical Preparations;Pleura;Pleural;preclinical development;preclinical study;Prognosis;Regimen;Reporting;Research;Research Project Grants;response;screening;small molecule;Surface;System;Systems Biology;Techniques;Testing;Therapeutic;therapeutic candidate;therapeutic miRNA;Thinness;Thymus Epithelial Neoplasm;Time;Tissues;tool;TP53 gene;transcription factor;Translating;Translational Research;Translations;tumor;tumor initiation;tumorigenesis;Untranslated RNA;Update;Xenograft procedure,microRNA-based and novel molecular therapeutics in thoracic cancers,11657,NA,NA,NA,NA,10,NA,NA,2631114,NA
11188177,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011659,NA,NA,1ZIABC011659-10,NCI:3152925\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14280085 (contact),"KANAKRY, CHRISTOPHER  (contact)",NA,NA,NA,Acute Graft Versus Host Disease;Allogeneic Bone Marrow Transplantation;Bone Marrow Transplantation;chimeric antigen receptor T cells;Clinic;Clinical;clinical efficacy;Clinical Research;clinical trial enrollment;Clinical Trials;cohort;conditioning;Cyclophosphamide;disorder control;Donor Lymphocyte Infusion;Dose;Drug Kinetics;Engraftment;Enrollment;Ensure;follow-up;Goals;graft vs host disease;Hematologic Neoplasms;Hematology;Hematopoietic;HLA Antigens;Human;Immune;Immunologics;improved;improved outcome;Institution;Laboratories;Laboratory Research;Major Histocompatibility Complex;Manuscripts;Mixed Lymphocyte Culture Test;Modeling;Modification;mouse model;Mus;Non-Malignant;novel strategies;Outcome;patient population;Patient-Focused Outcomes;Patients;Peripheral Stem Cell Transplantation;Phase;post-transplant;prevent;Prevention;prophylactic;Recovery;Relapse;Risk Reduction;Siblings;standard of care;stem;T-Lymphocyte;Toxic effect;Translating;Translations;transplant model;Transplant-Related Disorder;Transplantation;Work,Deciphering the efficacy of posttransplant cyclophosphamide in BMT,11659,NA,NA,NA,NA,10,NA,NA,3152925,NA
11188178,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011666,NA,NA,1ZIABC011666-10,NCI:423890\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8123119 (contact),"NICKLAUS, MARC  (contact)",NA,NA,NA,2019-nCoV;Behavior;Binding Proteins;cancer initiation;Chemicals;Chemistry;Clinical;Collaborations;computer generated;cost effective;Custom;Data;Databases;Development;drug candidate;drug development;Equipment and supply inventories;functional group;Future;Generations;Germany;Growth;HIV-1;in silico;Informatics;International;knowledgebase;Language;Logic;Malignant Neoplasms;N-terminal;Nature;new therapeutic target;novel;novel therapeutics;Outcome;Paper;Peer Review;Pilot Projects;Predictive Cancer Model;Process;Productivity;Property;Publishing;Reaction;Research;Resources;Route;Running;Sampling;screening;Sister;STAT3 gene;Structure;success;Systems Biology;Testing;tumor;virtual;virtual library;web server;Work;Writing,Synthetically Accessible Virtual Inventory (SAVI),11666,NA,NA,NA,NA,10,NA,NA,423890,NA
11188179,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011669,NA,NA,1ZIABC011669-10,NCI:222156\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8777676 (contact),"WANG, YUN XING M (contact)",NA,NA,NA,Award;beamline;cost;data acquisition;Data Analyses;Data Collection;In Situ;Investments;Ligands;member;Molecular;Molecular Conformation;movie;nanocrystal;new technology;pandemic disease;Phase Transition;Positioning Attribute;Preparation;Process;programs;Research;RNA;Sampling;Scientist;Site;Technology;Time;tool;Visualization;x-ray free-electron laser,NCI X-ray free electron laser (XFEL) initiative,11669,NA,NA,NA,NA,10,NA,NA,222156,NA
11188180,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011670,NA,NA,1ZIABC011670-10,NCI:1269731\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355387 (contact),"GOLDSZMID, ROMINA  (contact)",NA,NA,NA,adaptive immunity;Affect;angiogenesis;Antitumor Response;Bone Marrow;cancer therapy;Cells;chemotherapy;commensal bacteria;commensal microbes;Cues;Dendritic Cells;Development;Diet;Distant;Embryonic Development;Epithelium;Experimental Neoplasms;Fiber;Goals;gut microbiota;immune checkpoint blockade;Immune Evasion;Immune response;Immunity;Immunotherapy;improved;Individual;Infiltration;Inflammation;Inflammatory;Invaded;Lymphoid;Macrophage;Mammals;Metabolism;microbiota;Modeling;Molecular;monocyte;Mononuclear;Mus;Myeloid Cells;Natural Immunity;Nature;Neoplasm Metastasis;novel;novel therapeutic intervention;Outcome;pathogen;Pathologic;Pathway interactions;Phagocytes;Play;Population;Population Control;programs;Regulation;Resistance;Resolution;response;Role;Science;Signal Transduction;subcutaneous;Surface;System;systemic inflammatory response;Tissues;Transcriptional Regulation;tumor;Tumor Immunity;tumor microenvironment;tumor progression;Tumor Promotion;Vitamin D;Work,Role of the microbiota in regulating the mononuclear phagocyte system,11670,NA,NA,NA,NA,10,NA,NA,1269731,NA
11188181,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011679,NA,NA,1ZIABC011679-09,NCI:952361\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14731975 (contact),"SOWALSKY, ADAM  (contact)",NA,NA,NA,androgen deprivation therapy;ATAC-seq;Automobile Driving;Biochemical;Biopsy;Characteristics;Clinical;Development;Early Diagnosis;exome;exome sequencing;Genomics;Goals;Hormones;Image;laser capture microdissection;Malignant neoplasm of prostate;Malignant Neoplasms;Measurement;Microarray Analysis;Molecular;Neoadjuvant Therapy;Outcome;participant enrollment;Patients;Population;prevent;radiation response;Radiation therapy;Recurrence;Specimen;surveillance study;Survival Rate;Therapy Clinical Trials;Time;Tissues;transcriptome sequencing;tumor;ultrasound;whole genome,Molecular alterations driving the development of primary prostate cancers,11679,NA,NA,NA,NA,9,NA,NA,952361,NA
11188182,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011680,NA,NA,1ZIABC011680-09,NCI:211636\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14731975 (contact),"SOWALSKY, ADAM  (contact)",NA,NA,NA,Alleles;androgen deprivation therapy;androgen independent prostate cancer;Biochemical;Biological Assay;Blood;cancer recurrence;cell free DNA;ChIP-seq;Chromatin;Clinical Trials;cohort;Coupled;Detection;Diagnosis;Disease;DNA analysis;Enrollment;genome sequencing;Goals;Malignant neoplasm of lung;Malignant neoplasm of prostate;Metastatic Prostate Cancer;Methods;Neoadjuvant Therapy;Patients;Plasma;Point Mutation;Radiation therapy;Radical Prostatectomy;Recurrence;Sampling;Screening for Prostate Cancer;Specimen;Staging;Testing;treatment response;tumor DNA;whole genome,Detection of prostate cancer using circulating tumor DNA,11680,NA,NA,NA,NA,9,NA,NA,211636,NA
11188183,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011681,NA,NA,1ZIABC011681-09,NCI:1303805\OD:75000\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14731978 (contact),"KEARNEY, MARY  (contact)",NA,NA,NA,Acceleration;Affect;Anatomy;antiretroviral therapy;Binding;Biological Assay;CD4 Positive T Lymphocytes;Cell Survival;cell type;Cells;Cellular biology;Child;Chromosomes;Clonal Expansion;Clone Cells;Collecting Cell;coping;Data;detection assay;Family;follow-up;Frequencies;gene product;Gene Proteins;Genes;Genetic;Genetic Recombination;Genome;genome sequencing;HIV;HIV Genome;HIV Infections;homologous recombination;improved;in vivo;innovation;integration site;Interruption;Investigation;Length;Location;lymph nodes;Malignant Neoplasms;Manuscripts;Memory;Meta-Analysis;Methods;Mutation;novel;Participant;Patients;Play;Population;Preparation;pressure;Proliferating;Proteins;Provirus Integration;Proviruses;public database;Research;Role;Sampling;Science;self-renewal;Site;Source;Structure;T memory cell;T-Lymphocyte;T-Lymphocyte Subsets;telomere;Time;Tissues;Update;Viral;Viremia;Virion;Virus Replication;web page;Zinc Fingers,Dynamics and Genetics of HIV Proviruses Before and During Antiretroviral Therapy,11681,NA,NA,NA,NA,9,NA,NA,1378805,NA
11188184,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011682,NA,NA,1ZIABC011682-09,NCI:2244513\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14731980 (contact),"WEIGERT, ROBERTO  (contact)",NA,NA,NA,3-Dimensional;Ablation;Actins;Actomyosin;Affect;Animals;Area;Autophagocytosis;Behavior;Biological Models;Cancerous;Carcinogens;Carcinoma;Cell Culture Techniques;Cell membrane;cell motility;Cell Physiology;Cell Shape;Cells;Cellular Membrane;Cellular Morphology;Characteristics;Collagen;Complex;Confocal Microscopy;Cytoplasmic Granules;Cytoskeleton;Data;Data Analyses;Development;Endocytosis;Ensure;Environment;Epidermal Growth Factor Receptor;Epithelial Cells;Epithelium;Event;Exhibits;Exocytosis;Extracellular Matrix;Extracellular Space;Extravasation;ezrin;F-Actin;Family;Filament;Genes;Genetic;Glycolysis;Goals;Growth;Guanosine Triphosphate Phosphohydrolases;Head and Neck Squamous Cell Carcinoma;healing;Immune;immune activation;Immune response;Impairment;In Situ;in vivo;Infection;Infiltration;Inflammatory;interstitial;Invaded;Investigation;Lesion;light microscopy;Link;Lipids;Machine Learning;Maintenance;Measurement;mechanical force;member;Membrane;Mesenchymal;Metabolic stress;Metabolism;Methods;Microfilaments;Microscopy;migration;Modeling;Molecular;Monomeric GTP-Binding Proteins;Morphology;Mouse Strains;Myeloid Cells;Myosin Type II;NADH;Neoplasm Metastasis;neoplastic cell;neutrophil;non-muscle myosin;novel;Nutrient;Organ Culture Techniques;Oxidative Phosphorylation;Pathologic;Patients;pharmacologic;Phase;Physiological;PIK3CG gene;Play;polymerization;Polymers;premalignant;Process;Protein Isoforms;Proteins;recruit;Resolution;Rodent;scaffold;Secretory Vesicles;Series;Severe dysplasia;Shapes;Signal Transduction;spatiotemporal;System;Techniques;Tissues;tool;trafficking;tumor;tumor growth;tumor initiation;tumor progression;tumorigenic;two-photon;Visualization;wound,Molecular mechanisms of membrane remodeling,11682,NA,NA,NA,NA,9,NA,NA,2244513,NA
11188185,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011684,NA,NA,1ZIABC011684-09,NCI:431431\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201666 (contact),"YANG, CHUN ZHANG  (contact)",NA,NA,NA,Adopted;alpha ketoglutarate;Base Excision Repairs;Cell Death;Cell Line;Cell membrane;Cell Proliferation;Cell Therapy;Cells;Cellular biology;Chemosensitization;Clathrin-Coated Vesicles;Clustered Regularly Interspaced Short Palindromic Repeats;Cytosine;Cytoskeletal Modeling;cytotoxicity;Data;Dioxygenases;Disease;Disease Outcome;DNA;DNA Damage;DNA Repair;DNA Repair Disorder;DNA Repair Pathway;Endocytic Vesicle;Endocytosis Pathway;Epigenetic Process;Essential Genes;Exhibits;Foundations;functional genomics;Genetic Screening;genome-wide;Genomic approach;Glioma;Guide RNA;homologous recombination;Human;Hypermethylation;improved;inhibitor;Investigation;Investigational Therapies;Isocitrate Dehydrogenase;Knock-out;Lead;Libraries;Malignant Neoplasms;Metabolic Pathway;Modeling;Molecular;Molecular Biology;Molecular Profiling;Molecular Target;Movement;mTOR Inhibitor;mutant;Mutate;Mutation;Nicotinamide adenine dinucleotide;novel;Nutrient;Pathway interactions;Patients;Phagocytes;Phosphorylation;Phosphotransferases;PIK3CG gene;Poly(ADP-ribose) Polymerase Inhibitor;Production;Resistance;RNA library;Role;screening;stem cells;synergism;temozolomide;Tumor Suppression;uptake,Chemo-sensitizing IDH1-mutated glioma by molecular targeting,11684,NA,NA,NA,NA,9,NA,NA,431431,NA
11188186,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011687,NA,NA,1ZIABC011687-09,NCI:370378\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692451 (contact),"ROCHE, PAUL  (contact)",NA,NA,NA,Antigen-Presenting Cells;Antigens;Binding;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;Cell Physiology;Data;Defect;Dendritic Cells;draining lymph node;functional status;Goals;Immune system;In Vitro;in vivo;lymph nodes;Malignant Neoplasms;Molecular;Mus;neoplastic cell;novel;Peptides;prevent;Solid Neoplasm;subcutaneous;tumor;tumor microenvironment,Dysregulation of Antigen Presenting Cell Function in Cancer,11687,NA,NA,NA,NA,9,NA,NA,370378,NA
11188187,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011688,NA,NA,1ZIABC011688-09,NCI:375269\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11199937 (contact),"SINGER, DINAH S. (contact)",NA,NA,NA,Acetyltransferase;Apoptosis;Architecture;Autoantigens;autoreactivity;Blood Cells;Bone Marrow;Bromodomain;CD8-Positive T-Lymphocytes;CD8B1 gene;Cell Compartmentation;Cell Count;Cell Physiology;Cell Proliferation;Cell surface;Cells;chemokine;chemokine receptor;Chromatin;Chromatin Structure;Coculture Techniques;Defect;Development;Developmental Process;DNA Polymerase II;DNA Repair;Emigrations;epigenetic regulation;Epithelial Cells;Epithelium;Family;Frequencies;Gene Expression Regulation;Generations;Genes;Genetic Transcription;Goals;hematopoietic differentiation;Human;in vivo;Intestines;Ligands;Maintenance;Mesenchymal;Monitor;Mus;Organ;Pathway interactions;Peptides;Peripheral;Phenotype;Phosphorylation;Phosphotransferases;Play;Population;Process;Productivity;progenitor;Proliferating;Proteins;Regulatory T-Lymphocyte;Role;Series;single-cell RNA sequencing;skin hyperplasia;stem cells;Structure of thymic cortex;Surface;T-Cell Receptor;TAF7 gene;Thymic epithelial cell;thymocyte;Thymus Gland;Transcription Elongation;transcription factor;Transcription Initiation;Winged Helix,In vivo function of BRD4,11688,NA,NA,NA,NA,9,NA,NA,375269,NA
11188188,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011690,NA,NA,1ZIABC011690-09,NCI:107264\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14731989 (contact),"BROGNARD, JOHN  (contact)",NA,NA,NA,Alleles;Biochemical;Bioinformatics;Biological Assay;BRAF gene;cancer genomics;Communities;Cultured Cells;Dependence;Development;driver mutation;drug development;Evaluation;functional genomics;functional restoration;Genetic;genome editing;Genomic approach;Goals;Human;in vivo;Knowledge;loss of function;loss of function mutation;Malignant Neoplasms;Molecular;Monitor;mutant;Mutation;novel;Oncogenic;Pathway interactions;Patients;Phenotype;Phosphotransferases;Pongidae;Process;Research;response;Small Interfering RNA;Somatic Mutation;targeted treatment;tumor;tumorigenesis,Novel Tumor Suppressing Kinases in Cancer,11690,NA,NA,NA,NA,9,NA,NA,107264,NA
11188189,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011691,NA,NA,1ZIABC011691-09,NCI:2038007\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14731989 (contact),"BROGNARD, JOHN  (contact)",NA,NA,NA,anti-cancer research;Antibodies;Antibody-drug conjugates;cancer cell;Cancer Patient;Cell Survival;Colorectal Cancer;Development;Goals;Head and Neck Cancer;Head and Neck Squamous Cell Carcinoma;inhibitor;lung tumorigenesis;Malignant Breast Neoplasm;Malignant neoplasm of esophagus;Malignant neoplasm of ovary;Malignant Neoplasms;Modality;Molecular;novel;novel therapeutics;Oncogenic;Phosphotransferases;Play;precision drugs;Role;Squamous cell carcinoma;targeted treatment;Therapeutic Intervention;tumorigenesis,Oncogenic Kinases in Cancer,11691,NA,NA,NA,NA,9,NA,NA,2038007,NA
11188190,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011692,NA,NA,1ZIABC011692-09,NCI:1957723\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14280471 (contact),"LEBLANC, AMY  (contact)",NA,NA,NA,Address;Adjuvant;Adolescent;Adult;Age;anti-cancer research;Antineoplastic Agents;Area;arm;assay development;Biological;Biological Assay;Biological Markers;Biological Models;Biological Specimen Banks;Biology;Brain Neoplasms;Cancer Biology;cancer clinical trial;Cancer Model;Cancer Patient;cancer type;Canis familiaris;Characteristics;Child;Childhood;Childhood Osteosarcoma;Clinical;clinical application;Clinical Trials;cohort;Companions;comparative;Comparative Study;Complex;Conduct Clinical Trials;Data;design;Development Plans;Disease;Distant;dog genome;drug development;druggable target;Fluorescent in Situ Hybridization;Future;Gene Expression;Gene Expression Profile;Genomics;Goals;Growth;Human;Human Cell Line;human data;improved;improved outcome;In Vitro;in vivo;Infrastructure;Inherited;Investigation;Kidney;Knowledge;Laboratories;laboratory experiment;Liver;Lung;Lymphoid;Malignant Bone Neoplasm;Malignant Neoplasms;Metastatic Neoplasm to the Lung;Mission;Modeling;Molecular;Multi-Institutional Clinical Trial;Mus;nano-string;Natural History;Neoplasm Metastasis;Normal tissue morphology;novel therapeutic intervention;novel therapeutics;oncology program;oncology trial;Osteosarcoma;Patients;Pediatric Neoplasm;Pharmaceutical Preparations;Positioning Attribute;Pre-Clinical Model;Preclinical Drug Development;Primary Neoplasm;prognostic;prognostic value;programs;Publishing;Puma;Reagent;Research Design;Resource Development;Sampling;Sirolimus;Site;standard of care;success;Techniques;therapeutic target;Tissues;Translating;translation to humans;treatment response;tumor;Tumor Tissue;Work,Comparative Oncology Program Laboratory,11692,NA,NA,NA,NA,9,NA,NA,1957723,NA
11188191,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011696,NA,NA,1ZIABC011696-09,NCI:108763\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14280471 (contact),"LEBLANC, AMY  (contact)",NA,NA,NA,Adult;Affect;Ally;American;Astrocytoma;Basic Science;Biopsy;Brain Neoplasms;Breeding;Canis familiaris;Catalogs;CCR;Central Nervous System;Characteristics;Clinical;Clinical Trials;Collaborations;college;Companions;comparative;Data;Development;Diagnosis;Discipline;Disease;disease natural history;drug development;drug discovery;Early Diagnosis;Event;Excision;experience;Extramural Activities;Face;Funding;Future;Glioma;Goals;Grant;Group Structure;Histologic;Histology;Human;human disease;human model;Image;Immunotherapeutic agent;improved;improved outcome;Incidence;Income;Infrastructure;Internal Medicine;irradiation;Journals;Knowledge;Malignant Childhood Neoplasm;Malignant neoplasm of brain;Malignant Neoplasms;Medicine;meetings;member;meningioma;Modeling;Molecular;Morbidity - disease rate;National Center for Advancing Translational Sciences;neuro-oncology;Neurology;neuropathology;novel;oligodendroglioma;Oncology;oncology program;Operative Surgical Procedures;Outcome;Paper;Pathology;Patient Care;Patients;Pennsylvania;Pituitary Neoplasms;Play;Pre-Clinical Model;Prevention;Procedures;Publishing;Research;Research Personnel;Role;Specialist;statistics;Time;Training;transcriptome sequencing;tumor;United States National Institutes of Health;Universities;Veterinarians;Veterinary Medicine;Work;working group,Comparative Brain Tumor Consortium,11696,NA,NA,NA,NA,9,NA,NA,108763,NA
11188192,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011697,NA,NA,1ZIABC011697-09,NCI:1086504\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14731978 (contact),"KEARNEY, MARY  (contact)",NA,NA,NA,5&apos; Untranslated Regions;Address;animation;antiretroviral therapy;Binding;Biological Assay;Biological Process;Blood;Case Study;Cell Fraction;Cell Proliferation;Cell Separation;Cells;Clonal Expansion;Clone Cells;Code;Collecting Cell;CpG Islands;Data;Deamination;digital;DNA;DNA Methylation;env Genes;Epigenetic Process;epigenetic silencing;EZH2 gene;follow-up;Frequencies;Genes;Genetic Determinism;Genetic Transcription;Genome;genome sequencing;Guanine;Histone H3;HIV;HIV Infections;HIV-1;Immune;Immune response;In Vitro;in vivo;Individual;innovation;Interruption;Intervention;Investments;Laboratories;lymph nodes;Lysine;Manuscripts;Measures;member;Methods;Methylation;Multi-Drug Resistance;Natural Killer Cells;Nucleosomes;Opportunistic Infections;Patients;Peripheral Blood Mononuclear Cell;Persons;Plasma;Population;Preparation;prevent;Proliferating;promoter;Provirus Integration;Proviruses;Publications;Publishing;recruit;Reporting;Repressor Proteins;Research;resistance mutation;response;Rest;Retroviridae Infections;Reverse Transcription;RNA;RNA Splicing;Role;Sampling;Science;Site;Sorting;Source;Sulfate;symposium;T memory cell;T-Cell Activation;T-Lymphocyte;T-Lymphocyte Subsets;Technology;Testing;Time;Tissues;transcription factor;Transcription Initiation Site;Variant;viral fitness;Viremia;Virus;virus genetics;Virus Latency;Work,Effects of Antiretroviral Therapy on Transcriptional Activity of HIV Proviruses,11697,NA,NA,NA,NA,9,NA,NA,1086504,NA
11188193,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011698,NA,NA,1ZIABC011698-09,NCI:869203\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14731978 (contact),"KEARNEY, MARY  (contact)",NA,NA,NA,acute infection;Address;Aftercare;anti-PD-1;antiretroviral therapy;Biological Assay;Cell Fraction;cell killing;Cell Proliferation;Cells;Child;Clonal Expansion;Clone Cells;Collaborations;curative treatments;Cytotoxic T-Lymphocytes;cytotoxicity;Data;Disease remission;Dose;efficacy evaluation;Emodin;Event;Future;Genes;Genetic;Genetic Transcription;Genome;Heterogeneity;Histone Deacetylase Inhibitor;HIV;HIV Infections;HIV-1;Immune;Immune checkpoint inhibitor;improved;In Vitro;in vivo;Individual;Infection;Infusion procedures;inhibitor;insight;integration site;Intervention;Investments;lymph nodes;Maintenance;Manuscripts;Measures;Methods;Minor;Modification;National Institute of Allergy and Infectious Disease;Nature;neutralizing antibody;neutralizing monoclonal antibodies;new technology;North Carolina;Oncogenes;Opportunistic Infections;Participant;Patients;peripheral blood;Peripheral Blood Mononuclear Cell;Population;pressure;Production;Proliferating;Proviruses;Publications;Reporting;Research;Resistance;response;Retroviridae Infections;RNA;Sampling;Structure;symposium;T memory cell;T-Lymphocyte;Technology;Tissues;Universities;Viral;Virus;Vorinostat;Zinc Fingers,Impact of Interventions on Clonally Expanded Proviruses and Their RNA Expression,11698,NA,NA,NA,NA,9,NA,NA,869203,NA
11188194,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011699,NA,NA,1ZIABC011699-09,NCI:1086504\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14731978 (contact),"KEARNEY, MARY  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Acute;acute infection;Adherence;Affect;AIDS clinical trial group;Anti-Retroviral Agents;Anti-retroviral resistance;antiretroviral therapy;Binding;bioinformatics pipeline;Biological Assay;Cells;Clinical;Collaborations;cost;Data;Data Set;design;Drug resistance;drug resistance development;Enrollment;env Genes;Evolution;experimental study;Failure;Far East;Frequencies;Genes;Genetic;Genetic Recombination;Genome;genome sequencing;Genotype;Hawaii;high risk population;HIV;HIV drug resistance;HIV Envelope Protein gp120;HIV Genome;HIV Infections;improved;In Vitro;in vivo;Individual;Infection;insight;Integrase;integration site;Interruption;Length;Libraries;Link;Manuscripts;Medical;Minority;Multi-Drug Resistance;Mutation;nanopore;next generation;next generation sequencing;off-target mutation;Opportunistic Infections;Participant;Pattern;Pharmaceutical Preparations;Phylogenetic Analysis;Plasma;Population;Population Dynamics;pre-exposure prophylaxis;pressure;prevent;programs;Proviruses;Publications;rare variant;Recombinants;Red Cross;Regimen;Reporting;Research;Research Institute;Resistance;resistance mutation;response;Rest;Retroviridae Infections;Retrovirology;Role;Sampling;Science;Structure;symposium;Techniques;Technology;Thailand;transmission process;Variant;Viral;Viral Genome;Viremia;Virion;virtual;Virus,Ultrasensitive Single-Genome Sequencing to Study HIV Transmission and Evolution,11699,NA,NA,NA,NA,9,NA,NA,1086504,NA
11188195,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011704,NA,NA,1ZIABC011704-09,NCI:1627567\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692277 (contact),"CAPLEN, NATASHA  (contact)",NA,NA,NA,Address;Affinity;Area;Binding;Biochemical;Biological Assay;biophysical properties;Bone Tissue;Cancer Biology;cancer cell;cancer therapy;Categories;Cell Line;Cell membrane;Cell Physiology;Cell Survival;Cells;Chimeric Proteins;Chromosomes;Clinical;clinically relevant;cohort;combinatorial;comparison control;CRISPR-mediated transcriptional activation;Cytotoxic Chemotherapy;Data;defined contribution;Dependence;design;Desmoplastic;Detection;Development;Disease;Disease Progression;Distant;DNA;DNA Polymerase II;Dreams;ETS1 gene;Evaluation;Event;Ewings sarcoma;EWSR1 gene;Exclusion;Exhibits;Exons;Exposure to;F-Actin;FLI1 gene;FLI1 Transcription Factor;Focal Adhesions;Follow-Up Studies;Functional disorder;functional genomics;fusion gene;Fusion Oncogene Proteins;Future;G-Quartets;gene discovery;Gene Expression;Gene Expression Regulation;Genes;Genetic;Genetic Transcription;genome-wide;Growth;Guanine;Health;Heterogeneous-Nuclear Ribonucleoproteins;Human Chromosomes;Image;improved outcome;Individual;Introns;Investigation;Investigational Drugs;Knowledge;Life;liposarcoma;loss of function;Malignant Bone Neoplasm;Malignant Neoplasms;Mediating;Messenger RNA;Molecular Carcinogenesis;Molecular Target;Movement;mRNA Precursor;Mutation;Neoplasm Metastasis;Neoplasms;neoplastic cell;Neural Crest Cell;new therapeutic target;novel therapeutic intervention;Nucleic Acid Binding;nucleic acid binding protein;Nucleic Acids;Nucleoplasm;Oncogene Deregulation;Oncogenes;Oncogenic;Operative Surgical Procedures;Pathway interactions;Patient-Focused Outcomes;Patients;Pharmacotherapy;Phenotype;Phosphorylation;Physical condensation;Post-Transcriptional Regulation;Post-Translational Regulation;posttranscriptional;Process;progenitor;Proliferating;Promoter Regions;Property;Protein Family;protein function;Proteins;Publishing;Radiation;recruit;Refractory;Regulation;Relapse;Reporting;Repression;Research;Resolution;response;Reverse Transcription;Risk;RNA;RNA Binding;RNA Interference;RNA interference screen;RNA metabolism;RNA Processing;RNA Splicing;RNA Transport;Sarcoma;scaffold;Series;Signal Transduction;Site;Small RNA;soft tissue;standard care;Stimulus;Structure;superresolution microscopy;Survival Rate;TAF15 gene;Technology;Transcript;transcription factor;Transcriptional Regulation;transcriptome;Translations;Translocation Breakpoint;treatment response;tumor;Tumor Biology;tumorigenesis;Up-Regulation;Variant;Vinculin;Visualization;Work,Discovery of genes required for expression or activity of fusion oncogenes,11704,NA,NA,NA,NA,9,NA,NA,1627567,NA
11188196,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011707,NA,NA,1ZIABC011707-09,NCI:260118\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14732003 (contact),"LARION, MIOARA  (contact)",NA,NA,NA,Biological Assay;Biological Models;Cell Culture Techniques;Cell Line;Cells;DNA Methylation;established cell line;Glioma;Goals;histone methylation;In Vitro;in vivo;Mass Spectrum Analysis;Metabolic;Modeling;mouse model;Mus;Mutate;Mutation;Phenotype;protein expression;Research;Testing;Therapeutic;Therapeutic Effect;tumor;Western Blotting,The effect of therapeutics on mutated IDH1 cell lines and mice tumor models,11707,NA,NA,NA,NA,9,NA,NA,260118,NA
11188197,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011708,NA,NA,1ZIABC011708-09,NCI:260118\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14732003 (contact),"LARION, MIOARA  (contact)",NA,NA,NA,Apoptosis;Cell Death;Cell Death Induction;Cell Line;Cell Proliferation;Ceramides;Cholesterol;Cholesterol Homeostasis;Collaborations;combinatorial;Defect;Drug Combinations;efficacy evaluation;Enzymes;Equilibrium;established cell line;Fatty Acids;galactosylgalactosylglucosylceramidase;Glioma;Goals;Human;in vivo;Lead;Link;Metabolic;Metabolism;metabolomics;mouse model;Mus;Mutate;Mutation;oligodendroglioma;Running;Sampling;site-1 protease;Sphingolipids;Sphingosine;SPHK1 enzyme;Tissue Sample;tumor;Xenograft procedure,Targeted and untargeted metabolomics in IDH1 mutated xenografts in mice,11708,NA,NA,NA,NA,9,NA,NA,260118,NA
11188198,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011709,NA,NA,1ZIABC011709-09,NCI:130059\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14732003 (contact),"LARION, MIOARA  (contact)",NA,NA,NA,Biological Markers;Blood;Cerebrospinal Fluid;Data;Diagnosis;Disease remission;Measures;mutant;Patient Monitoring;Patients;Prognosis;Reporting;Sampling;Statistical Data Interpretation;Time;Tissues;treatment response;Urine,"Metabolite profiling of patients blood, urine, cerebrospinal fluid and tissue",11709,NA,NA,NA,NA,9,NA,NA,130059,NA
11188199,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011710,NA,NA,1ZIABC011710-09,NCI:260118\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14732003 (contact),"LARION, MIOARA  (contact)",NA,NA,NA,Brain;Clinical;Disease Progression;Glucose;Glutamine;In Vitro;in vivo;Label;Magnetic Resonance Imaging;Measures;Metabolic;mouse model;Mus;Normal Cell;Pathway interactions;pre-clinical;Source;tumor,In vivo and in vitro metabolic flux analysis in preclinical mouse models,11710,NA,NA,NA,NA,9,NA,NA,260118,NA
11188200,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011711,NA,NA,1ZIABC011711-09,NCI:390178\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14732003 (contact),"LARION, MIOARA  (contact)",NA,NA,NA,Biological;Brain Neoplasms;Cell Line;Cells;Cholesterol Esters;Classification;Collaborations;Databases;DNA;Endoplasmic Reticulum;Fatty Acids;Finland;Goals;improved;In Situ;in vivo;Incubators;inhibitor;Ions;Lipids;Machine Learning;Metabolic;Metabolism;Methodology;Methods;Microscopy;new technology;novel;oligodendroglioma;Organelles;Patients;Phospholipids;Proteins;Raman Spectrum Analysis;Resolution;RNA;Site;Slide;Tissues;tumor;tumor microenvironment;Universities;Visualization,Develop RAMAN imaging to visualize metabolism in cell lines and tissue,11711,NA,NA,NA,NA,9,NA,NA,390178,NA
11188201,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011714,NA,NA,1ZIABC011714-09,NCI:494832\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14280069 (contact),"GILBERT, MARK  (contact)",NA,NA,NA,"Adjuvant Therapy;Adrenal Cortex Hormones;Adult;Basic Science;Biology;Blood;Blood - brain barrier anatomy;Blood specimen;brain based;Brain Neoplasms;cancer immunotherapy;cancer therapy;Cells;checkpoint inhibition;clinical center;Clinical Trials;Collaborations;Complex;Correlative Study;design;efficacy evaluation;Epigenetic Process;Exhibits;Face;fighting;Foundations;Functional disorder;Future;Glioblastoma;gliosarcoma;Goals;Heat shock proteins;Hematologic Neoplasms;Hypoxia;Iatrogenesis;Immune;Immune checkpoint inhibitor;Immune Evasion;immune function;Immune response;Immune system;Immunologic Monitoring;Immunologics;Immunology;immunoregulation;Immunosuppression;Immunotherapeutic agent;Immunotherapy;Impairment;improved;improved outcome;in vivo;ipilimumab;Laboratories;Lymphocyte;Lymphocyte Function;Lymphopenia;Malignant neoplasm of central nervous system;Malignant Neoplasms;Metabolic;Molecular;Multi-Institutional Clinical Trial;Natural Immunity;neoantigens;neoplastic cell;Newly Diagnosed;Nivolumab;novel;Oncology;participant enrollment;Patients;pembrolizumab;Peptides;peripheral blood;Persons;phase II trial;Play;Predisposition;prevent;Primary Brain Neoplasms;Process;programmed cell death protein 1;programs;Proteins;Radiation therapy;Randomized;randomized, clinical trials;Regimen;Regulatory T-Lymphocyte;Research Personnel;response;Role;Running;sample collection;Sampling;Seminal;Silent Mutation;Solid;T-Lymphocyte;temozolomide;Tissues;Toxic effect;trafficking;translational immunology;Translational Research;treatment response;tumor;tumor microenvironment;Tumor-associated macrophages;United States National Institutes of Health;Vaccines;Work",Translational Immunology,11714,NA,NA,NA,NA,9,NA,NA,494832,NA
11188202,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011715,NA,NA,1ZIABC011715-09,NCI:382465\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692263 (contact),"ASHWELL, JONATHAN  (contact)",NA,NA,NA,Actins;Acute Graft Versus Host Disease;adaptive immune response;Calcineurin;Calcineurin inhibitor;Complex;Complication;confocal imaging;CRISPR/Cas technology;Cyclosporine;Cytoskeleton;Defect;Distal;Effectiveness;Event;Family;Genes;Human;Immune response;Immunity;Impairment;Jurkat Cells;knock-down;Knock-out;Ligands;Ligation;Lymphocyte-Specific p56LCK Tyrosine Protein Kinase;Mediating;mutant;nuclear factors of activated T-cells;Peptides;Phenotype;Phosphoric Monoester Hydrolases;Phosphorylation;Phosphotransferases;PPP3CA gene;Process;Protein Dephosphorylation;Protein Isoforms;Protein Tyrosine Kinase;Receptor Signaling;reconstitution;recruit;Role;Series;Serine;Signal Transduction;Signaling Molecule;Small Interfering RNA;Structure;T-Cell Activation;T-Cell Receptor;T-Lymphocyte;Threonine;Tissue Transplantation;ZAP-70 Gene,T cell receptor proximal signaling,11715,NA,NA,NA,NA,9,NA,NA,382465,NA
11188203,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011718,NA,NA,1ZIABC011718-09,NCI:430277\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10000506 (contact),"STEEG, PATRICIA SCHRIVER (contact)",NA,NA,NA,African American;Age;Age disparity;age related;aggressive breast cancer;Biological Assay;Biological Models;Brain;brain tissue;Breast Cancer Patient;Data;Development;Disease;Disseminated Malignant Neoplasm;DNA Sequence Alteration;Environment;Harvest;Hematogenous;Histology;Immunoblot Analysis;In Vitro;Infiltration;Inflammation;insight;Lasers;Macrophage;Malignant Breast Neoplasm;Malignant neoplasm of brain;Mammary Neoplasms;Mass Spectrum Analysis;Metabolism;Metastatic malignant neoplasm to brain;Microdissection;migration;Modeling;Multivariate Analysis;Mus;Mutation;Neoplasm Metastasis;neurotransmission;Outcome;Pathway Analysis;Patients;Phenotype;primary endpoint;Proteins;Proteomics;Resolution;Side;Signal Pathway;Tenascin;Testing;The Cancer Genome Atlas;triple-negative invasive breast carcinoma;tumor;Tumor Cell Migration;tumorigenesis;Woman;wound healing;young woman,Breast cancer aggressiveness in young patients,11718,NA,NA,NA,NA,9,NA,NA,430277,NA
11188204,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011720,NA,NA,1ZIABC011720-09,NCI:1095826\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9698291 (contact),"FREED, ERIC  (contact)",NA,NA,NA,antiretroviral therapy;Binding;Capsid Proteins;Cell membrane;Cell surface;Cells;Cellular biology;Complex;Destinations;Development;env Gene Products;Enzymes;gene product;Glycoproteins;Goals;HIV;HIV-1;HIV-2;inhibitor;Inositol;insight;Integration Host Factors;interest;Interferons;Molecular;Natural Immunity;nef Protein;novel;P-selectin ligand protein;particle;Pathway interactions;Phosphatidylinositols;Play;polyanion;protein function;Proteins;Research;Role;Site;SIV;Sphingomyelinase;structural determinants;trafficking;Viral;Virion;Virus;Virus Assembly;vpu Protein;Work,"Gag Trafficking, Assembly, and Release",11720,NA,NA,NA,NA,9,NA,NA,1095826,NA
11188205,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011721,NA,NA,1ZIABC011721-09,NCI:1095826\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9698291 (contact),"FREED, ERIC  (contact)",NA,NA,NA,antagonist;Anti-retroviral drug resistance;antiretroviral therapy;Binding Proteins;Cell membrane;cell type;Cells;Cellular biology;Complex;Cryoelectron Microscopy;Cytoplasmic Tail;Data;Defect;Development;Drug resistance;Elements;Future;Glycoproteins;glycosylation;Goals;guanylate;HIV;HIV-1;Human;Impairment;in vivo;inhibitor;Integrase;Integration Host Factors;interest;Maps;Mediating;Modification;Molecular;Molecular Conformation;Monkeys;Mutation;Natural Immunity;novel;particle;Pathway interactions;Play;Point Mutation;Process;Proteins;recruit;Research;Retroviridae;Role;Signal Transduction;SIV;Structure;trafficking;ubiquitin-protein ligase;Viral;Virion;Virus;Work,Envelope Glycoprotein Incorporation and Function,11721,NA,NA,NA,NA,9,NA,NA,1095826,NA
11188206,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011722,NA,NA,1ZIABC011722-09,NCI:904989\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14732019 (contact),"SHERN, JOHN  (contact)",NA,NA,NA,Adolescent;aggressive therapy;Biological Assay;Biological Models;Cells;chemotherapy;Chemotherapy and/or radiation;Child;Childhood;childhood sarcoma;Childhood Soft Tissue Sarcoma;Chromatin;Chromatin Structure;clinical translation;Clinical Trials;Clinical Trials Cooperative Group;Collaborations;Combined Modality Therapy;Complex;cyclin C;Cyclin-Dependent Kinases;Cyclins;Data;Diagnosis;Disease;disorder subtype;DNA-Directed RNA Polymerase;Drug Combinations;Epigenetic Process;Folic Acid Antagonists;FOXO1A gene;functional genomics;Funding;Gene Expression Regulation;gene repression;Genes;Genetic;Genetic Transcription;Genomics;Goals;high risk;high risk population;high-throughput drug screening;Histologic;inhibitor;insight;Knowledge;Malignant Neoplasms;Measures;Mediator;Metabolic stress;Methods;Molecular;molecular subtypes;Morbidity - disease rate;mortality;mutant;Mutation;National Center for Advancing Translational Sciences;neoplastic cell;Neurofibrosarcoma;novel therapeutics;Oncogenes;Operative Surgical Procedures;Pathway interactions;patient stratification;Patients;PAX3 gene;Pediatric Oncology Group;peripheral blood;permissiveness;Phosphorylation;Phosphotransferases;PIK3CA gene;PIK3CG gene;Point Mutation;Pre-Clinical Model;precision oncology;Preclinical Testing;Prognosis;prognostic tool;prognostication;programs;Radiation;Regimen;Relapse;relapse risk;response;Rhabdomyosarcoma;risk stratification;Sampling;Sarcoma;Signal Transduction;Soft tissue sarcoma;synergism;targeted treatment;Techniques;Testing;therapy development;Time;tool;Topoisomerase;Transcriptional Activation;Translating;Treatment Protocols;tumor;United States;Up-Regulation;Work;Xenograft Model,Genomic characterization and development of therapies for pediatric sarcoma,11722,NA,NA,NA,NA,9,NA,NA,904989,NA
11188207,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011726,NA,NA,1ZIABC011726-09,NCI:714745\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201697 (contact),"ALTAN-BONNET, GREGOIRE  (contact)",NA,NA,NA,antagonist;Antigens;Biochemical;Biology;cancer immunotherapy;CD8B1 gene;Cells;Collaborations;Communication;Computer Models;Development;Differential Equation;digital;Discrimination;Down-Regulation;Feedback;Goals;Heterogeneity;human model;immune activation;Immune response;Immunotherapy;Inflammatory Response;Lead;Leukocytes;Ligands;Lymphocyte;Methodology;Modeling;mouse model;Nature;novel;Phase;phenomenological models;Phenotype;Phosphoric Monoester Hydrolases;Phosphotransferases;Population;Proteins;Protocols documentation;Provider;PTPN6 gene;receptor;Regulation;response;Science;Signal Transduction;single cell analysis;small molecule inhibitor;Sorting;Specificity;Speed;T-Cell Activation;T-Lymphocyte;Testing;Theoretical model;tumor;tumor eradication;Validation,Phenotypic variability within isogenic population of lymphocytes,11726,NA,NA,NA,NA,9,NA,NA,714745,NA
11188208,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011732,NA,NA,1ZIABC011732-09,NCI:610483\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10712486 (contact),"LUO, JI  (contact)",NA,NA,NA,Anchorage-Independent Growth;Attention;cancer cell;Cancer cell line;Cancer Patient;Cells;Clinical Trials;Colorectal;Colorectal Cancer;Combined Modality Therapy;CRISPR/Cas technology;Dependence;Development;driver mutation;Drug Combinations;Drug resistance;Drug Targeting;Drug toxicity;Epithelial Cells;functional genomics;Genes;Genetic;Genetic Transcription;Goals;high-throughput drug screening;improved;in vivo;inhibitor;kinase inhibitor;KRAS2 gene;Libraries;loss of function;Lung;Malignant neoplasm of lung;Malignant neoplasm of pancreas;Malignant Neoplasms;MAP Kinase Gene;MEKs;Modality;Modeling;Multiple Myeloma;Mus;mutant;new therapeutic target;novel therapeutics;oncogene addiction;Oncogenes;Oncogenic;Pancreas;Pathway interactions;Patients;pharmacologic;PIK3CG gene;posttranscriptional;Pre-Clinical Model;prevent;ras Oncogene;Resistance;resistance mechanism;response;Signal Transduction;small molecule inhibitor;Stress;targeted treatment;Therapeutic;tool;treatment response;tumor;Xenograft procedure,Target discovery and combination therapy in KRAS mutant cancer,11732,NA,NA,NA,NA,9,NA,NA,610483,NA
11188209,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011733,NA,NA,1ZIABC011733-09,NCI:610483\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10712486 (contact),"LUO, JI  (contact)",NA,NA,NA,3-Dimensional;Adoption;Affect;Alveolar;Alveolar Cell;Biology;cancer cell;Cancer cell line;Carcinoma;cell behavior;Cell Culture Techniques;cell growth;Cell model;Cell Survival;Cells;cost;Development;Dissection;Epithelial Cells;Epithelium;Exhibits;Gene Expression;Genetic;Goals;Growth;Human;In Vitro;in vitro Model;in vivo;KRAS2 gene;Lung;Lung Adenocarcinoma;lung cancer cell;Malignant Neoplasms;metaplastic cell transformation;Methods;Microscope;Modeling;Molecular;monolayer;Mus;mutant;neoplastic cell;Oncogenes;Oncogenic;Organoids;Phenotype;scale up;Signal Transduction;spheroids;stem cells;stemness;Surface;System;targeted treatment;transplant model;tumor;tumor behavior;Xenograft procedure,Organoid models of KRAS mutant cancer,11733,NA,NA,NA,NA,9,NA,NA,610483,NA
11188210,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011734,NA,NA,1ZIABC011734-09,NCI:904989\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14732019 (contact),"SHERN, JOHN  (contact)",NA,NA,NA,Affect;Atlases;Benign;Biological Assay;Biological Models;Blood;cell free DNA;Cell Surface Proteins;cell type;Cells;Childhood Solid Neoplasm;Chromatin;Clinical;Clinical Trials;Clustered Regularly Interspaced Short Palindromic Repeats;Combined Modality Therapy;Complex;Data;design;Development;Disease;Disease Progression;Dissection;DNA;DNA sequencing;Early Diagnosis;Early treatment;Emerging Technologies;Engineering;Epigenetic Process;evidence base;FOXO1A gene;Genes;Genetic;Genetic Heterogeneity;Genetic Transcription;genome sequencing;genomic data;Genomics;Goals;Heterogeneity;improved;in vivo Model;Intervention;Legal patent;loss of function mutation;Malignant - descriptor;malignant state;member;Methods;Natural History;neoplastic cell;Nerve;NF1 gene;Patients;PAX3 gene;Pediatric Neoplasm;Plasma;Polycomb;Population;pressure;programs;Proteins;Proteomics;radiological imaging;Refractory Disease;Relapse;resistance mechanism;Rhabdomyosarcoma;Sampling;Schwann Cells;screening;single cell sequencing;small molecule;Specimen;Technology;Therapeutic;therapeutic target;therapy resistant;Transcription Repressor;Transcriptional Activation;Translations;tumor;tumor DNA;tumor heterogeneity;tumor progression;whole genome;Work,Genomic dissection of tumor heterogeneity and progression,11734,NA,NA,NA,NA,9,NA,NA,904989,NA
11188211,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011736,NA,NA,1ZIABC011736-09,NCI:340244\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6809564 (contact),"SHARAN, SHYAM  (contact)",NA,NA,NA,Animals;anti-cancer;Antineoplastic Agents;Biological Markers;Biomedical Engineering;Biopsy;cancer cell;Cancer Model;CAR T cell therapy;Categories;CD276 gene;Cells;chimeric antigen receptor T cells;Clinical;clinical translation;clinical trial protocol;clinically relevant;cohort;Collaborations;Collection;comparative;Disease Progression;Disease Resistance;drug efficacy;Drug Targeting;efficacy evaluation;efficacy study;Eligibility Determination;Enrollment;Epidermal Growth Factor Receptor;Evaluation;Evaluation Studies;Flow Cytometry;Formulation;Frequencies;Generations;Genetic Engineering;Genetically Engineered Mouse;Histopathology;Image;Immunocompromised Host;inhibitor;Integral Membrane Protein;Laboratories;Lung Neoplasms;Malignant neoplasm of lung;Malignant Neoplasms;Methods;Modeling;Molecular;Molecular Abnormality;molecular subtypes;mouse model;Mutagenesis;Non-Small-Cell Lung Carcinoma;novel;novel therapeutics;Oligonucleotides;Oncogenic;patient derived xenograft model;Patient Representative;Patients;Pattern;Pharmaceutical Preparations;Pharmacodynamics;pharmacokinetics and pharmacodynamics;Platinum;pre-clinical;preclinical development;preclinical evaluation;Prediction of Response to Therapy;programs;Publications;Recording of previous events;Recurrence;Regimen;Research Personnel;Resistance;response;Retinoblastoma Protein;RNA Polymerase II;small cell lung carcinoma;Surface Antigens;targeted treatment;Techniques;Therapeutic;therapeutic development;therapeutic evaluation;Tissues;Topoisomerase;transcriptome;treatment response;tumor;Work,Preclinical Development of Therapeutics in Murine Models of Lung Cancer,11736,NA,NA,NA,NA,9,NA,NA,340244,NA
11188212,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011737,NA,NA,1ZIABC011737-09,NCI:1701222\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6809564 (contact),"SHARAN, SHYAM  (contact)",NA,NA,NA,Address;Aftercare;Agonist;Alleles;Allografting;animal colony;Animals;anti-cancer;arm;Automobile Driving;BRCA1 gene;BRCA2 gene;Breast Cancer Model;Camptothecin;cancer cell;cancer subtypes;cancer vaccination;CCR;CDK4 gene;Circulation;Cisplatin;Classification;Clinical;Clinical Data;clinical development;clinical subtypes;clinically relevant;cohort;Collaborations;Collection;Combined Modality Therapy;comparative;Data;design;Development;Division of Cancer Prevention;Dose;drug efficacy;Drug Evaluation;efficacy testing;Epithelial Cells;Epithelial ovarian cancer;Epithelium;Evaluation;experimental arm;experimental study;Extramural Activities;Formulation;Funding;Genetic;Genetically Engineered Mouse;genomic aberrations;Histologic;hormone receptor-positive;hormone sensitivity;hormone therapy;Human;human disease;in vivo;inhibitor;irinotecan;Laboratories;Malignant Breast Neoplasm;Malignant neoplasm of ovary;Malignant Neoplasms;Mammalian Oviducts;Mammary gland;Modality;Modeling;Molecular;Molecular Profiling;mouse model;Mus;mutant;Mutation;novel;Oncogenic;Outcome;Ovarian;ovarian neoplasm;Pathway interactions;Patients;Pharmaceutical Preparations;Pharmacodynamics;Placebos;Poly(ADP-ribose) Polymerase Inhibitor;pre-clinical;pre-clinical assessment;pre-clinical research;preclinical evaluation;Preclinical Testing;Preparation;Preventive;Process;programs;protein biomarkers;Protein Family;Publishing;Reaction;Refractory;Research;Research Personnel;Resistance;response;Retinoblastoma Protein;Sampling;Schedule;Series;Serous;Skin;standard of care;System;The Cancer Genome Atlas;Therapeutic;therapeutic development;therapeutic evaluation;Therapeutic Intervention;therapy resistant;tool;Topoisomerase-I Inhibitor;Toxic effect;TP53 gene;Treatment Efficacy;tumor;tumor progression;Tumor Tissue,Therapeutic evaluation in ovarian and breast cancer GEM-GDA models,11737,NA,NA,NA,NA,9,NA,NA,1701222,NA
11188213,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011738,NA,NA,1ZIABC011738-09,NCI:2041466\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6809564 (contact),"SHARAN, SHYAM  (contact)",NA,NA,NA,Adjuvant;Allografting;Anatomy;Animals;anti-CTLA4 antibodies;anti-PD-1;anti-PD-L1 antibodies;anti-PD-L1 therapy;anti-PD1 therapy;Antibodies;Antitumor Response;Apoptosis;Biocompatible Materials;Biological;Biological Markers;biomarker evaluation;Biotechnology;BRAF gene;Cancer Vaccines;CDK4 gene;Characteristics;checkpoint therapy;Chemosensitization;Clinical;Clinical Management;clinically relevant;cohort;Collaborations;Complex;Cooperative Research and Development Agreement;Cutaneous Melanoma;cytokine;Data;Devices;Disease;disease model;Drug Combinations;drug development;efficacy evaluation;Engineering;Evaluation;Evaluation Research;Excision;experimental study;Fc Receptor;follow-up;Formulation;Generations;HGF gene;IgG1;imaging probe;immune checkpoint blockade;Immune checkpoint inhibitor;immune modulating agents;Immune system;Immunocompetent;Immunologics;Immunooncology;Immunotherapeutic agent;Incidence;Infiltration;inhibitor;Intervention;Joints;Laboratories;Lesion;Manuscripts;Measurable;Mediating;Melanoma;Melanoma patient;melanomagenesis;Metastatic Melanoma;Metastatic/Recurrent;Modality;Modeling;Molecular;Monitor;mouse model;multi-arm study;multidisciplinary;Mus;mutant;Mutation;Neoadjuvant Therapy;Neoplasm Metastasis;neoplastic cell;novel;Operative Surgical Procedures;Outcome;Pathway interactions;patient subsets;Pattern;PD-1 blockade;PD-L1 blockade;Pharmaceutical Preparations;Pharmacotherapy;pre-clinical;predictive signature;Primary Neoplasm;Privatization;Procedures;programs;Property;Recurrent tumor;repaired;Research Personnel;Resected;Resistance;response;Sampling;scaffold;Severities;Site;Surgical Models;targeted treatment;Testing;Therapeutic;Therapeutic Effect;Therapeutic Use Study;timeline;Tissues;tool;tumor;tumor growth;tumor microenvironment;Tumor-infiltrating immune cells;Vaccines;wound healing,Preclinical GEM and GDA Models of Primary and Metastatic Melanoma,11738,NA,NA,NA,NA,9,NA,NA,2041466,NA
11188214,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011739,NA,NA,1ZIABC011739-09,NCI:2041466\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6809564 (contact),"SHARAN, SHYAM  (contact)",NA,NA,NA,Acinar Cell;Adult;Affinity;Alleles;Allografting;Animals;anti-cancer;Antibody-drug conjugates;Antigens;Automobile Driving;C57BL/6 Mouse;cancer cell;cancer imaging;Cancerous;CCR;Cell membrane;Cell Therapy;cell type;Cells;cellular transduction;chimeric antigen receptor T cells;Clinical;Clinical Trials;Collaborations;Collection;comparative;Cre driver;cytokine;cytotoxic;design;Desmoplastic;Development;Disease;Drug Kinetics;Duct (organ) structure;Ductal Epithelium;Engineering;Epitopes;Evaluation;experimental study;Extracellular Matrix;Fibroblasts;follow-up;Gene Modified;Genetic Engineering;Genetic Recombination;Genomic DNA;glycosylation;Goals;home test;Homing;Human;Hyaluronidase;Immune response;Immune system;immunogenic;Immunologics;improved;in silico;In Vitro;in vivo;Infiltration;Inflammatory;Influentials;Interleukin-12;Intraepithelial Neoplasia;Invaded;Joints;KPC model;KRAS oncogenesis;KRAS2 gene;KRASG12D;Laboratories;Legal patent;Lesion;Liver;Lung;Macrophage;Malignant - descriptor;Malignant neoplasm of pancreas;Malignant Neoplasms;Mediating;Membrane;Mesenchymal;mesothelin;Metaplasia;Modeling;Molecular Abnormality;Morphology;mouse model;Mus;mutant;Mutation;Myelogenous;Myeloid Cells;N-terminal;nanobodies;neoantigens;Neoplasm Metastasis;next generation;novel;Oncogenic;Pancreas;Pancreatic Adenocarcinoma;pancreatic cancer model;Pancreatic duct;Pancreatic Ductal Adenocarcinoma;pancreatic ductal adenocarcinoma model;pancreatic neoplasm;Pathway interactions;patient derived xenograft model;Patients;Pediatric Oncology;Pharmaceutical Preparations;Physiological;polypeptide;Population;pre-clinical;Pre-Clinical Model;pre-clinical research;Preclinical Drug Evaluation;precursor cell;premalignant;Primary Neoplasm;programs;Property;Protein Isoforms;Proteins;Publishing;Reagent;recombinant viral vector;Reporting;Research;Research Personnel;response;Single Nucleotide Polymorphism;Site;Therapeutic;Tissues;tool;TP53 gene;transcriptome sequencing;Transgenes;tumor;Tumor Antibodies;Tumor Antigens;Tumor Tissue;tumorigenic;Ultrasonography;Up-Regulation;uptake;Xenograft procedure,Development and Preclinical Applications of Pancreatic Adenocarcinoma Models,11739,NA,NA,NA,NA,9,NA,NA,2041466,NA
11188215,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011743,NA,NA,1ZIABC011743-09,NCI:1329765\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14732039 (contact),"PAVLETIC, STEVEN  (contact)",NA,NA,NA,Address;Allogenic;Autoimmune Diseases;Biological Markers;Biology;Cancer Survivor;cancer therapy;Chronic;chronic graft versus host disease;Classification;Clinical;clinical phenotype;Clinical Research;Collaborations;Complication;Conduct Clinical Trials;disability;drug development;Evaluation;Extramural Activities;Hematopoietic Stem Cell Transplantation;Immune;Immunosuppression;International;Late Effects;multidisciplinary;Organ;Pathway interactions;Patient Care;Patients;prevent;programs;Research;Therapeutic Intervention;therapy development;tool;United States National Institutes of Health,NIH Chronic GVHD Study Group,11743,NA,NA,NA,NA,9,NA,NA,1329765,NA
11188216,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011744,NA,NA,1ZIABC011744-08,NCI:1805720\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201713 (contact),"ZHANG, PING  (contact)",NA,NA,NA,Adolescent and Young Adult;Affect;Ankyrins;Armadillo Repeat;Automobile Driving;Binding;Biochemical;Biological;Biological Models;Biological Process;Biology;Biophysics;bone;BRAF gene;Catalytic Domain;Cell Physiology;Cells;Chimera organism;Chimeric Proteins;Complex;Cryoelectron Microscopy;Cyclic AMP-Dependent Protein Kinases;Data;dimer;Disease;Family;Family Dasypodidae;Fibrolamellar Hepatocellular Carcinoma;Genetic;genetic regulatory protein;Goals;Guanosine Triphosphate Phosphohydrolases;Health;Heat-Shock Response;Holoenzymes;Human;human disease;Individual;Inherited;inhibitor;insight;Interdisciplinary Study;interest;Knowledge;Length;Leucine-Rich Repeat;Link;Liver diseases;LRRK2 gene;Malignant Childhood Neoplasm;Malignant neoplasm of liver;Malignant Neoplasms;Mammalian Cell;Medicine;MEKs;member;Modeling;Molecular;Molecular Chaperones;Molecular Conformation;monomer;Monomeric GTP-Binding Proteins;Mutation;N-terminal;novel therapeutic intervention;Oncogenic;Parkinson Disease;Pathologic;Pathway interactions;Patients;Phosphorylation;Phosphotransferases;Physiological;programs;protein function;Protein Kinase;Proteins;raf Kinases;Ras Signaling Pathway;Recording of previous events;Regulation;Research;Risk;Role;Signal Transduction;Structure;System;Tertiary Protein Structure;Therapeutic;transmission process;Vision;WD Repeat;Work;X-Ray Crystallography,Mechanistic Analyses of kinase signaling complexes,11744,NA,NA,NA,NA,8,NA,NA,1805720,NA
11188217,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011746,NA,NA,1ZIABC011746-08,NCI:598166\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6569088 (contact),"POMMIER, YVES  (contact)",NA,NA,NA,Adrenocortical Carcinoma;Biological Markers;Cancer Patient;Cell Cycle Checkpoint;Chromatin;Clinic;Clinical;clinical development;Clinical Trials;Combined Modality Therapy;Defect;DNA;DNA biosynthesis;DNA Damage;DNA Repair;DNA Sequence Alteration;Drug Targeting;Epigenetic Process;Gamma-H2AX;Genome;Genomic Instability;genomic signature;Genomics;H2AFX gene;Histones;immune checkpoint;inhibitor;insight;Malignant neoplasm of adrenal cortex;Malignant neoplasm of lung;Malignant Neoplasms;Metabolic;molecular marker;Molecular Target;neuroendocrine cancer;Neuroendocrine Tumors;novel therapeutic intervention;pharmacodynamic biomarker;Pharmacodynamics;Pharmacogenomics;pre-clinical;response;small cell lung carcinoma;targeted agent;targeted delivery;Testing;therapeutic development;TOP1 gene;Topoisomerase Inhibitors;tumor;Work,Development Therapeutics Branch Clinical Trials,11746,NA,NA,NA,NA,8,NA,NA,598166,NA
11188218,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011754,NA,NA,1ZIABC011754-08,NCI:538908\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8123309 (contact),"REILLY, KARLYNE M (contact)",NA,NA,NA,Acceleration;Affect;Anaplastic astrocytoma;Basic Science;Biological;Brain Neoplasms;cell growth;chemokine;Clinical Trials;cohort;Collaborations;Conduct Clinical Trials;cytokine;drug action;effective therapy;Excision;experimental study;Female;Genetic;genetic analysis;Genetic Diseases;Glioblastoma;Glioma;Gliomagenesis;Goals;Histone Deacetylase Inhibitor;Human;Immune system;Immunocompetent;Immunotherapy;Incidence;inhibitor;inhibitor therapy;interferon therapy;Interferons;Interleukins;kinase inhibitor;Knowledge;male;Malignant Glioma;Malignant Neoplasms;Modeling;Molecular;molecular targeted therapies;mouse model;Mus;Mutation;neoplastic cell;Nervous System;Neurofibromatosis 1;Neurofibrosarcoma;NF1 gene;Operative Surgical Procedures;Pathway interactions;Patients;peripheral blood;Peripheral Nerve Sheath Neoplasm;Pharmaceutical Preparations;Plexiform Neurofibroma;Protein Tyrosine Kinase;ras Oncogene;Research;Role;Sex Bias;Sex Differences;targeted treatment;Testing;Translational Research;tumor;Tumor Cell Line;tumor growth;tumorigenesis;Work,"Molecular, Cellular and Genetic Analyses of Malignancies Associated with NF1",11754,NA,NA,NA,NA,8,NA,NA,538908,NA
11188219,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011755,NA,NA,1ZIABC011755-08,NCI:286083\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201719 (contact),"WU, CHUAN  (contact)",NA,NA,NA,Antigens;Autophagocytosis;Blood Circulation;Cell Line;Cell Physiology;cell type;Cells;commensal bacteria;Communication;Complex;Diet;Disease;Enterocytes;Epithelial Cells;Epithelium;Exposure to;Gastrointestinal Diseases;Goblet Cells;gut inflammation;gut microbiome;Homeostasis;host-microbe interactions;Immune;Immune system;Immunologics;Inflammation;Intervention;intestinal barrier;intestinal epithelium;Intestinal Mucosa;Intestinal permeability;Intestines;intraepithelial;Invaded;Mediating;Microbe;microbial;microbial homeostasis;microbial host;microorganism;Mucous body substance;Mucous Membrane;Nutrient;pathogen;Pathogenesis;Physiology;Play;prevent;Proteins;Regulation;Role;Structure;Symbiosis;Tissues;Toxin;uptake;Work,Inter- and intra-epithelial regulation for intestinal barrier integrity,11755,NA,NA,NA,NA,8,NA,NA,286083,NA
11188220,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011756,NA,NA,1ZIABC011756-08,NCI:712374\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201721 (contact),"COMPTON, ALEX  (contact)",NA,NA,NA,Address;antiviral immunity;Autophagocytosis;Basic Science;Benefits and Risks;Blood;CCI-779;cell growth;Cell Line;Cell Survival;Cells;Cellular Metabolic Process;cellular targeting;Clinical;clinical investigation;Clinical Research;Endocytosis;Endosomes;Epithelial Cells;FRAP1 gene;Gene Modified;gene therapy;Goals;Human;Immune response;Immunosuppressive Agents;improved;in vivo;Infection;Influenza A virus;inhibitor;Innate Immune Response;Interferons;Journals;knock-down;Knock-out;Lentivirus Vector;Link;Malignant Neoplasms;Mediating;Metabolic;Metabolic Pathway;mTOR inhibition;mutant;Oncogenic;Paper;Pathway interactions;Patients;permissiveness;Pharmaceutical Preparations;PIK3CG gene;Predisposition;Property;Regimen;scaffold;Signal Pathway;Signal Transduction;Sirolimus;therapeutic gene;Time;Tissues;tumorigenesis;Ubiquitination;vacuolar H+-ATPase;Viral;Virus;Work,An Intrinsic Link between the Metabolic and Antiviral States of the Cell,11756,NA,NA,NA,NA,8,NA,NA,712374,NA
11188221,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011757,NA,NA,1ZIABC011757-08,NCI:2536004\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201723 (contact),"WOLIN, SANDRA  (contact)",NA,NA,NA,Affect;Animals;Archaea;Autoantibodies;Autoantigens;Bacteria;Bacterial Genes;Bacterial RNA;Binding;Biogenesis;Cell Physiology;Cells;Clinical;Complex;Enzymes;Excision;Failure;Goals;Human;human disease;Individual;Introns;Laboratories;Ligation;Mammalian Cell;Metabolism;Mus;nuclease;Operon;Organism;Orthologous Gene;Pathway interactions;Patients;Play;Proteins;repaired;Rheumatism;Ribonucleases;Ribonucleoproteins;RNA;RNA Decay;RNA Degradation;RNA-Binding Proteins;Role;Shapes;Signal Pathway;Sjogren&apos;s Syndrome;Structure;Systemic Lupus Erythematosus;Transcription Coactivator;Transfer RNA;tRNA Precursor;Untranslated RNA;Work,"Biogenesis, Function and Turnover of Noncoding RNAs",11757,NA,NA,NA,NA,8,NA,NA,2536004,NA
11188222,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011759,NA,NA,1ZIABC011759-08,NCI:2772481\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201727 (contact),"HERNANDEZ, JONATHAN  (contact)",NA,NA,NA,3-Dimensional;Biological Models;Biology;cancer care;CCR;Cells;Cholangiocarcinoma;clinical predictors;Clinical Trials;Couples;Cytoplasm;Development;Distant;Drug Evaluation;drug mechanism;epigenetic silencing;Excision;Exportins;Genes;Genetic;Goals;Human;imaging modality;Immune;Immune system;in vivo;inhibitor;Interruption;Kidney;Legal patent;Literature;Liver;Malignant neoplasm of ovary;Malignant Neoplasms;Mediating;Mediator;Metabolic;mimetics;Modeling;Molecular;mortality;Mutation;Neoplasm Metastasis;neoplastic cell;next generation sequencing;novel;Nuclear Export;Operative Surgical Procedures;Organ;Outcome;Pathway interactions;patient response;patient subsets;Patients;Perfusion;Peritoneal;Pharmaceutical Preparations;Phase;phase 2 study;Process;programs;Protein Export Pathway;Rare Diseases;Recurrence;response;Role;small molecule;Solid;Solid Neoplasm;stem;System;targeted agent;Therapeutic;tool;tumor;Tumor Biology;tumorigenesis;Up-Regulation,Interrogating the molecular underpinnings of metastatic colonization,11759,NA,NA,NA,NA,8,NA,NA,2772481,NA
11188223,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011761,NA,NA,1ZIABC011761-08,NCI:431431\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201666 (contact),"YANG, CHUN ZHANG  (contact)",NA,NA,NA,Anabolism;Animal Model;Antioxidants;beta-Transducin Repeat-Containing Proteins;Binding;Biochemical Pathway;Brain Neoplasms;brain pathway;cancer cell;Cell Death;Cell Line;Cell model;Cells;Cellular biology;cellular transduction;Consumption;coping;CRISPR screen;Cysteine;Data;Disease Outcome;Dissection;Drug Screening;Enzymes;Exhibits;experimental study;F Box Domain;Family;GCLC gene;GCLM gene;Genes;Genetic Transcription;Glioma;Glutamate-Cysteine Ligase;Glutamates;Glutathione;Glutathione Metabolism Pathway;Glycine;glycogen synthase kinase 3 beta;Goals;Guide RNA;Half-Life;Homeostasis;Impairment;improved;In Vitro;in vivo;inhibitor;interest;Investigation;Malignant Neoplasms;member;Metabolic;Metabolic Pathway;Metabolic stress;Mitochondria;Molecular;Molecular Biology;Molecular Target;mRNA sequencing;mutant;Mutate;Mutation;NADP;Natural Compound;neoplastic cell;novel;novel therapeutic intervention;nuclear factor-erythroid 2;Oxidation-Reduction;oxidative damage;Pathway interactions;Patients;Phosphorylation;PI3K/AKT;Play;pre-clinical;programs;Proliferating;Promoter Regions;protein degradation;Proteins;Reactive Oxygen Species;Reduced Glutathione;Respiration;RNA library;Role;solute;stem cells;Structure;synergism;Therapeutic;therapeutic target;transcription factor;Transcriptional Activation;transcriptome;Translations;triptolide;ubiquitin-protein ligase;Ubiquitination;WD Repeat;Xenograft procedure,Nrf2-goverened metabolic reprogram in IDH1-mutated glioma,11761,NA,NA,NA,NA,8,NA,NA,431431,NA
11188224,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011763,NA,NA,1ZIABC011763-08,NCI:1383497\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201732 (contact),"IGLESIAS-BARTOLOME, RAMIRO  (contact)",NA,NA,NA,Adult;adult stem cell;aging related;Alternative Therapies;Basal Cell;Basal cell carcinoma;Biological Models;cancer initiation;Cell Differentiation process;Cell Proliferation;cell regeneration;Cell Surface Receptors;Cells;Cyclic AMP-Dependent Protein Kinases;Dedications;Development;Diagnosis;Disease;Epithelial Cell Proliferation;Epithelial Cells;Epithelium;Equilibrium;Erinaceidae;Excision;Family;G-Protein-Coupled Receptors;G-substrate;Genetic Transcription;Goals;Growth;GTP-Binding Proteins;healthcare burden;Heterotrimeric G Protein Subunit;High Prevalence;Homeostasis;Human;Immunotherapy;Impairment;inhibitor;insight;interest;Intervention;keratinocyte;Laboratory Study;Location;Malignant Neoplasms;mouse model;Mus;Mutation;neoplastic cell;novel;novel therapeutic intervention;Oncogenic;Pathology;Pathway interactions;pharmacologic;programs;Proliferating;Proteins;Regulation;Research;Role;side effect;Signal Transduction;Skin;Skin Cancer;Skin Carcinoma;smoothened signaling pathway;stem cells;success;therapy resistant;tissue regeneration;Tissues;tumor;United States,Regulation of epithelial cell fate decisions in tissue homeostasis and cancer,11763,NA,NA,NA,NA,8,NA,NA,1383497,NA
11188225,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011765,NA,NA,1ZIABC011765-08,NCI:984541\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11592667 (contact),"LAZAREVIC, VANJA  (contact)",NA,NA,NA,Adaptive Immune System;Affinity;antimicrobial;Autoimmune Diseases;Autoimmune Responses;Autoimmunity;Automobile Driving;CD4 Positive T Lymphocytes;Cell Differentiation process;Cells;chronic inflammatory disease;Cues;Development;EGR2 gene;functional plasticity;gene regulatory network;Genetic Transcription;Helper-Inducer T-Lymphocyte;Homeostasis;Hypersensitivity;IL17 gene;immune function;Immune response;Immunity;immunopathology;Inflammatory Response;Maintenance;Nature;neuroinflammation;pathogen;Pathogenesis;Pathogenicity;Play;programs;repaired;Research;response;Role;Site;Tissue Preservation;Tissues;transcription factor;Transcriptional Regulation,Transcriptional regulation of inflammatory and autoimmune responses,11765,NA,NA,NA,NA,8,NA,NA,984541,NA
11188226,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011766,NA,NA,1ZIABC011766-08,NCI:1292817\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201736 (contact),"DE OLIVEIRA RODRIGUES BATISTA, PEDRO  (contact)",NA,NA,NA,Acute;alpha ketoglutarate;Bacteria;Binding;Biogenesis;cancer cell;Cancer cell line;cancer type;Cell Fate Control;Cell Proliferation;Cells;cellular engineering;Chemistry;Chronic;Comparative Study;Development;Dioxygenases;Disease;Energy Metabolism;Environment;Enzymes;epigenome;experimental study;Family;Follow-Up Studies;Fumarates;Gene Expression;Genome;Goals;Growth;Health;Homeostasis;Human;improved;inducible gene expression;Isocitrate Dehydrogenase;Malignant Neoplasms;Maps;Measures;Metabolic;Metabolism;Methods;Modeling;Modification;Molecular;Mutate;Pathway interactions;Phenotype;Play;Positioning Attribute;Proliferating;Protocols documentation;Regulation;Regulator Genes;RNA;RNA methylation;Role;Succinate Dehydrogenase;Succinates;Surveys;Tissues;Transfer RNA;Translations,Regulation of RNA biogenesis and function by RNA modifications,11766,NA,NA,NA,NA,8,NA,NA,1292817,NA
11188227,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011767,NA,NA,1ZIABC011767-08,NCI:1292670\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201738 (contact),"DAI, CHENGKAI  (contact)",NA,NA,NA,Affect;Amyloid;amyloid formation;amyloidogenesis;analog;assault;Automobile Driving;c-myc Genes;cancer addiction;Cancer Biology;cancer cell;cancer therapy;Cell Death;Cell Survival;combat;Complex;Congo Red;DNA Binding;experimental study;Gene Expression;Genetic;Genetic Transcription;genome-wide;Genomic DNA;Goals;Heat-Shock Response;Histone Acetylation;histone acetyltransferase;HSF1;Human;Impairment;in vivo;Investigation;knock-down;Laboratories;Leucine;Malignant Neoplasms;MAPK8 gene;Mediating;Mitochondria;Molecular Chaperones;neoplastic cell;Neurofibrosarcoma;NF1 gene;novel;novel therapeutic intervention;novel therapeutics;Oncogenic;Outcome;pharmacologic;preservation;Proteins;Proteome;Proteomics;proteostasis;proteotoxicity;recruit;Repression;Research;Research Project Grants;Role;Schwann Cells;Stress;stressor;transcription factor;Translational Repression;Translations;TSC2 gene;tumor;tumor growth;Ubiquitination;Xenograft Model,Preservation of Proteomic Stability and Promotion of Protein Lipidation by HSF1,11767,NA,NA,NA,NA,8,NA,NA,1292670,NA
11188228,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011768,NA,NA,1ZIABC011768-08,NCI:672396\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201740 (contact),"ARMSTRONG, TERRI S. (contact)",NA,NA,NA,Biological Specimen Banks;Budgets;CCR;Central Nervous System Neoplasms;Clinical;Collection;design;Disease;Education;Future;Genetic;high risk;interest;Malignant neoplasm of central nervous system;Natural History;neuro-oncology;Paper;Patients;Phase;Probability;Protocols documentation;sociodemographics;Syndrome;tumor,Natural History and Specimen Banking for Patients with CNS Tumors,11768,NA,NA,NA,NA,8,NA,NA,672396,NA
11188229,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011772,NA,NA,1ZIABC011772-08,NCI:1435309\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201744 (contact),"MUPPIDI, JAGAN  (contact)",NA,NA,NA,Accounting;activated B cell like;Address;Age;aged;Aging;Alleles;animal old age;Animals;Antibiotic Therapy;Antibodies;Antibody Affinity;Antigens;Area;ARHGEF1 gene;Autoimmunity;B-Lymphocytes;BCL2 gene;Biology;Cecum;cell behavior;Cell Cycle Inhibition;Cell Cycle Progression;Cell Death;Cell Death Induction;Cell Lineage;cell motility;Cell Survival;Cells;Chronic;Coupled;Cues;Data;Dependence;Development;Diet;Distal;Distant;draining lymph node;G Protein-Coupled Receptor Signaling;gain of function;gain of function mutation;Gene Expression;Generations;Genes;Genetic;Goals;GTP-Binding Proteins;Guanine Nucleotide Exchange Factors;Guanine Nucleotides;gut microbiota;Homeostasis;Host Defense;Human;Humoral Immunities;Immune response;Immunization;Immunoglobulin M;in vivo;Infection;insight;Knock-in;large cell Diffuse non-Hodgkin&apos;s lymphoma;Lobe;Lymph;lymph nodes;Lymphoid Tissue;Lymphoma;Lymphomagenesis;Malignant Neoplasms;Mediating;Memory;Memory B-Lymphocyte;mesenteric lymph node;microbial products;microbiota;Modeling;Molecular;molecular subtypes;Monomeric GTP-Binding Proteins;Mucous Membrane;Mus;Mutagenesis;Mutation;MYC Family Protein;novel;Nutrient;off-target mutation;overexpression;Pathway interactions;Peripheral;Peyer&apos;s Patches;Plasma Cells;PRDM1 gene;prevent;Process;programs;protein expression;Reaction;regional difference;Research;response;rho GTP-Binding Proteins;Role;Signal Transduction;Signaling Protein;Site;Small Intestines;Somatic Cell;Spleen;Stimulus;Structure of germinal center of lymph node;System;Testing;TLR7 gene;transcription factor;tumor;Virus Diseases;Work,The role of Galpha13 signaling in suppression of lymphoma,11772,NA,NA,NA,NA,8,NA,NA,1435309,NA
11188230,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011773,NA,NA,1ZIABC011773-08,NCI:1649495\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201746 (contact),"ZHUANG, ZHENGPING  (contact)",NA,NA,NA,Affect;Alleles;Applied Research;autosome;Basic Science;BHLH Protein;bHLH-PAS factor HLF;Binding;Bioenergetics;Body System;Cancer Biology;cancer genetics;Cardiovascular system;Carotid Body;Catecholamines;Cell model;cell type;Cells;Central Nervous System;Citric Acid Cycle;Clear Cell;Clinic;Clinical;clinical investigation;Clinical Research;Clinical Sciences;Collaborations;Congenital Abnormality;congenital anomaly;Cyst;Dedications;Development;Dimerization;Disease;disease-causing mutation;Embryo;Environment;Epigenetic Process;Equilibrium;Event;Extramural Activities;Family;Functional disorder;gain of function;Gene Mutation;Genes;Genetic;genetic variant;Germ Lines;Glioma;Goals;Human;Hydroxylation;Hyperplasia;Hypoxia;Hypoxia Inducible Factor;hypoxia inducible factor 1;Inherited;innovation;insight;interest;Intramural Research Program;Investigation;Knowledge;Laboratories;Laboratory Research;Lead;Link;loss of function;malformation;Malignant Neoplasms;Mediating;meningioma;Metabolic;Metabolism;migration;Modeling;Molecular;mosaic nature;Mosaicism;mouse model;multicatalytic endopeptidase complex;multidisciplinary;Mutation;Nature;NCI Center for Cancer Research;Neoplasm Metastasis;Neoplasms;Neoplasms in Vascular Tissue;neoplastic;neoplastic cell;nerve stem cell;Nervous System Neoplasms;Neural tube;neuro-oncology;Normal tissue morphology;normoxia;novel;Nuclear Translocation;Oncogenic;organ growth;Oxygen;Paraganglioma;Pathogenesis;Pathology;Pathway interactions;Patient Care;Patients;Phenotype;Physiological Processes;Play;Polycythemia;Predisposition;Procollagen-Proline Dioxygenase;Production;programs;Proline;Proteins;Regulation;Research;Research Personnel;Rhabdoid Cell;Role;Scientist;sexual dimorphism;Shunt Device;Signal Pathway;Signal Transduction;Somatic Mutation;Somatostatinoma;stem cell biology;Syndrome;System;targeted cancer therapy;Therapeutic;Therapeutic Studies;therapeutic target;Transgenic Mice;Transgenic Model;Translational Research;tumor;tumor progression;tumorigenesis;ubiquitin-protein ligase;Variant;Vascularization;vasculogenesis;VHL mutation;VHL protein;Von Hippel-Lindau Syndrome;Work,Hypoxia signaling in cancer development,11773,NA,NA,NA,NA,8,NA,NA,1649495,NA
11188231,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011774,NA,NA,1ZIABC011774-08,NCI:1753582\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201715 (contact),"HESKE, CHRISTINE  (contact)",NA,NA,NA,Adolescent and Young Adult;Area;cancer cell;Cancer Model;Cells;chemotherapy;Childhood;childhood sarcoma;Childhood Solid Neoplasm;Clinic;Clinical;clinical candidate;Clinical Research;Collaborations;combinatorial;Development;Developmental Therapeutics Program;DNA Damage;DNA Repair;DNA-dependent protein kinase;Doxorubicin;Drug Exposure;Enzymes;Etoposide;Ewings sarcoma;Genetic;Genetic Screening;Goals;Heat-Shock Proteins 90;Impairment;improved;inhibitor;inhibitor therapy;interest;irinotecan;lactate dehydrogenase A;Malignant Childhood Neoplasm;Malignant Neoplasms;Metabolic;Metabolism;Modeling;National Center for Advancing Translational Sciences;nicotinamide phosphoribosyltransferase;novel;novel therapeutics;Osteosarcoma;Pathway interactions;patient derived xenograft model;patient population;Patients;pharmacologic;phase 1 testing;Population;pre-clinical;Pre-Clinical Model;preclinical evaluation;preclinical study;Publishing;refractory cancer;replication stress;Research Personnel;Rhabdomyosarcoma;Role;Sarcoma;Screening procedure;standard of care;targeted agent;Testing;Topoisomerase;Translating;Translations;tumor;tumor DNA;tumor metabolism;Urologic Oncology;Work,Development and translation of novel therapies for pediatric sarcoma,11774,NA,NA,NA,NA,8,NA,NA,1753582,NA
11188232,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011779,NA,NA,1ZIABC011779-08,NCI:1068562\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201721 (contact),"COMPTON, ALEX  (contact)",NA,NA,NA,2019-nCoV;Acute;Amphipathic Alpha Helix;Anti-viral Therapy;Binding;biophysical properties;Cell Physiology;Cells;Cellular Membrane;Cellular Structures;Cholesterol;Communication;Cryoelectron Microscopy;Development;Ensure;Event;Exhibits;Family member;gene therapy;Glean;Glucose;HIV-1;Human;human pathogen;IFITM1 gene;Immune response;Immunologic Factors;Immunology;in silico;Infection;Influenza A virus;insight;Integral Membrane Protein;interest;Interferons;Journals;Learning;Mediating;Membrane;Membrane Fluidity;Membrane Fusion;Molecular;Molecular Biology;molecular dynamics;Nature;neurotransmission;new therapeutic target;novel;pathogenic virus;Pathway interactions;Play;Population;prevent;Process;Property;Protein Family;Proteins;Publishing;response;restoration;Role;Signal Transduction;SNAP receptor;Structure;Therapeutic Intervention;trafficking;tumorigenesis;tumorigenic;Viral;Viral Physiology;viral transmission;Virion;Virus;Virus Diseases;Virus Replication;Work;Zika Virus,Mechanisms of Virus Entry into Cells and Antiviral Barriers Limiting Entry,11779,NA,NA,NA,NA,8,NA,NA,1068562,NA
11188233,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011780,NA,NA,1ZIABC011780-08,NCI:1454350\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692409 (contact),"STAUDT, LOUIS  (contact)",NA,NA,NA,Accounting;anti-CD20;Apoptotic;BCL2 gene;Belief;Bypass;cell killing;Cell Line;Cell Survival;Cells;Chemicals;chemotherapy;chimeric antigen receptor T cells;Clinical;clinical development;clinical investigation;Combination Drug Therapy;Development;Drug Combinations;Drug Targeting;Family member;functional genomics;Genetic;Glucocorticoid Receptor;Immunotherapy;In complete remission;inhibitor;IRF4 gene;JAK1 gene;Journals;Laboratories;large cell Diffuse non-Hodgkin&apos;s lymphoma;lenalidomide;Lymphoma;Lymphoma cell;MCL1 gene;Medicine;Molecular;Molecular Profiling;molecular subtypes;Monitor;Monoclonal Antibody CD20;New England;NF-kappa B;Non-Hodgkin&apos;s Lymphoma;Oncogenic;Other Genetics;Outcome;overexpression;Pathway interactions;Patients;Pharmaceutical Preparations;PIK3CG gene;Pre-Clinical Model;Predisposition;Prednisone;Progression-Free Survivals;Recovery;Refractory;Regimen;Relapse;Reporting;Resistance;response;Revlimid;Safety;Signal Transduction;STAT3 gene;Survival Rate;targeted agent;Testing;Toxic effect;Translating;trial design;tumor;tumor DNA,Clinical development of mechanism-based lymphoma therapies,11780,NA,NA,NA,NA,8,NA,NA,1454350,NA
11188234,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011781,NA,NA,1ZIABC011781-08,NCI:408425\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201697 (contact),"ALTAN-BONNET, GREGOIRE  (contact)",NA,NA,NA,anti-CD20;Autoimmune;Biological Phenomena;Blood;Bone Marrow;Cancer Burden;Candida;cell type;Cells;checkpoint inhibition;Choristoma;cytokine;Disease;Erythrocytes;Goals;Hematology;Hematopoiesis;Hematopoietic;hematopoietic differentiation;Hematopoietic System;Homeostasis;Immune system;Immunotherapy;Infection;Inflammatory;interest;Leukocytes;Lymphoid Cell;Manuscripts;Measurement;Modeling;Mus;Myeloid Cells;Organ;Organism;response;Rest;Signal Transduction;Spleen;stem;Testing;Tissues;tumor immunology;tumorigenesis;Vascular blood supply;White Blood Cell Count procedure;Work,Dynamics of hematopoietic differentiation,11781,NA,NA,NA,NA,8,NA,NA,408425,NA
11188235,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011782,NA,NA,1ZIABC011782-08,NCI:352810\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692485 (contact),"KELLY, KATHLEEN  (contact)",NA,NA,NA,Address;Adenocarcinoma;Adenocarcinoma Cell;Adopted;androgen independent prostate cancer;Androgen Receptor;anti-cancer research;aurora kinase A;Automobile Driving;Biological;Biological Assay;Biological Markers;biomarker driven;Biopsy;Biopsy Specimen;bone;Cancer Biology;Cancer Patient;cancer therapy;Castration;CD276 gene;Cell Count;Cell Line;Cell Proliferation;Cells;Characteristics;Clinical;Clustered Regularly Interspaced Short Palindromic Repeats;cohort;Communities;Coupled;Data;disease heterogeneity;DNA Crosslinking Agent;DNA Repair;Dropout;efficacious treatment;enzalutamide;Epithelium;Evolution;Genetic Transcription;Genomics;Genotype;Goals;Heterogeneity;In Vitro;in vitro Model;in vivo;inhibitor;insight;Malignant neoplasm of prostate;Membrane Proteins;Mesenchymal;Metastatic Prostate Cancer;Methodology;Modeling;Molecular;Mutation;Neoplasm Metastasis;neoplastic cell;neuroendocrine phenotype;Neuroendocrine Prostate Cancer;Neurosecretory Systems;Organoids;Pathogenesis;patient derived xenograft model;patient population;Patients;Pharmaceutical Preparations;Phenotype;Population;Pre-Clinical Model;preservation;Procedures;progenitor;Prognosis;Prostate;Prostate Adenocarcinoma;prostate cancer model;pyrrolobenzodiazepine;RB1 gene;Receptor Inhibition;replication stress;Reporting;Research;Resistance;response;self-renewal;stem;stem cells;stemness;success;System;Therapeutic;Therapeutic antibodies;Tissues;TP53 gene;treatment response;trial design;tumor;tumor growth;Work,Mechanisms of pathogenesis in patient derived organoid models of prostate cancer,11782,NA,NA,NA,NA,8,NA,NA,352810,NA
11188236,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011784,NA,NA,1ZIABC011784-08,NCI:848283\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14280069 (contact),"GILBERT, MARK  (contact)",NA,NA,NA,Acceleration;analytical tool;Animals;Area;Belief;Big Data;Biochemical Pathway;Bioinformatics;bioinformatics tool;Biological;Biological Process;Biology;Biomedical Research;Blood specimen;Brain Neoplasms;Cancer Genome Anatomy Project;Cancer Research Project;cDNA Arrays;cell behavior;Cell Line;Cells;Central Nervous System Neoplasms;Chordoma;Classification;clinical care;Clinical Data;clinical practice;Clinical Trials;Collaborations;Collection;companion diagnostics;Complex;Computer Analysis;Data;data acquisition;Data Analyses;data platform;data streams;data warehouse;Databases;Decision Making;design;Development;differential expression;Disease;DNA;DNA biosynthesis;DNA Sequence;driving force;drug development;Enrollment;Evolution;Explosion;Formalin;Freezing;Functional disorder;Funding;Gene Expression Profile;Gene Expression Profiling;Generations;Genes;Genetic;Genetic Transcription;genome wide methylation;genome-wide;Genomic Data Commons;genomic profiling;Genomics;Germ Lines;Glioma;histone methylation;Human;Human Genome Project;Hybrids;Impact evaluation;improved;In Vitro;in vivo;Information Storage;Laboratories;laboratory experiment;Link;Mainstreaming;Malignant neoplasm of central nervous system;Malignant Neoplasms;Maps;metabolomics;methylation pattern;Microarray Analysis;MicroRNAs;Mining;Modality;Molecular;Molecular Analysis;molecular diagnostics;molecular targeted therapies;Monitor;Morphology;mRNA Translation;Natural History;Nature;neuro-oncology;novel;novel therapeutics;Nucleic Acids;older patient;Paraffin Embedding;participant enrollment;patient prognosis;patient stratification;Patients;Pattern;peripheral blood;Pharmacotherapy;Phenotype;precision medicine;Process;programs;prospective;protein aminoacid sequence;protein distribution;Proteins;Proteomics;Research;Research Personnel;Resolution;Resources;RNA chemical synthesis;sample collection;Sampling;Science;Signal Transduction Pathway;small molecule;Source;stem cells;System;Techniques;Technology;The Cancer Genome Atlas;Therapeutic;therapeutic biomarker;therapeutic target;three dimensional structure;Time;Tissue Sample;Tissues;transcriptomics;Translating;Treatment Efficacy;treatment response;treatment stratification;Tumor Biology;Tumor Tissue;user-friendly;Variant;whole genome;Work,Bioinformatics: Characterizing Brain Tumor Data,11784,NA,NA,NA,NA,8,NA,NA,848283,NA
11188237,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011785,NA,NA,1ZIABC011785-08,NCI:233139\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8123119 (contact),"NICKLAUS, MARC  (contact)",NA,NA,NA,Appearance;Area;Azides;Book Chapters;catalyst;Charge;Chemicals;Chemistry;Code;Collaborations;Computer software;Cyclization;Data;Databases;design;drug development;drug discovery;Environment;Equilibrium;Eye;foot;Hydrogen;improved;Informatics;Literature;migration;Molecular Weight;Motivation;Movement;Organic Chemistry;Paper;Property;Protons;Publications;quantum computing;Reaction;Recommendation;Records;Solvents;structural biology;Structure;System;tautomer;Techniques;Temperature;Terminology;Testing;Tetrazoles;tool;Variant;web services;web site;Work;working group,Better Understanding and Handling of Tautomerism,11785,NA,NA,NA,NA,8,NA,NA,233139,NA
11188238,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011789,NA,NA,1ZIABC011789-08,NCI:170228\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201761 (contact),"LIN, FRANK  (contact)",NA,NA,NA,early phase clinical trial;Goals;improved;Literature;Metastatic Pheochromocytoma;National Institute of Child Health and Human Development;Paraganglioma;Patients;phase 2 study;Progression-Free Survivals;rare cancer;safety assessment,Phase 2 study of Lu-177-DOTATATE in inoperable paraganglioma - pheochromocytoa,11789,NA,NA,NA,NA,8,NA,NA,170228,NA
11188239,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011790,NA,NA,1ZIABC011790-08,NCI:369985\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10270697 (contact),"SMART, DEEDEE  (contact)",NA,NA,NA,Affect;Amines;Animal Model;Animals;Brain;Brain Neoplasms;Chemicals;Clinical;Contrast Media;Cranial Irradiation;Diagnostic;experience;Future;Glutamate Metabolism Pathway;Glutamates;Hippocampus;Human;human subject;human tissue;Image;imaging facilities;Imaging Techniques;in vivo;Location;magnetic field;Magnetic Resonance Imaging;Measurable;Measures;Memory impairment;Metabolic;metabolic imaging;Methodology;Modeling;Molecular;Mus;Nerve Degeneration;neurotoxicity;Neurotransmitters;Oncology;Outcome;Patients;pre-clinical;Protons;Radiation;Radiation induced damage;radiation mitigator;radiation response;Radiation therapy;Radiation Toxicity;Radiation-Protective Agents;Recovery;Reporting;Research;Signal Transduction;Stress;Techniques;Testing;Therapeutic;Time;Tissues;tool;tumor;United States National Institutes of Health;Water,Metabolic imaging of the effects of brain radiotherapy,11790,NA,NA,NA,NA,8,NA,NA,369985,NA
11188240,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011793,NA,NA,1ZIABC011793-07,NCI:3252811\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687345 (contact),"THOMAS, ANISH  (contact)",NA,NA,NA,Address;American Society of Clinical Oncology;anti-cancer research;anti-tumor immune response;Antibody-drug conjugates;ATR gene;Award;Benchmarking;Biology;Biopsy;cancer cell;Cancer cell line;cancer heterogeneity;Cancer Science;cancer subtypes;cancer therapy;Cancer-Predisposing Gene;CAR T cell therapy;career;cell type;Cells;cellular targeting;Cessation of life;Characteristics;CHEK1 gene;Chemoresistance;chemotherapy;Chromosome abnormality;Chromosome Segregation;Clinical;Clinical Data;Clinical Trials;clinically relevant;clinically significant;Complex;Diagnosis;Disease;Disease remission;Disease Resistance;DNA;DNA amplification;DNA Damage;DNA Double Strand Break;DNA replication fork;Effectiveness;Epigenetic Process;epithelial to mesenchymal transition;Exclusion;Exhibits;extrachromosomal DNA;EZH2 gene;Faculty;Foundations;Future;gemcitabine;Gene Expression Profile;Gene Expression Profiling;Genes;Genetic;Genetic Transcription;Genetic Variation;Genomic Instability;Genomics;Goals;Heterogeneity;histone modification;Human;Immune;immune activation;immune checkpoint blockade;immune resistance;Immuno-Chemotherapy;Immunotherapy;improved;Inherited;inhibitor;insight;Intrinsic factor;JAK1 gene;K-Series Research Career Programs;Knowledge;Laboratories;Learning;life span;Malignant neoplasm of lung;Malignant Neoplasms;Maps;meetings;Mentors;Mismatch Repair Deficiency;Mission;Molecular;Molecular Profiling;Mutation;Neoplasm Metastasis;neoplastic cell;Neuroendocrine Cell;Neurosecretory Systems;next generation;non-genetic;Normal tissue morphology;notch protein;novel;novel therapeutic intervention;Nucleosomes;Outcome;paralogous gene;PARP inhibition;partial response;Patient Selection;Patients;Pattern;PDL1 inhibitors;personalized care;personalized medicine;Pharmacodynamics;phase I trial;phase II trial;Phenotype;Phosphorylation;Phosphotransferases;Physicians;Plasma;Play;Poly(ADP-ribose) Polymerase Inhibitor;Population;predicting response;Prediction of Response to Therapy;programs;Progression-Free Survivals;Quality of life;Randomized;Recurrence;Relapse;replication stress;Research;Research Personnel;Resistance;response;Risk Factors;Role;Scientific Advances and Accomplishments;Scientist;Shapes;Signal Transduction;Small Cell Carcinoma;small cell lung carcinoma;Smoking;Stress;stress management;targeted treatment;Techniques;The Cancer Genome Atlas;Therapeutic;therapy resistant;Time;Tissues;TOP1 gene;Topotecan;Toxic effect;transcriptomics;translational approach;Treatment outcome;tumor;Tumor Antigens;tumor DNA;tumor heterogeneity;Tumor Immunity;Tumor Markers;tumor microenvironment;tumor progression;Tumor Subtype;Tumor Suppressor Proteins;Work,Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies,11793,NA,NA,NA,NA,7,NA,NA,3252811,NA
11188241,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011798,NA,NA,1ZIABC011798-07,NCI:1356484\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687347 (contact),"ARDA, HATICE  (contact)",NA,NA,NA,Body System;Categories;Cell Lineage;cell type;Cells;Chromatin;Development;Diabetes Mellitus;diabetes risk;DNA;DNA Sequence;Elements;Enhancers;Exocrine pancreas;Gene Expression;Genome Mappings;Genomics;Goals;interest;Islets of Langerhans;Link;Logic;Malignant neoplasm of pancreas;Maps;Pancreas;Pancreatic Diseases;programs;reference genome;Regenerative Medicine;Regulatory Element;Research;risk variant;Technology;Work,Identification of genomic regulatory elements in pancreas cells,11798,NA,NA,NA,NA,7,NA,NA,1356484,NA
11188242,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011800,NA,NA,1ZIABC011800-07,NCI:1979063\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687349 (contact),"ESCORCIA, FREDDY  (contact)",NA,NA,NA,Ablation;Antibodies;Biological;cancer type;Cessation of life;Death Rate;Detection;Development;Diagnosis;Disease;Engineering;Excision;falls;first-in-human;Goals;high risk;Image;imaging agent;Immunotherapy;improved;Incidence;intrahepatic;Intravenous;Legal patent;Length;liver cancer model;Magnetic Resonance Imaging;Malignant neoplasm of liver;Malignant Neoplasms;Modality;Molecular;mouse model;nanobodies;novel;palliative;Patient Selection;Patients;Phase;Positron-Emission Tomography;Primary carcinoma of the liver cells;Radiation therapy;Radioembolization;Radiopharmaceuticals;screening;Survival Rate;Translating;Transplantation;treatment planning;tumor;United States;X-Ray Computed Tomography,Engineering HCC-selective PET agent,11800,NA,NA,NA,NA,7,NA,NA,1979063,NA
11188243,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011801,NA,NA,1ZIABC011801-07,NCI:381445\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201719 (contact),"WU, CHUAN  (contact)",NA,NA,NA,Antigens;CD4 Positive T Lymphocytes;Cell Communication;Cell Physiology;Cells;dietary;Enterocytes;Epithelial Cells;Epithelium;gut inflammation;Homeostasis;Immune;Immune Tolerance;interest;intestinal barrier;intestinal epithelium;intestinal homeostasis;Intestines;intraepithelial;Invaded;Microbe;Molecular;Mus;Play;response;Risk;Role;Signal Transduction;Symbiosis;T cell regulation;T-Lymphocyte,T cell regulation for intestinal barrier function,11801,NA,NA,NA,NA,7,NA,NA,381445,NA
11188244,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011802,NA,NA,1ZIABC011802-07,NCI:3110985\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687352 (contact),"RUPPIN, EYTAN  (contact)",NA,NA,NA,actionable mutation;Advanced Malignant Neoplasm;anti-cancer research;Antineoplastic Agents;cancer genetics;Cancer Patient;cancer therapy;Clinical;cohort;Data;Development;dosage;drug development;Drug resistance pathway;Drug Targeting;Drug usage;Effectiveness;fighting;Genes;Genetic;Genetic Complementation Test;genome-wide analysis;Genomics;improved;Laboratories;Malignant Neoplasms;Mediating;Methods;Mutation;patient stratification;Patients;Pharmaceutical Preparations;Pharmacotherapy;precision medicine;predicting response;Research;Resistance;response;Sampling;synthetic lethal interaction;targeted treatment;Therapeutic;tool;transcriptomics;tumor;whole genome;Work,Discovery of genetic interactions in cancer,11802,NA,NA,NA,NA,7,NA,NA,3110985,NA
11188245,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011803,NA,NA,1ZIABC011803-07,NCI:2073990\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687352 (contact),"RUPPIN, EYTAN  (contact)",NA,NA,NA,anti-cancer;Binding;Biological Markers;cancer immunotherapy;cancer type;CAR T cell therapy;checkpoint therapy;computer studies;Data;Effectiveness;Gene Expression Profiling;Genes;genome-wide analysis;immune checkpoint blockade;Immune checkpoint inhibitor;Immune response;Immune system;Immunotherapy;Machine Learning;Malignant Neoplasms;Melanoma;Metastatic Melanoma;Neuroblastoma;new therapeutic target;NF1 gene;novel;Outcome;patient response;Patients;Pharmaceutical Preparations;predicting response;predictive tools;Reporting;response;Role;Shapes;targeted treatment;Testing;Translations;tumor heterogeneity;Tumor Suppressor Proteins;urea cycle,Computational studies of cancer immunotherapy,11803,NA,NA,NA,NA,7,NA,NA,2073990,NA
11188246,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011804,NA,NA,1ZIABC011804-07,NCI:516915\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687355 (contact),"YOHE, MARIELLE  (contact)",NA,NA,NA,Animals;Cell Culture Techniques;Cell Proliferation;Cells;Cessation of life;Childhood Solid Neoplasm;clinical development;clinical translation;Clinical Trials;FRAP1 gene;Goals;Growth;IGF1R gene;Induction of Apoptosis;inhibitor;Malignant Childhood Neoplasm;MAP Kinase Gene;MEK inhibition;MEKs;Mitogen-Activated Protein Kinase Inhibitor;Monoclonal Antibodies;Mutate;Mutation;Neoplasm Metastasis;Neuroblastoma;neuroblastoma cell;Pathway interactions;Patients;Pharmaceutical Preparations;pre-clinical;preclinical study;Primary Neoplasm;Proto-Oncogene Proteins c-akt;RAS inhibition;Ras Inhibitor;Refractory;Relapse;Resistance development;response;Rhabdomyosarcoma;small molecule;synergism;targeted agent;Testing;Therapeutic;tumor;tumor initiation;Work;Xenograft Model,Dual Blockade of IGF1R and MEK synergistically inhibits pediatric cancers,11804,NA,NA,NA,NA,7,NA,NA,516915,NA
11188247,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011806,NA,NA,1ZIABC011806-07,NCI:2018107\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687358 (contact),"TAKAHAMA, YOUSUKE  (contact)",NA,NA,NA,Antigen Receptors;Antigens;Autoantigens;Biology;CCL21 gene;Cell Fate Control;Characteristics;Development;Embryo;Epithelial Cells;Epithelium;experimental study;Goals;Immune system;interest;Japan;Laboratories;Laboratory Research;Lymphocyte;Mature T-Lymphocyte;Molecular;pathogen;Play;Positioning Attribute;Process;Production;programs;Receptor Signaling;Research;Role;Self Tolerance;Specificity;Structure of thymic medulla;T-Lymphocyte;thymocyte;Thymus Gland,Thymus biology,11806,NA,NA,NA,NA,7,NA,NA,2018107,NA
11188248,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011807,NA,NA,1ZIABC011807-07,NCI:510532\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201697 (contact),"ALTAN-BONNET, GREGOIRE  (contact)",NA,NA,NA,Antibodies;Antigens;bioinformatics pipeline;Biological;Blood;Bone Marrow;Cell Differentiation process;Cell Proliferation;Cells;Coin;Collaborations;Communication;cytokine;Cytokine Signaling;Cytometry;Equilibrium;Goals;Grant;Hematology;Hematopoietic;high dimensionality;Homeostasis;Immune;Immunophenotyping;immunoregulation;Inflammation;Leukocytes;Lymphoid Tissue;Machine Learning;Manuscripts;Measurement;Measures;Methodology;Methods;Modeling;monocyte;Mus;Pharmaceutical Preparations;Phenotype;Physiologic pulse;Population;Preparation;Regulation;Research;Research Project Grants;Resolution;response;Running;Signal Pathway;Site;Spleen;Stains;T-Lymphocyte;Testing;tissue preparation;tumor;United States National Institutes of Health;White Blood Cell Count procedure;Work,Immunophenotyping by high-dimensional cytometry  and machine learning,11807,NA,NA,NA,NA,7,NA,NA,510532,NA
11188249,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011808,NA,NA,1ZIABC011808-07,NCI:436054\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355468 (contact),"RUIZ, SERGIO  (contact)",NA,NA,NA,Binding;Cell Nucleus;Cell Proliferation;Cells;Communication;Data;Defect;Development;Embryonic Development;Enhancers;Ensure;Extinction;Family;Gene Expression;Gene Expression Profile;Genes;Genetic Transcription;Goals;Growth;Malignant Neoplasms;MAP Kinase Gene;Membrane;Methyltransferase;Mouse Embryonic Stem Cells;Mus;NRAS gene;Nuclear;pluripotency;programs;Proteins;Publications;RAS genes;ras Proteins;Receptor Signaling;Role;Science;transcription factor;Transcription Repressor;transcriptome sequencing;Work,Role of ETS-Transcription Factors in Regulating Cell Fate,11808,NA,NA,NA,NA,7,NA,NA,436054,NA
11188250,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011809,NA,NA,1ZIABC011809-07,NCI:256502\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355468 (contact),"RUIZ, SERGIO  (contact)",NA,NA,NA,Amino Acids;Biological Assay;cancer stem cell;CDK2 gene;Cell Cycle;Cell Cycle Regulation;Cell Line;Cell Nucleus;Cells;Chimeric Proteins;Consensus;Cytoplasm;Development;Diapause;Embryo;ES Cell Line;Food;gastrulation;Gene Expression Profile;Goals;HELB gene;human DNA;human embryonic stem cell line;In Vitro;interest;Label;live cell imaging;Maintenance;Mammals;Maps;Measures;Molecular;mouse model;Mus;mutant;Nuclear Export;Nuclear Localization Signal;Pathway interactions;Phosphorylation Site;Physiological;Process;Proliferating;Proteins;Reporter;sensor;Signal Transduction;single-cell RNA sequencing;small molecule libraries;spatiotemporal;Specific qualifier value;System;tumor;Validation;Visualization,Identification of molecular pathways regulating quiescence in pluripotent cells,11809,NA,NA,NA,NA,7,NA,NA,256502,NA
11188251,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011810,NA,NA,1ZIABC011810-07,NCI:1157968\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355471 (contact),"VIDIGAL, JOANA  (contact)",NA,NA,NA,Binding;Biological Models;Catalytic Domain;Cell Culture Techniques;Cell Nucleus;Cell Proliferation;Cells;Cytoplasm;Data;Development;Disease;Elements;FRAP1 gene;Gene Expression;Genetic;Genetic Transcription;Genome;Goals;Homeostasis;in vivo;interest;Mammals;MicroRNAs;Mus;neuronal cell body;Nuclear;Pathway interactions;PIK3CG gene;posttranscriptional;Proteins;Proto-Oncogene Proteins c-akt;Regulation;Repression;RNA;RNA Interference;Role;Signal Transduction;Small RNA;Splenocyte;System;Testing;Tissues;tool;Whole Organism,Canonical and non-canonical roles of Argonaute proteins in mammals,11810,NA,NA,NA,NA,7,NA,NA,1157968,NA
11188252,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011811,NA,NA,1ZIABC011811-07,NCI:289492\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355471 (contact),"VIDIGAL, JOANA  (contact)",NA,NA,NA,Basic Science;Biomedical Research;Cells;Clinical Research;Code;Communication;Computer software;CRISPR screen;CRISPR/Cas technology;Data;design;Exons;fitness;Genome;genome-wide;genomic locus;Goals;Guide RNA;human disease;Libraries;Mammals;Manuscripts;Mediating;Molecular;Nature;Performance;Physiological;Proteins;Publications;RNA Sequences;RNA-Binding Proteins;Role;tool;Untranslated RNA,CRISPR tools to dissect the coding and non-coding genome,11811,NA,NA,NA,NA,7,NA,NA,289492,NA
11188253,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011813,NA,NA,1ZIABC011813-07,NCI:589954\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355468 (contact),"RUIZ, SERGIO  (contact)",NA,NA,NA,Binding Sites;Cell Death;Cells;ChIP-seq;Cleavage Under Targets and Release Using Nuclease;Communication;Complementary DNA;Data;Defect;Development;developmental plasticity;DNA Damage;Dose;Doxycycline;Embryo;embryo cell;Embryonic Development;Enhancers;Gene Cluster;Gene Expression Profile;Genes;Genome;Goals;Growth;Heterochromatin;Homeodomain Proteins;interest;knock-down;Maintenance;Malignant Neoplasms;Microinjections;Molecular;Nature;promoter;Protein Family;Proteins;Publications;Publishing;RNA Splicing;Rodent;Role;Totipotency;Totipotent;transcriptome sequencing;Whole Organism;Work;zygote,Molecular Determinants of Totipotency,11813,NA,NA,NA,NA,7,NA,NA,589954,NA
11188254,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011815,NA,NA,1ZIABC011815-07,NCI:702708\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10105415 (contact),"LAZZERINI DENCHI, EROS  (contact)",NA,NA,NA,Address;Biological Assay;Cell Compartmentation;Cell Proliferation;Cells;Chromosomes;Enzymes;Equilibrium;Germ Cells;Human;Length;Malignant Neoplasms;Mammalian Cell;Measures;Mediating;mutant;novel;Property;recruit;Regulation;RNA;Role;stem cells;System;Telomerase;telomere;Visualization,Identify modulators of telomerase activity,11815,NA,NA,NA,NA,7,NA,NA,702708,NA
11188255,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011816,NA,NA,1ZIABC011816-07,NCI:702708\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10105415 (contact),"LAZZERINI DENCHI, EROS  (contact)",NA,NA,NA,Automobile Driving;cancer cell;cancer type;Canis familiaris;Cell Line;comparative genomics;Ensure;Genes;Genetic Recombination;Genomics;Human;inhibitor;Length;Malignant Neoplasms;Mediating;Molecular;novel;Osteosarcoma;Pathway interactions;pharmacologic;Process;Proliferating;telomere;Telomere Maintenance;therapeutic target,Determine the mechanism of ALT-mediated telomere elongation,11816,NA,NA,NA,NA,7,NA,NA,702708,NA
11188256,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011819,NA,NA,1ZIABC011819-07,NCI:784374\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687374 (contact),"KHARE, ANUPAMA  (contact)",NA,NA,NA,Affect;Antibiotic Resistance;Antibiotics;antimicrobial;Bacteria;Behavior;Cells;chronic wound;Clinical;co-infection;Communities;Disease;Escherichia coli;fitness;Genes;genome-wide;Health;Human;Infection;interest;Life Style;Lung infections;Mediating;Microbial Biofilms;microbiome;microorganism;Modeling;Molecular;Motility;Mutation;novel;Oxidation-Reduction;Pathway interactions;Phenazines;Population;Postdoctoral Fellow;Production;Pseudomonas aeruginosa;Pulmonary Cystic Fibrosis;Pyocyanine;Research;Resistance;response;Staphylococcus aureus;Stenotrophomonas maltophilia;System;Testing;Wound Infection,Mechanisms of multi-species bacterial interactions,11819,NA,NA,NA,NA,7,NA,NA,784374,NA
11188257,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011821,NA,NA,1ZIABC011821-07,NCI:336161\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687374 (contact),"KHARE, ANUPAMA  (contact)",NA,NA,NA,Address;Antibiotic Resistance;Antibiotics;antimicrobial;Cessation of life;Evolution;Frequencies;Genes;Genetic Determinism;genomic locus;Genomics;Goals;Health;healthcare-associated infections;interest;Multi-Drug Resistance;mutant;novel;novel therapeutics;Pathway interactions;Play;Process;Role;Staphylococcus aureus;Testing;United States,Evolution of antibiotic resistance,11821,NA,NA,NA,NA,7,NA,NA,336161,NA
11188258,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011823,NA,NA,1ZIABC011823-06,NCI:1023609\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162076 (contact),"SHAH, NIRALI  (contact)",NA,NA,NA,Acute leukemia;Address;Adult;Age;Age Years;aged;Amendment;Antigen Targeting;Antigens;B lymphoid malignancy;B-Cell Acute Lymphoblastic Leukemia;B-Cell Leukemia;Back;bench to bedside;Biological;Biological Markers;Bispecific Antibodies;Blood;burden of illness;CAR antigen;CAR T cell therapy;Caring;CD19 gene;CD22 gene;Cell surface;Cell Therapy;cellular engineering;Chemoresistance;chemotherapy;Child;Childhood;chimeric antigen receptor T cells;Clinic;Clinical;clinical center;Clinical Trials;clinically relevant;Collaborations;combinatorial;Cytokine Receptors;Data;Data Set;design;Development;Disease;Disease remission;Dose;early phase clinical trial;eligible participant;Enrollment;Event;experience;experimental study;FDA approved;first-in-human;Flow Cytometry;Foundations;Frequencies;Future;Goals;Hematologic Neoplasms;Hemophagocytic Lymphohistiocytoses;Heterodimerization;high risk;Immune;immune effector cell-associated neurotoxicity syndrome;Immunotherapeutic agent;Immunotherapy;improved;improved outcome;Inflammatory;Infrastructure;Infusion procedures;insight;Investigation;Laboratories;leukemia/lymphoma;Mediating;Mission;Monitor;multidisciplinary;Myeloid Leukemia;Myeloproliferative disease;novel;novel strategies;novel therapeutics;Outcome;overexpression;Participant;patient stratification;Patient-Focused Outcomes;Patients;Phase;Phenotype;Philadelphia;pre-clinical;prevent;Process;programs;promoter;prospective;Prospective Studies;Publishing;receptor;Refractory;Relapse;Remission Induction;Research;Resistance;response;Risk Factors;risk mitigation;risk stratification;Safety;Salvage Therapy;Scientific Advances and Accomplishments;Series;Step Tests;Subgroup;T-Lymphocyte;targeted agent;Testing;Therapeutic;Therapeutic Index;Time;timeline;Toxic effect;Translating;translational approach;trial design;TSLP gene;United States National Institutes of Health;vector;Vision;Work;young adult,Development of Novel Approaches to Optimize CAR T-cell Therapies for B-cell Malignancies,11823,NA,NA,NA,NA,6,NA,NA,1023609,NA
11188259,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011826,NA,NA,1ZIABC011826-07,NCI:85115\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201761 (contact),"LIN, FRANK  (contact)",NA,NA,NA,Affect;Clinical Trials;Collaborations;Dental;FOLH1 gene;Future;Goals;Human;Methods;pre-clinical;Pre-Clinical Model;radioligand;Rodent;Salivary Glands;Translating;tumor;Update;uptake,Protection of Salivary Gland in PSMA-targeted radioligand therapy,11826,NA,NA,NA,NA,7,NA,NA,85115,NA
11188260,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011827,NA,NA,1ZIABC011827-07,NCI:85115\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201761 (contact),"LIN, FRANK  (contact)",NA,NA,NA,Combined Modality Therapy;DNA Damage;DNA Single Strand Break;gastroenteropancreatic neuroendocrine tumor;Lutetium;Malignant Neoplasms;Names;Neuroendocrine Tumors;Phase;Phase I/II Clinical Trial;Poly(ADP-ribose) Polymerase Inhibitor;Radioisotopes;repaired;stem,Phase 1-2 study of Lu177-DOTATATE and olaparib in neuroendocrine tumors,11827,NA,NA,NA,NA,7,NA,NA,85115,NA
11188261,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011828,NA,NA,1ZIABC011828-07,NCI:1302223\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,12419446 (contact),"PORAT SHLIOM, NATALIE  (contact)",NA,NA,NA,Biopsy;cancer prevention;Cell Separation;chemotherapy;Classification;Death Rate;Diagnostic;Diet;Drug resistance;Electron Microscopy;Exhibits;Fasting;Genetic Variation;Hepatic;Hepatocyte;Heterogeneity;Human;Image Analysis;image guided;Incidence;insight;intravital microscopy;Knowledge;Liver;liver cancer model;Liver diseases;Liver parenchyma;Malignant neoplasm of liver;Malignant Neoplasms;Metabolic dysfunction;Metabolic stress;Modeling;Molecular;mortality;Mus;novel therapeutic intervention;Patients;Physiological;Physiology;Primary Malignant Neoplasm of Liver;Process;Technology;Therapeutic;Tissues;tumor;tumor heterogeneity;tumorigenesis;United States;western diet,Hepatic organization and functions,11828,NA,NA,NA,NA,7,NA,NA,1302223,NA
11188262,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011830,NA,NA,1ZIABC011830-07,NCI:554448\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687383 (contact),"CAPPELL, STEVEN  (contact)",NA,NA,NA,Cell Cycle;Cell Cycle Regulation;Cells;Defect;DNA Damage;DNA Replication Damage;Exhibits;Future;G1 Phase;G1/S Transition;Goals;Individual;inhibitor;live cell imaging;Mammalian Cell;Measurement;Modeling;Molecular;Morphologic artifacts;prevent;response;S phase;Signal Pathway;Source;Stress;Work,Control of cell cycle commitment by APC-C-Cdh1,11830,NA,NA,NA,NA,7,NA,NA,554448,NA
11188263,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011831,NA,NA,1ZIABC011831-07,NCI:1300908\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687385 (contact),"SALOURA, VASSILIKI  (contact)",NA,NA,NA,Affect;Annual Reports;anti-PD1 therapy;Antibodies;Antisense Oligonucleotides;Binding;Biological Assay;cancer cell;cancer type;candidate identification;Categories;CD8-Positive T-Lymphocytes;Cell Cycle;Cell Line;Cell Nucleus;cell type;Cells;Cessation of life;chemokine;Chemotherapy and/or radiation;Chromatin;Chromatin Remodeling Factor;Clinical Trials;Clustered Regularly Interspaced Short Palindromic Repeats;Co-Immunoprecipitations;Colon;Combined Modality Therapy;Complex;Cytoplasm;Deposition;design;Disease;Distant Metastasis;Drug Kinetics;efficacy study;Epigenetic Process;Epithelium;ERBB2 gene;exhaust;experimental study;Family;gain of function;Genes;Genetic;Genetic Transcription;genome-wide;Goals;head and neck cancer patient;Head and Neck Neoplasms;Head and Neck Squamous Cell Carcinoma;histone methylation;Histone-Lysine N-Methyltransferase;Histones;HPV negative;HPV positive;Human;Immune;Immunocompromised Host;Immunoprecipitation;Immunotherapy;In Vitro;in vivo;inhibitor;Interferon-beta;Interferons;knock-down;Knock-in;Label;Lead;loss of function;Malignant neoplasm of lung;Malignant neoplasm of pancreas;Malignant Neoplasms;Mass Spectrum Analysis;Mediating;Mesenchymal;Messenger RNA;Metastatic/Recurrent;Methods;Methylation;Methyltransferase;mouse model;multimodality;Mus;mutant;Neoadjuvant Therapy;new therapeutic target;novel therapeutic intervention;Nuclear Extract;Oncogenic;Operative Surgical Procedures;overexpression;Pathway interactions;Patients;Pattern;pembrolizumab;Peptides;Phenotype;Platinum;Primary carcinoma of the liver cells;Prognosis;programmed cell death protein 1;programs;promoter;Protac;Protein Methylation;Protein Methyltransferases;Proteins;Radiation therapy;Reader;Recombinant Proteins;recruit;Recurrence;Regulation;Reporting;Repression;Research;response;Role;SCID Mice;Set protein;Site;Small Interfering RNA;Sorting;T cell infiltration;Tobacco use;Toxic effect;Translating;Tritium;tumor;tumor growth;tumor xenograft;Up-Regulation;Vascular Endothelial Growth Factor Receptor-1,The Role of Protein Methylation in Squamous Cell Carcinoma of the Head and Neck,11831,NA,NA,NA,NA,7,NA,NA,1300908,NA
11188264,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011832,NA,NA,1ZIABC011832-07,NCI:554448\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687383 (contact),"CAPPELL, STEVEN  (contact)",NA,NA,NA,CDK4 gene;Cell Cycle;Cell Cycle Regulation;Cells;Cellular Stress;Clinical;Data;Decision Making;Goals;hormone receptor-positive;Image;improved;inhibitor;innovation;Malignant Breast Neoplasm;Molecular;neoplastic cell;senescence,Study cell cycle regulation in dormant tumor cells,11832,NA,NA,NA,NA,7,NA,NA,554448,NA
11188265,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011835,NA,NA,1ZIABC011835-07,NCI:104482\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692609 (contact),"MACKEM, SUSAN  (contact)",NA,NA,NA,Acute;Age;Alleles;Allografting;Amplifiers;c-myc Genes;cancer cell;cell type;Cells;Compensation;conditional knockout;Dependence;design;Development;DNA Sequence Alteration;dosage;effective therapy;Endothelial Cells;Endothelium;Excision;Future;Gene Dosage;Genetic Models;Genetic Predisposition to Disease;Genetic Recombination;genetic testing;Genetic Transcription;Genome;Genomics;Genotype;Germ-Line Mutation;Growth;Hemangiosarcoma;Immunohistochemistry;Induction of Apoptosis;Knockout Mice;Li-Fraumeni Syndrome;LoxP-flanked allele;Malignant Neoplasms;Modeling;Monitor;mouse genetics;Mus;mutant;MYC Family Protein;MYC gene;Neoplasms;Oncogenic;Outcome;Pathologic;Pathway interactions;Patients;Pharmaceutical Preparations;Physiological;programs;Recovery;Reporter;RNA;Role;Siblings;Spectral Karyotyping;Tamoxifen;Testing;Therapeutic;therapeutic target;Thymic Lymphoma;Tissues;TP53 gene;tumor;tumor growth;tumor progression;Tumor Promoters;tumorigenesis;tumorigenic,Minimal Myc functional threshold for tumorigenesis,11835,NA,NA,NA,NA,7,NA,NA,104482,NA
11188266,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011837,NA,NA,1ZIABC011837-07,NCI:448265\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201740 (contact),"ARMSTRONG, TERRI S. (contact)",NA,NA,NA,Adult;Brain Neoplasms;Cells;Central Nervous System Neoplasms;Characteristics;Clinical;clinical predictors;cohort;Data Reporting;Disease;Early Diagnosis;Environmental Risk Factor;Exposure to;functional status;Genes;Genomics;Glioma;Health Status;Incidence;Knowledge;Malignant neoplasm of central nervous system;Malignant Neoplasms;Mutation;Outcome;Paper;Participant;Patient Self-Report;Persons;Physicians;Population;Predisposition;Primary Prevention;Process;Publications;Quality of life;rare cancer;Reporting;Risk;Risk Factors;Scientist;Self Efficacy;Symptoms;tumor,Outcomes and Risk of Rare Tumors,11837,NA,NA,NA,NA,7,NA,NA,448265,NA
11188267,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011838,NA,NA,1ZIABC011838-07,NCI:952361\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14731975 (contact),"SOWALSKY, ADAM  (contact)",NA,NA,NA,advanced disease;Castration;Cessation of life;Clinical;Genomics;Immunocompromised Host;In Vitro;Intervention;Malignant neoplasm of prostate;Malignant Neoplasms;Metastatic Prostate Cancer;Molecular;Neoplasm Metastasis;novel therapeutics;Patients;Phenotype;prostate cancer metastasis;prostate cancer model;Proteomics;Recurrence;Resistance;resistance mechanism;Sampling;therapy resistant;transcriptomics;Treatment outcome,Mechanisms of resistance to treatment in aggressive prostate cancers,11838,NA,NA,NA,NA,7,NA,NA,952361,NA
11188268,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011840,NA,NA,1ZIABC011840-07,NCI:755171\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687393 (contact),"WU, JING  (contact)",NA,NA,NA,antitumor effect;Apoptosis;Apoptotic;bench-to-bedside translation;Biochemical;Bioenergetics;biological adaptation to stress;Blood specimen;blood-brain barrier penetration;Brain Neoplasms;Cell Death Induction;cell killing;Cell model;Cells;Clinical;clinical investigation;Clinical Research;clinical trial analysis;Clinical Trials;cohort;Cohort Studies;Collaborations;Combined Modality Therapy;Contracts;CYP3A4 gene;Data;design;disease heterogeneity;Disease Resistance;disorder control;DNA Polymerase II;Dose;Drug usage;efficacy evaluation;Enrollment;Excision;Exhibits;Failure;FDA approved;Genetic Polymorphism;Glioblastoma;Glioma;glioma cell line;Growth;high-throughput drug screening;Hour;In Vitro;in vivo;in vivo Model;inhibitor;integration site;Investigational Drugs;Laboratories;Laboratory Finding;Laboratory Research;Link;Malignant Glioma;Malignant neoplasm of brain;Measures;Mitochondria;mitochondrial dysfunction;Modeling;Molecular;Moloney Leukemia Virus;mutant;Mutation;National Center for Advancing Translational Sciences;novel therapeutics;objective response rate;open label;Operative Surgical Procedures;Orphan Drugs;Oxidative Stress;Participant;Pathway interactions;Patient Outcomes Assessments;Patient Self-Report;Patients;Pharmaceutical Preparations;pharmacodynamic biomarker;Phase;phase I trial;Phase I/II Clinical Trial;phase II trial;Phosphorylation;Phosphotransferases;Plasma;pre-clinical;precision medicine;preclinical study;preservation;primary endpoint;Procedures;Process;Production;Progression-Free Survivals;Proteins;Provirus Integration;PTEN gene;Quality of life;Recommendation;Recurrence;resistance mechanism;response;RNA;Safety;screening;Severities;Survival Rate;Symptom Burden;Symptoms;systemic toxicity;targeted treatment;Testing;Therapeutic;Therapeutic Effect;therapy development;therapy resistant;Time;Tissue Sample;TOP1 gene;Transcription Process;transcriptomics;Translational Research;tumor;Tumor Biology;Tumor Tissue,Discovering novel therapies for glioma patients,11840,NA,NA,NA,NA,7,NA,NA,755171,NA
11188269,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011841,NA,NA,1ZIABC011841-07,NCI:755171\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687393 (contact),"WU, JING  (contact)",NA,NA,NA,aerobic glycolysis;Amendment;Biology;checkpoint therapy;Clinical;Clinical Management;clinical trial protocol;Clinical Trials;cohort;Collaborations;Compensation;Correlative Study;design;Detection;Development;Diffuse;Disease;Disease Progression;Enrollment;Excision;Extramural Activities;first-in-human;Funding;Glioblastoma;Glioma;Goals;Image;Imaging Device;imaging modality;imaging probe;imaging program;Immune checkpoint inhibitor;Investigational Therapies;Isocitrate Dehydrogenase;magnetic resonance spectroscopic imaging;Malignant Neoplasms;Mass Spectrum Analysis;Measurement;Metabolic;metabolic imaging;Metabolic Pathway;Molecular;Monitor;mutant;Mutate;Mutation;neuro-oncology;Nivolumab;Outcome;Oxidative Phosphorylation;Participant;Patients;peripheral blood;Pharmacotherapy;phase 1 study;Phase II Clinical Trials;Phenotype;preclinical study;Process;programs;Proliferating;Protocols documentation;Pyruvate;Research;Resources;response;Sampling;Scanning;Solid Neoplasm;Technology;Testing;Therapeutic;tool;treatment response;tumor;Tumor Tissue;United States National Institutes of Health;Warburg Effect,Understanding IDH mutant gliomas,11841,NA,NA,NA,NA,7,NA,NA,755171,NA
11188270,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011843,NA,NA,1ZIABC011843-07,NCI:1050974\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9414416 (contact),"YANG, JAMES C (contact)",NA,NA,NA,Affinity;Alleles;Antigens;Blood;BRAF gene;Cells;chemotherapy;China;Clinical;Codon Nucleotides;Collaborations;Common Neoplasm;DNA Sequence Alteration;engineered T cells;Epidermal Growth Factor Receptor;Epitopes;Human;Immune;Immune response;Immune system;immunogenic;Immunologics;Interleukin-12;Interleukin-2;KRAS2 gene;Malignant Neoplasms;malignant phenotype;manufacture;Mutate;Mutation;neoantigens;novel;Oncogenes;Organoids;Patients;PIK3CA gene;Proteins;ras Oncogene;receptor;Receptor Signaling;Recurrence;Site;Specificity;Standardization;T cell response;T cell therapy;T-Cell Receptor;T-Lymphocyte;Therapy trial;TP53 gene;Transgenic Mice;tumor,Identification and use of T-cell receptors recognizing common tumor mutations,11843,NA,NA,NA,NA,7,NA,NA,1050974,NA
11188271,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011846,NA,NA,1ZIABC011846-07,NCI:675934\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687397 (contact),"ALDAPE, KENNETH  (contact)",NA,NA,NA,Brain;Brain Neoplasms;Case Series;Cells;Central Nervous System Neoplasms;Cerebrospinal Fluid;Characteristics;chemotherapy;Chromosome 14;chromosome 1q gain;chromosome 3 loss;Classification;Clinical;cohort;Computing Methodologies;Copy Number Polymorphism;Data;Diagnosis;Disease;DNA copy number;DNA Methylation;Embryonal Neoplasm of the CNS;Excision;experience;follow-up;genomic profiles;Genomics;Goals;Heterogeneity;Histologic;Human;Individual;Leptomeninges;Location;Machine Learning;Malignant neoplasm of central nervous system;Malignant Neoplasms;Methylation;Molecular;neoplastic cell;Neuroblastoma;Neuroepithelial Neoplasms;new technology;Oncogenic;Outcome;Papillary Neoplasm;Patients;Pineal Region Tumor;Publishing;Recurrence;Recurrent tumor;relapse patients;Reporting;response;Sampling;Series;single cell analysis;Synaptophysin;Techniques;Transcript;tumor;tumor progression;virtual,Single-cell DNA methylation analysis of human cancer,11846,NA,NA,NA,NA,7,NA,NA,675934,NA
11188272,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011847,NA,NA,1ZIABC011847-07,NCI:675934\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687397 (contact),"ALDAPE, KENNETH  (contact)",NA,NA,NA,Accounting;Adjuvant;Adjuvant Radiotherapy;Adjuvant Therapy;Algorithms;Behavior;Biological;Biological Markers;CDKN2A gene;Cell Cycle;Cessation of life;Clinical;cohort;Data Set;Development;Dimensions;Disease;DNA;DNA Methylation;epigenome;Excision;experience;Genes;Genomics;Goals;Heterogeneity;Hypermethylation;Immunohistochemistry;individual patient;interactive tool;Intracranial Neoplasms;Learning;Location;Maps;meningioma;Metadata;Methylation;methylome;Molecular;mRNA Expression;Mutation;Nomograms;Operative Surgical Procedures;outcome prediction;Pathway interactions;Patient Selection;Patient-Focused Outcomes;Patients;personalized medicine;Population;prevent;prognostic;Radiation;Recurrence;Recurrent tumor;response;Role;standard of care;Subgroup;Therapeutic;Time;transcriptome sequencing;transcriptomics;tumor;tumor progression;Validation;Visualization,Development and validation of a predictor of meningioma recurrence,11847,NA,NA,NA,NA,7,NA,NA,675934,NA
11188273,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011848,NA,NA,1ZIABC011848-07,NCI:340244\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6809564 (contact),"SHARAN, SHYAM  (contact)",NA,NA,NA,Abdomen;Acinar Cell;Acinar Cell Carcinoma;Alleles;anaplastic thyroid cancer;Animals;APC gene;biobank;Biological;Biopsy;Cancer Model;cancer therapy;carcinogenesis;CCR;chemotherapy;Childhood Rhabdomyosarcoma;Clinical;cohort;Colonoscopy;combinatorial;comparative;CRISPR/Cas technology;Cyclin-Dependent Kinase Inhibitor 2A;Development;diagnostic strategy;Disease;disease model;Doxorubicin Hydrochloride Liposome;Drug Evaluation;Drug Targeting;drug testing;Engineering;Epigenetic Process;Evaluation;evaluation/testing;experimental study;Fibrous capsule of kidney;gastroenteropancreatic neuroendocrine tumor;Gastrointestinal tract structure;Genes;Genetic;Genetic Engineering;genome editing;Growth Factor;Hematopoietic Neoplasms;Histone Deacetylase Inhibitor;Histopathology;HIV Infections;HIV/AIDS;Imaging Device;Implant;implantation;improved;Incidence;Interleukin-6;Joints;Kaposi Sarcoma;Lesion;leukemia/lymphoma;Malignant - descriptor;Malignant neoplasm of pancreas;Malignant Neoplasms;Mission;Modeling;Molecular;Monitor;mouse model;Mus;Neuroblastoma;neuroendocrine cancer;Neuroendocrine Tumors;novel;Palpation;Pancreas;Papillary thyroid carcinoma;patient derived xenograft model;Patients;pre-clinical;pre-clinical assessment;Pre-Clinical Model;Preclinical Drug Evaluation;preclinical efficacy;Preparation;Procedures;programs;Proliferating;Protocols documentation;recombinase;Recurrence;Research Personnel;Research Support;Resources;response;sample collection;Sampling;Site;skin biopsy;small molecule inhibitor;somatostatin receptor 2;Stomach;success;Technology;Therapeutic;therapeutic development;therapeutic target;Tissues;transcriptomics;Transgenes;tumor;Tumor Suppressor Genes;Validation;Xenograft procedure,Preclinical Modelling and Therapeutic Development for Other Cancer Indications,11848,NA,NA,NA,NA,7,NA,NA,340244,NA
11188274,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011850,NA,NA,1ZIABC011850-06,NCI:696418\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687397 (contact),"ALDAPE, KENNETH  (contact)",NA,NA,NA,cancer biomarkers;cancer type;Categories;Central Nervous System Neoplasms;Classification;clinically relevant;Data;Data Set;deep learning;deep learning model;demographics;Diagnosis;digital pathology;DNA Methylation;DNA Sequence Alteration;Future;Gene Expression;genome wide methylation;genomic biomarker;Goals;Histopathology;Image;Medicine;Methylation;Modeling;Molecular;Nature;Paper;Pathologist;Patients;Publishing;Sampling;Slide;Testing;Time;Training;tumor,Genomic Biomarkers of Cancer,11850,NA,NA,NA,NA,6,NA,NA,696418,NA
11188275,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011852,NA,NA,1ZIABC011852-07,NCI:6254428\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9414412 (contact),"WIDEMANN, BRIGITTE  (contact)",NA,NA,NA,Adolescent and Young Adult;Adrenocortical Carcinoma;Adult;Advocacy;Advocate;Affect;Age;Back;biobank;Biological;Biological Models;Biological Specimen Banks;Biology;Biopsy;Blood;cancer imaging;CCR;Childhood;Chordoma;Clinic;Clinical;clinical center;Clinical Trials;cohort;Collection;Communication;Communities;community engagement;Country;COVID-19 pandemic;Data;Data Collection;Databases;Dedications;Deposition;Development;Disease;Educational workshop;Eligibility Determination;Enrollment;Evaluation;Experimental Models;Family;Funding;Gastrointestinal Stromal Tumors;genetic counselor;Goals;Health Personnel;Health Sciences;Histology;improved;Infrastructure;interest;International;Intervention;Learning;Malignant Childhood Neoplasm;Malignant Neoplasms;Medical History;Medical Oncology;Medical Records;medullary thyroid carcinoma;Molecular;Molecular Profiling;Mutate;Natural History;Neuroendocrine Tumors;novel therapeutics;Oncology;Online Systems;Operative Surgical Procedures;Oregon;Pancreatic carcinoma;Participant;participant enrollment;Patient advocacy;patient engagement;Patient Outcomes Assessments;Patients;PDGFRA gene;Pediatric Hospitals;Pediatric Neoplasm;Pediatric Oncology Group;Population;Process;programs;Protocols documentation;Quality of life;rare cancer;Recommendation;Recording of previous events;Research;Research Personnel;Review Literature;Sampling;Solid Neoplasm;Standardization;symposium;Testing;Texas;Translating;tumor;Tumor Pathology;United States National Institutes of Health;Universities;US State;Vertebral column;young adult,MyPART: My Pediatric and Adult Rare Tumor Network - Cures,11852,NA,NA,NA,NA,7,NA,NA,6254428,NA
11188276,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011853,NA,NA,1ZIABC011853-07,NCI:4449073\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14280069 (contact),"GILBERT, MARK  (contact)",NA,NA,NA,acceptability and feasibility;Adult;Advocacy;Advocate;Agreement;Anxiety;Apple;Award;Awareness;Biological Markers;Biological Specimen Banks;Blood;Books;Brain Neoplasms;cancer care;Caregivers;Caring;CCR;Central Nervous System Diseases;Central Nervous System Neoplasms;Clinic;Clinical Research;Clinical Trials;Clinical Trials Network;cohort;Collaborations;Collection;Communities;Comprehensive Cancer Center;COVID-19;Data;data sharing;Dedications;Diagnosis;Education;Educational Activities;Educational workshop;Ependymoma;Event;Exhibits;Extramural Activities;Facebook;first-in-human;Fostering;Genetic Counseling;genetic testing;Glioblastoma;Glioma;gliosarcoma;Goals;Group Meetings;Guidelines;Health;Health Services Accessibility;human study;Immune checkpoint inhibitor;Immune response;Immunologic Monitoring;Immunologic Tests;Immunotherapy;improved;improved outcome;Individual;individual patient;Information Technology;Infrastructure;inhibitor;Institution;International;Intervention;Journals;Laboratories;Language;Lead;Leadership;lectures;Malignant neoplasm of central nervous system;Malignant Neoplasms;Medical;Medulloblastoma;meetings;member;meningioma;Methods;Molecular;molecular subtypes;Monitor;Multi-Institutional Clinical Trial;multidisciplinary;mutant;MYCN gene;National Comprehensive Cancer Network;Natural History;neuro-oncology;Neurology;Newsletter;Nivolumab;novel;novel therapeutics;Observational Study;oligodendroglioma;Oncology;Operative Surgical Procedures;Oral;Outcome;Paper;Participant;participant enrollment;Pathology;Patient advocacy;patient advocacy group;patient oriented;Patient-Focused Outcomes;Patients;Pediatric Oncology;Persons;Pharmaceutical Preparations;Physicians;Play;Pregnancy;Primary Brain Neoplasms;Privatization;Professional counselor;programs;Provider;psychological distress;psychological symptom;Publishing;Quality of life;Radiation;Radiation Oncology;Recurrence;Reporting;Research;research clinical testing;Research Personnel;Research Project Grants;Retrospective Studies;Risk;Science;sharing platform;Site;SKIL gene;Sleep;Societies;Spanish;Support Groups;Surveys;survivorship;symposium;Symptom Burden;Symptoms;Telemedicine;Testing;Time;Tissues;tool;Topoisomerase Inhibitors;translational immunology;Translations;treatment response;treatment trial;tumor;United States;United States National Institutes of Health;Update;virtual;virtual reality environment;Visit;visiting scholar;web site;webinar,CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors - Cures,11853,NA,NA,NA,NA,7,NA,NA,4449073,NA
11188277,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011854,NA,NA,1ZIABC011854-07,NCI:1246805\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11592709 (contact),"OKEEFE, BARRY  (contact)",NA,NA,NA,"Acceleration;Actinobacteria class;Africa;Agreement;Analytical Chemistry;anti-cancer;anti-cancer research;antimicrobial;Antineoplastic Agents;Australia;Back;Basic Science;beta catenin;Bioinformatics;Biological Process;Biometry;Brazil;California;cancer cell;CCR;Chemicals;Collaborations;college;Communities;Computer software;Country;cytotoxic;Data;Data Collection;Databases;Disease;drug development;drug discovery;empowerment;Extramural Activities;Fermentation;Fractionation;Funding;fungus;genetic signature;genome sequencing;Genomics;Goals;Health;Helping to End Addiction Long-term;high throughput screening;Human;improved;Intramural Research;Investments;Korea;Laboratories;Legal patent;Libraries;Malignant Neoplasms;marine;material transfer agreement;Mediation;Medical center;Methods;Microbe;microorganism;Modernization;Molecular Target;Mus;National Cancer Institute;National Center for Advancing Translational Sciences;National Center for Complementary and Integrative Health;National Institute of Allergy and Infectious Disease;National Institute of Dental and Craniofacial Research;Natural product discovery;Natural Products;Natural Products Chemistry;new technology;novel;Organism;outreach;Plants;Procedures;Production;Productivity;programs;public database;Publishing;Research;Research Activity;Research Personnel;Resources;robotic system;Sampling;screening;screening program;Shipping;Soil;Source;Specimen;Spectroscopy, Fourier Transform Infrared;Structure;Sweden;Taxonomy;Technology;Terpenes;translational pipeline;tumor;United States;United States National Institutes of Health;Universities;whole genome;Work",NCI Program for Natural Products Discovery - Cures,11854,NA,NA,NA,NA,7,NA,NA,1246805,NA
11188278,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011855,NA,NA,1ZIABC011855-07,NCI:697518\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10712484 (contact),"GRETEN, TIM  (contact)",NA,NA,NA,Acceleration;Agreement;Antigen Presentation;Australia;Authorization documentation;Automobile Driving;Blood Transfusion;Bone Marrow;Breast Carcinoma;Canada;cancer therapy;cancer type;Carcinoma;CCR;CD28 gene;CD34 gene;CD47 gene;Cell Therapy;Cells;cellular engineering;chimeric antigen receptor T cells;China;clinic ready;Clinical;clinical center;clinical development;Clinical Protocols;clinical trial protocol;Clinical Trials;Colon Carcinoma;Contracts;CRISPR screen;Data Analyses;Engineering;Epidermal Growth Factor Receptor;Europe;falls;first-in-human;Funding;Genes;Genetic Engineering;Goals;Human;Immune signaling;Immunosuppression;Interleukin-12;Japan;Legal patent;Lentivirus Vector;Lung Carcinoma;Malignant Neoplasms;manufacture;Maps;Mediating;Membrane;Modern Medicine;monocyte;Myelogenous;Myeloid Cells;Myeloid Progenitor Cells;neoplastic cell;Organ Transplantation;Patients;Pharmaceutical Preparations;Phase I Clinical Trials;Play;Process;Production;programs;Property;Prostate carcinoma;Protocols documentation;Review Committee;Role;Skin graft;Therapeutic;tumor progression;United States National Institutes of Health;Validation;vector;Writing,Center for Cell-based Therapy - Cures,11855,NA,NA,NA,NA,7,NA,NA,697518,NA
11188279,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011859,NA,NA,1ZIABC011859-06,NCI:13412\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687385 (contact),"SALOURA, VASSILIKI  (contact)",NA,NA,NA,11q13;Acute;Apoptosis;Biological Markers;BIRC2 gene;Blood;Blood specimen;Bortezomib;cancer infiltrating T cells;CASP3 gene;CD8-Positive T-Lymphocytes;Cessation of life;chemoradiation;chemotherapy;Chemotherapy and/or radiation;Chemotherapy-Oncologic Procedure;Cisplatin;Clinical;Combination Drug Therapy;Contracture;Cranial nerve diseases;curative treatments;Cytotoxic Chemotherapy;Data;Disease;DNA Damage;DNA Sequence Alteration;Dose;Dose Limiting;Drug Kinetics;Drug Targeting;exome sequencing;Facial nerve structure;Goals;Half-Life;head and neck cancer patient;Head and Neck Squamous Cell Carcinoma;Human;Human Papilloma Virus-Related Malignant Neoplasm;Immune;improved;Investigation;irradiation;Limb structure;Maximum Tolerated Dose;Mediating;Mobility decline;Modality;Modification;Mucous Membrane;Mus;Mutation;novel therapeutic intervention;objective response rate;Ohio;Operative Surgical Procedures;palliative chemotherapy;Pathway interactions;Patients;Pharmaceutical Preparations;pharmacodynamic biomarker;phase 1 study;phase I trial;Phase I/II Trial;Postoperative Period;preclinical study;Prognosis;programmed cell death ligand 1;Progression-Free Survivals;Qualifying;Radiation;Radiation Oncology;Radiation therapy;Radiation-Sensitizing Agents;Radiodermatitis;Radiosensitization;Reactive Oxygen Species;Recurrence;Recurrent tumor;Regimen;response;Safety;safety assessment;Schedule;Spinal Cord;standard care;standard of care;Survival Analysis;Survival Rate;The Cancer Genome Atlas;Therapeutic;Toxic effect;transcriptome sequencing;trend;tumor;Tumor Tissue;United States National Institutes of Health;Universities;Unresectable;Visit;Weight,IMRRT for Locoregionally Recurrent Head and Neck Squamous Cell Carcinoma,11859,NA,NA,NA,NA,6,NA,NA,13412,NA
11188280,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011861,NA,NA,1ZIABC011861-06,NCI:28005\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201727 (contact),"HERNANDEZ, JONATHAN  (contact)",NA,NA,NA,Adenocarcinoma;Cessation of life;Development;Evaluation;Gastrointestinal tract structure;Humor;Innovative Therapy;Laboratories;Laboratory Research;Liver;Malignant neoplasm of gastrointestinal tract;Malignant Neoplasms;Metastatic Adenocarcinoma;Mission;Modeling;Neoplasm Metastasis;neoplasm therapy;neuroendocrine cancer;Neuroendocrine Tumors;novel;Operative Surgical Procedures;Patient Care;Patient-Focused Outcomes;phosphoproteomics;transcriptomics;Translational Research;United States;Work,Evaluating outcomes for patients with primary-metastatic gastrointestinal cancer,11861,NA,NA,NA,NA,6,NA,NA,28005,NA
11188281,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011869,NA,NA,1ZIABC011869-06,NCI:646143\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687355 (contact),"YOHE, MARIELLE  (contact)",NA,NA,NA,Address;Adult;Animal Model;Biochemical;Biological Assay;cancer prevention;cardiofaciocutaneous syndrome;Cardiomegaly;Cell Proliferation;Child;Childhood;Clinical;Clinical Investigator;Clinical Research;Clinical Trials;congenital heart abnormality;Costello syndrome;design;Development;Diagnosis;Disease;early phase clinical trial;effective therapy;efficacy evaluation;Embryo;epidemiology study;experimental study;Failure to Thrive;Fibroblasts;functional outcomes;gastrulation;General Population;Genes;Genetic Diseases;Genetic study;Genetically Engineered Mouse;Genomics;Germ Lines;Germ-Line Mutation;Goals;Grant;inhibitor;interdisciplinary approach;interest;Knockout Mice;Lead;Life;Long-Term Effects;Longitudinal cohort study;Malignant Childhood Neoplasm;Mammalian Cell;MAP Kinase Gene;MEKs;Modeling;Motor Activity;mouse model;Mus;Mutation;Myoblasts;Neurofibromatosis 1;Noonan Syndrome;novel;Pathway interactions;Patients;Pediatric Oncology;Peripheral Nerve Sheath Neoplasm;Phenotype;Plexiform Neurofibroma;Population;preclinical study;Prevention strategy;protein purification;Proteins;Risk;targeted agent;targeted treatment;Testing;Therapeutic;Tipifarnib;TP53 gene;Transfection;Transgenic Organisms;tumor;Variant;virulence gene;Work;Zebrafish;zebrafish development,Advancing RAS and RASopathy Therapies,11869,NA,NA,NA,NA,6,NA,NA,646143,NA
11188282,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011870,NA,NA,1ZIABC011870-06,NCI:2400798\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162108 (contact),"BUDHU, ANURADHA  (contact)",NA,NA,NA,3-Dimensional;Affect;African American population;anti-cancer research;Area;arm;Artificial Intelligence;BAY 54-9085;biliary tract;Bioinformatics;bioinformatics tool;Biological Markers;Biological Products;Biopsy Specimen;Blood;cancer clinical trial;capecitabine;Carcinoma;CCR;Cells;Cholangiocarcinoma;Clinical;clinical center;Clinical Data;clinical efficacy;Clinical Trials;Collaborations;Communities;Computational Biology;Data;Data Science;Data Set;Development;Diagnosis;DNA sequencing;Early Diagnosis;effective therapy;Elements;Environment;exome sequencing;Extramural Activities;Fellowship;Formalin;Foundations;Funding;Future;Genomics;Goals;health disparity;Heterogeneity;Hispanic Populations;Image Analysis;immune cell infiltrate;Immune checkpoint inhibitor;Immunophenotyping;Immunotherapy;improved;Individual;Infrastructure;insight;Institution;Intramural Research;Laboratories;Lead;liver cancer patient;liver development;Liver neoplasms;Machine Learning;Malignant neoplasm of liver;Malignant Neoplasms;Medical;Medicine;metabolomics;microbiome;Microscopy;Mission;Molecular;Molecular Profiling;molecular targeted therapies;multidisciplinary;Multimodal Imaging;multiplexed imaging;Mutation;Nature;neoplastic cell;new therapeutic target;novel;novel therapeutics;Oncologist;Optics;optimism;Outcome;oxaliplatin;Paraffin Embedding;participant enrollment;Patient Monitoring;patient response;patient subsets;Patient-Focused Outcomes;Patients;pembrolizumab;phase 2 study;phase 3 study;Pilot Projects;Positioning Attribute;precision medicine;predictive signature;prevent;Prevention;Prevention approach;Primary carcinoma of the liver cells;Primary Malignant Neoplasm of Liver;programs;prospective;Publishing;Race;Radiogenomics;Refractory;Relapse;Reporting;Research;Research Activity;Research Personnel;Resistance development;Resources;responders and non-responders;response;Retrospective Studies;Role;Sampling;single cell sequencing;Site;standard of care;statistical and machine learning;Subgroup;success;synergism;Testing;Tissue Embedding;Tissues;Training;Training and Education;Transcript;transcriptome;transcriptome sequencing;transcriptomics;Translational Research;Treatment outcome;treatment responders;treatment response;tumor;United States National Institutes of Health;Universities;Urine;Validation;Variant;Vision,Liver Cancer Program,11870,NA,NA,NA,NA,6,NA,NA,2400798,NA
11188283,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011874,NA,NA,1ZIABC011874-06,NCI:55388\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162113 (contact),"WIENER, LORI  (contact)",NA,NA,NA,12 year old;17 year old;7 year old;Address;Adolescent;Adult;Affect;Age;age group;Child;Childhood;Chronic Disease;chronic graft versus host disease;Clinical Trials;cognitive interview;Companions;Comprehension;Consensus;Data;design;Development;Disabling;Enrollment;Extramural Activities;Eye;Face;Genetic Diseases;graft vs host disease;Hematopoietic Stem Cell Transplantation;Immunosuppression;improved;instrument;Intestines;Judgment;Liver;Lung;Malignant Childhood Neoplasm;Measures;Musculoskeletal System;Oral cavity;Organ;Outcome Measure;Pain;Parents;Participant;Patient Outcomes Assessments;Patients;pediatric patients;Population;Procedures;Proxy;Psychometrics;psychosocial;Recommendation;Respondent;response;Sampling;Severities;Severity of illness;side effect;Site;Skin;Standardization;Stem cell transplant;Steroids;symptom management;Symptoms;Testing;transplant survivor;Transplantation;United States National Institutes of Health,Graft-Versus-Host Disease Symptom Management-Cures,11874,NA,NA,NA,NA,6,NA,NA,55388,NA
11188284,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011876,NA,NA,1ZIABC011876-06,NCI:369798\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201666 (contact),"YANG, CHUN ZHANG  (contact)",NA,NA,NA,Adopted;Animal Model;Biological;CRISPR/Cas technology;Disease Outcome;DNA cassette;Future;Gene Expression;gene-editing approach;Genes;Genetic;Genome;Gifts;Glioma;Guide RNA;Human;in vivo;in vivo Model;Investigation;knock-down;Modeling;mouse genome;mouse model;Mus;mutant;Mutate;Plasmids;Pre-Clinical Model;receptor;System;Transgenes;Translational Research;tumor;vector;Virus,Establish Preclinical Model for IDH-mutated Glioma,11876,NA,NA,NA,NA,6,NA,NA,369798,NA
11188285,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011877,NA,NA,1ZIABC011877-06,NCI:1962200\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162116 (contact),"TERABE, MASAKI  (contact)",NA,NA,NA,adaptive immunity;Affect;Aggressive course;analog;anti-tumor immune response;Antigen-Presenting Cells;Antigens;Astrocytes;Atlases;Binding;Brain;cancer type;Cell Communication;Cell Line;Cell Physiology;Cells;Characteristics;chemoradiation;Chemotaxis;Chinese;Clinical;clinical efficacy;Combined Modality Therapy;cytokine;Data;Data Set;design;Diagnosis;disease prognosis;Environment;Flow Cytometry;Frequencies;genetic signature;Genome;Glioblastoma;Glioma;glioma cell line;Glycolipids;granulocyte;Human;Iatrogenesis;Immune;Immune checkpoint inhibitor;Immune response;Immune system;Immunologics;immunoregulation;Immunosuppression;Immunotherapy;improved;in vivo;insight;invention;Leukocytes;lipid metabolism;Lipids;Malignant - descriptor;Malignant neoplasm of brain;Malignant Neoplasms;Modeling;Mus;Mutation;Myeloid Cells;Myeloid-derived suppressor cells;Natural Immunity;neoantigens;neoplastic cell;Normal Cell;novel;novel strategies;Operative Surgical Procedures;Outcome;Patients;peripheral blood;Peripheral Blood Mononuclear Cell;Play;Preventative vaccination;Primary Brain Neoplasms;Production;programs;protective effect;PTPRC gene;Published Comment;Reporting;Research;response;Role;Sampling;Signal Transduction;single-cell RNA sequencing;Structure;Sulfoglycosphingolipids;T memory cell;T-Lymphocyte;T-Lymphocyte Subsets;targeted treatment;Testing;The Cancer Genome Atlas;Therapeutic;Tissue Sample;Tissues;trafficking;Transcript;transcriptomics;tumor;Tumor Antigens;Tumor Immunity;tumor microenvironment;Tumor Tissue;tumor-immune system interactions;vaccination strategy;vaccine efficacy;Vaccines;vector;vector-based vaccine;Viral Vector,Immunological Analysis of Brain Cancer,11877,NA,NA,NA,NA,6,NA,NA,1962200,NA
11188286,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011884,NA,NA,1ZIABC011884-06,NCI:1446279\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162122 (contact),"CHEN, CHONGYI  (contact)",NA,NA,NA,Biological Process;Cells;Cellular Assay;Chromatin;Chromatin Structure;DNA Topoisomerases;Gene Expression;Gene Expression Regulation;Genes;genome-wide;Genomic Instability;Genomics;Goals;Human;Human Genome;Nuclear;Process;Regulation;Role;Superhelical DNA;Technology;Topoisomerase;Transcriptional Regulation,The dynamics of chromatin topology in human cells,11884,NA,NA,NA,NA,6,NA,NA,1446279,NA
11188287,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011886,NA,NA,1ZIABC011886-06,NCI:776238\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14280079 (contact),"ALEWINE, CHRISTINE  (contact)",NA,NA,NA,Affect;American Association of Cancer Research;Angiogenesis Inhibitors;Animal Model;Biopsy;Biopsy Specimen;Blood Vessels;cell killing;Cells;clinical center;Clinical Research;cohort;Combined Modality Therapy;Correlative Study;Cytotoxin;Data;density;Dose;Drug Kinetics;Elements;Endothelial Cells;Extramural Activities;Fibroblasts;first-in-human;Growth;Human;improved outcome;Integrin alphaVbeta3;Macrophage;Malignant neoplasm of pancreas;Malignant Neoplasms;Manuscripts;mouse model;Mus;Neoplasm Metastasis;novel;Pancreatic Ductal Adenocarcinoma;pancreatic ductal adenocarcinoma model;Patients;Pharmaceutical Preparations;Phase;preclinical study;Protein Engineering;rational design;Safety;safety testing;Sampling;Solid Neoplasm;Structure;symposium;Testing;Therapeutic;therapy resistant;Time;tumor;tumor growth;United States National Institutes of Health;Work,"First in Human Trials of ProAgio, a Cytotoxin",11886,NA,NA,NA,NA,6,NA,NA,776238,NA
11188288,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011888,NA,NA,1ZIABC011888-06,NCI:431712\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162126 (contact),"XIE, CHANGQING  (contact)",NA,NA,NA,bile duct;cancer cell;cancer stem cell;cancer type;Cell Reprogramming;Cells;Cholangiocarcinoma;cohort;Collecting Cell;Data;Diagnosis;experimental study;Gene Expression Profile;Heterogeneity;Immune;Immunotherapy;In Vitro;in vivo;Malignant neoplasm of gastrointestinal tract;Malignant Neoplasms;mouse model;Mus;Prognosis;programs;Proto-Oncogene Proteins c-akt;Reporting;Resistance;Resolution;Resources;RNA analysis;single-cell RNA sequencing;standard of care;stem-like cell;stemness;Stromal Cells;The Cancer Genome Atlas;transcriptome sequencing;transcriptomics;tumor microenvironment;tumorigenesis,Cancer Stem Cells in Cholangiocarcinoma,11888,NA,NA,NA,NA,6,NA,NA,431712,NA
11188289,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011889,NA,NA,1ZIABC011889-06,NCI:936245\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162128 (contact),"JIANG, PENG  (contact)",NA,NA,NA,anti-tumor immune response;Antigens;Atlases;cancer immunotherapy;Clinical;computational platform;Computer Models;cytokine;Data;density;effectiveness validation;Enhancers;Exclusion;Exhibits;experimental study;Genes;Human;Immune;immune checkpoint blockade;Immunooncology;Immunotherapy;Inferior;Knowledge;Lecithin;Mediating;Modeling;Mus;Protein Secretion;Proteins;Research;Resistance;Resources;Role;T-Cell Activation;tumor;Tumor Escape;Tumor-Secreted Protein,Data-driven inference of regulators for cytokine-mediated tumor killing,11889,NA,NA,NA,NA,6,NA,NA,936245,NA
11188290,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011890,NA,NA,1ZIABC011890-06,NCI:936245\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162128 (contact),"JIANG, PENG  (contact)",NA,NA,NA,anti-PD-1;Biological;cancer immunotherapy;cancer type;Cells;Characteristics;Clinical;Clinical Research;Code;cohort;computer framework;convolutional neural network;CTLA4 gene;Data;Gene Expression;Genes;genome-wide;human data;Human Genome;Image;imaging Segmentation;Imaging technology;Immunotherapy;in vivo;Individual;information organization;intercellular communication;Label;Learning;Malignant Neoplasms;Maps;Mediating;Methodology;Methods;mouse model;multi-scale imaging data;Patients;Phase;Physiological;Prognosis;Protein Analysis;protein biomarkers;Protein Secretion;Proteins;Proteomics;Sampling;Signaling Protein;Source;Spottings;Structure;Technology;Tissue imaging;Tissues;Training;transcriptomics;tumor,Computational approaches for the analyses of spatial profiling technologies,11890,NA,NA,NA,NA,6,NA,NA,936245,NA
11188291,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011892,NA,NA,1ZIABC011892-06,NCI:646143\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687355 (contact),"YOHE, MARIELLE  (contact)",NA,NA,NA,Acute Lymphocytic Leukemia;Acute Myelocytic Leukemia;Adult;arm;Benign;Binding;Biological;BRAF gene;Candidate Disease Gene;CBL gene;Childhood;Childhood Melanoma;Childhood Solid Neoplasm;Clinical;clinical efficacy;Clinical Trials;cohort;Collaborations;Data Analyses;design;Development;driver mutation;Drug Combinations;Drug Targeting;Embryonal Rhabdomyosarcoma;Eosinophilic Granuloma;Extracellular Signal Regulated Kinases;Farnesyl Transferase Inhibitor;FDA approved;Future;Genomics;Glioma;Guanine Nucleotides;Hematologic Neoplasms;Histology;Human;improved;inhibitor;Juvenile Myelomonocytic Leukemia;KRAS2 gene;Lead;loss of function mutation;Malignant - descriptor;Malignant Childhood Neoplasm;Malignant Neoplasms;MAP Kinase Gene;MEKs;Membrane;Methods;Modeling;Molecular Target;mutant;Mutate;Mutation;Neuroblastoma;Neurofibromatosis 1;Neurofibrosarcoma;Nevus;NF1 gene;novel;novel drug class;novel drug combination;objective response rate;Oncogenic;Oncoproteins;Pathway interactions;Patients;Pediatric Hematology;Pediatric Neoplasm;Phase;Phase II Clinical Trials;PI3K/AKT;Pilocytic Astrocytoma;Plexiform Neurofibroma;prenylation;prevent;primary endpoint;Protein Isoforms;PTPN11 gene;RAF1 gene;RAS genes;ras GTPase-Activating Proteins;Ras Inhibitor;ras Proteins;Ras/Raf;Relapse;Research Design;Research Personnel;Resistance;Rhabdomyosarcoma;Signal Transduction;Solid Neoplasm;Somatic Mutation;specific biomarkers;targeted agent;Testing;Tipifarnib;Translating;tumor;tumor growth;Work;Xenograft Model,Targeting RAS in Pediatric Cancer,11892,NA,NA,NA,NA,6,NA,NA,646143,NA
11188292,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011893,NA,NA,1ZIABC011893-06,NCI:448265\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201740 (contact),"ARMSTRONG, TERRI S. (contact)",NA,NA,NA,Animals;Behavior;behavior measurement;Behavioral;Behavioral Model;Biological;Blood;C57BL/6 Mouse;Central Nervous System;Central Nervous System Neoplasms;Cognition;Computer software;Cranial Irradiation;Darkness;Data;Data Analyses;Dose;early onset;Eating;experience;experimental study;Exposure to;Foundations;Genes;Genetic Polymorphism;Goals;Graph;Grooming;Hour;Human;Hypersomnias;Hypersomnolence;Individual;irradiation;Light;Low Dose Radiation;male;Monitor;mouse model;Mus;Natural History;Patients;Phase;Pre-Clinical Model;Procedures;Quality of life;Radiation;Radiation Dose Unit;radiation effect;Radiation therapy;Rest;Rodent;Sleep;sleep behavior;standard of care;Symptoms;System;Testing;Time;Translations;Travel;tumor;Walking;Work,Behavioral Correlates in Mouse Model of CNS radiation-induced hypersomnia,11893,NA,NA,NA,NA,6,NA,NA,448265,NA
11188293,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011894,NA,NA,1ZIABC011894-06,NCI:854688\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162133 (contact),"STARRETT, GABRIEL  (contact)",NA,NA,NA,3-Dimensional;Affect;anti-cancer research;Biology;Bladder;Bone Marrow Transplantation;cancer type;carcinogenicity;Cell Line;Cell model;Cells;Chromatin;Chromatin Loop;Clinical;clinically relevant;conditioning;Cystitis;Data;Data Analyses;Development;Disease;Dose;Engineering;Enzymes;Epidemiology;Epigenetic Process;Etiology;Event;Evolution;experimental study;Gene Expression;Genetic Transcription;Genome;genome sequencing;Genome Stability;Goals;Hemorrhage;Immune;Immunocompromised Host;Infection;knock-down;Malignant neoplasm of urinary bladder;Malignant Neoplasms;Manuscripts;Merkel cell carcinoma;Metabolism;Methods;Modeling;Molecular Conformation;Morphology;Mutagenesis;Mutagens;Mutation;novel;Oncogenic Viruses;Pathologic Mutagenesis;Patients;Pharmaceutical Preparations;Polyomavirus;Polyomavirus Infections;Preparation;Prevention;Process;prospective;Risk;Sebaceous Gland Neoplasms;Somatic Mutation;Specimen;Techniques;tissue archive;Tissues;transcriptome sequencing;Transplant Recipients;Tumor Biology;tumorigenesis;urinary;Urothelial Cell;Urothelium;Viral;viral DNA;Viral Oncogene;Virus;Virus Diseases;Virus Integration;virus related cancer;whole genome;Work,Biology of Virus-associated Cancers,11894,NA,NA,NA,NA,6,NA,NA,854688,NA
11188294,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011895,NA,NA,1ZIABC011895-06,NCI:170228\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201761 (contact),"LIN, FRANK  (contact)",NA,NA,NA,Calendar;Collaborations;Enrollment;FOLH1 gene;Future;Human;improved;industry partner;Institutional Review Boards;participant enrollment;Pharmaceutical Preparations;Pharmacologic Substance;Process;prostate cancer cell;Radiation Dose Unit;radioligand;Radiopharmaceuticals;side effect;Site;Testing;tumor;United States National Institutes of Health,Improving PSMA-based radioligand therapy via combination radioligand therapy,11895,NA,NA,NA,NA,6,NA,NA,170228,NA
11188295,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011896,NA,NA,1ZIABC011896-06,NCI:556986\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10687105 (contact),"MADAN, RAVI  (contact)",NA,NA,NA,Agreement;Androgen Antagonists;androgen deprivation therapy;androgen independent prostate cancer;Androgen Receptor;Area;Biochemical;Clinical Trials;Combination immunotherapy;Development;enzalutamide;Evaluation;FOLH1 gene;follow-up;Goals;Image;Immune;Immunologics;Immunotherapy;Industry;inhibitor;Malignant neoplasm of prostate;Nonmetastatic;novel;Pathway interactions;patient subsets;Patients;Population;Positron-Emission Tomography;Prostate;Protocols documentation;Quality of Life Assessment;Radiation;Radiopharmaceuticals;Recurrence;Reporting;response;Science;Vaccines,Evaluation of novel treatments in biochemically recurrent prostate,11896,NA,NA,NA,NA,6,NA,NA,556986,NA
11188296,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011897,NA,NA,1ZIABC011897-06,NCI:417740\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10687105 (contact),"MADAN, RAVI  (contact)",NA,NA,NA,Biochemical;Cancer Vaccines;chemotherapy;Clinical Trials;Combination immunotherapy;docetaxel;Evaluation;FOLH1 gene;Immune;Immune checkpoint inhibitor;Immune response;Immunotherapy;improved;Malignant neoplasm of prostate;Metastatic/Recurrent;Necrosis;novel;phase 1 study;phase 2 testing;Positron-Emission Tomography;Progression-Free Survivals;Radiation;Recurrence;Safety;serum PSA;synergism;therapeutic evaluation;Toxic effect;vaccine strategy;Work,Evaluation of Immune-based Combinations in Prostate Cancer,11897,NA,NA,NA,NA,6,NA,NA,417740,NA
11188297,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011899,NA,NA,1ZIABC011899-06,NCI:1683443\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162139 (contact),"SADOWSKI, SAMIRA  (contact)",NA,NA,NA,Affinity;analog;Award;Bees;Cancer Model;Cells;Characteristics;Clinical Trials;Collaborations;Detection;Development;Diagnostic Imaging;differential expression;Disseminated Malignant Neoplasm;Epigenetic Process;Excision;Goals;Growth;Histone Deacetylase Inhibitor;imaging agent;Industry;interest;Laboratories;Learning;Ligand Binding;Malignant Neoplasms;Modeling;Mus;Neoplasm Metastasis;neuroendocrine cancer;Neuroendocrine Tumors;novel;Operative Surgical Procedures;Organoids;Pathway interactions;Patients;Peptides;Pharmaceutical Preparations;Positron-Emission Tomography;Radio;Radiolabeled;receptor;Regulation;Somatostatin Receptor;somatostatin receptor 1;SSTR2 gene;Surface;targeted treatment;tumor;Tumor Escape;Up-Regulation;Work,Targeted Therapy in Neuroendocrine Cancer,11899,NA,NA,NA,NA,6,NA,NA,1683443,NA
11188298,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011900,NA,NA,1ZIABC011900-06,NCI:489473\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162141 (contact),"RAJAN, ARUN  (contact)",NA,NA,NA,B-Lymphocytes;CD4 Positive T Lymphocytes;Correlative Study;Dendritic Cells;Disease;Enrollment;Immune;immune-related adverse events;objective response rate;Participant;Patients;Pilot Projects;Recurrence;Refractory;Relapse;Safety;T-Lymphocyte;Thymic Carcinoma;Thymoma;Thymus Epithelial Neoplasm;Thymus Neoplasms,Pilot Study of Avelumab in Thymic Epithelial Tumors,11900,NA,NA,NA,NA,6,NA,NA,489473,NA
11188299,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011901,NA,NA,1ZIABC011901-06,NCI:1313961\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162143 (contact),"LEBENSOHN, ANDRES  (contact)",NA,NA,NA,Adherens Junction;Adult;Animal Model;Animals;APC gene;Apoptosis;beta catenin;Biochemical;Biochemical Reaction;Biological;Biological Process;cancer type;Cardiovascular Diseases;casein kinase;Cell Communication;Cell Cycle Arrest;Cell Physiology;Cell-Cell Adhesion;Cells;Clustered Regularly Interspaced Short Palindromic Repeats;Colorectal Cancer;comparative;Complex;Cues;Defect;Dental;Development;Diabetes Mellitus;Disease;Down-Regulation;Embryo;Embryonic Development;Endowment;Epithelium;Equilibrium;Evolution;FDA approved;forward genetics;gastric cancer cell;Genes;genetic analysis;Genetic Screening;genome wide screen;Goals;Haploidy;Helix-Turn-Helix Motifs;Human;Hyperactivity;Inhibition of Cell Proliferation;Instruction;Leucine Zippers;Life;Ligands;Link;malformation;Malignant neoplasm of gastrointestinal tract;Malignant Neoplasms;Mediating;Mediator;Mesenchymal;migration;Molecular;Morphogenesis;Mutate;Natural regeneration;Neoplasm Metastasis;Neurodegenerative Disorders;Oncogenic;Organ;Organism;Organoids;Outcome;Pathway interactions;Pattern;Pharmaceutical Preparations;Phosphotransferases;Physiological;Process;programs;Proteins;Regulation;Regulatory Element;Reporter;Research;Role;self-renewal;Signal Induction;Signal Pathway;Signal Transduction;skeletal;stem cells;Therapeutic;therapeutic target;tissue regeneration;Tissues;Transcription Coactivator;transcription factor;Transcriptional Activation;tumor;ubiquitin ligase;Ubiquitination;WNT Signaling Pathway;Xenopus laevis;zygote,"New regulatory mechanisms of WNT signaling in development, stem cells and cancer",11901,NA,NA,NA,NA,6,NA,NA,1313961,NA
11188300,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011902,NA,NA,1ZIABC011902-06,NCI:32631\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162141 (contact),"RAJAN, ARUN  (contact)",NA,NA,NA,Adverse event;Antibody-drug conjugates;Clinical Trials;Cornea;Development;Disease;efficacy evaluation;experience;In complete remission;Interruption;mesothelin;Multicenter Trials;neoplastic cell;objective response rate;Patients;Peripheral Nervous System Diseases;preclinical study;Thymic Carcinoma,Anetumab in Thymic Carcinoma,11902,NA,NA,NA,NA,6,NA,NA,32631,NA
11188301,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011903,NA,NA,1ZIABC011903-06,NCI:24951\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11592670 (contact),"TANNER, KANDICE  (contact)",NA,NA,NA,Antigens;Bacteria;Bacterial Spores;Binding;biomaterial compatibility;cancer cell;Cancer Vaccines;Cell surface;cell type;chemotherapeutic agent;Clinical;combinatorial;Cytosol;delivery vehicle;Doxorubicin;Drug Delivery Systems;Drug Targeting;Epitopes;ERBB2 gene;Goals;In Vitro;interest;Liposomal Doxorubicin;Malignant neoplasm of ovary;Malignant Neoplasms;Metastatic malignant neoplasm to brain;Modeling;Mus;Normal Cell;overexpression;particle;Patients;Peptides;Pharmaceutical Preparations;Phospholipids;Prognosis;Proteins;reconstitution;Reporting;Reproduction spores;side effect;Silicon Dioxide;small molecule;small molecule therapeutics;synthetic construct;System;targeted delivery;Testing;Therapeutic;Thick;Toxic effect;tumor;tumor eradication;tumor growth;tumor xenograft;vaccine platform;Work;Xenograft Model;Zebrafish,Synthetic bacteria as a targeted delivery system for small molecule therapeutics,11903,NA,NA,NA,NA,6,NA,NA,24951,NA
11188302,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011904,NA,NA,1ZIABC011904-06,NCI:1581549\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79971954 (contact),"WILSON, BRICE  (contact)",NA,NA,NA,2019-nCoV;Acceleration;anti-cancer research;assay development;bioactive natural products;Biochemical;Biochemistry;Biological;Biological Assay;Biological Models;Biology;Biophysics;Cells;Chemicals;Chemistry;Collaborations;Communicable Diseases;cytotoxicity;design;Development;Disease;DNA Repair Enzymes;drug discovery;Evaluation;Extramural Activities;FOXO1A gene;Future;high throughput screening;HIV;Information Technology;inhibitor;Intramural Research Program;Investments;Laboratories;Libraries;Malignant Epithelial Cell;Malignant neoplasm of prostate;Malignant Neoplasms;Molecular Biology;Molecular Target;Natural product discovery;Natural Products;Natural Products Chemistry;NCI Center for Cancer Research;neurodevelopment;novel;novel therapeutics;Oncogenic;Output;pandemic disease;Pathway interactions;PAX3 gene;Phenotype;Phosphotransferases;Pleural Mesothelioma;Principal Investigator;PRKACA gene;Productivity;programs;Protein Chemistry;Proteins;Publications;Reporting;repository;Research;Research Personnel;Science;Scientist;screening;Technology;transcription factor;translational applications;translational potential;Translational Research;United States National Institutes of Health;Untranslated RNA;Virus;Virus Diseases;Work,Assay development and screening for molecular targets and discovery,11904,NA,NA,NA,NA,6,NA,NA,1581549,NA
11188303,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011905,NA,NA,1ZIABC011905-06,NCI:163158\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162141 (contact),"RAJAN, ARUN  (contact)",NA,NA,NA,Antibodies;cancer biomarkers;Clinical;cohort;Combination immunotherapy;Correlative Study;Drug usage;Enrollment;Evaluation;immune activation;Monoclonal Antibodies;Non-Small-Cell Lung Carcinoma;Paper;participant enrollment;patient subsets;Patients;phase I trial;programmed cell death ligand 1;Publishing;response;Sampling;Signal Transduction;Solid Neoplasm;TGFB1 gene;Toxic effect,Anti-PD-L1-TGFb antibody (M7824) in advanced Non-Small Cell Lung Cancer,11905,NA,NA,NA,NA,6,NA,NA,163158,NA
11188304,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011906,NA,NA,1ZIABC011906-06,NCI:16316\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162141 (contact),"RAJAN, ARUN  (contact)",NA,NA,NA,anti-PD1 therapy;Carcinoembryonic Antigen;chemotherapy;Dose;Immunotherapy;Intercellular adhesion molecule 1;Lymphocyte Function-Associated Antigen-1;Malignant neoplasm of lung;Modified Vaccinia Virus Ankara;Mucin 1 protein;Nivolumab;Non-Small-Cell Lung Carcinoma;Patients;pembrolizumab;Platinum;Poxviridae;Publishing;Recurrence;safety assessment;Transgenes;vector,CV301 and Anti-PD-1 Therapy in Non-Small Cell Lung Cancer,11906,NA,NA,NA,NA,6,NA,NA,16316,NA
11188305,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011907,NA,NA,1ZIABC011907-06,NCI:163158\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162141 (contact),"RAJAN, ARUN  (contact)",NA,NA,NA,Clinical;cohort;Complement;DNA Damage;Enrollment;Immune checkpoint inhibitor;Immunologics;Immunotherapy;Individual;Measures;Monoclonal Antibodies;Non-Small-Cell Lung Carcinoma;PARP inhibition;Patients;phase II trial;Poly(ADP-ribose) Polymerase Inhibitor;predictive marker;programmed cell death ligand 1;Progression-Free Survivals;Recurrence;Signal Transduction;Toxic effect;tumor,Durvalumab in Combination with Olaparib in Non-Small Cell Lung Cancer,11907,NA,NA,NA,NA,6,NA,NA,163158,NA
11188306,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011914,NA,NA,1ZIABC011914-06,NCI:1508370\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162152 (contact),"ROSCHEWSKI, MARK  (contact)",NA,NA,NA,B-Cell Lymphomas;Biological Assay;Biopsy;Burkitt Lymphoma;cancer cell;Cells;Clinical;Clonal Evolution;detection method;Diagnosis;Disease Progression;Disease remission;Follicular Lymphoma;Gene Expression Profile;Genotype;Goals;high risk;Histologic;Human Herpesvirus 4;Immune;Immune Response Genes;improved;large cell Diffuse non-Hodgkin&apos;s lymphoma;Lymphoma;Mantle Cell Lymphoma;Molecular;Molecular Biology;Molecular Profiling;new therapeutic target;Non-Malignant;Patients;Positron-Emission Tomography;precision medicine;predicting response;predictive signature;Recurrent disease;resistance mechanism;response;Role;Systemic Therapy;targeted agent;Techniques;Time;Tissues;transcriptome sequencing;treatment response;tumor DNA,Molecular Biology of Lymphoma,11914,NA,NA,NA,NA,6,NA,NA,1508370,NA
11188307,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011916,NA,NA,1ZIABC011916-06,NCI:1541889\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162152 (contact),"ROSCHEWSKI, MARK  (contact)",NA,NA,NA,Agammaglobulinaemia tyrosine kinase;B-Cell Lymphomas;Central Nervous System Lymphoma;design;Disease remission;efficacy evaluation;Gene Expression Profile;Immune checkpoint inhibitor;In complete remission;Industry Collaboration;inhibitor;large cell Diffuse non-Hodgkin&apos;s lymphoma;Legal patent;Lymphoma;manufacture;Molecular;Pathway interactions;Patients;PIK3CG gene;predictive signature;Refractory;Relapse;Resistance;response;rituximab;Signal Transduction;Toxic effect;treatment strategy;tumor;Tyrosine Kinase Inhibitor,Pathway inhibitors in Lymphomas,11916,NA,NA,NA,NA,6,NA,NA,1541889,NA
11188308,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011919,NA,NA,1ZIABC011919-06,NCI:88203\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692485 (contact),"KELLY, KATHLEEN  (contact)",NA,NA,NA,Adenocarcinoma;Biological;Castration;Clustered Regularly Interspaced Short Palindromic Repeats;CRISPR screen;design;Differentiation and Growth;Dominant-Negative Mutation;Dropout;Epigenetic Process;Genes;Genetic Predisposition to Disease;Growth;in vivo;LNCaP;Malignant neoplasm of prostate;Malignant Neoplasms;Mediator;Methodology;Modeling;Neoplasm Metastasis;Neuroendocrine Prostate Cancer;Neurosecretory Systems;Null Lymphocytes;Organoids;Patients;Process;RB1 gene;Resistance;screening;therapeutic target;TP53 gene;transdifferentiation;Work,Identifying genetic vulnerabilities in neuroendocrine prostate cancer,11919,NA,NA,NA,NA,6,NA,NA,88203,NA
11188309,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011920,NA,NA,1ZIABC011920-06,NCI:687063\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14280074 (contact),"SRINIVASAN, RAMAPRASAD  (contact)",NA,NA,NA,Accounting;American Association of Cancer Research;American Society of Clinical Oncology;anti-cancer research;bHLH-PAS factor HLF;cancer subtypes;Central Nervous System Neoplasms;Clear Cell;Clinical Research;Data;design;Development;Disease;Evaluation;follow-up;Genes;Genetic Transcription;Germ Lines;Grant;Growth Factor Gene;hemangioblastoma;Hypoxia Inducible Factor;Immunotherapy;In complete remission;inhibitor;Islet Cell Tumor;Journals;Kidney Neoplasms;Malignant Neoplasms;Manuscripts;Mediating;Medicine;meetings;mutant;New England;novel;novel strategies;Ophthalmology;Organ;Outcome;Oxygen;pancreatic neoplasm;participant enrollment;Pathway interactions;Patients;PD-1 inhibitors;PD-1/PD-L1;pharmacologic;Phase;phase 2 study;Proteins;Publishing;Renal Carcinoma;Renal Cell Carcinoma;Reporting;Resistance;Resistance development;response;Retina;Safety;small molecule inhibitor;standard care;targeted agent;targeted treatment;therapy resistant;Time;translational pipeline;tumor;tumor microenvironment;Up-Regulation;Update;Vascular Endothelial Growth Factors;VHL mutation;Work,Novel Approaches to Targeting Cancers Associated with VHL Mutations,11920,NA,NA,NA,NA,6,NA,NA,687063,NA
11188310,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011923,NA,NA,1ZIABC011923-06,NCI:1586326\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162158 (contact),"TAYLOR, NAOMI  (contact)",NA,NA,NA,Adoptive Immunotherapy;alpha ketoglutarate;Antigens;B-Cell Acute Lymphoblastic Leukemia;cancer cell;Cancer Cell Growth;CCR;CD19 gene;CD22 gene;Cell Physiology;Cells;Characteristics;Childhood;Childhood Leukemia;chimeric antigen receptor;chimeric antigen receptor T cells;Clinical;Clinical Trials;Collaborations;computational pipelines;cytokine;Cytokine Receptors;Data;Diffuse;Disseminated Malignant Neoplasm;effector T cell;efficacy evaluation;Engineering;Environment;Equilibrium;Evaluation;extracellular;Generations;Glutamine;Goals;high risk;Immune;Immune response;Immunotherapeutic agent;Immunotherapy;In Vitro;Infusion procedures;interest;Investments;leukemia;Lymphoma;manufacture;Metabolic;Metabolism;Modeling;neoplasm immunotherapy;novel;novel strategies;Nutrient;Oxygen;Patient-Focused Outcomes;Patients;Phase;Phase I/II Clinical Trial;Phenotype;polarized cell;Process;Protocols documentation;Reaction Time;real time monitoring;receptor;Refractory;Regulatory T-Lymphocyte;Relapse;response;success;Surface;System;T cell differentiation;T cell regulation;T cell response;T cell therapy;T-Lymphocyte;Therapeutic;Time;TSLP gene;tumor;Tumor Antigens;tumor microenvironment;Tumor Tissue;United States National Institutes of Health;Universities;Variant;Waste Products,Metabolic regulation of T cell effector function and anti-tumor immunotherapy,11923,NA,NA,NA,NA,6,NA,NA,1586326,NA
11188311,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011924,NA,NA,1ZIABC011924-06,NCI:1586326\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162158 (contact),"TAYLOR, NAOMI  (contact)",NA,NA,NA,acquired immunodeficiency;Architecture;Arginine;Biogenesis;Blood;Bone Marrow;Cell Differentiation process;Cell Lineage;Cell Maintenance;Cell Physiology;cell regeneration;Cells;Compensation;congenital immunodeficiency;Cyclic Nucleotides;Cyclophosphamide;cytokine;Defect;Diamond-Blackfan anemia;Disease;DNA;Dysmyelopoietic Syndromes;engineered T cells;Equilibrium;Erythrocytes;Erythroid;erythroid differentiation;Erythropoiesis;Gene Proteins;Gene Transfer;Generations;Genes;Genetic Recombination;Genetic study;Glucose;Glutamine;Glycolysis;hematopoietic stem cell differentiation;Hematopoietic Stem Cell Transplantation;Hematopoietic stem cells;Home;Human;improved;in vivo;Individual;Kinetics;Length;loss of function mutation;Lymphoid;Lymphoid Cell;Lysine;Macaca;Mediating;Metabolic;Metabolism;migration;Mitochondria;Mus;Mutation;Myelogenous;novel;novel therapeutics;Nucleoside Transporter;Nucleotide Biosynthesis;Nucleotides;Nutrient;Oxidative Phosphorylation;Pathologic;Pathway interactions;Patients;Post-Translational Protein Processing;post-transplant;progenitor;programs;Proliferating;Protein Array;protein transport;Proteins;reconstitution;Regulation;Research;Resources;Ribosomal Proteins;Role;Secondary to;self-renewal;Signal Induction;Specific qualifier value;Spermidine;stem cell division;Stem cell transplant;stem cells;stemness;Supporting Cell;T cell differentiation;T cell reconstitution;T-Cell Development;T-Lymphocyte;Therapeutic;Thymus Gland;Time;translation factor;Translations;Transplantation,Metabolic programs regulating hematopoietic stem cell differentiation,11924,NA,NA,NA,NA,6,NA,NA,1586326,NA
11188312,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011927,NA,NA,1ZIABC011927-06,NCI:767708\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162076 (contact),"SHAH, NIRALI  (contact)",NA,NA,NA,Acute leukemia;Acute Myelocytic Leukemia;acute myeloid leukemia cell;Address;Adolescent and Young Adult;Adoptive Cell Transfers;Adult Acute Myeloblastic Leukemia;Allogenic;Amendment;Antigen Targeting;Antigens;arm;Autologous;B lymphoid malignancy;B-Cell Acute Lymphoblastic Leukemia;B-Lymphocytes;Back;bench to bedside;Biological;Biological Products;Blood;Bone Marrow Transplantation;CAR T cell therapy;CD22 gene;Cell Therapy;Cells;cellular engineering;chemotherapy;Child;Childhood;chimeric antigen receptor T cells;Clinical;clinical center;clinical translation;Clinical Trials;clinically relevant;cohort;Collaborations;combinatorial;Country;Data;design;Development;Disease remission;Disease-Free Survival;donor stem cell;Dose;early phase clinical trial;Engraftment;Enrollment;Evaluable Disease;experience;FLT3 gene;Foundations;Functional disorder;Future;Generations;Goals;Hematologic Neoplasms;Hematopoietic Stem Cell Transplantation;Hemophagocytic Lymphohistiocytoses;high risk;IL3RA gene;Immunotherapeutic agent;Immunotherapy;improved;improved outcome;Incidence;Inflammatory;Infrastructure;Infusion procedures;insight;international center;Investigation;leukemia;Licensing;manufacture;Marrow;Maximum Tolerated Dose;Mediating;meetings;mesothelin;Mission;Monitor;Morphology;mortality;multidisciplinary;Myeloid Leukemia;Myeloproliferative disease;novel;novel strategies;novel therapeutic intervention;novel therapeutics;Outcome;Patient-Focused Outcomes;Patients;Pediatric Oncology;pediatric patients;Phase;Phase I/II Trial;Population;post-transplant;Process;Program Development;programs;protocol development;Refractory;Relapse;Research;Resistance;response;Risk Factors;risk mitigation;safety and feasibility;Scientific Advances and Accomplishments;Services;Severities;Siblings;Stem cell transplant;Syndrome;T-Lymphocyte;Testing;Therapeutic;Therapeutic Index;Toxic effect;transplantation therapy;trial design;United States National Institutes of Health;vector;Vision;Work;young adult,Development of Novel Immunotherapeutic Strategies for Myeloid Malignancies,11927,NA,NA,NA,NA,6,NA,NA,767708,NA
11188313,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011928,NA,NA,1ZIABC011928-06,NCI:1339880\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10687150 (contact),"APOLO, ANDREA  (contact)",NA,NA,NA,Adenocarcinoma;Affect;Bladder;Bladder Adenocarcinoma;Bladder Carcinoma;Bladder Squamous Cell Carcinoma;bone;cancer type;Carcinoma;Caring;Clinical;Clinical Research;Clinical Trials;cohort;Collecting Ducts of Bellini Carcinoma;Country;Data;Data Pooling;Disease;Duct (organ) structure;exome sequencing;Genitourinary system;Histologic;Histology;Human;Immune;Incidence;Individual;ipilimumab;Literature;Malignant neoplasm of penis;Malignant neoplasm of testis;Malignant neoplasm of urinary bladder;Malignant Neoplasms;Mutation;Nivolumab;Patients;Penis carcinoma;Peripheral Blood Mononuclear Cell;Persons;Pharmaceutical Preparations;Phase;phase 1 study;phase 2 study;rare cancer;Rare Diseases;recruit;Renal Carcinoma;Resources;response;Science;Skin Appendage Carcinoma;Small Cell Carcinoma;Squamous cell carcinoma;transcriptome sequencing;Transitional Cell Carcinoma;tumor;Tumor Expansion;United States National Institutes of Health;Urethra;Urogenital Cancer;urogenital tract;Variant,Rare genitourinary tumors projects,11928,NA,NA,NA,NA,6,NA,NA,1339880,NA
11188314,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011936,NA,NA,1ZIABC011936-05,NCI:191715\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10274731 (contact),"WOOD, BRADFORD J (contact)",NA,NA,NA,3D Print;air filtration;Artificial Intelligence;artificial intelligence model;automated segmentation;Bacterial Pneumonia;Biopsy;Breathing;CCR;Cellular Phone;Characteristics;Chest imaging;Classification;Clinical;Clinical Trials;commercialization;Communities;COVID-19;crosslink;cytokine;Data;Data Aggregation;data curation;Data Set;Databases;deep learning;deep learning model;Detection;Development;Devices;Disease;Disease Outbreaks;Epidemiology;Exercise;Extramural Activities;Family suidae;federated learning;flu;Goals;Health;Healthcare;Hearing Tests;Image;image guided;image guided therapy;imaging modality;Immunology;Industry;industry partner;Infection;Influenza;Interventional radiology;Journals;Laboratories;large language model;Licensing;Liver;Magnetic Resonance Imaging;Malignant neoplasm of prostate;Malignant Neoplasms;Medical Imaging;medical specialties;Medicine;member;Methodology;minimally invasive;Modeling;multimodality;National Institute of Allergy and Infectious Disease;Nature;nonhuman primate;Organ;Outcome;pandemic disease;Pathway interactions;Performance;Phenotype;pre-clinical;Procedures;Publications;Radiology Specialty;Research;Resource-limited setting;Resources;respiratory;response;screening;sensor;Signal Transduction;Skin;smartphone application;Source;Spirometry;Standardization;Techniques;The Cancer Imaging Archive;Thermal Ablation Therapy;tool;Translating;tumor;United States National Institutes of Health;Validation;Ventilator;Viral Pneumonia;Voice;wearable data;wearable sensor technology;web app;web site;Work;X-Ray Computed Tomography,Development of COVID-19 and Cancer Tools with Artificial Intelligence,11936,NA,NA,NA,NA,5,NA,NA,191715,NA
11188315,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011940,NA,NA,1ZIABC011940-05,NCI:510540\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6802097 (contact),"FELBER, BARBARA K (contact)",NA,NA,NA,2019-nCoV;adaptive immune response;adaptive immunity;anakinra;Anti-Inflammatory Agents;Antibodies;Antigens;B-Lymphocytes;Binding;Biological Markers;Biology;Cancer Patient;CCL2 gene;CCL22 gene;CCL3 gene;CCL4 gene;CCL8 gene;Cells;chemokine;cohort;COVID-19;COVID-19 vaccination;COVID-19 vaccine;CXCL10 gene;CXCL13 gene;CXCR3 gene;cytokine;Data;Development;Disease;Early identification;Effectiveness;Goals;Hematologic Neoplasms;high risk;HIV vaccine;Humoral Immunities;IL16 gene;IL8 gene;Immune;Immune response;Immunity;Immunocompromised Host;Immunologic Markers;Individual;individual patient;Infection;Inflammatory;Innate Immune Response;Interferon Type II;Interleukin-15;Interleukin-16;Interleukin-6;Internships;Knowledge;Longevity;Longitudinal cohort;Messenger RNA;microorganism;Monitor;Nature;neutralizing antibody;novel;novel vaccines;Participant;Patients;Persons;Pfizer-BioNTech COVID-19 vaccine;Population;prognostic;Regimen;research and development;response;RNA vaccination;RNA vaccine;Role;SARS-CoV-2 immune response;SARS-CoV-2 infection;Shapes;Structure of germinal center of lymph node;TNF gene;Vaccinated;Vaccination;Vaccine Design;vaccine development;vaccine efficacy;vaccine platform;vaccine strategy;Vaccinee;Virus;volunteer,COVID-19 vaccine in naive individuals and cancer patients,11940,NA,NA,NA,NA,5,NA,NA,510540,NA
11188316,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011941,NA,NA,1ZIABC011941-05,NCI:1300408\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6572144 (contact),"BERZOFSKY, JAY A (contact)",NA,NA,NA,2019-nCoV;ACE2;Adjuvant;Affect;Air Movements;airway epithelium;aluminum sulfate;Animal Model;Animals;Antibodies;Antibody Specificity;Antibody titer measurement;Antigens;Appearance;Binding;Body Weight decreased;booster vaccine;Bronchoalveolar Lavage Fluid;Cancer cell line;CD8-Positive T-Lymphocytes;Cell Line;Cells;chemokine;Cholesterol;comparison control;Coupled;COVID-19;COVID-19 prevention;COVID-19 susceptibility;COVID-19 vaccine;Data;Dendritic Cells;Diet;dimer;Disease;disorder control;disorder prevention;DNA Vaccines;Dose;Electroporation;Epithelial Cells;experience;Female;Formulation;Gender;gender difference;Granulocyte-Macrophage Colony-Stimulating Factor;Hamsters;health goals;HIV vaccine;Human;Human Cell Line;Immune;Immune response;Immunity;Immunize;immunogenicity;Immunoglobulin A;Immunoglobulin G;immunopathology;improved;In Vitro;in vivo;indicated prevention;Industrialization;Infection;Infection prevention;Interferon Type I;Interleukin-12;Interleukin-15;Licensing;Ligands;Lung;lung cancer cell;Macaca;Macaca mulatta;male;Malignant neoplasm of lung;Medical center;Messenger RNA;Methods;Modeling;Monitor;Morbidity - disease rate;Mouse Strains;Mucosal Immunity;mucosal vaccine;Mucous Membrane;Mus;Myelogenous;Myeloid Cells;Myeloid-derived suppressor cells;nanoparticle;Nasal cavity;Natural Immunity;neutralizing antibody;Non-Small-Cell Lung Carcinoma;nonhuman primate;Nose;Obesity;Omega-3 Fatty Acids;Oropharyngeal;Persons;preclinical study;prevent;Production;Proteins;Public Health;Publishing;Reagent;receptor;receptor binding;Recombinants;respiratory challenge;Respiratory Mucosa;response;Risk Reduction;RNA vaccine;Role;Route;SARS-CoV-2 B.1.1.529;SARS-CoV-2 B.1.617.2;SARS-CoV-2 infection;SARS-CoV-2 spike protein;SARS-CoV-2 variant;Serum;Sex Bias;Site;SIV Vaccines;South African;T cell response;T-Lymphocyte;Testing;Texas;Time;TLR3 gene;TMPRSS2 gene;Touch sensation;transmission process;Universities;Vaccinated;Vaccination;vaccine candidate;vaccine trial;Vaccines;Variant;variants of concern;Vascular Endothelial Cell;Viral;viral transmission;Viral Vaccines;Virion;Virus;Work,Studies of the SARS-CoV-2 Spike Protein,11941,NA,NA,NA,NA,5,NA,NA,1300408,NA
11188317,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011942,NA,NA,1ZIABC011942-05,NCI:85728\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,12032135 (contact),"JONES, JENNIFER  (contact)",NA,NA,NA,2019-nCoV;CCR;Clinical;Collaborations;COVID-19;COVID-19 pandemic;COVID-19 treatment;Cryoelectron Microscopy;Detection;Disease;exosome;extracellular vesicles;HIV;human disease;Human Herpesvirus 4;Human Papillomavirus;Laboratories;Methodology;Methods;Molecular Analysis;Monitor;Mouse Mammary Tumor Virus;Mus;nanobiologic;nanobiology;particle;Publishing;Repetitive Sequence;Research;Resources;SARS-CoV-2 infection;Satellite Viruses;Technology;tool;transcriptome sequencing;tumor;Viral;Virus;Virus Diseases;Work,"Translational Nanobiology Approaches to Viral Diseases (HIV, HTLV, SARS-CoV2)",11942,NA,NA,NA,NA,5,NA,NA,85728,NA
11188318,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011944,NA,NA,1ZIABC011944-05,NCI:32788\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10687117 (contact),"TARASOVA, NADYA  (contact)",NA,NA,NA,Binding;biophysical techniques;Cells;Chemical Structure;Chemicals;Coronavirus Infections;COVID-19;COVID-19 therapeutics;COVID-19 treatment;Data;Databases;Development;Docking;Drug Screening;Eligibility Determination;Escherichia coli;Esters;Evaluation;Generations;Goals;Half-Life;high throughput screening;Human;improved;in silico;in vitro testing;Inflammatory;inhibitor;Lead;Libraries;Long COVID;Mediating;Methods;Mus;N-terminal;novel;Pharmacotherapy;physical state;Plasma;preclinical development;preclinical study;Property;protein structure;Proteins;Recombinants;screening;small molecule;STAT3 gene;Structure;Viral;Viral Proteins;virtual library;Virus,Development of COVID-19 cell entry inhibitors,11944,NA,NA,NA,NA,5,NA,NA,32788,NA
11188319,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011945,NA,NA,1ZIABC011945-05,NCI:201039\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6572342 (contact),"YARCHOAN, ROBERT  (contact)",NA,NA,NA,2019-nCoV;Active Sites;Acute Respiratory Distress Syndrome;Affect;Anti-viral Agents;Anti-viral Therapy;antiviral drug development;Binding;Biochemistry;CCR;cell killing;Cells;Cessation of life;Chiroptera;Coagulation Process;Collaborations;Coronavirus;Coughing;COVID-19;Cysteine;dimer;Dimerization;Disease Outbreaks;Exposure to;Fever;inhibitor;interest;Middle East Respiratory Syndrome Coronavirus;migration;Multiple Organ Failure;Nonstructural Protein;oxidation;Oxidative Stress;pandemic disease;Papain;Peptide Hydrolases;Physiological;Polyproteins;Predisposition;Prodrugs;Protease Inhibitor;Proteins;RNA Viruses;SARS coronavirus;SARS-CoV-2 inhibitor;SARS-CoV-2 protease;Severe Acute Respiratory Syndrome;Stress;Stroke;Structure;Toxic effect;Viral;Virus,Study of and development of antiviral drugs against SARS-CoV2 protease,11945,NA,NA,NA,NA,5,NA,NA,201039,NA
11188320,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011948,NA,NA,1ZIABC011948-05,NCI:1196333\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6569088 (contact),"POMMIER, YVES  (contact)",NA,NA,NA,2019-nCoV;Antibiotics;Antineoplastic Agents;atomic interactions;Bacteria;Binding;Biochemical;Biological Assay;Biological Process;C-terminal;Camptothecin;cancer predisposition;Catalytic Domain;CCR;Cell Line;Cell Nucleus;Cells;Chemicals;Clinical;Clone Cells;cofactor;Complex;CRISPR/Cas technology;Cryoelectron Microscopy;Cytoplasm;Cytoprotection;Defect;DNA;DNA Topoisomerase IV;Dominant-Negative Mutation;Drug Targeting;engineered beta cell;Engineering;Enzymes;experimental study;Family;Genetic Transcription;Genome Stability;Genomics;Growth;helicase;high throughput screening;Homeostasis;Human;Human Cell Line;Hybrids;Immune;Inflammatory;inhibitor;Integration Host Factors;Knock-in Mouse;Knock-out;Knockout Mice;Laboratories;Legal patent;Lethal Genes;Libraries;Lymphoid Cell;Mass Spectrum Analysis;Medicine;Metabolic;Metals;Minor;Modeling;Molecular Target;mutant;National Center for Advancing Translational Sciences;Natural Products;novel;Nucleic Acid Cleavage;Oligonucleotides;Pathway interactions;Pharmaceutical Preparations;Phenotype;Poisoning;Publishing;Reaction;Recombinants;Reporter;Reporting;Resolution;RNA;RNA Folding;RNA Splicing;RNA Viruses;Role;Running;Severe Acute Respiratory Syndrome;Single-Stranded DNA;Splenomegaly;Sterility;structural determinants;Structure;System;Testing;TOP1 gene;TOP2A gene;Topoisomerase;Topoisomerase II;Topoisomerase III;Topoisomerase-I Inhibitor;Transfection;Translations;tumor;United States National Academy of Sciences;Viral Physiology;Western Blotting;Yeasts,TOP3B as host factor and drug target,11948,NA,NA,NA,NA,5,NA,NA,1196333,NA
11188321,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011949,NA,NA,1ZIABC011949-05,NCI:233330\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9414396 (contact),"CARRINGTON, MARY N. (contact)",NA,NA,NA,Antibodies;Autoimmunity;B-Lymphocytes;Biological;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;CD8B1 gene;cohort;Collaborations;COVID-19;cytotoxicity;Data;Disease Outcome;Exhibits;Genes;Genetic;genetic association;genetic resistance;genetic variant;Genotype;Immune;Immune response;Immune Response Genes;Individual;Long COVID;Molecular;monocyte;neutralizing antibody;pathogen;Reporting;Research Personnel;response;Role;SARS-CoV-2 infection;SARS-CoV-2 variant;systemic inflammatory response;Testing;Vaccination,Host genetic resistance to COVID-19,11949,NA,NA,NA,NA,5,NA,NA,233330,NA
11188322,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011952,NA,NA,1ZIABC011952-05,NCI:176460\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6212020 (contact),"KREITMAN, ROBERT  (contact)",NA,NA,NA,2019-nCoV;Acute;anti-CD20;Antibodies;Antibody Response;antibody test;Antigens;B-Lymphocytes;CD4 Lymphocyte Count;CD4 Positive T Lymphocytes;Cell Count;chemotherapy;Clone Cells;cohort;Collaborations;COVID-19;COVID-19 pandemic;COVID-19 patient;COVID-19 survivors;COVID-19 test;COVID-19 vaccination;COVID-19 vaccine;Disease;Dose;experience;Future;Genes;Hairy Cell Leukemia;Half-Life;Heavy-Chain Immunoglobulins;Hematologic Neoplasms;Immune response;Immune system;Immunoglobulin G;Immunoglobulins;Individual;Infection;Learning;Lymphoma;Malignant Neoplasms;Maryland;Monoclonal Antibody CD20;Mutate;Mutation;Nucleocapsid;Outcome;Patients;Pattern;Peripheral;Persons;Population;Prognosis;Publications;Publishing;Recovery;response;Risk;rituximab;SARS-CoV-2 antibody;SARS-CoV-2 infection;SARS-CoV-2 positive;Symptoms;T-Lymphocyte;Testing;Time;Universities;Vaccination;Vaccines;Variant;Virus Diseases,Patterns of immune response in COVID-19 patients,11952,NA,NA,NA,NA,5,NA,NA,176460,NA
11188323,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011953,NA,NA,1ZIABC011953-05,NCI:1343174\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9786523 (contact),"KRUG, LAURIE T (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Animal Model;Animals;antiretroviral therapy;Area;B cell differentiation;B cell repertoire;B-Cell Lymphomas;B-Lymphocytes;Basic Science;Binding;Biochemical;Biological;Biopsy;Callithrix jacchus jacchus;Cancer Burden;Cause of Death;Cell Culture System;Cell Culture Techniques;Cell Proliferation;cell transformation;Cells;Clinical;Clinical Trials;Clonality;cohort;Collaborations;Complex;cytokine;Development;Disease;DNA Repair;DNA Replication Factor;Endothelial Cells;Enzymes;Epstein-Barr pathogenesis;Etiology;Event;gammaherpesvirus;Gene Expression;Gene Expression Profile;Genes;Genetic;Herpesviridae;Herpesviridae Infections;HIV;HIV/AIDS;Host Defense;Human;Human Herpesvirus 4;Human Herpesvirus 8;immunodeficiency;Implant;Individual;infected B cell;Infection;Interferons;Interphase Cell;Intervention;Investigation;Journals;Kaposi Sarcoma;Knock-out;Knowledge;Laboratories;Laboratory Animal Science;Learning;lymph nodes;Lytic;Malignant - descriptor;Malignant Neoplasms;Molecular;Morbidity - disease rate;mortality;mouse model;Multicentric Angiofollicular Lymphoid Hyperplasia;Mus;nucleotide metabolism;Nucleotides;Oncogenic;participant enrollment;pathogen;Pathogenesis;Pathogenicity;patient derived xenograft model;Patients;Persons;Pharmaceutical Preparations;Population;pre-clinical;pre-clinical research;primary effusion lymphoma;Process;programs;Proliferating;Property;Publishing;rational design;Research;Research Personnel;response;Risk;Role;Sampling;Series;Signal Transduction;skin xenograft;Source;STAT1 gene;STAT3 gene;System;T-Lymphocyte;Therapeutic;Trans-Activators;transcriptome sequencing;Transgenic Mice;tumor;tumor growth;United States National Institutes of Health;uracil-DNA glycosylase;Viral;viral DNA;Virus;virus host interaction,Investigation of viral and host determinants of gammaherpesvirus pathogenesis,11953,NA,NA,NA,NA,5,NA,NA,1343174,NA
11188324,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011954,NA,NA,1ZIABC011954-05,NCI:852381\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857415 (contact),"RAMASWAMI, RAMYA  (contact)",NA,NA,NA,Biological Assay;Blood;cancer diagnosis;cancer therapy;Cellular Assay;chemotherapy;Circulation;Clinical Data;Clinical Trials;Collaborations;Correlative Study;cytokine;Development;Disease;Evaluation;genomic platform;genomic profiles;Genomics;HIV;Human Herpesvirus 8;Inflammation;Inflammatory;Interleukin-12;Kaposi Sarcoma;Malignant Neoplasms;Modernization;Morbidity - disease rate;mortality;Multicentric Angiofollicular Lymphoid Hyperplasia;Natural History;Oncology;Pathogenicity;Pathway interactions;patient population;Patients;Persons;primary effusion lymphoma;prospective;Protocols documentation;Publishing;Role;Sampling;T-Lymphocyte;targeted treatment;Technology;Tissues;transcriptome sequencing;Tumor Subtype;United States,Targeted therapies for Kaposi sarcoma and KSHV-multicentric Castleman disease,11954,NA,NA,NA,NA,5,NA,NA,852381,NA
11188325,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011961,NA,NA,1ZIABC011961-05,NCI:552640\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14156081 (contact),"YOO, EUNA  (contact)",NA,NA,NA,Binding;Cells;Chemicals;chemoproteomics;Coupled;covalent bond;Cysteine;Development;Elements;GSTP1 gene;Immune;immune function;immune modulating agents;improved;interest;Investigation;Libraries;Ligands;Modification;Natural Products;novel;pharmacokinetics and pharmacodynamics;Phenotype;Proliferating;protein function;Proteins;Proteome;screening;Site;small molecule;Specificity;T-Cell Activation;Therapeutic;tool,Synthesis and characterization of covalent ligands,11961,NA,NA,NA,NA,5,NA,NA,552640,NA
11188326,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011962,NA,NA,1ZIABC011962-05,NCI:414480\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14156081 (contact),"YOO, EUNA  (contact)",NA,NA,NA,Animal Model;Biology;cancer type;Cell Death;Cell Surface Receptors;Cells;cross reactivity;cytokine;Cytoplasm;Cytotoxic T-Lymphocytes;Event;extracellular;Extracellular Matrix;Fluorescence Resonance Energy Transfer;Granzyme;Image;Imaging Device;imaging probe;Immune;Immune Evasion;Immune system;immunoregulation;Immunotherapy;in vivo;Inflammatory;inhibitor;interest;Kinetics;Measures;Mediating;Monitor;Natural Killer Cells;perforin;Play;protein aminoacid sequence;Regulation;Reporting;response;Role;Series;Serine Protease;T-Lymphocyte and Natural Killer Cell;tool;tumor;tumor microenvironment;tumor progression;VDAC1 gene,Understanding functional roles and regulation of granzymes,11962,NA,NA,NA,NA,5,NA,NA,414480,NA
11188327,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011963,NA,NA,1ZIABC011963-05,NCI:414480\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14156081 (contact),"YOO, EUNA  (contact)",NA,NA,NA,activity-based protein profiling;Anti-viral Response;Binding;Biological Assay;Biotin;Cell Line;chemical synthesis;Chemicals;Collaborations;combinatorial;Cysteine;divinyl sulfone;Enzymes;Family;functional group;Genes;high throughput screening;Immunologics;in silico;in vivo;inhibitor;Innate Immune System;Interferon Type I;Interferons;Lung Adenocarcinoma;member;Modeling;mutant;Mutate;National Center for Advancing Translational Sciences;Pathway interactions;Peptide Hydrolases;Peptide Library;Play;Preparation;Proteins;Publications;Reporter;Research;Role;Scanning;Series;Signal Transduction;small molecule;tool;tumorigenesis;Ubiquitin;ubiquitin isopeptidase;ubiquitin-protein ligase;ubiquitin-specific protease;Ubiquitination;Work,Targeting ISG15 and USP18,11963,NA,NA,NA,NA,5,NA,NA,414480,NA
11188328,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011965,NA,NA,1ZIABC011965-05,NCI:838796\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857425 (contact),"TAKEDA, DAVID  (contact)",NA,NA,NA,3-Dimensional;advanced prostate cancer;Affect;Androgen Receptor;Architecture;Automobile Driving;Binding;Biological Models;Cell Survival;Chromatin;chromatin immunoprecipitation;Cues;Disease Progression;Disease Resistance;effective therapy;Enhancers;Epigenetic Process;functional genomics;Gene Expression;Generations;Genetic Screening;Genetic Transcription;Genome;genome-wide;Genomic approach;histone modification;inhibitor;insight;Malignant neoplasm of prostate;Malignant Neoplasms;Normal Cell;novel;Pathogenesis;patient derived xenograft model;Play;programs;promoter;Prostate;prostate cancer cell;Protein-Arginine N-Methyltransferase;Receptor Signaling;Regulatory Element;response;Role;Signal Transduction;spatiotemporal;Therapeutic;therapeutic target;therapy resistant;transcription factor;tumor;tumorigenesis;tumorigenic,Mechanism of epigenetic activation during disease progression,11965,NA,NA,NA,NA,5,NA,NA,838796,NA
11188329,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011970,NA,NA,1ZIABC011970-05,NCI:42985\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11592683 (contact),"SCHNEEKLOTH, JOHN  (contact)",NA,NA,NA,2019-nCoV;Anti-viral Agents;betacoronavirus;Binding;Cell model;Clinical Trials;Coronavirus;COVID-19 outbreak;Drug Design;Economics;Elements;Laboratories;mortality;Pharmaceutical Preparations;remdesivir;Reporting;SARS-CoV-2 genome;screening;small molecule;Structure;Therapeutic;Untranslated RNA;viral genomics;Work,Targeting Functional RNA Elements in the SARS-CoV-2 Genome,11970,NA,NA,NA,NA,5,NA,NA,42985,NA
11188330,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011973,NA,NA,1ZIABC011973-05,NCI:838796\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857425 (contact),"TAKEDA, DAVID  (contact)",NA,NA,NA,Advanced Development;advanced disease;advanced prostate cancer;Androgen Receptor;Anti-androgen Therapy;Biopsy;Cells;ChIP-seq;Chromatin;chromatin immunoprecipitation;Clinical;Disease;Disease Progression;Enhancers;Epigenetic Process;epigenetic profiling;epigenomic profiling;Genomics;Goals;Histones;insight;Malignant neoplasm of prostate;Metastatic Neoplasm to the Bone;Methods;Neoadjuvant Therapy;novel;Patients;Plasma;Post-Translational Protein Processing;Prostatic Neoplasms;Radical Prostatectomy;Recurrence;Resistance;resistance mechanism;Role;Sampling;Site;Testing;therapeutic target;therapy resistant;Tissues;transcriptomics;tumor,Identification of epigenetic drivers of advanced prostate cancer,11973,NA,NA,NA,NA,5,NA,NA,838796,NA
11188331,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011975,NA,NA,1ZIABC011975-05,NCI:980885\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857435 (contact),"MAYER, CHRISTIAN  (contact)",NA,NA,NA,adaptive immune response;adaptive immunity;Affinity;Alleles;Antibody Affinity;Antibody Response;antigen binding;Antigen Receptors;Apoptosis;autoinflammation;autoreactive B cell;autoreactivity;B cell differentiation;B-Cell Antigen Receptor;B-Cell Development;B-Lymphocytes;Bone Marrow;CASP3 gene;Cell Death;Cell Maturation;Cell Survival;Cells;Cellular biology;Clonal Deletion;Cues;Dangerousness;Defect;Dendritic Cells;Development;Event;Fibroblasts;Genes;Goals;human disease;humoral immunity deficiency;Immunoglobulin A;Immunologist;immunoregulation;Inflammatory;Informal Social Control;inhibitor;Link;Mediating;Memory B-Lymphocyte;Methods;Monoclonal Antibodies;mucosal site;Mutation;NF-kappa B;Patients;Peripheral;peripheral tolerance;Phenotype;Physiological;Plasma Cells;Predisposition;Process;Production;Proliferating;Proteins;Reaction;Regulation;response;Self Tolerance;Signal Transduction;Structure of germinal center of lymph node;T-Lymphocyte;Testing;TNF gene,Regulation of self-tolerance and adaptive immunity by cell death and other cues,11975,NA,NA,NA,NA,5,NA,NA,980885,NA
11188332,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011976,NA,NA,1ZIABC011976-05,NCI:382465\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692263 (contact),"ASHWELL, JONATHAN  (contact)",NA,NA,NA,"2019-nCoV;Acceleration;Ankylosing spondylitis;Anti-CD40;Anti-Tumor Necrosis Factor Therapy;Antibodies;Antigen Presentation;Apoptotic;Autoimmune;B-Lymphocytes;Bone Marrow;Cell Count;Cell Physiology;Cell Surface Receptors;Cells;Couples;cytokine;Death Domain;Dendritic Cells;Disease;FDA approved;FLT3 ligand;Generations;Genetically Engineered Mouse;Growth;Human;human disease;Immune system;Immunosuppression;In Vitro;in vivo Model;Induction of Apoptosis;Infiltration;Inflammation;Inflammatory;Knockout Mice;KPC model;KRAS2 gene;Laboratory Finding;Macrophage;Malignant Neoplasms;Mediating;mortality;Mus;Neoplasm Transplantation;Oncogenic;Pancreatic Adenocarcinoma;Pathway interactions;programmed cell death ligand 1;Psoriasis;receptor;Receptors, Tumor Necrosis Factor, Type II;Rheumatoid Arthritis;Signal Transduction;Source;T-Cell Activation;T-Lymphocyte;therapeutic target;TNF gene;TNFRSF1A gene;TNFRSF1B gene;transcriptomics;tumor;Tumor Necrosis Factor Receptor;tumor progression;Tumor-infiltrating immune cells;tumorigenic;Virus Diseases;Work",TNF and inflammation,11976,NA,NA,NA,NA,5,NA,NA,382465,NA
11188333,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011977,NA,NA,1ZIABC011977-05,NCI:1913856\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857438 (contact),"VALKOV, EUGENE  (contact)",NA,NA,NA,Address;Affect;Affinity;age-related disease;Architecture;Autoimmune Diseases;Biochemical;Biological Assay;C-terminal;Catalytic Domain;Cell Line;Cells;Complex;Cryoelectron Microscopy;Crystallization;Cytoplasm;Disease;Docking;Enhancers;Enzymes;Excision;Exonuclease;Fission Yeast;Gene Expression;Gene Expression Regulation;genome editing;Goals;Human;improved;In Vitro;Individual;Infrastructure;insight;Investigation;Kinetics;Knock-out;Laboratories;Length;Malignant Neoplasms;Mammals;Mediating;Messenger RNA;Methodology;milligram;Modeling;Modification;Molecular;Molecular Conformation;Mutagenesis;Nerve Degeneration;Nucleotides;Oncogenic;Pathway interactions;Peptides;Phase;Physical condensation;Play;Poly(A) Tail;polyadenosine;Positioning Attribute;Post-Transcriptional Regulation;Process;Production;protein complex;Protein Complex Subunit;Protein Dynamics;protein protein interaction;protein purification;Proteins;Reaction;Recombinants;reconstitution;recruit;Regulation;Repression;Resolution;RNA;RNA Binding;RNA Decay;RNA Degradation;RNA purification;RNA-Binding Proteins;Role;Rotation;Site;Specificity;Structure;System;Tail;Testing;transcriptome;Translational Repression;Translations;Work;Yeasts,Molecular Mechanisms of mRNA Regulation and Decay,11977,NA,NA,NA,NA,5,NA,NA,1913856,NA
11188334,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011978,NA,NA,1ZIABC011978-05,NCI:228237\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857423 (contact),"HANNENHALLI, SRIDHAR  (contact)",NA,NA,NA,Alternative Splicing;biological adaptation to stress;BRAF gene;cancer therapy;cancer type;Cells;Cellular Stress;cohort;Collaborations;colonization resistance;comparative;Data;Data Set;Development;Embryo;embryo cell;Embryonic and Fetal Development;Evolution;Exclusion;Exhibits;experimental study;Gene Cluster;Gene Expression Profile;Genes;Genetic Transcription;Global Change;Human;Hybrids;Immune;immune checkpoint blockade;immune resistance;Immune System Diseases;Immunosuppression;Link;Malignant Neoplasms;Manuscripts;Maps;Mediating;melanoblast;melanocyte;Melanoma;Melanoma Cell;Mesenchymal;Metastatic Melanoma;Modeling;Molecular;Morphology;mouse model;Mus;Mutation;Natural regeneration;Neoplasm Metastasis;neoplastic cell;novel;Patients;Pattern;Pharmaceutical Preparations;Population;Predisposition;Process;Processed Genes;programs;Proliferating;Proteins;Publishing;Reporting;Resistance;Resolution;response;RNA Splicing;Role;Schools;Schwann Cells;single-cell RNA sequencing;stem;targeted treatment;therapy resistant;Time;tool;transcription factor;treatment response;tumor;tumorigenesis;Variant;Work;wound healing,Developmental and Homeostatic origins of cancer,11978,NA,NA,NA,NA,5,NA,NA,228237,NA
11188335,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011984,NA,NA,1ZIABC011984-05,NCI:342356\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857423 (contact),"HANNENHALLI, SRIDHAR  (contact)",NA,NA,NA,Affect;astrocyte progenitor;Bioconductor;Biological Markers;Biological Process;biological systems;Brain;Cancer Biology;cancer cell;cancer type;Cell Communication;Cell Physiology;Cell surface;cell type;Cells;Clinical;Clinical Trials;clinically relevant;computational pipelines;Data;Data Set;DNA Damage;Embryonic Development;gene function;Genes;Genetic;genetic signature;Genetic Transcription;Glioma;Human;Immune;intercellular communication;Malignant Neoplasms;malignant state;Manuscripts;Mediating;mutant;Myeloid Cells;neoplasm immunotherapy;Neurons;novel strategies;oligodendrocyte progenitor;Oncogenic;Outcome;patient stratification;Phenotype;Process;prognostic of survival;Proliferating;Proteins;Reporting;repository;responders and non-responders;response;stem cells;stemness;Therapeutic Intervention;Tissues;tool;transcriptomics;tumor;tumor microenvironment;tumor progression;Work;Writing,Context-specific functions of genes and cells,11984,NA,NA,NA,NA,5,NA,NA,342356,NA
11188336,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011987,NA,NA,1ZIABC011987-05,NCI:1388157\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857444 (contact),"SAHINALP, SULEYMAN  (contact)",NA,NA,NA,Algorithmic Software;Algorithms;Biopsy;Cell model;Cells;Combinatorial Optimization;computerized tools;Data;deep neural network;Evolution;exome;Genome;Goals;Growth;Heterogeneity;liquid biopsy;Malignant Neoplasms;mathematical algorithm;mathematical methods;Melanoma;methylome;Modeling;Mus;Mutation;neoplastic cell;novel;single cell sequencing;Techniques;Time;transcriptome;transcriptome sequencing;Trees;tumor;tumor heterogeneity;Work,Tumor evolution and intratumor heterogeneity,11987,NA,NA,NA,NA,5,NA,NA,1388157,NA
11188337,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011988,NA,NA,1ZIABC011988-05,NCI:347040\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857444 (contact),"SAHINALP, SULEYMAN  (contact)",NA,NA,NA,clinical trial recruitment;Computer software;Computer Systems;Data Analyses;Environment;Genome;genome analysis;genome wide association study;genomic data;Genomics;Goals;improved;interest;Machine Learning;Memory;Microprocessor;Modernization;Phase;privacy preservation;Secure;Techniques;Trust,Privacy Preserving Genome Analysis,11988,NA,NA,NA,NA,5,NA,NA,347040,NA
11188338,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011989,NA,NA,1ZIABC011989-05,NCI:1295687\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857447 (contact),"ROPER, NITIN  (contact)",NA,NA,NA,Biological;Cell Differentiation process;Cells;checkpoint inhibition;Epigenetic Process;Goals;Immunologics;Immunotherapy;interest;neuroendocrine cancer;Neuroendocrine Tumors;notch protein;predicting response;Research;response;Signal Transduction;small cell lung carcinoma;treatment response;Tumor Immunity;Work,Epigenetic and immunologic aspects of neuroendocrine cancers,11989,NA,NA,NA,NA,5,NA,NA,1295687,NA
11188339,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011990,NA,NA,1ZIABC011990-05,NCI:42813\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857449 (contact),"YOUKHARIBACHE, PHILIPPE  (contact)",NA,NA,NA,"2019-nCoV;ACE2;Amino Acid Transporter;Amino Acids;Animals;anti-cancer;Anti-viral Agents;Arginine;betacoronavirus;Binding;Biological Markers;Bovine leukemia;Bovine Leukemia Virus;CCL21 gene;Cell Differentiation process;Cell surface;Cell Surface Proteins;Cell Surface Receptors;Cells;Cellular Metabolic Process;Collaborations;Complex;computational pipelines;Computer software;Coronavirus;Data;data-driven model;design;Development;Diagnosis;Endogenous Retroviruses;Epitopes;Exhibits;Family;Feline Leukemia Virus;France;G-Protein-Coupled Receptors;Glucose;Glucose Transporter;Glutamine;Glycoproteins;Goals;Homologous Gene;Human;Human Genome;Human T-Cell Leukemia Viruses;Immune response;improved;In Vitro;in vivo;Inflammation;innovation;invention;Legal patent;Ligands;Measures;member;Membrane Proteins;Methodology;Methods;model building;Molecular;Mus;Neutral Amino Acid Transport Systems;Normal Cell;Nutrient;Oncogenic;Papio;Paris, France;Play;polypeptide;Primates;Process;Proteins;receptor;receptor binding;Receptor Cell;Research;Retroviridae;Role;Serine;SLC2A1 gene;software development;Specificity;Structure;Supersecondary Protein Structure;syncytin;System;TMPRSS2 gene;tool;tumorigenesis;Virus Diseases;virus envelope;Virus Receptors",Structural basis of viral RBDs binding to cell receptors,11990,NA,NA,NA,NA,5,NA,NA,42813,NA
11188340,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011993,NA,NA,1ZIABC011993-05,NCI:387686\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687355 (contact),"YOHE, MARIELLE  (contact)",NA,NA,NA,anti-cancer research;Cells;Childhood Soft Tissue Sarcoma;Collaborations;Combined Modality Therapy;Defect;Diagnosis;Differentiation Therapy;Exclusion;Failure;Genes;Genetic Transcription;Goals;GTPase-Activating Proteins;Homologous Gene;Invaded;knock-down;Molecular;Myoblasts;Neoplasm Metastasis;novel therapeutics;Nuclear;Paper;Pathway interactions;Phosphorylation;prevent;Prognosis;Publications;Publishing;Recurrence;Recurrent tumor;Regulation;Rhabdomyosarcoma;Role;Signal Transduction;Skeletal Muscle;therapeutic target;Transcription Coactivator;transcription factor;Tumor Cell Invasion;tumor growth;Tumor Suppressor Proteins;Work;Xenograft Model,Regulation of differentiation and invasion in RMS by ASAP1,11993,NA,NA,NA,NA,5,NA,NA,387686,NA
11188341,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011994,NA,NA,1ZIABC011994-05,NCI:152489\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692167 (contact),"HICKSTEIN, DENNIS  (contact)",NA,NA,NA,Age;alemtuzumab;Alkylating Agents;Allogenic;Busulfan;Chimerism;Clinical;cohort;conditioning;congenital immunodeficiency;curative treatments;Cyclophosphamide;Defect;Disease;disease phenotype;Donor Selection;donor stem cell;Dose;efficacy evaluation;Engraftment;exome sequencing;fludarabine;gain of function mutation;genome sequencing;Hematological Disease;Hematopoiesis;Hematopoietic Stem Cell Transplantation;hematopoietic transplantation;HLA-A gene;Immune;immune function;immunodeficiency;Infection;Life;loss of function;Marrow;mycophenolate mofetil;Myeloid Cells;neutrophil;Organism;Participant;Patients;post-transplant;programs;Prophylactic treatment;reconstitution;Recording of previous events;Recovery;Regimen;Resolution;response;Safety;Source;T-Lymphocyte;Tacrolimus;Transplantation Conditioning;whole genome;Whole-Body Irradiation,Allogeneic Hematopoietic Transplantation for Primary Immunodeficiency Diseases,11994,NA,NA,NA,NA,5,NA,NA,152489,NA
11188342,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011996,NA,NA,1ZIABC011996-05,NCI:478291\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9979589 (contact),"FIGG, WILLIAM DOUGLAS (contact)",NA,NA,NA,Affect;AIDS related cancer;Animal Disease Models;Anti-HIV Agents;Antibodies;Anticoagulants;BAY 54-9085;Blood;Blood coagulation;bone;CDK4 gene;Cell Cycle;Clinical;Clinical Pharmacology;comorbidity;Cyclin D1;cyclin D3;Cyclin-Dependent Kinase Inhibitor;Cyclins;CYP3A4 gene;Cytotoxic Chemotherapy;Disease remission;Dose;Drug Exposure;Drug Interactions;Drug Kinetics;Endothelial Cells;Endothelium;Gastrointestinal tract structure;Goals;Health;healthy volunteer;Hemorrhage;HIV;HIV diagnosis;HIV Seronegativity;HIV therapy;Human;Human Herpesvirus 8;improved;interest;Interleukin 6 Receptor;Kaposi Sarcoma;Laboratories;Liposomal Doxorubicin;Lung;Lymph Node Involvement;Malignant Neoplasms;Metastatic breast cancer;meter;Modeling;Morbidity - disease rate;Multicentric Angiofollicular Lymphoid Hyperplasia;Oral;Pathway interactions;Patients;Persons;Pharmaceutical Preparations;Phase;Phosphorylation;Phosphotransferases;pomalidomide;prevent;Proliferating;Proteins;Recurrence;Refractory;Relapse;Retinoblastoma;Retinoblastoma Protein;rifapentine;Ritonavir;Safety;Signal Pathway;Skin;Tenofovir;Therapeutic;Therapeutic Agents;therapeutic target;tocilizumab;Treatment Protocols;tuberculosis treatment;tumor;Umbilical vein;Work,Clinical Pharmacology and Drug-Drug Interactions in HIV-Associated Malignancy,11996,NA,NA,NA,NA,5,NA,NA,478291,NA
11188343,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011997,NA,NA,1ZIABC011997-05,NCI:214064\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857449 (contact),"YOUKHARIBACHE, PHILIPPE  (contact)",NA,NA,NA,Antibodies;antigen binding;Antigen Targeting;Architecture;Big Data;Binding;Bioinformatics;Biological;biophysical properties;biophysical techniques;Biophysics;CAR T cell therapy;CD19 gene;CD22 gene;CD28 gene;CD8B1 gene;Cell surface;Cell Surface Receptors;Chimera organism;chimeric antigen receptor;Clinical Trials;Collaborations;combinatorial;Complex;Computational Technique;Computer software;computerized tools;Data;data repository;Data Science;design;Dimerization;Disease;electron tomography;Elements;Engineering;Environment;extracellular;Extracellular Domain;FDA approved;flexibility;Goals;Immunoglobulin Domain;Immunotherapeutic agent;improved;in silico;In Vitro;in vivo;interest;Knowledge;Machine Learning;Mediating;Membrane;Methods;Microtomy;Mining;Modeling;Molecular;monomer;nanobodies;novel strategies;Process;Property;protein structure;Proteins;rational design;Reporting;Role;simulation;Specificity;Structure;Structure-Activity Relationship;Synapses;synaptogenesis;System;Techniques;tool;Toxic effect;X-Ray Crystallography,CAR and Antibodies Structure-Activity Relationships and molecular architecture,11997,NA,NA,NA,NA,5,NA,NA,214064,NA
11188344,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC011999,NA,NA,1ZIABC011999-05,NCI:1349480\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857458 (contact),"YOUNG, RYAN  (contact)",NA,NA,NA,Anemia;ARID1A gene;B-Lymphocytes;Biochemical;Biology;Blood;bone loss;Bone Marrow;Calcium;cancer diagnosis;cell growth;Cell Line;Cell Survival;Cells;Cellular biology;Cessation of life;Chromatin Remodeling Factor;Clinical;cofactor;Collaborations;conditional knockout;CRISPR screen;debilitating symptom;Dedications;design;Development;Disease;effective therapy;Essential Genes;experience;experimental study;Fracture;Future;Genes;Genetic Heterogeneity;Genetic Transcription;Goals;Growth;high risk;Human;Image;Immunity;improved;In Vitro;in vivo;inhibitor;IRF4 gene;Knock-in;Label;loss of function mutation;Malignant - descriptor;Malignant Neoplasms;Methods;Multiple Myeloma;Mus;Mutation;novel;novel therapeutics;Oncogenic;Pathway interactions;Patients;Pharmaceutical Preparations;plasma cell development;Plasma Cells;Pre-Clinical Model;Proteins;proteogenomics;Refractory;Relapse;Reporter;Research;Resistance;Resistance development;risk minimization;Role;Signal Transduction;SMARCA2 gene;SWI/SNF Family Complex;Symptoms;Therapeutic;therapeutic target;therapy resistant;tool;Translating;tumor;Tumor Suppressor Proteins;Variant,Identifying novel modes of oncogenic signaling in multiple myeloma,11999,NA,NA,NA,NA,5,NA,NA,1349480,NA
11188345,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012001,NA,NA,1ZIABC012001-05,NCI:326315\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162141 (contact),"RAJAN, ARUN  (contact)",NA,NA,NA,Adverse event;Aftercare;Cells;cohort;Disease;Enrollment;Epithelium;Evaluation;Immune;objective response rate;partial response;participant enrollment;Patients;phase II trial;programmed cell death ligand 1;Progression-Free Survivals;Recurrence;Refractory;Relapse;response;Safety;Thymic Carcinoma;Thymoma;Thymus Gland,Phase II Trial of Bintrafusp Alfa in Subjects with Thymoma and Thymic Carcinoma,12001,NA,NA,NA,NA,5,NA,NA,326315,NA
11188346,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012006,NA,NA,1ZIABC012006-05,NCI:981284\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857465 (contact),"MURGAI, MEERA  (contact)",NA,NA,NA,Address;Behavior;blood vessel development;Blood Vessels;cell growth;Cell Survival;cell type;Cells;Cessation of life;CSPG4 gene;Data;Distant;Epigenetic Process;Extracellular Matrix;Genetic;Goals;Growth;Hematopoietic;improved;Malignant Neoplasms;Mediating;Modeling;Molecular;Neoplasm Metastasis;neoplastic cell;Nodule;novel therapeutics;Organ;Pathogenesis;Pathogenicity;Pathway interactions;Patients;Pericytes;Phenotype;pluripotency;Population;Primary Neoplasm;Process;Production;Proliferating;recruit;response;Role;Site;Smooth Muscle Myocytes;Stromal Cells;Therapeutic;therapeutic development;Tissues;transcription factor;tumor;Vascular Smooth Muscle;Work,Perivascular plasticity in metastatic microenvironments,12006,NA,NA,NA,NA,5,NA,NA,981284,NA
11188347,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012007,NA,NA,1ZIABC012007-05,NCI:408425\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201697 (contact),"ALTAN-BONNET, GREGOIRE  (contact)",NA,NA,NA,"antagonist;Antigen Presentation;Antigens;betacoronavirus;Cells;Collaborations;Coronavirus;Cross Presentation;Defect;Discrimination;Dose;Experimental Models;Feedback;Goals;Human;IFIH1;Immune;Immune response;Immunology;interest;Intramural Research Program;Kinetics;Life Cycle Stages;Ligands;Modeling;Monitor;National Heart, Lung, and Blood Institute;Natural Killer Cells;Nature;Pathway interactions;Phenotype;Publications;response;RNA;T-Cell Activation;Testing;viral detection;viral RNA;Virus;Virus Diseases",Dynamics of viral infection,12007,NA,NA,NA,NA,5,NA,NA,408425,NA
11188348,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012008,NA,NA,1ZIABC012008-05,NCI:552519\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857468 (contact),"ZHAO, CHEN  (contact)",NA,NA,NA,aerosolized;Animal Model;Antibiotics;Bacteria;Cells;Clinical Trials;Collaborations;Complex;Enrollment;Goals;Immune;lung microbiota;metatranscriptomics;Methods;Microbe;microbiome;mouse model;neoplastic cell;Non-Small-Cell Lung Carcinoma;novel;Pathology;patient prognosis;Patients;pembrolizumab;Pennsylvania;Plants;preservation;Resolution;Sampling;Spatial Distribution;tumor;tumor growth;tumor microenvironment;Tumor Promotion;Universities,Study interactions between lung microbiota and immune cells in NSCLC,12008,NA,NA,NA,NA,5,NA,NA,552519,NA
11188349,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012009,NA,NA,1ZIABC012009-05,NCI:247461\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857470 (contact),"DAVIES, ERIN  (contact)",NA,NA,NA,Adolescent;Adult;adult stem cell;Anatomy;Animal Model;Animals;Anterior;beta catenin;blastema;cell type;Cells;Competence;Cues;Data;Defect;Development;Embryo;Embryonic Development;Failure;Genetic;Genetic Transcription;Genomics;hatching;Head;inhibitor;Injury;irradiation;knock-down;Manuscripts;Natural regeneration;Organogenesis;Pathway interactions;Pattern;Planarians;Platyhelminths;Pluripotent Stem Cells;Positioning Attribute;Printing;Production;Property;regenerative;Regenerative engineering;Reporting;Reverse engineering;RNA Interference;Signal Pathway;Source;stem cells;stem-like cell;Structure;System;Tissues;Work;wound,Mechanisms underlying the establishment of whole-body regeneration competence,12009,NA,NA,NA,NA,5,NA,NA,247461,NA
11188350,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012010,NA,NA,1ZIABC012010-05,NCI:1681063\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857472 (contact),"STRACKER, TRAVIS  (contact)",NA,NA,NA,cancer cell;Cancer Model;cancer therapy;cancer type;Candidate Disease Gene;Cell Fate Control;Clinical;CRISPR/Cas technology;Deposition;DNA;DNA Damage;DNA lesion;DNA Sequence Alteration;Genes;Genetic;Genetic Screening;Genomic Instability;Goals;Histones;In Vitro;in vivo;inhibitor;Malignant Breast Neoplasm;Malignant neoplasm of lung;Malignant neoplasm of prostate;Malignant Neoplasms;Methods;Mutation;neoplasm immunotherapy;neoplastic cell;Optics;Pathway interactions;Phosphotransferases;Proliferating;Proteomics;Recurrence;Research;Resistance;response;Role;screening;Series;Signal Pathway;small molecule;small molecule inhibitor;synthetic lethal interaction;targeted cancer therapy;targeted treatment;telomere;Telomere Pathway;Therapeutic Agents;therapy resistant;tumor growth;Work,Targeting the DNA damage response in cancer therapy,12010,NA,NA,NA,NA,5,NA,NA,1681063,NA
11188351,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012014,NA,NA,1ZIABC012014-05,NCI:413285\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9786523 (contact),"KRUG, LAURIE T (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Acute;adaptive immune response;AIDS related cancer;antiretroviral therapy;B cell repertoire;B-Cell Lymphomas;B-Lymphocytes;Cancer Burden;Cancer Etiology;Cause of Death;Cells;chemotherapy;Clinical;Clinical Trials;Codon Nucleotides;Collaborations;Complex;Cyclin-Dependent Kinases;design;Development;Disease;effective therapy;Enrollment;Flow Cytometry;gammaherpesvirus;gene complementation;gene editing technology;gene product;Genes;Goals;Growth;Herpesviridae;Herpesvirus Vaccines;high risk population;HIV;HIV/AIDS;Human Herpesvirus 4;Human Herpesvirus 8;Immune;immune modulating agents;Immune response;Immunotherapy;improved;Individual;Infection;Infection prevention;Innate Immune Response;Intervention;Journals;Kaposi Sarcoma;Laboratories;Lymphoma;Lymphoproliferative Disorders;lytic gene expression;Malignant neoplasm of nasopharynx;Malignant Neoplasms;malignant stomach neoplasm;Methods;Molecular;Morbidity - disease rate;mortality;mouse model;Mus;Mutate;Names;novel;novel vaccines;Oncogenic;pathogen;patient derived xenograft model;patient response;Patients;Peripheral Blood Mononuclear Cell;Persons;pomalidomide;Post-Translational Protein Processing;post-transplant;Pre-Clinical Model;pre-clinical research;primary effusion lymphoma;Process;programs;Publishing;recombinant virus;Research;Resolution;response;Risk;Sampling;small molecule inhibitor;standard care;Sterically Stabilized Liposome;success;T cell response;T-Lymphocyte;Testing;therapeutic genome editing;Therapeutic Intervention;tumor;tumorigenesis;Ubiquitination;Vaccination;vaccine candidate;vaccine formulation;vaccine strategy;Vaccines;Viral Genes;Viral Load result;Virus;Virus Replication,Novel interventions for gammaherpesvirus infection and AIDS-Related Malignancies,12014,NA,NA,NA,NA,5,NA,NA,413285,NA
11188352,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012015,NA,NA,1ZIABC012015-05,NCI:724002\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10105415 (contact),"LAZZERINI DENCHI, EROS  (contact)",NA,NA,NA,Apoptosis;cancer cell;Cell Cycle Arrest;Cell Proliferation;Cells;Chromosomes;Defect;DNA Damage;functional genomics;Gene Targeting;Genomic approach;Genomic Instability;Goals;Mammalian Cell;Mouse Embryonic Stem Cells;novel;Pathway interactions;Process;Property;Research Project Grants;response;stem cells;telomere,Mechanism of end protection in stem cells,12015,NA,NA,NA,NA,5,NA,NA,724002,NA
11188353,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012016,NA,NA,1ZIABC012016-05,NCI:230127\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10686755 (contact),"MERINO, MARIA  (contact)",NA,NA,NA,antigen-specific T cells;Benign;cancer cell;cancer therapy;CD3 Antigens;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;CD8B1 gene;cell type;Cells;cytotoxic;Data;density;Development;Drug Targeting;Evaluation;Flow Cytometry;Frequencies;immune cell infiltrate;Immune response;Immunotherapy;improved;Infiltration;intraepithelial;Kidney Neoplasms;Malignant - descriptor;Malignant neoplasm of lung;Malignant neoplasm of urinary bladder;Malignant Neoplasms;Memory;Molecular;Outcome;Pattern;Population;predicting response;prognostic;Renal Carcinoma;Renal Cell Carcinoma;response;Skin Cancer;Solid Neoplasm;Spatial Distribution;Structure;T-Lymphocyte;Testing;Tissues;tumor;Tumor Antigens;Tumor-infiltrating immune cells;Tumor-Infiltrating Lymphocytes,Immunotherapy of kidney cancer. Where do the T lymphocytes go in kidney cancer?,12016,NA,NA,NA,NA,5,NA,NA,230127,NA
11188354,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012017,NA,NA,1ZIABC012017-05,NCI:747993\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14732039 (contact),"PAVLETIC, STEVEN  (contact)",NA,NA,NA,Acute Myelocytic Leukemia;Adult;Allogenic;CCR;Child;Childhood Leukemia;Clinic;Clinical;Clinical Research;Clonal Hematopoietic Stem Cell;Collection;comorbidity;curative treatments;cytopenia;Dedications;Development;Diagnosis;Disease;Dysmyelopoietic Syndromes;Dysplasia;Elderly;genotoxicity;Hematopoietic Stem Cell Transplantation;Hereditary Disease;high risk;Immunotherapy;Individual;Ineffective Hematopoiesis;Laboratory Research;leukemia;Malignant - descriptor;Malignant Neoplasms;Marrow;Mission;Mutation;Myeloproliferative disease;Natural History;novel therapeutics;organizational structure;Partial Remission;Pathogenesis;Patients;peripheral blood;Pharmaceutical Chemistry;prevent;programs;Progressive Disease;Proteomics;Research Personnel;RUNX1 gene;Science;Secondary Myelodysplastic Syndrome;Therapeutic;Translating;Translations;United States National Institutes of Health;Vision;young adult,NIH Myeloid Malignancy Program,12017,NA,NA,NA,NA,5,NA,NA,747993,NA
11188355,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012018,NA,NA,1ZIABC012018-05,NCI:544042\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692585 (contact),"MITSUYA, HIROAKI  (contact)",NA,NA,NA,2019-nCoV;acquired drug resistance;Amino Acid Substitution;Amino Acids;Anti-viral Agents;Anti-viral resistance;benzothiazole;Binding;Biological Assay;Cell Culture Techniques;Cells;Clinical;covalent bond;COVID-19;COVID-19 susceptibility;COVID-19 therapeutics;COVID-19 treatment;Data;design;Development;Dimerization;Drug resistance;drug resistance development;Educational process of instructing;Enzymes;experimental study;FDA Emergency Use Authorization;Fluorine;global health;HIV;Hospitalization;Immunocompromised Host;In Vitro;inhibitor;K-18 conjugate;Literature;Mass Spectrum Analysis;Metabolism;molnupiravir;Mus;Mutation;Nature;nirmatrelvir;novel;Oral;Oral Administration;pandemic disease;Patients;Peptide Hydrolases;Pharmaceutical Preparations;Pharmacotherapy;Phenotype;Predisposition;Prophylactic treatment;Protease Inhibitor;Recombinants;remdesivir;Reporting;Resistance;Ritonavir;RNA Polymerase Inhibitor;RNA Viruses;RNA-Directed RNA Polymerase;Roentgen Rays;SARS coronavirus;SARS-CoV-2 B.1.1.529;SARS-CoV-2 infection;SARS-CoV-2 variant;Scanning;severe COVID-19;small molecule;Testing;theories;Therapeutic;therapeutic development;Transcript;Transgenic Mice;treatment duration;Treatment Protocols;Tube;Variant;Viral;viral fitness;Virus;Virus Inhibitors;Virus Receptors,Development of therapeutics for SARS-CoV-2 infection,12018,NA,NA,NA,NA,5,NA,NA,544042,NA
11188356,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012019,NA,NA,1ZIABC012019-05,NCI:946070\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857482 (contact),"GONATOPOULOS-POURNATZIS, THOMAS  (contact)",NA,NA,NA,3&apos; Splice Site;Address;Alternative Splicing;Automobile Driving;bioinformatics tool;Cell Physiology;Clustered Regularly Interspaced Short Palindromic Repeats;Code;Complex;Dedications;deep sequencing;Disease;endoplasmic reticulum stress;Event;Exons;EZH2 gene;functional genomics;Genes;Genetic;Genome;genome-wide;Goals;Human;innovation;interdisciplinary approach;Introns;Knowledge;Link;Malignant Neoplasms;Maps;Mechanics;Messenger RNA;Molecular;Molecular Analysis;Molecular Biology;Molecular Target;Monitor;mRNA Precursor;Neurodevelopmental Disorder;novel;Outcome;Pathogenesis;Pathway interactions;Phenotype;Process;Progeria;programs;Protein Isoforms;Proteins;Regulation;Regulatory Pathway;Reporter;Research;response;RNA;RNA Splicing;RNA-Binding Proteins;Role;Sampling;Signal Transduction;Syndrome;Techniques;Technology;transcriptome;XBP1 gene,Map Novel Regulatory Networks that Control Alternative Splicing,12019,NA,NA,NA,NA,5,NA,NA,946070,NA
11188357,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012021,NA,NA,1ZIABC012021-05,NCI:1444994\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857484 (contact),"WOLF, MATTHEW  (contact)",NA,NA,NA,3-Dimensional;anti-tumor immune response;Area;Biocompatible Materials;Biological Response Modifiers;cancer cell differentiation;cancer immunotherapeutics;cancer immunotherapy;Cancer Patient;cancer therapy;Cancer Vaccines;Chemicals;Collagen;Drug resistance;Engineering;Environment;Excision;Extracellular Matrix;fighting;Goals;Immune;Immune response;Immune system;Immunity;Immunologic Adjuvants;Immunologic Stimulation;Immunooncology;immunoregulation;Immunotherapy;Impaired wound healing;in vivo;Maintenance;Malignant Neoplasms;Medicine;Modeling;Molecular;multidisciplinary;next generation;Organoids;Patients;Plastics;Process;Regenerative Medicine;Reporting;Role;scaffold;Science;Solid Neoplasm;Surgical Models;System;Therapeutic;Tissue Engineering;Tissues;tool;tumor;tumor immunology;vaccine immunotherapy;wound healing,Cancer Biomaterials Engineering,12021,NA,NA,NA,NA,5,NA,NA,1444994,NA
11188358,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012024,NA,NA,1ZIABC012024-04,NCI:351718\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10202830 (contact),"LEE, KYUNG  (contact)",NA,NA,NA,Acidic Region;Acquired Immunodeficiency Syndrome;Affinity Chromatography;Aneuploidy;Animal Model;Automobile Driving;Binding;Biochemical;Biological;Biological Assay;Blood;C-terminal;carcinogenesis;CD4 Positive T Lymphocytes;Cell Cycle;Cell model;Cells;cellular targeting;Centrioles;Centrosome;chromosome missegregation;comorbidity;Complex;Cryoelectron Microscopy;Cultured Cells;Development;Elements;Event;Exhibits;Genome Stability;Goals;high risk;HIV-1;Human;Immune system;Incidence;Infection;Investigation;Link;Malignant Neoplasms;Molecular;mutant;Nature;novel strategies;Organelles;Pathogenesis;Persons;Phosphotransferases;Physiological;PLK1 gene;Predisposition;Procentriole;Process;Proteins;Proteomics;Research;Risk;Role;scaffold;Shapes;Structure;T-Cell Lymphoma;tumorigenesis;ubiquitin-protein ligase;X-Ray Crystallography,Unraveling the molecular link between HIVAIDS and cancer,12024,NA,NA,NA,NA,4,NA,NA,351718,NA
11188359,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012025,NA,NA,1ZIABC012025-04,NCI:5494609\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692619 (contact),"FRANCHINI, GENOVEFFA  (contact)",NA,NA,NA,Adenosine;Adjuvant;aluminum sulfate;ALVAC;Antibodies;antibody-dependent cell cytotoxicity;Antigens;Apoptotic;beta pleated sheet;Binding;Blood;booster vaccine;CCR5 gene;CD4 Positive T Lymphocytes;Cell Physiology;Cells;Clinic;Communicable Diseases;comparison control;Cytotoxic T-Lymphocytes;Data;Dendritic Cells;design;DNA;DNA Vaccines;efficacy trial;Engineering;Epigenetic Process;Epithelium;Epitopes;Exposure to;Female;Government;gp160;Grant;HIV;HIV envelope protein;HIV Envelope Protein gp120;HIV vaccine;Human;Hydroxides;IL17 gene;Immune response;Immune system;Immunity;Immunologics;Infection;infection risk;Inflammation;Inflammatory;inhibitor;Intellectual Property;Interleukin-10;Invertebrates;Investigation;Lead;Legal patent;Licensing;Link;liposomal formulation;Macaca;Macrophage;Malignant Neoplasms;Mediating;Memory;Modeling;Molecular Conformation;Monoclonal Antibodies;monocyte;Mucous Membrane;Myeloid Cells;Natural Immunity;natural killer cell protein 44-kDa;Natural Killer Cells;Necrosis;neutralizing antibody;nonhuman primate;novel;novel vaccines;Nucleocapsid;pathogen;Phase;prevent;Private Sector;Production;programs;Proteins;QS21;Recombinants;Regimen;response;Rest;Risk;SIV;Surface;synergism;T cell response;T-Cell Activation;Testing;Thailand;Training;trait;Translating;user-friendly;Vaccinated;Vaccination;vaccine efficacy;vaccine platform;vaccine trial;Vaccines;Vaginal Gel;Vaginal Ring;virucide;Virus;Virus Diseases;Zinc,Phase I HIV vaccine trial with DNAALVAC-HIV gp120 delta V1 vaccines,12025,NA,NA,NA,NA,4,NA,NA,5494609,NA
11188360,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012033,NA,NA,1ZIABC012033-04,NCI:946070\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857482 (contact),"GONATOPOULOS-POURNATZIS, THOMAS  (contact)",NA,NA,NA,Address;Alternative Splicing;Arginine;bioinformatics tool;Biological Assay;Cell Physiology;Cells;Clinical;clinically relevant;Code;Complex;Dedications;Disease;Engineering;Event;Exhibits;Exons;fitness;functional genomics;Gene Expression;Genes;Genetic;Genome;genome-wide;genomic platform;genomic tools;Genotoxic Stress;innovation;interdisciplinary approach;Investigation;Malignant Neoplasms;Messenger RNA;Modeling;Molecular Analysis;Molecular Target;Mutation;Neurodevelopmental Disorder;Outcome;Output;Patients;Phenotype;Process;programs;Proliferating;Protein Isoforms;Proteins;Renal Cell Carcinoma;repository;Research;RNA Splicing;screening;Serine;Splice-Site Mutation;Syndrome;TAF1 gene;TAF5 gene;Techniques;Technology;Tertiary Protein Structure;Transcription Initiation,Identify and Characterize Phenotypically Relevant Alternatively Spliced Exons,12033,NA,NA,NA,NA,4,NA,NA,946070,NA
11188361,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012034,NA,NA,1ZIABC012034-04,NCI:286083\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201719 (contact),"WU, CHUAN  (contact)",NA,NA,NA,Biological Response Modifiers;Cells;Chemicals;Communication;Complex;Cues;detection platform;Disease;Endocrine Glands;Enteric Nervous System;Environment;Esthesia;experience;Gastrointestinal Diseases;gut-brain axis;Homeostasis;Host Defense;Immune;Immune system;intestinal barrier;intestinal homeostasis;Intestinal Mucosa;Intestines;Irritable Bowel Syndrome;microbiota;Molecular;Nerve;Nervous System;Neurons;neuroregulation;Neurosecretory Systems;Organ;Physiology;Process;response;Sensory;Signal Transduction;Synaptic Transmission;System;Tissues;Translations;Work,Immune-neuron crosstalk regulates intestinal homeostasis,12034,NA,NA,NA,NA,4,NA,NA,286083,NA
11188362,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012037,NA,NA,1ZIABC012037-04,NCI:1611643\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355621 (contact),"WU, COLIN  (contact)",NA,NA,NA,Address;Apoptotic;Attention;Biochemical;Biogenesis;Biological Assay;Biological Process;Cell Death Induction;Cells;Cellular Stress;Cessation of life;Chemicals;CRISPR screen;Cues;Dissection;DNA Sequence Alteration;Gene Expression;Generations;Genetic Induction;genetic information;genome-wide;Goals;Human;Learning;Life;Mass Spectrum Analysis;Molecular;novel;Operon;Output;Pathway interactions;Process;programs;Proteins;Research;response;Ribosomal DNA;Ribosomal RNA;ribosome profiling;Ribosomes;Stress;System;Techniques;Translations,Noncanonical functions of the ribosome in response to cellular stress,12037,NA,NA,NA,NA,4,NA,NA,1611643,NA
11188363,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012038,NA,NA,1ZIABC012038-04,NCI:9907\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857435 (contact),"MAYER, CHRISTIAN  (contact)",NA,NA,NA,Antibodies;Antibody Response;Biological Assay;cross reactivity;design;Enzyme-Linked Immunosorbent Assay;Goals;Human;improved;Individual;Knowledge;Laboratories;Monkeypox virus;Research;Techniques;Therapeutic;unvaccinated;Vaccinated;Vaccines;Vaccinia;Viral Proteins;Virus,Antibody responses to viruses,12038,NA,NA,NA,NA,4,NA,NA,9907,NA
11188364,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012039,NA,NA,1ZIABC012039-04,NCI:1125614\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355624 (contact),"PAI, SUNG-YUN  (contact)",NA,NA,NA,Active Sites;Allogenic;Antibodies;Area;arm;Autologous;B-Lymphocytes;Bacteria;Blood;Blood donor;Bone Marrow;Boston;Busulfan;Canada;Cell Count;Cell Physiology;Cell Therapy;Cells;Cessation of life;chemotherapy;Child;Codon Nucleotides;conditioning;cytokine;Defect;design;Development;Disease;Dominant-Negative Mutation;Dose;Early Diagnosis;Enrollment;fighting;fungus;gene therapy;Gene therapy trial;Generations;Genes;Genetic;Goals;graft vs host disease;Hematopoietic Stem Cell Transplantation;Human Herpesvirus 4;Human Papillomavirus;IL2RG gene;Immune;immune reconstitution;Immune system;immunodeficiency;Immunoglobulin Gene Rearrangement;Immunoglobulins;Immunologics;In Vitro;Infant;Infection;Institution;JAK3 gene;Lead;Lentivirus Vector;Longevity;Lymphocyte Function;Lymphoma;Malignant Neoplasms;microorganism;Molecular;Morbidity - disease rate;mortality;mutant;Mutation;Natural Killer Cells;Oncogenic Viruses;Opportunistic Infections;Organism;participant enrollment;Patients;Pediatric Hospitals;Peptide Elongation Factor 1;peripheral blood;Persons;Plasmablast;Predisposition;prevent;Prior Chemotherapy;Production;promoter;Proteins;Protocols documentation;Randomized;Regimen;response;Risk;Safety;Sampling;Severe Combined Immunodeficiency;Signal Transduction;Site;standard care;System;T cell reconstitution;T-Cell Receptor Genes;T-Lymphocyte;Testing;Tissues;Toxic effect;Transgenes;tumor;Umbilical Cord Blood;United States;Viral;Virus;X-Linked Severe Combined Immunodeficiency,Pathobiology and treatment of patients with severe combined immunodeficiency,12039,NA,NA,NA,NA,4,NA,NA,1125614,NA
11188365,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012040,NA,NA,1ZIABC012040-04,NCI:2188697\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355624 (contact),"PAI, SUNG-YUN  (contact)",NA,NA,NA,Actins;Affect;Alkylating Agents;Allogenic;Area;Autoimmunity;Autologous;autosome;B-Lymphocytes;Biology;Blood Platelets;Bone Marrow Purging;Boston;Cell Cycle Kinetics;Cell Lineage;Cell model;Cell Physiology;Cell Therapy;cell type;Cells;Child;Chimerism;Clinical;Clinical Protocols;Clinical Trials;Codon Nucleotides;Complex;conditioning;congenital immunodeficiency;Cytoskeleton;Data;design;Development;Disease;DOCK8 deficiency;Eczema;Engraftment;Enrollment;Food Hypersensitivity;gene therapy;Gene therapy trial;Gene Transfer;Genes;Goals;Health;Hematology;Hematopoietic;Hematopoietic Stem Cell Transplantation;Hereditary Disease;Human;Human Herpesvirus 4;Human Papillomavirus;IgE;Immune;immune function;immune reconstitution;Immunity;immunodeficiency;Immunologic Deficiency Syndromes;improved;In Situ;Infection;Infection prevention;insight;intein;interest;irradiation;Knowledge;Laboratories;Length;Lentivirus Vector;Life;Link;Location;Lymphoma;Malignant Neoplasms;manufacture;monocyte;Mutation;Myeloid Cells;Natural Killer Cells;next generation;novel;novel strategies;Oncogenic Viruses;Outcome;Pathogenesis;Patients;Pattern;pre-clinical;Predisposition;prevent;promoter;Proteins;Publications;Publishing;reconstitution;reduce symptoms;Regimen;Regulatory Element;Severe Combined Immunodeficiency;side effect;Site;Symptoms;T cell regulation;T-Cell Development;T-Lymphocyte;Technology;Testing;Thrombocytopenia;Toxic effect;Trans-Splicing;transduction efficiency;transgene expression;Transgenes;Transplantation;vector;Vertebral column;Viral;Viral Vector;Virus Integration;Wiskott-Aldrich Syndrome;young adult,Pathobiology and treatment of patients with inborn errors of immunity,12040,NA,NA,NA,NA,4,NA,NA,2188697,NA
11188366,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012041,NA,NA,1ZIABC012041-04,NCI:316831\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14280079 (contact),"ALEWINE, CHRISTINE  (contact)",NA,NA,NA,Acinar Cell Carcinoma;Affect;Area;cancer diagnosis;CCR;Cells;chemotherapy;Clinical;Clinical Research;Clinical Trials;Collaborations;Correlative Study;disease model;Engineering;Exocrine pancreas;Extramural Activities;Genetic Transcription;Goals;Histologic;Histology;Human;Immune;improved outcome;inhibitor;Intervention;Malignant neoplasm of pancreas;Molecular;Molecular Profiling;Mus;Natural History;Neoplasm Metastasis;overexpression;Pancreas;pancreatic cancer cells;Pancreatic carcinoma;Pancreatic Ductal Adenocarcinoma;Pancreatic Exocrine Neoplasm;Patient-Focused Outcomes;Patients;Pharmaceutical Preparations;Phase;phase II trial;Phenotype;Poly(ADP-ribose) Polymerase Inhibitor;Pre-Clinical Model;Prognosis;programs;prospective;rare cancer;Reporting;Research;Research Personnel;Sampling;Site;small molecule;Solid Neoplasm;Squamous Differentiation;Testing;Therapeutic;tumor;Variant;Work,Rare Exocrine Tumors of the Pancreas,12041,NA,NA,NA,NA,4,NA,NA,316831,NA
11188367,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012042,NA,NA,1ZIABC012042-04,NCI:300216\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11199937 (contact),"SINGER, DINAH S. (contact)",NA,NA,NA,Binding;Chromatin Loop;Development;DNA Methylation;DNA Modification Process;DNA Sequence Alteration;Elements;Epigenetic Process;fly;Frequencies;Gene Expression;Gene Expression Profile;Gene Expression Regulation;Generations;Genes;Genetic;Genetic Transcription;Genomic Imprinting;Goals;histone modification;in vivo;Inheritance Patterns;insight;Link;Mammals;Mediating;Metabolic;MHC Class I Genes;Modification;Molecular;Mutation;Nucleosomes;Pattern;Phenotype;Plants;programmed cell death protein 1;promoter;Regulation;Reporting;RNA;Stress;Time;Tissues;trait;Trans-Activators;transgenerational epigenetic inheritance;Transgenes;Transgenic Organisms;transmission process;Untranslated RNA,Transgenerational Epigenetic Inheritance Mediated by a Core Promoter Element,12042,NA,NA,NA,NA,4,NA,NA,300216,NA
11188368,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012043,NA,NA,1ZIABC012043-04,NCI:1745039\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355629 (contact),"LEA, SUSAN  (contact)",NA,NA,NA,Antibiotics;Bacteria;Cryoelectron Microscopy;Cytoplasm;Disease;Enzymes;Flagella;Future;Gastrointestinal tract structure;Goals;Health;Helicobacter pylori;Human;Medical;Methods;Microbiology;Molecular;Molecular Conformation;Multiprotein Complexes;Nature;novel;pathogen;Pathway interactions;Process;Protein Conformation;Publishing;Research;Rotation;structural biology;System;Work;X-Ray Crystallography,Structural biology of host-pathogen interactions,12043,NA,NA,NA,NA,4,NA,NA,1745039,NA
11188369,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012045,NA,NA,1ZIABC012045-04,NCI:657016\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355631 (contact),"ISHII, KAZUSA  (contact)",NA,NA,NA,Address;Antigen Presentation;Antigen Targeting;Antigens;B lymphoid malignancy;B-Cell Leukemia;cancer cell;CAR T cell therapy;CD19 gene;CD22 gene;Cell Line;cellular transduction;chimeric antigen receptor;chimeric antigen receptor T cells;clinical translation;cross reactivity;cytokine;Data;Disease;Disease remission;disorder subtype;early phase clinical trial;engineered T cells;Goals;Hematologic Neoplasms;Hematological Disease;Hematology;HLA-A gene;HLA-A2 Antigen;Immunotherapeutic agent;in vivo;Inflammatory;interest;International;Legal patent;leukemia;leukemia/lymphoma;Leukemic Cell;Lymphoma;Lymphoma cell;Malignant lymphoid neoplasm;manufacture;Mediating;novel;Oncology;Patients;Peptide Fragments;pre-clinical;Process;programs;Resistance;resistance mechanism;Risk;Safety;Science;screening;Surface Antigens;synergism;systemic inflammatory response;T cell therapy;T-Cell Receptor;T-Cell Receptor Therapy;T-Lymphocyte;Testing;Toxic effect;tumor;Tumor Antigens;Tumor Escape;vector;Virus;Xenograft Model,TCR engineered T cell therapies for hematologic malignancies,12045,NA,NA,NA,NA,4,NA,NA,657016,NA
11188370,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012046,NA,NA,1ZIABC012046-04,NCI:921619\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8108820 (contact),"THIELE, CAROL J (contact)",NA,NA,NA,Address;Affect;Automobile Driving;Bar Codes;Binding;Biological Models;Blood Vessels;Cell Line;Cell Therapy;cell type;Cells;Companions;Complex;DNA Sequence Alteration;DNA sequencing;Drug Screening;Ecosystem;Environment;Epigenetic Process;Evolution;Genetic;Genetic study;Genomics;Growth;Heterogeneity;high risk;Immune;immunoregulation;In Vitro;in vitro Model;in vivo Model;insight;interest;Intervention;Modeling;Molecular;Mus;Mutation;Nature;Neoplasm Metastasis;neoplastic cell;neuroblast;Neuroblastoma;Normal tissue morphology;novel;Phenotype;Population Heterogeneity;pressure;prevent;Proteomics;Refractory;Relapse;Research Personnel;response;Saint Jude Children&apos;s Research Hospital;SCID Beige Mouse;Serum;single cell ATAC-seq;single-cell RNA sequencing;targeted treatment;Testing;Therapeutic;Therapeutic Intervention;therapeutically effective;therapy resistant;Tissues;transcriptome sequencing;treatment response;tumor;tumor growth;tumor heterogeneity;tumor microenvironment;tumor progression;Tumor Subtype;tumorigenesis;Xenograft Model,Neuroblastoma Tumor Microenvironment: tumor growth and immune regulation,12046,NA,NA,NA,NA,4,NA,NA,921619,NA
11188371,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012047,NA,NA,1ZIABC012047-04,NCI:769723\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10270608 (contact),"ZIEGELBAUER, JOSEPH  (contact)",NA,NA,NA,Affect;Africa South of the Sahara;angiogenesis;Anti-Inflammatory Agents;Antigen Presentation;Area;Automobile Driving;B-Cell Lymphomas;B-Cell NonHodgkins Lymphoma;B-Lymphocytes;Biological Assay;Biological Markers;Biopsy;CD4 Positive T Lymphocytes;Cell Count;Cell Culture Techniques;cell killing;Cell model;cell type;Cells;Characteristics;chemokine;chemotherapy;Clinical;clinically relevant;co-infection;Collaborations;Cutaneous;CXCL10 gene;cytokine;Data;Detection;Development;Diagnosis;Diagnostic Procedure;differential expression;Disease;Disease remission;Endothelial Cells;Environment;Etiology;experimental study;FLT4 gene;gastrointestinal;Gastrointestinal tract structure;Gene Expression;Gene Expression Profile;Genes;Genetic Transcription;Goals;healing;Heterogeneity;HIV;HIV Infections;HIV Seropositivity;Human;Human Herpesvirus 4;Human Herpesvirus 8;IL6 gene;Immune;Immune response;Immunocompromised Host;immunodeficiency;improved;In Vitro;Individual;Infection;Infiltration;Inflammation;Inflammatory;Inflammatory Response Pathway;insight;Interferon Type II;Interleukin-10;Investigation;Kaposi Sarcoma;KDR gene;Knowledge;Lesion;Location;Lung;Lymphatic Endothelial Cells;Lymphoproliferative Disorders;Lytic;Macrophage;Malignant Neoplasms;memory CD4 T lymphocyte;Methods;Morbidity - disease rate;mortality;Multicentric Angiofollicular Lymphoid Hyperplasia;Normal tissue morphology;novel diagnostics;novel therapeutic intervention;organ transplant recipient;Participant;Pathogenesis;Pathologic;Patients;Pattern;Persons;Phagocytosis;Play;Population;post-transplant;preference;primary effusion lymphoma;Production;progression risk;Publishing;Regulatory T-Lymphocyte;Rest;Risk;RNA;Role;Sampling;Site;Skin;Skin Kaposi&apos;s Sarcoma;skin lesion;Specimen;STC1 gene;targeted treatment;Therapeutic;Tissues;Transcript;transcriptome sequencing;treatment strategy;tumor;tumor microenvironment;tumorigenesis;United States;Vascular Endothelial Growth Factor Receptor-3;Viral;Viral Genes;Viral Load result;Virion;Virus;virus host interaction,Virus host interactions in clinical samples,12047,NA,NA,NA,NA,4,NA,NA,769723,NA
11188372,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012052,NA,NA,1ZIABC012052-04,NCI:781981\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9414470 (contact),"GOTTESMAN, MICHAEL  (contact)",NA,NA,NA,ABCB1 gene;ABCG2 gene;Adult;Antibodies;Astrocytes;ATP-Binding Cassette Transporters;Biological Assay;Biological Models;Blood;Blood - brain barrier anatomy;blood-brain barrier crossing;blood-brain barrier permeabilization;Brain;brain endothelial cell;brain tissue;Caring;Categories;Cells;Cerebrovascular system;coelenterazine;Collaborations;Consumption;cytotoxicity;Data;deep ocean;Drug Delivery Systems;Drug or chemical Tissue Distribution;Drug resistance;Firefly Luciferases;Fishes;Gastrointestinal tract structure;Generations;Genes;Glial Fibrillary Acidic Protein;Goals;high throughput analysis;high throughput screening;Homologous Gene;Human;improved;In Situ Hybridization;inhibitor;Kidney;Knock-out;Knockout Mice;Light;Liver;Luciferases;luciferin;Malignant Neoplasms;Measures;model organism;Modeling;Monitor;mouse model;Mus;nanoluciferase;National Center for Advancing Translational Sciences;Nature;novel;Orthologous Gene;Pattern;Penetration;Permeability;Placenta;Play;prevent;Promega;promoter;Property;Reaction;Resistance;Role;Shrimp;Signal Transduction;Site;Spinal Cord;Stains;Study models;Substrate Specificity;System;Testing;Time;Transgenic Organisms;Variant;Water;Zebrafish,Zebrafish model of blood-brain barrier to improve drug delivery to the brain,12052,NA,NA,NA,NA,4,NA,NA,781981,NA
11188373,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012053,NA,NA,1ZIABC012053-04,NCI:143965\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857447 (contact),"ROPER, NITIN  (contact)",NA,NA,NA,Adrenocortical Carcinoma;biobank;Cell Line;Clinic;Drug Screening;drug testing;drug use screening;Future;Genomics;Goals;molecular subtypes;Neuroendocrine Tumors;novel therapeutic intervention;novel therapeutics;Organoids;Patients;pharmacologic;Pre-Clinical Model;Prognosis;The Cancer Genome Atlas;Therapeutic;Therapeutic Studies;Translating;tumor;tumor heterogeneity,Developing ACC patient-derived organoids to identify therapeutic vulnerabilities,12053,NA,NA,NA,NA,4,NA,NA,143965,NA
11188374,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012054,NA,NA,1ZIABC012054-04,NCI:1300408\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6572144 (contact),"BERZOFSKY, JAY A (contact)",NA,NA,NA,Acute;Adjuvant;Affect;Affinity;Agonist;aluminum sulfate;ALVAC;Animals;anti-PD-L1;Antibiotics;Antibodies;Antigens;Avidity;Back;base;Binding;Blood Platelets;cancer immunotherapy;Cancer Vaccines;carboxypeptidase C;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;CD8B1 gene;Cell Aggregation;Cell Line;Cells;chemokine receptor;Citrobacter;Clinical Trials;Colitis;Collaborations;Colon;Cross Presentation;cytokine;Cytoprotection;Cytotoxic T-Lymphocytes;Data;design;DNA;Dose;Endosomes;Epigenetic Process;Epitopes;Exclusion;Fertilization;Funding;Genes;Genetic Transcription;Glycocalyx;Goals;gp160;Granulocyte-Macrophage Colony-Stimulating Factor;gut microbiota;Gut Mucosa;Helper-Inducer T-Lymphocyte;Histocompatibility;HIV;HIV Envelope Protein gp120;HIV Infections;HIV vaccine;HIV/SIV vaccine;Home;Homing;Human;IL17 gene;Immune;immune activation;Immune checkpoint inhibitor;Immune response;Immunity;Immunization;Immunodominant Epitopes;Immunoglobulin A;Immunology;Immunotherapy;imprint;improved;in vivo;Infection;Interferon Type II;Interferons;Interleukin-12;Interleukin-15;interleukin-21;invention;knock-down;Large Intestinal Mucosa;Large Intestine;Ligands;lymphoid structures;Macaca;Malignant Neoplasms;Melanoma patient;Memory;microbicide;microbiome;Modeling;Modification;monocyte;Mucosal Immunity;mucosal vaccine;Mucous Membrane;Mus;Myeloid-derived suppressor cells;nanoparticle;nanoparticle delivery;Natural Immunity;novel;novel strategies;Oral;OVA-8;PF4 Gene;Phase;Plasma Cells;Plasmablast;PPBP gene;Predisposition;prevent;Production;Proteins;receptor expression;Rectum;Regulation;Regulatory T-Lymphocyte;Research;response;Risk;Role;Safety;simian human immunodeficiency virus;single-cell RNA sequencing;Site;SIV;SIV Vaccines;Small Intestines;STAT1 gene;Stomach;Structure;Surface;synergism;T cell response;T-Cell Depletion;T-Lymphocyte;Testing;Textbooks;Time;TLR3 gene;Toll-like receptors;trafficking;Training;transcriptome sequencing;Transforming Growth Factor beta;Transgenic Mice;Translating;Translations;transmission process;Tretinoin;Vaccine Adjuvant;vaccine delivery;Vaccine Design;vaccine efficacy;vaccine immunogenicity;vaccine strategy;Vaccines;Vaccinia virus;Vagina;vaginal mucosa;Viral;Viral Antigens;viral detection;Viral Load result;viral transmission;Virus;Virus Diseases;Work,Vaccine strategies for HIVAIDS,12054,NA,NA,NA,NA,4,NA,NA,1300408,NA
11188375,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012055,NA,NA,1ZIABC012055-04,NCI:296953\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857470 (contact),"DAVIES, ERIN  (contact)",NA,NA,NA,Address;Adult;Algorithms;Anatomy;Animals;Atlases;Behavior;Bioinformatics;Biological Markers;CCR;cell fate specification;Cell Lineage;cell type;Cells;comparative;Data;Data Analyses;Data Set;Development;differential expression;digital;Dissociation;Dyes;Embryonic Development;Female;Fluorescence-Activated Cell Sorting;Gene Expression;Genes;Genetic Transcription;Germ Cells;germline stem cells;Heterogeneity;Homeostasis;In Situ Hybridization;in vivo;Laboratories;Lead;male;marine;Morphology;Natural regeneration;Nuclear;Platyhelminths;Pluripotent Stem Cells;Postdoctoral Fellow;Postembryonic;Preparation;programs;Protocols documentation;regenerative;Regulation;Reporting;Reproductive system;research facility;Resources;Sampling;Scientist;Sexual Maturation;single-cell RNA sequencing;Specific qualifier value;Stains;System;Technology;Tissue-Specific Gene Expression;Tissues;transcriptome sequencing;Validation;Work,Anatomical and gene expression resource for Macrostomum lignano,12055,NA,NA,NA,NA,4,NA,NA,296953,NA
11188376,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012056,NA,NA,1ZIABC012056-04,NCI:1465199\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355639 (contact),"MCEACHRON, TROY  (contact)",NA,NA,NA,Adolescent;Area;ATAC-seq;Automobile Driving;Biological Process;Bone neoplasms;Cell Nucleus;Cells;cellular targeting;Childhood;Clinical Research;clinical translation;Complex;CRISPR interference;CRISPR-mediated transcriptional activation;cytotoxic;Data;Data Analyses;data integration;Diagnosis;Disease;disease model;Disease Progression;DNA Sequence Alteration;Exclusion;Genetic;Genomics;Growth;Heterogeneity;Immune Evasion;Immune response;immunoregulation;Immunosuppression;Immunotherapeutic agent;Immunotherapy;Individual;Infiltration;Inflammatory;Lesion;Localized Disease;Lung;Lymphocyte;Lymphocytic Infiltrate;Medical;Metastatic Osteosarcoma;Metastatic to;Modality;Molecular;Molecular Target;mouse model;Neoplasm Metastasis;neoplastic cell;Non-Malignant;Nonmetastatic;Osteosarcoma;Pathway interactions;Patients;pharmacologic;Population;Process;Proteomics;Research;response;Specimen;Supporting Cell;Survival Rate;Therapeutic;Therapeutic Agents;therapy resistant;Tissues;transcriptome sequencing;transcriptomics;Treatment Efficacy;tumor;young adult,Identification of immune evasion mechanisms in the osteosarcoma microenvironment,12056,NA,NA,NA,NA,4,NA,NA,1465199,NA
11188377,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012057,NA,NA,1ZIABC012057-04,NCI:183850\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355641 (contact),"RAJAGOPAL, PADMA  (contact)",NA,NA,NA,Algorithms;American Association of Cancer Research;Biological;brca gene;BRCA mutations;cancer clinical trial;cancer type;Cell Line;Cell Survival;Cells;Cessation of life;chemotherapy;Clinical;Clinical Data;Clinical Trials;clinically relevant;Code;Computational algorithm;Confidence Intervals;Data;Data Set;Dependence;Disease;Disease-Free Survival;Drug Targeting;Eligibility Determination;ERBB2 gene;Event;evidence based guidelines;Gene Expression;gene interaction;Genes;Genetic;genetic testing;Germ Lines;Goals;Guidelines;hazard;Immunotherapy;immunotherapy trials;improved;In Vitro;in vivo;Individual;large scale data;Lethal Genes;Literature;Malignant Breast Neoplasm;Malignant Neoplasms;Manuscripts;Maps;Mediating;mutation carrier;Names;National Comprehensive Cancer Network;olympia;oncotype;overtreatment;patient response;Patients;Performance;Phylogenetic Analysis;placebo group;Poly(ADP-ribose) Polymerase Inhibitor;Population;precision oncology;predicting response;Prediction of Response to Therapy;preservation;prognostic value;prognostication;Proteins;Recommendation;Regimen;responders and non-responders;response;Reverse Transcriptase Polymerase Chain Reaction;RNA;Step Tests;symposium;targeted therapy trials;targeted treatment;Testing;Training;transcriptome;transcriptome sequencing;treatment responders;triple-negative invasive breast carcinoma;Validation;Work,Leveraging RNA and synthetic lethality in germline BRCA-mut breast cancer,12057,NA,NA,NA,NA,4,NA,NA,183850,NA
11188378,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012058,NA,NA,1ZIABC012058-04,NCI:183850\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355641 (contact),"RAJAGOPAL, PADMA  (contact)",NA,NA,NA,advanced breast cancer;advanced disease;Algorithms;Biological Markers;Biopsy;cancer clinical trial;CCR;Characteristics;Clinical;Clinical Data;Clinical Trials;cohort;Consent;Data;Death Rate;Disease;DNA;DNA sequencing;Enrollment;exome;Face;FDA approved;Frequencies;Frustration;Funding;genomic data;Germ Lines;Guidelines;Immune Sera;Immunotherapy;Institutional Review Boards;Label;Malignant Breast Neoplasm;Metastatic breast cancer;Methylation;molecular pathology;Mutation;objective response rate;open label;Participant;Patient Outcomes Assessments;patient population;patient subsets;Patients;Performance;peripheral blood;precision oncology;Progression-Free Survivals;Recommendation;Refractory;response;Review Committee;Risk Assessment;RNA;Symptoms;targeted treatment;Therapeutic;Tissues;transcriptome sequencing;transcriptomics;Translational Research;Treatment-related toxicity;triple-negative invasive breast carcinoma;tumor;tumor DNA;tumor microenvironment,Identifying Treatment Options using RNA-Based Synthetic Lethality and Rescue,12058,NA,NA,NA,NA,4,NA,NA,183850,NA
11188379,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012059,NA,NA,1ZIABC012059-04,NCI:858635\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355644 (contact),"NELLAN, ANANDANI  (contact)",NA,NA,NA,Address;Affect;Antigen Targeting;Antigens;Brain Neoplasms;cancer cell;cancer infiltrating T cells;CAR T cell therapy;Cause of Death;CCL2 gene;Cell secretion;Central Nervous System Neoplasms;chemokine;chemotherapy;Child;Childhood Brain Neoplasm;chimeric antigen receptor;chimeric antigen receptor T cells;Clinical Trials;combinatorial;Communication;cytokine;Cytotoxic Chemotherapy;cytotoxicity;Down-Regulation;Effectiveness;effector T cell;Ependymoma;ERBB2 gene;Excision;experience;extracellular;falls;Fourth ventricle structure;Generations;Genes;Genetic Transcription;Harvest;Hematologic Neoplasms;Heterogeneity;high risk;high risk population;immune activation;Immune system;Immunosuppression;Immunotherapy;Impairment;Implant;improved;Infiltration;Inflammatory;Inflammatory Infiltrate;Intervention;Intravenous;Learning;Ligands;Malignant Childhood Neoplasm;Malignant Neoplasms;Mediating;Medulloblastoma;monocyte;mouse model;Mus;Nature;neoplastic cell;NF-kappa B;novel;Nuclear Translocation;Operative Surgical Procedures;patient derived xenograft model;Patients;Pediatric Neoplasm;Phenotype;Poly-fluoroalkyl substances;Posterior Fossa;pre-clinical;preclinical efficacy;preclinical study;Proteins;Publishing;Radiation;receptor;Recurrence;Recurrent disease;Refractory;Regulatory T-Lymphocyte;RELA gene;Relapse;Research;Resistance;resistance mechanism;response;Role;Sampling;Serum;Solid Neoplasm;standard of care;Stimulus;success;T-Cell Receptor Therapy;T-Lymphocyte;TNF gene;Trastuzumab;tumor;tumor eradication;tumor heterogeneity;tumor-immune system interactions;young adult,Study of CAR T cells and mechanisms of resistance in pediatric brain tumors,12059,NA,NA,NA,NA,4,NA,NA,858635,NA
11188380,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012062,NA,NA,1ZIABC012062-04,NCI:242025\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858342 (contact),"TURKBEY, BARIS  (contact)",NA,NA,NA,accurate diagnosis;accurate diagnostics;Address;Algorithms;Area;Artificial Intelligence;Biopsy;burden of illness;cancer care;Cancerous;clinical practice;Clinical Trials;diagnostic accuracy;Diagnostic Neoplasm Staging;Evaluation;Focused Ultrasound Therapy;Future;Image;image guided;Image Guided Biopsy;image processing;improved;innovation;Magnetic Resonance Imaging;Malignant neoplasm of prostate;molecular imaging;Morphologic artifacts;novel imaging technique;patient variability;Patient-Focused Outcomes;personalized medicine;Procedures;prostate biopsy;Prostate Cancer therapy;Protocols documentation;Research;Resolution;Screening for Prostate Cancer;System;Techniques;Technology Transfer;Tissues;treatment planning,"Imaging, image guided biopsy and treatment of prostate cancer",12062,NA,NA,NA,NA,4,NA,NA,242025,NA
11188381,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012065,NA,NA,1ZIABC012065-03,NCI:1143096\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858344 (contact),"KANAKRY, JENNIFER  (contact)",NA,NA,NA,Abbreviations;Allogenic;Amendment;American;Antithymoglobulin;Cell Therapy;Cells;Clinical;Clinical Trials;Clinical Trials Data Monitoring Committees;conditioning;Correlative Study;Data Analyses;Disease;disorder control;Distal;efficacy evaluation;Engraftment;Enrollment;Equus caballus;Goals;graft vs host disease;Hematologic Neoplasms;Hematopoietic Stem Cell Transplantation;HIV;immune reconstitution;Infection;Infection Control;Infection prevention;Kinetics;Malignant Neoplasms;Manuscripts;novel;novel strategies;Oral;Organ;Patients;Peripheral;pharmacokinetics and pharmacodynamics;Process;Prophylactic treatment;Publishing;Radiation;Regimen;Societies;T-Cell Lymphoma;Toxic effect;Transplant Recipients;transplantation therapy,Reduced toxicity allogeneic hematopoietic cell transplantation in malignancies,12065,NA,NA,NA,NA,3,NA,NA,1143096,NA
11188382,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012066,NA,NA,1ZIABC012066-03,NCI:2361109\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858346 (contact),"NGUYEN, HONG HA ROSA  (contact)",NA,NA,NA,Antibodies;Area;Cancer Therapy Evaluation Program;CAR T cell therapy;Cellular immunotherapy;Childhood Solid Neoplasm;Clinical Research;Clinical Trials;CRISPR screen;Cytokine Gene;Development;Engineering;first-in-human;genome-wide;Goals;Immunotherapy;innovation;Laboratories;Natural Killer Cells;Neuroblastoma;novel therapeutics;Patients;Pre-Clinical Model;pre-clinical therapy;Process;Research Personnel;response;Structure;System;Transgenic Organisms;Translating;Translations;tumor;Work,Development of new therapies for neuroblastoma,12066,NA,NA,NA,NA,3,NA,NA,2361109,NA
11188383,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012069,NA,NA,1ZIABC012069-03,NCI:1047023\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355629 (contact),"LEA, SUSAN  (contact)",NA,NA,NA,Affinity;anti-cancer;Binding;blind;Cells;Complex;design;Human;improved;Infection;Knowledge;Lead;Membrane;novel;Pharmaceutical Preparations;protein folding;Proteins;Signal Transduction;small molecule;System;Technology;Therapeutic Agents;Work,Eukaryotic Protein Maturation and Transport,12069,NA,NA,NA,NA,3,NA,NA,1047023,NA
11188384,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012070,NA,NA,1ZIABC012070-03,NCI:698016\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355629 (contact),"LEA, SUSAN  (contact)",NA,NA,NA,Binding;Biological Process;cellular engineering;Collaborations;Complex;Cryoelectron Microscopy;Disease;Health;Human;insight;Membrane;Microbiology;Molecular;Nature;novel;Nucleic Acid Folding;Outcome;pathogenic bacteria;Pharmaceutical Preparations;Proteins;Publications;Publishing;receptor;RNA;RNA Folding;Series;Signal Transduction;structural biology;Structure;Therapeutic;Virulence,Structural biology collaborations,12070,NA,NA,NA,NA,3,NA,NA,698016,NA
11188385,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012071,NA,NA,1ZIABC012071-03,NCI:1560686\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858351 (contact),"WEYEMI, SOSSOU  (contact)",NA,NA,NA,ADP ribosylation;Aging;Antineoplastic Agents;ataxia telangiectasia mutated protein;Biochemical;Bioenergetics;Breast Cancer Cell;cancer cell;cancer therapy;Cell Death;Cell Line;Cell model;Cell Survival;Cells;Cessation of life;Citric Acid Cycle;Clinical;Clustered Regularly Interspaced Short Palindromic Repeats;CRISPR library;CRISPR/Cas technology;Cysteine;Data;desensitization;Disease;Disulfides;DNA Damage;DNA Repair;DNA Repair Gene;DNA Repair Inhibition;DNA Repair Pathway;Drug resistance;Fostering;Genes;Genetic;Genetic Screening;Genome;Genome Stability;Genomic Instability;Glycolysis;Goals;Homeostasis;homologous recombination;Human;Impairment;In Vitro;in vivo;inhibitor;Knock-out;Link;lung cancer cell;Malignant neoplasm of lung;Malignant Neoplasms;Mammalian Cell;Mediating;Metabolic;Metabolic Pathway;Metabolism;Mitochondria;Mus;Mutation;neoplastic cell;Non-Small-Cell Lung Carcinoma;Normal Cell;oxidation;Oxidation-Reduction;Oxidative Phosphorylation;PARP inhibition;Pathway interactions;Pentosephosphate Pathway;peroxiredoxin I;Pharmaceutical Preparations;Pharmacotherapy;Phosphotransferases;Play;Poly(ADP-ribose) Polymerase Inhibitor;Poly(ADP-ribose) Polymerases;precision medicine;programs;Proteins;pyruvate carrier;repaired;Research;Resistance;Resistance development;resistance mechanism;Respiration;response;Ribosomal Proteins;Role;Signal Transduction;Stress;synergism;Testing;Therapeutic;therapy resistant;TP53 gene;triple-negative invasive breast carcinoma;tumor progression,Dialogue between genomic instability and metabolism in diseases,12071,NA,NA,NA,NA,3,NA,NA,1560686,NA
11188386,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012072,NA,NA,1ZIABC012072-03,NCI:85581\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14732189 (contact),"GLOD, JOHN  (contact)",NA,NA,NA,Adult;Age;alpha ketoglutarate;Cancer Patient;cancer type;Caring;Catecholamines;Cells;Child;Classification;cohort;Collection;Data;demethylation;Dioxygenases;Disease;DNA;Early Diagnosis;Enzyme Inhibition;Enzymes;Excision;Family;Fumarates;Gastrointestinal Stromal Tumors;Germ Lines;Goals;High-Risk Cancer;Hypermethylation;inhibitor;Localized Disease;Magnetic Resonance Imaging;Malignant Neoplasms;Metabolic;metabolic profile;metabolomics;Methods;Methylation;Modeling;Molecular;mutant;Mutation;Natural History;Paraganglioma;participant enrollment;patient population;patient screening;Patients;Pediatric Oncology;peripheral blood;Pheochromocytoma;predictive signature;profiles in patients;prospective test;rare cancer;Renal Cell Carcinoma;Reporting;Research;Sampling;screening;Screening for cancer;screening guidelines;Serum;Solid Neoplasm;Succinate Dehydrogenase;Succinates;Testing;Training;training data;tumor;tumor DNA;Urine,Early Detection of Cancer Patients with Germline SDH Deficiency,12072,NA,NA,NA,NA,3,NA,NA,85581,NA
11188387,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012073,NA,NA,1ZIABC012073-03,NCI:672396\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201740 (contact),"ARMSTRONG, TERRI S. (contact)",NA,NA,NA,Acute;Adrenal Cortex Hormones;Affect;affective disturbance;Anxiety;anxiety states;Brain Neoplasms;Central Nervous System Neoplasms;Cessation of life;Circadian Dysregulation;Circadian Rhythms;Clinical Trials;Collection;computer generated;death anxiety;depressive symptoms;Diagnosis;diaries;Distress;Electronics;Emotional;emotional symptom;Environment;Equipment and supply inventories;experience;falls;Feeling;fitbit;Health;Health Technology;Heart Rate;Home;improved;indexing;Individual;Intervention;Learning;Measurement;Measures;Mental Depression;Mental disorders;Moods;National Comprehensive Cancer Network;Participant;participant enrollment;patient population;Patient Recruitments;Patient Self-Report;Patient-Focused Outcomes;Patients;Personal Satisfaction;Persons;Phase;physical symptom;Population;preference;Primary Brain Neoplasms;Questionnaires;Reporting;research clinical testing;Sleep;Sleep disturbances;sleep health;sleep quality;stress reduction;Surveys;Symptom Burden;Symptoms;Technology;telehealth;Thermometers;tumor;tumor diagnosis;virtual assessment;virtual reality;virtual reality headset;virtual reality intervention;wearable device,Implementation of telehealth and health technology to improve patient outcomes,12073,NA,NA,NA,NA,3,NA,NA,672396,NA
11188388,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012074,NA,NA,1ZIABC012074-03,NCI:2387218\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8289669 (contact),"PASTAN, IRA  (contact)",NA,NA,NA,Antibodies;Antibody Therapy;Antibody-drug conjugates;Binding;Bispecific Antibodies;Bite;Body Fluids;CAR T cell therapy;CD3 Antigens;Cell Line;Cell membrane;Cell Surface Proteins;Cells;chimeric antigen receptor T cells;Clinical Trials;Disease remission;Dose;FDA approved;Goals;Human;Immune;In complete remission;Malignant Neoplasms;Membrane;mesothelin;Mesothelioma;mouse model;Mus;neoplastic cell;novel;Peptide Hydrolases;recruit;response;T-Lymphocyte;targeted treatment;tumor,CAR-T Therapy of Mesothelin Expressing Cancers,12074,NA,NA,NA,NA,3,NA,NA,2387218,NA
11188389,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012075,NA,NA,1ZIABC012075-03,NCI:609957\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692167 (contact),"HICKSTEIN, DENNIS  (contact)",NA,NA,NA,Acute;Age;Allogenic;Anemia;autoinflammatory;Blood Platelets;Bone Marrow;Bone Marrow Cells;Bone marrow failure;Busulfan;Cessation of life;Characteristics;Classification;Clinical;clinical phenotype;conditioning;Cutaneous;Cyclophosphamide;cytopenia;design;Development;Disease;Dose;Drug Kinetics;Dysmyelopoietic Syndromes;Dysplasia;Ear;Eligibility Determination;Engraftment;Enzymes;Erythroid Progenitor Cells;Fever;fludarabine;Genes;Genetic;Glucocorticoids;graft vs host disease;Hematologic Neoplasms;Hematology;Hematopoietic Stem Cell Transplantation;Infiltration;Inflammatory;inflammatory marker;Link;Lung;Marrow;Methionine;Morbidity - disease rate;mortality;Mosaicism;Musculoskeletal;Mutation;mycophenolate mofetil;Myelogenous;Myeloproliferative disease;Names;Neutropenia;Nose;novel;Participant;patient population;Patients;phase 2 study;Plasma Cell Neoplasm;Polyarteritis Nodosa;post-transplant;Prednisone;Prophylactic treatment;Recurrence;Refractory;Regimen;Relapsing polychondritis;Research;Research Personnel;Secondary to;Sirolimus;skin lesion;Somatic Mutation;Steroids;Sweet&apos;s Syndrome;Syndrome;systemic inflammatory response;Temporal Arteritis;Testing;Thrombocytopenia;Time;Transfusion;Ubiquitin-Activating Enzymes;United States National Institutes of Health;Vacuole;Whole-Body Irradiation,Hematopoietic Stem Cell Transplant for VEXAS,12075,NA,NA,NA,NA,3,NA,NA,609957,NA
11188390,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012079,NA,NA,1ZIABC012079-03,NCI:615334\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858358 (contact),"MA, LICHUN  (contact)",NA,NA,NA,Biological Assay;cancer cell;Cancer Intervention;cancer therapy;Cells;Clinical;Detection;Early Diagnosis;Goals;Hepatology;Heterogeneity;Imaging technology;Immune;improved;indexing;liver cancer patient;Liver neoplasms;Malignant neoplasm of liver;Neoplasm Metastasis;neoplastic cell;novel strategies;Outcome;Patients;Publishing;Secondary to;Technology;Therapeutic;tumor;tumor heterogeneity;tumor-immune system interactions,Tumor heterogeneity in liver cancer,12079,NA,NA,NA,NA,3,NA,NA,615334,NA
11188391,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012083,NA,NA,1ZIABC012083-03,NCI:615334\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858358 (contact),"MA, LICHUN  (contact)",NA,NA,NA,Automobile Driving;cancer cell;Cancer Intervention;Cells;Classification;Evolution;Goals;Immunologic Surveillance;Immunotherapy;liver biopsy;liver cancer patient;Medicine;Molecular;patient prognosis;Patient-Focused Outcomes;Patients;Play;Publishing;Reporting;response;Role;transcriptomic profiling;Treatment Failure;treatment response;tumor;tumor heterogeneity;tumorigenesis,Tumor evolution in response to treatment,12083,NA,NA,NA,NA,3,NA,NA,615334,NA
11188392,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012086,NA,NA,1ZIABC012086-03,NCI:1103020\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858363 (contact),"MACHIDA, YUICHI  (contact)",NA,NA,NA,anti-cancer therapeutic;Architecture;Biochemical;cancer cell;Chemicals;crosslink;Data;Development;dimer;Dimerization;DNA;DNA biosynthesis;DNA Damage;DNA Repair;DNA replication fork;DNA-protein crosslink;Enzymes;Goals;Hydrophobic Interactions;improved;inhibitor;Interphase;Length;Molecular Sieve Chromatography;Movement;Mutation;Peptide Hydrolases;Pharmaceutical Preparations;Photometry;Protease Domain;Proteins;Recombinants;Regulation;Roentgen Rays;Serine Protease;Site;Structure;Therapeutic;Topoisomerase Inhibitors,DNA Replication and Repair,12086,NA,NA,NA,NA,3,NA,NA,1103020,NA
11188393,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012087,NA,NA,1ZIABC012087-03,NCI:888324\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858365 (contact),"ELMLUND, HANS  (contact)",NA,NA,NA,Algorithm Design;Cells;computational platform;computerized tools;computing resources;Cryo-electron tomography;Cryoelectron Microscopy;Data;data acquisition;Data Analyses;Data Collection;data quality;Data Set;Electron Microscopy;experimental study;Feedback;Future;Goals;Image;Image Analysis;image processing;image reconstruction;imaging modality;improved;instrument;Liquid substance;Manuals;Methods;Microscope;movie;nanocrystal;particle;Preparation;Procedures;Research Personnel;Robotics;Sampling;statistics;Stream;success;Time;Tissues,Unsupervised image processing methods for cryoEM analysis in real time,12087,NA,NA,NA,NA,3,NA,NA,888324,NA
11188394,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012088,NA,NA,1ZIABC012088-03,NCI:888324\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858365 (contact),"ELMLUND, HANS  (contact)",NA,NA,NA,3-Dimensional;Address;Algorithms;automated segmentation;Biological;Catalysis;Cells;Computer software;Cryoelectron Microscopy;Crystal Formation;Data;density;detector;Development;Electron Beam;Electron Microscopy;Electrons;expectation;experimental study;graphene;Growth;Heterogeneity;Image;Image Analysis;improved;Individual;insight;invention;Investigation;Ligands;Liquid substance;Maps;Methodology;Methods;Microscope;Morphology;nanocrystal;nanoparticle;nanoscale;particle;Performance;Population;Positioning Attribute;Property;quantitative imaging;Reaction;reconstruction;Research;Resolution;Rotation;Route;Sampling;Science;Series;Shapes;Structure;Substrate Interaction;Surface;Thermodynamics;Time;Time Series Analysis;Variant,Algorithms for atomic-resolution structure identification of nanocrystals,12088,NA,NA,NA,NA,3,NA,NA,888324,NA
11188395,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012089,NA,NA,1ZIABC012089-03,NCI:13412\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687385 (contact),"SALOURA, VASSILIKI  (contact)",NA,NA,NA,Admission activity;Adverse event;Area;arm;Beds;cancer imaging;Chemotherapy and/or radiation;clinical center;Clinical Protocols;Clinical Trials;Confidence Intervals;Data;design;Diagnosis;Dose;efficacy evaluation;Eligibility Determination;Enrollment;Evaluation;Event;Excision;experience;Fluorescence;fluorescence imaging;follow-up;Frequencies;Giant Cells;Head and Neck Cancer;Head and Neck Squamous Cell Carcinoma;Head and neck structure;histiocyte;Hour;Image;imaging system;indexing;individual patient;Inpatients;interstitial;Intravenous infusion procedures;Lasers;Length;Lesion;Light;Lighting;Measures;Medical;Medical Records;Neoadjuvant Therapy;open label;Operative Surgical Procedures;participant enrollment;Pathologic;Patients;Phase;phase 2 study;photoimmunotherapy;Phototherapy;Population;primary endpoint;Principal Investigator;Procedures;Progression-Free Survivals;Protocols documentation;Reaction;Real-Time Systems;Recurrence;Research Personnel;Resectable;Resected;response;Safety;safety assessment;Sampling;screening;Site;skin squamous cell carcinoma;standard of care;System;Telephone;Testing;Therapeutic Effect;Time;treatment duration;tumor;Tumor Cell Necrosis;United States National Institutes of Health;Visit,Neoadjuvant Photoimmunotherapy in Head and Neck Cancer,12089,NA,NA,NA,NA,3,NA,NA,13412,NA
11188396,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012091,NA,NA,1ZIABC012091-03,NCI:1612616\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858369 (contact),"BANDAY, ABDUL  (contact)",NA,NA,NA,Area;Automobile Driving;Bioinformatics;Biological;Bladder;Bladder Neoplasm;Cancer Biology;cancer cell;cancer risk;cancer therapy;cell transformation;Cells;Clinical;Clinical Trials;Clustered Regularly Interspaced Short Palindromic Repeats;Code;cofactor;Common Neoplasm;Deaminase;Dedications;Dependence;Development;Disease;DNA;DNA Sequence Alteration;driver mutation;druggable target;Enhancers;Enzymes;epithelial to mesenchymal transition;Evolution;Exhibits;functional genomics;Gene Expression;Genes;Genetic;genetic manipulation;genome wide association study;Germ-Line Mutation;Goals;Heterogeneity;immune cell infiltrate;Immunologic Surveillance;immunoregulation;improved;In Vitro;in vivo;Induced Mutation;Intrinsic factor;Knowledge;Malignant neoplasm of urinary bladder;Malignant Neoplasms;Maps;Mediating;Molecular;Multiomic Data;multiple omics;Muscle;Mutagenesis;Mutate;Mutation;Natural Immunity;neoantigens;Neoplasm Metastasis;new therapeutic target;Nucleic Acids;Nucleotides;Oligonucleotides;Outcome;Pathway interactions;Patient-Focused Outcomes;Patients;Phenotype;Play;prevent;Process;programs;promoter;Recurrence;Regulatory Element;Research;Resistance;response;RNA Splicing;Role;Somatic Mutation;Testing;Therapeutic;therapeutically effective;therapy resistant;Tissues;tool;Trans-Splicing;treatment response;tumor;tumor microenvironment;tumor progression;Tumor Subtype;tumorigenesis;tumorigenic;Untranslated RNA;Variant;Viral,Investigating mechanisms of bladder tumorigenesis and therapeutic resistance,12091,NA,NA,NA,NA,3,NA,NA,1612616,NA
11188397,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012092,NA,NA,1ZIABC012092-03,NCI:204179\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858371 (contact),"KRAUZE, ANDRA  (contact)",NA,NA,NA,Address;Adjuvant;Agreement;American;Artificial Intelligence;Brain;Brain Neoplasms;Classification;Clinic;Clinical;cohort;cone-beam computed tomography;Data;Data Set;data sharing;Diagnosis;Diagnostic;Excision;federated learning;follow-up;Glioblastoma;Glioma;Image;Immunotherapy;improved outcome;In complete remission;Linear Accelerator Radiotherapy Systems;Link;Magnetic Resonance Imaging;Managed Care;Medicine;Methylation;MGMT gene;Molecular;neuro-oncology;Neurologic;novel;Operative Surgical Procedures;partial response;Patient-Focused Outcomes;Patients;Postoperative Period;Progression-Free Survivals;Publishing;Radiation;Radiation therapy;response;Scanning;Selection for Treatments;Stable Disease;standard of care;Steroids;temozolomide;Time;Toxic effect;Treatment Efficacy;treatment optimization;tumor;tumor progression;Work,Using artificial intelligence and MRI to address limitations in glioblastoma,12092,NA,NA,NA,NA,3,NA,NA,204179,NA
11188398,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012093,NA,NA,1ZIABC012093-03,NCI:204179\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858371 (contact),"KRAUZE, ANDRA  (contact)",NA,NA,NA,Adjuvant;Agreement;Algorithms;Biological Markers;biomarker discovery;Brain;Brain Neoplasms;Classification;Clinic;Clinical;clinical application;clinical predictors;clinically relevant;cohort;Data;Data Set;Dose;Early treatment;Eligibility Determination;Excision;follow-up;Fostering;Fractionation;Glioblastoma;Glioma;Histone Deacetylase Inhibitor;Image;Immunotherapy;improved;irradiation;Magnetic Resonance Imaging;Managed Care;metabolomics;Neurologic;Operative Surgical Procedures;Pathway interactions;Patients;Pharmaceutical Preparations;predictive signature;prognostic;prognostic signature;proteogenomics;Proteome;Proteomics;Publishing;Radiation therapy;radiological imaging;response;Serum;standard of care;Steroids;Systemic Therapy;temozolomide;Time;Treatment Failure;tumor;Valproic Acid;Visit;Work,Proteogenomic characterization and biomarker discovery in glioblastoma,12093,NA,NA,NA,NA,3,NA,NA,204179,NA
11188399,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012094,NA,NA,1ZIABC012094-03,NCI:204179\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858371 (contact),"KRAUZE, ANDRA  (contact)",NA,NA,NA,Adjuvant;Agreement;Artificial Intelligence;Bioinformatics;Biological;Biological Markers;biomarker discovery;Brain;Brain Neoplasms;Classification;Clinic;Clinical;clinical application;Clinical Data;clinical predictors;Collaborations;Computational Biology;Data;Diagnosis;Diagnostic;disease natural history;Dose;Excision;follow-up;Fractionation;Genomics;Glioblastoma;Glioma;Image;Immunotherapy;improved;improved outcome;lens;Link;Magnetic Resonance Imaging;Managed Care;Measures;metabolomics;Methodology;neuro-oncology;Neurologic;novel;Operative Surgical Procedures;Patient-Focused Outcomes;Patients;Pattern;predictive signature;prognostic;prognostic signature;Progression-Free Survivals;Proteomics;Protocols documentation;Publishing;Radiation therapy;response;Serum;Signal Transduction;Staging;standard of care;Steroids;Stratification;Systemic Therapy;Systems Biology;temozolomide;Time;tumor;tumor progression;Tumor Volume;Valproic Acid;Work,Prognostic and predictive clinical and proteomic biomarker discovery in GBM,12094,NA,NA,NA,NA,3,NA,NA,204179,NA
11188400,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012095,NA,NA,1ZIABC012095-03,NCI:204179\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858371 (contact),"KRAUZE, ANDRA  (contact)",NA,NA,NA,Aftercare;Artificial Intelligence;Biological Markers;Clinical Data;Computer Analysis;Data;Data Aggregation;Data Analyses;data framework;data streams;Dose;Ensure;Genomics;Goals;Image;Laboratories;large scale data;Maintenance;Malignant Neoplasms;Organ;Pathology;Pattern;Process;Proteomics;Radiation;Radiation therapy;Resistance;response;Risk;Span 20;Structure;Surface;System;Testing;Time;Tissues;treatment planning;United States National Institutes of Health,Generating a multi-channel data framework for AI analysis in Radiation therapy,12095,NA,NA,NA,NA,3,NA,NA,204179,NA
11188401,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012096,NA,NA,1ZIABC012096-03,NCI:204179\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858371 (contact),"KRAUZE, ANDRA  (contact)",NA,NA,NA,Address;Algorithms;artificial intelligence algorithm;artificial intelligence model;Behavior;Biological;Biological Markers;Blood;cancer stem cell;Clinical;Clinical Data;Complex;Data;data cleaning;Data Collection;data harmonization;Data Set;data-driven model;design;Evaluation;Excision;Failure;feature selection;Glioblastoma;Histology;improved;improved outcome;Infrastructure;irradiation;Link;Location;Measures;Methods;Methylation;MGMT gene;Molecular;multidimensional data;Normal tissue morphology;novel;Oncology;Outcome;Patient imaging;Patient-Focused Outcomes;Patients;Performance;Printing;prognostic;protein expression;Proteomics;Publications;Publishing;Radiation therapy;Radiometry;Serum;Serum Proteins;Signal Pathway;Signal Transduction;Site;standard of care;stem cells;Testing;Time;tissue biomarkers;treatment optimization;tumor;Tumor Tissue;United States National Institutes of Health;Urine;Validation;Work,Advancing clinically meaningful AI algorithms to improve oncologic outcomes,12096,NA,NA,NA,NA,3,NA,NA,204179,NA
11188402,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012098,NA,NA,1ZIABC012098-03,NCI:1506114\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8777578 (contact),"JOHNSON, PETER F (contact)",NA,NA,NA,3&apos; Untranslated Regions;Adenocarcinoma;adenoma;Affinity Chromatography;Animals;Antineoplastic Agents;Area;Benign;Binding;Binding Proteins;Binding Sites;Biogenesis;BRAF gene;Bypass;cancer cell;Cancer cell line;Cell Senescence Induction;Cells;Complex;Cytoplasm;Cytostatics;Dependence;Development;disabled;Disease;DNA Damage;drug discovery;Elements;Endosomes;Exclusion;factor C;Fibroblasts;Future;Gene Expression;Genes;Goals;IL6 gene;in vivo;in vivo evaluation;Individual;Inflammatory;interest;Investigation;Knockout Mice;KRAS2 gene;KRASG12D;KSR gene;Laboratories;Lung Neoplasms;lung tumorigenesis;Malignant - descriptor;Malignant Neoplasms;MAPK1 gene;MAPK3 gene;MDM2 gene;Messenger RNA;Modeling;Modification;Molecular;Molecular and Cellular Biology;mRNA Decay;Mus;Mutate;neoplastic cell;Normal Cell;novel anticancer drug;Nuclear;Nuclear Decay;Nuclear Translocation;Oncogenes;Oncogenic;Oncoproteins;Pathway interactions;phosphoproteomics;Phosphorylation;Phosphorylation Inhibition;Phosphotransferases;Play;Population;Post-Translational Protein Processing;prevent;Probability;programs;Proliferating;protein degradation;Proteins;PTEN gene;RAS genes;RAS inhibition;ras Oncogene;recruit;Regulation;Repression;Research;restraint;Ribosomes;RNA Decay;Role;scaffold;senescence;senescence associated secretory phenotype;Signal Transduction;Site;small molecule inhibitor;therapeutic DNA;Tissues;TOLLIP gene;TP53 gene;Transcript;transcription factor;Translating;Translational Activation;Translations;tumor;Tumor Cell Line;Tumor Suppression;Tumor Suppressor Proteins;ubiquitin ligase,Control of Oncogenic Signaling Through Spatial Organization of Kinases and mRNAs,12098,NA,NA,NA,NA,3,NA,NA,1506114,NA
11188403,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012099,NA,NA,1ZIABC012099-03,NCI:611682\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858378 (contact),"AREGGER, MICHAEL  (contact)",NA,NA,NA,Cell Line;Cells;Chromosome Mapping;combinatorial;Data Analyses;Dependence;fitness;follow-up;functional genomics;Genes;Genetic;genome-wide;Goals;insight;knockout gene;Libraries;Malignant Epithelial Cell;Metabolic;novel;nuclease;Patients;Regulation;Renal Cell Carcinoma;screening;System;Therapeutic;Translations;Validation;Western Blotting,Interrogating genetic interactions  dependencies in renal cell carcinoma,12099,NA,NA,NA,NA,3,NA,NA,611682,NA
11188404,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012100,NA,NA,1ZIABC012100-03,NCI:436917\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858378 (contact),"AREGGER, MICHAEL  (contact)",NA,NA,NA,Cell Line;Cell surface;cell type;Clustered Regularly Interspaced Short Palindromic Repeats;combinatorial;Complex;DNA Damage;expression vector;Flow Cytometry;Gene Expression;Gene Targeting;Genes;Genetic Transcription;Individual;knockout gene;Malignant Neoplasms;nuclease;Pathway interactions;promoter;recruit;Repression;response;screening;System;Tissues;Transcription Coactivator;Transcription Repressor;Variant;Western Blotting;Work,Combinatorial CRISPR transcriptional perturbation screening platform,12100,NA,NA,NA,NA,3,NA,NA,436917,NA
11188405,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012101,NA,NA,1ZIABC012101-03,NCI:174767\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858378 (contact),"AREGGER, MICHAEL  (contact)",NA,NA,NA,Ablation;Binding Sites;Biological Process;Biomedical Research;Cells;Clustered Regularly Interspaced Short Palindromic Repeats;Code;combinatorial;cost;cost effective;Coupled;CRISPR screen;Data;design;Disease;DNA cassette;experimental study;expression vector;gene function;Genes;Genetic;genetic element;Genetic Screening;genome-wide;genomic platform;Genomics;Guide RNA;Hybrids;indexing;insight;Libraries;Link;loss of function;novel;Phenotype;prevent;Process;Proteins;Protocols documentation;Reagent;response;Role;screening;single cell analysis;single-cell RNA sequencing;Technology;therapeutic candidate;Therapeutic Intervention;transcriptome;transcriptomics,Establishing combinatorial screening platform coupled to single-cell analysis,12101,NA,NA,NA,NA,3,NA,NA,174767,NA
11188406,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012102,NA,NA,1ZIABC012102-03,NCI:524300\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858378 (contact),"AREGGER, MICHAEL  (contact)",NA,NA,NA,Algorithm Design;Cancer cell line;Cell Line;Clustered Regularly Interspaced Short Palindromic Repeats;Collection;combinatorial;Data;Databases;design;Exons;experimental study;fitness;Genes;Genetic;genetic element;Genetic Screening;genome editing;genome-wide;Genomics;Guide RNA;Human Genome;Hybrids;improved;Individual;knockout gene;Libraries;Maps;Modification;mouse genome;nuclease;online resource;paralogous gene;promoter;Property;Resources;scaffold;screening;searchable database;Signal Transduction;Site;System;Testing;Time;tool;Variant;Work,Improving editing efficiency and guide design of CHyMErA screening platform,12102,NA,NA,NA,NA,3,NA,NA,524300,NA
11188407,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012104,NA,NA,1ZIABC012104-03,NCI:408350\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858383 (contact),"KOLMOGOROV, MIKHAIL  (contact)",NA,NA,NA,11q;African American Women;African ancestry;Age;BIRC2 gene;BIRC3 gene;Cancer cell line;Cancer Etiology;cancer type;Canis familiaris;Cell Line;Cervical;Cessation of life;Chromosomal Insertion;Chromosomal Rearrangement;Chromosome abnormality;chromothripsis;clinical application;Collaborations;Complex;Country;Diagnosis;Diagnostic;Dicentric chromosome;Digestion;DNA;DNA sequencing;driver mutation;Event;Evolution;Exonuclease;Genomics;Goals;Head and Neck Cancer;Human papilloma virus infection;Human Papillomavirus;Individual;insight;integration site;Karyotype;Malignant neoplasm of cervix uteri;Malignant Neoplasms;Melanoma;Methods;Missouri;Modeling;multiple omics;Mus;nanopore;Osteosarcoma;Pattern;Pediatric Neoplasm;Prevalence;Research;Resources;Role;Site;targeted treatment;telomere;transcriptome sequencing;tumor;Variant,"The role of structural variation in promotion, evolution and treatment of various tumor types",12104,NA,NA,NA,NA,3,NA,NA,408350,NA
11188408,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012105,NA,NA,1ZIABC012105-03,NCI:1786891\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6802097 (contact),"FELBER, BARBARA K (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;adaptive immune response;adaptive immunity;Affect;Agonist;anti-PD-1;Apical;Area;B-Lymphocytes;Biology;Blood;Bone Marrow;Breast Cancer Cell;Breast Cancer Model;cancer immunotherapy;Cancer Model;Cancer Patient;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;CD8B1 gene;Cells;Characteristics;chemokine;Clinical;clinical application;Clinical Trials;Collaborations;collaboratory;combinatorial;Combined Modality Therapy;CXCL13 gene;cytokine;cytotoxic;cytotoxic CD8 T cells;Data;Dendritic Cells;design;Development;Disease;Disseminated Malignant Neoplasm;DNA Vaccines;Dose;Effector Cell;EO771;Evaluation;Exclusion;exhaustion;experimental study;Extramural Activities;Family;Fatty Acids;Fenofibrate;first-in-human;FLT3 ligand;Frequencies;Gene Expression;Gene Expression Profile;gene therapy;genetic signature;glycosylation;Goals;Growth Factor;HIV;HIV Infections;HIV therapy;IL7 gene;Immune;Immune response;Immune system;Immunity;Immunologic Memory;immunological intervention;immunoregulation;Immunotherapeutic agent;Immunotherapy;improved;Infiltration;inhibitor;interest;Interferons;Interleukin-15;interleukin-21;Intervention;ITGAM gene;Link;Location;lymph nodes;Lymphocyte;Lymphocyte Activation;Lymphocyte Function;Lymphocytic Infiltrate;Lymphoid;Lymphoid Cell;Lymphopoiesis;Macaca;Macaca mulatta;Maintenance;Malignant Neoplasms;Mediating;Metabolic;metabolic fitness;Metabolism;Methods;migration;Mitochondria;Modeling;monocyte;mouse model;Mus;Myelogenous;Myeloid Cells;National Institute of Allergy and Infectious Disease;Natural Killer Cells;Neoplasm Metastasis;orthotopic breast cancer;Oxygen Consumption;Pathway interactions;Phenotype;Plasma;Play;Population;PPAR alpha;pre-clinical;prevent;Production;Proliferating;Property;Proteomics;Protocols documentation;recruit;Regimen;Regulation;Regulatory T-Lymphocyte;Reporting;Research Personnel;response;Role;Shapes;simian human immunodeficiency virus;Site;SIV;SIV Vaccines;Structure of germinal center of lymph node;T-Cell Proliferation;T-Lymphocyte;Technology;Testing;transcriptomics;Treatment Efficacy;Treatment Protocols;triple-negative invasive breast carcinoma;tumor;tumor eradication;tumor growth;tumor microenvironment;Up-Regulation;uptake;vaccine strategy;Viral;Viral reservoir;viral RNA;Viremia;Virus;Work,Examining IL-15 and IL-7 as an immunotherapy agent in cancer and AIDS,12105,NA,NA,NA,NA,3,NA,NA,1786891,NA
11188409,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012106,NA,NA,1ZIABC012106-03,NCI:440525\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162141 (contact),"RAJAN, ARUN  (contact)",NA,NA,NA,Adverse event;Amendment;arm;Biogenesis;chemotherapy;Clinical;design;Development;Disease;Disease Progression;DNA Repair Pathway;Dose;Enrollment;experience;Frequencies;immunogenic cell death;inhibitor;intravenous administration;Molecular;Nausea;Neutropenia;novel therapeutics;objective response rate;partial response;Participant;Patients;Peripheral Nervous System Diseases;Pharmacotherapy;phase I trial;phase II trial;Platinum;Progression-Free Survivals;Progressive Disease;Property;Protocols documentation;Recurrence;Recurrent disease;Refractory;Relapse;Resistance;response;Ribosomes;Safety;Schedule;standard of care;Thrombocytopenia;Thymic Carcinoma;Thymoma;Thymus Epithelial Neoplasm;tumor;Unresectable,A Phase II Trial of PT-112 in Subjects with Thymoma and Thymic Carcinoma,12106,NA,NA,NA,NA,3,NA,NA,440525,NA
11188410,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012107,NA,NA,1ZIABC012107-03,NCI:85728\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,12032135 (contact),"JONES, JENNIFER  (contact)",NA,NA,NA,Biology;Biomedical Research;Classification;Communities;design;Development;Diagnostic;Disease;exosome;extracellular;extracellular vesicles;Foundations;Guidelines;improved;International;Knowledge;Language;liquid biopsy;Macromolecular Complexes;metrology;molecular diagnostics;Nomenclature;Ontology;Process;Research;Research Personnel;response;Terminology;Therapeutic;Update;working group,Classification and Ontology of Macromolecular Complexes in Liquid Biopsies,12107,NA,NA,NA,NA,3,NA,NA,85728,NA
11188411,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012108,NA,NA,1ZIABC012108-03,NCI:408350\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858383 (contact),"KOLMOGOROV, MIKHAIL  (contact)",NA,NA,NA,Address;Algorithms;Aneuploidy;Basic Science;Benchmarking;cancer genome;cancer genomics;Cell Line;Clinical;Clinical Research;clinically relevant;Clonality;Collaborations;Communities;Complex;Copy Number Polymorphism;Data;Data Set;Detection;detection method;Development;DNA Sequencing Facility;Extramural Activities;Genetic;Genomics;Graph;Malignant Childhood Neoplasm;Malignant Neoplasms;Methods;nanopore;Normal Cell;open source tool;Phase;reconstruction;Research Personnel;Sampling;sequencing platform;tool;tumor;Variant;variant detection,New algorithms for long-read cancer genomics,12108,NA,NA,NA,NA,3,NA,NA,408350,NA
11188412,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012109,NA,NA,1ZIABC012109-03,NCI:204174\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858383 (contact),"KOLMOGOROV, MIKHAIL  (contact)",NA,NA,NA,Algorithms;Bacteria;Brain;Collaborations;Complex;Computer software;cost;Data;Dryness;Genetic Recombination;gut microbiome;Human;Human Genome;Human Microbiome;metagenomic sequencing;Methylation;nanopore;Population;Sampling;Technology;United States National Institutes of Health;Variant,"Population-scale, long-read characterization of human genome and microbiome",12109,NA,NA,NA,NA,3,NA,NA,204174,NA
11188413,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012110,NA,NA,1ZIABC012110-03,NCI:933705\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858390 (contact),"BOXER, LISA  (contact)",NA,NA,NA,Affect;Binding Proteins;Brain;Cell division;cell type;Chromatin;Development;Disease;DNA;DNA Binding;DNA Damage;DNA Methylation;DNA Sequence;Epigenetic Process;experimental study;Face;Genes;Genetic Transcription;Genome;genome integrity;Genomic approach;Goals;histone modification;Hour;Impairment;insight;Lead;Learning;life span;loss of function mutation;Malignant Neoplasms;Memory;Methyl-CpG-Binding Protein 2;Methylation;Modification;Molecular;Mus;Mutation;Nervous System Disorder;Neurodevelopmental Disorder;Neurologic;Neurons;Organism;overexpression;postnatal;protein degradation;Proteins;Reader;Regulation;Research;Research Project Grants;Rett Syndrome;Role;Syndrome;transcriptome sequencing,Chromatin Regulation in Brain Development and Disease,12110,NA,NA,NA,NA,3,NA,NA,933705,NA
11188414,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012111,NA,NA,1ZIABC012111-03,NCI:147004\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692485 (contact),"KELLY, KATHLEEN  (contact)",NA,NA,NA,Address;Adenocarcinoma;advanced prostate cancer;Androgen Receptor;Androgens;Animal Model;Biology;Bone Tissue;Cell Survival;Clinical;clinical phenotype;Communities;deprivation;Development;experience;Goals;Growth;Human;in vivo;Incidence;inhibitor;Investigation;Malignant neoplasm of prostate;Metastatic Neoplasm to the Bone;metastatic process;Modeling;Neoplasm Metastasis;novel therapeutic intervention;Organoids;patient derived xenograft model;Patients;Phenotype;Physiology;prostate cancer metastasis;Publishing;RB1 gene;Receptor Signaling;Recovery;Reproducibility;Resistance;Role;soft tissue;Technology;Time;TP53 gene;treatment response;tumor;tumor heterogeneity,Biology of AR+ prostate cancer metastases and the role of the microenvironment,12111,NA,NA,NA,NA,3,NA,NA,147004,NA
11188415,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012112,NA,NA,1ZIABC012112-03,NCI:122567\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355641 (contact),"RAJAGOPAL, PADMA  (contact)",NA,NA,NA,Age;Area;Atlases;Breast Cancer Treatment;cancer genomics;cancer subtypes;cancer therapy;Categories;Clinical;Clinical Treatment;cloud based;Cohort Analysis;Consensus;Data;Data Analyses;data integration;Data Set;Diagnosis;Disease;Distant Metastasis;DNA;exome sequencing;Generations;genetic variant;Germ Lines;Germ-Line Mutation;Heterogeneity;human data;improved;Infrastructure;Linear Regressions;Literature;Logistic Regressions;Malignant Breast Neoplasm;Malignant Neoplasms;Meta-Analysis;Metastatic breast cancer;multiple omics;Outcome;Participant;Patients;Pharmaceutical Preparations;programs;Publications;Publishing;Race;Reporting;response;Sampling;Somatic Mutation;standard of care;systematic review;Testing;The Cancer Genome Atlas;Time;treatment response;tumor;United States National Institutes of Health;Update;Validation;validation studies;Variant,Germline-Somatic Interactions and Association with Treatment Response in Cancer,12112,NA,NA,NA,NA,3,NA,NA,122567,NA
11188416,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012113,NA,NA,1ZIABC012113-03,NCI:782016\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858394 (contact),"O'REILLY, FRANCIS  (contact)",NA,NA,NA,Address;Amino Acids;Antibiotics;Bacteria;Bacterial Antibiotic Resistance;Cancer Patient;Cells;Code;commensal bacteria;crosslink;Data;Diazomethane;Disease;DNA sequencing;DNA-Directed RNA Polymerase;Fractionation;Genes;Goals;gut bacteria;gut microbiota;Health;Hospitalization;Human;Leucine;Malignant Neoplasms;Maps;Mass Spectrum Analysis;Metabolic;microbiome;Modeling;Molecular;novel;pathogen;pathogenic bacteria;protein complex;protein structure prediction;Protein-Protein Interaction Map;Proteins;Proteome;Reporting;Resolution;RNA;Salmonella;Salmonella enterica;Sepsis;Site;technology development;Ultraviolet Rays,Discovery of novel protein complexes across human gut bacteria,12113,NA,NA,NA,NA,3,NA,NA,782016,NA
11188417,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012114,NA,NA,1ZIABC012114-03,NCI:782016\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858394 (contact),"O'REILLY, FRANCIS  (contact)",NA,NA,NA,Address;Binding Sites;Cell Nucleus;Cells;Cellular Stress;Complex;crosslink;Cryoelectron Microscopy;Data;Disease;Eukaryota;Eukaryotic Cell;Frustration;Genetic;Home;Human;In Situ;information processing;interest;Malignant Neoplasms;Maps;Mass Spectrum Analysis;Membrane;multicatalytic endopeptidase complex;Oncoproteins;Phase;Process;protein complex;protein protein interaction;protein purification;Proteins;Proteome;Proteomics;Research;stable cell line;structural biology;Structure;Techniques;Technology;Therapeutic;Work,The topology of protein-protein interactions in situ in eukaryotic cells,12114,NA,NA,NA,NA,3,NA,NA,782016,NA
11188418,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012116,NA,NA,1ZIABC012116-03,NCI:826515\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858397 (contact),"LEKO, VID  (contact)",NA,NA,NA,Acute Myelocytic Leukemia;Adoptive Cell Transfers;Adoptive Transfer;Blood;Bone Marrow;cancer immunotherapy;Cells;Characteristics;Clinical Protocols;cohort;Development;Dysmyelopoietic Syndromes;Goals;Hematologic Neoplasms;Hematology;In Vitro;Malignant Neoplasms;Mutation;Myelogenous;Myeloproliferative disease;neoantigens;next generation sequencing;Patient Transfer;Patients;Peptides;Peripheral Blood Mononuclear Cell;Prevalence;Research Project Grants;Solid;T cell response;T-Cell Receptor;T-Lymphocyte;translational goal;tumor;Validation,Targeting cancer neoantigens in patients with myeloid malignancies,12116,NA,NA,NA,NA,3,NA,NA,826515,NA
11188419,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012117,NA,NA,1ZIABC012117-03,NCI:517770\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858399 (contact),"PRATT, DREW  (contact)",NA,NA,NA,Awareness;Bioinformatics;bioinformatics pipeline;Body System;cancer classification;Central Nervous System Neoplasms;Chromatin;Classification;Classification Scheme;Clinical;Communities;Complement;Consensus;Data;deep learning;density;Development;Diagnostic;DNA Methylation;Factor Analysis;Gene Expression;Genetic Transcription;Goals;Hi-C;improved;L1 Elements;Laboratories;Link;Machine Learning;machine learning classifier;Malignant Neoplasms;Medical;Methodology;Methylation;multiple omics;Mutation;novel;Organ;Pathology;Pathway interactions;personalized diagnostics;precision medicine;Repetitive Sequence;Research;Signal Transduction;Source;Techniques;transcriptome sequencing;tumor;United States National Institutes of Health,DNA methylation-based machine classification of cancer,12117,NA,NA,NA,NA,3,NA,NA,517770,NA
11188420,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012118,NA,NA,1ZIABC012118-03,NCI:417740\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10687105 (contact),"MADAN, RAVI  (contact)",NA,NA,NA,androgen independent prostate cancer;Artificial Intelligence platform;Biochemical;Biological Markers;Cancer Patient;Castrate sensitive prostate cancer;Clinical Trials;Data;Development;Disease Progression;FOLH1 gene;Goals;Image;Malignant neoplasm of prostate;Monitor;Natural History;Patients;Positron-Emission Tomography;prospective;Recurrence;Resources;Role;Scanning;Therapeutic Intervention;Time,Defining Roles for PSMA PET Imaging in Prostate Cancer,12118,NA,NA,NA,NA,3,NA,NA,417740,NA
11188421,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012119,NA,NA,1ZIABC012119-03,NCI:197970\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857470 (contact),"DAVIES, ERIN  (contact)",NA,NA,NA,Adult;Amputation;Anatomy;Anterior;Apical;Atlases;Biological Markers;Cells;Collaborations;Data;Development;Embryonic Development;Female;Genetic;Germ Cells;germline stem cells;Gonadal structure;Homeostasis;Homologous Gene;Imaging Techniques;male;marine;Microscopy;Molecular;Morphogenesis;nano;Natural regeneration;Organ;Platyhelminths;Postembryonic;postnatal;Process;programs;Protocols documentation;Reaction;reconstruction;Regulation;reproductive;Reproductive system;Resources;Sampling;segregation;self assembly;self organization;sexual dimorphism;Signal Transduction;single-cell RNA sequencing;Source;Specific qualifier value;stem cells;Structure;Testis;Tissues;Transgenic Organisms;Visualization,Inductive germ cell specification and self-assembly of sexually dimorphic gonads,12119,NA,NA,NA,NA,3,NA,NA,197970,NA
11188422,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012120,NA,NA,1ZIABC012120-03,NCI:49492\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857470 (contact),"DAVIES, ERIN  (contact)",NA,NA,NA,Adult;Anatomy;Atlases;Benchmarking;Bioinformatics;Biological Assay;Cancer Biology;cell behavior;Cell Lineage;Cell Ontogeny;Cell Transplantation;Cells;Collaborations;comparative;Coupling;Data;Development;Developmental Biology;Embryo;Embryonic Development;experimental study;Gene Expression;Goals;Homeostasis;in silico;Individual;innovation;irradiation;Laboratories;Life Cycle Stages;Maps;Mediating;Molecular;Natural regeneration;Organism;Planarians;Platyhelminths;pluripotency;Pluripotent Stem Cells;Population;postnatal;programs;Property;Quality Control;regenerative;Regulation;Sampling;Scientist;single-cell RNA sequencing;Source;Specific qualifier value;System;Time;Tissues;transcriptome;transcriptomics,Embryonic origin of adult pluripotent stem cells and anatomical systems during planarian embryogenesis,12120,NA,NA,NA,NA,3,NA,NA,49492,NA
11188423,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012121,NA,NA,1ZIABC012121-03,NCI:1024494\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858404 (contact),"KLEMEN, NICHOLAS  (contact)",NA,NA,NA,Adoptive Cell Transfers;Affect;Aftercare;Biological Assay;Cancer cell line;CD28 gene;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;Cell Therapy;Cells;Clinical Trials;comparative efficacy;cost;cytokine;Data;Flow Cytometry;Gene Expression;Gene Proteins;Genes;Genetic;genetic approach;Growth;HLA-A11;Human;Immune;immune cell infiltrate;Immune response;Immunohistochemistry;Implant;improved;In Vitro;in vitro testing;in vivo;Infiltration;Injections;Interleukin-2;knock-down;KRAS2 gene;KRASG12D;MAP Kinase Gene;Modeling;Modification;Muromonab-CD3;Mus;Mutation;neoplastic cell;Oncogenic;Operative Surgical Procedures;overexpression;OX40;Pancreas;pancreatic cancer cells;Pathway interactions;Patients;Peripheral Blood Mononuclear Cell;pharmacologic;PIK3CG gene;Production;programmed cell death protein 1;Proliferating;Property;protein transport;PTEN gene;receptor;Role;Sampling;small hairpin RNA;small molecule inhibitor;Stains;subcutaneous;T cell differentiation;T cell therapy;T-Cell Proliferation;T-Cell Receptor;T-Lymphocyte;Testing;TNFRSF5 gene;TNFSF5 gene;Transcript;transport inhibitor;tumor;vector;Vertebral column;Viral Vector;Western Blotting,Retroviral genetic modification of PBLs to optimize expansion for cell therapy,12121,NA,NA,NA,NA,3,NA,NA,1024494,NA
11188424,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012122,NA,NA,1ZIABC012122-03,NCI:2233312\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858406 (contact),"NG, SAMUEL  (contact)",NA,NA,NA,addiction;Affect;Animal Model;ATAC-seq;Autologous;Basic Science;Binding;Biopsy Specimen;Breeding;cancer cell;Cancer Model;CC chemokine receptor 4;Cell Line;Cells;Chemicals;chimeric antigen receptor T cells;Clinical;clinical application;clinical development;clinical trial protocol;Clinical Trials;Collaborations;Complex;CRISPR screen;Data;Disease;Drug Screening;Elements;Ensure;Epigenetic Process;experimental study;first-in-human;fitness;Gene Expression;Generations;Genetic;Genetic Predisposition to Disease;Genetic Screening;Genetically Engineered Mouse;Germ Lines;Goals;Guanine;Guanine Nucleotide Exchange Factors;human study;Immunoblastic Lymphadenopathy;Immunotherapy;Impairment;implantation;Inferior;Infrastructure;insight;intravenous injection;Kinetics;loss of function;loss of function mutation;Lymphoma cell;Lymphomagenesis;Malignant - descriptor;Malignant Neoplasms;Modeling;Molecular;Mus;Mutation;Non-Hodgkin&apos;s Lymphoma;Non-Malignant;novel;novel therapeutics;Outcome;Pathogenesis;Pathway interactions;patient derived xenograft model;Patients;Peripheral;personalized immunotherapy;Pharmaceutical Preparations;phase I trial;Polycomb;Pre-Clinical Model;precision medicine;programs;Proteins;Protocols documentation;Research;rho;RHOA gene;Sampling;Sampling Studies;Signal Transduction;System;T-Cell Lymphoma;T-Lymphocyte;targeted treatment;Testing;Therapeutic;Toxic effect;transcription factor;transcriptomics;translational study;whole genome;Work,Targeting exploitable vulnerabilities in T-cell Lymphoma,12122,NA,NA,NA,NA,3,NA,NA,2233312,NA
11188429,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012128,NA,NA,1ZIABC012128-03,NCI:270790\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8778166 (contact),"GULLEY, JAMES L. (contact)",NA,NA,NA,Adolescent;Adult;Affect;Alternative Splicing;Antibody-drug conjugates;Antigens;Award;B-Cell Acute Lymphoblastic Leukemia;B-Lymphocytes;Back;Bone Tissue;Brain Neoplasms;Cancer cell line;Cancer Patient;CCR;CD19 gene;CD22 gene;Cell Line;chemotherapy;Childhood;Childhood Leukemia;childhood sarcoma;chimeric antigen receptor T cells;Clinical Trials;Data;early phase clinical trial;effective therapy;Encyclopedias;Evaluation;Exons;Experimental Models;experimental study;Extramural Activities;FDA approved;first-in-human;Gene Modified;Goals;Hematologic Neoplasms;high throughput analysis;Human;Immune;Immune Targeting;Immunooncology;Immunotherapeutic agent;Immunotherapy;imprint;improved;improved outcome;Laboratories;Libraries;Lymphoid Cell;Malignant Childhood Neoplasm;Malignant Neoplasms;manufacture;Mediating;Messenger RNA;Methodology;Natural Killer Cells;Neuroblastoma;Neuroendocrine Tumors;Neurosecretory Systems;NK cell therapy;novel;novel therapeutic intervention;Open Reading Frames;Operative Surgical Procedures;participant enrollment;patient prognosis;Patient-Focused Outcomes;Patients;PAX5 gene;Pediatric Hospitals;phase I trial;Population Heterogeneity;Pre-Clinical Model;prevent;Procedures;Process;protein expression;Recurrence;Refractory Disease;Relapse;Research;Resistance;Resistance development;response;RNA Splicing;RNA-Binding Proteins;Role;Sampling;Site;Soft tissue sarcoma;Solid Neoplasm;Source;T-Lymphocyte;Testing;Transcript;transcription factor;Transforming Growth Factor beta;Translating;Translational Research;tumor;Tumor Immunity;tumor microenvironment;Untranslated RNA;vaccine development;Variant;vector;Work;young adult,Bench to Beside and Back translational immuno-onocology-Cures,12128,NA,NA,NA,NA,3,NA,NA,270790,NA
11188430,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012130,NA,NA,1ZIABC012130-02,NCI:855233\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79355522 (contact),"FUJII, TAKEO  (contact)",NA,NA,NA,"4T1;Acceleration;Age;Animal Model;anti-cancer;Anticoagulants;Area;Astrocytes;blood-brain barrier disruption;Bone Marrow;Brain;Brain Ischemia;Breast Cancer Cell;Breast Cancer cell line;breast cancer metastasis;Breast Cancer Patient;breast cancer progression;Breast Cancer Treatment;C57BL/6 Mouse;cancer cell;Cancer Patient;Carotid Arteries;Cell Adhesion Molecules;Cells;chemokine;Circulation;Clinical;Clinical Research;Collaborations;Complete Blood Count;Control Groups;cytokine;Data;Deep Vein Thrombosis;Disease;Distant;Endothelial Cells;Environment;eosinophil;ERBB2 gene;Exhibits;Fatty acid glycerol esters;Female;Flow Cytometry;General Population;Goals;Growth;Hemorrhage;high risk;Immune;immune cell infiltrate;Immunocompetent;Immunofluorescence Immunologic;improved;Inbred BALB C Mice;Incidence;Inferior vena cava structure;Infiltration;Inflammation;Inflammatory;Injections;interest;Ischemia;Ischemic Stroke;Laboratory Study;Link;Malignant Breast Neoplasm;Malignant neoplasm of brain;Malignant Neoplasms;mammary;Metastatic malignant neoplasm to brain;Microglia;Microspheres;Modeling;monocyte;mouse model;Mus;Myeloid Cells;Myocardial Infarction;National Heart, Lung, and Blood Institute;Neoplasm Metastasis;neutrophil;novel;novel strategies;novel therapeutic intervention;Operative Surgical Procedures;Organ;Patients;Pericytes;Phase;Phenotype;Prognosis;PTPRC gene;Reporting;Research;Risk;RNA Sequences;Role;sham surgery;Stains;survival outcome;systemic inflammatory response;Testing;Therapeutic Intervention;Thrombocytopenia;thromboembolic stroke;Thromboembolism;Thrombosis;thrombotic complications;Time;trend;triple-negative invasive breast carcinoma;tumor;tumor microenvironment;tumor progression;Up-Regulation;venous thromboembolism",Elucidating the role of thrombosis and inflammation in breast cancer metastasis,12130,NA,NA,NA,NA,2,NA,NA,855233,NA
11188431,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012131,NA,NA,1ZIABC012131-02,NCI:4001732\NIDCD:488935\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79355524 (contact),"ALLEN, CLINT  (contact)",NA,NA,NA,Acceleration;Address;Adoptive Transfer;Aftercare;Alcohol abuse;anti-tumor immune response;Antigens;Autologous;Basic Science;Biopsy Specimen;Blood specimen;Cell surface;Cells;chimeric antigen receptor T cells;Chronic;chronic infection;Circulation;Clinical;clinical center;Clinical Research;confirmatory clinical trial;Correlative Study;Data;design;Development;Disease;early phase clinical trial;engineered T cells;Epithelial Neoplasms;Excision;Gene Expression;Goals;Head and Neck Neoplasms;Head and Neck Squamous Cell Carcinoma;Head and neck structure;Human papilloma virus infection;Human Papilloma Virus-Related Malignant Neoplasm;Human Papillomavirus;Human papillomavirus 11;Human papillomavirus 6;immune checkpoint blockade;Immunity;Immunotherapy;improved;In complete remission;industry partner;Infiltration;Laboratories;Life;Medical;Mus;Neoadjuvant Study;Neoadjuvant Therapy;Neoplasms;neoplastic cell;Newly Diagnosed;novel;novel strategies;novel therapeutics;novel vaccines;Operative Surgical Procedures;Papilloma;Papillomatoses;Pathway interactions;Patient-Focused Outcomes;Patients;Peripheral;Phase;phase 2 study;pre-clinical;programs;Protocols documentation;Recurrent respiratory papillomatosis;Repeat Surgery;Research;Residencies;respiratory;Shapes;Specimen;standard of care;T cell therapy;T-Cell Receptor;T-Lymphocyte;Therapeutic;therapeutic evaluation;therapeutic vaccine;Tissues;tobacco abuse;Transforming Growth Factor beta;Translating;trial planning;tumor;Tumor Debulking;Tumor Immunity;United States National Institutes of Health;Vaccination;vaccination outcome;Vaccine Design;Vaccine Therapy;Voice;Work,Enhancing anti-tumor immunity in head and neck neoplasms,12131,NA,NA,NA,NA,2,NA,NA,4490667,NA
11188432,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012132,NA,NA,1ZIABC012132-02,NCI:3090455\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79355526 (contact),"MUTHUSWAMY, SENTHIL  (contact)",NA,NA,NA,anti-cancer research;Autologous;Biotin;Biotinylation;Cell Line;Cell Polarity;Cell surface;Cell Surface Proteins;Cells;Clonal Evolution;Coculture Techniques;Complement;Drug resistance;gemcitabine;Gene Expression;Genetic Screening;Immune Evasion;Investigation;Knock-out;Label;Malignant Breast Neoplasm;Malignant neoplasm of pancreas;Modeling;Organoids;overexpression;Patients;peripheral blood;Pharmaceutical Preparations;Process;process optimization;Proteins;Resistance;Signal Transduction;T-Cell Receptor;T-Lymphocyte;Techniques;Therapeutic;tumor,Tumor organoids and cell polarity: models and mechanisms for cancer research,12132,NA,NA,NA,NA,2,NA,NA,3090455,NA
11188433,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012133,NA,NA,1ZIABC012133-02,NCI:1566149\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79355528 (contact),"KOIVOMAGI, MARDO  (contact)",NA,NA,NA,Active Sites;Affect;Aging;Alleles;alpha helix;analog;Antibodies;Attention;Binding;Biochemical;Bioinformatics;Biological Assay;C-terminal;cancer cell;candidate identification;Cell Cycle;Cell Cycle Inhibition;Cell Cycle Progression;Cell Differentiation process;Cell division;cell growth;Cell Line;Cell Proliferation;Cells;Chemical Engineering;Complex;Coupled;Cyclin D1;cyclin G1;Cyclin Regulation of Cell Cycle Pathway;Cyclin-Dependent Kinases;Cyclins;DNA;Docking;Engineering;Ensure;Equipment;experimental study;Family;Family member;G1 Arrest;G1/S Transition;Gene Expression;Genetic Screening;Genetic Transcription;Human;Imaging Techniques;improved;In Vitro;in vivo;inhibitor;Kinetics;Label;Laboratories;Link;Malignant Neoplasms;Mammalian Cell;Mass Spectrum Analysis;Metabolism;Methods;Modeling;Modification;Molecular;Mutation;Normal Cell;novel;Peptides;Phase;Phase Transition;phosphoproteomics;Phosphorylation;Phosphotransferases;Play;Postbaccalaureate;Postdoctoral Fellow;pre-doctoral;Preparation;prevent;Process;promoter;Protein C;protein protein interaction;Proteins;Proteome;Proteomics;Reagent;reconstitution;recruit;Regulation;Research;Resources;Retinoblastoma Protein;RNA Polymerase II;Role;Rotation;S phase;Saccharomycetales;Scientist;Side;Site;small molecule;Students;summer student;System;Techniques;Testing;Time;tool;Transcriptional Activation;transcriptomics;tumor;Visit;volunteer;Work;Yeasts,Biochemical mechanisms cyclin-dependent kinases use to control cell division,12133,NA,NA,NA,NA,2,NA,NA,1566149,NA
11188434,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012134,NA,NA,1ZIABC012134-02,NCI:475654\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79355530 (contact),"PENAS-PRADO, MARTA  (contact)",NA,NA,NA,Adult;Area;Biology;Caring;Central Nervous System Neoplasms;Clinical;clinical care;Clinical Data;Clinical Trials;cohort;Collaborations;Data;Databases;Development;Disease;disorder control;DNA Repair;Education;efficacy testing;Enrollment;Ependymoma;Face;follow-up;Geographic Locations;Goals;Immunotherapy;Information Technology;Institution;Institutional Review Boards;Knowledge;Lead;Leadership;Logistics;Medulloblastoma;Molecular;Multicenter Studies;multidisciplinary;MYCN gene;neuro-oncology;Participant;Pathology;Patients;Phase;Phase I/II Clinical Trial;Pre-Clinical Model;precision medicine;predictive marker;repository;Research;Research Personnel;Resistance;Role;Sampling;Site;Structure;Testing;therapeutic target;Topoisomerase;Treatment Protocols;tumor;Tumor Biology;Tumor Tissue;United States National Institutes of Health;virtual,Development of new treatments for rare CNS tumors,12134,NA,NA,NA,NA,2,NA,NA,475654,NA
11188435,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012135,NA,NA,1ZIABC012135-02,NCI:944345\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79355532 (contact),"ADORO, STANLEY  (contact)",NA,NA,NA,Address;Age;Animal Model;Blood;Blood Cells;Cell Differentiation process;Cell Physiology;Cells;Cellular biology;Chronic;Defect;design;Development;Disease;exhaustion;Functional disorder;Genes;genome integrity;Genomics;Goals;Hematopoiesis;Hematopoietic;hematopoietic differentiation;Hematopoietic Neoplasms;Hematopoietic stem cells;Homeostasis;Human;Immune;Impairment;Investigation;Knowledge;Link;Macrophage;Maintenance;Malignant - descriptor;Mammalian Cell;Mediator;multicatalytic endopeptidase complex;Myeloid Leukemia;novel;OmpR protein;Pathway interactions;programs;Protein Biosynthesis;Proteins;Proteome;Proteomics;proteostasis;proteotoxicity;Regulation;Research;response;Role;Sampling;Shapes;Signal Pathway;Stress;System;T-Cell Leukemia;T-Lymphocyte;Testing;thymocyte;Tissues;transcriptomics;translational engagement;Ubiquitin;Viral Cancer;Virus Diseases;Work,Proteostasis regulators in blood cell development and function,12135,NA,NA,NA,NA,2,NA,NA,944345,NA
11188436,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012136,NA,NA,1ZIABC012136-02,NCI:301675\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162152 (contact),"ROSCHEWSKI, MARK  (contact)",NA,NA,NA,Africa South of the Sahara;Burkitt Lymphoma;CD8-Positive T-Lymphocytes;Disease;disease natural history;Disease remission;Enrollment;Epstein-Barr Virus-Related Lymphoma;Extranodal;HIV;Hodgkin Disease;Human Herpesvirus 4;Immune checkpoint inhibitor;Immunity;In complete remission;Individual;Kinetics;large cell Diffuse non-Hodgkin&apos;s lymphoma;Large-Cell Immunoblastic Lymphoma;low income country;Nature;novel;Patients;Phase Ib/II Clinical Trial;Plasma;prognostic;Relapse;response;Safety;T-Cell Lymphoma;Translational Research;tumor,Checkpoint inhibitor treatment for EBV+ lymphoma among HIV+ individuals,12136,NA,NA,NA,NA,2,NA,NA,301675,NA
11188437,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012138,NA,NA,1ZIABC012138-02,NCI:340457\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201761 (contact),"LIN, FRANK  (contact)",NA,NA,NA,Calendar;Cells;Collaborations;efficacy evaluation;Enrollment;Head and Neck Cancer;industry partner;Institutional Review Boards;kidney cell;Lung;Maximum Tolerated Dose;Neuroendocrine Tumors;Paraganglioma;Participant;participant enrollment;Pharmacologic Substance;Phase I/II Clinical Trial;Pheochromocytoma;Process;radioligand;response;Retreatment;Site;Somatostatin Receptor;tumor;United States National Institutes of Health,Pb212 VMT alpha NET in treatment and re-treatment of SSTR+ tumors,12138,NA,NA,NA,NA,2,NA,NA,340457,NA
11188438,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012144,NA,NA,1ZIABC012144-02,NCI:116437\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355641 (contact),"RAJAGOPAL, PADMA  (contact)",NA,NA,NA,Bioinformatics;Blood;cancer prevention;cancer risk;cancer type;Classification;ClinVar;Data;disease-causing mutation;DNA;DNA Sequence Alteration;DNA sequencing;Etiology;exome;experience;Family;Family member;Genes;genetic variant;Genotype-Tissue Expression Project;Germ Lines;Hereditary Malignant Neoplasm;Housekeeping Gene;Inherited;insertion/deletion mutation;Malignant Neoplasms;Methylation;Mutation;nanopore;NCI Center for Cancer Research;next generation;Pathogenicity;Patients;Recording of previous events;Reproducibility;Risk;RNA;RNA Splicing;Sampling;Single Nucleotide Polymorphism;symposium;Syndrome;Technology;Testing;TP53 gene;transcriptome sequencing;tumor;Validation;Variant;variant of interest;Whole Blood,Long-Read DNA Sequencing and RNA Sequencing in LFS-Like Families,12144,NA,NA,NA,NA,2,NA,NA,116437,NA
11188439,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012145,NA,NA,1ZIABC012145-02,NCI:6128\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355641 (contact),"RAJAGOPAL, PADMA  (contact)",NA,NA,NA,CCR;Clinical;Clinical Trials;Detection;Image;Malignant Neoplasms;National Human Genome Research Institute;Natural History;Neoplasms;Participant;Patient Recruitments;Persons;pregnant;prenatal testing;recruit;Recruitment Activity;Reporting;Test Result;Testing;Woman,IDENTIFY Study: Natural History of Maternal Neoplasia,12145,NA,NA,NA,NA,2,NA,NA,6128,NA
11188440,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012146,NA,NA,1ZIABC012146-02,NCI:300216\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11199937 (contact),"SINGER, DINAH S. (contact)",NA,NA,NA,Active Sites;Alternative Splicing;Architecture;Binding;Binding Proteins;Bromodomain;c-myc Genes;Cellular Stress;Chromatin;chromatin remodeling;cohesin;Complex;Disease;Dissociation;DNA Polymerase II;Early Gene Transcriptions;Enzymes;EP300 gene;epithelial to mesenchymal transition;Event;Genes;Genetic Transcription;genome-wide;Heart Diseases;Histone Acetylation;histone acetyltransferase;Human;Immediate-Early Genes;Immune;Immune response;Inflammatory;Inflammatory Response;JNK-activating protein kinase;Kidney Diseases;Malignant Neoplasms;MAPK8 gene;Mediating;member;Mitosis;Mitotic;Nervous System Disorder;novel;Nucleoplasm;Nucleosomes;Phosphoric Monoester Hydrolases;Phosphorylation;Phosphotransferases;Productivity;promoter;prostate cancer cell;Protamine Kinase;Protein Dephosphorylation;Protein Family;recruit;Regulation;release factor;Reporting;response;RNA;RNA Splicing;Role;Signal Transduction;Stimulus;Stress;TAF7 gene;thymocyte;Tissues;Transcription Coactivator;Transcription Elongation;transcription factor;Transcription Initiation;Transcriptional Elongation Factors;Work,Regulation of BRD4 Function,12146,NA,NA,NA,NA,2,NA,NA,300216,NA
11188441,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012148,NA,NA,1ZIABC012148-02,NCI:258457\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687355 (contact),"YOHE, MARIELLE  (contact)",NA,NA,NA,Alveolar;Apoptosis;ATAC-seq;cancer type;Cell Differentiation process;Cell Line;cell motility;Cell Proliferation;Cells;Childhood Soft Tissue Sarcoma;ChIP-seq;Chromatin;chromatin remodeling;Chromatin Remodeling Factor;Chromosomal translocation;Classification;Co-Immunoprecipitations;CTNNB1 gene;Data;Data Analyses;experimental study;FGFR4 gene;FOXO1A gene;Gene Cluster;Genes;Growth;HDAC2 gene;healing;Histologic;ISWI;Knock-out;Methods;migration;Mutation;Myoblasts;myogenesis;Oncogenes;PAX3 gene;PAX7 gene;Phenotype;PIK3CA gene;prevent;Process;Proliferating;Protein Family;Protein Isoforms;Proteins;RALA gene;Rhabdomyosarcoma;Role;Running;Skeletal Muscle;skeletal muscle differentiation;SMARCA1 gene;Switching Complex;System;targeted cancer therapy;TP53 gene;transcriptome sequencing;transcriptomics;tumor;tumor progression;Tumor Suppressor Proteins;tumorigenesis;tumorigenic,The role of SMARCA1 in Rhabdomyosarcoma and Skeletal Muscle Differentiation,12148,NA,NA,NA,NA,2,NA,NA,258457,NA
11188442,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012150,NA,NA,1ZIABC012150-02,NCI:449823\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79355540 (contact),"BOUFRAQECH, MYRIEM  (contact)",NA,NA,NA,anaplastic thyroid cancer;ataxia telangiectasia mutated protein;bone;BRAF gene;Brain;cancer cell;cell killing;Cell Survival;Clinical Data;Clustered Regularly Interspaced Short Palindromic Repeats;Collaborations;Coupled;CRISPR screen;Disease;DNA Damage;Exhibits;Genes;Genetic Determinism;genome-wide;Genomic Instability;Goals;Human;improved;In Vitro;in vivo;inhibitor;Knock-out;knockout gene;Libraries;Link;Lung Carcinoma;Malignant Epithelial Cell;Malignant neoplasm of thyroid;Malignant Neoplasms;MAP Kinase Gene;Mediating;Mutation;novel;Oncogenic;Outcome;Pathway interactions;Patient-Focused Outcomes;Patients;Pre-Clinical Model;precision oncology;Reporting;Resistance;resistance mechanism;response;Site;targeted agent;targeted treatment;Therapeutic;Toxic effect;treatment response;Tyrosine Kinase Inhibitor,Unlocking mechanisms of resistance to targeted therapy in thyroid cancer,12150,NA,NA,NA,NA,2,NA,NA,449823,NA
11188443,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012151,NA,NA,1ZIABC012151-02,NCI:13412\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687385 (contact),"SALOURA, VASSILIKI  (contact)",NA,NA,NA,Antigen Presentation;antitumor effect;arm;cancer cell;disorder control;Dose;drug withdrawal;efficacy evaluation;Eligibility Determination;EZH2 gene;Head and Neck Cancer;head and neck cancer patient;Head and Neck Squamous Cell Carcinoma;Hematologic Neoplasms;HPV-negative head and neck cancer;In complete remission;inhibitor;Intervention;ipilimumab;Lead;novel;partial response;patient population;Patients;PDL1 inhibitors;pembrolizumab;Peripheral;Phase;phase 2 study;premature;Progression-Free Survivals;Prostate;Randomized;Recommendation;Renal Cell Carcinoma;response;Safety;safety study;Stable Disease;T-Cell Lymphoma;Urothelial Cell,Valemetostat in combination with pembrolizumab in head and neck cancer,12151,NA,NA,NA,NA,2,NA,NA,13412,NA
11188444,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012152,NA,NA,1ZIABC012152-02,NCI:230961\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8123309 (contact),"REILLY, KARLYNE M (contact)",NA,NA,NA,Adolescent and Young Adult;Affect;Binding;Biological;Biological Models;Biology;Cancer cell line;Cell Death;Cell Line;Cell membrane;Cell Nucleus;Cells;Characteristics;Chordoma;Chromatin;Clinical;Clinical Trials;Clinical Trials Design;cohort;Combined Modality Therapy;Dependence;design;drug candidate;Drug Modelings;drug repurposing;Drug Screening;Drug Synergism;drug testing;effective therapy;Energy-Generating Resources;Engineering;Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;epigenomics;Experimental Designs;experimental study;Extracellular Matrix Proteins;EZH2 gene;FDA approved;Goals;Growth;Growth Factor;Health Sciences;high throughput screening;Histology;improved;inhibitor;insight;Intervention;Kidney;Learning;Libraries;Liver;Malignant Neoplasms;Metabolic;metabolic abnormality assessment;Modeling;Molecular;Molecular Conformation;molecular subtypes;novel;Nutrient;Oregon;Organ;Pathway interactions;patient derived xenograft model;Patients;Pattern;Pediatric Neoplasm;Pharmaceutical Preparations;Population;Prognosis;rare cancer;Ras Signaling Pathway;Reagent;Research;Skin;SMARCB1 gene;solute;Starvation;Stomach;targeted treatment;Testing;Tissue Microarray;Tissues;tool;transcriptomics;trial design;tumor;Universities;Visualization;Work,Biology and molecular vulnerabilities in SMARCB1-deficient tumors,12152,NA,NA,NA,NA,2,NA,NA,230961,NA
11188445,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012153,NA,NA,1ZIABC012153-02,NCI:788231\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9414416 (contact),"YANG, JAMES C (contact)",NA,NA,NA,3-Dimensional;Adoptive Cell Transfers;Antigens;Autologous;cancer regression;Carcinoma;Cholangiocarcinoma;Clinical;Clinical Protocols;Colon Carcinoma;Data;Immune;Malignant Breast Neoplasm;Malignant neoplasm of pancreas;Malignant Neoplasms;Methods;Mutation;neoantigens;Organoids;Orphan;Patients;response;screening;success;T cell response;T cell therapy;T-Lymphocyte;Technology;Treatment Failure;tumor;Tumor Antigens;two-dimensional,Studying Immune Recognition of Epithelial Cancers Using Organoids,12153,NA,NA,NA,NA,2,NA,NA,788231,NA
11188446,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012154,NA,NA,1ZIABC012154-02,NCI:546592\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79355545 (contact),"KRISHNA, SRI  (contact)",NA,NA,NA,Alleles;Antibodies;antigen-specific T cells;Appointment;Bar Codes;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;Cell Separation;Cell Therapy;Cells;Cellular immunotherapy;Common Neoplasm;DNA;driver mutation;engineered T cells;Engineering;Epithelium;Equipment;gene therapy;Haplotypes;Histocompatibility Antigens Class I;HLA Antigens;Human;invention;KRAS2 gene;Libraries;Malignant Neoplasms;mutant;Mutate;Mutation;National Cancer Institute;NCI Center for Cancer Research;neoantigens;Oligonucleotides;Papillomavirus;Patients;Peptides;peripheral blood;Phenotype;Positioning Attribute;Postbaccalaureate;Postdoctoral Fellow;Proteomics;Reagent;recruit;Research;Research Personnel;Sampling;Source;T cell receptor repertoire sequencing;T-Cell Receptor;T-Lymphocyte;Technology;tenure track;Tissue Sample;transcriptome sequencing;tumor;Tumor Antigens;Tumor-Infiltrating Lymphocytes;Virus,Identifying antitumor T cell receptors for cellular immunotherapy,12154,NA,NA,NA,NA,2,NA,NA,546592,NA
11188447,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012155,NA,NA,1ZIABC012155-02,NCI:366290\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10712486 (contact),"LUO, JI  (contact)",NA,NA,NA,adult stem cell;Affect;Age;age effect;age related;age related decline;Aging;Alveolar;alveolar type II cell;Bone Marrow Transplantation;cancer initiation;Cancer Model;Cells;Chemicals;Computer software;Cutaneous;Development;Disease;Ectoderm;Endoderm;Environment;epigenomics;experimental study;Gene Expression Profile;Genetic;human old age (65+);Immune;Immune response;Immune system;In Vitro;Inflammation;Intervention;Intrinsic factor;keratinocyte;Lesion;Lung;Lung Adenocarcinoma;Macrophage;Malignant neoplasm of lung;Malignant Neoplasms;Metastatic Neoplasm to the Lung;Modeling;Monitor;mouse model;Mus;Mutagens;mutant;Myeloid Cells;old mice;Oncogenes;Oncogenic;Phosphopeptides;phosphoproteomics;Phosphotransferases;Play;Primary Cell Cultures;Process;ras Oncogene;Ras Signaling Pathway;Role;self-renewal;Signal Transduction;single-cell RNA sequencing;Skin;Skin Cancer;stem cells;Study models;Testing;Tissues;transcriptomics;Transplantation;tumor;tumor behavior;tumor growth;tumor initiation;tumor microenvironment;Tumor Promotion;Tumor Suppressor Genes;Tumor-associated macrophages;tumorigenesis;tumorigenic;Tumorigenicity,Factors that influence age-dependent Ras mutant cancer development in mice,12155,NA,NA,NA,NA,2,NA,NA,366290,NA
11188448,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012156,NA,NA,1ZIABC012156-02,NCI:546592\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79355545 (contact),"KRISHNA, SRI  (contact)",NA,NA,NA,Adoptive Cell Transfers;antigen-specific T cells;Appointment;Blood;cancer cell;cancer immunotherapy;Cancer Patient;Carcinoma;CD86 gene;CD8B1 gene;Cell Physiology;Cell Proliferation;Cell Surface Proteins;Cell Therapy;Cells;Deposition;Disseminated Malignant Neoplasm;draining lymph node;Engineering;Equipment;exhaust;exhaustion;Failure;Frequencies;Functional disorder;Genetic Transcription;Goals;Human;human model;immune checkpoint blockade;Immunity;Impairment;improved;In Vitro;Journals;Mediating;Membrane Proteins;mouse model;National Cancer Institute;NCI Center for Cancer Research;neoantigens;Neoplasm Metastasis;Patients;peripheral blood;Phenotype;Population;Postbaccalaureate;Postdoctoral Fellow;Preparation;programmed cell death protein 1;Property;prospective;protein biomarkers;protein expression;Publishing;Reagent;recruit;Research;Research Personnel;Sensitivity and Specificity;Solid;Source;stem;success;T cell differentiation;T-Lymphocyte;Technology;tenure track;Testing;Tissues;transcriptomics;tumor;Tumor Expansion,Studying phenotypic states of antitumor human T cells,12156,NA,NA,NA,NA,2,NA,NA,546592,NA
11188449,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012157,NA,NA,1ZIABC012157-02,NCI:971478\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11142408 (contact),"KOCHENDERFER, JAMES  (contact)",NA,NA,NA,American Society of Hematology;Animals;Autoimmune Diseases;CAR T cell therapy;chimeric antigen receptor T cells;Clinical Trials;Development;Goals;In Vitro;in vitro testing;invention;Laboratory Study;Legal patent;Malignant Neoplasms;meetings;Mus;Play;Preparation;Role;Series;T-Cell Receptor;T-Lymphocyte;Testing;Work;γδ T cells,Development of CAR T cells targeting T-cell malignancies,12157,NA,NA,NA,NA,2,NA,NA,971478,NA
11188450,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012158,NA,NA,1ZIABC012158-02,NCI:809564\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11142408 (contact),"KOCHENDERFER, JAMES  (contact)",NA,NA,NA,Acute;Acute Myelocytic Leukemia;Antigens;Autologous;Cell Line;chimeric antigen receptor T cells;Clinical Protocols;clinical trial enrollment;Collaborations;Dysmyelopoietic Syndromes;Genes;genetically modified cells;Goals;Hematologic Neoplasms;Human;In Vitro;mouse model;Mus;Mutate;Mutation;Myeloproliferative disease;neoantigens;participant enrollment;Phase I Clinical Trials;preclinical study;Process;Protocols documentation;T cell therapy;T-Cell Receptor;T-Lymphocyte;targeted treatment;Testing;therapy development;Time;Writing,Adoptive T-cell Therapies Targeting Mutations in Hematologic Malignancies,12158,NA,NA,NA,NA,2,NA,NA,809564,NA
11188451,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012161,NA,NA,1ZIABC012161-01,NCI:1430563\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79972104 (contact),"ALDRICH, LESLIE  (contact)",NA,NA,NA,Affect;Autophagocytosis;Binding;Biochemistry;Biological;Biological Assay;Biological Process;Biology;Cancer Biology;cancer therapy;Catabolic Process;Cells;Cellular biology;Chemicals;Complex;Development;Disease;disease phenotype;drug discovery;Endosomes;Energy Transfer;Eukaryota;Evaluation;Fluorescence Polarization;Goals;Health;healthy aging;high throughput screening;Homeostasis;Human;human disease;improved;in vivo;inhibition of autophagy;inhibitor;Interdisciplinary Study;interest;Laboratories;Lamin Type A;Lead;Lipids;Lysosomes;Malignant Neoplasms;Medical;Neurodegenerative Disorders;new therapeutic target;novel;novel therapeutic intervention;novel therapeutics;Organic Chemistry;Pathway interactions;Pharmaceutical Chemistry;Phenotype;Phosphotransferases;Positioning Attribute;protein protein interaction;Proteins;Recycling;research clinical testing;Role;screening;small molecule;small molecule inhibitor;targeted treatment;Therapeutic;therapeutic development;therapeutic target;trafficking,Development of small-molecule autophagy modulators,12161,NA,NA,NA,NA,1,NA,NA,1430563,NA
11188452,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012162,NA,NA,1ZIABC012162-01,NCI:1088170\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79972106 (contact),"DZUTSEV, AMIRAN  (contact)",NA,NA,NA,Affect;Animal Model;anti-cancer research;Bacteria;cancer immunotherapy;cancer therapy;CAR T cell therapy;Clinical Trials;commensal microbes;Complex;detection method;Development;Distant;Ecosystem;Elements;fungus;host-associated microbial communities;host-microbe interactions;Human;human subject;Immune checkpoint inhibitor;Immune response;Immunotherapy;improved;Investigation;Malignant Neoplasms;Manipulative Therapies;Methodology;Methods;Microbe;microbial;microbial products;microbiome;microbiota;microorganism;Mucous Membrane;Multiomic Data;Natural Killer Cells;Neoplasm Metastasis;neoplastic cell;novel;Organ;Outcome;Patients;pre-clinical;Primary Neoplasm;Property;Research;Risk;Role;Sensitivity and Specificity;Site;Skin;Surface;T cell therapy;T-Lymphocyte;Tissues;tool;tumor;tumor progression;Virus;Work,"Investigation of role of microbiota in development, progression and therapy of cancers",12162,NA,NA,NA,NA,1,NA,NA,1088170,NA
11188453,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012163,NA,NA,1ZIABC012163-01,NCI:569113\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79972108 (contact),"HARMON, STEPHANIE  (contact)",NA,NA,NA,advanced prostate cancer;Appearance;Appointment;Architecture;artificial intelligence algorithm;autoencoder;Biological;Biological Markers;Biopsy;cancer cell;Clinical;clinical implementation;Clinical Management;Clinical Protocols;Clinical Trials;cohort;Collaborations;Collection;Complex;cost effective;Data;Development;digital;digital pathology;Disease;Equipment;genomic predictors;Genomics;Heterogeneity;Image;image processing;imaging biomarker;Individual;Institution;Literature;Localized Disease;Machine Learning;Magnetic Resonance Imaging;Malignant neoplasm of prostate;Malignant neoplasm of urinary bladder;Malignant Neoplasms;Measures;Medical;Metastatic Prostate Cancer;Methods;model development;Modeling;Molecular;molecular imaging;Morphology;mortality;Multi-Institutional Clinical Trial;Multimodal Imaging;multimodality;National Cancer Institute;NCI Center for Cancer Research;neoplastic cell;novel;Nuclear;Operative Surgical Procedures;Outcome;outcome prediction;Pathology;pathology imaging;Patient-Focused Outcomes;Patients;Pattern;Postbaccalaureate;Postdoctoral Fellow;predicting response;predictive modeling;predictive tools;Process;prognostic;Radical Prostatectomy;radiological imaging;Reagent;recruit;Research;Research Personnel;research study;response;Sampling;Scanning;Space Perception;Specimen;standard of care;Systemic Therapy;Techniques;Technology;tenure track;therapeutic development;therapy resistant;tool;Training;Translating;Translations;Validation;Work,Development and Validation of Artificial Intelligence Algorithms in Digital Pathology,12163,NA,NA,NA,NA,1,NA,NA,569113,NA
11188454,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012164,NA,NA,1ZIABC012164-01,NCI:600568\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79972110 (contact),"MONTEIRO, DIANA  (contact)",NA,NA,NA,Academia;Adopted;Affect;beamline;Biology;CCR;Chemicals;Chimeric Proteins;Collaborations;Communication;Crystallization;Crystallography;data analysis pipeline;data handling;Death Rate;Development;Drug Design;drug development;drug discovery;Emerging Communicable Diseases;experimental study;Funding;Hand;Harvest;Immunocompromised Host;Industrialization;Infrastructure;instrumentation;Laboratories;large datasets;Liquid substance;Malignant Neoplasms;Metabolic Pathway;Natural Products;Oncogenic;Proteins;Robot;Roentgen Rays;Sampling;Sarcoma;Science;screening;Source;Structure;Synchrotrons;Technology,High throughput crystallographic compound screening,12164,NA,NA,NA,NA,1,NA,NA,600568,NA
11188455,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012165,NA,NA,1ZIABC012165-01,NCI:1186242\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79972112 (contact),"NIETHAMER, TERREN  (contact)",NA,NA,NA,activating transcription factor 3;Acute;Adult;adult stem cell;Alveolar;Appointment;Atlases;Blood capillaries;Blood Vessels;Cancer Biology;Capillary Endothelial Cell;cell behavior;Cell Line;Cell Proliferation;cell type;Cells;Chronic lung disease;Communication;Complex;Confocal Microscopy;Development;Developmental Biology;Distal;Embryo;Endothelial Cells;Endothelium;Epithelium;Equipment;functional restoration;Future;Gases;Heterogeneity;Homeostasis;Impairment;Individual;Infection;Injury;Interferons;Laboratories;Lung;lung development;lung regeneration;lung repair;Malignant neoplasm of lung;Maps;Mus;National Cancer Institute;Natural regeneration;NCI Center for Cancer Research;Population;Postbaccalaureate;Postdoctoral Fellow;postnatal;postnatal development;Process;Pulmonary alveolar structure;Reagent;recruit;Regenerative research;Research;Research Personnel;research study;Resources;response to injury;Role;Signal Transduction;single-cell RNA sequencing;Specific qualifier value;Structure;Structure of parenchyma of lung;targeted treatment;Technology;tenure track;Tissues;Training;transcription factor;Vascular regeneration;Viral;Virus Diseases;Work,Endothelial plasticity and signaling in development and regeneration of the lung,12165,NA,NA,NA,NA,1,NA,NA,1186242,NA
11188456,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012166,NA,NA,1ZIABC012166-01,NCI:436070\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79972114 (contact),"TSCHERNIA, NICHOLAS  (contact)",NA,NA,NA,bench to bedside;Cell Therapy;clinical center;clinically actionable;cytokine release syndrome;Dedications;Development;digital health;Early identification;Educational workshop;Extramural Activities;Fostering;Futility;Goals;Immune;industry partner;investigator-initiated trial;Laboratories;laboratory equipment;Malignant Neoplasms;Monitor;NCI Center for Cancer Research;novel;Outcome;Protocols documentation;Secondary to;Solid Neoplasm;Temperature;Testing;Toxic effect;United States National Institutes of Health;wearable device;Work;Writing,Cellular Therapy Discovery for Solid Tumors,12166,NA,NA,NA,NA,1,NA,NA,436070,NA
11188457,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012167,NA,NA,1ZIABC012167-01,NCI:1914491\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8778172 (contact),"CHOYKE, PETER L (contact)",NA,NA,NA,Age;Area;artificial intelligence model;cancer therapy;Classification;clinical decision-making;Data;Diagnosis;Diagnostic;Disease;Goals;Human;Image;improved;Lesion;Magnetic Resonance Imaging;Malignant neoplasm of prostate;Outcome;Patients;Positron-Emission Tomography;prognostic tool;Prostate;PSA level;radiologist;Radiopharmaceuticals;Research;Research Personnel;Scanning;Screening for Prostate Cancer;tumor;Work,Radiopharmaceutical Imaging and Therapy of Cancer,12167,NA,NA,NA,NA,1,NA,NA,1914491,NA
11188458,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012169,NA,NA,1ZIABC012169-01,NCI:891939\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79972117 (contact),"NGUYEN, JOE  (contact)",NA,NA,NA,Affect;Algorithms;Area;Biopsy;cancer cell;carcinogenesis;cell behavior;Cell Line;Cells;Clinical;Clustered Regularly Interspaced Short Palindromic Repeats;Complex;CRISPR/Cas technology;Data;Data Set;Death Rate;deep learning;deep learning model;Development;diagnostic strategy;diagnostic tool;Disease Progression;Early Diagnosis;Engineering;Environment;Future;gene network;Generations;Genes;Genetic Engineering;Goals;Head and Neck Cancer;high risk;Human;improved;individual patient;innovation;insight;Intervention;Investigation;Knock-out;Mediating;metabolomics;Methodology;mimetics;Modeling;Molecular;mouse model;mouth squamous cell carcinoma;multidisciplinary;Multiomic Data;multiple omics;Mus;new therapeutic target;novel;oral lesion;Pathogenesis;Patient-Focused Outcomes;Patients;Pattern;personalized diagnostics;personalized strategies;Phylogenetic Analysis;Play;potential biomarker;premalignant;programs;Proteomics;Regulatory Pathway;Research;Risk Assessment;Role;Sensitivity and Specificity;Signal Transduction;single-cell RNA sequencing;Smoker;Spatial Distribution;targeted treatment;Therapeutic Intervention;therapeutic target;Tissues;Tobacco;tongue root;Training;transcriptomics;treatment strategy;tumor;Tumor Burden;tumor progression;tumor-immune system interactions,Unraveling the Molecular Underpinnings of Premalignant Oral Lesion Transformation into Head and Neck Cancer,12169,NA,NA,NA,NA,1,NA,NA,891939,NA
11188459,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012170,NA,NA,1ZIABC012170-01,NCI:1220219\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79972119 (contact),"COOK, LEAH  (contact)",NA,NA,NA,Appointment;bone;Bone neoplasms;Disease;Environment;Equipment;ethnic diversity;Goals;Immune;innovation;Laboratories;Malignant Neoplasms;Metastatic Neoplasm to the Bone;Metastatic Prostate Cancer;Modeling;National Cancer Institute;NCI Center for Cancer Research;Neoplasm Metastasis;neutrophil;Patients;Postbaccalaureate;Postdoctoral Fellow;Process;programs;Reagent;recruit;Research;Research Personnel;research study;Role;Technology;Training,Investigating the role of neutrophils in bone metastasis,12170,NA,NA,NA,NA,1,NA,NA,1220219,NA
11188460,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012173,NA,NA,1ZIABC012173-01,NCI:309964\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9786523 (contact),"KRUG, LAURIE T (contact)",NA,NA,NA,Address;American;Antibodies;Antigens;B-Lymphocytes;Biological Assay;cell type;Cells;Clinical;Collaborations;Data;design;Disease;Engineering;Funding;gammaherpesvirus;Genome;Glycoproteins;Herpesviridae;Herpesviridae Infections;Heterogeneity;Human;Human Herpesvirus 4;Human Herpesvirus 8;human model;immune activation;Immune Evasion;Immune response;Immunocompetent;immunogenicity;Immunosuppression;in vivo;in vivo Model;Incidence;Infectious Mononucleosis;Institution;Laboratories;Link;Lytic;Malignant Neoplasms;Modeling;Multiple Sclerosis;Mus;novel;pathogen;Pathogenesis;Patients;Pattern;prevent;programs;Proteins;Protocols documentation;Recombinants;response;Role;Serum;Standardization;Structure;System;T-Lymphocyte;Testing;Tissues;United States;Vaccinated;Vaccination;vaccination strategy;vaccine efficacy;vaccine formulation;vaccine platform;Vaccines;Validation;Viral Antigens;Virus,Strategic Herpesvirus Immune Evasion and Latency Defense,12173,NA,NA,NA,NA,1,NA,NA,309964,NA
11188461,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012175,NA,NA,1ZIABC012175-01,NCI:129229\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687355 (contact),"YOHE, MARIELLE  (contact)",NA,NA,NA,Adult;checkpoint inhibition;Child;Childhood;Childhood Melanoma;Clinical;cohort;Evaluation;Family;Funding;Germ Lines;Guidelines;humanized mouse;immune checkpoint;Immunocompetent;improved;Inherited;inhibitor;MAP Kinase Gene;Melanoma;Modeling;molecular marker;mouse model;Mutation;novel;Outcome;Pathway interactions;preclinical study;Prospective Studies;Research;Resistance;resistance mechanism;Risk;Sampling;Susceptibility Gene;therapeutic target;transcriptome sequencing;transcriptomics;treatment guidelines;treatment response;tumor;variant of unknown significance;whole genome,Improving Pediatric Melanoma Outcomes in a Longitudinally Evaluated Cohort,12175,NA,NA,NA,NA,1,NA,NA,129229,NA
11188462,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012176,NA,NA,1ZIABC012176-01,NCI:570593\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857423 (contact),"HANNENHALLI, SRIDHAR  (contact)",NA,NA,NA,Address;Adrenocortical Carcinoma;Affect;African;Aftercare;anti-cancer research;Bacteria;Benchmarking;Binding;Biological Process;Brain Neoplasms;cancer cell;Cancer Etiology;Cancer Patient;cancer subtypes;cancer type;Cell Fraction;Cell Line;cell type;Cells;Cessation of life;chemotherapy;Clinical;Clinical Trials;Code;Collaborations;CRISPR/Cas technology;Data;data integration;Data Set;differential expression;Disease;Disparate;Disseminated Malignant Neoplasm;DNA Sequence Alteration;Drug resistance;drug sensitivity;Drug Targeting;Endothelium;Epigenetic Process;Etiology;Exhibits;extracellular vesicles;Future;Gene Expression;Genes;Genetic Polymorphism;genetic signature;Genetic Transcription;Heterogeneity;Human;immune checkpoint blockade;Immune response;Immunotherapy;improved;Incidence;Knock-out;Liver;Lung;Lymphoid;Malignant Breast Neoplasm;Malignant neoplasm of lung;Malignant neoplasm of prostate;Malignant Neoplasms;Manuscripts;Mediating;Mediator;Melanoma;men;Metastatic malignant neoplasm to brain;Metastatic Melanoma;metastatic process;Modeling;mouse model;Mutation;Myelogenous;Neoplasm Metastasis;Network-based;non-genetic;novel;Patients;Pharmaceutical Preparations;Pharmacotherapy;polygenic risk score;Population;Predictive Factor;prognostic;programs;Property;Publishing;Resistance;responders and non-responders;response;Role;Shapes;single-cell RNA sequencing;Stimulus;Therapeutic;therapy resistant;Thinness;Tissues;tool;transcription factor;transcriptomics;Treatment Failure;treatment response;triple-negative invasive breast carcinoma;tumor;tumor microenvironment;tumor-immune system interactions;tumorigenesis;tumorigenic;Untranslated RNA;Work;Writing;Yeasts,Transcriptional heterogeneity and regulatory mechanisms in tumor microenvironment,12176,NA,NA,NA,NA,1,NA,NA,570593,NA
11188463,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012177,NA,NA,1ZIABC012177-01,NCI:644606\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857468 (contact),"ZHAO, CHEN  (contact)",NA,NA,NA,Affect;CD8-Positive T-Lymphocytes;Cell Physiology;Cells;Dendritic Cells;imaging system;Immune;Immunotherapy;Knowledge;Label;lymph nodes;Mediating;Memory;Methods;Monitor;Non-Small-Cell Lung Carcinoma;Pathway interactions;Play;recruit;Reporter;Role;System;T-Lymphocyte;therapeutic target;Time;tumor;Tumor Immunity;tumor microenvironment;two-photon,Elucidate how dendritic cells affect T cells' function in the TME of non-small cell lung cancer,12177,NA,NA,NA,NA,1,NA,NA,644606,NA
11188464,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012178,NA,NA,1ZIABC012178-01,NCI:644606\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857468 (contact),"ZHAO, CHEN  (contact)",NA,NA,NA,Address;Alveolar Macrophages;CD8-Positive T-Lymphocytes;Cell Physiology;Crossbreeding;Enterobacteria phage P1 Cre recombinase;Genetic;innovation;ITGAX gene;Lung;Macrophage;Mediating;Modeling;Modification;mouse model;Mouse Strains;Mus;new therapeutic target;Non-Small-Cell Lung Carcinoma;Pathway interactions;Population;Role;System;T-Lymphocyte;Tissues;treatment strategy;tumor;tumor microenvironment,Study the interactions between alveolar macrophages and T cells in non-small cell lung cancer,12178,NA,NA,NA,NA,1,NA,NA,644606,NA
11188465,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012179,NA,NA,1ZIABC012179-01,NCI:400379\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79972110 (contact),"MONTEIRO, DIANA  (contact)",NA,NA,NA,Aconitic Acid;Active Sites;Binding;cancer cell;cancer therapy;Carboxy-Lyases;Cell Proliferation;Cells;chemotherapy;Crystallization;Crystallography;design;Environment;Enzymes;Goals;high throughput screening;Immune Evasion;Immune system;in silico;inhibitor;Ligands;Malignant Neoplasms;Metabolic;Metabolic Pathway;Metabolism;novel;novel therapeutics;Nutritional Requirements;Oncogenic;Pharmaceutical Chemistry;Play;protein expression;Proteins;Protocols documentation;Regulation;Resolution;screening;small molecule;Structure;Structure-Activity Relationship;Testing;Tissues;trait;tumor growth;Work,hIRG1 medicinal chemistry effort,12179,NA,NA,NA,NA,1,NA,NA,400379,NA
11188466,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012181,NA,NA,1ZIABC012181-01,NCI:200189\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79972110 (contact),"MONTEIRO, DIANA  (contact)",NA,NA,NA,Biological Assay;Cancer Patient;Cancer Prognosis;Cells;Clinical Trials;Collaborations;Communicable Diseases;Complex;Crystallization;Data;design;DNA biosynthesis;DNA Repair;Drug Design;drug discovery;Drug Targeting;Environment;in vivo;Inhibition of Cell Proliferation;inhibitor;interest;Ligands;Malignant Breast Neoplasm;Malignant neoplasm of pancreas;Malignant Neoplasms;Modeling;Monitor;novel;Oncogenic;Organism;overexpression;Penetration;Play;Prognosis;Proliferating Cell Nuclear Antigen;Proteins;Role;scaffold;screening;structural biology;Structure;Techniques;Testing;therapeutic target;Trypanosoma brucei brucei;Virginia,PCNA as an oncogenic drug target,12181,NA,NA,NA,NA,1,NA,NA,200189,NA
11188467,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012182,NA,NA,1ZIABC012182-01,NCI:500473\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79972110 (contact),"MONTEIRO, DIANA  (contact)",NA,NA,NA,Basic Science;biophysical analysis;cancer type;Cancerous;CCR;Cells;Cessation of life;Chimeric Proteins;Clinical;Development;Disease;FOXO1A gene;high throughput screening;in silico;interest;Mediating;Modeling;new therapeutic target;novel;novel therapeutics;Oncogenic;Organic Chemistry;Pathway interactions;PAX3 gene;Peptides;protein degradation;protein phosphatase inhibitor-2;protein protein interaction;Proteins;Proteomics;Structure;Synthesis Chemistry;tool;Ubiquitin;Ubiquitination;Validation;working group,Structural studies of oncogenic fusion proteins and development of novel PROTACS,12182,NA,NA,NA,NA,1,NA,NA,500473,NA
11188468,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012185,NA,NA,1ZIABC012185-01,NCI:300284\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79972110 (contact),"MONTEIRO, DIANA  (contact)",NA,NA,NA,Affect;Architecture;Brain;Cell Physiology;Collaborations;design;Drug Design;in silico;inhibitor;Modeling;Molecular;novel;novel therapeutics;prolyl oligopeptidase;Protein Secretion;Resolution;Serine Protease;Signal Transduction;Signaling Protein;Structure;Structure-Activity Relationship,Structure-activity relationships in PreP inhibitor design,12185,NA,NA,NA,NA,1,NA,NA,300284,NA
11188469,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012187,NA,NA,1ZIABC012187-01,NCI:767708\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162076 (contact),"SHAH, NIRALI  (contact)",NA,NA,NA,Acute leukemia;Address;Adult;Affect;American;anakinra;antagonist;Antibodies;Antigens;Award;B lymphoid malignancy;B-Cell Acute Lymphoblastic Leukemia;B-Cell Leukemia;B-Cell Lymphomas;Back;bench to bedside;Biological;Biology;Blood Coagulation Disorders;Blood Component Removal;CAR T cell therapy;CD22 gene;CD28 gene;CD3 Antigens;CD8B1 gene;Cell Therapy;Cells;cellular engineering;Child;Childhood;chimeric antigen receptor T cells;Clinical;clinical center;clinical investigation;Clinical Trials;clinically relevant;Collaborations;combinatorial;Communicable Diseases;Consensus;Cryopreservation;cytokine;cytokine release syndrome;cytopenia;Dedications;Development;Disease remission;Dose;early phase clinical trial;Effector Cell;Evaluation;experience;Ferritin;Foundations;Functional disorder;Future;Goals;Guidelines;Hematologic Neoplasms;Hematology;Hemophagocytic Lymphohistiocytoses;Hepatic;high dimensionality;high risk;Hydrocortisone;IL18 gene;Immune;immune effector cell-associated neurotoxicity syndrome;Immunotherapeutic agent;Immunotherapy;improved;improved outcome;Incidence;Inflammation;Inflammatory;Inflammatory Response;Infrastructure;Infusion procedures;insight;Interferon Type II;Interleukin-1 Receptors;interpatient variability;Investigation;Knowledge;Late Effects;Learning;leukemia/lymphoma;Life;Lymphopenia;Macrophage activation syndrome;manufacture;Mediating;Minor;Mission;Modeling;Modification;Multicenter Trials;multidisciplinary;Multiple Myeloma;Myeloid Leukemia;Myeloproliferative disease;National Comprehensive Cancer Network;Natural Killer Cells;Non-Malignant;novel;novel strategies;novel therapeutics;Oncology;Outcome;Package Insert;Patient-Focused Outcomes;Patients;pre-clinical;predictive tools;prevent;Process;Production;Prognosis;programs;Protocols documentation;Publishing;Recovery;Refractory;Relapse;Reporting;Research;Resistance;response;Rheumatology;Risk;Risk Factors;risk mitigation;Role;Scientific Advances and Accomplishments;Severities;Societies;Syndrome;synergism;T-Lymphocyte;Testing;Therapeutic;Therapeutic Index;tocilizumab;Toxic effect;transplantation therapy;treatment strategy;United States National Institutes of Health;Vision;Work;young adult;γδ T cells,Comprehensive Interrogation of Toxicity Profiles Associated with Novel CAR T-cell Constructs,12187,NA,NA,NA,NA,1,NA,NA,767708,NA
11188470,ZIA,CA,1,N,NA,NA,NA,NA,ZIABC012188,NA,NA,1ZIABC012188-01,NCI:197970\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857470 (contact),"DAVIES, ERIN  (contact)",NA,NA,NA,4-Hydroxy-Tamoxifen;Adult;adult stem cell;Animals;Behavior;Catalytic RNA;cell fate specification;Cell Lineage;Cells;Chimeric Proteins;Clone Cells;CRISPR/Cas technology;Development;Event;Fluorescence Microscopy;Generations;Genetic Recombination;Germ Cells;Goals;Guide RNA;Homeostasis;imaging approach;Inherited;Label;Maintenance;marine;Mediating;Monitor;Natural regeneration;Pharmaceutical Preparations;Physiological;Platyhelminths;Population;Production;promoter;regenerative;Regulation;Reporter;RNA;Somatic Cell;stem cell fate;stem cells;System;Technology;Testing;Tissues;tool;Transgenic Organisms;Work,Development of transgenic tools to assess adult stem cell potency and behavior in the regenerative flatworm Macrostomum lignano,12188,NA,NA,NA,NA,1,NA,NA,197970,NA
11188471,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL040003,NA,NA,1ZIACL040003-22,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,1931303 (contact),"SUMMERS, RONALD M. (contact)",NA,NA,NA,Abdominal Aortic Aneurysm;abdominal CT;accurate diagnosis;Affect;American;Area;Atherosclerosis;Body Composition;bone;Cancer Etiology;Cathartics;Cessation of life;Colon;Colonic Polyps;Colonoscopy;Colorectal;Colorectal Cancer;colorectal cancer screening;Computed Tomographic Colonography;computer aided detection;Computer software;Consumption;deep learning;Densitometry;detection platform;Diabetes Mellitus;Diagnosis;Disease;Economics;follow-up;Future;Goals;Human;Image;improved;Incidence;Intestines;Kidney Calculi;Laboratories;Length;Malignant Neoplasms;Measures;Metabolic syndrome;Methods;Minerals;Modification;Optics;Osteoporosis;Pancreas;Patients;Perception;Physicians;Polyps;Preparation;radiologist;sarcopenia;screening;Sedation procedure;Sensitivity and Specificity;software development;Techniques;Testing;Time;Training;Tube;X-Ray Computed Tomography,Computer Aided Detection for CT Colonography,40003,NA,NA,NA,NA,22,NA,NA,0,NA
11188472,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL040004,NA,NA,1ZIACL040004-22,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,1931303 (contact),"SUMMERS, RONALD M. (contact)",NA,NA,NA,Abdomen;abdominal CT;Algorithms;Arterial Fatty Streak;Artificial Intelligence;Big Data;Body Composition;Clinical;computer aided detection;Computer Assisted;Computer-Assisted Diagnosis;Computers;convolutional neural network;Data;deep learning;Detection;Diagnosis;Diagnostic;diagnostic accuracy;Diagnostic Errors;Disease;disease diagnosis;Early Diagnosis;Edema;Health;Image;image registration;improved;Kidney;large language model;Lead;Lesion;Liver;Machine Learning;Magnetic Resonance Imaging;Measurement;Medical Imaging;Methods;MRI Scans;Muscle;Network-based;Organ;Pancreas;Patients;Performance;Phase;Physicians;radiological imaging;radiologist;Reporting;Roentgen Rays;Scientific Advances and Accomplishments;skills;Spleen;Techniques;Training;training data;United States National Institutes of Health;Variant;X-Ray Computed Tomography,Computer Aided Detection for Radiologic Images,40004,NA,NA,NA,NA,22,NA,NA,0,NA
11188473,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090033,NA,NA,1ZIACL090033-12,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,12471618 (contact),"MANNES, ANDREW  (contact)",NA,NA,NA,7q11.23;Absence of pain sensation;Acute Pain;Address;Advanced Malignant Neoplasm;Affect;Afferent Neurons;Agonist;Analgesics;Anesthesia procedures;Animals;Arthralgia;Autopsy;Axon;Basic Science;Behavior;Binding;Biological;Brain;Calcium;Calcium ion;cancer pain;Case Study;Cells;Central Nervous System;Cerebrospinal Fluid;chronic pain;chronic painful condition;Clinical;Clinical Protocols;Clinical Research;clinical trial protocol;Clinical Trials;Collaborations;Copy Number Polymorphism;Coupled;cytotoxicity;density;Development;direct application;Dorsal;Dose;effective intervention;Exhibits;experimental study;FDA approved;Gene Expression;Genes;Genetic;Genetic Variation;genomic locus;Goals;Human;human tissue;Immune;Immunofluorescence Immunologic;In Situ Hybridization;Individual;Infiltration;Inflammation;information processing;Injections;injured;Institutional Review Boards;Intervention;Intractable Pain;Investigation;Ion Channel;Joints;Knowledge;Lesion;Lidocaine;Mechanics;Mediating;Methodology;Modeling;Molecular;Molecular Biology;Morton&apos;s Neuroma;Motor;National Center for Complementary and Integrative Health;National Institute on Deafness and Other Communication Disorders;Nerve;Nerve Endings;Nerve Fibers;nerve injury;Neuroma;Neuronal Plasticity;Neurons;neurosurgery;Nociception;Nociceptors;novel therapeutic intervention;oral mucositis;Organ Donor;osteoarthritis pain;overexpression;Pain;Pain management;pain processing;Pain Research;pain sensation;pain sensitivity;pain signal;painful neuropathy;Pathway interactions;Patients;perineural;Peripheral;Peripheral Nerves;Peripheral Nervous System;Persistent pain;Phantom Limb Pain;pharmacologic;Pharmacotherapy;phase 1 study;Phase I Clinical Trials;Physiological Processes;Pilot Projects;pre-clinical;Pre-Clinical Model;preclinical study;preservation;pressure;prevent;Process;programs;Property;Proprioception;Proteins;Protocols documentation;Publications;Publishing;Regional Cancer;Research;Resiniferatoxin;Route;Sensory Ganglia;Serious Adverse Event;Signal Transduction;single nucleus RNA-sequencing;Site;Skin;small molecule;sodium ion;species difference;Spinal Cord;Spinal Ganglia;Stains;subcutaneous;Surgical incisions;Synapses;Techniques;Therapeutic;Therapeutic Agents;Time;tissue injury;Tissues;Touch sensation;transcriptome sequencing;Transducers;translational potential;Translational Research;translational study;transmission process;Trigeminal Neuralgia;TRPV1 gene;United States National Institutes of Health;wound healing;Writing,Integrative And Molecular Studies Of Pain And Pain Control,90033,NA,NA,NA,NA,12,NA,NA,0,NA
11188474,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090034,NA,NA,1ZIACL090034-12,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,12471618 (contact),"MANNES, ANDREW  (contact)",NA,NA,NA,Acute Pain;Adaptive Immune System;Address;Affect;Afferent Neurons;Analgesics;Animal Model;Animals;Antibodies;antibody detection;antigen test;Antigens;Autoantibodies;Autoantigens;Autoimmune;Autoimmune Diseases;Autoimmune Process;Autoimmune Responses;Autoimmunity;Autopsy;Bacterial Infections;Biological;Biological Assay;Biological Factors;Biological Markers;Body part;C Fiber;Cell membrane;Cell Surface Proteins;Cells;Central Nervous System;Cerebrospinal Fluid;Cessation of life;chemotherapeutic agent;Chemotherapy-induced peripheral neuropathy;Chickenpox;Chronic;chronic neuropathic pain;chronic pain;chronic pain patient;chronic painful condition;Clinical;cohort;Communicable Diseases;Communication;Complex;cytokine;Data;Data Set;Diabetes Mellitus;diabetic;Diagnostic;diagnostic biomarker;diagnostic tool;Diameter;Disease;disorder control;drug development;Dysesthesias;Enzymes;Evaluation;Evolution;Extracellular Domain;Fiber;Ganglia;Generations;Genome;Goals;Headache;Herpes zoster disease;Herpesvirus 1;Herpesvirus Type 3;Human;human disease;Immune;Immune response;Immunology;Immunoprecipitation;Infection;Inflammation;Injury;Innate Immune System;insight;Intervention;Investigation;Ion Channel;Knowledge;latency associated transcript;Ligands;Liquid substance;Luciferases;luminescence;Maintenance;Mammalian Cell;Measures;Membrane;Membrane Proteins;Metabolic Diseases;Methodology;Migraine;Modeling;Molecular;Nature;Nerve;Nerve Endings;Nerve Fibers;nerve injury;Nervous System;Nervous System Disorder;neural;Neurobiology;Neuroimmunomodulation;Neurons;Neuropathy;Nociception;Nociceptors;Operative Surgical Procedures;Pain;pain chronification;Pain Disorder;painful neuropathy;Paraneoplastic Polyneuropathy;pathogenic autoantibodies;Pathogenicity;Pathologic;Patients;Peptides;Peripheral Nerves;Peripheral Nervous System Diseases;Persons;Pharmaceutical Preparations;Phase;Plasma;Postherpetic neuralgia;Predictive Value;Process;Production;Protein Fragment;Proteins;Publishing;receptor;Recombinant Proteins;Recording of previous events;Reporting;Research;Role;Saliva;Sampling;Schwann Cells;Serum;Signal Pathway;Signaling Protein;Specificity;Spinal Cord;Spinal cord damage;Structure of trigeminal ganglion;System;Technology;Testing;Thinking;Time;tissue injury;Tracer;Transcript;transcriptome;transcriptome sequencing;translational research program;Transmembrane Domain;transmission process;Trauma;Traumatic injury;Viral;virology;Virus;Virus Diseases;Whole Blood,Mechanisms of Pain and Immune Processes,90034,NA,NA,NA,NA,12,NA,NA,0,NA
11188475,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090035,NA,NA,1ZIACL090035-11,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,12471618 (contact),"MANNES, ANDREW  (contact)",NA,NA,NA,Absence of pain sensation;Acute Pain;Address;Analgesics;analog;Anesthetics;Animal Model;Autopsy;Axon;Basic Science;behavior measurement;Biochemical;Biological;Brain;Cancer Control;cancer pain;Canis familiaris;Capsaicin;Capsicum;CARTPT gene;Cells;chronic pain;chronic painful condition;clinical pain;clinical practice;Clinical Research;Clinical Trials;clinically relevant;Code;combinatorial;Communication;Complex;Custom;Data;Data Analyses;density;design;Development;Disease;dorsal horn;effective intervention;endogenous opioids;Environment;Enzymes;Esthesia;Experimental Models;Exposure to;Fluorescent in Situ Hybridization;ganglion cell;Gene Expression;gene induction;Generations;Genes;Goals;Hour;Human;human study;human tissue;Immune;In Situ;In Situ Hybridization;in vivo;Individual;Inflammation;Inflammatory;insight;Intervention;Investigation;Ion Channel;Knowledge;Leucocytic infiltrate;Ligands;lipidomics;Lipids;Macrophage;Measures;Mediating;Mediator;Messenger RNA;Methods;Molecular;Molecular Biology;Molecular Neurobiology;Molecular Profiling;mu opioid receptors;Muscle satellite cell;Nerve;nerve damage;nerve injury;neural;neural circuit;Neuroglia;neuronal cell body;Neurons;Neuropathy;Neuropeptides;neurotransmission;Nociception;Nociceptors;non-opioid analgesic;novel strategies;Opioid;Opioid agonist;opioid epidemic;Organ;Organ Donor;Pain;Pain management;pain sensation;painful neuropathy;Pathologic;Pathway interactions;Patient Recruitments;Patients;Peptides;perineural;Peripheral;Phenotype;Photobleaching;Physiology;Population;Process;prodynorphin;proenkephalin;programs;Proteins;Protocols documentation;Publications;Rattus;receptor;recruit;Regulation;Reporting;Research;Resiniferatoxin;Resolution;Rodent;Role;Route;Sampling;Sensory Nerve Endings;Signal Pathway;Signal Transduction;single nucleus RNA-sequencing;Site;Skin;software infrastructure;Spinal;Spinal Cord;Spinal Ganglia;Spine pain;Supporting Cell;Surgeon;Surgical incisions;System;Techniques;therapeutic development;Therapeutic Intervention;Therapeutic Uses;Time;Tissues;Transcript;transcriptome;transcriptome sequencing;transcriptomics;transmission process;TRPV1 gene;Work;wound;wound closure;wound healing,The Pain Neural Transcriptome,90035,NA,NA,NA,NA,11,NA,NA,0,NA
11188476,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090085,NA,NA,1ZIACL090085-03,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,15687400 (contact),"MERKE, DEBORAH  (contact)",NA,NA,NA,21-hydroxylase deficiency;adeno-associated viral vector;Adenovirus Vector;Adrenal Glands;Adult;Age;Animals;Biodistribution;Cardiovascular Diseases;Cessation of life;clinical development;Clinical Trials;Congenital adrenal hyperplasia;CYP21A2 gene;Death Rate;Dependovirus;design;Diagnosis;Dose;effective therapy;efficacy evaluation;enzyme activity;expression vector;first-in-human;gene therapy;Human;human study;Incidence;Injections;intravenous injection;Lead;Life;life span;Mendelian disorder;Metabolic Diseases;Monitor;Mus;nonhuman primate;open label;Participant;Patients;Phase;Phenotype;pre-clinical;programs;Quality of life;Recombinants;Research Design;Risk;Safety;safety assessment;Serotyping;sex;Shock;standard of care;Steroid biosynthesis;vector;vector genome;Weight Gain,Gene Therapy for Congenital Adrenal Hyperplasia through Administration of an Adeno-Associated Virus (AAV) Serotype 5-Based Recombinant Vector Encoding the Human CYP21A2,90085,NA,NA,NA,NA,3,NA,NA,0,NA
11188477,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090090,NA,NA,1ZIACL090090-03,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,15687400 (contact),"MERKE, DEBORAH  (contact)",NA,NA,NA,"21-hydroxylase deficiency;Adrenal Cortex Diseases;Adrenal Glands;Adult;Aldosterone;androgen excess;Androgens;Biochemical;Biological Markers;Circadian Rhythms;Clinical;clinical center;conventional therapy;design;Dexamethasone;disorder control;Dose;Failure;Formulation;Glucocorticoids;Goals;Growth;Hormonal;Hormone replacement therapy;Hormones;Hour;Hydrocortisone;improved;Infertility;International;Long-Term Effects;Menstruation;Metabolic syndrome;Multicenter Studies;novel;novel therapeutic intervention;Obesity;Osteoporosis;Outcome;Patient-Focused Outcomes;Patients;Phase;phase 2 study;phase 3 study;Phase III Clinical Trials;Physiological;Prednisone;Pregnancy;primary outcome;Randomized;Randomized, Controlled Trials;Reporting;restoration;Serum;standard care;United States National Institutes of Health;Virilism",Modified-release Hydrocortisone Therapy as a Treatment for CAH,90090,NA,NA,NA,NA,3,NA,NA,0,NA
11188478,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090091,NA,NA,1ZIACL090091-03,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,15687400 (contact),"MERKE, DEBORAH  (contact)",NA,NA,NA,10 year old;21-hydroxylase deficiency;6p21.3;Acceleration;Adrenal gland hypofunction;Adrenal Gland Neoplasms;Adrenal hormone preparation;Adult;Affect;androgen excess;Androgens;Anxiety;Attenuated;Biochemical;Bone Density;bone health;Cardiovascular Diseases;cardiovascular risk factor;carrier status;Child;Child Development;Childhood;Chimera organism;chimeric gene;Chromosome 6;Chromosome Arm;Chronic;Chronic stress;Clinical;Clinical Management;clinical phenotype;Clinical Trials;Cognition;cohort;Complex;Congenital adrenal hyperplasia;Country;COVID-19 pandemic;critical period;CYP21A2 gene;Data;design;Development;Disease;disorder control;Distress;early experience;efficacy evaluation;Ehlers-Danlos Syndrome;emerging adult;Emotional;Enrollment;Epigenetic Process;Etiology;Evaluation;Exposure to;Female infertility;Future;Gene Deletion;Gene Duplication;General Population;Genes;Genetic;Genetic Counseling;Genetic study;Genotype;Glucocorticoids;Gonadal Steroid Hormones;Gonadotropin-Releasing Hormone Analog;Growth;Growth and Development function;health related quality of life;Height;High Prevalence;Hormonal;Hyperandrogenism;in utero;Individual;instrument;Knowledge;Life;life span;male;Maps;Measurement;Mediating;Memory;men;Mental Health;Metabolic;Molecular;Morbidity - disease rate;Names;National Health and Nutrition Examination Survey;Natural History;Neonatal Screening;novel;Outcome;Patient Outcomes Assessments;Patient Recruitments;Patients;Phenotype;Population;Precocious Puberty;premature;profiles in patients;promote resilience;protective factors;Pseudogenes;psychologic;Psychological Impact;Puberty;Quality of life;Rare Diseases;Reporting;research clinical testing;Research Personnel;response;Retrospective Studies;Risk;Risk Assessment;Role;screening program;sex;Sex Differences;Steroid 21-Monooxygenase;Syndrome;Tenascin;tenascin X;Testicular Neoplasms;Therapeutic Intervention;US State;Variant;Woman,Natural History Study of Patients with Excess Androgen,90091,NA,NA,NA,NA,3,NA,NA,0,NA
11188479,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090092,NA,NA,1ZIACL090092-03,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,15687400 (contact),"MERKE, DEBORAH  (contact)",NA,NA,NA,Adrenal Gland Hyperfunction;Adrenal Glands;Adult;Androgen Antagonists;Androgens;Aromatase Inhibitors;bone;Child;Child Development;clinical center;conventional therapy;Data Analyses;Dose;Estrogens;Flutamide;Goals;Gonadal Steroid Hormones;Growth;Growth and Development function;Height;Hydrocortisone;Hyperandrogenism;improved;Letrozole;novel;Patients;prevent;prospective;Randomized;Regimen;Retrospective Studies;Treatment Protocols;United States National Institutes of Health,Novel treatment approaches: sex steroid blockade in children,90092,NA,NA,NA,NA,3,NA,NA,0,NA
11188480,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090093,NA,NA,1ZIACL090093-03,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,15687400 (contact),"MERKE, DEBORAH  (contact)",NA,NA,NA,Adrenal Glands;Adrenal hormone preparation;adverse outcome;Affinity;alternative treatment;Androgens;Androstenedione;antagonist;Biological Markers;Chronic;Clinical Research;Congenital adrenal hyperplasia;Corticotropin;Corticotropin-Releasing Hormone;CRF receptor type 1;Development;Disease;disorder control;Dose;Double-Blind Method;Functional disorder;Glucocorticoids;healthy volunteer;Hypothalamic structure;Maintenance;Minor;novel therapeutics;Patients;Phase;phase 2 study;Physiological;Pituitary Gland;placebo controlled study;placebo group;Placebos;Production;Randomized;receptor;Reporting;safety study;Serum;small molecule,Study of a corticotropin releasing factor-1 receptor antagonist for the treatment of congenital adrenal hyperplasia,90093,NA,NA,NA,NA,3,NA,NA,0,NA
11188481,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090097,NA,NA,1ZIACL090097-03,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,78855914 (contact),"PATTERSON, AMY PATE  (contact)",NA,NA,NA,"Affect;African Trypanosomiasis;age related;antagonist;APOL1 gene;Apolipoprotein A-I;Apolipoproteins;Apolipoproteins B;Atherosclerosis;Biology;Blood Vessels;Cardiovascular Diseases;CD36 gene;Cells;Cholesterol Esters;Chronic;Clinical;Collaborations;Coronary Arteriosclerosis;coronary plaque;Cytidine;Data;Defense Mechanisms;Development;DNA;endothelial dysfunction;Event;Family;fatty acid transport;Frequencies;Genome;Hepatitis B Virus;High Density Lipoproteins;high risk;Host Defense;Host Defense Mechanism;Human;Hydrolysis;Immunity;In Vitro;in vivo;Induced Mutation;Infection;Inflammation;Innate Immune Response;Innate Immune System;Integral Membrane Protein;Intervention;Investigation;Kidney;Kidney Diseases;Link;lipid metabolism;Lipids;Lipoprotein Binding;Lipoprotein Receptor;Lipoproteins;Liver;Low Density Lipoprotein Receptor;Low-Density Lipoproteins;Lung;lung injury;Lytic;Malignant - descriptor;Malignant Neoplasms;Mediating;Messenger RNA;Metabolic syndrome;Metabolism;Molecular;Mutate;Mutation;National Heart, Lung, and Blood Institute;Natural Immunity;Nucleocapsid;Organ;Parasites;particle;pathogen;Pathologic;Pathway interactions;Pattern;Peptides;pgRNA;Phospholipids;Physiological;Play;polypeptide;Population;preference;prevent;prophylactic;Protein Family;protein function;Proteins;Publishing;receptor;Regulation;Research;Reverse Transcription;Risk;RNA Splicing;Role;SARS-CoV-2 pathogenesis;SARS-CoV-2 spike protein;Signal Transduction;Site;Sorting;SR-B proteins;Therapeutic;therapeutic target;Tissues;Transcription Process;Triglycerides;Trypanosoma;Trypanosoma brucei rhodesiense;uptake;Uridine;Variant;vascular endothelial dysfunction;Viral Cancer;Virus Diseases;Work",Role of Class B Scavenger Receptors in Lipid Metabolism and Inflammation,90097,NA,NA,NA,NA,3,NA,NA,0,NA
11188482,ZIA,CL,1,N,NA,NA,NA,NA,ZIACL090109,NA,NA,1ZIACL090109-01,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,12471618 (contact),"MANNES, ANDREW  (contact)",NA,NA,NA,3D Print;Adult;Animal Model;burden of illness;Caring;Clinical Trials;cost;design;Devices;Emergency Situation;endotracheal;Evaluation;first-in-human;Goals;Human;human data;In Vitro;Lung;Lung Diseases;Maintenance;Mechanical Ventilators;Operative Surgical Procedures;Organ Donor;Oxygen;patient population;Patients;pre-clinical;pressure;Preventive;Respirators;respiratory;Schedule;Systemic disease;Time;Training;Translating;Tube;Ventilator;Work,"First in-human trial of Miniature in-line pressure cycled, emergency respirator device at the end of scheduled surgical procedure",90109,NA,NA,NA,NA,1,NA,NA,0,NA
11188483,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000206,NA,NA,1ZIADA000206-39,NIDA:1772670\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,79972144 (contact),"SU, TSUNG PING  (contact)",NA,NA,NA,addiction;Adrenal Glands;Affect;Agonist;Alzheimer&apos;s Disease;Amnesia;Amygdaloid structure;antagonist;behavioral study;Binding;Biochemical;Biological;Biological Process;Brain;Calcium;Cell membrane;Cells;Cellular biology;Cellular Stress;Client;Clinical;Cocaine;Cocaine Dependence;cocaine reward;cocaine self-administration;Cocaine withdrawal;cohort;craving;Data;Decision Making;Development;Disease;dopaminergic neuron;Dose;Electrophysiology (science);endocannabinoid signaling;Endoplasmic Reticulum;Fentanyl;Foundations;Future;gamma-Aminobutyric Acid;Genomics;Glutamates;Goals;Heart;human disease;Hydrogen Peroxide;Hyperalgesia;in vivo Model;Incubated;Induced Neurons;Integral Membrane Protein;knock-down;Knock-out;Knockout Mice;Laboratories;Life;Ligands;Lipid Binding;Liver;Lung;Malignant Neoplasms;Mediating;Mental Depression;Methamphetamine;migration;Molecular;Molecular Chaperones;Molecular Mechanisms of Action;monomer;Morphine;Mothers;mu opioid receptors;Mus;National Institute of Drug Abuse;Nature;Neonatal Abstinence Syndrome;neuronal excitability;Neurons;novel;novel therapeutics;Nuclear;Opioid;Organ;Organism;Oxidative Stress;Pain;Parkinsonian Disorders;Pentazocine;Peripheral;pharmacologic;Play;preclinical study;preconditioning;Pregnancy;presynaptic;Process;Property;Proteins;Publications;Publishing;pup;Rattus;Receptor Activation;RNA;RNA Binding;Role;Self Administration;Sensory;sigma receptors;sigma-1 receptor;Signal Transduction;Spleen;Stimulus;Stress;stressor;Stroke;Structure;Testing;Thapsigargin;Tissues;Tubular formation;vapor;Work,Biological And Biochemical Characterization Of Sigma Receptors,206,NA,NA,NA,NA,39,NA,NA,1772670,NA
11188484,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000434,NA,NA,1ZIADA000434-25,NIDA:3516114\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,1972860 (contact),"SHAHAM, YAVIN  (contact)",NA,NA,NA,Abstinence;adverse outcome;Agonist;Animal Model;antagonist;Behavior;Behavioral;Brain;Claustral structure;Cocaine;Corpus striatum structure;Cues;Desire for food;Drug usage;Drug user;Event;Exposure to;Extinction;Fentanyl;Food;Goals;Heroin;Home;human subject;Laboratory Animals;Methamphetamine;Modeling;Negative Reinforcements;Neurobiology;neurochemistry;Neurons;Neurotransmitters;non-drug;novel;Opioid;Oxycodone;peer;Persons;Pharmaceutical Preparations;programs;psychostimulant;Rattus;Recording of previous events;Relapse;Reporting;Research;Rewards;Role;Self Administration;Social Interaction;Stimulus;System;Testing,Neurobiology Of Relapse To Opiate and Psychostimulant Drugs,434,NA,NA,NA,NA,25,NA,NA,3516114,NA
11188485,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000467,NA,NA,1ZIADA000467-21,NIDA:3269973\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,8183775 (contact),"HOPE, BRUCE  (contact)",NA,NA,NA,3-Dimensional;addiction;Address;Adult;Area;Attenuated;Back;Bathing;Behavior;Behavioral;beta-Galactosidase;Brain;Brain region;Breeding;Calcium;Cell Nucleus;Cells;Characteristics;Chemicals;Cocaine;cocaine seeking;cocaine self-administration;Collaborations;conditioned place preference;Corpus striatum structure;Cue-induced relapse;Cues;Dendritic Spines;Dissociation;Drug Addiction;drug induced behavior;drug of abuse;Electrophysiology (science);Environment;Enzymes;experimental study;Exposure to;Extinction;Fluorescence-Activated Cell Sorting;Food;FOS gene;Glutamates;Goals;Green Fluorescent Proteins;Heroin;Human;Image;Injections;Label;LacZ Genes;learned behavior;Learning;Light;Malignant Neoplasms;Mediating;Memory;Messenger RNA;Methods;Microscopy;Modeling;Molecular;Morphology;Mus;N-Methylaspartate;Neuronal Plasticity;Neurons;Neurotransmitters;novel;Nucleus Accumbens;Pharmaceutical Preparations;Phosphorylation;Play;Prefrontal Cortex;Preparation;Presynaptic Terminals;Procedures;Process;Proteins;Rattus;Relapse;Resolution;response;Rewards;Role;Self Administration;Signal Transduction;Slice;Social Interaction;Sorting;Stimulus;suicide substrates;Synapses;Synaptosomes;temporal measurement;therapeutic target;Training;transcriptome sequencing;Transgenic Organisms,Characterization of neuronal ensembles activated during cue-induced reward seeking,467,NA,NA,NA,NA,21,NA,NA,3269973,NA
11188486,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000469,NA,NA,1ZIADA000469-21,NIDA:2565601\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,8017433 (contact),"YANG, YIHONG  (contact)",NA,NA,NA,Acetylcholine;addiction;Address;Adolescent;adverse childhood events;aged;Algorithms;Anterior;Architecture;Area;Autopsy;Behavioral;Bilateral;Brain;brain based;Brain Diseases;Brain region;Buffers;Cell Nucleus;Characteristics;Chronic;cingulate cortex;clinical application;cognitive control;cognitive development;cognitive function;cohort;Communities;connectome;Corpus striatum structure;Data;Development;Diagnostic;Disease;DSM-V;Effectiveness;Etiology;Exhibits;experience;falls;Female;follow-up;Frequencies;Functional disorder;Functional Magnetic Resonance Imaging;Gene Expression;human data;imaging biomarker;improved;indexing;Individual;Least-Squares Analysis;Link;Magnetic Resonance Imaging;Major Depressive Disorder;Manuscripts;Medial;mental development;Mental disorders;Meta-Analysis;Methodology;Methods;Modeling;Molecular;Molecular Analysis;Motor;neural;neurobiological mechanism;neuroimaging;neurophysiology;neuroregulation;Noise;outcome prediction;Parietal Lobe;Pathologic;Pathway interactions;personalized intervention;Persons;preadolescence;Prefrontal Cortex;prospective;Psychiatric therapeutic procedure;Psychiatry;Psychopathology;putamen;receptor;Relapse;repetitive transcranial magnetic stimulation;Reproducibility;Research Project Grants;resilience;resilience factor;Resolution;Rest;Scalp structure;Scanning;Schizophrenia;Serotonergic System;Signal Transduction;Site;Spatial Distribution;Structure;Substance Use Disorder;System;Techniques;tool;Transcranial magnetic stimulation;Treatment Efficacy;Verbal Auditory Hallucinations;Work;Youth,Development of MRI Techniques for Applications in Substance Use Disorders,469,NA,NA,NA,NA,21,NA,NA,2565601,NA
11188487,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000493,NA,NA,1ZIADA000493-19,NIDA:3218958\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,10672068 (contact),"FERRE, SERGI  (contact)",NA,NA,NA,abuse liability;Acute;Address;Adrenergic Receptor;Affect;Amino Acids;Anxiety;Attention deficit hyperactivity disorder;Attentional deficit;Behavior;Behavior monitoring;Behavioral;behavioral phenotyping;behavioral study;Binding;Biochemical;Biological Assay;Brain;Cell Nucleus;Cells;Clinical Research;Cognitive;Complement;Corpus striatum structure;dimer;Disease;Dopamine;Dopamine Receptor;Dopaminergic Cell;dopaminergic neuron;DRD4 gene;Efferent Pathways;enantiomer;endophenotype;experimental study;extracellular;Fentanyl;flexibility;Fluorescence;foot;frontal lobe;gain of function;Galanin;Gene Modified;Genes;Genetic Polymorphism;Glutamates;Goals;hippocampal pyramidal neuron;Human;Impairment;Impulsivity;In Vitro;in vivo;Individual Differences;interest;Link;loss of function;Mammalian Cell;Medial;Mediating;Mediator;Methadone;Microdialysis;Minisatellite Repeats;Molecular Conformation;molecular dynamics;Monitor;Morphine;Movement;mu opioid receptors;Mus;Neurons;neuropsychiatric disorder;neurotransmission;NMDA receptor antagonist;Norepinephrine;novel;Opioid;Opioid agonist;opioid use disorder;optogenetics;Outcome;Perfusion;Personality Traits;pharmacologic;Phenotype;Play;Population;Proline;Property;Protein Isoforms;Protomer;Rattus;receptor;Reporting;response;Rewards;Risk Taking;Role;Self Administration;Shock;Short-Term Memory;Site;social;social deficits;Stimulus;Structure;Substance Use Disorder;Techniques;Transfection;Transmembrane Domain;Variant;Ventral Tegmental Area,Functional and Pharmacological Significance of Receptor Heteromers in the CNS,493,NA,NA,NA,NA,19,NA,NA,3218958,NA
11188488,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000499,NA,NA,1ZIADA000499-17,NIDA:1066680\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,15666314 (contact),"EPSTEIN, DAVID  (contact)",NA,NA,NA,Automobile Driving;Behavior;Behavioral;Clinic;Cocaine use disorder;Complement;Data;Data Analyses;Drug Monitoring;Drug usage;Drug user;Ecological momentary assessment;Environment;Faculty;Goals;interest;Life;marijuana use;marijuana use disorder;meetings;member;Mental association;mental state;Methods;Mitragyna;Moods;Motivation;National Institute of Drug Abuse;Nicotine;opioid use disorder;Outcome;Outpatients;Paper;Participant;Persons;Pharmaceutical Preparations;Physiological;Plants;Population;Postdoctoral Fellow;Publications;Publishing;real time model;real time monitoring;Reporting;Research;Running;Sampling;Site;telework;Testing;Time;Tobacco,"Real-Time Assessment of Drug Use, Along with Mental States and Environments",499,NA,NA,NA,NA,17,NA,NA,1066680,NA
11188489,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000511,NA,NA,1ZIADA000511-18,NIDA:5386047\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,9414910 (contact),"MORALES, MARISELA  (contact)",NA,NA,NA,Animal Model;Behavior;Clinical Research;Cocaine;cocaine seeking;cohort;combinatorial;conditioned place preference;Dopamine;dopaminergic neuron;Drug Addiction;drug of abuse;Enzymes;Fiber;Follow-Up Studies;gamma-Aminobutyric Acid;Glutamate Decarboxylase;Glutamate Transporter;Glutamates;Goals;Implant;interdisciplinary approach;Measures;mesolimbic system;Mus;Neurons;Nucleus Accumbens;optical fiber;Output;Pathway interactions;Play;Population;preference;recombinase;Regulation;Relapse;reward processing;Rewards;Role;selective expression;Serotonin;serotonin transporter;Site;SLC17A8 gene;Study models;Synapses;Transgenic Mice;Tyrosine 3-Monooxygenase;vector;Ventral Tegmental Area;Viral Vector,Neuronal connectivity within the mesolimbic system,511,NA,NA,NA,NA,18,NA,NA,5386047,NA
11188490,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000527,NA,NA,1ZIADA000527-17,NIDA:3303010\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,9693020 (contact),"RICE, KENNER  (contact)",NA,NA,NA,Agonist;analog;antagonist;Antibodies;Antibody Affinity;Antibody Response;Antigens;antinociception;Appearance;Bacterial Proteins;Behavioral;Biological Assay;Brain;Buprenorphine;Candy;carfentanil;chemical synthesis;Child;China;Clinical Medicine;Clinical Research;Color;combat;Combined Vaccines;Complex;cost;Cyclic AMP;Data;design;Disease;Dose;Drug abuse;drug action;Drug Addiction;drug of abuse;Drug Targeting;Exhibits;Fentanyl;Firearms;Goals;Haptens;head-to-head comparison;Heroin;Homicide;imaging agent;Immunize;immunogenic;Immunoglobulin G;improved;In Vitro;in vivo;interest;Label;Legal patent;Licensing;Ligands;manufacture;Mediating;Methadone;Mexico;Monoclonal Antibodies;Mouse Strains;multidisciplinary;Mus;mutant;Naloxone;Naltrexone;Narcotics;new chemical entity;novel;novel therapeutics;novel vaccines;Opioid;opioid abuse;Opioid Antagonist;opioid epidemic;opioid mortality;Opioid Receptor;Opium;overdose death;Pain;Papaver;Pattern;Peripheral;Pharmaceutical Chemistry;Pharmaceutical Preparations;Pharmacologic Substance;phenylmorphan;pill;Population;Positron-Emission Tomography;Powder dose form;prevent;Prevention;Production;programs;Proteins;rational design;Rattus;receptor;Research;Research Personnel;response;Seizures;Series;small molecule;Stress;Suicide;synthetic opioid;System;Tablets;Technology;Tetanus Toxoid;tool;Toxic effect;Vaccine Production;Vaccines;vehicular accident;Ventilatory Depression,Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors,527,NA,NA,NA,NA,17,NA,NA,3303010,NA
11188491,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000549,NA,NA,1ZIADA000549-16,NIDA:1181780\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,79972144 (contact),"SU, TSUNG PING  (contact)",NA,NA,NA,Affinity;Agonist;Autophagocytosis;Brain;C9ORF72;Cell Nucleus;Cell Physiology;Cell Survival;Cells;Clinical;Cytosol;Data;design;Disease;Drug usage;Fluvoxamine;frontotemporal lobar dementia amyotrophic lateral sclerosis;Impairment;Importins;Ligands;Mediating;Metabolism;Molecular Chaperones;neurobiological mechanism;Neurobiology;Neurodegenerative Disorders;Neuroglia;neuronal survival;Neurons;non-opioid analgesic;Nuclear;Nuclear Pore;Nuclear Pore Complex Proteins;nucleocytoplasmic transport;Pathologic;Poison;Pore Proteins;receptor;recruit;RNA;Serotonin;sigma-1 receptor;Signaling Molecule;Stress;Therapeutic Agents;therapeutic development;transcription factor,Neurobiological Basis of Neuronal Survival,549,NA,NA,NA,NA,16,NA,NA,1181780,NA
11188492,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000586,NA,NA,1ZIADA000586-13,NIDA:796168\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,9693010 (contact),"HARVEY, BRANDON  (contact)",NA,NA,NA,Acute;adeno-associated viral vector;Affect;Cell Line;Cells;Chronic;Clustered Regularly Interspaced Short Palindromic Repeats;Corpus striatum structure;CRISPR/Cas technology;DNA;Dose;drug of abuse;Exposure to;GAG Gene;Genetic Transcription;Genome;Goals;Health;HIV;HIV Long Terminal Repeat;In Vitro;in vivo;Investments;Long Terminal Repeats;Luciferases;Methamphetamine;Microglia;Modeling;Monitor;neuroinflammation;Neurons;neurotoxicity;novel;Pharmaceutical Preparations;pol genes;Production;promoter;Proteins;Proviruses;psychostimulant;Research;Ribonucleoproteins;RNA;Rodent;Role;Substance Addiction;tool;Transgenic Organisms;vector;Work,"Microglia, HIV and drugs of abuse",586,NA,NA,NA,NA,13,NA,NA,796168,NA
11188493,ZIA,DC,1,N,NA,NA,NA,NA,ZIADC000059,NA,NA,1ZIADC000059-25,NIDCD:3294154\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,9414961 (contact),"KELLEY, MATTHEW  (contact)",NA,NA,NA,Adult;Afferent Neurons;Alagille Syndrome;Alleles;Animals;Auditory;Bioinformatics;Candidate Disease Gene;candidate identification;Cell Survival;cell type;Cells;Cochlea;cochlear development;Collaborations;Cranial Nerves;Data;deafness;Defect;Development;Developmental Process;Ear;Embryonic Development;Epithelium;Fibroblast Growth Factor;Ganglia;Gene Expression;Gene Expression Profile;Genes;Genetic;Genetic Transcription;Germ Cells;Goals;Hair Cells;Hearing;hearing impairment;hearing restoration;hindbrain;Human;improved;interest;Laboratories;Labyrinth;Mammals;Mediator;member;Molecular;Mus;Mutant Strains Mice;nerve supply;Neurons;Neurosciences;novel;Organ of Corti;otoconia;Outer Hair Cells;Pathway interactions;Patients;Pattern;Phenotype;Process;Production;Reporting;Research;Research Personnel;Role;Sensory;Signal Pathway;Signal Transduction;single-cell RNA sequencing;Specific qualifier value;spiral ganglion;Structure;Supporting Cell;Suppressor-Effector T-Lymphocytes;Syndrome;System;Testing;transcription factor;transcriptome;Transgenic Mice;Universities;Vestibular dysfunction;Vestibular function;Vestibular Hair Cells;vestibular system,Hair Cell Development in the Mammalian Cochlea,59,NA,NA,NA,NA,25,NA,NA,3294154,NA
11188494,ZIA,DC,1,N,NA,NA,NA,NA,ZIADC000064,NA,NA,1ZIADC000064-24,NIDCD:4143326\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,79336343 (contact),"HERTZANO, RONNA  (contact)",NA,NA,NA,"Age;Algorithms;Amikacin;Aminoglycoside Antibiotics;Animal Model;Antineoplastic Agents;arterial calcification of infancy;Auditory;Auditory Evoked Potentials;Auditory system;autosome;Brain Neoplasms;Cantor;Characteristics;Cisplatin;Clinical;Clinical Research;Clinical Trials;CLN3 gene;cloud based;Code;Collaborations;Computer software;Computerized Medical Record;Congenital disorders of glycosylation;Cryptococcal Meningitis;Data;Data Analyses;Data Analytics;Data Science;data sharing;Data Storage and Retrieval;data visualization;design;Development;Disease;Early Diagnosis;Electrocochleographies;electronic data;Electronics;Environmental Risk Factor;Equilibrium;experience;Extramural Activities;Family;Funding;Gangliosidoses;Genotype;Grant;Healthcare;Hearing;hearing impairment;Hearing problem;human model;improved;Infrastructure;inhibitor therapy;interest;ketotic hyperglycinemia;Laboratories;Labyrinth;large scale data;loss of function;malformation;Manuscripts;McCune-Albright Syndrome;Measures;Medical;MEKs;Mentors;Mentorship;Methodology;methylmalonic aciduria;multidisciplinary;National Heart, Lung, and Blood Institute;National Human Genome Research Institute;National Institute of Allergy and Infectious Disease;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;National Institute of Child Health and Human Development;National Institute of Dental and Craniofacial Research;National Institute of Neurological Disorders and Stroke;National Institute on Deafness and Other Communication Disorders;Natural History;Neimann-Pick&apos;s Disease Type C;Neurofibromatosis 1;New Agents;Noise;Normal Range;Osteogenesis Imperfecta;otoacoustic emission;ototoxicity;Paper;Patients;Persons;Phenotype;Physiologic pulse;Platinum;Posture;Predisposition;Prevalence;Prevention;programs;prospective;Protocols documentation;Publishing;Radiation therapy;Reference Values;Relapse;Research;Research Design;Research Infrastructure;Research Personnel;Retrospective Studies;Risk;Risk Factors;Science;Scientist;sex;Sex Differences;Smith-Lemli-Opitz Syndrome;Spielmeyer-Vogt Disease;Steroids;Stimulus;Surveillance Program;System;Technology;Testing;Time;tool;Training Programs;Translational Research;treatment trial;Type 7 Spinocerebellar Ataxia;United States National Institutes of Health;Usher Syndrome;Vestibular function;vestibular system;Visualization software;Work",Clinical Analysis of Disorders of Hearing and Balance,64,NA,NA,NA,NA,24,NA,NA,4143326,NA
11188495,ZIA,DC,1,N,NA,NA,NA,NA,ZIADC000082,NA,NA,1ZIADC000082-13,NIDCD:2190021\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,79336343 (contact),"HERTZANO, RONNA  (contact)",NA,NA,NA,Affect;Animal Model;Animals;Auditory;autosome;Basic Science;clinical center;Clustered Regularly Interspaced Short Palindromic Repeats;Cochlea;deafness;disability;Dizziness;DNA Sequence Alteration;Equilibrium;Gene Delivery;gene therapy;Genes;Genome;genome editing;hair cell regeneration;Hearing;hearing impairment;hearing loss treatment;hereditary hearing loss;Human;improved;Inherited;interest;Labyrinth;mouse model;Mus;Mutation;Natural History;novel;Operative Surgical Procedures;Pathology;Patient Recruitments;Patients;Population;Process;programs;Proteins;Research;transcription factor;Translating;Trauma;United States National Institutes of Health;Usher Syndrome;Vestibular function;vestibular system;WHRN gene,Inner ear gene therapy program,82,NA,NA,NA,NA,13,NA,NA,2190021,NA
11188496,ZIA,DC,1,N,NA,NA,NA,NA,ZIADC000098,NA,NA,1ZIADC000098-01,NIDCD:1415699\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,79350266 (contact),"LEVY, JOSHUA  (contact)",NA,NA,NA,2019-nCoV;Address;Ageusia;Airway Disease;Allergic;Amendment;American;antigen test;Area;aspirin-exacerbated respiratory disease;Attitude;Award;Basic Science;Chronic Sinusitis;Clinic;Clinical;clinical center;Clinical Data;Clinical Practice Guideline;Clinical Protocols;Clinical Research;clinically relevant;Collection;COVID-19 screening;Data;Dinoprostone;Disease;Disseminated eosinophilic collagen disease;Epithelial Cells;Goals;Health;healthy volunteer;Hypersensitivity;Immunology;Immunotherapy;improved;Inflammation;Inflammatory;Inhalant dose form;Institutional Review Boards;interest;Irrigation;Journals;Knowledge;Lead;Liquid substance;Manuscripts;Medical;medical specialties;meetings;Methods;Nasopharynx;National Institute of Allergy and Infectious Disease;National Institute on Deafness and Other Communication Disorders;Natural History;Neurologic;Nose;novel therapeutics;Olfactory dysfunction;Olfactory Epithelium;Operative Surgical Procedures;oropharyngeal swab;Otolaryngology;Participant;Patient Care;Patients;Peripheral;polyposis;programs;Protocols documentation;Provider;Recommendation;Research Personnel;research study;Reverse Transcriptase Polymerase Chain Reaction;saliva sample;Sampling;SARS-CoV-2 B.1.1.529;Sensory Disorders;Signal Transduction;Sinus;Sinusitis;Smell Perception;Societies;Specimen;Surveys;Taste Perception;Techniques;Tissue Sample;Tissues;translational study;Viral Load result;Work,Sinonasal and Olfaction Program,98,NA,NA,NA,NA,1,NA,NA,1415699,NA
11188497,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK011011,NA,NA,1ZIADK011011-17,NIDDK:1342753\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9693116 (contact),"BUCHANAN, SUSAN  (contact)",NA,NA,NA,Acinetobacter;Antibiotic Resistance;Antibiotics;antimicrobial;Area;Bacteria;Bacterial Outer Membrane Proteins;Bacteriophages;Binding;Binding Proteins;Biochemistry;capsule;Cations;Cells;Citrates;Clinical;Code;colicin;Colicin Ia;Collaborations;Communicable Diseases;Complex;Computer Analysis;crosslink;Cryoelectron Microscopy;Data;design;Development;drug development;drug discovery;Drug Targeting;efflux pump;Electron Microscopy;Electrophysiology (science);Elements;Engineering;Enterobactin;Escherichia coli;experimental study;Family;Generations;Genetic;Gram-Negative Bacteria;Human;Human Genome;in silico;insight;Integral Membrane Protein;interest;Ions;Iron;Klebsiella pneumoniae;Length;Libraries;Lipids;Lower Organism;lysin;Manuscripts;Membrane;Membrane Proteins;Membrane Transport Proteins;Metals;Molecular;Molecular Conformation;molecular dynamics;Motor;Movement;Mutation;nanodisk;nanomachine;National Institute of Allergy and Infectious Disease;Nature;Neisseria;Neisseria meningitidis;new therapeutic target;novel;pathogen;pathogenic bacteria;Pathogenicity;Pathway interactions;Patient Isolation;periplasm;Pesticin;Pharmacologic Substance;Plague;Plasma Proteins;Positioning Attribute;Preparation;protein complex;Protein Engineering;Protein Import;protein structure;Proteins;Proton-Motive Force;Protons;Pseudomonas aeruginosa;Pseudomonas Infections;Pump;receptor;receptor binding;Regulation;Resistance development;Resolution;Roentgen Rays;Role;screening;Serum;Siderophores;Signal Transduction;small molecule;Spectrum Analysis;stoichiometry;Structure;success;Surface;System;Toxin;Transferrin;Transition Elements;Translating;uptake;Vaccines;Virulence;Work;X-Ray Crystallography;Yersinia pestis;Zinc,Structural characterization of OM proteins from Gram-negative pathogens,11011,NA,NA,NA,NA,17,NA,NA,1342753,NA
11188498,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK013022,NA,NA,1ZIADK013022-21,NIDDK:201462\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415029 (contact),"CHOW, CARSON  (contact)",NA,NA,NA,Bayesian Analysis;Biological;Communicable Diseases;Complex;COVID-19;COVID-19 pandemic;Data;Data Analyses;Diabetes Mellitus;Diet;Differential Equation;Disease;disease model;dynamic system;epidemiologic data;experimental study;Fat Body;Future;Goals;human model;Immune;Immunologic Memory;Individual;Infectious Agent;Inflammatory Response;Insulin;interest;Lipolysis;Machine Learning;Macronutrients Nutrition;Malignant Neoplasms;mathematical model;Measurement;Metabolism;Methods;Modeling;novel;Obesity;Population;Property;reaction rate;SARS-CoV-2 infection;Sepsis;Serology;Spreading Cortical Depression;System;Techniques;Thinness;Time;Tissues,Modeling and data analysis of complex diseases,13022,NA,NA,NA,NA,21,NA,NA,201462,NA
11188499,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK013024,NA,NA,1ZIADK013024-18,NIDDK:268616\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415029 (contact),"CHOW, CARSON  (contact)",NA,NA,NA,Affect;Architecture;Area;Behavior;Biophysics;Brain;Brain region;Cells;Complex;Computer Models;Data;Decision Making;Disease;drug action;Electrophysiology (science);Equilibrium;Genes;Goals;Human;Individual;Ion Channel;Learning;learning strategy;Machine Learning;Modeling;Modernization;Molecular;neural;Neurons;Pattern;Psychophysics;Recurrence;Scheme;Specific qualifier value;Stimulus;Synapses;Time;Training,Analysis of cortical function,13024,NA,NA,NA,NA,18,NA,NA,268616,NA
11188500,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK013027,NA,NA,1ZIADK013027-18,NIDDK:253513\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9693120 (contact),"SHERMAN, ARTHUR  (contact)",NA,NA,NA,Action Potentials;Adult;Alpha Cell;Azides;Basic Science;Behavior;Beta Cell;Biophysical Process;Calcium;calcium metabolism;Calcium Oscillations;Cell Respiration;cell type;Cells;Chemicals;Child;Circulation;clinically significant;Communication;Coupled;Coupling;Cyclic AMP;D Cells;Defect;Diabetes Mellitus;Differential Equation;Endocrine;enzyme activity;Enzymes;Exocytosis;experimental study;Feedback;Fructose;gain of function mutation;genome wide association study;Glucagon;Glucokinase;Glucose;glucose metabolism;Glyburide;Glycolysis;Hereditary Disease;Hormone secretion;Human;Hyperinsulinism;Hypoglycemia;Impairment;Individual;Insulin;insulin granule;insulin secretion;interest;Investigation;Ion Channel;ion dynamics;islet;Islets of Langerhans;Journals;Life;Link;Liver;loss of function mutation;mathematical model;Mathematics;Membrane;Metabolic;Michigan;millisecond;Mitochondria;model development;Modeling;neonatal diabetes mellitus;Non-Insulin-Dependent Diabetes Mellitus;Oral;Organ;oxidation;Pancreas;Pathogenesis;Pharmaceutical Preparations;Phase;Physiologic pulse;Physiological;Plasma;Play;Potassium;Protein Kinase C;Published Comment;Publishing;Pyruvate Kinase;Reporting;Respiration;response;Rodent;Role;Signal Pathway;simulation;Sodium Azide;Somatostatin;Stimulus;Structure of beta Cell of islet;Suggestion;Sulfonylurea Compounds;System;theories;Time;Tissues;Tolbutamide;tool;Universities;Wisconsin;Work;Writing,Stimulus secretion coupling in pancreatic beta-cells,13027,NA,NA,NA,NA,18,NA,NA,253513,NA
11188501,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK013028,NA,NA,1ZIADK013028-18,NIDDK:56336\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9693120 (contact),"SHERMAN, ARTHUR  (contact)",NA,NA,NA,3-Dimensional;Action Potentials;Adult;Affect;Anterior Pituitary Gland;Astrocytes;Attention;Bioinformatics;Blood Cells;Blood Vessels;Calcium;Calcium Channel;Calcium Signaling;cell type;Cells;Chemicals;Chimeric Proteins;circadian;Code;Communication;comparative;Coupled;Darkness;Data;desensitization;Development;Differential Equation;Discontinuous Capillary;Dose;Embryo;embryonic stem cell;Endocrine;Endoplasmic Reticulum;Endothelial Cells;Enzymes;Exocytosis;Family;Future;G-Protein-Coupled Receptors;Gene Expression Profiling;Generations;Genes;Genetic Markers;Genetic Transcription;Genomics;Gland;gland development;Heterogeneity;Hodgkin Disease;hormonal signals;Hormone secretion;Hormones;Hypothalamic structure;In Situ Hybridization;insulin secretion;intercellular communication;interest;lactotroph;Manuscripts;mathematical model;Mediating;Mediator;Melatonin;Membrane;Membrane Lipids;Microglia;Modeling;National Institute of Child Health and Human Development;Natural regeneration;Nerve;neural;Neuroglia;Neurons;Neurotransmitters;Nobel Prize;notch protein;novel;Organelles;Pattern;pharmacologic;Phosphatidylinositols;Phosphorylation;Phosphotransferases;Physiology;PI3 gene;Pineal gland;Pinealocyte;Pituitary Gland;Pituitary Hormones;Population;postmitotic;postnatal;Preparation;Process;Production;progenitor;programs;Prolactin;Publishing;Quantitative Reverse Transcriptase PCR;Rattus;receptor;Receptor Gene;Resources;Role;Sampling;Second Messenger Systems;SERPINA4 gene;Signal Transduction;Signaling Protein;single-cell RNA sequencing;Solid;Somatostatin;Somatostatin Receptor;somatostatin receptor 3;somatostatin receptor 5;Specificity;stem cell biomarkers;stem cells;Stress;Structure of beta Cell of islet;System;Time;Tissues;tool;transcriptomics;Validation;Vertebrates;Vesicle;voltage;Work;wortmannin,Mathematical Modeling of Neurons and Endocrine Cells,13028,NA,NA,NA,NA,18,NA,NA,56336,NA
11188502,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK013030,NA,NA,1ZIADK013030-16,NIDDK:189847\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415045 (contact),"PERIWAL, VIPUL  (contact)",NA,NA,NA,Acute;Address;Biological Models;Bolus Infusion;Cardiovascular Diseases;Clinical;convolutional neural network;Data;Data Set;deep learning;Defect;Development;Diabetes Mellitus;Disease;Enzymes;Glucose;Goals;Hour;Hypertension;in vivo;indexing;Insulin;insulin regulation;Insulin Resistance;insulin sensitivity;Insulin Signaling Pathway;intravenous glucose tolerance test;Lipolysis;Malignant Neoplasms;mathematical model;Mathematics;Methodology;Methods;Mitochondria;Modeling;Modification;neural network;Nonesterified Fatty Acids;Nonlinear Dynamics;novel;Obesity;Output;Performance;physiologic model;Physiological;Plasma;Protocols documentation;Quantitative Evaluations;reconstruction;Regulation;Research;response;Risk Factors;Role;Sampling;Serum;systemic inflammatory response;Techniques;Testing;Time;Tissues;Training;Width;Work,Quantitative Estimation of Sensitivity of Lipolysis to Insulin,13030,NA,NA,NA,NA,16,NA,NA,189847,NA
11188503,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK013036,NA,NA,1ZIADK013036-18,NIDDK:97137\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,8316036 (contact),"HALL, KEVIN  (contact)",NA,NA,NA,Affect;Agonist;bariatric surgery;Behavior;Biological Sciences;Body Composition;Body Weight;Body Weight Changes;Calories;Clinical;Clinical Management;Clinical Sciences;Complex;Computer Models;Computer Simulation;Continuous Glucose Monitor;Data;design;Eating;energy density;Energy Metabolism;Engineering;experimental study;Food;GLP-I receptor;Glucose;Goals;Human;human model;Intake;interstitial;Intervention;knowledge integration;mathematical model;Mathematical Model Simulation;Metabolic;Metabolic Diseases;Metabolism;Modeling;physical science;Regulation;Research;response;System;Testing;Time;tool,"Computational modeling of human metabolism, body weight and composition",13036,NA,NA,NA,NA,18,NA,NA,97137,NA
11188504,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK013037,NA,NA,1ZIADK013037-18,NIDDK:1165649\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,8316036 (contact),"HALL, KEVIN  (contact)",NA,NA,NA,Adult;Affect;Body Composition;Body fat;Body Weight;Body Weight Changes;Carbohydrates;Clinical Research;Clinical Trials;Consumption;Crossover Design;design;Diet;Eating;energy density;Energy Intake;Energy Metabolism;Exercise;Fat-Restricted Diet;Fiber;Food;Human;improved;ketogenic diet;Ketosis;Macronutrients Nutrition;men;Metabolism;nicotinamide riboside supplementation;Obesity;obesity development;Overweight;Physiology;Randomized;randomized placebo controlled trial;Role;Running;Sleep;sugar;Testing;Time;Woman,"Interactions of diet, exercise, metabolism, and weight change in humans",13037,NA,NA,NA,NA,18,NA,NA,1165649,NA
11188505,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK013038,NA,NA,1ZIADK013038-18,NIDDK:97137\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,8316036 (contact),"HALL, KEVIN  (contact)",NA,NA,NA,Behavior;Body Composition;Body Weight;Collaborations;cost;data integration;Development;Diabetes Mellitus;Eating;Endocrinology;Energy Metabolism;Human;improved;Investigation;Laboratories;mathematical model;Molecular;mouse model;Mus;National Institute of Diabetes and Digestive and Kidney Diseases;Obesity;Organism;Physical activity;Regulation;Rodent,"Regulation of rodent energy metabolism, body weight and composition",13038,NA,NA,NA,NA,18,NA,NA,97137,NA
11188506,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK015600,NA,NA,1ZIADK015600-29,NIDDK:1206821\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415073 (contact),"OLIVER, BRIAN  (contact)",NA,NA,NA,Adult;Aging;Animals;Atlases;Attention;Biological;Biomedical Research;cell type;Cells;Chemicals;ChIP-seq;Chromatin Structure;Code;Communities;comparative;Computational Technique;Consumption;Data;Deposition;Development;differential expression;Disease;DNA;DNA Sequence;DNA-Binding Proteins;Drosophila genus;egg;Elements;Event;experimental study;Exposure to;FDA approved;Female;follow-up;functional genomics;Gene Expression;gene function;gene interaction;gene network;Genes;Genetic;genetic information;Genetic Models;Genetic Screening;Genetic Techniques;Genetic Transcription;Genome;genome-wide;Genomics;Germ Cells;Germ Lines;gonad development;Gonadal structure;Health;Human;human disease;Human Genome;human model;improved;in vivo;Individual;interest;Investments;knock-down;learning network;literacy;Machine Learning;male;Maps;Measures;Mediating;Methodology;model organism;Molecular Genetics;mutant;network models;novel strategies;Obesity;Outcome;Ovary;Pathway interactions;Pattern;Pharmaceutical Preparations;Phase;Phenotype;Physiology;positional cloning;Process;Protein Isoforms;Proteins;public repository;Reagent;Regulatory Element;Resources;response;RNA Interference;Sex Bias;single-cell RNA sequencing;small hairpin RNA;sperm cell;stem cell function;stem cell model;success;Systems Biology;Testing;Testis;Time;tissue/cell culture;Tissues;tool;Toxic Environmental Substances;transcription factor;transcriptome sequencing;Tumor Stem Cells;Validation;whole genome;Work,Drosophila Functional Genomics,15600,NA,NA,NA,NA,29,NA,NA,1206821,NA
11188507,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK015602,NA,NA,1ZIADK015602-18,NIDDK:2337313\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415061 (contact),"LEI, ELISSA  (contact)",NA,NA,NA,Acute T Cell Leukemia;Architecture;Area;Beckwith-Wiedemann Syndrome;beta Globin;Binding;Binding Sites;Biology;Bombyx;Bombyx mori;CCCTC-binding factor;Cell Culture Techniques;cell type;Cells;Chromatin;Chromosome Segregation;Chromosomes;Complex;Defect;Development;Disease;DNA;egg;Enhancers;Erythropoiesis;Euchromatin;Event;Future;Gene Expression;Generations;Genes;genetic information;Genetic Transcription;Genome;Germ Lines;Glioma;H19 gene;Heterogeneity;Homeobox Genes;Homologous Gene;IGF2 gene;imprint;Kinetics;Kinetochores;Masks;Meiosis;Metaphase;Microscopy;Microtubules;Moths;multiple omics;Mus;mutant;Nephroblastoma;novel;Nuclear;Oncogene Activation;Organism;postmitotic;Process;promoter;protein complex;Proteins;recruit;Regulation;reproductive success;retinal rods;Rod;segregation;Shapes;Sister;Site;Sorting;Specific qualifier value;Specificity;sperm cell;Spermatogenesis;Structure;System;telomere;Testing;Transcription Repressor;Transcriptional Regulation;transcriptome;Work,Chromatin Insulator Function and Nuclear Organization,15602,NA,NA,NA,NA,18,NA,NA,2337313,NA
11188508,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK015603,NA,NA,1ZIADK015603-18,NIDDK:3109205\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,2411917 (contact),"DEAN, JURRIEN  (contact)",NA,NA,NA,Acrosome;Adult;Binding;Biocompatible Materials;Cell division;Cell Lineage;Cell Maintenance;Cells;child bearing;Childhood;chromatin remodeling;cohort;Complex;Congenital Abnormality;Contraceptive methods;Cytokinesis;Cytoplasmic Granules;Dependence;Development;Disease;egg;Embryo;embryo cell;Ensure;Ethics;Event;Exocytosis;exosome;Extracellular Matrix;Female;Fertilization;Gametogenesis;Gene Combinations;Genes;Genome;Germ Cells;Glycoproteins;Growing Follicle;Haploidy;Human;Human Development;human disease;Individual;insight;Investigation;Maintenance;male;Mammalian Oviducts;Mammals;Mediating;Meiosis;Molecular;Molecular Biology;Morphology;mouse model;Mus;natural Blastocyst Implantation;Neonatal;next generation sequencing;Ovary;Ovulation;Patients;piRNA;Polyspermic Fertilizations;Population Growth;postnatal;Pre-implantation Embryo Development;Prevention;Process;Prophase;Proteins;Public Health;reproductive;Reproductive Medicine;Reproductive Technology;Research;Ribonucleases;RNA Helicase;Role;Somatic Cell;Specificity;sperm cell;Spermatocytes;Spermatogonia;Spermiogenesis;stem cell niche;stem cells;Structure;Surface;Taxon;Technology;Testis;Therapeutic;Totipotency;transcription termination;Translations;Zona Pellucida,"Molecular Biology of Mammalian Gametogenesis, Fertilization and Early Development",15603,NA,NA,NA,NA,18,NA,NA,3109205,NA
11188509,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK024151,NA,NA,1ZIADK024151-22,NIDDK:650516\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415126 (contact),"O'CONNELL, KEVIN  (contact)",NA,NA,NA,Address;Alanine;Alleles;Area;Autosomal recessive primary microcephaly;Binding;Biochemical;Birth;C2 Domain;Caenorhabditis elegans;Candidate Disease Gene;CCDC6 gene;cell motility;Cell surface;cell type;Cells;Centrioles;Centrosome;Chromosome Segregation;Cilia;Clustered Regularly Interspaced Short Palindromic Repeats;Complex;confocal imaging;Daughter;Defect;Diffusion;Dimensions;Disease;Dwarfism;Embryo;Escherichia coli;Event;Exhibits;Failure;Flagella;Gene Conversion;gene function;Gene Mutation;Generations;Genes;genetic approach;Genetic Screening;genome editing;Genomics;Glutamates;Goals;Growth;In Vitro;Individual;interest;Investigation;kinetosome;Knowledge;Laboratories;Lead;Length;Lesion;Link;loss of function;Maintenance;Maps;Mass Spectrum Analysis;Microtubule-Organizing Center;Microtubules;migration;mimetics;Mitosis;Mitotic;Mitotic spindle;Molecular;molecular phenotype;Mothers;mutant;Mutation;mutation screening;Nematoda;novel;Organelles;overexpression;Phenotype;Phosphorylation;Phosphotransferases;Play;Positioning Attribute;postmitotic;Process;Production;Proteins;Radial;Recombinant Proteins;recruit;Role;scaffold;screening;Serine;Shapes;Signal Transduction;Site;Structure;Suppressor Genes;Suppressor Mutations;Temperature;Threonine;Time;time use;Tissues;Western Blotting,Centrosome Maturation and Duplication in the C. elegans Embryo,24151,NA,NA,NA,NA,22,NA,NA,650516,NA
11188510,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK024946,NA,NA,1ZIADK024946-27,NIDDK:1041227\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415108 (contact),"MASISON, DANIEL  (contact)",NA,NA,NA,Affect;Alzheimer&apos;s Disease;Amyloid;Amyloidosis;ATP Hydrolysis;Behavior;Binding;Biochemical;Biological Assay;Biophysics;cell growth;Cell Physiology;cell type;Cells;Cellular Stress;Client;cohort;Cytoprotection;Development;Diabetes Mellitus;Disease;Distant;Drug Targeting;Environment;Family member;Goals;Growth;Heat-Shock Proteins 70;Heat-Shock Proteins 90;Human;Impairment;in vivo;insight;interest;Modeling;Molecular;Molecular Chaperones;Molecular Conformation;molecular mechanics;Mutate;Mutation;novel strategies;Organism;Output;paralogous gene;Pathology;Phenotype;Physiological;Play;Point Mutation;Prions;Process;protein folding;protein function;Protein Structure Initiative;Proteins;proteostasis;Quality Control;Reaction;Regulation;response;Role;Site;Solubility;Source;Specific qualifier value;Specificity;Structure;Structure-Activity Relationship;sup35;Supporting Cell;System;targeted treatment;Tertiary Protein Structure;therapeutic candidate;Therapeutic Intervention;Toxic effect;translation factor;Work;yeast genetics;Yeasts,Hsp70 and Hsp90 chaperones,24946,NA,NA,NA,NA,27,NA,NA,1041227,NA
11188511,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK024950,NA,NA,1ZIADK024950-18,NIDDK:1360954\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,6480561 (contact),"WICKNER, REED B. (contact)",NA,NA,NA,Alzheimer&apos;s Disease;Amino Acid Sequence;Amyloid;amyloid formation;amyloid structure;Amyloidosis;Architecture;Bacterial Infections;beta pleated sheet;Binding Proteins;Carbon;Cells;Complex;Defect;Diphosphates;Disadvantaged;Disease;DNA;expectation;F-Box Proteins;Filament;Frequencies;Generations;Genes;Genetic;Glutamate-Ammonia Ligase;Glycerol;Growth;Human;human disease;In Vitro;in vivo;Infection;Innate Immune System;Inositol;Learning;Mammals;Mediating;Minority;Mitochondria;Modeling;Molecular Chaperones;Molecular Conformation;mRNA Decay;multicatalytic endopeptidase complex;Mutagenesis;mutant;Mutation;National Institute of Diabetes and Digestive and Kidney Diseases;Nature;next generation sequencing;Non-Insulin-Dependent Diabetes Mellitus;non-prion;Normal Cell;overexpression;Parkinson Disease;Pathogenicity;Pathology;Pathway interactions;Polyphosphates;prevent;Prevention;Prion Diseases;prion seeds;prion-like;Prions;Process;Production;Protein Conformation;protein protein interaction;Protein Structure Initiative;Proteins;pyrophosphatase;restoration;Ribosomes;Science;solid state nuclear magnetic resonance;Son;Source;Stress;Structure;System;Testing;Time;transcription factor;ubiquitin-protein ligase;Variant;Virus Diseases;Work;yeast prion;Yeasts,Prions of Yeast and Anti-Prion Systems,24950,NA,NA,NA,NA,18,NA,NA,1360954,NA
11188512,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK024954,NA,NA,1ZIADK024954-15,NIDDK:347076\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415108 (contact),"MASISON, DANIEL  (contact)",NA,NA,NA,Affect;Agreement;Amino Acids;Amyloid;amyloid formation;Cell division;Cells;Cytosol;daughter cell;Dependence;Deposition;Disease;Drug Metabolic Detoxication;Fiber;Generations;Goals;Heat-Shock Proteins 70;Human;In Vitro;in vivo;interest;Liquid substance;Mediating;member;misfolded protein;Molecular;Molecular Chaperones;Monitor;monomer;Mothers;Mutation;N-terminal;Organism;Pathology;Phase;Phenotype;Physiological;Point Mutation;polyglutamine;Prions;Process;Production;Property;protein aggregation;Proteins;PrP;Quality Control;recruit;Role;segregation;sup35;System;Tertiary Protein Structure;Tissues;Toxic effect;transmission process;Work;Yeasts,Chaperone-amyloid interactions,24954,NA,NA,NA,NA,15,NA,NA,347076,NA
11188513,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK024962,NA,NA,1ZIADK024962-18,NIDDK:650516\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415126 (contact),"O'CONNELL, KEVIN  (contact)",NA,NA,NA,"Affect;Alleles;Autoantigens;Axon;Behavior;Binding;Biogenesis;Biological Assay;Caenorhabditis elegans;Cell Cycle;Cell division;cell type;Cells;Centrioles;Centrosome;Clustered Regularly Interspaced Short Palindromic Repeats;Collaborations;copolymer;Cytology;Data;Daughter;Defect;design;Development;Embryo;embryo cell;Exhibits;experimental study;Failure;Fathers;Female;follow-up;Genes;genetic analysis;Genotype;Germ Lines;Goals;helicase;Image;interest;Investigation;Knock-out;Label;male;Meiosis;Messenger RNA;MicroRNAs;Microscopy;Microtubule-Organizing Center;Microtubules;Mitosis;Mitotic;Modeling;Mothers;mutant;Mutation;National Heart, Lung, and Blood Institute;Neurons;Nuclear;Organism;Orthologous Gene;overexpression;Pathway interactions;Phenotype;Phosphotransferases;Postembryonic;premature;Process;Production;Protein phosphatase;Proteins;Regulation;response;RNA-Binding Proteins;Role;Sexual Reproduction;sperm cell;Spermatocytes;Syndrome;Temperature;Time;Tissues;Tube;Visit;Work;Zinc Fingers;zygote",Developmental Regulation of Centrosome Duplication,24962,NA,NA,NA,NA,18,NA,NA,650516,NA
11188514,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK025016,NA,NA,1ZIADK025016-50,NIDDK:106183\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415155 (contact),"SCHECHTER, ALAN  (contact)",NA,NA,NA,"Adhesions;Affect;alpha Globin;alpha-Thalassemia;Anabolism;Anemia;Annual Reports;Archives;Biology;biophysical analysis;Blood coagulation;Blood flow;career;CD34 gene;Cells;Central Nervous System;central sensitization;Cerebral Malaria;Circulation;clinical center;clinical effect;Clinical Research;cohort;Collaborations;Collection;Complex;contrast enhanced;Cyclic GMP;Data;Development;Developmental Biology;Disease;Drug usage;Enzymes;Erythrocytes;Erythroid;Erythroid Cells;Erythropoietin;Exhibits;Fees;Fellowship Program;Festival;Fetal Hemoglobin;Forearm;Functional disorder;Funding;gamma Globin;Gene Expression;Genes;Genetic;Genetic Diseases;Globin;Growth;Head;Hematopoietic;Hemoglobin;Hemoglobin concentration result;Hemolysis;Historical Aspects;Human;hydroxyurea;Impairment;improved;Institution;interest;International;Intramural Research Program;Ions;Journals;Laboratories;Lead;lectures;Life;Malaria;MAP Kinase Gene;Measurement;Measures;Medicine;meetings;member;Metabolism;Modality;Molecular Genetics;mTOR Signaling Pathway;Multicenter Studies;Muscle;Myeloproliferative disease;Myocardial;National Heart, Lung, and Blood Institute;Nitric Oxide;Nitric Oxide Donors;Nitric Oxide Synthase;Nitrites;novel strategies;novel therapeutics;Oral;Organ;Pain;pain perception;pandemic disease;Pathogenesis;Pathway interactions;Patients;perfusion imaging;Peripheral Nervous System;Pharmaceutical Preparations;pharmacologic;Phenotype;Philosophy;PI3 gene;polymerization;Polymers;Positioning Attribute;Process;Production;programs;Proto-Oncogene Proteins c-akt;Publications;Publishing;Recording of previous events;recruit;Reporting;Research;response;Reticulocyte count;Science;Series;Severity of illness;Sickle Cell;Sickle Cell Anemia;Sickle Hemoglobin;Signal Transduction;symposium;Syndrome;System;Textbooks;Thalassemia;Therapeutic;thrombotic;transcription factor;treatment effect;treatment response;ultrasound;United States National Institutes of Health;Universities;Variant;Work;Writing",Control Of the Human Erythrocytic Hemoglobin Phenotype and Approaches to the Therapy of Sickle Cell Disease,25016,NA,NA,NA,NA,50,NA,NA,106183,NA
11188515,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK025021,NA,NA,1ZIADK025021-49,NIDDK:409495\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415153 (contact),"NOGUCHI, CONSTANCE  (contact)",NA,NA,NA,Adipose tissue;Adult;Adverse effects;Affect;Age;Age Months;Anemia;Animal Model;Binding;biological adaptation to stress;Biological Assay;blood glucose regulation;bone;bone health;Bone Marrow;Bone Marrow Cells;CD34 gene;Cell Proliferation;Cell Separation;Cell Surface Receptors;Cells;Chronic Kidney Failure;Chronic stress;Combined Modality Therapy;Data;deoxyhemoglobin;Development;Diet;diet-induced obesity;Dose;Embryo;Environmental Risk Factor;EPOR gene;Erythrocytes;Erythroid;Erythroid Progenitor Cells;Erythropoiesis;Erythropoietin;Erythropoietin Receptor;ESR1 gene;Estrogens;Exhibits;Fatty acid glycerol esters;feeding;Female;Fetal Hemoglobin;fracture risk;Gene Modified;Glucose;glucose tolerance;Growth;Guanosine Monophosphate;Hematocrit procedure;Hematopoietic;Hemoglobin;High Fat Diet;Hormones;Human;Human Cloning;hydroxyurea;Hypoxia;improved;In Vitro;Inflammation;inhibitor;insight;Insulin Resistance;interstitial cell;Investigation;Kidney;Knockout Mice;Knowledge;Link;lipid biosynthesis;male;Mediating;Metabolic;Metabolism;Modification;mouse model;Mus;Nitric Oxide;Nitric Oxide Donors;Nitric Oxide Synthase;Nitric Oxide Synthase Type I;NOS3 gene;Obesity;Osteogenesis;Ovariectomy;Oxygen;Pathway interactions;Patients;peripheral blood;pharmacologic;Production;progenitor;Proliferating;protective effect;receptor;Receptor Activation;receptor expression;recombinant human erythropoietin;Regulation;response;Role;sex;Sickle Cell;Sickle Cell Anemia;Signal Pathway;stem cell survival;Thalassemia;Therapeutic;Tissue Survival;Tissues;transcription factor;Transplantation;treatment comparison;Wild Type Mouse;women&apos;s treatment,Erythropoietin treatment for anemia and hematopoietic/erythroid progenitor cell responses,25021,NA,NA,NA,NA,49,NA,NA,409495,NA
11188516,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK025061,NA,NA,1ZIADK025061-49,NIDDK:1228486\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415153 (contact),"NOGUCHI, CONSTANCE  (contact)",NA,NA,NA,Acute;Adipose tissue;Adult;Affect;Anemia;Animal Model;Animals;Binding;biological adaptation to stress;Biological Assay;Biological Models;Blood Vessels;Body Weight Changes;Brain;Brown Fat;cardioprotection;Cardiovascular system;Cell Proliferation;Cell Survival;Cerebrum;Chronic;Chronic Kidney Failure;Communities;cytokine;Defect;diet-induced obesity;Dose;EFRAC;Endothelial Cells;Energy Metabolism;Erythrocytes;Erythroid;Erythroid Progenitor Cells;Erythropoiesis;Erythropoietin;Erythropoietin Receptor;Estrogens;Exhibits;experimental study;Fatty acid glycerol esters;feeding;Female;Gene Expression;Gene Modified;Genes;Glucose;Heart failure;heart function;Hematocrit procedure;Hemodialysis;High Fat Diet;High Prevalence;Hormones;Human;Hypothalamic structure;Hypoxia;improved;in utero;Inflammation;Injury;insight;Insulin Resistance;Investigation;Kidney;Left;Life;lipid metabolism;Liver;Luciferases;Maintenance;male;Mediating;Metabolic;Metabolism;Morphology;mouse model;Mus;Muscle;Nitrates;Nitric Oxide;Nitric Oxide Signaling Pathway;Nitric Oxide Synthase;Nitric Oxide Synthase Type I;Non-Insulin-Dependent Diabetes Mellitus;Obesity;Ovariectomy;Oxygen;Patients;Phenotype;Pima Indian;Play;Predisposition;Process;Production;Proliferating;promoter;protective effect;receptor;receptor expression;Recombinant Erythropoietin;Regulation;repaired;Reporter Genes;response;RUNX1 gene;secondary analysis;Shortening Fraction;Signal Pathway;Signal Transduction;Skeletal Muscle;stem cell survival;Supplementation;Thinness;Tissue Survival;Tissues;transcription factor;Transgenic Organisms;ubiquitin ligase;Vascular Endothelium;Ventricular;Wild Type Mouse;wound healing,Receptor Mediated Erythropoietin Metabolic Response,25061,NA,NA,NA,NA,49,NA,NA,1228486,NA
11188517,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK025104,NA,NA,1ZIADK025104-18,NIDDK:955647\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415155 (contact),"SCHECHTER, ALAN  (contact)",NA,NA,NA,Acute;Adsorption;Affect;Aging;Animal Experiments;Animal Model;Animals;Arginine;Australia;Back;Biochemical;Biological Assay;Biopsy Specimen;Blood;Blood coagulation;Blood flow;Blood Platelets;Blood specimen;Blood Vessels;bone;Canis familiaris;cardiovascular effects;Cell Culture Techniques;Cessation of life;Chemistry;Chronic;Clinical;clinical application;Clinical Research;clinically significant;Collaborations;Compensation;Cornea;Critical Care;Cyclic GMP;Diabetes Mellitus;Diet;dietary;Dietary Intervention;Disease;Dry Eye Syndromes;endothelial dysfunction;Erythrocytes;Exercise;Eye;eye chamber;falls;Family suidae;Food;Frequencies;Functional disorder;genetic manipulation;Glaucoma;Goals;Health Benefit;Hemoglobin;Hormones;Human;human subject;human tissue;Human Volunteers;Hypoxia;improved;Individual;Infusion procedures;Ingestion;Inhalation;inhaled nitric oxide;Institutional Review Boards;Insulin;Insulin Resistance;Ions;Isotopes;Juice;Label;Laboratories;Lacrimal gland structure;Leg;Legal patent;Liver;Lung;Macular degeneration;Mammalian Cell;Mammals;Mass Spectrum Analysis;Measurement;Measures;Medical center;Medicine;Metabolic;metabolic abnormality assessment;Metabolic Pathway;Metabolism;Methods;Muscle;muscle form;muscle physiology;Muscular Atrophy;National Institute of Diabetes and Digestive and Kidney Diseases;Nitrates;Nitric Oxide;Nitrites;Nitrogen;nitrogen metabolism;Nitrogen Oxides;nutrition;Nutritional;Obesity;older patient;Older Population;Ophthalmologist;Ophthalmology;Organ;oxidation;Oxygen;Pathway interactions;Patients;Performance;Persons;Pharmaceutical Preparations;pharmacologic;Pharmacology;Physicians;Physiologic Intraocular Pressure;Physiological;Plants;Process;Production;Property;Protocols documentation;Publications;Publishing;Pulmonary Hypertension;Pump;Reaction;Reporting;Rest;Retina;Rodent;Sampling;sarcopenia;Sclera;Sickle Cell;Skeletal Muscle;Study models;Surface;Syndrome;System;Testing;Texas;Thalassemia;Time;Tissues;Tracer;United States National Institutes of Health;Universities;uptake;Variant;vascular bed;volunteer;Writing,Clinical Applications of Nitrite and Nitrate,25104,NA,NA,NA,NA,18,NA,NA,955647,NA
11188518,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK029023,NA,NA,1ZIADK029023-34,NIDDK:3399817\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,79336348 (contact),"CLORE, MARIUS  (contact)",NA,NA,NA,3-Dimensional;Amyloid;Amyloid beta-Protein;amyloid fibril formation;autosome;Binding;Binding Proteins;Biochemical Process;Biological Process;biophysical techniques;Biophysics;Calcium;Calmodulin;Cell Nucleus;chaperonin;Complex;Computing Methodologies;Darkness;DBL Oncoprotein;Development;Diameter;Disease;DNA;Electron Spin Resonance Spectroscopy;Fingers;Freezing;Genetic Transcription;Goals;HIV Protease;HIV-1;Huntington Disease;Huntington gene;Kinetics;Laboratories;Macromolecular Complexes;macromolecule;Measurement;Measures;method development;Methods;Molecular Chaperones;Molecular Conformation;molecular recognition;Molecular Weight;monomer;Multidimensional NMR Techniques;nanoparticle;Nature;Nerve Degeneration;NMR Spectroscopy;novel;novel strategies;Nucleic Acids;Pathway interactions;Physiologic pulse;Play;polyglutamine;polypeptide;protein complex;Protein Dynamics;protein folding;protein protein interaction;Proteins;Relaxation;Research;RNA-Directed DNA Polymerase;sensor;Signal Transduction;Slide;solid state nuclear magnetic resonance;Spectrum Analysis;Spin Labels;Structure;System;Techniques;Tertiary Protein Structure;Thumb structure;transcription factor;Visualization;Work,Structure and Dynamics Of Macromolecules In Solution By NMR,29023,NA,NA,NA,NA,34,NA,NA,3399817,NA
11188519,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK029029,NA,NA,1ZIADK029029-28,NIDDK:763076\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,6570188 (contact),"TYCKO, ROBERT  (contact)",NA,NA,NA,Address;Amides;Amino Acids;Amyloid;Area;Biological Models;Biopolymers;cold temperature;computer studies;Copper;Data;Dependence;Deposition;Deuterium;Development;Diameter;DNA;Electron Spin Resonance Spectroscopy;Equipment;Evaluation;Evolution;experimental study;Film;Fluorescent Dyes;Freezing;Goals;Helium;HIV-1;Hydrogen;Imaging technology;improved;isopentane;Journals;Letters;Ligand Binding;Liquid substance;Magnetic Resonance;Magnetic Resonance Imaging;mathematical analysis;Measurement;Measures;Metals;method development;Methods;millisecond;Molecular Structure;Nitrogen;NMR Spectroscopy;novel;Nuclear;Nucleic Acids;optical spectra;Paper;Peptides;Physics;Physiologic pulse;Process;protein folding;Proteins;Publications;Publishing;radio frequency;Reporting;self assembly;Series;Signal Transduction;solid state nuclear magnetic resonance;Solvents;Speed;Study models;Surface;tau Proteins;Techniques;Technology;Temperature;temperature jump;Time;Tissues;Torsion;Work;Writing,Development of Solid State NMR Methods and Technology,29029,NA,NA,NA,NA,28,NA,NA,763076,NA
11188520,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK029031,NA,NA,1ZIADK029031-26,NIDDK:641688\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415217 (contact),"ANFINRUD, PHILIP  (contact)",NA,NA,NA,absorption;Active Sites;Affinity;Aluminum;Arctic Regions;Bacteria;base;beamline;Behavior;Binding;Biochemical;Biochemical Reaction;biophysical analysis;Bite;Blood capillaries;Carboxyhemoglobin;Cells;chemical reaction;Chemicals;Code;cold temperature;computer science;Computer software;Computers;data acquisition;Data Set;design;detection platform;digital;Drug Design;Electronics;Ensure;Environment;Enzymes;Equilibrium;Event;Exhibits;Fishes;Genetic Recombination;Head;High temperature of physical object;Higher Order Chromatin Structure;Home;Industry;insight;instrument;kinematics;Laboratories;Lasers;Learning;Life;Light;Lighting;Logic;macromolecule;Measurement;Methods;millisecond;Molecular;molecular scale;Monitor;Motion;movie;novel;novel strategies;Operating System;operation;Optics;Output;Performance;photonics;Physiologic pulse;Population;Positioning Attribute;Postdoctoral Fellow;pressure;Procedures;Process;Productivity;protein structure;Pump;Pythons;Ramp;reaction rate;Resistance;Resolution;Roentgen Rays;Running;Sampling;Semiconductors;Series;Services;Signal Transduction;Site;software development;Source;Spectrum Analysis;Structure;Surface;Syringes;System;Techniques;technology development;Temperature;temperature jump;Testing;Time;Tube;undergraduate student;United States National Institutes of Health;Update;Vent;volunteer;Water,Ultrafast Biophysical Studies of Biomolecules at the NIH,29031,NA,NA,NA,NA,26,NA,NA,641688,NA
11188521,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK029046,NA,NA,1ZIADK029046-18,NIDDK:988068\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,15195448 (contact),"BAX, ADRIAAN  (contact)",NA,NA,NA,2019-nCoV;3-Dimensional;Acceleration;Active Sites;Agreement;Algorithms;alpha helix;aqueous;Binding;C-terminal;Calmodulin;Chemicals;Collection;Data;data acquisition;Data Analyses;Data Set;Databases;Deposition;dynamic system;Equilibrium;experimental study;falls;Four-dimensional;Goals;improved;Ligation;Liquid substance;maltose-binding protein;Measurement;Measures;Methods;Modeling;Molecular Conformation;Molecular Structure;monomer;Motion;mutant;N-terminal;NMR Spectroscopy;novel;Pattern;Peptide Hydrolases;polypeptide;Population;Process;programs;protein data bank;Protein Dynamics;protein structure;Proteins;Residual state;Resolution;restraint;Roentgen Rays;Sampling;SARS-CoV-2 protease;Scheme;Spectrum Analysis;Structure;Suspensions;System;Time;Vertebral column;Virus;X ray diffraction analysis,Methods to accelerate protein structure determination by solution NMR,29046,NA,NA,NA,NA,18,NA,NA,988068,NA
11188522,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK029053,NA,NA,1ZIADK029053-18,NIDDK:1563891\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415209 (contact),"EATON, WILLIAM  (contact)",NA,NA,NA,"Abnormal Hemoglobins;Adenosine Triphosphate;Antisickling Agents;Ants;Binding;Biological Assay;Blood;Cell Volumes;Characteristics;Chronic;Clinical Trials;Data Analyses;diphosphoglycerate;Disease;Dose;Drug Kinetics;drug repurposing;Erythrocytes;Fetal Hemoglobin;Fiber;Foundations;Frequencies;Funding;Genes;Hemoglobin;Hemoglobin concentration result;Hemolysis;high throughput screening;Human;hydroxyurea;Individual;inhibitor;Libraries;machine learning algorithm;Measurement;Methods;Microscope;Molecular Conformation;Molecular Disease;molecular drug target;Monitor;Mus;mutant;nanomolar;National Heart, Lung, and Blood Institute;Nitrogen;novel therapeutics;Oral;Organ;Oxygen;Pain;Pathogenesis;Patients;Pharmaceutical Preparations;Pharmacodynamics;Pharmacotherapy;phase 1 study;Phase II/III Clinical Trial;polymerization;Polymers;Pyruvate Kinase;Safety;Sample Size;screening;Serum;Sickle Cell;Sickle Cell Anemia;Sickle Hemoglobin;sickling;small molecule;Structure;System;targeted treatment;Testing;Therapeutic;Therapeutic Agents;therapeutically effective;Time;Transgenic Organisms;United States Food and Drug Administration;Whole Blood",Sickle cell disease molecular pathogenesis and drug therapy,29053,NA,NA,NA,NA,18,NA,NA,1563891,NA
11188523,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK029058,NA,NA,1ZIADK029058-18,NIDDK:641688\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415217 (contact),"ANFINRUD, PHILIP  (contact)",NA,NA,NA,Active Sites;Articular Range of Motion;base;beamline;Biochemical;Biochemical Reaction;biophysical analysis;Cells;chemical reaction;chromophore;Code;Communication;Complement;complex data;Computer software;Computer Systems;Computers;Crystallization;Crystallography;Data;data acquisition;Data Analyses;Data Collection;detector;Development;Electronics;Electrons;Ensure;Enzymes;Equipment;Event;Exhibits;experimental study;Fingerprint;free-electron laser;Generations;Goals;Higher Order Chromatin Structure;Hybrids;improved;Infrastructure;insight;Instruction;Lasers;Learning;Life;Literature;macromolecule;Methodology;Methods;Modeling;Modification;Molecular Conformation;molecular modeling;Motion;Motor;Names;Noise;Operating System;operation;Optics;Output;Pathway interactions;Pattern;Phase;Photons;Physiologic pulse;Physiological;Play;Positioning Attribute;protein function;protein structure;Proteins;Publishing;Pump;Reaction;Records;Reporting;Resolution;Roentgen Rays;Role;Sampling;Secondary to;Shapes;Side;Signal Transduction;Signaling Protein;Site;software development;Source;Specific qualifier value;Spectrum Analysis;Spottings;Structure;Structure-Activity Relationship;Synchrotrons;System;Temperature;Theoretical Studies;Time;virtual;Work,Ultrafast Biophysical Studies of Biomolecules at the APS,29058,NA,NA,NA,NA,18,NA,NA,641688,NA
11188524,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK029061,NA,NA,1ZIADK029061-18,NIDDK:381538\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,6570188 (contact),"TYCKO, ROBERT  (contact)",NA,NA,NA,Address;Agreement;Alzheimer&apos;s Disease;Amyloid;Amyloid beta-Protein;Amyloid Fibrils;amyloid formation;Area;Atomic Force Microscopy;beta pleated sheet;Chemicals;Cryoelectron Microscopy;Darkness;Data;density;Electron Microscope;Genetic Polymorphism;Goals;Growth;Hydrogen Bonding;Journals;Length;Measurement;microscopic imaging;Molecular;Molecular Structure;Morphology;nanometer;neurotoxicity;Paper;Peptides;Physical Chemistry;Polymorph;Proteins;Publishing;Registries;self assembly;Series;solid state nuclear magnetic resonance;Structure;Thick;Transmission Electron Microscopy;Width;Work,Structural Studies of Alzheimer's beta-Amyloid Fibrils,29061,NA,NA,NA,NA,18,NA,NA,381538,NA
11188525,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK031115,NA,NA,1ZIADK031115-41,NIDDK:288422\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9245839 (contact),"JACOBSON, KENNETH ALAN (contact)",NA,NA,NA,Address;Adenosine;ADORA2A gene;Affinity;Agonist;Agreement;Alendronate;Amides;Amines;amino group;analog;antagonist;Antineoplastic Agents;Apomorphine;Binding;Binding Sites;Biological;Biological Assay;bone;bone loss;Cardiovascular system;Charge;chemical synthesis;Chemicals;Clinical;Complex;Coupling;Delayed-Action Preparations;Dendrimers;Derivation procedure;design;Detection;Development;Disease;Distal;Docking;Dopamine;DRD2 gene;Drug Carriers;drug discovery;Drug Screening;Drug Targeting;Environment;Enzymes;Exposure to;extracellular;Extracellular Domain;flexibility;Flow Cytometry;Fluorescence Resonance Energy Transfer;fluorophore;Frequencies;functional group;G-Protein-Coupled Receptors;Geometry;Glucose;Glucuronates;GPR105 receptor;Hydrophobicity;Immobilization;improved;Inflammation;inhibitor;Kinetics;Knockout Mice;Knowledge;Laboratories;Length;Ligand Binding;Ligands;Lipids;Malignant Neoplasms;Mediating;Membrane;Membrane Lipids;Metabolic;Methods;Modeling;Modification;Molecular Conformation;molecular modeling;Mus;Mutagenesis;nanocarrier;nanoGold;Nerve Degeneration;novel;nucleobase;nucleotide receptor;Parents;Parkinsonian Disorders;particle;Penetration;Peptides;permissiveness;Pharmaceutical Preparations;pharmacokinetics and pharmacodynamics;pharmacologic;Pharmacology;pharmacophore;Phospholipids;Phosphotransferases;PLK1 gene;Polo-Box Domain;Polymers;Positioning Attribute;prevent;Prodrugs;Property;Proteins;Pulmonary Inflammation;Purinergic P1 Receptors;Quantum Dots;radioligand;receptor;receptor binding;Reporter;Research;Roentgen Rays;scaffold;screening;Screening procedure;side effect;Signal Pathway;Site;small molecule;Structure;Structure-Activity Relationship;Surface;Time;tissue injury;Tissues;tool;Transmembrane Domain;Trees;Uracil Nucleotides;Vestibule;Work;Xanthines,Functionalized Congeners of Bioactive Compounds,31115,NA,NA,NA,NA,41,NA,NA,288422,NA
11188526,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK031116,NA,NA,1ZIADK031116-37,NIDDK:721055\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9245839 (contact),"JACOBSON, KENNETH ALAN (contact)",NA,NA,NA,Acids;Acute Promyelocytic Leukemia;Adipocytes;Adipose tissue;Affinity;Agonist;airway hyperresponsiveness;Allergic;analog;antagonist;Apoptosis;Area;Asthma;asthma exacerbation;asthma model;attenuation;Benzopyrans;Binding;Biological;Biological Availability;Body System;Body Weight;Brain;carbene;cardioprotection;CCL24 gene;Cell Death;Cell Physiology;Cell Proliferation;Cell Surface Receptors;Cells;chemical property;chemical synthesis;Chemicals;Chemotactic Factors;Chemotaxis;Chronic Disease;chronic neuropathic pain;chronic pain;Collaborations;Communication;Crystallography;cytokine;deprivation;design;Development;Diabetes Mellitus;diet-induced obesity;Digestive System Disorders;Disease;drug discovery;Drug Screening;Endocrine System Diseases;Energy-Generating Resources;Enzymes;eosinophil;Eosinophilia;Epidemic;extracellular;Family;Fasting;Fatty acid glycerol esters;Fatty Acids;Fatty Liver;Feedback;Fibrinolytic Agents;Flow Cytometry;Fluorescent Probes;Future;G-Protein-Coupled Receptors;Glucocorticoids;Glucose;glucose tolerance;Glycerol;Goals;GPR105 receptor;Heart failure;Hematopoietic;High Fat Diet;Homology Modeling;Human;Immune response;Immune system;improved;in vivo;Inflammation;Inflammatory Response;Insulin;insulin sensitivity;Intercalated Cell;Ion Channel;Islet Cell;Islets of Langerhans;Kidney;Knock-out;Knockout Mice;Laboratories;Laboratory Research;Leukemic Cell;Libraries;Ligands;Lipolysis;Lung;Malignant Neoplasms;MAPK8 gene;Mediating;Medicine;Metabolic;Microglia;Molecular Conformation;molecular dynamics;molecular modeling;molecular recognition;Molecular Structure;Mus;Muscle Cells;Mutagenesis;Nerve Degeneration;Nervous System;Neurodegenerative Disorders;Neurotransmitters;neutrophil;Non-Insulin-Dependent Diabetes Mellitus;novel;novel therapeutics;nucleotide receptor;Nucleotides;Obesity;P2X-receptor;Pain;pain signal;Pancreas;Pathway interactions;Peptide Hydrolases;Peripheral;Peroxisome Proliferator-Activated Receptors;Pharmaceutical Preparations;pharmacokinetics and pharmacodynamics;pharmacologic;Physiological;Population;prevent;Production;Property;protein structure function;purinoceptor P2Y6;Pyrimidine Nucleotides;radioligand;receptor;recruit;Reporting;Research;Resistance;response;Ribose;Role;scaffold;Signal Pathway;Signal Transduction;Skeletal Muscle;small molecule;stem cell differentiation;Stress;Structure;Structure-Activity Relationship;subcutaneous;Synapses;System;systemic inflammatory response;Therapeutic;Therapeutic Intervention;therapeutic target;Tissues;tool;Uridine Diphosphate Sugars;Visceral;Wild Type Mouse,Development of P2Y Receptor Ligands,31116,NA,NA,NA,NA,37,NA,NA,721055,NA
11188527,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK031117,NA,NA,1ZIADK031117-37,NIDDK:865266\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9245839 (contact),"JACOBSON, KENNETH ALAN (contact)",NA,NA,NA,Adenine;Adenosine;Adenosine A2B Receptor;Adenosine Kinase;ADORA3 gene;Affinity;Agonist;antagonist;anti-cancer;Anti-glaucoma Agent;Anti-Inflammatory Agents;Anticonvulsants;Area;ATP-Binding Cassette Transporters;Binding;Binding Proteins;Biological;Brain;cancer cell;cancer immunotherapy;Cardiovascular system;Central Nervous System;cerebroprotection;chemical synthesis;Chemicals;chemotherapeutic agent;Chemotherapy-Oncologic Procedure;chronic constriction injury;Chronic Disease;chronic neuropathic pain;Clinical Trials;Collaborations;computerized;design;Development;Disease;disease model;drug action;drug development;Enzyme Inhibition;Event;Future;G-Protein-Coupled Receptors;Glaucoma;Heart;Hyperalgesia;Immune system;in silico;In Vitro;Inflammatory;inhibitor;interest;interleukin-23;Ischemia;Laboratories;Legal patent;Lesion;Licensing;Life;Ligands;Light;Lipids;Lung;Machine Learning;Malignant Neoplasms;Masks;Medical;Membrane;Modeling;Modification;Molecular;Molecular Conformation;molecular modeling;molecular recognition;Morphine;mouse model;Mus;nanomolar;Neurodegenerative Disorders;NF-kappa B;Normal Cell;novel;Nuclear Magnetic Resonance;nucleoside analog;Nucleosides;Nucleotides;Opioid;overexpression;Pain;Pathway interactions;Patients;Peripheral;Pharmaceutical Preparations;pharmacologic;Pharmacologic Substance;Phase III Clinical Trials;physical property;Positioning Attribute;positive allosteric modulator;preclinical development;preservation;prevent;Process;Prodrugs;programs;Proliferating;Protein Kinase C;Psoriasis;Public Health;Pulmonary Fibrosis;Purinergic P1 Receptors;rational design;receptor;Receptor Activation;Reporting;Research;Ribose;Roentgen Rays;Role;scaffold;screening;Side;side effect;Signal Pathway;Signal Transduction;Signal Transduction Pathway;Site;Skeletal Muscle;Skin;Source;Stress;stroke clinical trials;Structure;System;Technology;Therapeutic;therapeutic target;Therapeutic Uses;Thiophenes;three dimensional structure;tool;Topical application;translational medicine;translational potential;Traumatic Brain Injury;tumor;tumor microenvironment;Visceral pain;Wisconsin;Withdrawal;X-Ray Crystallography,Development of Drugs Acting at Adenosine Receptors,31117,NA,NA,NA,NA,37,NA,NA,865266,NA
11188528,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK031126,NA,NA,1ZIADK031126-18,NIDDK:576844\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9245839 (contact),"JACOBSON, KENNETH ALAN (contact)",NA,NA,NA,Adenine;Adenosine;Adenosine A1 Receptor;ADORA3 gene;Affinity;Agonist;analog;antagonist;Astronomy;base;Binding;Binding Proteins;Binding Sites;California;Cardiovascular Diseases;Charge;chemical synthesis;Chemicals;Clinical;Collaborations;Complex;Computational Technique;Computer Models;Crystallography;Databases;design;Disease;Docking;Drug Design;drug development;Drug Kinetics;drug-like compound;Elements;extracellular;Family;G-Protein-Coupled Receptors;Homologous Gene;Homology Modeling;Human;Hydrophobicity;in silico;Inflammation;insight;Isoxazoles;kappa opioid receptors;lead optimization;Libraries;Ligands;Maps;Materia Medica;Measures;Membrane;Methods;Modeling;Molecular;molecular dynamics;molecular recognition;Mus;Mutagenesis;Niacinamide;novel;Nucleosides;Nucleotides;obesity treatment;Opioid Antagonist;Pain;Performance;piperidine;predictive modeling;Productivity;Protein Databases;Purinergic P1 Receptors;Purines;Purinoceptor;Pyrimidines;radioligand;Rattus;receptor;Reporting;Resolution;Retrieval;Ribose;Roentgen Rays;Role;scaffold;screening;Sequence Alignment;Series;Serotonin;Signal Transduction;small molecule;Structure;Structure-Activity Relationship;success;System;three-dimensional modeling;Universities;virtual;virtual library;virtual screening;Water;water conservation;X-Ray Crystallography,Computer Modeling of G Protein-Coupled Receptors,31126,NA,NA,NA,NA,18,NA,NA,576844,NA
11188529,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK031127,NA,NA,1ZIADK031127-18,NIDDK:432633\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9245839 (contact),"JACOBSON, KENNETH ALAN (contact)",NA,NA,NA,ABCB1 gene;ABCG2 gene;Action Potentials;Acute;addiction;Adenosine;Adenosine A3 Receptor;Affect;Agonist;analog;Animal Experiments;antagonist;ATP-Binding Cassette Transporters;Behavior Disorders;Binding;Binding Sites;Biological;Biological Process;Calcium ion;Calsequestrin;cancer therapy;Cardiac;Cardiac Myocytes;Cardiomyopathies;cardioprotection;Cardiotonic Agents;Cardiovascular system;Cations;Cavia;Cells;Central Nervous System;cerebroprotection;Chronic;Cocaine;Collaborations;Connecticut;Cryoelectron Microscopy;Data;design;Dopamine;dopamine transporter;drug action;drug development;Drug Kinetics;Dynamin;extend lifespan;extracellular;Goals;Guanine Nucleotides;Heart failure;heart function;Heart Hypertrophy;Human;Hydrolysis;in vivo;Industry;Infiltration;Inflammation;Inflammatory;inhibitor;inorganic phosphate;interest;Ion Channel;Ion Channel Gating;Ischemic Stroke;Learning;Licensing;Ligands;Lung;Macrophage;Mediating;Membrane Potentials;Memory;meter;Microglia;middle cerebral artery;Modeling;Molecular Conformation;Molecular Structure;monoamine;monocyte;Mus;Muscle Cells;Myeloid Cells;Naphthalene;neuroprotection;novel;novel strategies;Nucleosides;Nucleotidases;nucleotide analog;Nucleotides;Oral;Oral Administration;Oregon;overexpression;P2X-receptor;Pain management;Peripheral;Permeability;Pharmaceutical Preparations;Phenotype;phosphonate;Positioning Attribute;potassium ion;preference;Preparation;Privatization;Pump;radioligand;Rattus;receptor;Receptor Activation;Receptor Inhibition;Recovery;Regulation;Reporting;Resistance;Rest;Ribose;Role;Scanning;Sodium;sodium ion;stroke model;stroke recovery;stroke therapy;structural biology;Structure;Structure-Activity Relationship;symporter;System;Testing;Time;Tropanes;Universities;uptake;Vasodilator Agents;Ventricular,Development of Drugs Acting at Ion Channels,31127,NA,NA,NA,NA,18,NA,NA,432633,NA
11188530,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK031129,NA,NA,1ZIADK031129-18,NIDDK:176451\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,12672769 (contact),"WESS, JURGEN  (contact)",NA,NA,NA,Agonist;Arrestin Beta 1;Arrestins;beta-arrestin;Binding;Clathrin;Clinical;clinically relevant;coated pit;Couples;Coupling;desensitization;extracellular;Family;G alpha q Protein;G-Protein-Coupled Receptors;Generations;Goals;GTP-Binding Proteins;Heterotrimeric GTP-Binding Proteins;In Vitro;in vivo;interest;Manuscripts;Mediating;member;Molecular;Molecular Conformation;Muscarinic Acetylcholine Receptor M3;Muscarinic M3 Receptor;mutant;Nature;Pharmaceutical Preparations;pharmacologic;Pharmacotherapy;Phosphorylation;Phosphotransferases;Physiology;Preparation;Process;Property;Protein Family;prototype;Publications;receptor;receptor function;recruit;Rhodopsin;Signal Transduction;Signaling Molecule;Site-Directed Mutagenesis;Structure;Work,Molecular basis of G protein-coupled receptor function,31129,NA,NA,NA,NA,18,NA,NA,176451,NA
11188531,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK031135,NA,NA,1ZIADK031135-18,NIDDK:621127\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415259 (contact),"BEWLEY, CAROLE  (contact)",NA,NA,NA,Acids;Adjuvant;Agriculture;Anabolism;Anti-Bacterial Agents;anti-cancer therapeutic;anti-tumor drug;Anti-viral Agents;Antibiotics;antimicrobial;arm;artificial intelligence model;Bacteria;Bacterial Infections;Basic Science;Binding;Biological;Biological Assay;C-terminal;Cell division;Cell Wall;cellular targeting;Chemical Structure;Circular Dichroism;Clinic;Clinical;Clinical Research;Collection;Communicable Diseases;Coupled;Cyclization;Cytoskeletal Proteins;Development;diene;Drug resistance;drug resistant pathogen;Ecology;Engineering;Enterococcus faecium;Enzymes;Exhibits;experimental study;Family;fungus;Genome;genome sequencing;Goals;Gossypium;Growth;Human;In Vitro;in vivo;Incidence;inhibitor;Interdisciplinary Study;Invertebrates;Legal patent;Ligase;Marine Invertebrates;marine natural product;Mass Spectrum Analysis;methicillin resistant Staphylococcus aureus;microbial;microbiome;microorganism;Mining;Molecular Conformation;Molecular Structure;N-terminal;Names;natural product inspired;Natural Products;Nature;NMR Spectroscopy;novel;novel antibiotic class;Nucleosides;Optical Rotation;Organism;Pathway interactions;Peptide Biosynthesis;peptide natural products;Peptides;polyketides;polypeptide;Production;Property;Protease Inhibitor;Research;Research Project Grants;Resistance;Resolution;Ribosomes;secondary metabolite;small molecule;Source;structural biology;Techniques;Therapeutic;Vancomycin resistant enterococcus;Vancomycin-resistant S. aureus;Variant;Veterinary Medicine;Vibrational Circular Dichroism;Work;X-Ray Crystallography,"Discovery, Structural Studies and Biosynthesis of Biologically Active Natural Products and Natural Product-Like Inhibitors",31135,NA,NA,NA,NA,18,NA,NA,621127,NA
11188532,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK031143,NA,NA,1ZIADK031143-20,NIDDK:1264396\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,1950565 (contact),"APPELLA, DANIEL H (contact)",NA,NA,NA,Abbreviations;Acquired Immunodeficiency Syndrome;Affinity;Base Sequence;Binding;Biological;Bioterrorism;cancer cell;Cells;Chemicals;Chemistry;clinical diagnostics;Coupling;design;Detection;detection assay;Development;diagnostic technologies;Disease;disease diagnostic;Disease Marker;DNA Sequence;Enzyme Inhibitor Drugs;Goals;Growth;HIV;improved;interest;invention;Link;Manuscripts;Methods;MicroRNAs;Modification;Monitor;novel;nucleic acid detection;overexpression;pathogen;Patients;Penetration;Peptides;Plasma;Property;Publishing;receptor;Research;RNA;RNA Sequences;small molecule;small molecule inhibitor;Specificity;technology platform;tool;Work,Chemically Modified Peptide Nucleic Acids,31143,NA,NA,NA,NA,20,NA,NA,1264396,NA
11188533,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK033006,NA,NA,1ZIADK033006-46,NIDDK:83603\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,2427880 (contact),"MIZUUCHI, KIYOSHI  (contact)",NA,NA,NA,Area;Attention;Bacterial Chromosomes;Bacteriophage mu;Behavior;Binding;Binding Proteins;Cells;Centromere;Chromosomes;Complex;CTPase;Distant;DNA;DNA Binding;DNA Integration;DNA Sequence;DNA-Binding Proteins;Eukaryota;F Factor;Gene Rearrangement;HIV;Homologous Gene;Investigation;Magnetism;Modeling;Monitor;mu opioid receptors;Nature;Phase;Physical condensation;Plasmids;Process;Prokaryotic Cells;Property;protein complex;Protein Family;Proteins;Reaction;Site;System;Transposase;viral DNA;Virus,Study of the dynamics of higher order protein DNA complexes involved in variety of DNA transactions,33006,NA,NA,NA,NA,46,NA,NA,83603,NA
11188534,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK033007,NA,NA,1ZIADK033007-20,NIDDK:787\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9693116 (contact),"BUCHANAN, SUSAN  (contact)",NA,NA,NA,2019-nCoV;Active Sites;Adopted;Affect;Affinity;Analytical Centrifugation;Binding;Biological;Biophysics;C-terminal;cancer type;CCCTC-binding factor;Cell Nucleus;Chromatin;Chromatin Structure;cohesin;Complex;design;dimer;Dimerization;Disease;DNA;DNA Binding Domain;DNA-Binding Proteins;drug development;Equilibrium;Event;Evolution;Exhibits;Genetic Transcription;Genome;Genomic DNA;Genomics;Histones;Human;inhibitor;interest;intermolecular interaction;Link;macromolecular assembly;Macromolecular Complexes;Measures;Mediating;Methods;Molecular Conformation;monomer;mutant;Mutate;Mutation;N-terminal;National Institute of Diabetes and Digestive and Kidney Diseases;Nuclear;Orthologous Gene;Peptide Hydrolases;Play;Polyproteins;Process;Property;Protease Inhibitor;Proteins;Protomer;Recombinants;Research;research and development;RNA;Role;sedimentation equilibrium;sedimentation velocity;Shapes;Site;Spermatogenesis;stoichiometry;Structure;Tail;Time;tool;Virus Replication;Work;Zinc Fingers,Biophysics of Macromolecular Complexes,33007,NA,NA,NA,NA,20,NA,NA,787,NA
11188535,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK033008,NA,NA,1ZIADK033008-14,NIDDK:711485\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415299 (contact),"YE, YIHONG  (contact)",NA,NA,NA,Address;Adopted;Affinity Chromatography;Anemia;Animals;Back;Basement membrane;Biogenesis;Cells;Client;cofactor;Collaborations;Collagen;Complex;Confocal Microscopy;coping;CRISPR screen;Cytosol;Data;Deposition;Development;Dislocations;Drosophila genus;Endoplasmic Reticulum;endoplasmic reticulum stress;Ensure;Enzymes;erythroid differentiation;Eukaryota;Fluorescence;genome-wide;Goals;Golgi Apparatus;Hemoglobin;Heterogeneity;HIV;Homeostasis;Human;human disease;Immune response;Immunologic Surveillance;Impairment;improved;Lysine;Lysosomes;Mammalian Cell;Mediating;Membrane;Membrane Proteins;Messenger RNA;misfolded protein;Modeling;Molecular;Molecular Chaperones;Molecular Conformation;multicatalytic endopeptidase complex;Multiprotein Complexes;Mus;Names;neuron development;novel;Pathogenesis;Pathway interactions;Play;polypeptide;Polyubiquitination;preservation;prevent;Production;Protein Biosynthesis;Protein Secretion;Protein translocation;Proteins;Proteolytic Processing;proteostasis;Quality Control;receptor;recruit;Research;Retrieval;Ribosomes;Role;Route;secretory protein;sensor;Site;Solubility;Sorting;stress reduction;stress tolerance;Substrate Specificity;Tail;trafficking;Translating;TRAPP transport protein particle;Triage;Ubiquitin;ubiquitin isopeptidase;ubiquitin ligase;Ubiquitination;Virus;Virus Diseases,Mechanism of protein quality control at the endoplasmic reticulum,33008,NA,NA,NA,NA,14,NA,NA,711485,NA
11188536,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK036119,NA,NA,1ZIADK036119-29,NIDDK:589937\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415315 (contact),"YANG, WEI  (contact)",NA,NA,NA,Adopted;Affect;ATP Hydrolysis;ATP phosphohydrolase;Base Pair Mismatch;Base Pairing;Binding;Binding Proteins;blood-brain barrier crossing;C-terminal;CAG repeat;Cells;Chromatin Loop;Colorectal Cancer;Communication;Complex;Dactinomycin;daughter strand;Detection;Devices;Dissociation;DNA;DNA biosynthesis;DNA Structure;Drug Targeting;endonuclease;Escherichia coli;Eukaryota;exodeoxyribonuclease;Genome;Goals;helicase;Hereditary Nonpolyposis Colorectal Neoplasms;Homologous Gene;Human;inhibitor;insertion/deletion mutation;intercalation;interest;Length;macromolecule;Maintenance;Malignant Neoplasms;Manuscripts;Measures;Mediating;Methods;Methylation;Mismatch Repair;Molecular;Movement;Mutagenesis;nanomolar;Nucleotides;Pathologic;Patients;Persons;Power stroke;Predisposition;preservation;prevent;Process;Proteins;Publishing;recruit;repair function;Research;Resistance;Role;screening;Series;Signal Transduction;Specificity;SS DNA BP;stem;Structure;Surgical incisions;Time;Toxic effect;Trinucleotide Repeat Expansion;Trinucleotide Repeats;Visualization,Structural and mechanistic studies Of DNA mismatch repair,36119,NA,NA,NA,NA,29,NA,NA,589937,NA
11188537,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK036139,NA,NA,1ZIADK036139-18,NIDDK:1342753\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9693116 (contact),"BUCHANAN, SUSAN  (contact)",NA,NA,NA,Adopted;Affinity;Antibiotics;Bacteria;beta barrel;Binding;Biochemical;Biogenesis;Biological Assay;Cells;Characteristics;Chloroplasts;Communication;Complex;Cryoelectron Microscopy;Cytoplasm;Detergents;Disease;experimental study;falls;Future;Gram-Negative Bacteria;Health;Homologous Gene;Human;human disease;In Vitro;Individual;insight;interest;Lateral;Lipid Bilayers;Lipids;Manuscripts;Membrane;membrane biogenesis;Membrane Proteins;Mitochondria;mitochondrial dysfunction;Molecular Chaperones;Molecular Conformation;Motion;nanodisk;nanomolar;Nature;Outer Mitochondrial Membrane;particle;Peptide Signal Sequences;Peptidoglycan;peptidomimetics;Peripheral;periplasm;Preparation;Protein Biosynthesis;Protein Export Pathway;Protein Import;Protein translocation;Proteins;Publications;Publishing;Research;Resolution;Role;Rotation;Science;Signal Transduction;small molecule inhibitor;Sorting;Streptococcus thermophilus;structural biology;Structure;Surface;targeted treatment;TOM translocase;Voltage-Dependent Anion Channel;Work;Writing,structural characterization of bacterial secretion channels,36139,NA,NA,NA,NA,18,NA,NA,1342753,NA
11188538,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK036146,NA,NA,1ZIADK036146-18,NIDDK:471950\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415315 (contact),"YANG, WEI  (contact)",NA,NA,NA,Active Sites;adduct;Archaea;Bacteria;Bacteriophage T7;base;Base Pair Mismatch;Benzopyrenes;Binding;Biochemical;Bypass;Catalysis;Cells;Chemical Agents;chemical bond;Chemicals;Chemistry;Complex;Conserved Sequence;Cryoelectron Microscopy;Dedications;DNA;DNA Binding;DNA biosynthesis;DNA Damage;DNA lesion;DNA Modification Process;DNA polymerase zeta;DNA replication fork;DNA-Directed DNA Polymerase;Elements;Enzymes;Escherichia coli;Exposure to;Family;Genetic Recombination;genome integrity;Genomics;Geometry;Goals;helicase;Human;Ions;Kinetics;Lesion;Life;member;Metals;Modification;Molecular;Multienzyme Complexes;Mutagenesis;mutant;Mutation;novel;Nucleotides;Polymerase;polymerization;Polymers;Positioning Attribute;Predisposition;Process;Proteins;Publishing;Pyrimidine Dimers;Reagent;repaired;Research;Series;Site;Structure;Translations;ultraviolet irradiation,Structural and mechanistic studies of translesion DNA synthesis,36146,NA,NA,NA,NA,18,NA,NA,471950,NA
11188539,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK036147,NA,NA,1ZIADK036147-18,NIDDK:589937\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415315 (contact),"YANG, WEI  (contact)",NA,NA,NA,Active Sites;Antigen Receptors;artemis;B-Lymphocytes;Back;Biochemical;cell type;Cells;Chromatin Structure;Chromosome abnormality;Code;Collaborations;Complex;Cryoelectron Microscopy;Development;DNA;DNA Ligases;DNA polymerase mu;DNA Sequence;DNA Structure;DNA-dependent protein kinase;DNA-Directed DNA Polymerase;Epigenetic Process;Gene Rearrangement;Genes;Genetic Recombination;Goals;Growth;Immune system;Immunoglobulin Genes;Immunoglobulins;Invaded;J segment gene;Ligase;Ligation;Light;Lymphocyte;Lymphoid;Malignant - descriptor;Manuscripts;Mediating;Molecular;Molecular Conformation;Nature;Nonhomologous DNA End Joining;nuclease;overexpression;Paper;Pathway interactions;Peptide Signal Sequences;Phase;Process;Publishing;Receptor Gene;recombinase;Regulation;Series;Signal Transduction;Site;structural biology;Structure;T-Cell Receptor Genes;Transposase;V(D)J Recombination;Vertebrates;Work;Writing,Structural and mechanistic studies of V(D)J recombination,36147,NA,NA,NA,NA,18,NA,NA,589937,NA
11188540,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK036153,NA,NA,1ZIADK036153-18,NIDDK:2179575\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,79972202 (contact),"DYDA, FRED  (contact)",NA,NA,NA,3-Dimensional;Adaptive Immune System;Adopted;Aedes;Affinity;Anopheles gambiae;Antibiotic Resistance;Architecture;Bacteria;Binding;Biological Assay;biophysical techniques;C-terminal;Cabbage - dietary;Cancer Control;cancer immunotherapy;casein kinase II;Cell Culture Techniques;Cell Physiology;Cell Therapy;cell type;Cells;chimeric antigen receptor T cells;Chiroptera;Chromosomes;Classification;Code;Complex;cost effective;Cryoelectron Microscopy;Crystallography;Culicidae;design;Development;dimer;Dimerization;DNA;DNA Binding Domain;DNA Transposons;DNase-I Footprinting;Elements;emerging antibiotic resistance;engineered stem cells;Engineering;Enzymes;Eukaryotic Cell;Evolution;Excision;experimental study;Future;Gene Rearrangement;gene therapy;Genes;Genetic;Genetic Engineering;Genome;genome editor;genomic locus;Genomics;Goals;Growth;Human;Human Engineering;In Vitro;Insect Control;Insecta;Insertional Mutagenesis;insight;interest;Investigation;Left;Length;Libraries;Location;Malaria;Mammals;Medical;member;Modification;Moths;Musca domestica;N-terminal;Nature;novel;Nucleic Acids;Paste substance;Pathogenesis;Phosphorylation;Phosphorylation Site;Plants;presynaptic;prevent;Process;programs;promoter;Proteins;Protomer;Publications;Publishing;Rationalization;recombinase;reconstitution;Research;Resolution;Roentgen Rays;Role;Site;Specificity;Structural Biochemistry;structural biology;Structure;System;Tertiary Protein Structure;Therapeutic;tool;transgenic insect;transmission process;Transposase;transposon/insertion element;vector;Work;Yellow Fever,Structure and function of eukaryotic DNA transposases,36153,NA,NA,NA,NA,18,NA,NA,2179575,NA
11188541,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK036164,NA,NA,1ZIADK036164-18,NIDDK:1003241\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,2427880 (contact),"MIZUUCHI, KIYOSHI  (contact)",NA,NA,NA,alpha Tubulin;Anti-Bacterial Agents;ATP phosphohydrolase;Bacteria;Binding;Binding Proteins;Biochemical;Biochemical Reaction;Biology;biophysical techniques;Biophysics;Cell division;cell preparation;Cells;Collaborations;Complex;Development;Diffusion;dimer;Dissociation;dynamic system;Escherichia coli;Event;Filament;Fluorescence;fluorescence microscope;Foundations;Glass;Goals;Guanosine Triphosphate;Homologous Gene;imaging study;In Vitro;in vivo;in vivo imaging;Individual;inhibitor;instrument;Kinetics;Knowledge;Label;Length;Lipid Bilayers;mathematical methods;Membrane;Mind;mind control;Modeling;Molecular;Molecular Conformation;molecular dynamics;Monitor;National Institute of Diabetes and Digestive and Kidney Diseases;Nature;novel;Pattern;Pattern Formation;Phase;Play;polymerization;Polymers;protein complex;Protein Family;Proteins;Reaction;reconstitution;Role;Scientist;self organization;Set protein;Slide;Surface;System;Techniques;Time,Study of the mechanism of septum localization during bacterial cell division,36164,NA,NA,NA,NA,18,NA,NA,1003241,NA
11188542,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK036165,NA,NA,1ZIADK036165-18,NIDDK:585224\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,2427880 (contact),"MIZUUCHI, KIYOSHI  (contact)",NA,NA,NA,Anti-Bacterial Agents;Architecture;Area;ATP Hydrolysis;ATP phosphohydrolase;Bacteria;Bacterial Chromosomes;Behavior;Binding;Binding Proteins;Biochemical;Biological Models;Biophysical Process;biophysical techniques;Carpet;Cell division;Cell-Free System;Cells;Centromere;Chromosome Segregation;Complex;Coupling;CTPase;Cyanobacterium;Daughter;daughter cell;Development;Diffusion;Dissociation;DNA;DNA Binding;DNA biosynthesis;DNA Sequence;dynamic system;Ensure;Escherichia coli;Eukaryota;Event;F Factor;Family;Filament;Fluorescence;fluorescence microscope;Foundations;Generations;Genetic;Genome;Glass;Glycocalyx;Goals;Homologous Gene;Homologous Protein;imaging study;Immobilization;in vivo;in vivo imaging;Individual;Inherited;instrument;Kinetics;Knowledge;Label;Learning;Length;mathematical methods;Mitotic;Modeling;Molecular;Molecular Conformation;Monitor;Motion;novel;Organelles;plasmid DNA;Plasmids;Polymers;Positioning Attribute;Process;Prokaryotic Cells;protein distribution;Protein Dynamics;Protein Family;Proteins;Reaction;reconstitution;segregation;Set protein;Slide;Streptococcus pyogenes;Surface;System;Techniques;Time;Transportation,Study of the mechanism of bacterial chromosome partitioning systems,36165,NA,NA,NA,NA,18,NA,NA,585224,NA
11188543,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK036167,NA,NA,1ZIADK036167-18,NIDDK:1430913\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,2402847 (contact),"GELLERT, MARTIN F. (contact)",NA,NA,NA,Adaptive Immune System;Binding;Biochemical;C-terminal;Chordata;Chromatin;cofactor;Complex;Cryoelectron Microscopy;DNA;DNA Repair;DNA-dependent protein kinase;Ephrin-A5;Eukaryota;Exonuclease;Genes;Genetic Recombination;histone modification;Histones;homologous recombination;Human;Immunoglobulins;Lysine;Methylation;Multiprotein Complexes;Nonhomologous DNA End Joining;Process;protein complex;protein structure;Proteins;Publications;Reporting;Resolution;Role;Shark;Site;Structure;T-Cell Receptor Genes;V(D)J Recombination;Work,Structural studies of proteins involved in DNA repair and recombination,36167,NA,NA,NA,NA,18,NA,NA,1430913,NA
11188544,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK036169,NA,NA,1ZIADK036169-18,NIDDK:1654506\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415357 (contact),"CRAIGIE, ROBERT  (contact)",NA,NA,NA,Active Sites;Affect;Amides;Amino Acids;Anti-viral Therapy;Binding;Biochemical;biophysical analysis;C-terminal;Cell Culture Techniques;Cell Nucleus;Cells;Clinical;Collaborations;Complex;Consumption;Cryoelectron Microscopy;Cytoplasm;Data Analyses;Data Collection;density;design;Disease;Distal;DNA;DNA biosynthesis;DNA Integration;Drug Combinations;Drug resistance;Drug Targeting;ds-DNA;Enzymes;Exhibits;Filtration;Genome;Goals;HIV;HIV Integrase;HIV-1;HIV-1 integrase;Ice;improved;In Vitro;in vitro activity;in vivo;Individual;Infection;inhibitor;inorganic phosphate;Integrase;Integrase Inhibitors;Length;Maps;Mediating;methyl group;Modeling;Molecular;mutant;Mutate;Mutation;Nitrogen;novel drug class;Nucleoproteins;Nucleotides;Pathway interactions;Pharmaceutical Preparations;Positioning Attribute;preference;Property;Proteins;Protomer;Publishing;Reaction;reconstitution;Resistance;Resistance development;resistance mutation;Resolution;Retroviridae;RNA-Directed DNA Polymerase;Role;Sodium Chloride;Structure;Synapses;Tail;Testing;Time;Vertebral column;Vial device;Viral;viral DNA;Viral Genome;Viral Proteins;viral RNA;Virus;Virus Integration;Work,Studies of nucleoprotein complexes involved in retroviral DNA integration,36169,NA,NA,NA,NA,18,NA,NA,1654506,NA
11188545,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK043006,NA,NA,1ZIADK043006-48,NIDDK:2060746\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,78847903 (contact),"JHA, SMITA  (contact)",NA,NA,NA,adenoma;adverse outcome;Appearance;Biological Assay;Blood;bone;Calcium;Catheters;CCND1 gene;CDK6-associated protein p18;Clinical;Collaborations;Craniosynostosis;Cyclin D1;demineralization;Diagnosis;Disease;Endocrine Gland Neoplasms;Endocrine Glands;Etiology;Excision;exome sequencing;Face;Familial hypocalciuric hypercalcemia;Family;Fracture;Frequencies;gain of function mutation;GCM2 gene;Genes;Genetic Counseling;Genotype;Germ-Line Mutation;Gland;Growth;hearing impairment;Hyperparathyroidism;Hypoparathyroidism;Image;Impairment;indexing;Infarction;Inherited;interest;ionization;Jaw;Kidney Calculi;kinase inhibitor;Low Prevalence;malignant parathyroid gland tumor;Malocclusion;Measurement;Mediastinal;Medical Records;men;Metaphyseal chondrodysplasia;Modeling;Multiple Endocrine Neoplasia Type 1;Mutate;Mutation;Neck;neuromuscular;operation;Operative Surgical Procedures;optic nerve disorder;Osteopenia;Other Genetics;Parathyroid Adenoma;Parathyroid gland;Parathyroid Neoplasms;Parathyroidectomy;Pathologic;Patients;Pharmaceutical Preparations;Phenotype;Predisposition;proband;Process;Recurrence;Recurrent Laryngeal Nerve;Refractory;Repeat Surgery;Serum;Severities;Signs and Symptoms;skeletal;skills;Structure;success;Syndrome;Testing;Tissues;tumor;tumorigenesis;United States National Institutes of Health;Variant;Work,"Hyperparathyroidism -- Etiology, Diagnosis and Treatment",43006,NA,NA,NA,NA,48,NA,NA,2060746,NA
11188546,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK043012,NA,NA,1ZIADK043012-23,NIDDK:163274\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,2519801 (contact),"SIMONDS, WILLIAM F (contact)",NA,NA,NA,1q25;Adult;Affect;Amino Acids;autosome;Bilateral;Biochemical;Blood Tests;Calcium-Sensing Receptors;cell growth;Chromosome 1;Chromosome Arm;Clinical;clinical center;clinical investigation;Clinical Research;Critical Pathways;Cystic kidney;Discipline of Nuclear Medicine;Disease;Family;gain of function mutation;GCM2 gene;gene conservation;Gene Mutation;Genes;Genetic;Genotype;Germ Lines;Germ-Line Mutation;Goals;Heterozygote;Human Subject Research;Hyperparathyroidism;Hyperparathyroidism-jaw tumor syndrome;Image;Impairment;Individual;individual patient;Inherited;insight;International;Jaw;Kidney Neoplasms;kindred;Leukocytes;Link;loss of function mutation;malignant parathyroid gland tumor;member;MEN1 gene;Metabolic Diseases;Minority;MRI Scans;Mutation;Mutation Analysis;Names;Nature;Neoplasms;Patient Admission;Patients;Penetrance;peripheral blood;Phenotype;Predisposition;Proliferating;protein function;Proteins;Protocols documentation;Qualifying;Receptor Gene;Research Personnel;Roentgen Rays;Signal Transduction;Site;Solid;Syndrome;Testing;trait;transmission process;tumor;Tumor-Suppressor Gene Inactivation;United States National Institutes of Health;Urine;Visit;X-Ray Computed Tomography,"Clinical Investigation of FIHP, Parathyroid Cancer & the HPT-JT Syndrome",43012,NA,NA,NA,NA,23,NA,NA,163274,NA
11188547,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK043302,NA,NA,1ZIADK043302-31,NIDDK:412149\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415374 (contact),"WEINSTEIN, LEE  (contact)",NA,NA,NA,Adult;Age;Alleles;Autoimmune Diseases;autosome;Binding;Blocking Antibodies;Brain;calcification;Calcium;Cell Surface Receptors;Central Nervous System;Characteristics;Chondrocytes;Chromogranin A;Clinical;clinical investigation;clinical phenotype;Congenital Disorders;Cyclic AMP;Defect;Deletion Mutation;Development;Disease;DNA Methylation;DNA Sequence Alteration;Elements;Energy Metabolism;Epiphysial cartilage;Exons;Fathers;gene product;Generations;Genes;Genetic;Genetic Transcription;Germ Lines;glucose metabolism;GNAS gene;Goals;Gonadotropins;Growth;Gs alpha mutations;Hereditary Disease;Heterotopic Ossification;Heterotrimeric GTP-Binding Proteins;Heterozygote;histone methylation;hormone resistance;hormone sensitivity;Hormones;Human;Hypercalcemia;Hyperparathyroidism;Hypothalamic structure;implantation;imprint;Inherited;Insulin Resistance;Invaded;Journals;Kidney;Knock-out;Knockout Mice;Lesion;Link;Medicine;Messenger RNA;Metabolic;Modeling;Molecular;Morbid Obesity;Mothers;mouse model;Mus;Mutate;Mutation;neurobehavioral;Neurosecretory Systems;New England;Obesity;Operative Surgical Procedures;Osteoblasts;overexpression;Paper;Parathyroid Neoplasms;paternal imprint;Pathogenesis;Patients;Physiologic Ossification;Progressive osseous heteroplasia;promoter;Protein Isoforms;Proteins;Proximal Kidney Tubules;Pseudohypoparathyroidism;Pseudopseudohypoparathyroidism;PTH gene;Publishing;receptor;Reporting;Resistance;Resistance development;response;Second Messenger Systems;sex;Signal Pathway;Signaling Molecule;Skin;soft tissue;Somatotropin-Releasing Hormone;subcutaneous;Thyrotropin;Tissues;transmission process;United States National Institutes of Health;virtual;Vitamin D;Vitamin D Analog,Studies Of Pseudohypoparathyroidism And Related Disorders,43302,NA,NA,NA,NA,31,NA,NA,412149,NA
11188548,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK043304,NA,NA,1ZIADK043304-31,NIDDK:1306188\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,2519801 (contact),"SIMONDS, WILLIAM F (contact)",NA,NA,NA,Acylation;Alternative Splicing;Behavioral;Binding;Binding Proteins;Bioinformatics;Biological Models;Biology;Brain;Cell Line;Cell membrane;Cell Nucleus;Complex;Cytosol;Development;Enzymes;extracellular;Family;Gene Modified;genetic regulatory protein;genomic data;Germ Lines;GNB5 gene;Goals;GTP-Binding Proteins;Guanine Nucleotides;Heterodimerization;Human;Ion Channel;loss of function;mammalian genome;Membrane;Modeling;Molecular;Mus;Mutation;neural;Neuroanatomy;Neuroendocrine Cell;Neurons;Neurosecretory Systems;Pattern;Physiology;Property;protein complex;Protein Isoforms;Proteins;public database;receptor;receptor coupling;Research Project Grants;Retinal Photoreceptors;RGS Proteins;Rodent;Role;Signal Transduction;Signaling Protein;Stimulus;Structure;System;Transcript;Transducers;Work,Mechanism of G Protein Beta5/ R7-RGS Protein/ R7BP Complex Signal Transduction,43304,NA,NA,NA,NA,31,NA,NA,1306188,NA
11188549,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK043313,NA,NA,1ZIADK043313-20,NIDDK:206075\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415374 (contact),"WEINSTEIN, LEE  (contact)",NA,NA,NA,"Adipocytes;Adipose tissue;Adrenergic Agonists;Alleles;Birth;Bone Marrow;Brain;Brown Fat;Cell Cycle;Cells;Central Nervous System;Chromogranin A;Chronic;Collaborations;Complex;Couples;Critical Pathways;Cyclic AMP;Cyclin-Dependent Kinases;Cyclins;Data;Development;Disease;Distal;Edema;Embryo;Endocrine;Energy Metabolism;Exons;Feedback;Female;Fibrous Dysplasia;gene product;Genes;Genetic Recombination;Germ Lines;Germ-Line Mutation;glucagon-like peptide 1;glucose metabolism;GNAS gene;Gonadal structure;Gs alpha mutations;GTP-Binding Protein alpha Subunits;Hepatocyte;Heterozygote;Homing;Homozygote;hormone resistance;Hormones;Human;Hypertriglyceridemia;Hypothalamic structure;imprint;in vivo;Individual;Inflammation;Inherited;Insulin;Insulin Resistance;islet;Islet Cell;Islets of Langerhans;Knock-in Mouse;Knock-out;Knockout Mice;Laboratories;Liver;LoxP-flanked allele;Lymphocyte;Lymphocyte Biology;male;McCune-Albright Syndrome;Mediating;Metabolic;Metabolic Activation;metabolic phenotype;metabolic rate;Metastatic Neoplasm to the Liver;Methylation;Modeling;Morbid Obesity;Mothers;mouse model;Mus;mutant;Mutation;Nephrons;neural circuit;Neurosecretory Systems;Nucleic Acid Regulatory Sequences;Obesity;offspring;Osteogenesis;overexpression;Pancreatic Endocrine Carcinoma;Partner in relationship;Patients;Perinatal;Phenotype;Phosphotransferases;Physiology;Pituitary Gland;Placenta;Play;postnatal period;Primary carcinoma of the liver cells;Production;promoter;Protein Isoforms;Proteins;Proximal Kidney Tubules;Pseudohypoparathyroidism;PTH gene;receptor;Receptors, Adrenergic, beta-3;Regulation;Renal function;Renin;Reporting;RNA Splicing;Role;Secondary to;Signal Transduction;Site;Study models;subcutaneous;suckling;Sympathetic Nervous System;Thinness;Thyroid Gland;Tissues;Trans-Activators;Transcript;Transgenic Organisms;United States National Institutes of Health;Up-Regulation;urinary;virtual;WNT Signaling Pathway",Role of the Gnas Gene in Metabolic Regulation,43313,NA,NA,NA,NA,20,NA,NA,206075,NA
11188550,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK043315,NA,NA,1ZIADK043315-18,NIDDK:206075\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415374 (contact),"WEINSTEIN, LEE  (contact)",NA,NA,NA,Acute;Agonist;Alleles;Area;Beta Cell;Blood Pressure;Body Composition;Body Weight;Brain region;Brown Fat;cardiovascular effects;Cardiovascular system;Cell Physiology;cell type;Cells;Central Nervous System;Chemistry;comparison control;Corticotropin;Corticotropin-Releasing Hormone;Couples;Cyclic AMP;Defect;Development;Diabetes Mellitus;Diet;diet-induced obesity;Disease;Eating;energy balance;Energy Metabolism;Enterobacteria phage P1 Cre recombinase;Exons;Female;Food Energy;Food Intake Regulation;Generations;Genes;Genetic Recombination;Germ-Line Mutation;Glucose;Glucose Intolerance;glucose metabolism;glucose tolerance;Gs alpha mutations;GTP-Binding Protein alpha Subunits;GTP-Binding Proteins;Heart Rate;Heterozygote;High Fat Diet;Hormones;Horns;Human;Hyperglycemia;Hyperlipidemia;Hypertension;Hypertriglyceridemia;Hypothalamic structure;Impairment;imprint;improved;In Situ Hybridization;Injections;Insulin;Insulin Resistance;Knock-out;Knockout Mice;Leptin;Leptin resistance;Lipids;loss of function mutation;LoxP-flanked allele;male;Malignant Neoplasms;Measurement;Measures;Mediating;Melanocortin 4 Receptor;Melanocortin 4 receptor mutation;Metabolic;metabolic phenotype;metabolic rate;Metabolism;Middle Hypothalamus;Morbid Obesity;mouse model;Mus;mutant;Mutation;Nerve;nestin protein;Neurons;novel therapeutics;Obesity;Organ Weight;paraventricular nucleus;Parents;Partner in relationship;Pathway interactions;Patients;Phenotype;Physiological;Play;Population;Prevalence;Pro-Opiomelanocortin;promoter;Pseudohypoparathyroidism;receptor;reduced food intake;Regulation;Resistance;response;Role;Serum;Signal Pathway;Signal Transduction;Site;Spinal Cord;Structure of beta Cell of islet;Sympathetic Nervous System;System;Testing;Therapeutic Agents;Thermogenesis;Tissues;Transgenes;Transgenic Organisms;uncoupling protein 1;Virus,Role of Gs-alpha in central regulation of energy and glucose metabolism,43315,NA,NA,NA,NA,18,NA,NA,206075,NA
11188551,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK043316,NA,NA,1ZIADK043316-18,NIDDK:206075\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415374 (contact),"WEINSTEIN, LEE  (contact)",NA,NA,NA,"Acute;Adipocytes;adipokines;adiponectin;Adipose tissue;Adrenergic Agents;Adrenergic Agonists;Affect;Alleles;beta-adrenergic receptor;Body fat;Body Temperature;Body Weight;Brown Fat;Catecholamines;Cell Differentiation process;Cells;Central Nervous System;Coupled;Cyclic AMP;Diet;Embryo;Energy Metabolism;Enterobacteria phage P1 Cre recombinase;Environment;Exons;Fatty acid glycerol esters;fatty acid-binding proteins;Fibroblasts;Functional disorder;gene induction;Genes;Genetic Recombination;Germ Lines;glucose metabolism;glucose tolerance;Growth;Gs alpha mutations;GTP-Binding Proteins;Heart;Heterozygote;High Fat Diet;Histologic;Human;Hypoglycemia;Impairment;improved;In Vitro;in vivo;Insulin Resistance;insulin sensitivity;Insulin-Like Growth Factor I;Knock-out;Lead;lipid biosynthesis;lipid metabolism;Lipids;Lipolysis;Liver;LoxP-flanked allele;Mediating;Metabolic;Metabolic Activation;Modeling;Molecular;Morbid Obesity;Mus;Muscle;Obesity;Partner in relationship;Pathway interactions;Pattern;Peripheral;Phenotype;Production;programs;Receptors, Adrenergic, beta-3;Regulation;response;Role;Signal Pathway;Site;Skeletal Muscle;Sympathetic Nervous System;Thermogenesis;Thinness;Tissues;Transgenic Mice;uncoupling protein 1;Urine;Weight Gain",Role of Gs-alpha in regulation of adipose tissue growth and function,43316,NA,NA,NA,NA,18,NA,NA,206075,NA
11188552,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK043317,NA,NA,1ZIADK043317-18,NIDDK:206075\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415374 (contact),"WEINSTEIN, LEE  (contact)",NA,NA,NA,adenylate kinase;Adipose tissue;Adrenergic Agents;Aerobic;Affect;Aging;analog;Area;Atrophic;beta-adrenergic receptor;Body Composition;Body Weight;Calories;Chemistry;Chronic;Cyclic AMP;Diet;Dissociation;Eating;energy balance;Energy consumption;Energy Metabolism;Enterobacteria phage P1 Cre recombinase;Exons;Fiber;Food Energy;Genetic Recombination;Genetic Transcription;Glucose;Glucose Clamp;glucose metabolism;glucose tolerance;glucose uptake;Growth;GTP-Binding Proteins;High Fat Diet;Hyperinsulinism;Hypoglycemia;Impairment;Insulin;Insulin Resistance;insulin secretion;Kinetics;Knock-out;LoxP-flanked allele;Metabolic;Metabolism;Mitochondria;Modeling;Mus;Muscle;Muscle Fibers;Muscular Atrophy;Myocardium;Myosin Heavy Chains;Partner in relationship;Pathway interactions;Phenotype;Play;Prediabetes syndrome;Production;promoter;Property;receptor;reduced muscle mass;Regulation;response;Role;Serum;Signal Transduction;Site;Skeletal Muscle;skeletal muscle metabolism;Sympathetic Nervous System;Testing;Thermogenesis;transcription factor;Transgenic Mice;Troponin;Wasting Syndrome,Role of Gs-alpha in regulation of skeletal muscle metabolism,43317,NA,NA,NA,NA,18,NA,NA,206075,NA
11188553,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK043318,NA,NA,1ZIADK043318-18,NIDDK:206075\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415374 (contact),"WEINSTEIN, LEE  (contact)",NA,NA,NA,Address;Adult;Alpha Cell;Apoptosis;Architecture;Beta Cell;Birth;Body Weight;CCND2 gene;cell growth;Cell Line;Cell Physiology;Cell Proliferation;Cells;Cyclic AMP;Development;Diabetes Mellitus;Duct (organ) structure;Enterobacteria phage P1 Cre recombinase;Exocrine pancreas;Exons;experimental study;Functional disorder;Genes;Genetic Recombination;Glucagon;glucagon-like peptide 1;Glucose;Glucose Intolerance;Growth;Hyperglycemia;impaired glucose tolerance;in vivo;incretin hormone;Insulin;Insulin deficiency;insulin sensitivity;IRS2 gene;islet;Islets of Langerhans;Life;LoxP-flanked allele;Malabsorption Syndromes;Mediating;mouse model;Mus;Mutation;pancreatic juice;Partner in relationship;postnatal;Proliferating;promoter;Rattus;Regulation;Role;Signal Pathway;Signal Transduction;single-cell RNA sequencing;Site;Structure of alpha Cell of islet;Therapeutic;Transgenic Mice,Role of Gs-alpha in pancreatic islet cell growth and function,43318,NA,NA,NA,NA,18,NA,NA,206075,NA
11188554,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK047023,NA,NA,1ZIADK047023-23,NIDDK:1295098\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415429 (contact),"SUMNER, ANNE  (contact)",NA,NA,NA,Adult;Affect;Africa;Africa South of the Sahara;African;African American population;African ancestry;Age;allostatic load;American;Area;Authorization documentation;Beta Cell;Biological Assay;Black Populations;Body fat;Body Image;Body mass index;Body Size;Cardiometabolic Disease;cardiometabolic risk;cardiometabolism;Caring;Cell Physiology;Child;clinical practice;cohort;Collaborations;Data;design;Detection;detection sensitivity;Development;Diabetes Mellitus;Diagnosis;Diagnostic;diagnostic biomarker;Diagnostic tests;Diagnostics Research;Discrimination;Disease;Early Intervention;Education;Emigrations;Enrollment;epidemiology study;Equation;Equilibrium;Etiology;Exclusion;Exercise;expectation;Failure;fasting plasma glucose;Fructosamine;Genetic study;Glucose;glucose tolerance;Glucosephosphate Dehydrogenase Deficiency;glycosylated serum albumin;Goals;Health;Health behavior;heart disease risk;Heart Diseases;Heterogeneity;High Density Lipoproteins;Hyperglycemia;Immigrant;Immigration;improved;improved outcome;insight;Insulin Resistance;International;Investigation;Investments;Journals;Life;Low income;Maintenance;Measures;Medical Research;Metabolic stress;Methods;migration;National Human Genome Research Institute;Natural History;Non obese;novel diagnostics;Obesity;OGTT;Patient Care;perceived stress;Performance;Persons;Physiological;Pittsburgh Sleep Quality Index;Population;power analysis;Prediabetes syndrome;preference;preventive intervention;Protocols documentation;psychosocial;Public Health;Publications;Publishing;Race;Recommendation;Reduce health disparities;Refugees;Reproducibility;Research;research clinical testing;Research Design;Resource Allocation;Risk Factors;screening;Sleep;sleep quality;social determinants;South Africa;Spouses;Stress;sugar;Testing;tool;trait;Triglycerides;United States;Universities;validation studies;willingness;Work,Diabetes and Heart Disease Risk in Blacks,47023,NA,NA,NA,NA,23,NA,NA,1295098,NA
11188555,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK047035,NA,NA,1ZIADK047035-18,NIDDK:383354\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415407 (contact),"FORREST, DOUGLAS  (contact)",NA,NA,NA,Address;Auditory;Auditory system;Binding Sites;Biological Models;Brain;Brain region;Cell Differentiation process;Cell Lineage;Cell Separation;cell type;Cells;Central Nervous System;Chromatin;Clinic;Cochlea;Collaborations;Cone;Defect;Development;developmental disease;Disease;Epilepsy;experimental study;Eye Movements;Functional disorder;gain of function;ganglion cell;Gene Activation;Gene Expression;Gene Mutation;gene network;Generations;Genes;genetic analysis;genetic approach;Genetic Models;Genetic Transcription;Genomics;Goals;Head Movements;Hormones;Human;human disease;Impairment;insight;Intellectual functioning disability;Interneurons;Knock-in;Ligands;Light;loss of function;Mammalian Genetics;Mammals;Mediating;Modeling;Molecular Analysis;Morphology;Mutation;Nervous System;neural;Neurodegenerative Disorders;neurodevelopment;neurogenesis;Neuronal Differentiation;Neurons;next generation sequencing;novel;Nuclear Orphan Receptor;Nuclear Receptors;Optic Nerve;Organ;Orphan;osteoprotective;Pathway interactions;Pattern;Photoreceptors;Physiological;precursor cell;Predisposition;Procedures;Process;Protein Isoforms;receptor;receptor function;Receptor Gene;Regulation;Reporting;Retina;Retinal Cone;retinal progenitor cell;Retinoids;Rod;Role;Seizures;Sensory;sensory input;sensory system;Spinal Cord;stem cells;superior colliculus Corpora quadrigemina;System;Testing;Tissues;transcription factor;transmission process;Undifferentiated;Universities;Vertebrate Photoreceptors;Vision;visual information;Visual Pathways,Orphan nuclear receptors and mammalian development,47035,NA,NA,NA,NA,18,NA,NA,383354,NA
11188556,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK047036,NA,NA,1ZIADK047036-18,NIDDK:1022277\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415407 (contact),"FORREST, DOUGLAS  (contact)",NA,NA,NA,Address;Affinity Chromatography;Apoptosis;Apoptotic;Binding Sites;Biological Models;Blood Circulation;Cell Death;Cell membrane;cell type;Cells;Chromatin;chromatin modification;Circulation;cofactor;color detection;Color Visions;Cone;Cone dystrophy;Cre driver;Defect;Development;developmental disease;differential expression;Endocrine system;Enzymes;Exposure to;Functional disorder;Gene Duplication;Gene Expression Regulation;gene network;Generations;Genes;Genetic;Genetic Models;Genomic approach;Genomics;Goals;Hormonal;Human;Impairment;insight;Investigation;Iodide Peroxidase;Knowledge;Light;Link;Maintenance;Mammalian Genetics;Mediating;Membrane Transport Proteins;Modeling;Monitor;mouse model;Mutation;next generation sequencing;novel;novel marker;Opsin;Pathway interactions;Photoreceptors;Physiological;Population;Predisposition;prevent;Process;Protein Isoforms;receptor;Regulation;Resolution;response;Retina;Retinal Cone;Retinal Degeneration;Retinal Diseases;Role;single cell sequencing;System;Techniques;Testing;THRB gene;Thyroid Diseases;Thyroid Function Tests;Thyroid Hormone Receptor;Thyroid Hormone Receptor Gene;Thyroid Hormones;Time;Tissues;transcription factor;transcriptome;transcriptome sequencing;uptake;Vision;Visual System,Functions of thyroid hormone in retinal development,47036,NA,NA,NA,NA,18,NA,NA,1022277,NA
11188557,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK047037,NA,NA,1ZIADK047037-18,NIDDK:1150061\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415407 (contact),"FORREST, DOUGLAS  (contact)",NA,NA,NA,Address;Adrenal Cortex;Adrenal Glands;Adult;Age;Aging;Anterior Pituitary Gland;Auditory system;Binding;Binding Sites;Biological Process;Brain;cell cortex;Cell Differentiation process;Cell membrane;Cell Physiology;cell type;Cells;Chromatin;chromatin modification;Circulation;Clinical;Cochlea;cochlear development;Cre driver;Development;differential expression;Disease;Endocrine;Endocrine Glands;Endocrine system;Enhancers;Enzymes;Event;Fetus;Functional disorder;Gene Expression;Gene Expression Profile;Gene Expression Regulation;Genes;Genetic;genetic manipulation;Genetic Models;Genetic study;Genetic Transcription;Genomic approach;Genomic DNA;Genomics;Hearing;Homeostasis;Hormones;Human;Infant;Iodide Peroxidase;Kidney;Ligands;Liver;Lung;Mediating;Membrane Transport Proteins;Metabolic;Molecular;Mus;Mutation;novel;Organ;Pattern;Pituitary Gland;pituitary thyroid axis;Population;Positioning Attribute;Presbycusis;Production;promoter;Protein Isoforms;receptor;receptor binding;receptor function;Receptor Gene;Resistance;response;Retina;Retinal Cone;Role;Sensory;sexual dimorphism;Site;Specificity;Syndrome;System;Testing;Testis;THRA gene;THRB gene;Thyroid Diseases;Thyroid Function Tests;Thyroid Gland;Thyroid Hormone Receptor;Thyroid Hormones;Thyrotropin;Tissues;transcription factor;Transcriptional Regulation;uptake,Tissue-specific functions of thyroid hormone receptors,47037,NA,NA,NA,NA,18,NA,NA,1150061,NA
11188558,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK047050,NA,NA,1ZIADK047050-18,NIDDK:589467\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,11992032 (contact),"BROWN, REBECCA  (contact)",NA,NA,NA,Acromegaly;Adipose tissue;Autoantibodies;Cardiovascular Diseases;Cells;Clinical Research;Collaborations;Diabetes Mellitus;Disease;Dyslipidemias;Etiology;Familial generalized lipodystrophy;Familial partial lipodystrophy;FDA approved;Functional disorder;Genes;Glucose;HIV-Associated Lipodystrophy Syndrome;Hormones;Insulin;Insulin Receptor;Insulin Resistance;Insulin Signaling Pathway;interest;Intramural Research Program;Learning;Lipodystrophy;Metabolic;Molecular;Molecular Genetics;Mutation;National Institute of Diabetes and Digestive and Kidney Diseases;Natural History;non-alcoholic fatty liver disease;Non-Insulin-Dependent Diabetes Mellitus;Obesity;Pathway interactions;patient population;Patients;Plasma;Rare Diseases;Receptor Gene;Recording of previous events;Reporting;reproductive;Resistance;response;Syndrome;Texas;Therapeutic;Universities,Molecular and Clinical Studies of Insulin Resistance,47050,NA,NA,NA,NA,18,NA,NA,589467,NA
11188559,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK047052,NA,NA,1ZIADK047052-18,NIDDK:589467\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,11992032 (contact),"BROWN, REBECCA  (contact)",NA,NA,NA,Adipocytes;adipokines;Adipose tissue;Agonist;Amino Acids;Animal Model;Antibodies;Biology;Blood Glucose;Body Weight decreased;Clinical;clinical efficacy;Clinical Trials;Disease;Eating;Endocrine;Endocrine Glands;Excretory function;Familial generalized lipodystrophy;Fasting;Fatty acid glycerol esters;FDA approved;Gene Mutation;Genes;Glycosylated hemoglobin A;Goals;Heart Hypertrophy;Hormones;Human;improved;Insulin;Insulin Receptor;Insulin Resistance;Intervention;Leptin;Leptin deficiency;leptin receptor;Leptin resistance;lipid biosynthesis;Lipodystrophy;Liver;Liver Function Tests;Measures;Metabolic;Morbid Obesity;Mus;Mutation;nonalcoholic steatohepatitis;novel;novel therapeutics;Obese Mice;Obesity;Oxidative Stress;Patients;polypeptide;Proteins;Quality of life;Replacement Therapy;reproductive function;Rodent;Safety;Severities;Steatohepatitis;Tissues;Triglycerides;Urine;Weight;Work,Clinical utility of leptin therapy in syndromic forms of insulin resistance.,47052,NA,NA,NA,NA,18,NA,NA,589467,NA
11188560,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK052037,NA,NA,1ZIADK052037-18,NIDDK:1780659\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415472 (contact),"BERNSTEIN, HARRIS  (contact)",NA,NA,NA,alpha helix;Antibiotics;Antigens;Bacterial Infections;Bacterial Outer Membrane Proteins;Bacterial Translocation;beta barrel;Biogenesis;Biological;Biology;Bioremediations;Bordetella pertussis;C-terminal;Cell Physiology;Chloroplasts;clinical development;Complex;Escherichia coli;Evolution;Exhibits;experimental study;extracellular;Extracellular Space;Family;Goals;Gram-Negative Bacteria;Homeostasis;Hydrophobic Surfaces;In Vitro;in vivo;inhibitor;insight;Integral Membrane Protein;interest;Libraries;Link;Lipid Bilayers;lipidomics;Lipids;Mediating;member;Membrane;Membrane Proteins;Methods;Mitochondria;Modeling;monomer;mutant;N-terminal;novel;Nutrient;Organism;Paper;Pathogenicity;Peripheral;periplasm;Periplasmic Proteins;pertactin;Play;polypeptide;Property;Protein Family;protein function;Protein translocation;Proteins;proteoliposomes;prototype;Pseudomonas aeruginosa;Reaction;reconstitution;Reporting;Role;scaffold;screening;Structure;Surface;Technology;Testing;Transmembrane Domain;uptake;Vaccine Antigen;Vaccines;Virulence;Virulence Factors;Work,Biogenesis of bacterial outer membrane proteins,52037,NA,NA,NA,NA,18,NA,NA,1780659,NA
11188561,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK053211,NA,NA,1ZIADK053211-18,NIDDK:704429\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,6570335 (contact),"LEVINE, MARK A (contact)",NA,NA,NA,absorption;Adopted;alpha Tocopherol;antiretroviral therapy;ascorbate;Ascorbic Acid;Ascorbic Acid Deficiency;Austria;Biochemistry;Biological Availability;Blood;Canada;China;Clinical;clinical center;Clinical Data;Clinical Research;cohort;Collection;Coupled;Data;Data Analyses;Denmark;Detection;Diabetes Mellitus;Diet;dietary;Disease;disorder prevention;Dose;Drug Kinetics;experimental study;Fabry Disease;Fatty Liver;Filtration;France;Functional disorder;Germany;Goals;Health;High Pressure Liquid Chromatography;High Prevalence;HIV;HIV therapy;Hospitalization;Hour;Human;In Situ;Ingestion;Intake;Intestinal Absorption;Japan;Kidney;Kidney Diseases;Kinetics;Learning;Malignant Neoplasms;Measurement;Mediating;men;Modeling;Molecular;Molecular Biology;novel;Oral Ingestion;Persons;Physiological Processes;Physiology;Plasma;Prevalence;prevent;Publishing;Rare Diseases;Recommendation;Recommended Dietary Allowance;Renal function;Reporting;Role;Safety;sample collection;Sampling;sex;Single Nucleotide Polymorphism;Specificity;Techniques;Therapeutic;Tissues;Tocopherols;Uncertainty;United States;United States National Academy of Sciences;United States National Institutes of Health;urinary;Urine;Validation;Vitamin Deficiency;Vitamin E;Vitamins;Woman;X-Linked Genetic Diseases;young man;young woman,Vitamin C (ascorbic acid) recommended dietary ingestion,53211,NA,NA,NA,NA,18,NA,NA,704429,NA
11188562,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK053212,NA,NA,1ZIADK053212-18,NIDDK:640390\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,6570335 (contact),"LEVINE, MARK A (contact)",NA,NA,NA,absorption;Acids;Advanced Malignant Neoplasm;Animal Model;Animals;Anti-viral Agents;Antibiotics;ascorbate;Ascorbic Acid;Bacteria;Biological Availability;Blood;Blood Vessels;Bypass;cancer cell;cancer therapy;Case Series;Cell Death;Cells;Cessation of life;chemical synthesis;chemotherapy;Clinic;Clinical;Clinical Trials;cofactor;Consumption;Coupled;COVID-19;Data;demethylation;design;Diffusion;Disease;DNA;DNA Damage;Dose;double-blind placebo controlled trial;Drug Kinetics;Enzymes;Evaluation;Excretory function;experimental study;extracellular;Extramural Activities;Generations;Glutathione;Homeostasis;Human;Hydrogen Peroxide;Immune checkpoint inhibitor;In Vitro;in vivo;Infectious Agent;Intravenous;intravenous administration;Investigation;Iron;Kidney;Laboratories;Light;Malignant Neoplasms;Measurement;Mediating;Membrane;Metals;Mitochondria;Modality;Molecular Mechanisms of Action;novel;Oral;Oral Ingestion;Outcome;oxidation;Pathologic;Patients;Pattern;Peroxidases;Persons;pharmacokinetic model;pharmacologic;Pharmacologic Ascorbate;Phase;Phase I/II Trial;Phase II Clinical Trials;Physicians;Physiological;Placebo Control;Plasma;Play;Poly(ADP-ribose) Polymerases;pre-clinical;prevent;Prodrugs;Proteins;Publishing;Reactive Oxygen Species;Recommended Dietary Allowance;repaired;Reporting;Research Personnel;Role;Safety;Sepsis;Testing;Therapeutic;Time;Tissues;Toxic effect;treatment group;tumor growth,Ascorbic acid as a pharmacologic agent in disease treatment,53212,NA,NA,NA,NA,18,NA,NA,640390,NA
11188563,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK053213,NA,NA,1ZIADK053213-17,NIDDK:704429\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,6570335 (contact),"LEVINE, MARK A (contact)",NA,NA,NA,absorption;alpha Tocopherol;bench to bedside;Biological Availability;Biological Markers;Canada;Circulation;Clinical;Clinical Research;Country;Data;Deuterium;Diet;dietary;Dietary intake;dietary requirement;Disease;Dose;Drug Kinetics;Erythrocytes;experimental study;Fat-Soluble Vitamin;Fatty acid glycerol esters;Fatty Liver;Foundations;Functional disorder;Goals;Health;Hemolysis;Hepatitis;Hour;Human;Hydrogen Peroxide;improved;In Vitro;Ingestion;Institutionalization;Intravenous;intravenous administration;Kinetics;Label;Lipoproteins;Liver;Measures;men;Movement;nonalcoholic steatohepatitis;Obesity;Oral;Oral Administration;Pathway interactions;Persons;Physiology;Preparation;prevent;Recommendation;Recommended Dietary Allowance;stable isotope;Steatohepatitis;Testing;validation studies;Vitamin E;Vitamin E Deficiency;Vitamins;Weight;Woman;Work,Vitamin E Pharmacokinetics And Biomarkers In Normal And Obese Women,53213,NA,NA,NA,NA,17,NA,NA,704429,NA
11188564,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK053218,NA,NA,1ZIADK053218-18,NIDDK:608370\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,6570335 (contact),"LEVINE, MARK A (contact)",NA,NA,NA,Affect;Animals;Area;Ascorbic Acid;Biochemistry;Cell Physiology;Clinical;Coupled;Data Set;Diabetes Mellitus;Diet;Disease;Drug Kinetics;Eating;Erythrocytes;Fasting;Food;Foundations;fruits and vegetables;Health;Heart;Human;Ingestion;Intake;Knowledge;Maintenance;Measures;Methodology;Methods;Modeling;Mole the mammal;Molecular Biology;paracrine;Persons;Physiology;Plasma;Recommendation;Sampling;Techniques;Tissues;Vitamins;Work,Vitamin C (ascorbic acid) physiology,53218,NA,NA,NA,NA,18,NA,NA,608370,NA
11188565,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK054500,NA,NA,1ZIADK054500-28,NIDDK:2126338\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415738 (contact),"LIANG, T. JAKE  (contact)",NA,NA,NA,3-Dimensional;Affect;Africa;alpha helix;Amino Acid Sequence;Amino Acids;Anti-viral Response;Binding;Binding Proteins;Bioinformatics;Biological Assay;Biological Models;C-terminal;Cell Cycle Progression;Cells;CHD4 gene;Clinical;comparison control;Complex;Cysteine;deep learning;Dependence;Disease;Enzyme-Linked Immunosorbent Assay;Europe;Exclusion;Exhibits;extracellular;Fluorescence;Gene Proteins;Genes;Genetic Polymorphism;Genotype;HBV Genotype;HBXIP gene;Helix-Turn-Helix Motifs;Hepatitis;Hepatitis B;Hepatitis B Infection;Hepatitis B Virus;Hepatitis B X-Protein;Hepatocyte;HepG2;Homologous Gene;Human;Immune;in silico;In Vitro;in vivo;in vivo Model;Individual;Infection;insight;Integration Host Factors;Interferon alpha;Intervention;Investigation;knock-down;Knock-out;KRAS2 gene;Length;Libraries;Life Cycle Stages;lipid biosynthesis;Literature;Liver;Liver diseases;Modeling;Molecular;Mus;Mutagenesis;Mutation;N-terminal;Natural Immunity;Neuroblastoma;novel;NRAS gene;Nuclear Receptors;Nucleic Acids;Nucleotides;Oncogenes;Pathogenesis;Peptides;Persons;Phenotype;predictive modeling;Process;Productivity;protein expression;Protein Isoforms;Proteins;replication factor C;Reporting;screening;Sequence Alignment;Simian virus 5;Small Interfering RNA;Solubility;stable cell line;Stains;Structural Models;Structure;Subgroup;T-Lymphocyte;targeted treatment;Tertiary Protein Structure;therapeutic development;three-dimensional modeling;Transfection;Translating;United States;Validation;Variant;Viral;Viral Antigens;Virus;Virus Diseases;Virus Replication;Virus-Cell Membrane Interaction;Western Blotting;whole genome,"Molecular Mechanisms Of Hepatitis B Viral infection, Pathogenesis And Persistence",54500,NA,NA,NA,NA,28,NA,NA,2126338,NA
11188566,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK054503,NA,NA,1ZIADK054503-28,NIDDK:2063799\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415738 (contact),"LIANG, T. JAKE  (contact)",NA,NA,NA,2019-nCoV;Affect;anti-hepatitis B;Anti-viral Agents;anti-viral efficacy;antiviral drug development;Attenuated;Biological Assay;Biological Models;Cell Culture Techniques;Cell fusion;Cell model;Cell Survival;Cells;Chronic;Chronic Hepatitis;Chronic Hepatitis B;Clinical;COVID-19;COVID-19 patient;cytotoxic;cytotoxicity;Detection;Development;Disease;drug development;Goals;Hepatitis B e Antigens;Hepatitis B Virus;Hepatitis C;Hepatitis C virus;Hepatocyte;HepG2;high risk;high throughput screening;Human;Immune;Immunosorbents;in silico;infancy;Infection;interest;Investigation;Libraries;Link;Liver Cirrhosis;liver injury;luminescence;Measures;Mediating;Modeling;Molecular;Mutation;Normal Cell;novel;novel therapeutics;Nuclear Magnetic Resonance;Pathogenicity;Patients;Pharmacologic Substance;Population;preclinical study;Primary carcinoma of the liver cells;Public Health;remdesivir;SARS-CoV-2 B.1.1.529;SARS-CoV-2 infection;Site;small molecule;small molecule libraries;Technology;Therapeutic;Titrations;transmission process;vaccine access;Vaccines;Validation;Variant;Viral;viral DNA;Viral hepatitis;Virus;Virus Diseases;Virus Replication,Molecular Approaches To Antiviral Development For Viral Hepatitis and Other Viral Diseases,54503,NA,NA,NA,NA,28,NA,NA,2063799,NA
11188567,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK054505,NA,NA,1ZIADK054505-28,NIDDK:2063799\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415738 (contact),"LIANG, T. JAKE  (contact)",NA,NA,NA,Adaptive Immune System;Affinity;Animal Model;Anti-viral Agents;Anti-viral Response;Antibodies;Binding;Biological Assay;Biological Models;Blood specimen;Cells;Complex;design;Development;Encapsulated;Endosomes;Engraftment;Genotype;Glycoproteins;Hepatitis B Therapy;Hepatitis C;Hepatitis C Therapy;Hepatitis C Vaccine;Hepatitis C Viremia;Hepatitis C virus;Hepatocyte;Human;immunodeficiency;Immunoprecipitation;improved;In Vitro;in vivo;in vivo Model;Infection;Interferometry;Intravenous;Length;Libraries;lipid nanoparticle;Liver;Liver diseases;Mediating;model development;Modeling;Molecular;Monitor;mouse model;Mus;nanobodies;nanoparticle delivery;Negative Staining;neutralizing antibody;non-alcoholic fatty liver disease;Oral Administration;Pan Genus;Phage Display;Preventive vaccine;Process;Production;Proteins;Receptor Cell;Recombinants;Reproducibility;RNA;Serum;Source;Structure;Study models;Technology;therapeutic vaccine;therapy development;Transfection;Transmission Electron Microscopy;treatment response;vaccine candidate;vaccine development;Viral;Viral hepatitis;Viremia;Virus Replication;X-Ray Crystallography,"Therapy, Vaccine and Model Development in Viral Hepatitis and Liver Diseases",54505,NA,NA,NA,NA,28,NA,NA,2063799,NA
11188568,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK054506,NA,NA,1ZIADK054506-27,NIDDK:544331\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,6570335 (contact),"LEVINE, MARK A (contact)",NA,NA,NA,absorption;Animals;ascorbate;Ascorbic Acid;Biochemistry;Blood Component Removal;Brain;Cells;Computer software;Data;Data Analyses;Depressed mood;Disease;DNA Methylation;Dose;Drug Kinetics;Epithelium;Excretory function;Filtration;Gene Expression;Genes;Genetic;Genetic Transcription;Growth;Human;human subject;in vivo;Inbred BALB C Mice;Inbreeding;Individual;Intake;Intestinal Absorption;Investigation;Kidney;Knockout Mice;Laboratories;Learning;Lymphocyte;Messenger RNA;Molecular Biology;monocyte;Mus;Neurons;Nutrient;Pathway interactions;Physiological Processes;Plasma;Play;Population;Recommended Dietary Allowance;Regulation;response;RNA;Single Nucleotide Polymorphism;Testing;Time;Tissues;trend;Urine;Weaning;Whole Blood;Woman,Vitamin C (ascorbic acid) Biochemistry and Molecular Biology,54506,NA,NA,NA,NA,27,NA,NA,544331,NA
11188569,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK054508,NA,NA,1ZIADK054508-27,NIDDK:2610971\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415518 (contact),"REHERMANN, BARBARA  (contact)",NA,NA,NA,Adult;Antibiotics;Bacteria;bacteriome;C57BL/6 Mouse;Cell Maturation;Cell Physiology;Chronic;Complex;diet-induced obesity;Disease;Embryo Transfer;experimental study;follow-up;Fostering;fungus;Generations;Genes;Genetic;Goals;gut microbiota;Hepatic;High Fat Diet;High Prevalence;host-microbe interactions;Human;Immune;Immune response;Immunity;Immunologic Factors;Immunologics;Inflammation;Inflammatory;Laboratories;Laboratory mice;Life;Lymphoid;Lymphoid Cell;Mammals;Metabolic;Metabolism;Microbe;microbial;microbiome;microbiome analysis;microbiome therapeutics;microbiota;Mites;Modeling;Modernization;mouse model;Mus;Myelogenous;Nature;offspring;Organ;pathogen;Pathogenesis;Phase;Phenotype;Physiology;Pre-Clinical Model;preclinical study;programs;prospective;Protozoa;Regulation;Regulatory T-Lymphocyte;Reporting;response;Ribosomal RNA;rRNA Genes;Science;Series;Sex Bias;Shapes;stool sample;systemic inflammatory response;Time;Virus;women versus men,Regulation of hepatic and systemic immune responses,54508,NA,NA,NA,NA,27,NA,NA,2610971,NA
11188570,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK054509,NA,NA,1ZIADK054509-27,NIDDK:1814404\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415518 (contact),"REHERMANN, BARBARA  (contact)",NA,NA,NA,16S ribosomal RNA sequencing;Acute;adaptive immune response;Affect;Anti-viral Therapy;Antibodies;Antineoplastic Agents;Area;Award;B-Lymphocyte Subsets;B-Lymphocytes;bench to bedside;Cell Nucleus;Chronic Hepatitis B;chronic infection;Chronic viral hepatitis;circular RNA;Cirrhosis;Clinical;co-infection;Cosmetics;cost;COVID-19 pandemic;Data;differential expression;Disease;DNA Viruses;Drug Kinetics;effective therapy;end stage liver disease;fecal microbiota;First Pregnancy Trimester;Flare;follow-up;Genes;genetic signature;Genetic Transcription;Genome;gut microbiome;gut microbiota;Hepatitis;Hepatitis B Therapy;Hepatitis B Virus;Hepatitis C virus;Hepatitis Delta Virus;Hepatitis Viruses;Hepatocyte;Immune;Immune response;immunogenic;Immunoglobulin G;Immunoglobulin M;Immunology;Infection;Inflammatory Response Pathway;Innate Immune Response;liver inflammation;Malignant neoplasm of liver;medical schools;Messenger RNA;microbial;microbiota;microbiota composition;Modeling;nanoparticle;pandemic disease;Pathogenesis;patient population;Patients;Pattern;Pegylated Interferon Alfa;Peripheral Blood Mononuclear Cell;Persons;Pharmaceutical Preparations;Phase;Play;Polyethylene Glycols;post pregnancy;Postpartum Period;pre-pandemic;Pregnancy;Preventive vaccine;Process;programs;prospective;Prospective Studies;Regulatory Pathway;Reporting;Research;RNA vaccine;RNA Viruses;Role;SARS-CoV-2 antibody;SARS-CoV-2 spike protein;Second Pregnancy Trimester;Severity of illness;Signal Transduction;single-cell RNA sequencing;Soaps;Third Pregnancy Trimester;TNF gene;translational medicine;Translational Research;United States National Institutes of Health;unsupervised clustering;Vaccines;Vertical Disease Transmission;Vertical Transmission;Viral;Viral hepatitis;Visit,Immunology of Acute and Chronic Viral Hepatitis,54509,NA,NA,NA,NA,27,NA,NA,1814404,NA
11188571,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK054510,NA,NA,1ZIADK054510-20,NIDDK:2117630\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415512 (contact),"PHILPOTT, CAROLINE  (contact)",NA,NA,NA,absorption;Affect;Affinity Chromatography;Anemia;Antibodies;Binding;Binding Proteins;Biochemical;Biological;Biological Assay;cell fixing;Cell Nucleus;Cells;Circulation;cofactor;Computer software;confocal imaging;Confocal Microscopy;Coupled;Defect;Detection;Diet;Dietary Iron;DNA;Enterocytes;Enzymes;Erythrocytes;Exhibits;Ferritin;Fluorescence;Friedreich Ataxia;Genes;Genetic;Genetic Diseases;Genetic Materials;Genome;Growth;hepcidin;Hereditary hemochromatosis;Homeostasis;Hormones;Human;human disease;In Situ;Incubated;intestinal epithelium;Intestines;Iron;iron absorption;iron metabolism;Iron Overload;Kinetics;Label;Ligation;Liver;Location;Maintenance;Mass Spectrum Analysis;Measurement;Mediating;Membrane;metal transporting protein 1;Metals;Methods;Molecular Chaperones;Mus;Nuclear;Nutrient;Nutritional Requirements;Oligonucleotides;Organism;Oxidation-Reduction;Oxidative Stress;Permeability;Process;Production;protein protein interaction;Proteins;Regulation;Reporting;Role;Signal Transduction;Site;Stains;Toxic effect;Toxin;Up-Regulation;uptake;virtual;Visualization,Identification of human genes of iron homeostasis,54510,NA,NA,NA,NA,20,NA,NA,2117630,NA
11188572,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK054514,NA,NA,1ZIADK054514-18,NIDDK:1110575\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415730 (contact),"HELLER, THEO  (contact)",NA,NA,NA,Aftercare;Biology;Blood;Chronic;Chronic Hepatitis;Chronic Hepatitis C;Clinical;Data;Disease;Disease Progression;Enrollment;follow-up;Follow-Up Studies;Hepatitis C;Hepatitis C virus;Hepatitis D;Infection;inhibitor;Intention;interferon therapy;Interferons;Investigation;Laboratories;Liver diseases;Manuscripts;Morbidity - disease rate;mortality;Patients;Phase;prenylation;Process;Publishing;Relapse;Ritonavir;therapy development;treatment trial;United States National Institutes of Health;Viral hepatitis;Work,Investigation of management and disease manifestations of viral hepatitis,54514,NA,NA,NA,NA,18,NA,NA,1110575,NA
11188573,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK054517,NA,NA,1ZIADK054517-18,NIDDK:614571\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415732 (contact),"GHANY, MARC  (contact)",NA,NA,NA,Address;Affect;African American;Age;Alaska Native;analog;anti-IgG;Antibodies;Asian;Biopsy;Black race;Cessation of life;Chronic Hepatitis B;Chronic viral hepatitis;Cirrhosis;Clinical;cohort;cost;COVID-19 vaccination;COVID-19 vaccine;Data;Development;digital;Disease Progression;effective therapy;Effectiveness;Enrollment;Environmental Risk Factor;falls;FDA approved;functional outcomes;Gender;Gene Expression;Gene set enrichment analysis;Genes;genetic element;Genotype;HBV Genotype;Hepatitis B;Hepatitis B e Antigens;Hepatitis B Infection;Hepatitis B Surface Antigens;Hepatitis B Virus;Hepatocyte;Histologic;Hour;Immune response;immunogenicity;Immunologics;improved outcome;Incidence;Individual;Infection;Institutional Review Boards;interest;Interferons;intrahepatic;Knowledge;Liver;liver biopsy;Liver diseases;meetings;Messenger RNA;Modality;multi-racial;Multivariate Analysis;National Institute of Diabetes and Digestive and Kidney Diseases;Natural History;novel;novel strategies;Nucleocapsid;nucleoside analog;Oral;Outcome;Participant;Pathogenesis;Patient Monitoring;Patients;Persons;Pharmaceutical Preparations;Population;post SARS-CoV-2 infection;Prevalence;Primary carcinoma of the liver cells;primary endpoint;Probability;Protocols documentation;Race;racial disparity;racial population;Regimen;Relapse;Reporting;Research;Resistance;response;Risk;RNA vaccine;SARS-CoV-2 infection;SARS-CoV-2 negative;SARS-CoV-2 spike protein;secondary analysis;side effect;Small Interfering RNA;Socioeconomic Factors;Stains;Surrogate Endpoint;Technology;Therapeutic;therapy outcome;Tissue-Specific Gene Expression;transcriptomics;treatment disparity;tribal health;United States;United States National Institutes of Health;Vaccination;Viral;viral DNA;Virus Diseases,"Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis B",54517,NA,NA,NA,NA,18,NA,NA,614571,NA
11188574,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK055105,NA,NA,1ZIADK055105-18,NIDDK:711461\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415529 (contact),"RANE, SUSHIL  (contact)",NA,NA,NA,Acinar Cell;age related;Area;autoimmune pathogenesis;Beta Cell;Binding;Bone Marrow;CCND2 gene;CDK2 gene;CDK4 gene;CDKN2A gene;Cell Compartmentation;Cell Cycle;cell growth;Cell Line;Cell Lineage;Cell Physiology;Cell Proliferation;cell regeneration;Cells;Cellular biology;Chemicals;Clinical;clinical application;Cyclin D1;cyclin-dependent kinase inhibitor 1B;Deterioration;Development;diabetes management;Diabetes Mellitus;diabetes mellitus therapy;diagnostic development;Disease;Ductal Epithelium;E2F transcription factors;Embryo;embryonic stem cell;Endocrine;Epithelium;established cell line;Exhibits;Functional impairment;Generations;Genetic Transcription;Goals;Growth;Hyperplasia;Impairment;inhibitor;Injury;Insulin;Investigation;islet;islet stem cells;Islets of Langerhans;Knockout Mice;Location;Maintenance;Mesenchymal;Mesenchyme;Metabolic stress;mortality;mouse model;Mus;Natural regeneration;novel;Obesity;Organ;Pancreas;pancreas development;Pancreatic Diseases;Pancreatic duct;Pathogenesis;Pathologic;Pathway interactions;Phosphotransferases;Physiological;Play;Pluripotent Stem Cells;postnatal;precursor cell;Primary Cell Cultures;Process;progenitor;Proliferating;proliferation potential;promoter;Property;recruit;Regenerative capacity;Regenerative response;Regulation;Reporting;Research;response;Retinoblastoma Protein;Role;Source;Splenocyte;stem cells;Therapeutic;Toxin;TP53 gene;transdifferentiation;Translating;treatment strategy,Cell Cycle Regulators in Pancreatic Development and Disease,55105,NA,NA,NA,NA,18,NA,NA,711461,NA
11188575,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK055107,NA,NA,1ZIADK055107-18,NIDDK:711461\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415529 (contact),"RANE, SUSHIL  (contact)",NA,NA,NA,Address;Animal Model;blood glucose regulation;cancer risk;cdc Genes;Cell Cycle;Cell Cycle Progression;Cell Cycle Proteins;Cell Death;Cells;Development;Diabetes Mellitus;energy balance;Energy Metabolism;epidemiologic data;Exercise;Exposure to;Future Generations;genomic locus;Glucose;glucose tolerance;Goals;Growth;High Fat Diet;Homeostasis;Insulin;Investigation;Malignant Neoplasms;Metabolic;mouse model;Mus;Mutation;Obesity;Obesity associated disease;Organ;Pathogenesis;Pathway interactions;Phenotype;Probiotics;Process;Proteins;Public Health;Role;Technology;Tissues;Transforming Growth Factor beta;Transgenic Mice,Cell Cycle Regulators in Diabetes and Obesity,55107,NA,NA,NA,NA,18,NA,NA,711461,NA
11188576,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK056014,NA,NA,1ZIADK056014-18,NIDDK:389298\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415586 (contact),"PROIA, RICHARD  (contact)",NA,NA,NA,age related neurodegeneration;Ataxia;beta-Galactosidase;Biology;Brain;Catabolism;Clinical;CRISPR/Cas technology;Degradation Pathway;Disease;disease mechanisms study;DNA Sequence Alteration;enzyme deficiency;Exhibits;Frontotemporal Dementia;Ganglioside GM1;Gangliosidosis GM1;Gaucher Disease;Gene Expression;gene-editing approach;Genes;GLB1 gene;Glycolipids;Goals;Human;insight;Knockout Mice;Lead;life span;Link;Lipids;Lysosomal Storage Diseases;Mediating;Metabolism;Modeling;mouse model;Mus;Mutation;Nerve Degeneration;Neuraminidase;Neurodegenerative Disorders;neuroinflammation;novel;Parkinson Disease;Patients;Residual state;response;Role;Severities;species difference;Sphingolipids;Tay-Sachs Disease;Testing;Therapeutic;therapeutic target;tool,Mouse Models of Novel Sphingolipid Biology and Disease Mechanisms,56014,NA,NA,NA,NA,18,NA,NA,389298,NA
11188577,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK056016,NA,NA,1ZIADK056016-18,NIDDK:3503685\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415586 (contact),"PROIA, RICHARD  (contact)",NA,NA,NA,2019-nCoV;Acute;age related neurodegeneration;alpha synuclein;Autophagocytosis;Biology;Body System;Brain;brain cell;cell injury;Cell Membrane Structures;Cell Physiology;Complex;coronavirus disease;COVID-19;Disease;disease model;DNA Sequence;DNA Sequence Alteration;Event;Frontotemporal Dementia;Gaucher Disease;gene therapy;Glycosphingolipids;Goals;Hela Cells;Hypoxia;Impairment;Injury;insight;Link;Lipids;Lysosomal Storage Diseases;Mediator;Membrane Structure and Function;Metabolism;mouse model;Mus;mutation correction;Nerve Degeneration;Nervous System;Neurodegenerative Disorders;Neuroglia;neuroinflammation;Neurologic;Neurologic Symptoms;Neurons;Neuropathogenesis;neuropathology;Open Reading Frames;Parkinson Disease;Pathologic;Pathway interactions;Play;Process;Proteins;Role;SARS-CoV-2 infection;Signal Transduction;Sphingolipids;systemic inflammatory response;Tay-Sachs Disease;therapeutic target;therapy development;Virus;Virus Diseases,Sphingolipid Biology of Neurodegeneration,56016,NA,NA,NA,NA,18,NA,NA,3503685,NA
11188578,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK057602,NA,NA,1ZIADK057602-28,NIDDK:923459\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,6570353 (contact),"USDIN, KAREN P. (contact)",NA,NA,NA,Affect;Alleles;autism spectrum disorder;Basic Science;Brain;CGG repeat;Chromosome Fragile Sites;Clinic;Diagnosis;Disease;Double Strand Break Repair;epigenetic silencing;Event;FMR1 gene;Folic Acid;Fragile X Syndrome;frataxin;Frequencies;Friedreich Ataxia;FXTAS;gene product;Gene Silencing;Genes;Genetic Diseases;Genetic Transcription;genome integrity;Glutaminase;Goals;Heritability;Heterochromatin;Human Genetics;Human Genome;Intellectual functioning disability;interest;Introns;Life;Mediating;messenger ribonucleoprotein;Microsatellite Repeats;Molecular;Mutation;Nature;Nerve Degeneration;Online Mendelian Inheritance In Man;Open Reading Frames;ovarian dysfunction;Pathologic;Pathology;preservation;primary ovarian insufficiency;Process;Progress Reports;Proteins;response;Risk;Risk Management;screening;Spinocerebellar Ataxias;Synapses;Tandem Repeat Sequences;tool;Transcript;Translational Regulation;Untranslated Regions;Work,The consequences of the unusual mutation responsible for the Repeat Expansion Diseases,57602,NA,NA,NA,NA,28,NA,NA,923459,NA
11188579,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK057807,NA,NA,1ZIADK057807-18,NIDDK:682245\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,6570360 (contact),"COHEN-FIX, ORNA  (contact)",NA,NA,NA,Affect;Aging;Architecture;Biological Models;Caenorhabditis elegans;Candidate Disease Gene;Cell Cycle;Cell Nucleolus;Cell Nucleus;cell type;Cell Volumes;Cells;Chemicals;Chromosome Segregation;Defect;Development;Disease;Elements;Eukaryota;Exposure to;Gene Expression Profile;Growth;Intervention;Lamins;Lipids;Malignant Neoplasms;Mitosis;Mitotic;model organism;Morphology;mutant;Mutation;neutrophil;Nuclear;Nuclear Envelope;Partner in relationship;Pathology;Pathway interactions;Pheromone;Phospholipids;Play;Process;programs;Proteins;Regulation;response;Role;Saccharomycetales;Shapes;Signal Transduction;System;Testing;transcription factor;vesicle transport;Yeasts,Nuclear architecture in budding yeast,57807,NA,NA,NA,NA,18,NA,NA,682245,NA
11188580,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK057808,NA,NA,1ZIADK057808-18,NIDDK:1128672\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,6570353 (contact),"USDIN, KAREN P. (contact)",NA,NA,NA,5&apos; Untranslated Regions;Address;Affect;Age;Alleles;Binding;Biological Models;CAG repeat;cell type;Cells;CGG repeat expansion;Child;Complex;CRISPR/Cas technology;Data;Diagnosis;Disease;disease model;effective therapy;embryonic stem cell;FMR1 gene;Fragile X Syndrome;Gene Dosage;Genes;Genetic Diseases;genome integrity;genome wide association study;genomic locus;Glutaminase;Goals;Human Genetics;Human Genome;Huntington Disease;In Vitro;Individual;induced pluripotent stem cell;insight;interest;intergenerational;Knock-out;Lesion;Malignant Neoplasms;Mammals;Microsatellite Instability;Microsatellite Repeats;Mismatch Repair;MLH1 gene;Modeling;mouse model;Mutation;null mutation;Online Mendelian Inheritance In Man;Onset of illness;Patients;PMS1 gene;PMS2 gene;preference;prevent;Process;Progress Reports;Proteins;Reporting;Risk;Role;role model;Severity of illness;Shapes;Short Tandem Repeat;Single Nucleotide Polymorphism;Somatic Cell;Testing;Therapeutic;therapeutic target;transmission process;Weight;Work,The mutational mechanism responsible for the Repeat Expansion Diseases,57808,NA,NA,NA,NA,18,NA,NA,1128672,NA
11188581,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK057813,NA,NA,1ZIADK057813-18,NIDDK:395674\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,2068471 (contact),"HINTON, DEBORAH M (contact)",NA,NA,NA,Amino Acid Transporter;Antibiotic Resistance;Antibiotics;Apical;Bacteria;Bacterial Adhesins;Bacterial Infections;Base Pairing;Betaproteobacteria;Binding Sites;Bioinformatics;Bordetella pertussis;Communicable Diseases;Computer Analysis;Cytoplasm;Data;Data Set;Development;Disease;Disease Outbreaks;DNA-Directed RNA Polymerase;Enzymes;Epithelial Cells;Fatty Acids;gene conservation;Gene Expression;Gene Expression Regulation;gene induction/repression;gene product;Genes;Genetic Transcription;genome-wide;Glycolates;glyoxylate;Goals;Gram-Negative Bacteria;Health;Hemagglutinin;Homologous Gene;Incidence;Infant Mortality;Infection;LacZ Genes;lipid metabolism;Messenger RNA;Metabolic;Metabolic Pathway;Molecular Chaperones;mRNA Stability;mutant;Nucleotides;Organism;pathogen;Pathogenesis;Pathway interactions;Pertussis;Pertussis Vaccine;phenylacetic acid;Phosphorylation;Phosphotransferases;Play;Post-Transcriptional Regulation;Process;programs;promoter;pyruvate dehydrogenase;Regulation;Regulon;Reporter;Repression;response;Reverse Transcription;ribonuclease E;Ribosomes;RNA;Role;sensor;Sigma Factor;Site;Small RNA;Sugar Acids;Symptoms;System;Testing;Time;Toxin;Transcriptional Regulation;transcriptome sequencing;transcriptomics;Translations;transmission process;Type III Secretion System Pathway;Untranslated RNA;Upper respiratory tract;Virulence;Virulence Factors;virulence gene;Western Europe;Work,Regulation of Virulence Genes in Bordetella pertussis,57813,NA,NA,NA,NA,18,NA,NA,395674,NA
11188582,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK057814,NA,NA,1ZIADK057814-10,NIDDK:395674\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,2068471 (contact),"HINTON, DEBORAH M (contact)",NA,NA,NA,Accounting;Adherent Invasive Escherichia coli;Affect;Ampicillin Resistance;Anabolism;Antibiotic Resistance;antimicrobial;Aspartic Acid;Autoimmune Diseases;Bacteria;Bacterial RNA;beta-Lactamase;Binding;Biological Assay;Biology;Cell Physiology;Cells;Child;cold temperature;Communicable Diseases;Congenital Abnormality;Crohn&apos;s disease;Data Set;Development;Diabetes Mellitus;Disease;DNA;DNA-Directed RNA Polymerase;Drug Efflux;efflux pump;Elements;Environment;Escherichia coli;Etiology;Family;fighting;Fucose;Gastrointestinal tract structure;Gene Expression;Gene Expression Process;Gene Expression Regulation;Genes;Genetic;Genetic Transcription;Growth;Housekeeping Gene;Human Development;human disease;Immune;In Vitro;Inflammatory Bowel Diseases;insight;Invaded;Life Style;Liquid substance;Macrophage;Malignant Neoplasms;Membrane;Methionine;Microbial Biofilms;Molecular;mucoid;mutant;Mutation;Nervous System Disorder;Operon;pathobiont;Pathogenesis;pathogenic Escherichia coli;Pattern;Phenotype;Positioning Attribute;Process;promoter;Promoter Regions;Pump;Regulation;Salmonella;Sequence Homologs;Sigma Factor;Single Nucleotide Polymorphism;Spacer DNA;Specificity;Structure;System;Testing;Transcription Initiation;Transcription Initiation Site;Transcriptional Regulation;transcriptome sequencing;Valine;Variant;Work,Control of Transcription Initiation,57814,NA,NA,NA,NA,10,NA,NA,395674,NA
11188583,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK060101,NA,NA,1ZIADK060101-18,NIDDK:1648310\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,2069335 (contact),"HANOVER, JOHN A. (contact)",NA,NA,NA,aging related disease;Alleles;Alzheimer&apos;s Disease;Amyloid beta-Protein Precursor;Animal Disease Models;Animal Model;Animals;Beta Cell;Biological Models;Biological Process;Brain;Caenorhabditis elegans;Cell Death;Cells;chromatin immunoprecipitation;Complex;COVID-19 impact;cytokine release syndrome;Data;Defect;detection of nutrient;Development;Diabetes Mellitus;diabetes pathogenesis;differentiation in vitro;Disease;DNA Methylation;DNA Repair;Embryo;embryo cell;embryonic stem cell;Enterobacteria phage P1 Cre recombinase;Enzymes;epigenetic regulation;Excision;Exhibits;Fatty acid glycerol esters;Fibroblasts;fly;FTD with parkinsonism;gain of function;Gene Expression;Genes;Genetic;Genetic Models;Genetic Transcription;Genome;germline stem cells;Glycogen;Goals;Growth;Hexosamines;Human;human disease;hyperphosphorylated tau;Immune;imprint;Inflammatory;Insulin;Insulin Resistance;insulin secretion;insulin signaling;insulin-like signaling;Knock-out;knockout animal;Larva;Leptin;Link;Longevity;loss of function;Macronutrients Nutrition;Malignant Neoplasms;Mediating;Messenger RNA;Metabolic;Metabolic syndrome;Metabolism;Mexican Americans;Mitochondria;Modeling;Molecular;Mus;Muscle;mutant;Nematoda;Nerve Degeneration;Neurodegenerative Disorders;neurogenesis;Neuropathy;Non-Insulin-Dependent Diabetes Mellitus;Nutrient;O-GlcNAc transferase;Obesity;Organism;overexpression;oxidative damage;Pathogenesis;Pathway interactions;peptide O-linked N-acetylglucosamine-beta-N-acetylglucosaminidase;Phosphorylation;Physiological;pituitary gland development;Play;Polycomb;Polysaccharides;promoter;protective effect;Protein Isoforms;Proteins;Receptor Gene;response;reverse genetics;Role;Signal Pathway;Signal Transduction;Signal Transduction Pathway;stem cell biology;stem cell fate;stem cell population;Structure of beta Cell of islet;Susceptibility Gene;tau Proteins;Tauopathies;Technology;Temperature;therapeutic target;Tissues;Transcriptional Regulation;Transgenic Mice;Transgenic Model;Transgenic Organisms;Translations;Trehalose;Triglycerides;Virus Diseases;Work,Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of Disease,60101,NA,NA,NA,NA,18,NA,NA,1648310,NA
11188584,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK060102,NA,NA,1ZIADK060102-18,NIDDK:329662\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,2069335 (contact),"HANOVER, JOHN A. (contact)",NA,NA,NA,Ablation;Architecture;autosome;Basic Science;beta catenin;Binding;Biochemical;Caenorhabditis elegans;Calcium;Calmodulin;campomelic dysplasia;cell growth regulation;Cell Nucleus;Cells;Cellular Stress;Clinical Sciences;Defect;Diabetes Mellitus;Disease;DNA;DNA Binding;Family;Genes;Genetic;genetic approach;glycosylation;Goals;gonad development;HMG-Box Domains;Homologous Gene;Human;human disease;Image;inhibitor;Insulin;insulin signaling;Link;Maintenance;male;Mammals;Mediating;member;Molecular;Mus;Mutation;Nematoda;novel;novel strategies;Nuclear;Nuclear Export;Nuclear Import;Nuclear Proteins;nucleocytoplasmic transport;Organism;Pathway interactions;Patients;Phenotype;Phosphotransferases;Physiological;Population;Process;Proteins;receptor;Regulation;Role;Running;sensor;sertoli cell;sex;Signal Transduction;small molecule;small molecule inhibitor;Stem cell pluripotency;Susceptibility Gene;Syndrome;System;TCF7L2 gene;trafficking;transcription factor;Translating;uptake;Work;Yeasts,Calmodulin-driven Nuclear Trafficking linked to diabetes and insulin signaling,60102,NA,NA,NA,NA,18,NA,NA,329662,NA
11188585,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK060103,NA,NA,1ZIADK060103-18,NIDDK:1318649\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,2069335 (contact),"HANOVER, JOHN A. (contact)",NA,NA,NA,Acetylation;Adhesiveness;alpha Karyopherins;Animal Model;Apoptosis;Apoptotic;Biochemistry;Biology;casein kinase;Catalytic Domain;cell growth;Cell Nucleus;Cell Proliferation;Cells;Chemicals;Chromatin;Chronic Disease;Complex;Coronary Arteriosclerosis;COVID-19;Cryoelectron Microscopy;cytokine release syndrome;Cytoplasm;Defect;detection method;detection of nutrient;Development;Diabetes Mellitus;Diagnostic;Disease susceptibility;Dissection;DNA Methylation;DNA Methylation Regulation;DNA Repair;Environment;enzyme substrate;Enzymes;Epigenetic Process;Escherichia coli;Excision;Exhibits;Fibroblasts;Future;Gene Chips;Gene Expression;gene product;gene repression;Genes;Genetic;Genetic Transcription;Glycogen;Glycogen Synthase Kinase 3;Hexosamines;high throughput screening;High-Throughput Nucleotide Sequencing;histone acetyltransferase;Histone Deacetylase;Histones;Human;Image;Immune system;imprint;inhibitor;Insulin Resistance;insulin signaling;intrauterine environment;Length;Leptin;Link;Lipids;Mediating;Metabolic Diseases;Metabolism;Methods;Methylation;Mitochondria;Modification;Molecular;Morbidity - disease rate;Movement;multicatalytic endopeptidase complex;Mutation Analysis;Natural Products;Nerve Degeneration;Neurodegenerative Disorders;Non-Insulin-Dependent Diabetes Mellitus;Nuclear;Nuclear Pore Complex;nucleocytoplasmic transport;Nutrient;Nutrient availability;Obesity;Oxidative Stress;Participant;Pathway interactions;peptide O-linked N-acetylglucosamine-beta-N-acetylglucosaminidase;Phosphorylation;Phosphotransferases;Play;Polysaccharides;Predisposition;Proliferating;protein complex;Protein Isoforms;Proteins;Reagent;recruit;Regulation;Resistance;response;Role;sensor;Signal Pathway;Signal Transduction;Signal Transduction Pathway;Signaling Molecule;Site;Site-Directed Mutagenesis;Skeletal Muscle;small molecule inhibitor;stem cell self renewal;Stimulus;Structure;sugar nucleotide;Techniques;Technology;Testing;Therapeutic;Virus Diseases;X Chromosome,Enzymes of O-GlcNAc cycling linked to type-2 diabetes and neurodegeneration,60103,NA,NA,NA,NA,18,NA,NA,1318649,NA
11188586,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK061000,NA,NA,1ZIADK061000-27,NIDDK:2183970\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415662 (contact),"HENNIGHAUSEN, LOTHAR  (contact)",NA,NA,NA,2019-nCoV;Acceleration;Affect;Alternative Splicing;Atlases;Binding;Binding Sites;biochemical tools;Biological;Biological Process;Biological Response Modifiers;Biomedical Research;Cells;Cessation of life;clinically relevant;cohort;combinatorial;Combined Modality Therapy;Complex;Computational Science;Computer Hardware;Computing Methodologies;COVID-19 pandemic;COVID-19 patient;CRISPR/Cas technology;cytokine;Data Set;Detection;Development;Disease;Distal;Elements;Enhancers;Epigenetic Process;Exhibits;Experimental Genetics;Explosion;Focal and Segmental Glomerulosclerosis;Fostering;gene discovery;Gene Expression;Gene Expression Profile;Gene Expression Regulation;gene regulatory network;Genes;Genetic;genetic approach;genetic architecture;Genetic Epistasis;Genetic Transcription;Genome;genome editing;Genome engineering;Genomics;glomerulosclerosis;Growth;Heritability;Histologic;Hormonal;Hormones;Human;human disease;Human Genome;Immune;Immune response;immune RNA;Immune system;immunoregulation;improved;in vivo;Individual;Injury;insight;interdisciplinary approach;Interleukin-15;Interleukins;International;international partnership;Investigation;Janus kinase;Kidney;kidney cell;Kidney Diseases;kidney dysfunction;Lactation;leukemia;Link;Mammals;mammary;Mammary gland;mammary gland development;Medicine;Messenger RNA;milk production;Molecular;mouse genome;mouse model;Mutation;Network-based;novel therapeutics;organ growth;Pathway interactions;Patients;Pattern;Phosphorylation;Physiology;podocyte;Pregnancy;Premature aging syndrome;Prognosis;programs;Prolactin;Publications;Publishing;quantum computer;quantum computing;Regulatory Element;Renal glomerular disease;Reporting;Reproducibility of Results;Research;Risk;RNA Splicing;Role;Sampling;SARS coronavirus;SARS-CoV-2 B.1.1.529;SARS-CoV-2 variant;Scientist;sexual dimorphism;Signal Pathway;Signal Transduction;Single Nucleotide Polymorphism;STAT protein;Stat5 protein;Techniques;therapeutic development;therapeutic target;therapeutically effective;Time;Tissues;tool;Transcript;transcription factor;Transcriptional Regulation;transcriptome;transcriptome sequencing;Vaccination;Vaccinee;Variant;Viral;Virus Diseases;Virus Replication,Genetic Approaches To Understanding Organ Development and Function,61000,NA,NA,NA,NA,27,NA,NA,2183970,NA
11188587,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK069012,NA,NA,1ZIADK069012-17,NIDDK:682245\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,6570360 (contact),"COHEN-FIX, ORNA  (contact)",NA,NA,NA,Address;Affect;Architecture;Caenorhabditis elegans;Cell Cycle;Cell Nucleus;Cells;Centrosome;Chromosomes;Confocal Microscopy;CRISPR/Cas technology;Development;Disease;Electron Microscopy;Elements;Embryo;Fertilization;Genes;Genetic;genetic regulatory protein;Genome;Goals;insight;Lead;Libraries;Link;Malignant Neoplasms;Mammals;Membrane;Microtubules;migration;Mitosis;Morphology;Mus;novel;Nuclear;Nuclear Envelope;Nuclear Structure;Organelles;Permeability;PLK1 gene;Premature aging syndrome;Process;Proteins;Resolution;Reticulum;RNA Interference;Role;Shapes;Structural Protein;Testing;Tubulin;Yeasts,Nuclear architecture in C. elegans,69012,NA,NA,NA,NA,17,NA,NA,682245,NA
11188588,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK069015,NA,NA,1ZIADK069015-42,NIDDK:347768\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9693500 (contact),"KRAKOFF, JONATHAN  (contact)",NA,NA,NA,10 year old;Acceleration;Adipocytes;Adult;Affect;Age;anandamide;Area Under Curve;Arousal;awake;Basal metabolic rate;Behavior;Biopsy;Body mass index;Body Size;Body Weight;Body Weight Changes;Brain-Derived Neurotrophic Factor;Cell membrane;Ceramides;Childhood;Childhood diabetes;Closure by clamp;cohort;cost;Cross-Sectional Studies;Data;Development;Diabetes Mellitus;diabetes risk;Diabetic Nephropathy;Diabetic Retinopathy;dietary;dihydroceramide desaturase;Dose;Eating;Endocannabinoids;energy balance;Energy Metabolism;Etiology;euglycemia;factor A;Fasting;fasting plasma glucose;Fatty acid glycerol esters;follow-up;Food;gallstone disease;Gene Cluster;Genetic;genetic variant;Glucose;glucose production;glucose uptake;Goals;Hepatic;Hour;Human;Hyperglycemia;Hyperinsulinism;Hyperphagia;Impairment;In Vitro;Individual;Insulin;Insulin Resistance;insulin secretion;interest;Investigation;Kidney Diseases;Life;Lipids;Lipolysis;Lipoproteins;Longitudinal Studies;Longterm Follow-up;Low-Density Lipoproteins;Macronutrients Nutrition;Measurement;Measures;Mediating;Mediation;Mediator;Melanocortin 4 Receptor;Metabolic;Metabolic Diseases;metabolic rate;Metabolism;Movement;Muscle;Mutation;Native Americans;Non-Insulin-Dependent Diabetes Mellitus;novel;Obesity;OGTT;oxidation;Physical activity;Play;Promoter Regions;Receptor Gene;Renal function;Reproducibility;respiratory;response;Rest;Risk Factors;risk prediction;Role;Seasons;sedentary lifestyle;Serum;Signal Transduction;Single Nucleotide Polymorphism;Skeletal Muscle;Sleep;Sphingolipids;Sphingomyelins;Structure of beta Cell of islet;Testing;Thermogenesis;Time;total energy expenditure;Variant;Weight;Weight Gain,Risk Factors and Etiology of Obesity and Type 2 Diabetes,69015,NA,NA,NA,NA,42,NA,NA,347768,NA
11188589,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK069028,NA,NA,1ZIADK069028-36,NIDDK:459823\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,11593162 (contact),"HANSON, ROBERT  (contact)",NA,NA,NA,Adolescent;Age;American Indian Population;American Indians;Amerindian;Arizona;Basal metabolic rate;Beta Cell;Blood specimen;Body measure procedure;Body Size;Candidate Disease Gene;causal variant;Cell Line;Cell Physiology;Chronic Disease;Collaborations;Data;Diabetes Mellitus;diabetes risk;Disease;DNA;DNA Methylation;epidemiology study;Epigenetic Process;Ethnic Population;exome sequencing;Family;Future;Gene Frequency;Genes;genetic association;Genetic Determinism;genetic epidemiology;genetic information;genetic linkage;genetic pedigree;Genetic Techniques;genome sequencing;genome wide association study;genome-wide;Genotype;Growth;high body mass index;High Prevalence;Incidence;Indigenous American;Individual;Inherited;LDL Cholesterol Lipoproteins;lymphoblast;Maps;maturity onset diabetes of the young;Methods;middle age;Mothers;Native-Born;Nature;Non-Insulin-Dependent Diabetes Mellitus;novel;Nuclear;Obesity;Odds Ratio;Parents;Participant;Persistent Hyperinsulinemia Hypoglycemia of Infancy;Pima Indian;polygenic risk score;Population;population based;Predisposition;recruit;Reproducibility;Retinal Diseases;Risk;risk variant;Role;Sampling;Signal Transduction;Susceptibility Gene;TCF7L2 gene;Variant;whole genome,Genetic Epidemiology of Diabetes and Obesity,69028,NA,NA,NA,NA,36,NA,NA,459823,NA
11188590,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK069029,NA,NA,1ZIADK069029-17,NIDDK:2434377\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9693500 (contact),"KRAKOFF, JONATHAN  (contact)",NA,NA,NA,Abdomen;Anhedonia;Behavioral;Body Temperature;Body Weight Changes;Brown Fat;Calibration;Calories;Carbohydrates;Characteristics;Cognitive;Consumption;Data;depressive symptoms;deprivation;design;Diet;dietary;Dietary Factors;Dietary Intervention;Dopamine;Drops;energy balance;Energy Metabolism;Enrollment;Epinephrine;examination questions;Excretory function;Expenditure;Fasting;Fatty acid glycerol esters;Fatty Acids;feeding;Fibroblast Growth Factor;fibroblast growth factor 21;flexibility;fluorodeoxyglucose;Future;ghrelin;glucose tolerance;Goals;Heat Losses;High Fat Diet;Hormonal;Hour;Human;Hunger;Individual;Iowa;Lipids;Liver;Longterm Follow-up;Macronutrients Nutrition;Measurement;Measures;Mediating;Metabolic;metabolomics;Modeling;Obesity;Outcome;oxidation;Pancreatic Polypeptide;Participant;PET/CT scan;Phenotype;Physiological;Plasma;precision nutrition;preference;Protein-Restricted Diet;Proteins;rate of change;Reproducibility;Research Design;respiratory;response;Rest;Rodent Model;Role;Scanning;Series;Sleep;Sympathetic Nervous System;Testing;Thermogenesis;Thyroid Gland;Thyroid Hormones;urinary;Visualization;Weight;Weight Gain;weight loss intervention;weight maintenance;Work,Factors which predict variance in weight change,69029,NA,NA,NA,NA,17,NA,NA,2434377,NA
11188591,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK069071,NA,NA,1ZIADK069071-28,NIDDK:418217\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9827998 (contact),"BAIER, LESLIE J (contact)",NA,NA,NA,Acinar Cell;Adipocytes;Adult;Affect;Affinity;Age;Age of Onset;Alleles;American Indians;Amerindian;Arizona;Bardet-Biedl Syndrome;Binding;Binding Sites;Biological Assay;Birth;Birth Weight;Body fat;Body mass index;Candidate Disease Gene;Cells;Childhood;Clinical;clinical care;Code;Collaborations;Communities;Complement 3a;Complex;Data;Development;Diabetes Mellitus;Diagnosis;Disease;early onset;Enzymes;Exocrine pancreas;exome;fetal;Frequencies;Functional disorder;G-Protein-Coupled Receptors;Gene Frequency;Genes;Genetic;Genetic Transcription;Genetic Variation;Genotype;glucagon-like peptide 1;glucose metabolism;glucose production;Growth;Health;High Prevalence;Homology Modeling;Human;Hyperinsulinism;IGF1R gene;Impairment;In Vitro;Indigenous;indigenous community;Individual;innovation;Insulin;Insulin Resistance;insulin secretion;Insulin-Like Growth Factor Binding Protein 4;knock-down;Knockout Mice;Leptin;lipid biosynthesis;lipid metabolism;Lipolysis;loss of function;Low Birth Weight Infant;Luciferases;Maintenance;Measurement;Measures;Mediating;Medical Records;member;molecular dynamics;Morbid Obesity;Mus;Mutation;Native-Born;neonatal diabetes mellitus;Neuropeptides;Non-Insulin-Dependent Diabetes Mellitus;novel;Obesity;overexpression;pancreas development;Pathway interactions;Peptides;Peroxisome Proliferator-Activated Receptors;Persistent Hyperinsulinemia Hypoglycemia of Infancy;Persons;Pharmacotherapy;Phosphorylation;Physiological;PI3K/AKT;Pima Indian;Population;population based;postnatal;Predisposition;prenatal;Privatization;promoter;protective allele;Proteins;prototype;public database;rare variant;receptor;receptor binding;Reporting;Risk;risk variant;RNA;Rodent;Role;Sampling;Signal Transduction;STAT3 gene;Structure-Activity Relationship;Transactivation;Tribes;United States;Untranslated RNA;Variant;Western Blotting;Woman,Structural Analysis Of Candidate Genes For Type 2 Diabetes and Obesity,69071,NA,NA,NA,NA,28,NA,NA,418217,NA
11188592,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK069075,NA,NA,1ZIADK069075-27,NIDDK:994003\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415698 (contact),"BOGARDUS, CLIFTON  (contact)",NA,NA,NA,Adipose tissue;Age;Arizona;Body Composition;Body mass index;Complement;Data;Diabetes Mellitus;Disease;exome;exome sequencing;Exons;Expression Profiling;follow-up;Functional disorder;Gene Expression;Gene Expression Profiling;Genes;Genetic;Genetic Polymorphism;genome sequencing;genome wide association study;Genotype;Glucose Clamp;glucose production;High Prevalence;Hyperinsulinism;in vivo;Incidence;Insulin;Insulin Resistance;metabolic phenotype;Muscle;Native American population;non-diabetic;Non-Insulin-Dependent Diabetes Mellitus;Nucleotides;Obesity;Pima Indian;Population;Predisposition;Prevalence;prototype;Reporting;Single Nucleotide Polymorphism;Skeletal Muscle;Susceptibility Gene;Tissue Sample;Transcript;volunteer;whole genome;Work,Gene Expression Profiling On Insulin Resistance And Obesity,69075,NA,NA,NA,NA,27,NA,NA,994003,NA
11188593,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK069088,NA,NA,1ZIADK069088-18,NIDDK:1391073\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9693500 (contact),"KRAKOFF, JONATHAN  (contact)",NA,NA,NA,active method;Affect;Anodes;Area;Body Composition;Body Weight Changes;Body Weight decreased;Brain;brain magnetic resonance imaging;Brain region;Central Nervous System;Cognitive;cognitive testing;Data;Decision Making;density;Desire for food;Development;Eating;Energy Intake;Energy Metabolism;Failure;follow-up;Food;food craving;Functional Magnetic Resonance Imaging;Goals;gray matter;Hormones;Hunger;improved;Individual;Inflammatory;Intake;Interleukin-6;Intervention;Left;Magnetic Resonance Imaging;Measures;Mediating;men;metabolic rate;Neuroanatomy;neuroimaging;Neurons;obese person;Obesity;Outpatients;Patients;Performance;Positron;Positron-Emission Tomography;Prefrontal Cortex;prefrontal lobe;Procedures;Research Design;reward processing;Role;Satiation;satiety center;Scanning;Testing;Thinness;transcranial direct current stimulation;treatment effect;treatment group;Woman,Neuronal activity and its role in adiposity and food intake,69088,NA,NA,NA,NA,18,NA,NA,1391073,NA
11188594,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK069091,NA,NA,1ZIADK069091-18,NIDDK:2782146\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9693500 (contact),"KRAKOFF, JONATHAN  (contact)",NA,NA,NA,Acids;Affect;Alanine;Amino Acids;Anion Gap;Basal metabolic rate;behavior prediction;Behavioral;Biological Markers;blood glucose regulation;Body Size;Body Weight Changes;Calories;Carbohydrates;Carbon Isotopes;Childhood;Clinical Trials;cold temperature;Collection;computerized;Consumption;Data;design;Desire for food;Devices;Diet;dietary;Dietary History;Dietary Practices;Dietary Proteins;Dopamine;Dose;Drops;Eating;energy balance;Energy Intake;Energy Metabolism;Equation;experience;Fasting;Fatty acid glycerol esters;Fatty Acids;fibroblast growth factor 21;Fishes;flexibility;Follow-Up Studies;Food;food insecurity;Food Selections;Fructose;Future;Genetic;Genotype;glucagon-like peptide 1;Goals;gut microbiome;Hair;Height;High Fat Diet;Hormonal;Hormones;Hour;Hyperphagia;Individual;Ingestion;Inpatients;Intake;Intervention;Leucine;Link;Lipids;Liquid substance;long chain fatty acid;Machine Learning;Macronutrients Nutrition;Measurement;Measures;Meat;Mediation;Metabolic;metabolic rate;Metabolism;metabolomics;Methods;Modeling;Monounsaturated Fatty Acids;Natural History;Nitrogen Isotopes;novel;obese person;Obesity;Obesity Epidemic;Outcome;Outpatients;oxidation;Participant;Pathway interactions;Pattern;Perception;Physiological;Plasma;preference;protective effect;Proteins;Psychosocial Factor;Questionnaires;Records;recruit;reduced food intake;Reproducibility;Residual state;respiratory;Rewards;Risk Factors;Role;Saline;Saturated Fatty Acids;Sensitivity and Specificity;Socioeconomic Status;soft drink;stable isotope;Sucrose;sugar;sweetened beverage;System;Temperature;Testing;Thinness;Thirst;thirst regulation;Threonine;Time;trial comparing;urinary;Variant;warm temperature;Water;Water consumption;Weight Gain;weight loss intervention;Work,Regulators of Food Intake,69091,NA,NA,NA,NA,18,NA,NA,2782146,NA
11188595,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK069094,NA,NA,1ZIADK069094-18,NIDDK:459823\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,11593162 (contact),"HANSON, ROBERT  (contact)",NA,NA,NA,Albuminuria;American Indians;Blood specimen;Cardiovascular Diseases;Cell Line;Cholesterol;Collaborations;Complications of Diabetes Mellitus;Development;Diabetes Mellitus;Diabetic Nephropathy;Diabetic Neuropathies;Diabetic Retinopathy;DNA;DNA analysis;DNA Methylation;East Asian;epidemiology study;Ethnic Population;Family;Family Study;follow-up;Frequencies;Genetic;genetic association;Genetic Determinism;genetic epidemiology;genetic linkage;genetic pedigree;Genetic study;Genetic Techniques;genome wide association study;genome-wide;genome-wide analysis;genome-wide linkage;Genomic Segment;Genotype;Glucose Clamp;Hispanic Populations;Hyperinsulinism;Incidence;Indigenous American;Individual;Insulin Resistance;interest;Investigation;Kidney Diseases;Kidney Failure;Linkage Disequilibrium Mapping;lymphoblast;Maps;Measures;Methods;Micronesia;Morbidity - disease rate;Nuclear;Pacific Islander;peripheral blood;Pima Indian;Population;Predisposition;recruit;Renal function;Risk;sample collection;Sampling;segregation;Single Nucleotide Polymorphism;Susceptibility Gene;Techniques;trait;United States;Variant,Genetic Epidemiology of Diabetic Complications,69094,NA,NA,NA,NA,18,NA,NA,459823,NA
11188596,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK071010,NA,NA,1ZIADK071010-17,NIDDK:907898\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9693530 (contact),"WANK, STEPHEN  (contact)",NA,NA,NA,Ablation;Affect;Age of Onset;autosome;Biochemical;Biopsy;capsule;Carcinoid Tumor;carrier testing;cell regeneration;Cell Survival;Cells;chemotherapy;Clinical;clinical application;Collection;Colonoscopy;deep learning;Detection;Development;Diagnosis;Diagnostic;diagnostic screening;Diagnostic tests;Disease;Distal;DNA;effective therapy;Endocrine;Endoscopy;Enrollment;Enterochromaffin Cells;Epithelial Cells;Esophagogastroduodenoscopy;Evaluation;Excision;exome sequencing;Family;Family member;Family Study;follow-up;Gastrointestinal Carcinoid Tumor;Gene Mutation;Genes;Genetic;genetic analysis;genetic linkage analysis;Genotype;Germ Lines;Hereditary Malignant Neoplasm;histological specimens;Histology;human old age (65+);Image;imaging modality;Impairment;improved;Incidence;indexing;Individual;Inherited;Injury;inositol polyphosphate multikinase;Intention;intestinal epithelium;intestinal homeostasis;Intestinal Neuroendocrine Neoplasm;Intestines;kindred;Knowledge;Length;Lesion;lifetime risk;Location;Magnetic Resonance Imaging;Mediating;member;Metabolic;Methods;Modality;Morbidity - disease rate;mortality;Mucous Membrane;Mus;mutant;Mutate;Mutation;Natural History;neoplastic cell;Nuclear;Operative Surgical Procedures;Paneth Cells;Pathologic;Patients;PDPK1 gene;peripheral blood;Phenotype;Phosphorylation;Phosphotransferases;PIK3CG gene;Population;Primary Neoplasm;proband;Process;Prognostic Factor;Protein Truncation;Proteins;Proto-Oncogene Proteins c-akt;rare cancer;recruit;Recurrent disease;Reserve Stem Cell;Role;Sampling;Scanning;screening;Sensitivity and Specificity;Small Intestinal Carcinoid Tumor;Small Intestinal Neoplasm;Small Intestines;somatostatin analog;Specimen;stem cells;Survival Rate;Susceptibility Gene;Symptoms;Syndrome;Testing;tissue regeneration;TP53 gene;tumor;tumor DNA;tumorigenesis;X-Ray Computed Tomography,Natural History of Familial Carcinoid Tumor,71010,NA,NA,NA,NA,17,NA,NA,907898,NA
11188597,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075003,NA,NA,1ZIADK075003-21,NIDDK:1770122\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415443 (contact),"GE, KAI  (contact)",NA,NA,NA,Acetylation;Acetyltransferase;Acute;Binding;cancer type;Cell Differentiation process;Cell Fate Control;cell type;Cells;Chromatin Remodeling Factor;cofactor;Complex;congenital heart abnormality;Data;Development;developmental disease;Embryonic Development;embryonic stem cell;Enhancers;EP300 gene;epigenomics;Feedback;Fingers;Gene Expression;gene induction;Genes;Genetic Transcription;Genets;Histones;ISWI;Kabuki Make-Up Syndrome;lipid biosynthesis;Malignant Neoplasms;Mammalian Cell;Mediating;Mediator;Methyltransferase;MLL gene;Modeling;mouse development;Mus;muscle regeneration;Mutate;myogenesis;novel;Nuclear Protein;Pathogenesis;Play;PPAR gamma;protein complex;Proteins;Reader;recruit;Regulation;RNA Polymerase II;Role;stem cells;Tissues;transcription factor;Transcriptional Regulation;Tumor Suppression,Enhancer regulation by H3K4 methyltransferase KMT2D/MLL4 and associated factors,75003,NA,NA,NA,NA,21,NA,NA,1770122,NA
11188598,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075007,NA,NA,1ZIADK075007-20,NIDDK:1024796\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,15187433 (contact),"MUNIYAPPA, RANGANATH  (contact)",NA,NA,NA,Address;Adipocytes;Adult;adult obesity;Affect;African;African American population;African ancestry;American;Behavioral;Beta Cell;biobank;biobehavior;Blood;Blood Glucose;Blood specimen;Body Composition;Body mass index;Body Weight;Body Weight decreased;cardiovascular health;Cell Physiology;Child;Chronic;clinical center;Clinical Research;Closure by clamp;Coin;Collaborations;Communities;comorbidity;Consumption;Degenerative polyarthritis;design;Deuterium;Development;Diabetes Mellitus;diabetes risk;Eating;Eating Behavior;economic impact;Economics;Education;Energy Metabolism;Enrollment;epidemiology study;Ethnic Origin;euglycemia;European;Evaluation;exome sequencing;Fasting;Fatty acid glycerol esters;food marketing;Fostering;Functional disorder;Gastric Inhibitory Polypeptide;Gene Expression;genetic testing;glucagon-like peptide 1;Glucose;Glucose Clamp;glucose disposal;glucose production;Health;healthy volunteer;Heart Diseases;Hepatic;high risk;Hispanic Populations;Homeostasis;Human;Hyperglycemia;Hyperinsulinism;Hypertension;Impairment;improved;incretin hormone;indexing;Individual;Inflammation;Infusion procedures;Insulin;Insulin Resistance;insulin secretion;insulin sensitivity;Intervention;Intervention Studies;Intestinal Hormones;Intestinal Secretions;Intravenous;intravenous glucose tolerance test;islet;Life Expectancy;Liver diseases;Magnetic Resonance Spectroscopy;Malignant Neoplasms;mathematical model;Measurement;Measures;Mental Depression;Metabolic;Metabolism;Methodology;Methods;Modeling;multidisciplinary;Muscle;Natural History;non-diabetic;Non-Insulin-Dependent Diabetes Mellitus;obese person;Obesity;OGTT;Oral;Overweight;patient oriented research;Patients;Persons;Phenotype;Physical activity;Plasma;Policies;Population;Prediabetes syndrome;Predictive Value;Predisposing Factor;Procedures;Protocols documentation;Public Opinion;Race;recidivism;Relapse;Reporting;Research;Resources;response;Risk Factors;Sleep Apnea Syndromes;South Asian;Specimen;stable isotope;Stroke;Structure of beta Cell of islet;Techniques;Testing;Time;Tissue Sample;Tracer;trait;translational study;United States;United States National Institutes of Health;Urinary Incontinence;Urine;Variant;volunteer;Weight,"Biobehavioral Studies of Obesity, Weight loss and Recidivism",75007,NA,NA,NA,NA,20,NA,NA,1024796,NA
11188599,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075008,NA,NA,1ZIADK075008-19,NIDDK:277644\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415730 (contact),"HELLER, THEO  (contact)",NA,NA,NA,"Affect;Anatomy;Biology;Blood Platelets;Body System;Bone Marrow Transplantation;Case Series;Case Study;Categories;Chronic;Chronic Granulomatous Disease;Cirrhosis;Clinic;Clinical;clinical center;clinically relevant;cohort;Collaborations;congenital hepatic fibrosis;Consult;Data Collection;Development;Disease;Disease Progression;drug induced liver injury;end stage liver disease;gallin;Genetic Diseases;graft vs host disease;Hematological Disease;Hepatic;Hyperplasia;individual patient;Infection;Injury;interest;Investigation;Iron Overload;Knock-out;Knowledge;Laboratories;Lesion;Liver;liver biopsy;liver development;Liver diseases;liver hyperplasia;Manuscripts;model development;Modeling;mortality;Mortality Determinants;Mutation;National Heart, Lung, and Blood Institute;National Institute of Allergy and Infectious Disease;Natural History;neutrophil;pathogen;Patients;Portal Hypertension;Production;Protocols documentation;Publishing;regenerative;Reporting;Research;Respiratory Burst;Risk;Safety;sample collection;Services;Sickle Cell;Sickle Cell Anemia;Study models;Syndrome;System;Systemic disease;Time;United States National Institutes of Health;Viral hepatitis;Work",Investigation of non-cirrhotic portal hypertension.,75008,NA,NA,NA,NA,19,NA,NA,277644,NA
11188600,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075009,NA,NA,1ZIADK075009-19,NIDDK:502831\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415732 (contact),"GHANY, MARC  (contact)",NA,NA,NA,Address;Aftercare;Anti-Inflammatory Agents;Anti-viral Agents;Anti-viral Therapy;Ascites;B-Cell Lymphomas;Bacteria;Biopsy Specimen;Cardiovascular Diseases;cardiovascular disorder risk;cardiovascular risk factor;Cause of Death;Cells;Cholesterol;Chronic;Chronic Hepatitis C;chronic infection;Cirrhosis;Clinical;cohort;Collaborations;COVID-19 pandemic;Detection;Development;Diabetes Mellitus;dysbiosis;Dyslipidemias;Environmental Risk Factor;Extrahepatic;Fasting;fatty acid biosynthesis;Fibrosis;follow-up;General Population;Genetic Polymorphism;genetic predictors;Genotype;gut microbiome;gut microbiota;Hemorrhage;Hepatic;Hepatic Encephalopathy;Hepatitis C;Hepatitis C virus;Hepatocyte;Human;Incidence;Individual;Interferons;Intestines;Life Cycle Stages;Lipids;Lipoproteins;Liver;liver biopsy;Liver diseases;Liver Fibrosis;liver inflammation;Low-Density Lipoproteins;Malignant Neoplasms;Mediating;Metabolism;microbial;microbiome;Monitor;mortality;Natural History;novel marker;Outcome;particle;pathobiont;Pathogenesis;Pathway interactions;Patient Participation;Patient-Focused Outcomes;Patients;Peritonitis;Persons;Play;Primary carcinoma of the liver cells;prospective;Proteins;Public Health;response;Risk;Role;Serum;Time;United States;Variant;Viral;viral RNA,"Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis C",75009,NA,NA,NA,NA,19,NA,NA,502831,NA
11188601,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075012,NA,NA,1ZIADK075012-19,NIDDK:896178\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9827998 (contact),"BAIER, LESLIE J (contact)",NA,NA,NA,6-Phosphofructo-2-kinase;Acute;Adipose tissue;Adult;Affect;Alleles;American Indians;Atrophic;Basal metabolic rate;Beta Cell;Binding;Binding Sites;Biological;Biological Assay;Biopsy;Body fat;Body mass index;Caucasians;CCAAT-Enhancer-Binding Proteins;CDKN1C gene;Cell Line;cell type;Cells;Childhood;Cholesterol;Code;cohort;Collaborations;Communities;Complications of Diabetes Mellitus;CRISPR/Cas technology;Custom;Data;Databases;design;Diabetic Nephropathy;Disease;Energy Metabolism;Ethnic Population;Expenditure;falls;Fasting;follow-up;Follow-Up Studies;Frequencies;Fructose;Gender;Gene Cluster;Gene Expression;Gene Frequency;gene-editing approach;Genes;Genetic study;Genetic Transcription;genetic variant;genome wide association study;genome-wide;genomic data;genomic variation;Genotype;Genotype-Tissue Expression Project;Glucocorticoid Receptor;Glucocorticoids;glucose metabolism;Hepatic;High Prevalence;Human;in silico;Indigenous;indigenous community;Individual;Inpatients;Insulin;insulin secretion;Introns;Kidney;kidney biopsy;Kidney Glomerulus;Knock-out;Leukemic Cell;Linkage Disequilibrium;Liver;Low-Density Lipoproteins;Luciferases;manufacture;Maps;Measures;Meta-Analysis;Metabolic;metabolic rate;Minor;Mus;Muscle;muscle form;Muscular Atrophy;non-diabetic;Non-Insulin-Dependent Diabetes Mellitus;NR3C1 gene;Obesity;Persons;Phenotype;Physiological;Pima Indian;Plasma;Population;promoter;Protein Isoforms;Quantitative Trait Loci;Reporting;Resistance;response;Reverse Transcriptase Polymerase Chain Reaction;Risk;risk variant;RNA Splicing;Role;Sampling;scaffold;Signal Transduction;Site;Skeletal Muscle;Southwestern United States;System;Time;Tissue Sample;Tissues;trait;transcription factor;Tribes;Tyrosine 3-Monooxygenase;urban Native American;Variant;ventilation;whole genome;Y Chromosome,Follow-Up Studies of a Genome-Wide Association Analysis in Pima Indians,75012,NA,NA,NA,NA,19,NA,NA,896178,NA
11188602,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075013,NA,NA,1ZIADK075013-19,NIDDK:1813730\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,11142809 (contact),"ROTMAN, YARON  (contact)",NA,NA,NA,Adipose tissue;Adult;Affect;Agonist;Alleles;Animal Model;Biological Assay;Breath Tests;Carbohydrates;cell injury;Cell model;Cirrhosis;clinical center;clinical predictors;Clinical Trials;cohort;Collaborations;Comparative Study;comparison control;density;Development;Devices;Diglycerides;Disease;Drug Industry;Early identification;Eating;effective therapy;Effectiveness;end stage liver disease;Energy Metabolism;Enrollment;Enzymes;Fatty acid glycerol esters;fatty acid oxidation;Fatty Acids;Fatty Liver;Fibrosis;Food Energy;Functional disorder;Genes;genetic association;Genetic study;genetic variant;GLP-I receptor;healthy volunteer;Hepatic;Hepatocyte;high risk;Histologic;Human;human subject;Hydroxysteroid Dehydrogenases;improved;in vivo;Individual;Inflammation;Ingestion;Injury;insulin signaling;interest;intrahepatic;Knockout Mice;Label;lipidome;lipidomics;Lipids;Lipodystrophy;Liquid substance;Liver;Liver diseases;liver injury;liver transplantation;loss of function;Malignant neoplasm of liver;Metabolic;Metabolic dysfunction;Morbidity - disease rate;mortality;mouse model;National Institute of Diabetes and Digestive and Kidney Diseases;Natural History;new therapeutic target;non-alcoholic fatty liver disease;nonalcoholic steatohepatitis;novel therapeutics;Nutrient;Obesity;Oral;Overweight;particle;Pathogenesis;Pathway interactions;Patients;pediatric patients;Persons;Phenotype;Physiological;Physiology;Plasma;Population;Proteins;response;Role;Sampling;Severities;Single Nucleotide Polymorphism;Steatohepatitis;Structure;Study models;therapeutic target;Time;transcriptomics;United States;United States National Institutes of Health,"Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy",75013,NA,NA,NA,NA,19,NA,NA,1813730,NA
11188603,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075017,NA,NA,1ZIADK075017-16,NIDDK:758624\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415443 (contact),"GE, KAI  (contact)",NA,NA,NA,Acceleration;Adipocytes;Adipose tissue;Binding;Brown Fat;CCAAT-enhancer-binding protein-delta;cell growth;Cells;Chromatin;Chromatin Remodeling Factor;conditional knockout;CREB1 gene;Data;Defect;Development;Diabetes Mellitus;EGR2 gene;Enhancers;epigenome;epigenomics;gene induction;Genes;genomic profiles;Glucocorticoid Receptor;Histone H3.3;histone methylation;Histones;Hour;Impairment;in vivo;ISWI;Knock-in Mouse;Knock-out;Knockout Mice;Ligands;lipid biosynthesis;Literature;Mediating;Methyltransferase;MLL gene;MLL2 gene;Molecular Chaperones;Morbidity - disease rate;mortality;Mus;Muscle Development;mutant;myogenesis;Non-Insulin-Dependent Diabetes Mellitus;Obesity;Phase;Phosphorylation;Play;postnatal;PPAR gamma;precursor cell;promoter;Proteins;Reader;Regulation;Reporting;Repression;Resources;Risk Factors;RNA Polymerase II;Role;Site;SWI/SNF Family Complex;transcription factor;transcriptome,Epigenomic regulation of adipogenesis and adipose expansion,75017,NA,NA,NA,NA,16,NA,NA,758624,NA
11188604,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075020,NA,NA,1ZIADK075020-16,NIDDK:176451\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,12672769 (contact),"WESS, JURGEN  (contact)",NA,NA,NA,Acetylcholine;Alpha Cell;Alzheimer&apos;s Disease;Animals;Area;Behavioral;Bladder;Body Weight;cell type;cholinergic;Collaborations;Cre-LoxP;detrusor muscle;Development;Disease;Drug Addiction;drug seeking behavior;Endowment;Enteroendocrine Cell;Food Intake Regulation;G-Protein-Coupled Receptors;Gene Targeting;Genes;Glucagon;Glucose;Goals;Homeostasis;Hypothalamic structure;Individual;insulin secretion;Kidney;Knock-out;Knockout Mice;Learning;Ligands;locomotor control;Mediating;member;Memory;Mental Depression;Metabolic;Moods;Muscarinic Acetylcholine Receptor;Muscarinic Agonists;Muscarinics;Muscle Contraction;mutant;Mutant Strains Mice;Nerve;Neurons;new therapeutic target;Non-Insulin-Dependent Diabetes Mellitus;novel;obesity treatment;Outcome Study;Overactive Bladder;Parkinson Disease;Peripheral;Pharmaceutical Preparations;Phenotype;Physiological;Physiology;Play;Process;Publishing;Regulation;response;Role;Schizophrenia;Sensory;Signal Pathway;Signal Transduction;Site;small molecule;Structure of beta Cell of islet;targeted treatment;Technology;therapeutic target;Tissues;transmission process;Urination;Work,Muscarinic acetylcholine receptor subtypes: physiological roles,75020,NA,NA,NA,NA,16,NA,NA,176451,NA
11188605,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075023,NA,NA,1ZIADK075023-16,NIDDK:658712\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,15195448 (contact),"BAX, ADRIAAN  (contact)",NA,NA,NA,2019-nCoV;Affect;alpha helix;Attenuated;Binding;biophysical techniques;Capsid Proteins;Cell fusion;Cell membrane;Cells;Cryoelectron Microscopy;Data;design;Detergents;Ebola;Equilibrium;Hemagglutinin;HIV-1;in silico;Influenza;influenzavirus;inhibitor;Lipids;Mediating;Membrane;Membrane Fusion;Micelles;Modeling;Molecular;Mutation;NMR Spectroscopy;Pathogenicity;Property;Proteins;Resolution;Roentgen Rays;SARS-CoV-2 B.1.1.529;SARS-CoV-2 spike protein;Site;Structure;Tertiary Protein Structure;Transmembrane Domain;transmission process;Variant;Viral;Viral Fusion Proteins;Virus;Water,Structural study of the HIV1 gp41 coat protein,75023,NA,NA,NA,NA,16,NA,NA,658712,NA
11188606,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075031,NA,NA,1ZIADK075031-16,NIDDK:763076\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,6570188 (contact),"TYCKO, ROBERT  (contact)",NA,NA,NA,Adopted;Aluminum Oxide;Amino Acid Sequence;Amino Acids;Amyloid;aqueous;Area;Bee Venoms;Behavior;beta pleated sheet;Binding Proteins;biophysical properties;Biophysics;C-terminal;Chemicals;Cryoelectron Microscopy;Data;density;Development;Diameter;Electron Microscopy;Environment;Eukaryotic Cell;experimental study;flexibility;Freezing;Glutamine;Goals;Hydration status;Hydrogels;Individual;Isotope Labeling;Journals;Label;Length;Ligation;Liquid substance;Measurement;Membrane;Methods;mimetics;Modeling;Mole the mammal;Molecular Conformation;Molecular Structure;monomer;nano;nanopore;Neurodegenerative Disorders;Nuclear Pore;Organelles;Paper;Peptides;Phase;phosphonate;Physical condensation;Population;Population Distributions;Pore Proteins;Property;Proteins;Publications;Recombinants;RNA;RNA Processing;RNA Transport;RNA-Binding Protein FUS;Sampling;self assembly;Series;Signal Transduction;solid state nuclear magnetic resonance;Structure;Surface;synthetic peptide;System;Temperature;Tertiary Protein Structure;Transition Temperature,Structural and Biophysical Properties of Low Complexity Proteins,75031,NA,NA,NA,NA,16,NA,NA,763076,NA
11188607,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075033,NA,NA,1ZIADK075033-16,NIDDK:2089857\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415083 (contact),"DEAN, ANN  (contact)",NA,NA,NA,Address;Adult;Affect;Architecture;beta Globin;beta Thalassemia;Binding;cardiogenesis;Cell Differentiation process;Cell Lineage;cell type;Cells;Chromatin;Chromatin Loop;chromatin remodeling;Chromatin Structure;Chromosome Territory;Chromosomes;Complex;conditional knockout;Development;Disease;Elements;embryonic stem cell;enhancer binding protein;Enhancers;Epigenetic Process;Erythroid;Erythroid Cells;Family;Fetal Hemoglobin;GATA1 gene;Gene Activation;Gene Expression;Gene Family;gene repression;Genes;Genetic Diseases;Genetic Transcription;Genome;Globin;Goals;Health;Hematopoiesis;Hematopoietic;Hemoglobin;Hemoglobinopathies;histone modification;Histones;Homologous Gene;Human;human disease;insight;Knock-out;LIM Domain;LMO2 gene;Locus Control Region;Malignant Neoplasms;Meta-Analysis;MLL gene;Mus;Mutation;neurogenesis;Nuclear;Nucleic Acid Regulatory Sequences;Pathway interactions;Pattern;Play;Process;promoter;Property;Proteins;recruit;Regulation;Research;retinogenesis;RNA;Role;Sickle Cell Anemia;Specificity;TAL1 gene;Therapeutic;Tissues;transcription factor;Transcriptional Activation;transcriptome,"Chromatin Structure, Epigenetic and Developmental Regulation of Mammalian Gene",75033,NA,NA,NA,NA,16,NA,NA,2089857,NA
11188608,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075035,NA,NA,1ZIADK075035-16,NIDDK:127112\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,10272309 (contact),"AGARWAL, SUNITA  (contact)",NA,NA,NA,accurate diagnosis;Achievement;Adipocytes;Amino Acids;Benign;Biological Assay;Biological Models;Biological Process;C-terminal;Cancer Patient;CDK6-associated protein p18;CDKN2A gene;Cell Cycle;Cell Cycle Progression;Cell Cycle Regulation;Cell Line;Cell Proliferation;cell transformation;cell type;Cells;ChIP-seq;chromatin isolation by RNA purification sequencing;Cosmetics;Cyclin-Dependent Kinase Inhibitor;Cyclin-Dependent Kinase Inhibitor Gene;Data;Defect;Derivation procedure;Detection;differentiation in vitro;disease model;DNA Methylation;Down-Regulation;Duodenum;embryonic stem cell;Endocrine;Endocrine Gland Neoplasms;Enhancers;Epigenetic Process;Ethnic Origin;Event;exome sequencing;Family;follower of religion Jewish;GCM2 gene;Gene Cluster;Gene Expression;Gene Expression Microarray Analysis;Gene Family;Gene Mutation;Genes;Genetic Transcription;Genetically Engineered Mouse;genome sequencing;genome-wide;genome-wide analysis;genomic locus;Genomic Segment;Germ Lines;Germ-Line Mutation;gland development;Goals;Heterozygote;Histone H3;histone methylation;histone modification;Homeostasis;Human;Hyperparathyroidism;imaging modality;Inherited;insight;insulinoma;interest;islet;Islet Cell Tumor;Islets of Langerhans;kindred;Knock-in Mouse;Knockout Mice;Lead;Lipoma;Loss of Heterozygosity;Lysine;malignant parathyroid gland tumor;Maps;Menin;MET gene;Methylation;methylome;Molecular;Molecular Genetics;Mouse Embryonic Stem Cells;mouse model;Multiple Endocrine Neoplasia Type 1;Mus;Mutation;Neoplasms;Neuroendocrine Tumors;novel;novel strategies;Null Lymphocytes;Pancreas;Parathyroid Adenoma;Parathyroid gland;Parathyroid Neoplasms;Pathway interactions;Patients;Phenotype;Pheochromocytoma;Pituitary Neoplasms;positional cloning;Primary Cell Cultures;programs;Prolactin;Proliferating;protein complex;Proteins;Proto-Oncogenes;Regulation;Reporter;Risk Assessment;Role;Small Intestines;Somatic Mutation;Specimen;Syndrome;Tissues;tumor;tumor DNA;tumor initiation;tumor progression;Tumor Suppressor Proteins;tumorigenesis;Untranslated RNA;Up-Regulation;Variant;venous thromboembolism;Work,Genes associated with endocrine tumorigenesis,75035,NA,NA,NA,NA,16,NA,NA,127112,NA
11188609,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075037,NA,NA,1ZIADK075037-16,NIDDK:589937\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415315 (contact),"YANG, WEI  (contact)",NA,NA,NA,ATP phosphohydrolase;base;Binding;Biochemical;biophysical properties;Cells;chemotherapy;Cisplatin;Complex;Data;Deamination;Detection;dimer;DNA;DNA Adducts;DNA lesion;DNA Repair;DNA-Directed RNA Polymerase;endonuclease;ERCC3 gene;Excision;Excision Repair;helicase;Individual;Intervention;Label;Lesion;Molecular;Molecular Conformation;Nuclear Extract;Nucleotide Excision Repair;Oligonucleotides;overexpression;plasmid DNA;Plasmids;Postdoctoral Fellow;Process;protein purification;Protein Subunits;Proteins;Publications;Reaction;reconstitution;recruit;Repair Complex;Research;Resolution;Series;SS DNA BP;Structure;transcription factor TFIIH;UV induced;Work;Writing;XPA gene,Biophysical characterization of DNA repair complex TFIIH,75037,NA,NA,NA,NA,16,NA,NA,589937,NA
11188610,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075040,NA,NA,1ZIADK075040-16,NIDDK:1531006\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,2028622 (contact),"KIMMEL, ALAN R (contact)",NA,NA,NA,3&apos; Untranslated Regions;Adhesions;Affinity;Affinity Chromatography;Anabolism;Back;Bacteria;beta pleated sheet;Binding;Binding Proteins;Biochemical;Biological Assay;Biological Process;Calcium;Calpain;Cardiovascular Diseases;Cell Adhesion;Cell Aggregation;Cell Communication;Cell Density;cell growth;cell motility;Cell Physiology;Cells;cellular development;Cellularity;Characteristics;Chemotactic Factors;Chemotaxis;cofactor;Communication;Complex;Coupled;Coupling;Cues;Cyclic AMP;Cyclic AMP Receptors;Cytoplasm;Data;Deamination;density;Derivation procedure;desensitization;Development;Dictyostelium;Dimerization;directional cell;Dominant-Negative Mutation;Dose;Elements;Ensure;Epidermal Growth Factor;Epidermal Growth Factor Receptor;Eukaryota;Eukaryotic Cell;Event;Exhibits;experimental study;Family;Family member;Fatty Liver;Feedback;folate-binding protein;Folic Acid;Foundations;G Protein-Coupled Receptor Signaling;G-Protein-Coupled Receptors;Gene Expression;Gene Silencing;Genes;Genetic;Genetic Transcription;Genomics;Growth;Growth and Development function;GTP-Binding Proteins;Heterocyclic Compounds;Heterodimerization;Homeostasis;Homo;human disease;Image;Individual;Insulin Resistance;Integral Membrane Protein;interest;Kinetics;Length;Ligands;Lipid Mobilization;Lipids;mammalian genome;Mammals;MAPK1 gene;Mass Spectrum Analysis;Mediating;member;Membrane;Messenger RNA;Metabolic;Metabolic Diseases;Modeling;Molecular;Molecular Conformation;molecular modeling;Monitor;Mouse Strains;Movement;mRNA Stability;mutant;Mutate;Mutation;Natural Immunity;novel;Null Lymphocytes;Nutrient;Nutrient Depletion;Organelles;Organism;overexpression;Pathway interactions;Pattern;Peptide Hydrolases;perilipin;Periodicals;Phagocytes;Phenocopy;Phenotype;Phosphorylation;Phosphotransferases;Play;Population;posttranscriptional;preference;Process;Prokaryotic Cells;Property;protein complex;Protein Secretion;Protein Sequence Analysis;Proteins;Pterins;receptor;Receptor Activation;receptor binding;receptor function;Receptor Signaling;recruit;Regulation;Research;Resistance;response;Risk Factors;RNA Binding;RNA Splicing;RNA Stability;Role;scaffold;self organization;Sequence Deletion;Series;Signal Pathway;Signal Transduction;Site;Source;Starvation;steroid hormone;Surface;System;Territoriality;three-dimensional modeling;TIS11 protein;Tissues;Totipotent cell;trafficking;Transcript;Transcription Process;transcriptome sequencing;Translational Repression;Transmembrane Domain;Up-Regulation;Variant,SIGNALING PATHWAYS IN CONTROL OF GROWTH AND DEVELOPMENT,75040,NA,NA,NA,NA,16,NA,NA,1531006,NA
11188611,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075042,NA,NA,1ZIADK075042-15,NIDDK:2367163\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,10672500 (contact),"GERMINO, GREGORY  (contact)",NA,NA,NA,Address;Affect;anterior chamber;Autosomal Dominant Polycystic Kidney;Autosomal Recessive Polycystic Kidney;Binding;Biological Models;Brain;Cell Culture System;Cells;Clinical;Collection;combinatorial;Cystic Kidney Diseases;Dedications;Development;Diameter;Disease;disease model;End stage renal failure;Eye;gene function;Gene Modified;Genes;Genetic;genome wide association study;Hereditary Disease;Human;Hydrophthalmos;in vivo;Individual;insight;interest;Intervention;Kidney;Laboratories;Length;Life;Link;Maintenance;Manuscripts;Methods;Molecular;Morphology;Mus;Mutant Strains Mice;Mutate;Nephrons;novel therapeutics;Open-Angle Glaucoma;Organ;Organoids;Pathogenesis;Phenotype;Polycystic Kidney Diseases;Preparation;Process;Proprotein Convertase 1;Proprotein Convertase 2;Proteins;Publishing;Renal function;Renal tubule structure;Reporting;Reproducibility;response to injury;Role;Sampling;Sequence Deletion;Severity of illness;Signal Pathway;Structure;System;Testing;Tubular formation;United States;Update;Variant,The role of PKD proteins in regulating tubular morphology,75042,NA,NA,NA,NA,15,NA,NA,2367163,NA
11188612,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075050,NA,NA,1ZIADK075050-12,NIDDK:1109653\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9693530 (contact),"WANK, STEPHEN  (contact)",NA,NA,NA,Affect;Area;base;BMI1 gene;Bromodeoxyuridine;Cell Differentiation process;Cell division;Cell Lineage;cell motility;Cells;Classification;Data;Development;Developmental Process;Distal;Duodenum;Endocrine;Enterochromaffin Cells;Enteroendocrine Cell;Ephrins;Epithelial Cells;Epithelium;epithelium regeneration;Erinaceidae;Gastrointestinal tract structure;Genetic Induction;Genetic Markers;Genetic Models;Goals;Homeostasis;Hormones;Human;ileum;In Situ Hybridization;In Vitro;in vivo;insight;interest;intestinal crypt;intestinal epithelium;Intestinal Neuroendocrine Neoplasm;Intestines;Ions;Label;LGR5 gene;Location;Maintenance;Mediating;Mesenchyme;Methods;Microscopic;migration;Mitochondrial DNA;Mitotic spindle;Modeling;Molecular;Monitor;Morphology;Mucous Membrane;Mus;Mutation;Neurons;Neurosecretory Systems;notch protein;novel;Organ;Organoids;Paneth Cells;Pathologic;Patients;Pattern;peptide hormone;Population;Positioning Attribute;precursor cell;Predisposition;Process;Property;Reporting;Reserve Stem Cell;RNA;Role;self-renewal;Signal Pathway;Small Intestinal Neoplasm;Small Intestines;Space Perception;stem cell biomarkers;stem cell division;stem cell genes;stem cell niche;stem cell population;stem cells;stemness;System;Tissues;transcription factor;tumor;tumorigenesis;Villus;WNT Signaling Pathway;Work,Presence and role of Enteroendocrine Cells Residing at the Intestinal Crypt Base,75050,NA,NA,NA,NA,12,NA,NA,1109653,NA
11188613,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075056,NA,NA,1ZIADK075056-14,NIDDK:618224\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415374 (contact),"WEINSTEIN, LEE  (contact)",NA,NA,NA,Acute;adiponectin;Adipose tissue;Agonist;Alleles;Biochemical;cardiovascular effects;Central Nervous System;Chondrocytes;Collaborations;Cyclic AMP;Defect;diet-induced obesity;early-onset obesity;Eating;energy balance;Energy Metabolism;Enterobacteria phage P1 Cre recombinase;Enzymes;extracellular;Genes;Germ Lines;glucose metabolism;Goals;GTP-Binding Proteins;Hormones;Human;Hyperphagia;Hypothalamic structure;hypothalamic-pituitary-adrenal axis;In Vitro;in vivo;Knock-out;Knockout Mice;Liver;LoxP-flanked allele;Mediating;Melanocortin 4 Receptor;Melanocortin 4 receptor mutation;melanocortin receptor;Metabolic;Morbid Obesity;Mus;mutant;Mutation;Neurotransmitters;Obesity;paraventricular nucleus;Pathway interactions;Peripheral;Phenotype;Phospholipase C;Play;promoter;Property;receptor;Receptor Inhibition;Receptor Signaling;Regulation;Resistance;Role;Signal Transduction;Tissues;Transgenes;Transgenic Mice;Transgenic Organisms;transmission process;virtual,Role of Gq/11-alpha in metabolic regulation,75056,NA,NA,NA,NA,14,NA,NA,618224,NA
11188614,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075057,NA,NA,1ZIADK075057-14,NIDDK:339914\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,6570283 (contact),"REITMAN, MARC L (contact)",NA,NA,NA,Ablation;Acute;Affinity;Agonist;Alpha Cell;Area;attenuation;Beta Cell;Biology;Blood Pressure;Body Temperature;Body Weight;Bombesin;Bombesin Receptor;bombesin receptor subtype 3;Brain;Brain Stem;Cannabinoids;Cardiovascular Diseases;Cell Line;Cell Nucleus;Cholelithiasis;combinatorial;comorbidity;complement pathway;Cre driver;Degenerative polyarthritis;Drug Kinetics;Dyslipidemias;Eating;Effectiveness;Fasting;Feedback;G-Protein-Coupled Receptors;Genetic;Genetic Transcription;Glucose;Goals;Health;Heart Rate;Homeostasis;Hypertension;Hypothalamic structure;improved;insulin secretion;interest;Islets of Langerhans;Knock-out;Leptin;Life Expectancy;Ligands;Malignant Neoplasms;member;metabolic rate;Midbrain structure;mouse genetics;Mus;Names;Neurons;neuropeptide Y;Non-Insulin-Dependent Diabetes Mellitus;Obesity;obesity treatment;Oral;paraventricular nucleus;Pathway interactions;Pharmacology;Physiology;Population;Preoptic Areas;recombinase;reduced food intake;Regulation;Research;Rest;Risk;Rodent;Role;Signal Pathway;Sympathetic Nervous System,Physiology and Pharmacology of BRS3 (Bombesin Receptor Subtype-3),75057,NA,NA,NA,NA,14,NA,NA,339914,NA
11188615,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075058,NA,NA,1ZIADK075058-14,NIDDK:418217\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9827998 (contact),"BAIER, LESLIE J (contact)",NA,NA,NA,Adipocytes;Adipose tissue;Adult;Affect;Alleles;American Indians;Amish;Animals;Architecture;Arizona;Asian ancestry;Body mass index;Butyrates;Candidate Disease Gene;Cell Size;Cells;Child;Childhood;clinical phenotype;Code;Codon Nucleotides;Complex;D-Amino Acid Dehydrogenase;Data;detection assay;Development;diabetes mellitus genetics;diabetes risk;Diabetic Nephropathy;Disease;disorder risk;DNA;Dopamine;Dyslipidemias;East Asian;Elements;energy balance;Energy Metabolism;enzyme activity;Enzymes;Ethnic Population;European;European ancestry;Exclusion;Exhibits;exome;exome sequencing;Familial partial lipodystrophy;Fatty Acids;Fatty Liver;FOXO1A gene;Frequencies;Gene Frequency;Genes;Genetic Transcription;genome sequencing;genome wide association study;genome-wide;Genomics;Genotype;Glucose;Glycerol;Heritability;Hour;Human;Hydrolysis;IGFBP4 gene;Impairment;In Vitro;Indigenous;Indigenous American;indigenous community;Individual;Infusion procedures;insertion/deletion mutation;Insulin;Insulin Resistance;insulin sensitivity;Insulin-Like Growth Factor I;Insulin-Like Growth-Factor-Binding Proteins;Isoproterenol;Knockout Mice;Large-Scale Sequencing;Link;Lipase;lipid biosynthesis;lipid metabolism;Lipids;Lipolysis;Longitudinal Studies;loss of function;loss of function mutation;Measures;Mediating;Methods;Minor;Modeling;Morbid Obesity;Mus;new therapeutic target;Non-Insulin-Dependent Diabetes Mellitus;Nonesterified Fatty Acids;Nonsense Codon;novel;NTRK2 gene;Nuclear;Obesity;OGTT;oxidation;Pathogenicity;Pathway interactions;Persons;Phase;Phenotype;PI3K/AKT;Plasma;Population;Prediabetes syndrome;Predisposition;Privatization;protein degradation;Protein Isoforms;Proteins;rare variant;Reporter;Reporting;Research Personnel;Risk;Role;Sampling;Serine;Siblings;Signal Transduction;Single Nucleotide Polymorphism;Sleep;Somatomedins;sterol esterase;Techniques;Testing;Therapeutic;Threonine;trait;Triglycerides;United States;Variant;whole genome,Whole Genome and Whole Exome Sequencing to Identify Genes for Type 2 Diabetes and Obesity,75058,NA,NA,NA,NA,14,NA,NA,418217,NA
11188616,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075062,NA,NA,1ZIADK075062-13,NIDDK:339914\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,6570283 (contact),"REITMAN, MARC L (contact)",NA,NA,NA,Anti-Obesity Agents;Biological Assay;Biology;Body Temperature;Bupropion;cost effective;Diabetes Mellitus;drug development;Eating;Energy Metabolism;Goals;Homeostasis;Human;human model;Knowledge;liraglutide;Medical;metabolic rate;Metabolism;mouse model;Mus;Naltrexone;Obesity;obesity treatment;orlistat;Persons;Pharmaceutical Preparations;Pharmacodynamics;pharmacologic;Pharmacological Treatment;Pharmacotherapy;Phentermine;Physiologic Thermoregulation;Physiology;Temperature;Therapeutic;topiramate;Translating;United States;virtual;Work,Pharmacologic approaches to the treatment of obesity,75062,NA,NA,NA,NA,13,NA,NA,339914,NA
11188617,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075063,NA,NA,1ZIADK075063-13,NIDDK:339914\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,6570283 (contact),"REITMAN, MARC L (contact)",NA,NA,NA,Adult;Agonist;awake;Basal metabolic rate;Biology;Body Temperature;Body Weight;Body Weight decreased;Brain;Brown Fat;Cardiac;circadian;clinical development;cold stress;cost;Darkness;diet-induced obesity;Disease;Dissection;Diurnal Rhythm;drug efficacy;drug testing;Energy Intake;Energy Metabolism;Evaluation;Exhibits;Expenditure;experimental study;fibroblast growth factor 21;Food;GDF15 gene;glucagon-like peptide 1;Home;Homeostasis;House mice;Human;human disease;human model;inter-individual variation;Knockout Mice;Light;Link;Mammals;Measurement;Measures;Melanocortin 4 Receptor;Metabolic;metabolic rate;Modeling;Mus;Muscle;Obesity;Peptide YY;Pharmaceutical Preparations;Phase;Photoperiod;Physical activity;Physiological;Physiology;prevent;Rest;Sampling;Shapes;Sleep;Temperature;Thermogenesis;Time;total energy expenditure;virtual;Weight-Loss Drugs;Work,What can body temperature tell us about energy homeostasis?,75063,NA,NA,NA,NA,13,NA,NA,339914,NA
11188618,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075064,NA,NA,1ZIADK075064-13,NIDDK:339914\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,6570283 (contact),"REITMAN, MARC L (contact)",NA,NA,NA,Acute;Adrenergic Agonists;Adult;Biology;Body Temperature;Body Weight;Brown Fat;comorbidity;Dinitrophenols;energy balance;Energy Metabolism;Ensure;experimental study;Genes;Goals;Histamine;Homeostasis;House mice;Human;Insulin Resistance;interest;Knockout Mice;Mammals;metabolic rate;Modeling;Mus;natural hypothermia;Neurons;Obese Mice;Obesity;Preoptic Areas;Protons;receptor;Role;Temperature;Tissues,Role of brown adipose tissue (BAT) in energy balance,75064,NA,NA,NA,NA,13,NA,NA,339914,NA
11188619,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075069,NA,NA,1ZIADK075069-13,NIDDK:201462\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415029 (contact),"CHOW, CARSON  (contact)",NA,NA,NA,Binding;biochemical model;Biological Assay;Cells;cellular imaging;cofactor;Collaborations;Computer software;Data;Data Set;design;Dose;experimental study;Gene Expression;gene product;Genes;Genetic Transcription;Goals;Image;Kinetics;Location;Malignant Neoplasms;Mediating;Messenger RNA;Modeling;molecular imaging;MYC gene;next generation;novel;open source;Pharmaceutical Preparations;Positioning Attribute;predictive modeling;Process;Reaction;Repression;Resolution;response;RNA;Site;Spliced Genes;Steroid Receptors;Steroids;Theoretical model;theories;Time;whole genome;Writing,Modeling gene transcription,75069,NA,NA,NA,NA,13,NA,NA,201462,NA
11188620,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075070,NA,NA,1ZIADK075070-13,NIDDK:459823\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,11593162 (contact),"HANSON, ROBERT  (contact)",NA,NA,NA,Arizona;Biolectric Impedance;Body Composition;Calories;Clinical Research;Collaborations;Community Health;Cross-Sectional Studies;Data;Diabetes Mellitus;Diet;Disease;DNA Methylation;doubly-labeled water;Eligibility Determination;Energy Metabolism;Enrollment;Environment;environmental change;epidemiology study;epigenetic marker;Ethnography;experience;Fatty acid glycerol esters;Fiber;Frequencies;Genetic;Genetic Polymorphism;genetic variant;Glycosylated hemoglobin A;Goals;health belief;Height;High Prevalence;Immune System Diseases;Indirect Calorimetry;Individual;Insulin-Dependent Diabetes Mellitus;Life Style;Low Prevalence;Measurement;Measures;men;Methods;Mexican;Mexico;Modernization;National Institute of Diabetes and Digestive and Kidney Diseases;Non-Insulin-Dependent Diabetes Mellitus;Obesity;obesity risk;oral glucose tolerance;Oral health;Other Genetics;Physical activity;Pima Indian;Population;Prevalence;Research Personnel;Rest;Societies;Surveys;Technology;total energy expenditure;United States;Universities;Variant;ventilation;waist circumference;Weight;Woman,Diabetes and Obesity in Mexican Pima Indians,75070,NA,NA,NA,NA,13,NA,NA,459823,NA
11188621,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075071,NA,NA,1ZIADK075071-13,NIDDK:459823\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,11593162 (contact),"HANSON, ROBERT  (contact)",NA,NA,NA,American Indians;Blood Glucose;Blood specimen;Chronic;Code;Collaborations;Complications of Diabetes Mellitus;Data;Development;Diabetes Mellitus;diabetes risk;diabetic;disorder risk;DNA Methylation;Environmental Risk Factor;Epidemiology;epidemiology study;Epigenetic Process;Family;follow-up;Frequencies;Gene Expression;Gene Expression Profile;Genes;Genetic;genetic epidemiology;Genetic Polymorphism;Genetic Transcription;genome-wide;genome-wide analysis;Genomic DNA;Genotype;Goals;Heritability;high risk;high risk population;histone modification;identity by descent;Individual;Insulin Resistance;Kidney Diseases;Longitudinal Studies;Measures;Metabolic Diseases;Metabolism;metabolomics;Modality;Molecular;Molecular Profiling;Muscle;Natural Selections;non-diabetic;Non-Insulin-Dependent Diabetes Mellitus;Obesity;Parents;Pathway interactions;Pattern;peripheral blood;Peripheral Nervous System Diseases;Phenotype;Process;protein expression;Proteins;recruit;Research Personnel;Retinal Diseases;Risk;Risk Factors;RNA;Sampling;Skeletal Muscle;Techniques;Texas;Transcript;transcriptomics;Universities;Variant,Molecular Profiling of Diabetes and its Complications,75071,NA,NA,NA,NA,13,NA,NA,459823,NA
11188622,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075073,NA,NA,1ZIADK075073-13,NIDDK:733021\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415529 (contact),"RANE, SUSHIL  (contact)",NA,NA,NA,Activins;Adult;Beta Cell;Biological Assay;Biology;Cell Physiology;Cells;clinically relevant;Complex;Diabetes Mellitus;diabetes pathogenesis;Dominant-Negative Mutation;established cell line;Exhibits;Functional disorder;Gene Expression;gene repression;Genes;Genetic Transcription;Glucose;glucose tolerance;Human;Hyperinsulinism;Hypoglycemia;improved;in vivo;Insulin;Insulin Receptor;insulin regulation;insulin secretion;islet;Islets of Langerhans;Knowledge;Morphogenesis;mouse model;Mus;Non-Insulin-Dependent Diabetes Mellitus;nonhuman primate;Pancreas;pancreas development;Pancreatic Diseases;Pathway Analysis;Pathway interactions;Play;promoter;Regulation;Repression;Role;Sampling;Signal Pathway;Signal Transduction;Small Interfering RNA;Transforming Growth Factor beta,Transforming Growth Factor Beta Superfamily Signaling in Pancreas Biology,75073,NA,NA,NA,NA,13,NA,NA,733021,NA
11188623,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075078,NA,NA,1ZIADK075078-13,NIDDK:459823\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,11593162 (contact),"HANSON, ROBERT  (contact)",NA,NA,NA,"adjudication;Adult;Age Years;aged;Aging;American Indian Population;Angiography;Anti-Hypertensive Agents;Blinded;Blood Vessels;Body mass index;Body Weight decreased;Cardiovascular Diseases;cardiovascular risk factor;Cardiovascular system;Cause of Death;Cells;Cessation of life;Clinic;Clinical;clinical center;Clinical Research;Clinical Trials;Compensation;Complex;Complications of Diabetes Mellitus;Coronary;Coronary heart disease;Data Collection;design;Development;Diabetes Mellitus;diabetes prevention program;Disease remission;Education;Electrocardiogram;Energy Intake;Enrollment;Environment;epidemiology study;Event;Expectancy;Eye;follow-up;Follow-Up Studies;frailty;gene environment interaction;gene interaction;Genes;genetic architecture;genome wide association study;Genotype;Glucose;Goals;group intervention;hazard;Health;Health Care Costs;heart disorder diagnosis;Heart failure;Heterogeneity;high risk;Hospitalization;Incidence;Insulin;Insulin Resistance;insulin secretion;interest;Intervention;intervention effect;intervention program;Intervention Studies;Kidney;life span;Life Style;Life Style Modification;lifestyle intervention;Long-Term Effects;Longterm Follow-up;macrovascular disease;Malignant Neoplasms;Measures;Mediating;Metformin;Microvascular Dysfunction;Modeling;mortality;mortality risk;Multi-Institutional Clinical Trial;Myocardial Infarction;Native Americans;Non-Insulin-Dependent Diabetes Mellitus;Obesity;Outcome;Outcome Study;Overweight;Participant;Pattern;Peripheral;Persons;Phase;Physical activity;Placebos;prevent;Prevention;primary outcome;Primary Prevention;programs;Quality of life;Randomized;randomized, clinical trials;Recording of previous events;recruit;Reporting;Research;response;revascularization;Risk;Risk Factors;Role;secondary analysis;secondary outcome;Stroke;Subgroup;success;Techniques;tertiary prevention;Testing;therapy design;Time;trait;Treadmill Tests;treatment effect;treatment program;Unstable angina;volunteer;Work",Primary and Tertiary Prevention of type 2 diabetes,75078,NA,NA,NA,NA,13,NA,NA,459823,NA
11188624,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075083,NA,NA,1ZIADK075083-12,NIDDK:6769984\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,11992030 (contact),"GHARIB, AHMED  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Affect;Anti-Inflammatory Agents;Arterial Fatty Streak;Atherosclerosis;Blood Vessels;Body mass index;burden of illness;Cardiac;Choline;Controlled Environment;Coronary;Coronary Arteriosclerosis;Coronary artery;Coronary Vessel Anomalies;Coronary Vessels;Cushing Syndrome;detection method;Development;Disease;Early Diagnosis;experience;Fatty acid glycerol esters;glucose metabolism;Glycogen;Heart;HIV;HIV/AIDS;Human;Image;imaging modality;improved;Ionizing radiation;lipid metabolism;Lipids;Liver;Liver Fibrosis;Liver Glycogen;magnetic field;Magnetic Resonance Imaging;Magnetic Resonance Spectroscopy;Measurement;Measures;Metabolic;Methods;millisecond;Monitor;Morphology;Motion;Muscle;Noise;non-invasive imaging;Pancreas;Patients;Phase;Protons;Publications;Recovery;Resolution;response;Signal Transduction;Spectrum Analysis;Subcutaneous Tissue;Techniques;Thick;Time;Visualization,Advanced Non Invasive Vascular Imaging Methods,75083,NA,NA,NA,NA,12,NA,NA,6769984,NA
11188625,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075085,NA,NA,1ZIADK075085-12,NIDDK:127112\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,10272309 (contact),"AGARWAL, SUNITA  (contact)",NA,NA,NA,Adrenal Gland Neoplasms;Affect;Angiofibroma;Anterior Pituitary Gland;Apoptosis;Apoptotic;ATRX gene;autosome;Beta Cell;Binding Proteins;Biological;Biological Markers;Blood;Carcinoid Tumor;CBLB gene;Cell Cycle Progression;Cell Differentiation process;Cell Line;Cell Nucleus;Cell Proliferation;cell transformation;cell type;Cells;Central Nervous System Neoplasms;ChIP-seq;clinically relevant;Collagen nevus of skin;Data;DAXX gene;Defect;design;Diabetes Mellitus;Disease of parathyroid glands;effective therapy;Embryo;Embryonic Development;embryonic stem cell;Endocrine;Endocrine Gland Neoplasms;Ependymoma;Epigenetic Process;Esophageal Neoplasms;Event;Face;Gene Expression;Gene Expression Profile;Gene Mutation;Genes;Genetic;Germ-Line Mutation;glycogen synthase kinase 3 beta;glycogen synthase kinase 3 beta inhibitor;Goals;Hematopoietic stem cells;Heterozygote;Human;Impairment;Inherited;inhibitor;inhibitor therapy;insulinoma;interest;Intestinal Neuroendocrine Neoplasm;Investigation;Islet Cell Tumor;Islets of Langerhans;Leiomyoma;Life;Link;Lipoma;Lithium Chloride;Mediating;Menin;meningioma;Molecular;Molecular Profiling;morphogens;mortality;mouse model;Multiple Endocrine Neoplasia Type 1;Mus;mutant;Mutation;Nature;neonatal diabetes mellitus;Neuroendocrine Cell;neuroendocrine differentiation;Neuroendocrine Tumors;Nuclear RNA;Oncogenic;Pancreas;pancreatic neoplasm;Parathyroid Adenoma;Parathyroid gland;Parathyroid Neoplasms;Pathogenesis;Pathway interactions;Patients;Phosphorylation;Phosphotransferases;Polyamines;posttranscriptional;Primitive foregut structure;protein expression;Protein Isoforms;Proteins;proteomic signature;Proto-Oncogene Protein c-met;rare variant;receptor;Recurrence;Regulation;RNA-Binding Proteins;Role;skin lesion;Small Intestines;Smooth Muscle Tumor;Specific qualifier value;Specificity;Stomach;Syndrome;synthetic peptide;telomere;Therapeutic;therapeutic target;Thymoma;Thymus Carcinoid Tumor;Thymus Gland;Thymus Neoplasms;Tissue Differentiation;Tissues;transcription factor;transcriptome sequencing;transcriptomics;tumor;tumor progression;tumorigenesis;Up-Regulation;Uterine Fibroids,Role of tissue differentiation factors in endocrine tumorigenesis,75085,NA,NA,NA,NA,12,NA,NA,127112,NA
11188626,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075087,NA,NA,1ZIADK075087-12,NIDDK:505592\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,8929927 (contact),"KRASHES, MICHAEL J. (contact)",NA,NA,NA,Acute;Agonist;Amygdaloid structure;Anatomy;Animals;Behavioral;Binding;Body Weight;cell type;Chronic;Complex;Data;Dependovirus;design;designer receptors exclusively activated by designer drugs;Eating;Enterobacteria phage P1 Cre recombinase;experimental study;falls;feeding;Feeding behaviors;Feeling;Future;G-Protein-Coupled Receptors;Grant;Hormones;Hypothalamic structure;Immunohistochemistry;in vivo;Injections;Ion Channel;Ion Pumps;Knock-out;Knockout Mice;Label;Laboratories;Lateral;Ligands;Light;LoxP-flanked allele;Maps;Medial;Mediating;Melanocortin 4 Receptor;melanocyte;midbrain central gray substance;Modality;Mus;neural;neural circuit;neural network;neuronal cell body;Neurons;Nose;Nucleus Accumbens;Nucleus solitarius;Obesity;optical imaging;optogenetics;Output;parabrachial nucleus;Pharmacogenetics;pharmacologic;Physiological;Population;preference;Pro-Opiomelanocortin;promoter;Protocols documentation;receptor;Receptor Gene;Regulation;Reporter;restoration;Role;Satiation;Self Stimulation;Signal Transduction;Site;Structure of nucleus infundibularis hypothalami;Structure of terminal stria nuclei of preoptic region;Synaptophysin;Thalamic structure;Tracer;Transgenic Organisms;Virus,Probing neural circuits underlying satiety,75087,NA,NA,NA,NA,12,NA,NA,505592,NA
11188627,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075088,NA,NA,1ZIADK075088-12,NIDDK:505592\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,8929927 (contact),"KRASHES, MICHAEL J. (contact)",NA,NA,NA,Acute;Animals;Behavior;behavior change;Bilateral;Binge Eating;Biological Assay;Body Weight;Body Weight decreased;Chronic;comparison control;Consumption;designer receptors exclusively activated by designer drugs;Eating;Eating Behavior;Ensure;Equipment;experimental study;Fatty acid glycerol esters;feeding;Feeding behaviors;Food;Food Access;food consumption;Future;Hour;Hunger;Hyperphagia;Hypothalamic structure;in vivo;Measures;Mediating;Monitor;Motor Activity;Mus;neural;Neurons;Nose;Obese Mice;optogenetics;Oxygen Consumption;Pharmacogenetics;Population;Property;Protocols documentation;Psychological reinforcement;Reagent;reduced food intake;Reporting;Role;Satiation;Signal Pathway;Thinness;Time;tool;Transgenic Organisms;Viral;Weight Gain;willingness;Work,Investigating addictive/compulsive feeding behavior,75088,NA,NA,NA,NA,12,NA,NA,505592,NA
11188628,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075089,NA,NA,1ZIADK075089-12,NIDDK:505592\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,8929927 (contact),"KRASHES, MICHAEL J. (contact)",NA,NA,NA,Acute;Agonist;antagonist;Antibodies;Area;Attention;Attenuated;Behavior;Biological Assay;Body Weight;cell type;conditioned place preference;design;Diffuse;Dorsal;Drosophila genus;Eating;Equipment;experimental study;feeding;Feeding behaviors;Food;Frequencies;Hippocampus;Homeostasis;Hypothalamic structure;Immunohistochemistry;In Vitro;in vivo;Injections;Length;Leptin;leptin receptor;Love;Measurement;Melanocortin 4 Receptor;Memory;memory process;Mus;neural circuit;Neurons;Obsession;optogenetics;Output;Paper;Pattern;pharmacologic;Positioning Attribute;promoter;Protocols documentation;Publishing;Rabies virus;receptor;receptor expression;reduced food intake;Retrieval;Rodent;Role;Satiation;Signal Transduction;Slice;STAT3 gene;Synapsins;Testing;tool;Viral;Virus,Unraveling hippocampal networks related to food memories,75089,NA,NA,NA,NA,12,NA,NA,505592,NA
11188629,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075090,NA,NA,1ZIADK075090-12,NIDDK:505592\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,8929927 (contact),"KRASHES, MICHAEL J. (contact)",NA,NA,NA,adeno-associated viral vector;Age;Amygdaloid structure;Animals;Anxiety;Appetite Regulation;Area;Attention;Auditory;Behavior;Behavioral;Behavioral Paradigm;Brain;Code;Complex;Computer software;Consumption;Costs and Benefits;Cues;Dangerousness;Desire for food;Disease;driving behavior;Eating;Environment;experimental study;Fasting;feeding;Feeding behaviors;fighting;Food;Fright;Hunger;Laboratories;Libraries;Link;Literature;male;Measures;Mediating;Monitor;Motivation;motivational processes;Mus;Nature;neural circuit;Neurons;Obesity;optogenetics;Output;Pharmacogenetics;Physiological;Play;Population;preference;Process;programs;Risk Assessment;Risk Taking;Rodent;Role;Satiation;Signal Transduction;Source;Synaptophysin;System;Testing;tool;Urine;Visual,Investigating the interaction of motivational systems,75090,NA,NA,NA,NA,12,NA,NA,505592,NA
11188630,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075091,NA,NA,1ZIADK075091-12,NIDDK:189847\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415045 (contact),"PERIWAL, VIPUL  (contact)",NA,NA,NA,2019-nCoV;Accounting;Amino Acid Sequence;Amino Acids;antiretroviral therapy;Biological;Capsid;Chronology;combinatorial;Complex;computing resources;Coupling;Data;Data Collection;Data Set;Data Storage and Retrieval;Development;Disease Outbreaks;Drug resistance;Entropy;env Glycoproteins;Equilibrium;Evolution;expectation;Face;Family;fitness;Future;Genetic Anticipation;Genetic Epistasis;genome-wide analysis;Growth;heuristics;HIV;HIV-1 drug resistance;Homologous Protein;Immune system;improved;Individual;Infection;Information Sciences;insight;Integrase;large datasets;large scale data;Lead;lens;macromolecule;Methodology;Methods;Modeling;Mutate;Mutation;Names;neutralizing antibody;novel;pathogen;Pathway interactions;Pattern;Peptide Hydrolases;Persons;Pharmaceutical Preparations;Pharmacotherapy;Phylogenetic Analysis;Population;Positioning Attribute;pressure;Probability;protein function;protein structure;protein structure prediction;Proteins;Publications;Regimen;resistance mutation;Rest;Retrotransposon;RNA-Directed DNA Polymerase;Role;Route;SARS-CoV-2 genome;Science;Sequence Alignment;Sequence Analysis;success;System;Techniques;Technology;Therapeutic;therapeutic target;tool;Treatment Protocols;Viral;viral fitness;Viral Genome;Viral Proteins;Virus;Work,Pattern Identification in Sequence Activity Data,75091,NA,NA,NA,NA,12,NA,NA,189847,NA
11188632,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075104,NA,NA,1ZIADK075104-12,NIDDK:1027263\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,12029799 (contact),"BEST, ROBERT  (contact)",NA,NA,NA,2019-nCoV;Accounting;Address;Affinity;Amyloid;Amyloid Fibrils;Area;Cell Nucleus;Cells;Charge;Collaborations;Collagen;Collagen Fiber;Complex;Coupling;Cytoplasmic Granules;Data;Data Set;Dependence;design;Development;Disease;doctoral student;Evolution;Exclusion;experimental study;Extracellular Matrix;Fluorescence Resonance Energy Transfer;Friction;Goals;Grain;improved;interest;Investigation;Ions;Length;Liquid substance;Measurement;Measures;member;Membrane;Membrane Proteins;Methodology;Methods;Modeling;models and simulation;Molecular;Molecular Conformation;molecular dynamics;Molecular Structure;Neutrons;non-Native;novel;Nuclear Proteins;Nucleic Acids;Organelles;Osmotic Pressure;Pathway interactions;Peptide Hydrolases;Peptides;Phase;Physical condensation;Procedures;Property;protein aggregation;protein complex;Protein Dynamics;protein folding;protein function;protein misfolding;Proteins;protonation;Regulation;Resolution;Roentgen Rays;Running;Scanning;Set protein;Signal Transduction;simulation;single-molecule FRET;Site;Sodium Chloride;Structure;System;Temperature;theories;Universities;Work,"Understanding protein folding, evolution and function via molecular simulation",75104,NA,NA,NA,NA,12,NA,NA,1027263,NA
11188633,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075105,NA,NA,1ZIADK075105-11,NIDDK:152422\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,14269697 (contact),"CHUNG, STEPHANIE THERESE (contact)",NA,NA,NA,Adipose tissue;African;African American;African American population;African American Women;African ancestry;African Women;Age;Biological;black women;Blood Glucose;Body fat;Body mass index;cardiometabolic risk;Circulation;Clinical Endocrinology;Complex;Contractor;design;Detection;detection sensitivity;Development;Diabetes Mellitus;diabetes risk;Diet;Dietary Assessment;Disease;Eligibility Determination;Employee;Endocrinology;Energy Metabolism;epidemiology study;ethnic difference;Ethnic Origin;Evaluation;Fasting;fasting glucose;Fatty acid glycerol esters;fatty acid metabolism;Fatty Acids;genetic analysis;genetic variant;Gluconeogenesis;Glucose;glucose metabolism;glucose production;glycogenolysis;health care availability;Heart Diseases;Hepatic;Hyperglycemia;insight;Insulin;Insulin Resistance;Journals;Life Style;lipid metabolism;lipidomics;Liver;Low Prevalence;low socioeconomic status;Manuscripts;Measures;Metabolism;metabolomics;Non-Insulin-Dependent Diabetes Mellitus;novel;Nutritional;Pathway interactions;Peer Review;Physical activity;Physiological;Population;precision nutrition;Prediabetes syndrome;Premenopause;Preparation;Protocols documentation;Psychosocial Factor;Publishing;Race;racial difference;Research;Resources;Risk Factors;screening;Screening procedure;secondary analysis;Testing;Tissues;Triglycerides;Variant;White Women;Woman;Women&apos;s study,"Nested Study: Identifying Risk for Diabetes and Heart Disease in Women: A Study of African-American, African and White Federal Employees and Contractors",75105,NA,NA,NA,NA,11,NA,NA,152422,NA
11188634,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075107,NA,NA,1ZIADK075107-11,NIDDK:582825\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,8316036 (contact),"HALL, KEVIN  (contact)",NA,NA,NA,Adult;Affect;antagonist;Body fat;Body mass index;Brain;Brain region;Clinical Research;Complex;Corpus striatum structure;Data;dietary;Dopamine D2 Receptor;Eating;Eating Behavior;Fasting;Food;Habits;high body mass index;Hour;Human;Individual;Mathematics;Measures;Methodology;Nature;neural;neural circuit;neural correlate;neuroimaging;Neurosciences;Obesity;Perception;Physiological;Positron-Emission Tomography;radioligand;receptor binding;Reporting;Research;research study;response;reward processing;Signal Transduction;Standardization;Stimulus;Techniques;Time,Neuroscience of human food perception and eating behavior,75107,NA,NA,NA,NA,11,NA,NA,582825,NA
11188635,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075111,NA,NA,1ZIADK075111-10,NIDDK:2043787\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,14269701 (contact),"HAASE, ASTRID  (contact)",NA,NA,NA,Adult;Age;age-related disease;Animals;Autoimmune Diseases;Biochemistry;Biogenesis;Biology;Biotechnology;Cancer Biology;Cells;chromatin modification;Complex;Conflict (Psychology);Development;Discrimination;Disease;Drosophila genus;Ensure;Epigenetic Process;Event;experimental study;Fertility;fly;Foundations;Gene Expression;Genes;Genetic;genetic element;genetic makeup;Genetic Transcription;Genome;genome integrity;Genome Stability;genomic locus;Genomics;Germ Cells;Germ Lines;Goals;Human;Immune system;innovation;Insecta;insight;Length;Maintenance;Mediating;meetings;Molecular;Mus;Mutagenesis;next generation sequencing;novel;Parasites;Pathway interactions;piRNA;Play;Positioning Attribute;posttranscriptional;preference;Proteins;Repression;restraint;RNA;RNA Decay;RNA Interference;Role;Secure;Small RNA;Somatic Cell;Specificity;Surveys;System;targeted treatment;Time;Toxic effect;Transcript;Untranslated RNA;Uridine;Virus;Yeasts,PIWI proteins and PIWI-interacting small RNAs guard the genomic integrity of germ cells,75111,NA,NA,NA,NA,10,NA,NA,2043787,NA
11188636,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075112,NA,NA,1ZIADK075112-10,NIDDK:424049\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,14269703 (contact),"CYPESS, AARON  (contact)",NA,NA,NA,Acute;Adipocytes;Adipose tissue;Adult;Anatomy;Atlases;Biological Markers;Biological Models;Biopsy;Brown Fat;Cell Physiology;Cell surface;Cells;Chad;Collaborations;Communities;COVID-19;COVID-19 susceptibility;Data;Development;Energy Metabolism;Fatty acid glycerol esters;FGF21 gene;fibroblast growth factor 21;Gene Expression;Gene Expression Profiling;Gene Targeting;Genetic;genetic signature;Genetic Transcription;Growth;Heterogeneity;HIV;Human;Human Cell Line;immunodeficiency;improved;In Vitro;in vitro Model;in vivo;insulin sensitivity;Intervention;IRF4 gene;lipid biosynthesis;Lipodystrophy;Maps;medical schools;Metabolic;Metabolism;MicroRNAs;Molecular;Neck;novel;Nude Mice;Oncology;Organ;Patients;PET/CT scan;Physiological;Physiology;Plasma;Positron-Emission Tomography;Process;programs;Reporting;Risk;Rodent;Role;stem cell model;Structure;Testing;Tissues;Transplantation;ultrasound;United States National Institutes of Health;Wood material,"The Molecular, Cellular, and Genetic characterization of Human Adipose Tissue and its Role in Metabolism",75112,NA,NA,NA,NA,10,NA,NA,424049,NA
11188637,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075113,NA,NA,1ZIADK075113-10,NIDDK:1544779\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,14269705 (contact),"CHUNG, HOI SUNG  (contact)",NA,NA,NA,abeta accumulation;aggregation pathway;Alexa594;Alzheimer&apos;s Disease;American;Amyloid Fibrils;Binding;Binding Proteins;cell growth regulation;Chemicals;Collaborations;Color;Complex;Data;Data Analyses;Development;Diffusion;Disease;Event;experimental analysis;experimental study;fluorescence imaging;fluorescence lifetime imaging;Fluorescence Resonance Energy Transfer;fluorophore;Genetic Polymorphism;Genetic Transcription;Goals;Heterogeneity;Image Analysis;imaging modality;Individual;Journals;Label;Malignant Neoplasms;Methods;Microscopic;Molecular;Molecular Conformation;Monitor;Parkinson Disease;Pathology;Pathway interactions;Pattern;Peptides;Phase;Physical Chemistry;Process;protein aggregation;protein folding;Protein Isoforms;protein misfolding;Proteins;Publications;Publishing;Resolution;Role;Signal Transduction;single molecule;single-molecule FRET;Societies;Statistical Data Interpretation;stoichiometry;Structure;Time;tool;Variant;Work,Single molecule studies of protein binding and aggregation,75113,NA,NA,NA,NA,10,NA,NA,1544779,NA
11188638,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075114,NA,NA,1ZIADK075114-10,NIDDK:59745\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9827998 (contact),"BAIER, LESLIE J (contact)",NA,NA,NA,Affect;Age;American Indians;bead chip;Beta Cell;Biological;Blood;Blood specimen;Cardiovascular Diseases;Cell Physiology;Cell Proliferation;Child;cohort;CYP1A1 gene;Cytosine;Data Set;Development;Diabetes Mellitus;diabetes risk;diabetic;Disease;DNA;DNA Methylation;Embryonic Development;Environment;Epigenetic Process;epigenetic regulation;epigenome-wide association studies;Ethnic Population;Exposure to;Fatty acid glycerol esters;Fetal Development;Fetal health;Future;Gene Expression Regulation;Genes;Genetic Enhancer Element;genome-wide;genome-wide analysis;Genomics;gestational weight gain;glucose tolerance;Guanine;hazard;Health;high risk;Hypermethylation;Impairment;in utero;Individual;Infant;Inflammation;inorganic phosphate;Insulin;insulin secretion;Intercistronic Region;Leukocytes;Life;logarithm;Longitudinal Studies;Maps;maternal diabetes;Maternal Health;maternal obesity;Measures;Metabolic;Metabolic Diseases;Methylation;methylation pattern;Modification;Mothers;Native Americans;Non-Insulin-Dependent Diabetes Mellitus;novel;Obesity;offspring;Outcome;Pathway interactions;peripheral blood;Pima Indian;Placenta;Population;Pregnancy;Pregnancy Complications;Reporting;Risk;Role;RRAS2 gene;Sampling;Siblings;Signal Transduction;Site;Source;STC1 gene;Testing;text searching;Time;Tissues;transmission process;Weight;Weight Gain,Epigenetic modifications associated with intrauterine exposure to maternal type 2 diabetes.,75114,NA,NA,NA,NA,10,NA,NA,59745,NA
11188639,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075115,NA,NA,1ZIADK075115-10,NIDDK:282700\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,14269703 (contact),"CYPESS, AARON  (contact)",NA,NA,NA,Ablation;Acids;Address;adipocyte differentiation;Adipocytes;Adipose tissue;Adrenergic Agents;Adrenergic Agonists;Adrenergic Receptor;Agonist;Anabolism;Anatomy;Arachidonate 12-Lipoxygenase;Bile Acids;Biochemistry;Bioinformatics;Blood Pressure;Body fat;Body measure procedure;Boston;Brown Fat;C57BL/6 Mouse;Cardiovascular system;Cell Line;Cells;Clinical;Clinical Trials;Collaborations;Collection;Corticotropin;COVID-19;Cyclic AMP;Data;Diabetes Mellitus;Diet;diet-induced obesity;Dose;Ephedrine;Experimental Models;Failure;Fatty acid glycerol esters;fatty acid metabolism;Gene Expression;Gene Expression Profile;Gene Expression Profiling;Gene Targeting;Generations;Genes;genetic signature;glucose metabolism;glucose tolerance;glucose uptake;Health;Heart Rate;Heterogeneity;High Fat Diet;Human;Human Cell Line;Human Cloning;immunodeficiency;impaired glucose tolerance;Impairment;improved;In Vitro;in vitro Model;in vivo;Inflammation;inflammatory marker;Insulin;Insulin Resistance;insulin signaling;Leukocytes;Ligand Binding;Ligands;lipidomics;Lipolysis;Maps;Mass Spectrum Analysis;Mediating;medical schools;member;Messenger RNA;Metabolic;Metabolic Diseases;Mitochondria;Modeling;mRNA Expression;Mus;Neck;Norepinephrine;novel;Nude Mice;obese patients;Obesity;Oxygen Consumption;Patients;pharmacologic;Pharmacological Treatment;Phosphorylation;Physiology;Population;Postdoctoral Fellow;Process;receptor expression;Respiration;response;Risk;Rodent;Role;Sampling;Signal Pathway;Skeletal Muscle;Sympathomimetics;Testing;Thermogenesis;Time;Tissue Differentiation;Tissues;TNF gene;Transplantation,Mechanisms Underlying Adipose Tissue Thermogenesis,75115,NA,NA,NA,NA,10,NA,NA,282700,NA
11188640,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075116,NA,NA,1ZIADK075116-10,NIDDK:706749\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,14269703 (contact),"CYPESS, AARON  (contact)",NA,NA,NA,Acute;adiponectin;Adipose tissue;Adrenergic Agonists;Adrenergic Receptor;Adult;Adverse effects;Advisory Committees;Anti-diabetic Drugs;Anti-Inflammatory Agents;Antioxidants;Atlases;Axilla;Basal metabolic rate;bile acid metabolism;Bile Acids;Binding;Biological Markers;Bladder;Blood;Body Composition;Body mass index;Body Weight;Brown Fat;Cardiovascular system;Catecholamines;Cervical;Chronic;Clinical;Clinical Trials;clinically relevant;Collaborations;COVID-19 treatment;Development;Diabetes Mellitus;Diastolic blood pressure;Dose;Effectiveness;effectiveness study;Energy Metabolism;experience;Fatty acid glycerol esters;Fatty Acids;FDA approved;fluorodeoxyglucose;fluorodeoxyglucose positron emission tomography;Future;Gallbladder;Glucose;High Density Lipoproteins;Hormones;Hour;Human;improved;Individual;Inflammation;Insulin;insulin secretion;insulin sensitivity;interest;intravenous glucose tolerance test;Investigation;Label;Lipolysis;Lipoproteins;male;Measures;Mediastinal;meetings;men;Metabolic;Metabolic Diseases;Metabolism;metabolomics;Methods;microbiome;Obesity;Oral;Overactive Bladder;Paper;Patients;Pharmaceutical Preparations;pharmacologic;Phase;Physiological;Physiology;Pilot Projects;Placebos;Plasma;Polycystic Ovary Syndrome;Positron-Emission Tomography;primary endpoint;Publishing;Regional Anatomy;Relaxation;Reporting;Reproductive Health;Resistance;Resolution;response;Risk;Rodent;Series;Supraclavicular;Thermogenesis;Thinness;Thioctic Acid;Tissues;uptake;Woman;X-Ray Computed Tomography;young man,Physiological Responses to Activation of Human Brown Adipose Tissue,75116,NA,NA,NA,NA,10,NA,NA,706749,NA
11188641,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075122,NA,NA,1ZIADK075122-09,NIDDK:677398\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,14759023 (contact),"NIEMAN, LYNNETTE  (contact)",NA,NA,NA,Admission activity;Adrenal Gland Hyperfunction;Adrenal Glands;Adrenal Mass;Adrenalectomy;Adrenergic Receptor;Algorithms;Bilateral;Biochemical;Blood Pressure;Case Study;Catecholamines;Corticotropin;Corticotropin-Releasing Hormone;Cushing Syndrome;Cushingoid habitus;Desmopressin;Dexamethasone;dexamethasone suppression test;Diagnosis;Diagnostic;diagnostic accuracy;diagnostic tool;Differential Diagnosis;Dose;Doxazosin;Etiology;Excision;Histopathology;Hydrocortisone;hypertensive;Immunohistochemistry;improved;Magnetic Resonance Imaging;Measures;Metanephrine;Morbidity - disease rate;Nodule;older women;Pathology;Patients;Performance;Periodicity;Peripheral;Petrosal Sinus Sampling;Pheochromocytoma;Physiological;Pituitary Gland;Pituitary Gland Adenoma;Pituitary-dependent Cushing&apos;s disease;Plasma;Positron-Emission Tomography;Postoperative Period;Predictive Value;Publishing;Quality of life;Radioisotopes;Recording of previous events;Recovery;Reporting;Research Personnel;response;Scanning;Serum;Specificity;Techniques;Test Result;Testing;tool;tumor;X-Ray Computed Tomography,The differential diagnosis and treatment of Cushing's syndrome,75122,NA,NA,NA,NA,9,NA,NA,677398,NA
11188642,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075132,NA,NA,1ZIADK075132-09,NIDDK:1887012\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,14759031 (contact),"GUYDOSH, NICHOLAS  (contact)",NA,NA,NA,5&apos; Untranslated Regions;Address;Affect;Aging;Anticodon;Apoptosis;Apoptotic;Biochemistry;Biological Assay;Biological Process;C-terminal;Cell Nucleus;Cells;Code;Codon Nucleotides;Collaborations;Communicable Diseases;computerized tools;Data;Development;endonuclease;Ensure;environmental change;Event;Fluorescence;Fluorescence Microscopy;Frequencies;gamma-Glutamyl Hydrolase;Gene Expression;Gene Expression Regulation;Genes;Genetic Code;Genetic Transcription;Goals;Guanine + Cytosine Composition;Health;Human;Image;Infection;Innate Immune Response;interest;Isoleucine;Kinetics;Length;Malignant Neoplasms;Measures;Messenger RNA;Molecular;mRNA Decay;mRNA Transcript Degradation;mRNA Translation;new therapeutic target;nitrogen metabolism;Nonsense Codon;Nonsense-Mediated Decay;novel;Nutrient;Open Reading Frames;Oxidative Stress;Pancreatic ribonuclease;Pathway interactions;Phenotype;Phosphotransferases;Play;premature;prevent;Process;programs;Proline;promoter;Protein Array;Protein Isoforms;Proteins;Quality Control;recruit;Recycling;release factor;Reporter Genes;Research;Residual state;Respiratory syncytial virus;Respiratory Syncytial Virus Infections;response;Ribonucleases;Ribosomal Proteins;Ribosomal RNA;ribosome profiling;Ribosomes;RNA;RNA Degradation;Role;sensor;Signal Pathway;single molecule;Stress;Techniques;Terminator Codon;Testing;Time;Transcript;transcriptome;transcriptome sequencing;Transfection;Transfer RNA;Translating;Translation Initiation;Translation Process;translational genetics;Translational Regulation;Translations;Ubiquitin;Universities;Viral;viral RNA;Virus;Virus Diseases;Work;Yeasts,Molecular mechanism of the ribosome and functions of translational regulation,75132,NA,NA,NA,NA,9,NA,NA,1887012,NA
11188643,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075133,NA,NA,1ZIADK075133-09,NIDDK:914529\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,14269697 (contact),"CHUNG, STEPHANIE THERESE (contact)",NA,NA,NA,Address;Adolescent;Adult;Affect;African American;African American population;African ancestry;Age;aged;American;Anti-diabetic Drugs;Beta Cell;Cell Physiology;Cells;Child;Childhood;Combined Modality Therapy;Complication;Data;Data Analyses;design;Diabetes Mellitus;Diagnosis;Disease;Disparity;Drug Kinetics;Early treatment;eligible participant;Enrollment;Extrahepatic;Fatty Acids;follow-up;Gene Frequency;Genes;Genetic;Genetic Polymorphism;glucagon-like peptide 1;Gluconeogenesis;Glucose;glucose production;glucose tolerance;Glycosylated hemoglobin A;Goals;gut bacteria;health disparity;Hepatic;Hepatocyte;Heritability;high risk;Hormones;improved;improved outcome;Individual;Inpatients;Insulin;insulin secretion;insulin sensitivity;International;Intervention;Intervention Trial;Intestines;Light;Lipolysis;liraglutide;Liver;Manuscripts;Medical History;medication compliance;meetings;Metabolic;Metformin;Minor;minority children;Modeling;Monitor;Morbid Obesity;Non-Insulin-Dependent Diabetes Mellitus;novel;novel therapeutics;Oral;Outcome;Outpatients;Palmitates;Participant;Pathologic;Pathway interactions;Patients;Pharmaceutical Preparations;Physical Examination;Pilot Projects;Population;Precision Medicine Initiative;Prediabetes syndrome;Predictive Factor;Preparation;primary outcome;proctolin;Public Health;Publishing;Randomized;randomized trial;recruit;Regimen;Research;Research Design;Role;Running;screening;Single Nucleotide Polymorphism;Societies;solute;Testing;Therapeutic;therapeutic target;Time;treatment arm;Treatment Failure;Visit;Work;Youth,Therapeutic targets in African-American youth with type 2 diabetes,75133,NA,NA,NA,NA,9,NA,NA,914529,NA
11188644,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075135,NA,NA,1ZIADK075135-09,NIDDK:1034506\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,1950565 (contact),"APPELLA, DANIEL H (contact)",NA,NA,NA,Acetyl Coenzyme A;Acquired Immunodeficiency Syndrome;Biological Testing;chemical synthesis;Clinical;Collaborations;Death Rate;Drug Kinetics;Drug resistance;FDA approved;Female;Formulation;Generations;HIV;HIV Infections;HIV resistance;HIV-1;Human;in vivo;Injectable;Lead;Lysine;male;Metabolism;microbicide;Molecular;Peripheral Blood Mononuclear Cell;Pharmaceutical Preparations;Positioning Attribute;preclinical toxicity;prevent;Process;Prodrugs;Proteins;Resistance development;resistant strain;scaffold;Toxic effect;transacylation;Translating;transmission process;Vaccines;Variant;Viral;Viral Physiology;Virus;Virus Replication;Work,Small Molecular Inactivators of HIV,75135,NA,NA,NA,NA,9,NA,NA,1034506,NA
11188645,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075136,NA,NA,1ZIADK075136-09,NIDDK:2627652\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,14759036 (contact),"ZHANG, JINWEI  (contact)",NA,NA,NA,Adopted;Amino Acids;Amino Acyl-tRNA Synthetases;Aminoacylation;Antibiotics;Anticodon;Architecture;Bacteria;Bacterial Infections;Binding;Binding Proteins;Biogenesis;Biological Assay;Biological Models;biophysical analysis;Cell Physiology;Cellular Stress;Collaborations;Communication;Complex;dark matter;Data;Development;Dinucleoside Phosphates;Elbow;Elements;Enzymes;Family;flexibility;Fluorescence;Gene Expression;Gene Expression Regulation;Genes;Genetic Transcription;Genome;Gram-Positive Bacteria;Homeostasis;Human;human pathogen;Immunity;In Vitro;insight;Isomerism;Life;Location;Maintenance;MALAT1 gene;Malignant Neoplasms;Metabolic;Metabolic Diseases;Metabolism;mimicry;Modeling;Molecular;Molecular Biology;Molecular Conformation;Mutation Analysis;National Institute of Diabetes and Digestive and Kidney Diseases;Nature;novel;Nucleic Acids;Nutritional;Oligonucleotides;Oligosaccharides;Plant Viruses;Play;prevent;protein folding;Proteins;Publishing;recruit;Research;Resolution;response;Retroviridae;RNA;RNA Binding;RNA-targeting therapy;RNase P;single-molecule FRET;small molecule;Specificity;spleen exonuclease;Starvation;Stress;structural biology;structural determinants;Structure;sugar;System;targeted treatment;Thermodynamics;trafficking;transcription termination;Transfer RNA;Translation Initiation;Translations;triple helix;Untranslated RNA;Virus Diseases;Work;Yeasts,Noncoding RNA structures and interactions in cellular stress responses and immunity,75136,NA,NA,NA,NA,9,NA,NA,2627652,NA
11188646,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075137,NA,NA,1ZIADK075137-09,NIDDK:253513\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9693120 (contact),"SHERMAN, ARTHUR  (contact)",NA,NA,NA,Adolescence;Africa;African;Agreement;Apoptosis;bariatric surgery;base;Behavior;Beta Cell;Blood Glucose;blood glucose regulation;Caloric Restriction;Cell Physiology;Chronic;Clinical Research;Closure by clamp;Collaborations;Compensation;cost;cost effective;Data;design;Deterioration;Diabetes Mellitus;diabetes pathogenesis;diabetes risk;Diagnosis;Diagnostic;diagnostic criteria;Disease;disease model;Ethnic Population;Etiology;European;experience;Far East;fasting glucose;Feedback;Glucose;Glucose Clamp;glucose tolerance;Goals;Homeostasis;Hour;Human;Hyperglycemia;Hyperinsulinism;Immigrant;indexing;Individual;Infusion procedures;Insulin;Insulin Resistance;insulin secretion;insulin sensitivity;International;Intervention;intravenous glucose tolerance test;Investigation;mathematical model;Measures;Mediating;Modeling;National Institute of Diabetes and Digestive and Kidney Diseases;Non-Insulin-Dependent Diabetes Mellitus;Obesity;OGTT;Parameter Estimation;Participant;Pathogenesis;Pathway interactions;Persons;Physiology;Population;Prediabetes syndrome;Prevalence;prevent;Prevention;Process;Public Health;Publishing;Regulation;Reporting;Resistance;Resolution;response;Risk Factors;Rodent;Sampling;screening;Severities;Source;Standard Model;Structure of beta Cell of islet;Thinness;Time;Work,Modeling Pathogenesis of Type 2 Diabetes,75137,NA,NA,NA,NA,9,NA,NA,253513,NA
11188647,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075141,NA,NA,1ZIADK075141-08,NIDDK:988068\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,15195448 (contact),"BAX, ADRIAAN  (contact)",NA,NA,NA,abeta accumulation;Acceleration;Address;Alzheimer&apos;s Disease;Amyloid beta-Protein;Atmospheric Pressure;Back;Biological Models;C-terminal;Collaborations;computer studies;Data;Development;dimer;Disease;Dissociation;Equilibrium;Etiology;experimental study;Gills;Hydrostatic Pressure;insight;Isomerism;Kinetics;Maps;Measures;Methods;millisecond;Molecular Conformation;Monitor;monomer;mutant;Neurodegenerative Disorders;NMR Spectroscopy;novel;Parkinson Disease;Pathway interactions;Peptides;Physiological;polypeptide;Population;pressure;Process;Proline;protein folding;protein misfolding;Proteins;Relaxation;Solvents;Structure;Technology;Temperature;Theoretical Studies;Thermodynamics;Time;Ubiquitin;virtual;Work,Study of protein folding and misfolding by NMR spectroscopy,75141,NA,NA,NA,NA,8,NA,NA,988068,NA
11188648,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075143,NA,NA,1ZIADK075143-08,NIDDK:711485\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415299 (contact),"YE, YIHONG  (contact)",NA,NA,NA,2019-nCoV;3-Dimensional;ACE2;Actins;Affinity;alpha synuclein;Alternative Therapies;analog;Astrocytes;Binding;Biological Assay;Brain;breakthrough infection;candidate identification;Cell fusion;Cell membrane;Cell surface;Cell Surface Receptors;Cells;Charge;Chemicals;chemokine;Classification;Complement;Complex;COVID-19 pandemic;cytokine;cytotoxicity;Development;Disease;DNA Topoisomerases;dopaminergic neuron;dorsal motor nucleus;drug repurposing;Drug Targeting;Embryo;Endocytosis;Endoplasmic Reticulum;extracellular;Family;FDA approved;Fluorescence;Gene Expression Profile;Gene Expression Profiling;Glycosaminoglycans;Goals;Golgi Apparatus;graph neural network;Health;Heparan Sulfate Proteoglycan;Heparitin Sulfate;Human;In Vitro;Infection;Inflammatory;inhibitor;Integrins;knock-down;Label;late endosome;Lewy Bodies;Ligation;Lung;Lysosomes;Mammalian Cell;Maps;MAPT gene;Mediating;Membrane;Membrane Proteins;Metalloproteases;Methods;misfolded protein;Mitoxantrone;Modeling;Network-based;Neurodegenerative Disorders;Neuroglia;neuron loss;Neurons;neurotoxic;neurotransmission;new therapeutic target;Nucleosomes;olfactory bulb;Parkinson Disease;Pathologic;Pathology;Pathway interactions;Patients;Pattern;Peptide Signal Sequences;Pharmaceutical Preparations;Physiological;PIK3CG gene;polypeptide;pre-formed fibril;prion hypothesis;Process;protein aggregation;Protein Export Pathway;Protein Secretion;Proteins;Proteomics;proteotoxicity;Quality Control;receptor;recruit;Reporting;Research Project Grants;response;SARS-CoV-2 entry inhibitor;SARS-CoV-2 spike protein;sensor;severe COVID-19;Signal Transduction;Stereotyping;Subgroup;Surface;synuclein;System;tau aggregation;tau Proteins;Tauopathies;Tissues;Topoisomerase Inhibitors;Toxic effect;Training;transcriptome sequencing;transmission process;Transplantation;ubiquitin isopeptidase;Up-Regulation;uptake;Vaccines;Viral;viral entry inhibitor;virtual;Virus;Virus Diseases;Work,Unconventional protein secretion-mediated protein quality control in health and diseases,75143,NA,NA,NA,NA,8,NA,NA,711485,NA
11188649,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075145,NA,NA,1ZIADK075145-08,NIDDK:948647\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415299 (contact),"YE, YIHONG  (contact)",NA,NA,NA,Adult;Alzheimer&apos;s Disease;Attenuated;Autophagocytosis;Cell Differentiation process;Cell membrane;Cells;Chemicals;Co-Immunoprecipitations;Collection;COS-7 Cell;Coupled;Defect;Drosophila genus;Endoplasmic Reticulum;Endosomes;Eukaryotic Cell;Excision;exosome;Extracellular Space;extracellular vesicles;Failure;Family member;fly;Functional disorder;Goals;Heat shock proteins;Homeostasis;human disease;Inherited;inhibitor;knock-down;late endosome;Lead;Lipofuscin;Lysosomes;Mammalian Cell;Mediating;member;Membrane Fusion;Membrane Proteins;Methods;misfolded protein;Modeling;Molecular Chaperones;multicatalytic endopeptidase complex;mutant;Mutation;Nerve Degeneration;Neurodegenerative Disorders;Neuronal Ceroid-Lipofuscinosis;Neurons;neurotoxic;Nuclear;overexpression;Parkinson Disease;Pathway interactions;Patients;Physiological;polypeptide;Population;Process;Proliferating;protein degradation;Protein Family;protein folding;Protein Isoforms;protein misfolding;Protein Secretion;Protein translocation;Proteins;Proteomics;proteostasis;proteotoxicity;Quality Control;receptor;Reporting;Research Project Grants;Role;Route;secretion process;Serum;SNAP23 gene;Stains;Starvation;Stress;Surface;Synapses;synuclein;tau Proteins;transmission process;Triage;Ubiquitin;ubiquitin isopeptidase;Variant;Vesicle;Western Blotting,Roles of protein misfolding in neurodegenerative diseases,75145,NA,NA,NA,NA,8,NA,NA,948647,NA
11188650,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075146,NA,NA,1ZIADK075146-06,NIDDK:189847\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415045 (contact),"PERIWAL, VIPUL  (contact)",NA,NA,NA,Algorithm Design;Algorithmic Analysis;Algorithms;AQP1 gene;Atlases;Back;Biological;Biological Assay;Biological Models;Biology;Black Box;Bladder;Cell Cycle;Cell Differentiation process;Cell Physiology;cell type;Cells;Characteristics;Classification;Compensation;Computing Methodologies;cost;Data;Data Analyses;data complexity;Data Set;deep learning;deep learning model;density;Development;Dimensions;Dropout;Drosophila genus;dynamic system;Endothelial Cells;Equation;experimental study;Gene Expression;generative models;Genes;Genetic Transcription;Goals;graph neural network;Hand;Heart;Heterogeneity;high dimensionality;Human;human tissue;improved;indexing;insight;learning network;Maps;mathematical model;Measurement;Measures;Methods;Modeling;models and simulation;Morphologic artifacts;multidimensional data;Mus;Noise;novel;Output;Pattern;Performance;Probability;Probability Learning;response;Reverse engineering;RNA;screening;simulation;single-cell RNA sequencing;Sodium Chloride;Speed;Stress;Techniques;Testing;Time;Tissues;Training;transcriptome sequencing;Variant;water channel,Single Cell Data Analysis Algorithms,75146,NA,NA,NA,NA,6,NA,NA,189847,NA
11188651,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075147,NA,NA,1ZIADK075147-08,NIDDK:2200565\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,15198060 (contact),"MCJUNKIN, KATHERINE  (contact)",NA,NA,NA,adenylate;Animals;Behavior;Biogenesis;Biological;Biological Models;Biological Process;Biology;Caenorhabditis elegans;Caffeine;Catalysis;Cell Lineage;Cessation of life;Clustered Regularly Interspaced Short Palindromic Repeats;Complex;CRISPR/Cas technology;Development;Disease;Embryo;Embryonic Development;Equilibrium;Exhibits;Family;Gene Expression;Gene Expression Regulation;Gene Silencing;Genes;Genetic;genome editing;insight;Malignant Neoplasms;Mediating;member;Messenger RNA;MicroRNAs;model organism;Modification;Molecular;Mutagenesis;mutant;Mutation;Names;novel;Nucleotides;Organism;Pathway interactions;Phenotype;Physiological Processes;Plants;Play;Post-Transcriptional Regulation;pressure;programs;Proteins;Regulation;Research;Ribonuclease H;RNA;RNA Interference;Role;Stereotyping;Therapeutic;Time;Tissue Differentiation;tool;Untranslated RNA;uridylate,Biological functions and post-transcriptional regulation of microRNAs,75147,NA,NA,NA,NA,8,NA,NA,2200565,NA
11188652,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075150,NA,NA,1ZIADK075150-06,NIDDK:339518\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,16147217 (contact),"KOH, CHRISTOPHER  (contact)",NA,NA,NA,Adult;Annual Reports;Ascites;Biochemical;Caring;Chronic Hepatitis B;Chronic Hepatitis C;Chronic Hepatitis D;chronic liver disease;Chronic viral hepatitis;Cirrhosis;Clinic;Clinical;clinical center;Clinical Trials;cohort;Combined Modality Therapy;Communities;Congresses;Data;Data Analyses;deep learning model;Disease;Dose;Effectiveness;elastography;Enrollment;experience;Farnesyl Transferase Inhibitor;FDA approved;Fibrosis;Follow-Up Studies;Goals;Hepatitis B;Hepatitis C;Hepatitis C virus;Hepatitis D;Hepatitis Delta Virus;Hepatology;human subject;Individual;Infection;Injury;Institutional Review Boards;Interferons;International;Journals;Knowledge;Liver;Liver diseases;Lonafarnib;Manuscripts;mathematical model;Measures;Medical;meetings;Methods;Modality;Monitor;National Institute of Diabetes and Digestive and Kidney Diseases;novel;novel therapeutics;open label;Outcome Study;Patient Participation;Patients;Peer Review;peginterferon alfa-2a;Performance;Pharmaceutical Preparations;Phase;Placebos;primary outcome;Principal Investigator;Process;Protease Inhibitor;Publications;Publishing;Radiology Specialty;Reporting;Research;Research Personnel;response;Risk;Ritonavir;Safety;Scanning;serological marker;Serology;Site;Spleen;Staging;success;Therapeutic;Therapeutic Trials;tool;treatment response;United States National Institutes of Health;vibration;Viral;Viral hepatitis;viral RNA;Virus Diseases;Work;X-Ray Computed Tomography,Management and Treatment of Chronic Delta Hepatitis Infection and other Liver Diseases,75150,NA,NA,NA,NA,6,NA,NA,339518,NA
11188653,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075151,NA,NA,1ZIADK075151-06,NIDDK:407664\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,2068471 (contact),"HINTON, DEBORAH M (contact)",NA,NA,NA,Alleles;Anti-Bacterial Agents;arms race;Bacterial Antibiotic Resistance;Bacterial RNA;Bacteriophage T4;Bacteriophages;Biological;Biology;dark matter;Development;Environment;Equilibrium;Family;Fluorescence;gene product;Genes;genetic information;Growth;Homologous Gene;Impairment;improved;Infection;interest;Laboratories;Mediating;Mediation;Messenger RNA;Molecular Chaperones;mRNA Expression;mutant;novel;nuclease;overexpression;Post-Transcriptional Regulation;posttranscriptional;Process;protein folding;Proteins;Reporter;repository;Resources;rho;Ribonucleases;RNA;RNA Binding;RNA-Binding Proteins;System;termination factor;transcription termination;Work,Host Takeover by Bacteriophage T4,75151,NA,NA,NA,NA,6,NA,NA,407664,NA
11188654,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075153,NA,NA,1ZIADK075153-05,NIDDK:4182166\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9827998 (contact),"BAIER, LESLIE J (contact)",NA,NA,NA,Abnormal Karyotype;Adult;Affect;Alleles;Alpha Cell;Beta Cell;Binding;Biological Assay;Biological Models;Catalogs;CDKN1C gene;Cell Differentiation process;Cell Line;cell type;Cells;channel blockers;Clone Cells;Clustered Regularly Interspaced Short Palindromic Repeats;Collecting Cell;Communities;CRISPR/Cas technology;Data;Development;Diabetes Mellitus;diabetes risk;Diazoxide;Dideoxy Chain Termination DNA Sequencing;Disease;disease model;Endocrine;endocrine pancreas development;Enhancers;fetal;Flow Cytometry;Gene Combinations;Gene Expression;Gene Expression Profiling;Gene Expression Regulation;Genes;Genetic;genetic variant;genomic locus;Glucose;glucose metabolism;glucose tolerance;Goals;H19 gene;Haplotypes;Heterozygote;High birth weight infant;Human;human induced pluripotent stem cells;Hyperinsulinism;Hypermethylation;Hypoglycemia;imprint;in utero;Indigenous American;indigenous community;Individual;induced pluripotent stem cell;infancy;Inherited;INS gene;Insulin;insulin regulation;insulin secretion;Introns;islet;Islets of Langerhans;Lead;Linkage Disequilibrium;Maps;Methylation;Modeling;Molecular;Mutation;mutation correction;Non-Insulin-Dependent Diabetes Mellitus;Obesity;Pancreas;Parents;Pathogenesis;Phenotype;pluripotency;prevent;Privatization;Procedures;progenitor;programs;Protocols documentation;Reporting;Research Design;response;Risk;risk variant;RNA analysis;Signal Transduction;single-cell RNA sequencing;Site;Structure of beta Cell of islet;System;Therapeutic Agents;therapeutic evaluation;Therapeutic Intervention;Time;Tissues;Tolbutamide;tool;transcriptome sequencing;transcriptomics;Translating;TRPM5 gene;Variant,Differentiation of human induced pluripotent stem cells as a tool to study the effects of type 2 diabetes loci.,75153,NA,NA,NA,NA,5,NA,NA,4182166,NA
11188655,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075154,NA,NA,1ZIADK075154-05,NIDDK:658712\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,15195448 (contact),"BAX, ADRIAAN  (contact)",NA,NA,NA,2019-nCoV;aerosolized;Aerosols;Air;Area;aspirate;Back;Breathing;Chemicals;Clinical;COVID-19 pathogenesis;COVID-19 pneumonia;Deposition;Detection;detector;Development;Diffuse;Escalator;Exhalation;Generations;Incidence;Infection;Influenza;Inhalation;laboratory experiment;Lasers;light scattering;Link;Liquid substance;Location;Lower respiratory tract structure;Lung;Microscopic;pathogen;Pharyngeal structure;Physics;Pneumococcal Pneumonia;Pneumonia;Process;Research;respiratory;Sarcosine;Site;Sleep Apnea Syndromes;Snoring;Soft Palate;soft tissue;sound;Stream;Streptococcus;Surface;Tracer;vibration,Observation and quantification of respiratory droplets by laser light scattering,75154,NA,NA,NA,NA,5,NA,NA,658712,NA
11188656,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075155,NA,NA,1ZIADK075155-05,NIDDK:242663\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415662 (contact),"HENNIGHAUSEN, LOTHAR  (contact)",NA,NA,NA,2019-nCoV;ACE2;Address;Adult-Onset Still&apos;s Disease;Affect;Agammaglobulinaemia tyrosine kinase;Alternative Splicing;Antibodies;Antibody Formation;Antibody Response;Austria;B-Lymphocytes;Biomedical Research;Blood;Blood specimen;booster vaccine;cancer transplantation;cell type;Cells;Chronic Lymphocytic Leukemia;Classification;Clinical;clinical practice;Clinical Research;Complete Blood Count;computerized tools;COVID-19;COVID-19 pandemic;COVID-19 patient;COVID-19 prevention;COVID-19 vaccination;cytokine release syndrome;Data;diagnostic tool;Disease;Dose;Effectiveness;Europe;Event;Exhibits;experience;experimental study;FDA Emergency Use Authorization;Flare;Gene Expression;Gene Expression Profiling;Genes;genetic signature;Genetic Transcription;genome-wide;Germany;Human;Immune;immune activation;Immune response;Immune system;Immune System Diseases;Immunity;Immunize;Immunocompromised Host;immunological status;Immunologics;improved;In Vitro;Individual;individual response;Infection;Inflammation;Inflammatory Response;inhibiting antibody;inhibitor;insight;Interferons;International;international partnership;Italy;Janus kinase;Kidney;kinase inhibitor;leukemia;leukemia treatment;Link;Logistics;Lung;Lymphocyte Depletion;male;Mediating;Messenger RNA;Methods;Mus;Mutation;neutralizing antibody;neutrophil;organ transplant recipient;pandemic disease;pathogen;Pathway interactions;Patients;Pattern;Persons;Pfizer-BioNTech COVID-19 vaccine;Population;Population Group;Prevalence;Production;Publishing;receptor;receptor binding;Recording of previous events;Recovery;Reporting;Research;response;RNA analysis;Safety;Sampling;SARS-CoV-2 B.1.1.529;SARS-CoV-2 exposure;SARS-CoV-2 immune response;SARS-CoV-2 infection;SARS-CoV-2 variant;Sequence Alignment;Severity of illness;Signal Pathway;Signal Transduction;Small-Cell Lymphoma;South Korea;Spliced Genes;symptomatology;System;T cell response;T-Cell Receptor;T-cell receptor repertoire;Therapeutic Uses;tool;tositumomab;transcriptome;transcriptome sequencing;Tyrosine Kinase Inhibitor;United States Food and Drug Administration;Vaccination;Vaccinee;Vaccines;vaccinology;Variant;vector-based vaccine;Viral;Virus,COVID-19: immune response and systems vaccinology,75155,NA,NA,NA,NA,5,NA,NA,242663,NA
11188657,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075157,NA,NA,1ZIADK075157-04,NIDDK:626379\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,78338306 (contact),"CHELOHA, ROSS  (contact)",NA,NA,NA,Address;Adenosine;Affect;Alpaca;Angiotensin Receptor;Animal Model;Antibodies;antibody conjugate;Binding;Biological;Biological Assay;Biology;Camels;Cell Surface Proteins;Cell Surface Receptors;Cells;Characteristics;Chemicals;Chemistry;chronic pain;design;Development;Diabetes Mellitus;Disease;Exhibits;G-Protein-Coupled Receptors;GLP-I receptor;Goals;Immune system;In Vitro;Inflammation;interest;Llama;Mammalian Cell;Marriage;Methodology;Methods;Muscarinic Acetylcholine Receptor;nanobodies;novel strategies;Organic Chemistry;Osteoporosis;Peptides;pharmacologic;Pharmacologic Substance;Physiological;Process;Property;protein function;Proteins;Reagent;receptor;receptor function;response;small molecule;Specificity;Surface;TACR1 gene;Testing;Therapeutic;tool;unnatural amino acids,New tools from chemistry and antibodies to address receptor function,75157,NA,NA,NA,NA,4,NA,NA,626379,NA
11188658,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075158,NA,NA,1ZIADK075158-04,NIDDK:1638330\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,78340848 (contact),"NARAYAN, PRIYANKA  (contact)",NA,NA,NA,Acceleration;Address;Alzheimer&apos;s Disease;Alzheimer&apos;s disease related dementia;Alzheimer&apos;s disease risk;apolipoprotein E-4;Area;Astrocytes;Biochemistry;cell type;Chemicals;Collaborations;Development;Disease;disorder risk;Environmental Risk Factor;Genetic;glial activation;Human;human induced pluripotent stem cells;induced pluripotent stem cell;lipid metabolism;Lipids;Mediating;metabolomics;Microglia;Molecular;Molecular Biology;Motility;mutant;mutation screening;Netherlands;Neurodegenerative Disorders;Neuroglia;neuroinflammation;Neurons;novel;novel therapeutics;Pathway interactions;patient population;Predisposition;prevent;Prevention strategy;Process;protective allele;Public Health;Research;Research Personnel;resilience;Risk;Risk Factors;Role;Shapes;Therapeutic;trafficking;United States National Institutes of Health;Variant;ward;Work,Investigating the molecular basis of risk and resilience to Alzheimer's disease,75158,NA,NA,NA,NA,4,NA,NA,1638330,NA
11188659,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075159,NA,NA,1ZIADK075159-04,NIDDK:2043853\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,78338308 (contact),"SINHA, MADHUMITA  (contact)",NA,NA,NA,18 year old;Adolescence;adverse pregnancy outcome;Age Years;Alaska Native;American Indians;Area;Arizona;Award;Barker Hypothesis;Belief;bench to bedside;Biochemical;Biological Factors;Biological Markers;Birth;Birth Weight;Body Composition;Body mass index;Child;Childbirth;Childhood;Clinical;cohort;Communities;Consent;Data;Diabetes Mellitus;diabetes risk;diabetic;early childhood;Enrollment;Environmental Risk Factor;epidemiology study;Ethnic Population;experience;Exposure to;Family;Fatty Liver;Frequencies;Future;Genetic;gestational weight gain;Goals;Grant;Growth;gut microbiome;Health;health determinants;Health Policy;Health Status;High Prevalence;high risk;high risk population;Hispanic;Hispanic Americans;Indigenous American;infancy;Infant;Inflammatory;innovation;Institutional Review Boards;Intramural Research Program;intrauterine environment;Life;Life Cycle Stages;lifestyle factors;Longitudinal cohort;Longitudinal Studies;maternal risk;Mediating;Metabolic;metabolic profile;metabolome;methylome;metropolitan;microbiome composition;Molecular;Mothers;National Institute of Diabetes and Digestive and Kidney Diseases;Native Americans;neurodevelopment;Non-Insulin-Dependent Diabetes Mellitus;novel;Obesity;obesity in children;offspring;Participant;Pattern;phenotypic data;Placenta;Population;Population Group;Postpartum Period;predictive modeling;Pregnancy;Pregnant Women;prenatal;prepregnancy;prevent;Proteome;Psychosocial Factor;recruit;Research;Risk;Risk Factors;Role;Serum;Socioeconomic Factors;Southwestern United States;transcriptome;Umbilical Cord Blood;United States National Institutes of Health;Urban Community;Visit;Weight,Epidemiologic studies of maternal and early life metabolic risk,75159,NA,NA,NA,NA,4,NA,NA,2043853,NA
11188660,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075160,NA,NA,1ZIADK075160-04,NIDDK:227095\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,78338308 (contact),"SINHA, MADHUMITA  (contact)",NA,NA,NA,"10 year old;Active Learning;Address;Adult;Affect;Alaska Native;American Indians;Award;Behavior Therapy;bench to bedside;Caregivers;Child;Clinic;Collaborations;Colorado;Communities;community-level factor;COVID-19 impact;COVID-19 pandemic;COVID-19 pandemic effects;Data Analyses;Data Collection;Diabetes Mellitus;diabetes risk;Educational Curriculum;Enrollment;Ethnic Population;experience;fatty liver disease;Funding;Future;genetic variant;Grant;gut microbiota;Health;Health behavior;Hispanic Populations;Hybrids;improved;Incidence;Individual;intervention program;Learning;lifestyle intervention;Mediating;Metabolic;microbial;minority children;Morbid Obesity;motivational enhancement therapy;National Institute of Diabetes and Digestive and Kidney Diseases;native youth;Navajo;non-alcoholic fatty liver disease;Obesity;obesity in children;obesity prevention;open data;operation;Outcome Study;Overweight;pandemic disease;Parents;Participant;participant enrollment;patient engagement;Persons;Prevalence;primary caregiver;Procedures;Process;programs;Publications;racial minority population;Randomized, Controlled Trials;Regulation;remote delivery;remote visit;Research;Reservations;resilience;Risk Factors;Role;Rural;Safety;Sampling;Schedule;Site;Susceptibility Gene;Tribes;United States;United States National Institutes of Health;Universities;Variant;virtual;Visit;Youth",Diabetes/obesity prevention in youth,75160,NA,NA,NA,NA,4,NA,NA,227095,NA
11188661,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075161,NA,NA,1ZIADK075161-04,NIDDK:189847\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415045 (contact),"PERIWAL, VIPUL  (contact)",NA,NA,NA,3-Dimensional;Address;Agreement;Algorithms;Alpha Cell;Animals;Architecture;Auxins;Beta Cell;Biological;cell type;Characteristics;Chromatin Loop;Chromosomes;cohesin;Collection;complex data;Computer software;Consumption;cost;D Cells;Data;Data Analyses;Data Set;Development;Diabetes Mellitus;DNA;Endocrine;Energy Metabolism;Equilibrium;Fatty acid glycerol esters;Functional disorder;Genes;Genome;genome-wide;Genomics;Glucagon;Glucose;graph theory;Hi-C;Hormone secretion;Hour;Human Genome;Image;Impairment;improved;Insulin;interest;Interruption;islet;Islets of Langerhans;large datasets;Location;Manuals;Maps;Memory;Metabolic;Methods;multidimensional data;nerve supply;Noise;novel;Organ;Pattern;Process;Property;protein complex;Pythons;Regulation;Resolution;Running;Science;Signal Transduction;statistics;Structure;System;Three-Dimensional Imaging;Time;tool;two-dimensional;user-friendly;Vascularization;Work,Computing persistent homology in biological datasets,75161,NA,NA,NA,NA,4,NA,NA,189847,NA
11188662,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075162,NA,NA,1ZIADK075162-04,NIDDK:117987\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9415315 (contact),"YANG, WEI  (contact)",NA,NA,NA,2019-nCoV;ATP Hydrolysis;Base Pairing;betacoronavirus;Binding;Biochemical;Biological Assay;C-terminal;Catalytic Domain;Cell Separation;Cells;Cessation of life;Charge;Classification;Clinical Trials;Colorado;Complex;Coronavirus;Coupled;COVID-19;COVID-19 pandemic;COVID-19 treatment;Cryoelectron Microscopy;Data;Dengue Fever;design;Disease Outbreaks;DNA;DNA Primase;ds-DNA;foot;Future;Genes;Genetic Transcription;Genome;Goals;helicase;Hepatitis C;Human;Human poliovirus;improved;In Vitro;in vivo;Individual;Infection;inhibitor;International;Left;Maps;Membrane;Middle East Respiratory Syndrome;Middle East Respiratory Syndrome Coronavirus;Modeling;Molecular;movie;Mus;Names;Nonstructural Protein;novel coronavirus;Nucleic Acids;Open Reading Frames;pandemic disease;Papain;Pathogenesis;Patients;Peptide Hydrolases;Persons;Pharmaceutical Preparations;Polyproteins;Postdoctoral Fellow;Power stroke;Preparation;prevent;Process;protein purification;Proteins;remdesivir;Reporting;Rhinovirus;RNA;RNA chemical synthesis;RNA Helicase;RNA replication;RNA Viruses;RNA-Directed RNA Polymerase;SARS coronavirus;Science;Severe Acute Respiratory Syndrome;Small RNA;Specificity;Structural Genes;Structure;Symptoms;Taxonomy;Testing;Time;United States National Institutes of Health;Vaccines;Vesicle;Viral;Viral Physiology;viral RNA;Viral Structural Proteins;Virion;Virus;Virus Assembly;Virus Diseases;Virus Inhibitors;Virus Replication;Visit;X-Ray Crystallography;Yellow fever virus,Characterization of replication and transcription of SARS-CoV-2,75162,NA,NA,NA,NA,4,NA,NA,117987,NA
11188663,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075165,NA,NA,1ZIADK075165-03,NIDDK:294733\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,11992032 (contact),"BROWN, REBECCA  (contact)",NA,NA,NA,Adipose tissue;antagonist;Appearance;Dyslipidemias;Fasting;Fatty acid glycerol esters;Glycerol;Goals;Growth Hormone Receptor;Insulin Receptor;Insulin Resistance;Insulin-Like Growth Factor I;Lipodystrophy;Lipolysis;Measures;Mediating;Metabolic Diseases;non-alcoholic fatty liver disease;Nonesterified Fatty Acids;Palmitates;Pathogenicity;Patients;pegvisomant;Rare Diseases;recruit;Somatotropin;subcutaneous;Variant,Growth hormone inhibition in severe insulin resistance,75165,NA,NA,NA,NA,3,NA,NA,294733,NA
11188664,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075166,NA,NA,1ZIADK075166-03,NIDDK:753658\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,78848023 (contact),"LOUIS, JOHN  (contact)",NA,NA,NA,2019-nCoV;Active Sites;Adopted;Affinity;Anti-viral Agents;antiviral drug development;Appearance;Binding;Biochemical;biophysical techniques;C-terminal;Caspase;Chymase;Complex;COVID-19 treatment;Dengue Virus;dimer;Dimerization;Dissociation;Drug resistance;Engineering;Enzymes;Equilibrium;Escherichia coli;improved;In Vitro;inhibitor;insight;Investigation;Kinetics;Length;Mediating;method development;Methods;mimetics;Modeling;Molecular;Molecular Conformation;Monitor;monomer;mutant;Mutation;N-terminal;nirmatrelvir;Norovirus;Pathway interactions;Paxlovid;Peptide Hydrolases;Polyproteins;Population;Process;Protease Inhibitor;Protein Dynamics;Rapid screening;Reaction;Recombinants;Reporting;resistance mutation;Sampling;SARS coronavirus;SARS-CoV-2 protease;single molecule;Site;Spectrum Analysis;Structure;Temperature;Thermodynamics;three dimensional structure;Time;Variant;Viral;Virus;Visualization;X-Ray Crystallography,Biochemical and Structural Studies of Viral Proteases,75166,NA,NA,NA,NA,3,NA,NA,753658,NA
11188665,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075167,NA,NA,1ZIADK075167-03,NIDDK:621929\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,78848025 (contact),"LUTAS, ANDREW  (contact)",NA,NA,NA,Animal Behavior;Animals;Area;awake;Axon;Behavior;behavioral response;Biochemical;Biochemistry;Biosensor;Body Weight;Brain;Brain region;Brain Stem;Complex;Cyclic AMP;Desire for food;Diabetes Mellitus;Dopamine;Eating;Fluorescence;Fluorescence Microscopy;Food;G Protein-Coupled Receptor Signaling;G-Protein-Coupled Receptors;GCG gene;Genetic;Goals;Hour;Hypothalamic structure;imaging approach;Implant;in vivo;in vivo fluorescence imaging;lens;Ligands;Measures;Modeling;Molecular;Monitor;Motivation;Mus;neural circuit;Neuromodulator;Neurons;neuroregulation;neurotransmitter release;novel therapeutic intervention;novel therapeutics;obesity treatment;Opioid;Optics;parabrachial nucleus;pharmacologic;Physiological;Population;presynaptic;Presynaptic Terminals;Process;receptor;Receptor Activation;Reporting;Resolution;Role;Signal Transduction;Signaling Molecule;Site;Slice;Stimulus;Synaptic Vesicles;Time;two photon microscopy;vesicular release;Visualization,Compartmentalized molecular signaling in neural circuits controlling appetite,75167,NA,NA,NA,NA,3,NA,NA,621929,NA
11188666,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075168,NA,NA,1ZIADK075168-03,NIDDK:621929\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,78848025 (contact),"LUTAS, ANDREW  (contact)",NA,NA,NA,Address;adult obesity;Affect;American;Amygdaloid structure;Animals;Area;awake;Behavior;Behavioral Assay;Biochemical;Biosensor;Brain;Calories;Cues;Cyclic AMP;Cyclic AMP-Dependent Protein Kinases;Decision Making;Diabetes Mellitus;Dopamine;Dorsal;Eating;Enkephalins;Equipment;feeding;Feeding behaviors;Fluorescence;Food;food craving;food marketing;G-Protein-Coupled Receptors;Genetic;Glutamates;Goals;Heart Diseases;Hormones;Human;Image;inhibitor;Learning;Microscope;model organism;Molecular;Monitor;motivated behavior;Motivation;Mus;neural;neural circuit;Neuromodulator;Neurons;Neuropeptides;neuroregulation;Obesity;Obesity Epidemic;Operant Conditioning;optogenetics;parabrachial nucleus;Pharmacological Treatment;Physiological;Play;postsynaptic;Presynaptic Terminals;Reporting;Resolution;response;Risk;Role;Sensory;Serotonin;Signal Pathway;Signal Transduction;social;Stimulus;synergism;System;Therapeutic;transcription factor;two-photon;Ventral Tegmental Area,Neuromodulator signals regulating cue-induced feeding,75168,NA,NA,NA,NA,3,NA,NA,621929,NA
11188667,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075169,NA,NA,1ZIADK075169-03,NIDDK:640775\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,78848025 (contact),"LUTAS, ANDREW  (contact)",NA,NA,NA,addiction;Address;Adenylate Cyclase;Animal Model;Area;awake;Behavior;Biosensor;Brain Stem;cell type;Central Nervous System;Chronic;comorbidity;Consumption;craving;Desire for food;Diet;Dopamine Receptor;Eating;effective therapy;Energy consumption;Equipment;Fasting;feeding;Fluorescence;Fluorescence Microscopy;Food;G Protein-Coupled Receptor Signaling;G-Protein-Coupled Receptors;GCG gene;Goals;hedonic;Hunger;Hypothalamic structure;improved;in vivo fluorescence;Ligands;Measurement;Measures;melanocortin receptor;Methods;Microscopy;Molecular;Monitor;Motivation;Mus;neural circuit;Neurons;Obesity;obesity treatment;optical imaging;pharmacologic;phosphoric diester hydrolase;Photometry;Population;receptor;Receptor Activation;Receptor Signaling;Resolution;Rodent Model;Safety;Satiation;Signal Transduction;Transgenic Mice;Treatment Efficacy;two photon microscopy;Viral Genes;Visualization;Work,Investigating appetite control by G protein-coupled receptors,75169,NA,NA,NA,NA,3,NA,NA,640775,NA
11188668,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075170,NA,NA,1ZIADK075170-03,NIDDK:2511722\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,78848029 (contact),"MIROSHNIKOVA, YEKATERINA  (contact)",NA,NA,NA,3-Dimensional;Aggressive behavior;Aging;Aneuploidy;Architecture;Area;Attenuated;Behavior;Biochemical;biological adaptation to stress;Biological Models;Cancer Patient;cell fate specification;Cell Maintenance;Cell Nucleus;Cells;Cellular biology;Chromatin;clinically relevant;Colorectal Cancer;Complex;Cytoskeleton;Disease;Elements;emerin;Environment;Exhibits;experimental study;Gene Expression;Gene Expression Profile;Gene Expression Regulation;Genes;Genetic Transcription;Genome;Health;Heterochromatin;high throughput screening;Homeostasis;Human Genome;Immune;Immunofluorescence Immunologic;immunopathology;Impairment;In Vitro;interest;Intrinsic factor;Link;Malignant Neoplasms;Mammalian Cell;mechanical drive;mechanical force;Mechanical Stress;Mechanics;mechanotransduction;Mediating;Metabolic;Morphology;morphometry;Nature;Neoplasm Metastasis;Nuclear;Nuclear Envelope;Nuclear Lamina;Nuclear Pore;Organoids;Outcome;Paper;Pathway interactions;Patients;Peripheral;Process;prognostic;Proteins;Proteomics;Publications;quantitative imaging;Repression;Research;Risk;Role;Shapes;Signal Transduction;stem cell fate specification;Stereotyping;superresolution imaging;System;Tissues;TP53 gene;transcriptome;Work;Writing,Nuclear and chromatin mechanics in cell fate specification,75170,NA,NA,NA,NA,3,NA,NA,2511722,NA
11188669,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075171,NA,NA,1ZIADK075171-03,NIDDK:1188332\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,78848031 (contact),"WANG, QUAN  (contact)",NA,NA,NA,Adopted;Area;Base Pairing;Binding;Biochemical;Biological;Biological Assay;Complement;CRISPR/Cas technology;design;Detection;detector;Disease;DNA;Dyes;Exhibits;Experimental Designs;experimental study;Fluorescence;Fluorescence Resonance Energy Transfer;follow-up;frontier;gene editing technology;Goals;Guide RNA;Heterogeneity;Holoenzymes;Immobilization;Individual;insight;instrument;instrumentation;Investigation;Kinetics;Learning;Measurement;Methamphetamine;Methods;millisecond;Modality;Molecular;Molecular Conformation;Molecular Probes;Molecular Structure;Nature;new technology;Noise;novel;Pathway interactions;Performance;Photons;Publishing;Reaction;Resolution;Ribonucleoproteins;RNA;RNA Conformation;single molecule;single-molecule FRET;Site;Source;Specificity;Spectrum Analysis;structural biology;Structure;Surface;System;Time;tool;ultra high resolution;Uncertainty,Probing single-molecule structure and dynamics with an anti-Brownian trap,75171,NA,NA,NA,NA,3,NA,NA,1188332,NA
11188670,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075172,NA,NA,1ZIADK075172-03,NIDDK:2385640\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,78853715 (contact),"FRAKES, ASHLEY  (contact)",NA,NA,NA,Age of Onset;age related;Aging;Animals;Astrocytes;Awareness;Behavioral Assay;Biological Models;Brain;brain health;Caenorhabditis elegans;Cells;Cellular Stress;Central Nervous System;Communication;Disease;endoplasmic reticulum stress;extend lifespan;first responder;functional genomics;Genetic;Goals;Homeostasis;Longevity;Metabolic Diseases;Microscopy;misfolded protein;Mus;Neurodegenerative Disorders;Neuroglia;Neurologist;Nutrient;Patients;Peripheral;Play;prevent;protein aggregation;Proteins;Publishing;Regulation;Resistance;response;Role;Signal Transduction;Signaling Molecule;stem;Stress;stressor;therapeutic biomarker;therapeutic target;Tissues;tool;transcription factor;Transcriptional Activation;Viral;Work;XBP1 gene,Glial regulation of ER stress resistance,75172,NA,NA,NA,NA,3,NA,NA,2385640,NA
11188671,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075174,NA,NA,1ZIADK075174-02,NIDDK:163274\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,2519801 (contact),"SIMONDS, WILLIAM F (contact)",NA,NA,NA,Acceleration;Affect;Alzheimer&apos;s Disease;analytical method;Behavioral;Disease;disorder risk;Disparity;Etiology;Gender;gene discovery;Genes;Genetic;genetic analysis;genetic variant;Genetic Variation;Genome;genome-wide;Genomics;high risk;Hypertension;indexing;Intercistronic Region;Introns;Investigation;Maps;Missense Mutation;Non-Insulin-Dependent Diabetes Mellitus;Obesity;Risk;risk variant;RNA Splicing;Single Nucleotide Polymorphism;Site;Variant,Analysis of polygenic disease risk and etiology by indexing ancestry- and gender-specific gene variants predicted to impact function,75174,NA,NA,NA,NA,2,NA,NA,163274,NA
11188672,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075175,NA,NA,1ZIADK075175-02,NIDDK:1634523\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,79342242 (contact),"RODGERS, MARGARET  (contact)",NA,NA,NA,5&apos; Splice Site;Address;Area;Base Pairing;Binding Proteins;Biological;Biology;Collaborations;Coupling;Disease;Genetic;Genetic Transcription;Goals;Guide RNA;In Vitro;in vivo;in vivo imaging;interest;Kinetics;Laboratories;Messenger RNA;Microscopy;Modification;Molecular;Molecular Biology;National Institute of Child Health and Human Development;Nucleotides;Pathway interactions;Process;Protein Biochemistry;Proteins;reconstitution;Regulation;Reporter;Research;Resolution;Ribonucleoproteins;Ribosomal RNA;Ribosomes;RNA;RNA Biochemistry;RNA Folding;RNA Processing;RNA Splicing;single molecule;Site;Small Nucleolar Ribonucleoproteins;Small RNA;Spliceosome Assembly Pathway;Spliceosomes;Structure;System;Time;tool;Transcription Elongation;U1 Small Nuclear Ribonucleoprotein;United States National Institutes of Health;Work;yeast genetics,Molecular mechanisms for co-transcriptional assembly of ribonucleoproteins,75175,NA,NA,NA,NA,2,NA,NA,1634523,NA
11188673,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075177,NA,NA,1ZIADK075177-02,NIDDK:503282\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,79342245 (contact),"HSU, CHRISTINE  (contact)",NA,NA,NA,Abdomen;Academic Medical Centers;American;Artificial Intelligence;artificial intelligence model;Biological Markers;cancer risk;Carcinoma;Cirrhosis;Clinical;Clinical Data;clinical predictors;cohort;Collaborations;Data;Data Set;Demographic Factors;Development;Fibrosis;Image;image processing;Institutional Review Boards;Laboratories;Liver diseases;Magnetic Resonance Imaging;Malignant neoplasm of liver;model building;Modeling;Outcome;Patients;Primary carcinoma of the liver cells;Protocols documentation;radiological imaging;Radiology Specialty;Recommendation;recruit;Retrospective Studies;Risk;screening;Screening for Hepatocellular Cancer;ultrasound;United States National Institutes of Health,Retrospective Study to Develop a Model Using Artificial Intelligence to Predict Hepatocellular Carcinoma Risk in Cirrhosis,75177,NA,NA,NA,NA,2,NA,NA,503282,NA
11188674,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075179,NA,NA,1ZIADK075179-01,NIDDK:635974\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,79972337 (contact),"WALDMAN, MERYL  (contact)",NA,NA,NA,Antibodies;Biological Assay;Cells;clinical care;Complement;Data;Development;Disease remission;Dyslipidemias;Evolution;Future;Immune;Immunologics;Kidney Diseases;Mediating;Membranous Glomerulonephritis;Memory B-Lymphocyte;Monitor;Population;programs;Protocols documentation;Relapse;Research;Role;Sampling,Studies of Immunologically-Mediated Kidney Diseases,75179,NA,NA,NA,NA,1,NA,NA,635974,NA
11188675,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075181,NA,NA,1ZIADK075181-01,NIDDK:272560\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,79972337 (contact),"WALDMAN, MERYL  (contact)",NA,NA,NA,arm;B-Lymphocytes;belimumab;Benefits and Risks;Cells;Cyclosporine;Disease remission;Dose;Effectiveness;effectiveness evaluation;Enrollment;Idiopathic Membranous Nephropathy;Intravenous;Intravenous infusion procedures;Membranous Glomerulonephritis;Multicenter Trials;Nephrotic Syndrome;Partial Remission;Participant;Pharmaceutical Preparations;Pilot Projects;Placebos;primary endpoint;Proteinuria;Randomized;Regimen;response;rituximab;Safety;Schedule;Serum Albumin;subcutaneous;Testing;treatment duration;treatment trial,Treatment trials- Rituximab plus cyclosporine for  MN and Belimumab plus rituximab for MN  (REBOOT),75181,NA,NA,NA,NA,1,NA,NA,272560,NA
11188676,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075183,NA,NA,1ZIADK075183-01,NIDDK:509285\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,78848031 (contact),"WANG, QUAN  (contact)",NA,NA,NA,absorption;Cryoelectron Microscopy;cryogenics;Disease;Dyes;flexibility;Freezing;Geometry;human disease;Image;Individual;Maps;Measures;Methods;Molecular;Molecular Conformation;Molecular Structure;Performance;physical model;Preparation;Proteins;RNA;Sampling;Scheme;simulation;single-molecule FRET;Spectrum Analysis;structural biology;Temperature;tool;Work,Towards cryogenic single-molecule FRET spectroscopy as a structural biology tool,75183,NA,NA,NA,NA,1,NA,NA,509285,NA
11188677,ZIA,DK,1,N,NA,NA,NA,NA,ZIADK075184,NA,NA,1ZIADK075184-01,NIDDK:1004817\OD:160000\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,78338306 (contact),"CHELOHA, ROSS  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Address;Affinity;Anti-viral Agents;anti-viral efficacy;Antibodies;Binding;Biological;CCR5 gene;CD4 Positive T Lymphocytes;Cell surface;cell type;chemical synthesis;clinical application;Collection;CXCR4 gene;Development;Dose;Generations;Goals;HIV;HIV Envelope Protein gp120;HIV Infections;improved;Individual;Infection prevention;inhibitor;Length;Link;Mammalian Cell;Medical;Membrane;Methods;Monoclonal Antibodies;mutant;nanobodies;novel;novel strategies;Pathogenicity;Peptides;Pharmaceutical Preparations;polypeptide;Predisposition;Proteins;receptor;Recombinants;Regimen;Reporting;Research;resistance mechanism;Role;Scheme;side effect;Site;Specificity;synthetic peptide;Therapeutic;therapeutic target;tool;Toxic effect;transmission process;Viral;Viral Drug Resistance;Viral Physiology;Viral Proteins;viral resistance;Virus;Virus Diseases;virus infection mechanism;Virus Inhibitors,Development of new antibody-fusion inhibitor conjugates to block HIV infection,75184,NA,NA,NA,NA,1,NA,NA,1164817,NA
11188678,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES025034,NA,NA,1ZIAES025034-30,NIEHS:925678\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,8549521 (contact),"ZELDIN, DARRYL C (contact)",NA,NA,NA,2019-nCoV;Acids;Action Potentials;Affect;Alteplase;Anabolism;Anatomy;angiogenesis;animal model selection;Antiinflammatory Effect;Apoptosis;arachidonate;Arachidonic Acids;Area;Atherosclerosis;attenuation;beta-adrenergic receptor;Biochemical;Blood Vessels;Cardiac;Cardiac Electrophysiologic Techniques;Cardiac Myocytes;Cardiovascular Diseases;cardiovascular disorder risk;Cardiovascular Physiology;Cardiovascular system;Cell Adhesion Molecules;cohort;COVID-19;CYP2C19 gene;CYP2J2 gene;CYP2J5 gene;Cytochrome P450;cytokine;cytokine release syndrome;eicosanoid metabolism;Eicosanoids;Endothelial Cells;Endothelium;Enzymes;Epoxide hydrolase;Evaluation;Exhibits;Gene Expression;Genes;Genetic Polymorphism;Glycols;Goals;Growth;Heart;heart function;Human;human coronavirus;human disease;human model;Hydrolase;Hydrolysis;Hypertension;Hypoxia;improved;in vivo;inhibitor;Injury;Ischemia;ischemic injury;Kidney;Kidney Diseases;Knockout Mice;Left Ventricular Function;Malignant Neoplasms;Microsomal Epoxide Hydrolase;Molecular;multi-ethnic;Mus;Myocardial Ischemia;Myosin Heavy Chains;Nitric Oxide;novel coronavirus;Pathway interactions;Physiology;promoter;Recovery;Recovery of Function;Renal function;Research;Retina;Role;SARS coronavirus;Severe Acute Respiratory Syndrome;Sodium-Restricted Diet;Tennessee;Transgenic Mice;Tumor Promotion;Variant;vascular smooth muscle cell migration;Vascularization;Vasodilator Agents;Ventricular Cardiac alpha-Myosin;Work,Characterization And Functional Significance Of P450 Arachidonate Epoxygenases,25034,NA,NA,NA,NA,30,NA,NA,925678,NA
11188679,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES025041,NA,NA,1ZIAES025041-27,NIEHS:462839\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,8549521 (contact),"ZELDIN, DARRYL C (contact)",NA,NA,NA,Adherence;Adoption;Age;Agreement;allergen Bla g 1;Allergens;Allergic;Allergic Disease;Area;Asthma;asthma exacerbation;asthmatic patient;Attitude;care systems;Characteristics;cockroach allergen;Collaborations;comorbidity;Complex;cooking;Data;design;Development;Disease;Dust;Endotoxins;Environment;Environmental Exposure;environmental intervention;Environmental Risk Factor;environmental tobacco smoke;Exposure to;food allergen;Goals;Guidelines;Health;Home;Housing;Human;Hypersensitivity;IgE;Immunologics;implementation strategy;improved;indoor air;indoor allergen;insight;Investigation;Irritants;Knowledge;large datasets;Lead;Measures;Mediating;Medical;Modeling;Monitor;Morbidity - disease rate;mortality;National Ambulatory Medical Care Survey;National Health and Nutrition Examination Survey;Neighborhood Health Center;Participant;Patient Care;Patient Self-Report;Patients;Pattern;Prevalence;Primary Care;programs;Provider;Questionnaires;Recommendation;Research;Research Personnel;Respiratory Disease;Role;Schools;Self Efficacy;Serum;skills;Source;Specialist;Surveys;Testing;Time;trend;U.S. Department of Housing and Urban Development;United States National Center for Health Statistics;uptake;Work,Indoor Allergens And Asthma,25041,NA,NA,NA,NA,27,NA,NA,462839,NA
11188680,ZIA,ES,1,N,NA,NA,NA,NA,ZIAES025043,NA,NA,1ZIAES025043-25,NIEHS:925678\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,8549521 (contact),"ZELDIN, DARRYL C (contact)",NA,NA,NA,Acute;adaptive immune response;airway hyperresponsiveness;Allergens;Allergic;allergic airway inflammation;Alveolar Cell;Alveolar Macrophages;alveolar type II cell;Anabolism;Appearance;Attenuated;Biochemical;Bleomycin;Body Temperature Changes;Body Weight;Breeding;Bronchoalveolar Lavage Fluid;Bronchoconstriction;CCL17 gene;Cell Adhesion Molecules;Cell Count;Cells;chemokine;Clara cell;cyclooxygenase 1;cyclooxygenase 2;cysteinyl-leukotriene;Cytochrome-c Oxidase Deficiency;cytokine;Data;Defect;Dinoprostone;Distal;Endotoxins;Environment;environmental agent;eosinophil;Eotaxin;Equilibrium;Exhibits;Genes;Genotype;Goals;Histopathology;Host resistance;Human;Hydroxyproline;IgE;immune function;Immune response;In Vitro;in vivo;indexing;Infection;Inflammation;Inflammatory;Inflammatory Response;Inflammatory Response Pathway;Influenza;influenza infection;influenzavirus;Inhalation;Intercellular adhesion molecule 1;Interleukin-13;Interleukin-4;Interleukin-5;Knock-out;Knockout Mice;Leukotriene B4;Leukotrienes;Lipopolysaccharides;Liquid substance;Lung;Lung Compliance;Lymphocyte;Mechanics;methacholine;Modeling;Morphology;mortality;MUC5AC gene;Mus;Ovalbumin;overexpression;Pharmaceutical Preparations;Physiological;promoter;Prostaglandin Production;Prostaglandin-Endoperoxide Synthase;Prostaglandins;PTGS2 gene;Pulmonary Fibrosis;pulmonary function;Pulmonary Inflammation;respiratory;response;Role;Stimulus;T-Lymphocyte;Transgenes;Transgenic Mice;Trichrome stain;Type II Epithelial Receptor Cell;Up-Regulation;vanadium pentoxide;Vascular Cell Adhesion Molecule-1;Viral;Virus Diseases;Wild Type Mouse,Alterations In Pulmonary Immune Function And Host Resistance In COX Null Mice,25043,NA,NA,NA,NA,25,NA,NA,925678,NA
11188681,ZIA,LM,1,N,NA,NA,NA,NA,ZIALM010021,NA,NA,1ZIALM010021-03,NLM:955919\,INTRAMURAL RESEARCH,2024,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,10673164 (contact),"LU, ZHIYONG  (contact)",NA,NA,NA,Advanced Development;age related;Age related macular degeneration;Algorithms;American;Anterior;Appearance;Area;Area Under Curve;Benign;Blindness;Blood Vessels;Body Regions;Cataract;Categories;Characteristics;Classification;Clinic;Clinical;Clinical Data;clinical decision support;clinical decision-making;clinical imaging;clinical investigation;Clinical Research;Clinical Trials;Color;Communities;Computer software;Computerized Medical Record;Confidence Intervals;Data;Data Set;deep learning;deep learning algorithm;Detection;Diagnosis;Disease;disease diagnosis;disease prognosis;Epidemiology;Evaluation;Eye diseases;Fundus;Fundus photography;Human;Image Analysis;improved;Individual;insight;Label;large-scale imaging data;lymph nodes;lymphadenopathy;Machine Learning;machine learning algorithm;Magnetic Resonance Imaging;Malignant - descriptor;Medical Imaging;Methods;Mining;Modernization;MRI Scans;multimodality;Natural Language Processing;Neoplasm Metastasis;neural network;novel;Nuclear;Ophthalmologist;Ophthalmology;Participant;Patient Care;patient population;Patients;Pelvis;Performance;Persons;Play;Population;Process;Prognosis;prognostic;radiologist;Radiology Specialty;Reading;Rectum;Regional Anatomy;Reporting;Research;Retina;retinal imaging;Risk;Role;screening;Severities;Singapore;Specialist;Staging;success;System;Techniques;Testing;Text;Thoracic Radiography;Training;United States National Institutes of Health;Update;Visualization;Work;X-Ray Computed Tomography;X-Ray Medical Imaging,Machine learning for medical imaging: automated disease diagnosis and prognosis,10021,NA,NA,NA,NA,3,NA,NA,955919,NA
11188682,ZIA,LM,1,N,NA,NA,NA,NA,ZIALM010026,NA,NA,1ZIALM010026-01,OD:238440\,INTRAMURAL RESEARCH,2024,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,14763163 (contact),"JAEGER, STEFAN  (contact)",NA,NA,NA,15 year old;Acquired Immunodeficiency Syndrome;Africa;Aftercare;Agreement;antiretroviral therapy;Asia;Bacteriology;Cardiac;Caribbean region;Central America;Clinic;Clinical;clinical center;Clinical Data;clinical diagnosis;Clinical Research;co-infection;cohort;Communities;comorbidity;Country;Data;data portal;Data Set;Database Management Systems;Databases;Diagnosis;Disease;Disease Management;Drug resistance;Drug resistance in tuberculosis;drug-sensitive;Epidemic;Epidemiology;Etiology;experimental study;Funding;Future;genomic data;Geographic Locations;Geography;Guidelines;Health;Hepatitis;HIV;HIV Seronegativity;HIV Seropositivity;HIV/AIDS;HIV/TB;Impairment;Individual;insight;interest;International;Laboratories;Language;Lung;Machine Learning;machine learning classifier;machine learning method;Malawi;Malignant Neoplasms;member;Mental Health;Modeling;Mozambique;multidisciplinary;National Institute of Allergy and Infectious Disease;neglect;NIH Office of AIDS Research;North America;Outcome;Paper;Participant;Patient-Focused Outcomes;Patients;Persons;Phenotype;Pilot Projects;Prediction of Response to Therapy;predictive modeling;Preventive Medicine;programs;prospective;Pulmonary Tuberculosis;Quality of life;Radiologic Finding;radiological imaging;Records;Research;Research Personnel;Research Priority;Research Project Grants;Resources;Risk;Sample Size;Sampling;Series;Severities;Site;Social Medicine;socioeconomics;South Africa;South America;Southern Africa;standard of care;Substance Use Disorder;Switzerland;System;Thoracic Radiography;Training;training data;treatment and outcome;Treatment outcome;Tuberculosis;tuberculosis treatment;United States National Institutes of Health;United States National Library of Medicine;Universities;Update;working group;X-Ray Computed Tomography;X-Ray Medical Imaging;Zambia;Zimbabwe,"Enhancing the International Epidemiology Databases to Evaluate AIDS (IeDEA): A Pilot Study in Utilizing Machine Learning to Predict Treatment, Outcomes, and Phenotypes for HIV Patients Living with TB",10026,NA,NA,NA,NA,1,NA,NA,238440,NA
11188683,ZIA,LM,1,N,NA,NA,NA,NA,ZIALM200881,NA,NA,1ZIALM200881-17,NLM:1691242\,INTRAMURAL RESEARCH,2024,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,9694413 (contact),"OVCHARENKO, IVAN  (contact)",NA,NA,NA,Address;Animal Model;Binding Sites;cardiogenesis;Cardiovascular Diseases;Cause of Death;cell type;Code;Cognitive;Collaborations;comparative;comparative genomics;Complement;Computational algorithm;Computational Biology;computerized tools;Computing Methodologies;Development;Diagnostic;diagnostic development;Disease susceptibility;DNA Sequence;DNA Sequence Rearrangement;drug development;drug discovery;Elements;encryption;Enhancers;Evolution;Extramural Activities;follow-up;Gene Expression;Gene Expression Regulation;Gene Rearrangement;gene repression;Genes;Genetic Diseases;Genetic Enhancer Element;Genetic Transcription;Genome;Goals;Heart;Heart Diseases;Human;Human Genome;in vivo;in vivo evaluation;laboratory experiment;Machine Learning;Maps;model organism;Motivation;Mus;Mutation;novel;Organ;Pathway interactions;Phenotype;Play;Population;Proteins;Rana;Recording of previous events;Regulation;Regulatory Element;Regulatory Pathway;Research;Role;Sequence Analysis;Shapes;Site;Specificity;statistics;Techniques;therapeutic development;Tissues;transcription factor;transgene expression;United States;Untranslated RNA;Validation;Variant;whole genome;Zebrafish,Regulatory landscape of the human genome: comparative and evolutionary analysis.,200881,NA,NA,NA,NA,17,NA,NA,1691242,NA
11188684,ZIA,LM,1,N,NA,NA,NA,NA,ZIALM200887,NA,NA,1ZIALM200887-17,NLM:1529471\,INTRAMURAL RESEARCH,2024,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,9694419 (contact),"PRZYTYCKA, TERESA  (contact)",NA,NA,NA,Address;advanced system;Algorithmic Software;Algorithms;Awareness;Binding;Biological;biological systems;cancer biomarkers;cancer type;Cell Adhesion;Cell Physiology;Cell Proliferation;Cells;Collaborations;Complex;Computational algorithm;Computational Biology;Computer Models;Computing Methodologies;Data;data integration;Dependence;Development;diagnostic biomarker;Disease;DNA;Drosophila genus;Elements;Environment;Epithelium;Evolution;explainable machine learning;Exposure to;fly;Future;G Protein-Coupled Receptor Signaling;Gene Dosage;Gene Expression;Gene Expression Profile;Gene Expression Regulation;gene function;Genes;Genetic;Genotype;Germ Cells;Germ Lines;Goals;gonad development;Gonadal structure;Graph;graph theory;Growth Factor;Health;heterogenous data;Immune;Immune response;innovation;insight;intercellular communication;interest;Investigation;Karyotype;Language;large datasets;large scale data;Machine Learning;machine learning model;Malignant Neoplasms;Melanoma;Mesenchymal;Methods;Modeling;Molecular;Mus;Mutation;National Institute of Diabetes and Digestive and Kidney Diseases;non-genetic;Normal tissue morphology;Pathway interactions;Phenotype;Play;Population;predictive marker;Process;Prognostic Marker;Property;Regulation;Regulatory Element;Reporting;Research;Resources;response;RNA;Role;Sampling;sex;Sex Chromosomes;sex determination;sexual dimorphism;Signal Transduction;Somatic Cell;Structure;System;Systems Biology;Techniques;Technology;The Cancer Genome Atlas;theories;Tissues;tool;tumor;tumor initiation;tumor microenvironment;tumor progression;Tumor Promotion,"Algorithmic approaches to systems biology, data integration, and evolution",200887,NA,NA,NA,NA,17,NA,NA,1529471,NA
11188685,ZIA,LM,1,N,NA,NA,NA,NA,ZIALM202010,NA,NA,1ZIALM202010-05,NLM:1764774\,INTRAMURAL RESEARCH,2024,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,77871574 (contact),"JIANG, XIAOFANG  (contact)",NA,NA,NA,Anatomy;Animals;Bacteria;Bacteriophages;Bilirubin;Binding Proteins;Cloud Computing;Collection;Communities;Comparative Genomic Analysis;Data;Databases;deep learning;Development;Diet;Enzymes;Evolution;Family;Firmicutes;Funding;Future;gastrointestinal;Gene Cluster;Genes;Genetic;genomic data;Genomics;Goals;gut microbiome;Health;Heme;Human;human disease;Human Microbiome;Icterus;Infant;Inflammatory Bowel Diseases;insight;interest;Manuscripts;Maryland;Metagenomics;microbial;Microbial Biofilms;microbial genome;microbial genomics;Microbiology;microbiome;model organism;Nature;novel;Outcome;Oxidoreductase;Patients;Phage Receptors;Phenotype;Prophages;Protein Family;Proteins;Publishing;receptor binding;Recording of previous events;Resources;Role;Shapes;Side;Specificity;therapy development;tool;trait;Translating;Universities;Vibrio;Viral Genome;Virulence Factors;Work,Comparative genomic analysis of bacteria species,202010,NA,NA,NA,NA,5,NA,NA,1764774,NA
11188686,ZIA,LM,1,N,NA,NA,NA,NA,ZIALM202011,NA,NA,1ZIALM202011-05,NLM:1102984\,INTRAMURAL RESEARCH,2024,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,77871577 (contact),"PORTER, LAUREN  (contact)",NA,NA,NA,Adopted;Algorithms;Alzheimer&apos;s Disease;Amino Acid Sequence;Autoimmune;Bacterial Infections;Biochemistry;Biological;Biological Process;Cells;Communication;Disease;Functional disorder;Genome;Genomics;Goals;Health;Heterogeneity;Homologous Gene;Human;human disease;Life;Malignant Neoplasms;Methods;Molecular Conformation;Nature;news;Paper;protein aminoacid sequence;protein folding;protein structure;Proteins;Publications;Publishing;Research;Role;Structure;Testing;Textbooks;Training;Validation;Work;Writing,Predictions and experimental validation of fold-switching proteins,202011,NA,NA,NA,NA,5,NA,NA,1102984,NA
11188687,ZIA,LM,1,N,NA,NA,NA,NA,ZIALM237241,NA,NA,1ZIALM237241-02,NLM:3750145\,INTRAMURAL RESEARCH,2024,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,10673164 (contact),"LU, ZHIYONG  (contact)",NA,NA,NA,Access to Information;Address;Algorithms;Area;artificial intelligence model;Attention;Benchmarking;Biological;chatbot;ChatGPT;Chemicals;Clinical;clinically significant;Collaborations;Communities;Complex;Comprehension;computer science;Data;Data Science;Data Set;Databases;design;Development;Disease;Evaluation;Event;experimental study;flexibility;Fostering;Generations;genetic variant;Goals;Growth;Guidelines;Hallucinations;Human;Image;improved;Information Retrieval;Information Services;Language;large language model;Learning;lexical;Literature;Machine Learning;Medical;Medicine;Methodology;Modeling;Names;Natural Language Processing;online resource;open source;Performance;Persons;Physicians;Population;posters;pre-trained transformer;Probability;Process;Proteins;PubMed;Reporting;Research;research and development;Resources;response;Retrieval;Scientist;Semantics;Series;Source;symposium;System;Techniques;Technology;Text;tool;Training;Update;Vertebral column;virtual;Vision,Machine Learning and Natural Language Processing for Biomedical Applications,237241,NA,NA,NA,NA,2,NA,NA,3750145,NA
11188688,ZIA,LM,1,N,NA,NA,NA,NA,ZIALM240126,NA,NA,1ZIALM240126-01,NLM:882387\,INTRAMURAL RESEARCH,2024,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,79972352 (contact),"LUNA, AUGUSTIN  (contact)",NA,NA,NA,2019-nCoV;Address;Area;Basic Science;Biochemical;bioinformatics pipeline;Biological;biological standardization;Biology;cell behavior;Cell Line;Cells;Characteristics;clinical decision-making;Clinical Research;clinical subtypes;Clinical Trials;Communities;Complex;Computer Analysis;Computer Models;COVID-19;COVID-19 pandemic;Data;Data Reporting;Data Set;Development;Disease;DNA Sequence Alteration;drug repurposing;Drug Targeting;Elements;experimental study;Feedback;Gene Expression Regulation;Generations;Goals;Graph;graph database;Heterogeneity;human disease;improved;Institution;interoperability;Knowledge;Machine Learning;machine learning method;Malignant Neoplasms;Maps;Measurement;Measures;member;Metabolism;Methodology;Methods;molecular subtypes;Mutation;novel;Oncogenic;Pharmaceutical Preparations;Pharmacogenomics;Pharmacotherapy;Pre-Clinical Model;predictive marker;Property;Proteomics;rare cancer;Research;Research Personnel;response;Sarcoma;Scientist;Semantics;Signal Transduction;single cell analysis;Standardization;symposium;System;Systems Biology;Systems Development;Testing;tool;Translational Research;usability;Visual;Work,Computational Analysis of Drug Response in Biological Networks,240126,NA,NA,NA,NA,1,NA,NA,882387,NA
11188689,ZIA,MD,1,N,NA,NA,NA,NA,ZIAMD000011,NA,NA,1ZIAMD000011-07,NIMHD:646598\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,15700330 (contact),"EL-TOUKHY, SHERINE  (contact)",NA,NA,NA,"access disparities;adaptive intervention;Adolescent;adolescent health;Adult;Age;American Public Health Association;Awareness;Behavior;behavior change;Behavioral;Behavioral Medicine;Black Populations;Blood;Bluetooth;Body Temperature;Cellular Phone;Characteristics;Cigar;cigarette smoke;cigarette smoking;Cognitive;cohort;COVID-19 patient;COVID-19 test;Data;design;Devices;Diagnosis;digital;digital health;digital technology;Disease;Disease Surveillance;disparity reduction;Documentation;Ecological momentary assessment;Education;Effectiveness;efficacy evaluation;Electronic cigarette;Electronic Health Record;Eligibility Determination;Enrollment;Environment;Ethnic Origin;evidence base;experimental study;Female;Future;Goals;handheld mobile device;Health;Health behavior;Health Benefit;health data;Health Disparities Research;health disparity;health disparity populations;Health Information National Trends Survey;Health Personnel;Health Professional;Heart Rate;heart rate variability;human old age (65+);Improve Access;improved;Individual;insight;Internet;Intervention;Journals;Latino Population;Long COVID;Longitudinal, observational study;male;Manuscripts;Measures;meetings;member;Mental Health;mHealth;minority disparity;mobile computing;Monitor;never smoker;Nicotine;Operating System;Paper;Patient Outcomes Assessments;Patient Self-Report;Patients;Pattern;Peer Review;Persons;physical conditioning;Physiological;Population;Post-Acute Sequelae of SARS-CoV-2 Infection;precision medicine;Predisposition;Prevention Research;primary endpoint;Procedures;Protocols documentation;Provider;Publishing;Race;remote monitoring;Reporting;Research;respiratory;SARS-CoV-2 positive;screening;secondary endpoint;sex;Sleep;sleep onset;Sleep Stages;Smoking;smoking cessation;social media;Societies;sociodemographics;socioeconomic disadvantage;Subgroup;Surveys;Symptoms;System;Tablets;Technology;Telephone;Test Result;Time;Tobacco;tobacco prevention;tobacco products;Tobacco use;tobacco user;tool;trend;Update;uptake;wearable device;Youth",Digital Health and Health Disparities Research Lab,11,NA,NA,NA,NA,7,NA,NA,646598,NA
11188690,ZIA,MD,1,N,NA,NA,NA,NA,ZIAMD000015,NA,NA,1ZIAMD000015-06,NIMHD:797190\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,15700343 (contact),"WILLIAMS, FAUSTINE  (contact)",NA,NA,NA,Accounting;Adult;Affect;African American;aged;Alcohol consumption;alcohol measurement;Anxiety;Asian;Behavior;biopsychosocial factor;Black race;Cannabis;Cardiovascular system;Caring;Categories;Cessation of life;Characteristics;Chronic Disease;chronic pain;Clinical;Communication;COVID-19 pandemic;culturally appropriate intervention;Data;depression prevention;depressive symptoms;Electronic cigarette;electronic cigarette use;Emotional;Employment;Ethnic Origin;Ethnic Population;Exhibits;experience;food insecurity;food security;Generations;Health;health care delivery;Health Fairs;Health Insurance;Healthcare;High Prevalence;Hispanic Populations;Hypertension;Immigrant;Immigration;improved;Individual;Insurance Coverage;Intervention;Interview;Life;marijuana use;Mediation;Mental Depression;Mental disorders;Mental Health;mortality risk;multi-racial;Not Hispanic or Latino;Outcome;pandemic disease;Participant;Patient Self-Report;Pattern;Personal Satisfaction;Persons;Physical activity;Physical Function;Population;Prevalence;Probability;psychological distress;Psychosocial Factor;Race;racial population;Reporting;Research;Respondent;Risk;Sampling;satisfaction;screening;sex;Sleep Disorders;social;Social support;sociodemographics;Stress;structural determinants;substance use;Surveys;Symptoms;trend;Unemployment;Well in self,Understanding Immigrants Stress-Related Mental Health to Promote and Improve Mental Wellbeing,15,NA,NA,NA,NA,6,NA,NA,797190,NA
11188691,ZIA,MD,1,N,NA,NA,NA,NA,ZIAMD000018,NA,NA,1ZIAMD000018-05,NIMHD:674172\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,78838607 (contact),"MARIÑO-RAMÍREZ, LEONARDO  (contact)",NA,NA,NA,"Admixture;African;Age;Algorithms;Area;biobank;Biomedical Research;case control;Catalogs;Code;cohort;Computer software;Country;Data;Data Set;Databases;deprivation;Diagnosis;directed attention;Disease;Disparate;Disparity;Electronic Health Record;Ethnic Population;European;European ancestry;Funding;Genes;Genetic;genetic analysis;genetic architecture;Genetic Programming;genetic variant;Genetic Variation;genome wide association study;genome-wide;genomic data;Genomics;Goals;Health;health determinants;health disparity;Health equity research;health inequalities;Healthcare;High Prevalence;Hispanic Americans;improved;Individual;interest;International Classification of Diseases;International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10);Internet;Latin America;Latin American;Least-Squares Analysis;Low Prevalence;Maps;Methods;Modernization;Native American community;Native Americans;Non-Insulin-Dependent Diabetes Mellitus;Participant;Pattern;Performance;personalized genomic medicine;Persons;Phenotype;Population;Population Group;Prevalence;Principal Component Analysis;programs;Public Health;repository;Research;Research Project Grants;residence;Running;Rye cereal;Sampling;Sampling Biases;sex;socioeconomics;Speed;Time;tool;Underrepresented Populations;Underserved Population;Variant;Visualization",Genomics and Biobank Research for Health Equity,18,NA,NA,NA,NA,5,NA,NA,674172,NA
11188692,ZIA,MD,1,N,NA,NA,NA,NA,ZIAMD000019,NA,NA,1ZIAMD000019-05,NIMHD:427972\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,77854926 (contact),"FORDE, ALLANA  (contact)",NA,NA,NA,Address;Adult;African American;African American Women;African ancestry;Alaska Native;American Indians;Anxiety;Asian;Behavior;Biological;Black race;black women;cancer diagnosis;cardiovascular health;cardiovascular risk factor;Caucasians;Centers for Disease Control and Prevention (U.S.);Characteristics;Chi-Square Tests;Chronic;Code;cost;County;COVID-19;COVID-19 test;COVID-19 treatment;COVID-19 vaccination;COVID-19 vaccine;Data;Data Sources;Decision Making;depressive symptoms;Development;Discrimination;Education;Educational Status;Eligibility Determination;Equitable healthcare;ethnic difference;ethnic discrimination;ethnic disparity;ethnic health disparity;ethnic minority population;Ethnic Population;experience;Factor Analysis;Focus Groups;Fright;Future;future pandemic;Goals;Government;Health;Health Disparities Research;health disparity;Healthcare;Healthcare Systems;Heterogeneity;High Prevalence;high risk;Hispanic;Hypertension;indexing;Inequity;Insurance Coverage;Intervention;Interview;Laboratories;Language;Latina;Latino;Loneliness;lung cancer screening;Malignant neoplasm of lung;Malignant Neoplasms;maltreatment;Manuscripts;marginalization;Measures;Medical;models and simulation;Morbidity - disease rate;mortality;mortality disparity;multi-racial;Native Hawaiian or Other Pacific Islander;Nested Case-Control Study;Not Hispanic or Latino;Participant;perceived stress;Persons;preference;Prevalence;Preventive;Preventive service;programs;psychological distress;psychosocial;Psychosocial Factor;Qualitative Methods;Race;racial difference;racial discrimination;racial disparity;racial minority population;racial population;racism;Recommendation;Regression Analysis;Reporting;Research;response;Risk;Safety;Science;screening;side effect;simulation;Sister;Sleep disturbances;Spanish;stressor;Structural Racism;Structure;Surveys;Testing;Transportation;treatment services;trend;Trust;Vaccination;vaccine acceptance;White Women;willingness,Race Related Stressors and Health Disparities Research Program,19,NA,NA,NA,NA,5,NA,NA,427972,NA
11188693,ZIA,MD,1,N,NA,NA,NA,NA,ZIAMD000020,NA,NA,1ZIAMD000020-04,NIMHD:217985\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,78338321 (contact),"TAMURA, KOSUKE  (contact)",NA,NA,NA,access disparities;Address;Adolescent;Adult;African American Women;biobank;Biological Markers;boys;C-reactive protein;Cardiovascular Diseases;cardiovascular disorder risk;Caring;Characteristics;cohort;Cohort Studies;Collaborations;Communities;community violence;Cost Savings;County;Data;Data Set;density;depressive symptoms;deprivation;Diabetes Mellitus;Disease;Disparity;disparity elimination;disparity reduction;Extramural Activities;Female;Gender;girls;Goals;Health;health determinants;Health Professional;Hour;indexing;Inflammatory;Intervention;Investments;Jackson Heart Study;Laboratories;Link;Longitudinal Studies;male;Manuscripts;Mediating;Medical Care Costs;men;Mental Depression;Mental Health;Metabolic syndrome;middle age;mortality;Multi-Ethnic Study of Atherosclerosis;National Longitudinal Survey of Adolescent to Adult Health;neighborhood safety;Neighborhoods;Non-Insulin-Dependent Diabetes Mellitus;Obesity;older adult;Outcome;Overweight;Participant;Physical activity;Physical environment;Population;Postbaccalaureate;Postdoctoral Fellow;Prevalence;productivity loss;Psychiatric Hospitals;Psychosocial Factor;Public Health;Publishing;Research;Research Personnel;Research Project Grants;residential segregation;Risk;Risk Factors;Role;Safety;Savings;sedentary lifestyle;segregation;Severities;Sleep;sleep health;social cohesion;Social Environment;Stress;structural determinants;Substance Use Disorder;Testing;Time;Weight;Woman;Work,Socio-Spatial Determinants of Health (SSDH),20,NA,NA,NA,NA,4,NA,NA,217985,NA
11188694,ZIA,MD,1,N,NA,NA,NA,NA,ZIAMD000022,NA,NA,1ZIAMD000022-02,NIMHD:74960\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,79311880 (contact),"JAYASEKERA, JINANI  (contact)",NA,NA,NA,Address;Aerobic Exercise;Age;aged;Behavioral;Big Data;Biopsy;Breast;Breast Cancer Detection;Breast Cancer Prevention;Breast Cancer survivor;breast density;cancer care;Cancer Intervention and Surveillance Modeling Network;care delivery;Caring;Cessation of life;Characteristics;Clinical;clinical practice;Collaborations;Collection;comorbidity;Complex;Conduct Clinical Trials;Confidence Intervals;Data;Data Sources;Databases;Death Rate;Decision Aid;Decision Making;Development;Diagnosis;Dose;efficacy evaluation;Equity;ethnic disparity;Event;Exercise;Family;Future;Genomics;Guidelines;hazard;health equity;Health equity research;health goals;health literacy;Health Personnel;Health Services;High Risk Woman;human old age (65+);human very old age (85+);improved;Individual;instrument;International;Intervention;knowledge base;Laboratory Research;Life;Link;Malignant Breast Neoplasm;Malignant Neoplasms;Mammographic screening;Mammography;Manuscripts;mathematical ability;mathematical model;Mathematical Model Simulation;Measurement;Measures;meetings;Meta-Analysis;Metastatic breast cancer;Modeling;models and simulation;mortality;network models;novel;Observational Study;older women;Online Systems;Outcome;Output;Participant;Patient-Focused Outcomes;Patients;Pattern;Peer Review;personalized decision;personalized health care;Policies;Process;programs;Publications;PubMed;racial disparity;Recommendation;Recording of previous events;Recreation;Recurrence;Reporting;Research;research study;response;Risk Factors;Science;screening;Second Primary Cancers;shared decision making;simulation;Structural Racism;Study models;Subgroup;survivorship;systematic review;Target Populations;Testing;tool;Uncertainty;uptake;usability;Validation;Variant;web based interface;Woman;Women&apos;s mortality;working group,Health Equity and Decision Sciences,22,NA,NA,NA,NA,2,NA,NA,74960,NA
11188695,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC000550,NA,NA,1ZIASC000550-44,NCI:1198546\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,9692515 (contact),"JAFFE, ELAINE  (contact)",NA,NA,NA,Address;Adipocytes;Adipose tissue;African American;Age;Alleles;American;Asian population;Autoimmune Diseases;Awareness;B-Cell Lymphomas;B-Cell Neoplasm;B-Lymphocytes;Biology;BRAF gene;Caucasians;Cell Differentiation process;Cell Proliferation;cell type;Cells;Childhood;Classification;Clinical;Clinical Management;clinical practice;Clonal Expansion;Clonality;Consensus;CSF1R gene;Cutaneous;Cytotoxic T-Lymphocytes;Dendritic Cells;Diagnosis;Diagnostic;diagnostic criteria;diagnostic tool;Disease;disease classification;East Asian;eosinophil;Eosinophilia;Eosinophilic Granuloma;Ethnic Origin;ETV3 gene;European;Exhibits;follow-up;Functional disorder;General Population;Genetic;genetic approach;Genomic approach;genomic profiles;Genomics;Genotype;Germ-Line Mutation;Goals;Heel;Hematologic Neoplasms;Hematopoietic Neoplasms;Hispanic;histiocyte;Histiocytosis;Histologic;Immune system;Immunohistochemistry;immunomodulatory therapies;Immunophenotyping;improved;Individual;Inferior;insight;International;Ki-1 Large-Cell Lymphoma;Knowledge;KRAS2 gene;langerin;Link;Literature;Lobular;Lymphocyte;lymphoid neoplasm;Lymphoma;Malignant Neoplasms;MAP2K1 gene;Modification;Molecular;Morphology;Mutation;Mutation Analysis;NCOA2 gene;Neoplasms;Nodal;Nomenclature;North America;novel diagnostics;Panniculitis;Pathogenesis;Pathologic;Patients;Phenotype;Plasma Cells;Polynesian;Process;Prognosis;Property;Publications;Recommendation;Reporting;Scientist;Series;Signal Pathway;South Asian;Stains;subcutaneous;Subcutaneous Nodule;Symptoms;T-Cell Lymphoma;T-Lymphocyte Gene Rearrangement;Terminology;Time;Tissues;transcriptome sequencing;Translating;treatment response;tumor;Update;Variant;Work,Lymphoma Disease Discovery and Definition,550,NA,NA,NA,NA,44,NA,NA,1198546,NA
11188696,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC004020,NA,NA,1ZIASC004020-47,NCI:1733876\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,6572144 (contact),"BERZOFSKY, JAY A (contact)",NA,NA,NA,Adenoviruses;Adjuvant;Affect;Affinity;Age;Agonist;Allogenic;alpha-galactosylceramide;analog;anergy;anti-PD-1;anti-PD-L1;Antibodies;Antigen Presentation;Antigens;Arylsulfatases;Autologous;Avidity;Binding;Biotechnology;Breeding;Cancer Etiology;cancer immunotherapy;Cancer Vaccines;CCR;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;cell killing;Cells;Cholesterol;Clinic;Clinical;Clinical Trials;Combined Vaccines;Cooperative Research and Development Agreement;cytokine;Cytoprotection;Cytotoxic T-Lymphocytes;Data;Dose;Endometrial Carcinoma;Endosomes;Epitopes;Equilibrium;ERBB2 gene;Evaluable Disease;Excision;extracellular;Failure;FOXP3 gene;Gene Expression Profile;Glycolipids;Goals;Granulocyte-Macrophage Colony-Stimulating Factor;Growth;gut microbiome;Helper-Inducer T-Lymphocyte;Histocompatibility;HLA-A2 Antigen;Human;IL17 gene;Immune checkpoint inhibitor;Immune response;Immunity;Immunologic Surveillance;Immunology;immunoregulation;Immunotherapy;improved;inhibitor;Interleukin-12;Interleukin-13;Interleukin-15;invention;KDR gene;Knock-in Mouse;Knockout Mice;Ligands;Lipids;Lung;Malignant Breast Neoplasm;Malignant neoplasm of prostate;Malignant Neoplasms;Mammary Neoplasms;Mediating;Melanoma patient;Metastatic Neoplasm to the Lung;Microbe;microbiome;microbiome alteration;Modification;Mucosal Immunity;Mucous Membrane;Mus;Myeloid Cells;Myeloid-derived suppressor cells;Natural Immunity;Neoplasm Metastasis;neoplastic cell;novel;novel strategies;Omega-3 Fatty Acids;Pathway interactions;Patients;PD-1 blockade;PD-L1 blockade;Peptides;Phase I Clinical Trials;phase I trial;Phase I/II Trial;PPBP gene;preclinical study;prevent;Primary Neoplasm;Process;Publishing;Purinergic P1 Receptors;Rattus;receptor for advanced glycation endproducts;recruit;Regulation;Regulatory T-Lymphocyte;Research;response;Role;Safety;Sampling;scavenger receptor;single-cell RNA sequencing;Skin;Stimulant;Structure;Sulfoglycosphingolipids;synergism;T cell response;T-Cell Depletion;T-Lymphocyte;Testing;Therapeutic Effect;Time;Tissues;TLR3 gene;Toll-like receptors;Training;transcriptome sequencing;Transforming Growth Factor beta;Transgenic Mice;Translating;Translations;Transmembrane Domain;Trastuzumab;Tropism;tumor;Tumor Antigens;tumor growth;Tumor Immunity;Tumor Promotion;Vaccine Adjuvant;Vaccine Design;vaccine efficacy;vaccine immunogenicity;vaccine strategy;Vaccinee;Vaccines;Viral Cancer;viral transmission;Virus;Virus Diseases;Work,Vaccine and immunotherapy strategies for cancer and viruses causing cancer,4020,NA,NA,NA,NA,47,NA,NA,1733876,NA
11188697,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC006321,NA,NA,1ZIASC006321-45,NCI:1505416\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,9692291 (contact),"MITCHELL, JAMES  (contact)",NA,NA,NA,Attention;Blood flow;cancer cell;cancer therapy;Cell Cycle;Cells;chemotherapy;Clinical Trials;contrast enhanced;Cytolysis;Data;Diameter;Dose;Electron Spin Resonance Spectroscopy;Exposure to;Functional Imaging;Gamma-H2AX;Goals;Heat-Shock Proteins 90;Hemoglobin;Human;Hypoxia;Image;improved;In Vitro;in vivo;inhibitor;interest;Ionizing radiation;KRAS2 gene;Lactate Dehydrogenase;lactate dehydrogenase A;Lymphocyte;Magnetic Resonance Imaging;Manuscripts;Measurement;Mediating;metabolic imaging;Metabolism;Mitochondria;Modification;Molecular;molecular imaging;Molecular Target;Mus;Mutation;neoplastic cell;Normal tissue morphology;novel;Oncology;Oxygen;Oxygen Consumption;Physiology;pre-clinical research;Process;programmed cell death protein 1;Publications;Publishing;Pyruvate;Radiation;radiation effect;Radiation induced damage;radiation response;Radiation Tolerance;Radiation-Protective Agents;Radiosensitization;Ras Inhibitor;Research;Research Design;Resistance;response;Rodent;senescence;senescent cell;T-Cell Activation;T-Lymphocyte;targeted agent;Therapeutic;tissue oxygenation;Tissues;Toxic effect;Translating;treatment response;tumor;tumor hypoxia;tumor microenvironment;Tumor Tissue;vasculogenesis,Modulation of Therapeutic Response,6321,NA,NA,NA,NA,45,NA,NA,1505416,NA
11188698,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC006330,NA,NA,1ZIASC006330-44,NCI:168013\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,7937849 (contact),"MILLER, ROBERT  (contact)",NA,NA,NA,3-Dimensional;absorption;Affect;Agreement;Anatomy;Authorization documentation;base;Child;Clinical;code development;Computer software;computerized;Computers;cost;COVID-19;Custom;detector;Development;Diagnostic;Diagnostic radiologic examination;Dose;dosimetry;Electrons;Environment;Epidemiology;Extramural Activities;Four-dimensional;Generations;Goals;Government;Growth;Image;improved;indexing;Individual;Joints;Learning;Legal patent;Link;Linux;Lung;Measurement;Medical center;Methodology;Methods;Modality;Modeling;Monte Carlo Method;Motion;Operating System;Organ;Output;patient population;Performance;Persons;Phase;Production;Radiation;Radiation therapy;Radiosurgery;recruit;Research;response;Roentgen Rays;Scanning;Security;Site;software development;Source;System;Techniques;Testing;treatment planning;Vendor;Work;X-Ray Computed Tomography,Radiation Field Modeling and Computerized Treatment Planning,6330,NA,NA,NA,NA,44,NA,NA,168013,NA
11188699,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC006387,NA,NA,1ZIASC006387-37,NCI:250903\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,9692291 (contact),"MITCHELL, JAMES  (contact)",NA,NA,NA,Animals;Anti-Inflammatory Agents;Antioxidants;Bacteria;Bile Acids;Body Weight decreased;cancer therapy;carcinogenesis;catalase;cell injury;Cells;Chemicals;Chemoprevention;Consumption;Control Animal;Control Groups;Diet;Disease;Drug Targeting;Environment;fatty acid metabolism;feeding;Free Radicals;Gene Expression;Genes;germ free condition;glucagon-like peptide 1;Goals;gut microbiome;gut microbiota;High Fat Diet;Human;Immune;Ionizing radiation;Laboratories;Lead;Mediating;Metabolism;Modeling;Molecular;Mus;Nerve Degeneration;Obesity;Outcome;Oxidative Stress;Oxygen;pathogen;Pathologic;Pathway interactions;Phenotype;prevent;Process;Proteins;Publications;Radiation;Radiation induced damage;Reaction;Reactive Oxygen Species;Role;Signal Pathway;Signal Transduction;Superoxide Dismutase;tempol;Thinness;Tissues;United States National Institutes of Health;Weight Gain;Weight maintenance regimen,Nitroxides as Protectors Against Oxidative Stress,6387,NA,NA,NA,NA,37,NA,NA,250903,NA
11188700,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC006538,NA,NA,1ZIASC006538-31,NCI:760679\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,9979589 (contact),"FIGG, WILLIAM DOUGLAS (contact)",NA,NA,NA,3-Dimensional;Affect;Alkaloids;analog;angiogenesis;Angiogenesis Inhibition;Angiogenesis Inhibitors;Angiogenesis Pathway;Anti-Bacterial Agents;anti-cancer;anti-fungal agents;Anti-Inflammatory Agents;antiangiogenesis therapy;Antineoplastic Agents;Aorta;Attention;Binding;Biological;Biological Assay;Biological Markers;Biological Models;C-terminal;cancer therapy;Chemical Structure;chemotherapy;Chick Embryo;Clinical;Collaborations;Complex;Cysteine;Cytochrome P450;design;Development;Drug Design;drug development;Drug resistance;Drug Screening;Endothelial Cells;Energy Metabolism;EP300 gene;Exhibits;Fluorescence;Fluorine;glutarimide;high throughput screening;Histidine;Human;Hypoxia;Hypoxia Inducible Factor;hypoxia inducible factor 1;Imides;immune modulating agents;immunoregulation;improved;In Vitro;in vivo;in vivo Model;Inflammation;Inflammatory;inhibitor;interest;Invaded;Isoenzymes;Laboratories;Lead;lead candidate;Legal patent;Libraries;Malignant neoplasm of prostate;Malignant Neoplasms;marine;Measures;Metabolic Biotransformation;migration;Modeling;Molecular;Molecular Target;Multiple Myeloma;Natural Product Drug;Natural Products;Natural Products Chemistry;New Agents;New Zealand;novel;novel therapeutics;Patients;Pharmaceutical Preparations;Pharmacology;Pharmacotherapy;Phthalimides;Play;Porifera;pre-clinical;Pre-Clinical Model;preclinical development;preclinical study;Preparation;Property;protein expression;protein protein interaction;Pyrroloiminoquinones;rational design;Rattus;Regimen;Relapse;Reporting;repository;Research;research clinical testing;Resistance;Role;Saphenous Vein;Scanning;secondary analysis;Series;small molecule inhibitor;Solid Neoplasm;spheroids;Structure;Structure-Activity Relationship;Synthesis Chemistry;targeted treatment;Thalidomide;Therapeutic;therapeutically effective;Time;Toxic effect;Transactivation;Tube;tumor;Tumor Angiogenesis;tumor growth;ubiquitin-protein ligase;United States National Institutes of Health;Viral;Western Blotting;Zebrafish,Development of Anticancer Agents,6538,NA,NA,NA,NA,31,NA,NA,760679,NA
11188701,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC006737,NA,NA,1ZIASC006737-33,NCI:100520\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,6572342 (contact),"YARCHOAN, ROBERT  (contact)",NA,NA,NA,AIDS related cancer;Anti-HIV Agents;Anti-HIV Therapy;anti-PD-1;anti-PD-L1;Binding;Collaborations;Development;Diagnosis;Goals;HIV;HIV Infections;HIV Protease;HIV resistance;HIV-1;HIV-1 integrase;Immune checkpoint inhibitor;Immune response;Impairment;Life Cycle Stages;Nature;novel;novel therapeutics;Nuclear Localization Signal;Oncology;Pathogenesis;Patients;pembrolizumab;Peptide Hydrolases;Pharmaceutical Preparations;Prevention strategy;Preventive therapy;Protease Inhibitor;Research;Resistance;Variant;Viral;Viral reservoir;Virus;Virus Diseases,Development of Preventive Strategies and Therapy for HIV Infection,6737,NA,NA,NA,NA,33,NA,NA,100520,NA
11188702,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC006738,NA,NA,1ZIASC006738-33,NCI:326425\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,9692585 (contact),"MITSUYA, HIROAKI  (contact)",NA,NA,NA,Acetals;Acetates;Acquired Immunodeficiency Syndrome;Active Sites;Affect;Affinity;Amides;Annual Reports;Anti-Retroviral Agents;Anti-viral Therapy;antiretroviral therapy;antiviral drug development;Area;Aspartate;benzenesulfonamide;Binding;Binding Sites;Biological;Biological Assay;Carboxylic Acids;Cardiovascular Diseases;Cells;chloroacetate;Chronic;Clinical;Cyclosporine;Data;design;Development;Disease;drug development;Effectiveness;Elements;enantiomer;Enzyme Inhibition;Enzymes;Epidemic;Ethane;Evaluation;Exhibits;FDA approved;General Population;Genetic;high risk;HIV;HIV Infections;HIV resistance;HIV-1;HIV-1 drug resistance;HIV-1 protease;HIV-Associated Lipodystrophy Syndrome;HIV/AIDS;Hydrogen Bonding;Hydrophobicity;Hyperlipidemia;improved;indexing;Individual;Infection;inhibitor;inhibitor therapy;insight;Integrase;Lead;Life Expectancy;Ligand Binding;Ligands;Lipase;Lipids;Molecular;Molecular Conformation;Multi-Drug Resistance;mutant;nanomolar;non-nucleoside reverse transcriptase inhibitors;novel;Nucleosides;Optics;Oxygen;Patients;Peptide Hydrolases;Periodicity;Pharmaceutical Preparations;pharmacologic;Population;Prognosis;Protease Inhibitor;Proteins;Quality of life;Regimen;Reporting;Research;Resolution;Reverse Transcriptase Inhibitors;Risk Estimate;Roentgen Rays;scaffold;Series;Side;side effect;Signal Transduction;Stains;Structure;success;Sulfonamides;System;tetrahydrofuran;Treatment Failure;Treatment Protocols;Variant;Vertebral column;Viral;Viral Physiology;X-Ray Crystallography,Development of Antiviral Therapy of HIV-1 Infection,6738,NA,NA,NA,NA,33,NA,NA,326425,NA
11188703,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC006741,NA,NA,1ZIASC006741-32,NCI:780978\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,6572212 (contact),"WILSON, WYNDHAM H (contact)",NA,NA,NA,Adverse effects;Advisory Committees;AIDS-Related Lymphoma;B-Cell Activation;B-Cell Lymphomas;B-Lymphocytes;Burkitt Lymphoma;Categories;Cells;chemotherapy;Cities;Classification;Clinical;Clinical Research;Clinical Trials;Collaborations;Consensus;Cytotoxic agent;Development;Dose;Doxorubicin;Drug Kinetics;Drug Targeting;druggable target;effective therapy;Elements;Empiricism;gene therapy;Genetic;Gray Zone Lymphoma;Hepatic;high risk;HIV;HIV Infections;Human Herpesvirus 4;immunodeficiency;Immunosuppression;Impairment;improved outcome;Incidence;indexing;Indolent;Inflammasome;insight;International;large cell Diffuse non-Hodgkin&apos;s lymphoma;lymphoid neoplasm;Lymphoma;Lymphoproliferative Disorders;Macrophage;Mantle Cell Lymphoma;Mediastinal;Molecular;Molecular Biology;molecular subtypes;Mycoses;NF-kappa B;novel;Outcome;Pathway interactions;Patients;Pharmacodynamics;Research;research study;Role;Schedule;Signal Transduction;standard of care;Structure of germinal center of lymph node;targeted agent;Therapeutic;therapy outcome;Thymus Gland;Toxic effect;Translating;translational study;treatment program;tumor DNA;Validation;Variant,Therapeutic Strategies and Molecular Correlates in Aggressive B-cell Lymphomas,6741,NA,NA,NA,NA,32,NA,NA,780978,NA
11188704,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC007263,NA,NA,1ZIASC007263-32,NCI:1252350\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,14821366 (contact),"LIPKOWITZ, STANLEY  (contact)",NA,NA,NA,Adaptive Immune System;Agonist;Animals;Antibodies;Apoptosis;Binding Proteins;Breast Cancer Cell;Breast Cancer cell line;Breast Cancer Model;Breast Cancer Patient;Breast Cancer Treatment;cancer cell;cancer subtypes;Caspase;Cell Death;Cell Death Induction;cell killing;Cells;Cessation of life;chemotherapeutic agent;Clinical Trials;Collaborations;Combined Modality Therapy;Credentialing;Data;Drug Synergism;Drug usage;Endometrial Carcinoma;Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Epigenetic Process;Family;functional genomics;Genes;Genetic;Induction of Apoptosis;Innate Immune System;Ligands;Malignant Breast Neoplasm;Mediating;member;Mitochondria;National Center for Advancing Translational Sciences;Necrosis;novel;novel drug class;Pathway interactions;Patients;Peptide Hydrolases;Pharmaceutical Preparations;Phase II Clinical Trials;pre-clinical;preclinical study;Protein Tyrosine Kinase;Proteins;receptor;recruit;Resistance;targeted agent;targeted treatment;TNF gene;TNFRSF10A gene;TNFRSF10B gene;TNFRSF1A gene;Toxic effect;Trastuzumab;tumor initiation;Tumor Necrosis Factor Ligand Superfamily Member 6;Tumor Necrosis Factor Receptor;Work,Activating Cell Death Pathways in Breast Cancer Cells,7263,NA,NA,NA,NA,32,NA,NA,1252350,NA
11188705,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC007281,NA,NA,1ZIASC007281-31,NCI:551427\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,9692213 (contact),"WINK, DAVID  (contact)",NA,NA,NA,4T1;Adjuvant;Alzheimer&apos;s Disease;Antineoplastic Agents;Antioxidants;Antitumor Response;Biological;Biology;Biopsy;breast cancer progression;cancer therapy;cancer type;Cardiovascular Diseases;chemical reaction;Chemicals;Chemistry;Chemotherapy and/or radiation;Clinical Treatment;Clinical Trials;Collaborations;Communicable Diseases;Development;Disease;Disease Progression;DNA;DNA Repair;drug efficacy;Estrogen receptor negative;Future;genotoxicity;Goals;Growth;Heart Diseases;Heart failure;Hospitals;Immune system;improved;Inflammation;Inflammatory;Kinetics;Malignant Breast Neoplasm;Malignant Neoplasms;Mediator;Metabolic;Methodist Church;migration;Modeling;Myocardial Ischemia;Neoadjuvant Therapy;Nerve Degeneration;Nitric Oxide;Nitric Oxide Donors;Nitric Oxide Synthase;Nitric Oxide Synthetase Inhibitor;NOS2A gene;novel;novel therapeutic intervention;Oncogenic;Outcome;Oxidation-Reduction;Oxidative Stress;pathogen;Pathway interactions;Patients;Phase;preconditioning;Production;Prognosis;Proliferating;PTGS2 gene;Radiation therapy;Reactive Oxygen Species;Reperfusion Injury;Reperfusion Therapy;Reporting;Research;Research Personnel;Series;Siblings;Signal Transduction;Solid;stem;System;Thermodynamics;Time;Toxicology;triple-negative invasive breast carcinoma;tumor;Work;Xenograft Model,Nitric Oxide as a Modifier of Oxidative Stress,7281,NA,NA,NA,NA,31,NA,NA,551427,NA
11188706,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC009144,NA,NA,1ZIASC009144-40,NCI:646030\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,9692465 (contact),"LEVENS, DAVID L. (contact)",NA,NA,NA,Active Sites;Acute;Affinity Chromatography;Binding;Binding Proteins;Binding Sites;Biological Assay;c-myc Genes;cancer cell;Cell Differentiation process;cell growth;Cells;Chromatin;Chromatin Loop;Chromatography;Development;DNA;DNA sequencing;Elements;experimental study;Feedback;Gene Expression;Genes;Genetic;Genetic Transcription;genome-wide;Genomics;Goals;Human;In Vitro;in vivo;insight;knock-down;Knock-in;Knock-out;Knockout Mice;Laboratories;Malignant Neoplasms;Measures;melting;Molecular;Molecular Conformation;Monitor;Mus;MYC gene;nanopore;Normal Cell;nuclease;Output;Pathologic;Pathology;Pathway interactions;Phase;Physical condensation;Physiologic pulse;Physiological;Preparation;prevent;promoter;Proteins;Pump;rapid test;Reaction;reconstitution;Regulation;response;Series;Signal Pathway;Signal Transduction;Site;Stress;System;Testing;Therapeutic;tool;Topoisomerase;transcription factor;transcription factor TFIIH;Transcriptional Activation;Work,Mechanisms of transcription factor integration at the c-myc promoter,9144,NA,NA,NA,NA,40,NA,NA,646030,NA
11188707,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC009172,NA,NA,1ZIASC009172-36,NCI:965406\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,8778188 (contact),"ROBERTS, DAVID D (contact)",NA,NA,NA,Acute;adaptive immune response;Adult;Affect;aged;Agonist;aldehyde dehydrogenase 1;angiogenesis;Angiogenesis Inhibition;Angiogenesis Inhibitors;antagonist;Anthracycline;anti-tumor immune response;Antibodies;Antigen Presentation;Autophagocytosis;Blocking Antibodies;Blood flow;Blood Platelets;Blood Pressure;Bone Marrow;Breast Carcinoma;c-myc Genes;cancer cell;cancer immunotherapy;cancer stem cell;CD34 gene;CD47 gene;CD47-SIRPα;CD8-Positive T-Lymphocytes;Cell Line;Cell Surface Receptors;Cell Survival;Cells;Clinical Trials;Cyclic GMP;Cyclic GMP-Dependent Protein Kinases;cytotoxic;Data;DNA Repair;Epithelium;Erythrocytes;Erythroid;Erythropoiesis;Excision;Exhibits;Extracellular Matrix;Extramedullary;Family suidae;Flow Cytometry;Gene Expression;Genes;Genetic Transcription;Glycoproteins;Growth;Hemostatic function;Human;immune checkpoint;inhibiting antibody;innate immune checkpoint;Ionizing radiation;Irradiated tumor;Ischemia;ischemic injury;KDR gene;Knockout Mice;Ligands;Macrophage;Maintenance;Malignant Breast Neoplasm;Malignant Epithelial Cell;Malignant Neoplasms;Mammospheres;MDA MB 231;Mediating;Mesenchymal;Metabolism;mouse model;mRNA Expression;Multipotent Stem Cells;Mus;Myeloid Cells;Myocardium;Natural Killer Cells;Neoplasm Metastasis;neoplastic cell;Nitric Oxide;Non-Malignant;NOS3 gene;novel;Null Lymphocytes;Pathway interactions;Phagocytes;Play;progenitor;Prognosis;Proliferating;protein expression;PTPN6 gene;PTPNS1 gene;Radiation Injuries;radiation resistance;Rattus;receptor;Recombinants;Recovery;Regulation;Reperfusion Injury;Reporting;response;Role;self-renewal;SHPS-1 protein;Signal Pathway;Signal Transduction;Signal Transduction Pathway;Smooth Muscle Myocytes;soft tissue;Soluble Guanylate Cyclase;Spleen;stem cells;Stromal Cells;T-Lymphocyte;Therapeutic;Thrombospondin 1;Thrombospondins;tissue culture;tissue stress;Tissue Survival;Tissues;transcription factor;transcriptome;Transgenic Mice;transmission process;treatment response;tumor;Tumor Immunity;tumor progression;tumor xenograft;Vascular Smooth Muscle;Wild Type Mouse,Cellular Interactions with Thrombospondin,9172,NA,NA,NA,NA,36,NA,NA,965406,NA
11188708,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC009174,NA,NA,1ZIASC009174-36,NCI:107268\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,8778188 (contact),"ROBERTS, DAVID D (contact)",NA,NA,NA,adaptive immune response;Aging;Anabolism;anti-CTLA4;Antibodies;Antigens;antiviral immunity;autocrine;Autoimmune Diseases;B-Lymphocytes;Biological Markers;Blood Platelets;CD47 gene;cell behavior;Cell Differentiation process;Cell Surface Receptors;cell type;Cells;checkpoint therapy;Communicable Diseases;CTLA4 gene;cytokine;Cytotoxic T-Lymphocytes;Dendritic Cells;Development;Eating;Extracellular Matrix;Extracellular Space;FDA approved;Glycoproteins;Human;Hydrogen Sulfide;Hyperglycemia;Immune;Immune checkpoint inhibitor;Immune response;Immunity;Immunocompetent;Immunosuppression;In Vitro;in vivo;Inflammatory;Injury;Innate Immune Response;insight;Interleukin-2;ipilimumab;irradiation;Ischemia;Macrophage;Mediating;Mediator;Melanoma;Melanoma Cell;Modeling;Mus;nanomolar;Natural Killer Cells;neoplastic cell;neutrophil;new combination therapies;Nitric Oxide;NK Cell Activation;Patients;Phagocytosis;Physiological;Plasma;Production;Prognostic Marker;receptor;Receptor Signaling;Reporting;response;Role;SHPS-1 protein;Signal Transduction;Stress;T-Cell Activation;T-Cell Receptor;T-Lymphocyte;Therapeutic;Thrombospondin 1;Transforming Growth Factor beta;translational applications;tumor;Tumor Immunity;tumor immunology;tumor microenvironment;Vascular Endothelial Growth Factors;Work,Roles of CD47 Signaling in Tumor Immunology,9174,NA,NA,NA,NA,36,NA,NA,107268,NA
11188709,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC009179,NA,NA,1ZIASC009179-36,NCI:285819\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,9414468 (contact),"STETLER-STEVENSON, WILLIAM  (contact)",NA,NA,NA,Acute Disease;Alanine;Angiogenesis Inhibitors;Apoptosis;Basement membrane;Behavior;Biological;Breast Cancer cell line;C-terminal;cancer cell;cell growth;cell motility;Cell Physiology;Cell surface;Cell Surface Receptors;cell type;Chronic Disease;Complex;Cultured Tumor Cells;Data;Development;Disintegrins;Disulfides;Elements;Endothelium;Enzyme Inhibitor Drugs;Enzymes;Equilibrium;experimental study;Extracellular Matrix;Family;Fibroblasts;fibrosarcoma;Future;Gelatinase A;gene product;Genes;Glioblastoma;Goals;Growth;Growth Factor;Growth Factor Inhibition;Human;In Vitro;in vivo;Inhibition of Matrix Metalloproteinases Pathway;inhibitor;Interstitial Collagenase;Invaded;Investigation;Laboratories;link protein;Lung;lung cancer cell;Matrix Metalloproteinase Inhibitor;Matrix Metalloproteinases;Mediating;member;Metalloproteases;Methods;migration;MMP14 gene;MMP9 gene;N-Glycosylation Site;N-terminal;Neoplasm Metastasis;neoplastic cell;Normal tissue morphology;novel;Pathology;Physiology;prevent;Protease Inhibitor;Proteins;Receptor Protein-Tyrosine Kinases;Reporting;Research;Residual state;Role;Signal Pathway;Signal Transduction;Tail;Therapeutic;Thrombospondins;TIMP2 gene;TIMP3 gene;Tissue Inhibitor of Metalloproteinase-1;Tissue Inhibitor of Metalloproteinases;Tissues;tumor;tumor microenvironment;tumor progression;tumorigenic;Vascular Endothelial Cell;Zinc,"The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis",9179,NA,NA,NA,NA,36,NA,NA,285819,NA
11188710,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC010074,NA,NA,1ZIASC010074-29,NCI:904298\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,9692445 (contact),"NECKERS, LEONARD  (contact)",NA,NA,NA,Address;Alternative Splicing;androgen independent prostate cancer;Androgen Receptor;Androgens;Anti-androgen Therapy;Area;Binding;cancer site;Carbon;Castration;Cells;Citric Acid Cycle;Client;Collaborations;Compensation;Complex;Dependence;deprivation;Development;drug development;Electron Transport;enzalutamide;Genetic Transcription;glucose uptake;Glutamine;Heat-Shock Proteins 70;Heat-Shock Proteins 90;Homologous Gene;HSF1;In Vitro;in vivo;inhibitor;Knock-out;Length;Ligand Binding Domain;magnetic resonance spectroscopic imaging;Magnetic Resonance Spectroscopy;Malignant neoplasm of prostate;Malignant neoplasm of urinary bladder;Malignant Neoplasms;Mediating;Metabolic;Mitochondria;Molecular Chaperones;monomer;Neoplasm Metastasis;non-invasive imaging;novel;novel strategies;Oncogenic;Outcome;Oxidative Phosphorylation;Pharmaceutical Preparations;Phenocopy;Phosphotransferases;preference;Production;programs;Prostate;Proteins;Publications;Pyruvate;Regulation;Renal Carcinoma;Reproducibility;Research;Residual state;Resistance;Respiration;RNA Splicing;Role;Signal Transduction;Source;Translations;Urologic Diseases,HSP90 and HSP70 Chaperone Proteins and Interactors in Cellular Signal Transduction,10074,NA,NA,NA,NA,29,NA,NA,904298,NA
11188711,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC010093,NA,NA,1ZIASC010093-28,NCI:1247492\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,6572356 (contact),"SCHRUMP, DAVID  (contact)",NA,NA,NA,Aberrant DNA Methylation;Adjuvant Therapy;Adoptive Immunotherapy;aerosolized;Antigen Presentation Pathway;Antigens;Apoptosis;Azacitidine;Biodistribution;BMX gene;cancer cell;Cancer Center;Cancer Patient;cancer stem cell;cancer/testis antigen;Cell Separation;Cells;chromatin remodeling;Chromatin Structure;Chronic;Clinical;Clinical Protocols;Clinical Trials;COVID-19 pandemic;cytokine;Data;Decitabine;demethylation;derepression;DNA;DNA Methylation;Drug Kinetics;Drug Stability;Early Diagnosis;epigenetic drug;Epigenetic Process;epigenetic therapy;epigenomics;Evaluation;Event;Exhibits;experience;first-in-human;Gene Expression;Genes;Germ Lines;Goals;Growth;Hawaii;HDAC8 gene;Histone Deacetylase Inhibitor;Histone-Lysine N-Methyltransferase;Histones;Human;immune checkpoint blockade;Immune response;Immunocompetent;immunogenicity;Immunosuppression;Immunotherapy;In Vitro;in vivo Model;Individual;Inhalation;inhibitor;Institution;Interleukin-12;Interleukin-15;International;Intervention;laboratory experiment;Life;liquid biopsy;Lung;Malignant - descriptor;Malignant neoplasm of esophagus;Malignant neoplasm of lung;Malignant neoplasm of thorax;Malignant Neoplasms;Malignant Pleural Mesothelioma;Manuscripts;Mediating;Mesothelial Cell;Mesothelioma;Metastatic Neoplasm to the Lung;minimally invasive;Modeling;Modification;Molecular;Mus;Mutation;Neoadjuvant Therapy;Neoplasm Metastasis;Neoplasms;Nivolumab;Non-Small-Cell Lung Carcinoma;Normal Cell;Nucleosomes;Operative Surgical Procedures;Oral;Oral Examination;Participant;Pathway interactions;Patients;Peer Review;pembrolizumab;Perioperative;Pharmaceutical Preparations;Phase;Phase I/II Clinical Trial;phase II trial;Positioning Attribute;preclinical study;prevent;programs;Proteins;Protocols documentation;Publications;Publishing;radiological imaging;Regimen;response;Scanning;Series;symposium;Syndrome;systemic toxicity;Techniques;Testis;Tetrahydrouridine;Thoracic Neoplasms;Thoracic Oncology;Toxic effect;TP53 gene;Translational Research;Treatment Protocols;treatment response;tumor;Tumor Suppressor Genes;Universities;Vaccines;virtual;Writing,Epigenetic Therapy for Thoracic Malignancies,10093,NA,NA,NA,NA,28,NA,NA,1247492,NA
11188712,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC010354,NA,NA,1ZIASC010354-25,NCI:1884219\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,9414412 (contact),"WIDEMANN, BRIGITTE  (contact)",NA,NA,NA,Acceleration;Achievement;Adolescent;Adult;Age;Atlases;Benign;Biological Markers;Biology;Biopsy;cell free DNA;Cells;Child;Childhood;Clinic;Clinical;Clinical Investigator;Clinical Trials;Clinical Trials Network;Collaborations;Combined Modality Therapy;Country;Cutaneous;Data;Decision Making;Development;Developmental Therapeutics Program;Disease remission;Dose;drug development;drug discovery;Early Intervention;early phase clinical trial;Educational workshop;effective therapy;Enrollment;Evaluation;Excision;Extramural Activities;functional outcomes;Funding;Genetic;Genetic Predisposition to Disease;Goals;Growth;high risk;Histologic;hyperactive Ras;Image;inhibitor;innovation;insight;Intervention;Intervention Trial;Knowledge;Lesion;Liquid substance;Location;Magnetic Resonance Imaging;Malignant - descriptor;Malignant Childhood Neoplasm;Malignant Neoplasms;Manuscripts;Measurement;Medical;MEKs;Mission;Molecular;Morbidity - disease rate;Natural History;neurofibroma;Neurofibromatoses;Neurofibromatosis 1;Neurofibrosarcoma;Nodular Lesion;novel;novel therapeutics;participant enrollment;Pathogenesis;Pathologic;Pathway interactions;Patient Care;Patients;Pediatric Oncology;Pediatric Oncology Group;Peripheral Nerve Sheath Neoplasm;Persons;pet animal;Pharmacodynamics;Phase;phase I trial;phase II trial;Plexiform Neurofibroma;Population;Positioning Attribute;Predisposition;premalignant;prevent;Prevention;Prevention strategy;Prevention trial;programs;rare cancer;Recommendation;Refractory;refractory cancer;Registries;Reporting;Research Personnel;Resources;response;Risk;Sarcoma;Science;Secondary Prevention;Series;Site;Solid Neoplasm;Syndrome;targeted agent;targeted treatment;therapy development;Toxic effect;treatment strategy;trial design;tumor;United States;United States National Institutes of Health;young adult,Therapies for patients with rare tumors and genetic tumor predisposition,10354,NA,NA,NA,NA,25,NA,NA,1884219,NA
11188713,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC010355,NA,NA,1ZIASC010355-25,NCI:962192\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,9414375 (contact),"TOSATO, GIOVANNA  (contact)",NA,NA,NA,angiogenesis;Angiogenesis Inhibitors;Angiogenic Factor;Biochemical;Blood Cells;cancer care;cancer cell;Cancer Model;Cancer Patient;cancer therapy;cell growth;Cell Physiology;Characteristics;chemotherapy;Clinic;Complex;Development;Drug Targeting;Endothelial Cells;Endothelial Growth Factors;Epigenetic Process;Extracellular Matrix;Genetic;Goals;Heterogeneity;Immune Targeting;Individual;Knowledge;Link;Malignant Neoplasms;Metabolic;migration;Neoplasm Metastasis;neoplastic cell;new therapeutic target;Nutrient;Oxygen;Performance;Pericytes;Pharmaceutical Preparations;Physiological;pre-clinical;Process;receptor;recruit;Research;Resistance;Signal Transduction;Site;targeted treatment;Testing;Therapeutic;therapeutic target;Time;treatment response;tumor;Tumor Angiogenesis;Tumor Expansion;tumor growth;Tumor Immunity;tumor microenvironment;tumor progression;Vascular blood supply;Vascular Endothelial Growth Factors;VEGFA gene,Angiogenesis and Tumor Growth,10355,NA,NA,NA,NA,25,NA,NA,962192,NA
11188714,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC010356,NA,NA,1ZIASC010356-25,NCI:481097\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,9414375 (contact),"TOSATO, GIOVANNA  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;AIDS related cancer;angiogenesis;Angiogenesis Inhibitors;body cavity;cancer type;Cause of Death;cell growth;Cell Proliferation;Cells;Clinical;cytokine;Development;Dose;Drug Targeting;Endothelial Cells;Environment;Environmental Risk Factor;experimental study;Exposure to;Genes;Genetic;Goals;HIV Infections;HIV/AIDS;Hodgkin Disease;Human;Human Herpesvirus 8;Immunity;improved;Inflammatory;interest;Kaposi Sarcoma;lenalidomide;Leukemic Cell;Link;Lymphatic Endothelial Cells;Lymphoma cell;Malignant neoplasm of lung;Malignant Neoplasms;Molecular;Multicentric Angiofollicular Lymphoid Hyperplasia;Mus;mutant;Mutant Strains Mice;Nature;novel therapeutics;Oryctolagus cuniculus;Pathogenesis;patient population;Patients;Pharmaceutical Preparations;pomalidomide;primary effusion lymphoma;Process;Proliferating;Proteins;Reporting;Research;Role;Signal Transduction;success;Syndrome;T-Lymphocyte;Testing;Thalidomide;Therapeutic;Time;Tissues;tumor;Tumor Angiogenesis;tumor progression;Tumor Promotion;tumorigenic;Vascular Endothelial Cell;Viral;virus related cancer;Work,A Role for KSHV in the Pathogenesis of Malignancies,10356,NA,NA,NA,NA,25,NA,NA,481097,NA
11188715,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC010357,NA,NA,1ZIASC010357-25,NCI:1845350\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,2110131 (contact),"ZHENG, ZHI-MING  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Adenosine;Alternative Splicing;Animal Model;B-Cell Lymphomas;B-Lymphocytes;Binding;biomarker identification;body cavity;cancer gene expression;carcinogenesis;CASP7 gene;Cell Proliferation;cell transformation;Cells;Cervical dysplasia;Chromosomes;chronic infection;clinical diagnosis;clinical prognosis;Code;cytokine;Development;dimer;DNA Tumor Viruses;Elements;Exons;Gene Expression;Genes;Genetic Transcription;Genome;genome-wide;Goals;Gossypium;Herpesviridae Infections;high risk;HIV;hnRNP A1;HPV E7;HPV-High Risk;Human Herpesvirus 8;Human papilloma virus infection;Human Papillomavirus;Human papillomavirus 16;IL6 gene;Infection;Inflammation;Interleukin-10;Interruption;Introns;Kaposi Sarcoma;Laboratories;Lesion;Lytic;Lytic Phase;Malignant neoplasm of anus;Malignant neoplasm of cervix uteri;Malignant Neoplasms;malignant oropharynx neoplasm;Mediating;MicroRNAs;Modeling;monomer;mRNA Precursor;Multicentric Angiofollicular Lymphoid Hyperplasia;Mus;Natural Immunity;Oncogenic;Oncogenic Viruses;Open Reading Frames;Oryctolagus cuniculus;overexpression;Papillomavirus;Papillomavirus Infections;Papillomavirus Transforming Protein E6;Patients;Play;Post-Transcriptional Regulation;posttranscriptional;pre-clinical;Pre-mRNA Polyadenylation Factor;primary effusion lymphoma;Production;Proteins;Proto-Oncogenes;Regulation;RNA;RNA Caps;RNA Instability;RNA Splicing;RNA-Binding Proteins;RNA-Protein Interaction;Role;Series;Sexual Transmission;Site;Spliceosomes;Stress;stress granule;Structure;Study models;Tail;Therapeutic;Transcript;Translation Initiation;Translational Repression;Translations;tumor;Tumor Suppressor Proteins;Untranslated RNA;Viral;viral carcinogenesis;viral DNA;Viral Oncogene;viral RNA;virology;Virus Integration,Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,10357,NA,NA,NA,NA,25,NA,NA,1845350,NA
11188716,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC010366,NA,NA,1ZIASC010366-24,NCI:229739\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,9692453 (contact),"KHAN, JAVED  (contact)",NA,NA,NA,Artificial Intelligence;Attention;biomarker development;cancer genomics;Classification;Clinical;convolutional neural network;Data;deep learning;Diagnosis;DNA analysis;DNA Sequence Alteration;driver mutation;Event;Genes;Genetic;Germ Lines;Goals;Hematoxylin and Eosin Staining Method;Histologic;Image;improved;large language model;Malignant Childhood Neoplasm;Maps;Modeling;Molecular;molecular subtypes;Morphology;multimodality;Neural Network Simulation;next generation sequencing;Outcome;outcome prediction;Pathway interactions;Patients;Play;predicting response;predictive modeling;Prognosis;Proteomics;Rhabdomyosarcoma;risk prediction;Role;therapeutic target;Time;tumor DNA,Predicting Response and Prognosis in Pediatric Cancers,10366,NA,NA,NA,NA,24,NA,NA,229739,NA
11188717,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC010372,NA,NA,1ZIASC010372-24,NCI:655320\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,9692373 (contact),"CAMPHAUSEN, KEVIN  (contact)",NA,NA,NA,Affect;Biogenesis;Biology;blood-brain barrier penetration;Characteristics;Clinic;Clinical;Clinical Trials;clinically relevant;Collaborations;Development;DNA;Dose;Drug Delivery Systems;Drug Kinetics;drug testing;experience;Failure;FDA approved;Functional disorder;Glioblastoma;Goals;Histone Deacetylase Inhibitor;Image;improved;In Vitro;in vivo;inhibitor;irradiation;Megakaryocytes;metabolic imaging;Metabolism;MGMT gene;Modeling;Molecular;National Center for Advancing Translational Sciences;novel;novel marker;Patients;Pharmaceutical Preparations;Pharmacology;pre-clinical;preclinical development;preclinical study;predictive modeling;Primary Neoplasm;programs;Proteins;Publishing;Radiation therapy;Radiation-Sensitizing Agents;Reaction Time;Recurrence;response;Ribosomes;Role;Testing;Toxicology;Translating;Translations;tumor;Work,Pre-clinical Development of Radiation Sensitizers for Patients with Glioblastoma,10372,NA,NA,NA,NA,24,NA,NA,655320,NA
11188718,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC010373,NA,NA,1ZIASC010373-24,NCI:1529082\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,9692373 (contact),"CAMPHAUSEN, KEVIN  (contact)",NA,NA,NA,Address;Agreement;arm;Biopsy;Brain Neoplasms;brain volume;Cancer Therapy Evaluation Program;chemotherapy;Clinic;Clinical;clinical care;clinical center;clinical development;Clinical Trials;clinically relevant;cohort;Collaborations;Common Terminology Criteria for Adverse Events;Cooperative Research and Development Agreement;Data;Databases;Development;DNA;Dose;European Organization for Research and Treatment of Cancer;Excision;follow-up;Image;improved;Industry;inhibitor;Intramural Research Program;irradiation;Location;Long-Term Survivors;Magnetic Resonance Imaging;Modernization;Molecular Target;Morbidity - disease rate;Nature;Neurologic Symptoms;Neurology;Newly Diagnosed;Newly Diagnosed Disease;novel;novel therapeutics;Pain;Patient imaging;Patients;Pattern;Performance Status;Pharmaceutical Preparations;Pharmacologic Substance;Phase;phase 1 study;phase 3 study;phase II trial;phase III trial;preclinical study;Publications;Publishing;Radiation;Radiation Dose Unit;Radiation therapy;Radiation Therapy Oncology Group;Radiation-Sensitizing Agents;radiological imaging;Recommendation;Recurrence;Recurrent tumor;Reporting;Research;response;Role;Running;Scheme;standard of care;Structure;success;synergism;Systemic Therapy;targeted agent;Time;time interval;Toxic effect;Translating;tumor;United States National Institutes of Health;Valproic Acid;Work,The Synergy Between Radiotherapy and Molecularly Targeted Agents,10373,NA,NA,NA,NA,24,NA,NA,1529082,NA
11188719,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC010375,NA,NA,1ZIASC010375-24,NCI:300216\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,11199937 (contact),"SINGER, DINAH S. (contact)",NA,NA,NA,26S proteasome;Affect;Alanine;Binding;Biogenesis;Biological Assay;Biological Process;Breast Cancer cell line;cancer cell;CD4 Positive T Lymphocytes;Cell Differentiation process;Cell Line;Cell Nucleus;Cell Physiology;Cell Proliferation;Cell Survival;cell type;Chromatin;Clustered Regularly Interspaced Short Palindromic Repeats;Complex;Cytoplasm;Dissociation;DNA;DNA Polymerase II;DNA-Directed RNA Polymerase;embryo cell;Endosomes;Event;experimental study;Future;Gene Expression;Gene Expression Regulation;Genetic Transcription;Goals;Heat-Shock Proteins 70;Immunoprecipitation;In Vitro;in vivo;Individual;insight;interest;Maps;Mediating;Mediator;melting;Molecular;Molecular Chaperones;Molecular Conformation;Multiprotein Complexes;Mus;mutant;Mutate;Mutation;Nucleotides;Peripheral;Phenotype;Phosphorylation;Phosphotransferases;Play;Point Mutation;Polyribosomes;Post-Translational Modification Site;Post-Translational Protein Processing;Productivity;programs;Proliferating;promoter;Protein Biosynthesis;Proteins;recruit;Recycling;Regulation;Reporting;Research;Rest;RNA;RNA Binding;RNA chemical synthesis;RNA Splicing;RNA Transport;Role;Series;Signal Transduction;Site;STAT3 gene;success;TAF1 gene;TAF7 gene;Technology;thymocyte;TP53 gene;trafficking;Transcript;Transcription Elongation;transcription factor;transcription factor TFIIE;transcription factor TFIIF;transcription factor TFIIH;Transcription Initiation;Transcription Process;Transcriptional Regulation;Transgenic Mice;Translations,TAF7: A Check-point Regulator in Transcription Initiation and Translation,10375,NA,NA,NA,NA,24,NA,NA,300216,NA
11188720,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC010376,NA,NA,1ZIASC010376-24,NCI:1719715\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,9417013 (contact),"LIU, ZHENG-GANG  (contact)",NA,NA,NA,Achievement;Acquired Immunodeficiency Syndrome;Acute;anti-cancer research;Antineoplastic Agents;Apoptosis;apoptosis inducing factor;Apoptotic;Arthritis;Autoimmune Diseases;Binding;Biological;Breast Cancer Model;cancer therapy;cancer type;CD8-Positive T-Lymphocytes;Cell Death;Cell Death Induction;Cell Proliferation;Cell surface;Cell Surface Proteins;Cells;Cessation of life;Chronic;chronic inflammatory disease;COVID-19;COVID-19 treatment;Crohn&apos;s disease;cytokine;cytokine release syndrome;cytotoxicity;Data;deprivation;Development;Diagnosis;Disease;Dose;E-Cadherin;Equilibrium;Event;Future;genetic regulatory protein;Glucose;Goals;Human;Immune;improved;Inflammation;Inflammatory;Inflammatory Response;inhibitor;Knowledge;KRAS2 gene;Laboratories;Life;Malignant Breast Neoplasm;Malignant neoplasm of lung;Malignant Neoplasms;Mediating;Mediator;Molecular;Mus;Necrosis;Neoplasm Metastasis;neoplastic cell;novel;Pathogenesis;Pathology;Pathway interactions;Peptide Hydrolases;Physiological;Play;Production;Proteins;receptor;Regulation;Research;response;Rheumatoid Arthritis;Role;Septic Shock;Signal Pathway;Signal Transduction;Specific qualifier value;T-Lymphocyte;Therapeutic;Therapeutic Agents;Thrombosis;Tissues;TNF gene;Transforming Growth Factors;Translating;tumor;Tumor Promotion;tumorigenesis;Virus Diseases;Work,"TNF Signaling, Cell Death and Cancer",10376,NA,NA,NA,NA,24,NA,NA,1719715,NA
11188721,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC010378,NA,NA,1ZIASC010378-24,NCI:207937\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,9692357 (contact),"APLAN, PETER  (contact)",NA,NA,NA,Acute Myelocytic Leukemia;Aneuploidy;Animal Model;Animals;Cell Line;Cells;chemotherapy;Childhood Acute Myeloid Leukemia;Chromosomal translocation;chromosome missegregation;Chromosomes;Clinical;Collaborations;Development;efficacy evaluation;experimental study;FLT3 gene;fusion gene;gene cloning;Generations;Genes;Genetic;Hematologic Neoplasms;Hematopoietic;Hematopoietic stem cells;in vivo;inhibitor;Lesion;leukemia;Link;Malignant - descriptor;Malignant Neoplasms;Manuscripts;Menin;Mus;Mutate;Mutation;Nodal;novel;NUP98 gene;Oncogenic;overexpression;Patients;pediatric patients;Point Mutation;premalignant;Process;Proto-Oncogenes;Publishing;Recurrence;response;Testing;Time;TP53 gene;Transgenic Mice;Translocation Breakpoint;Transplantation;Yeasts,Activation of Proto-Oncogenes by Chromosomal Translocation,10378,NA,NA,NA,NA,24,NA,NA,207937,NA
11188722,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC010379,NA,NA,1ZIASC010379-24,NCI:623811\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,9692357 (contact),"APLAN, PETER  (contact)",NA,NA,NA,ABCB1 gene;Acute Myelocytic Leukemia;Acute T Cell Leukemia;acute T-cell lymphoblastic leukemia cell;B-Lymphocytes;Biological Assay;Biological Models;cancer cell;CCR;CDKN1A gene;Cell Line;Cells;Chemoresistance;chemotherapy;childhood sarcoma;Chromosomal Rearrangement;Chromosomal translocation;Clonal Expansion;Clustered Regularly Interspaced Short Palindromic Repeats;Collaborations;Cytarabine;Cytidine;Cytosine;Development;Distant;DNA;DNA copy number;DNA Double Strand Break;DNA Insertion Elements;DNA Methyltransferase Inhibitor;driver mutation;Event;exome sequencing;experimental study;Frequencies;fusion gene;Fusion Oncogene Proteins;Genes;Genetic Transcription;Genome;Genomic Segment;genotoxicity;Goals;Human;In Vitro;in vitro Assay;in vivo Model;Induced Mutation;interstitial;leukemia;Link;Lymphoblastic Leukemia;Malignant - descriptor;Malignant Childhood Neoplasm;Malignant Neoplasms;Manuscripts;Mediating;Methotrexate;Methylation;Mitochondria;Molecular;Mus;Mutagens;Mutation;NF1 gene;novel;Nuclear;Oncogenes;Oncogenic;Phenotype;Phosphorylation;Phosphotransferases;Point Mutation;Pre-Clinical Model;Preparation;prevent;Production;Proto-Oncogenes;PTEN gene;Publishing;Recurrence;repaired;Reproducibility;Resistance;Resistance development;RNA;Role;Single Nucleotide Polymorphism;Structure;T-Cell Leukemia;T-Lymphocyte;thyroid neoplasm;Tumor Suppressor Genes;Vincristine,"Mutation Mechanisms Leading to Malignant Transformation, Including Chromosomal Translocation and Point Mutations",10379,NA,NA,NA,NA,24,NA,NA,623811,NA
11188723,ZIA,CA,1,N,NA,NA,NA,NA,ZIASC010384,NA,NA,1ZIASC010384-24,NCI:152489\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,9692167 (contact),"HICKSTEIN, DENNIS  (contact)",NA,NA,NA,Allogenic;Animal Model;Autologous;Bone Marrow;Bone Marrow Cells;Bone Marrow Stem Cell;canine model;Canis familiaris;Cells;Child;clinical phenotype;Clinical Trials;Complication;conditioning;Defect;Detection;Disease;disease phenotype;Dog Diseases;donor stem cell;Engraftment;Flow Cytometry;Future;gene correction;Gene Expression;Gene Modified;gene replacement;gene therapy;Gene Transfer;gene transfer vector;Generations;Genetic;Genetic Diseases;genotoxicity;graft vs host disease;Hematopoietic;Hematopoietic Stem Cell Transplantation;Hematopoietic stem cells;Homologous Transplantation;Human;immune reconstitution;Individual;ITGB2 gene;Lentivirus Vector;Leukocyte Adhesion Deficiency;Leukocytes;Membrane;Methods;Modeling;Patients;Pre-Clinical Model;promoter;receptor;Regimen;Retroviral Vector;Spumavirus;stem cell biology;stem cell gene therapy;Study models;success;Surface;Testing;Transgenes;Transplantation;vector;Viral;Viral Genes;Viral Vector,Hematopoietic Stem Cell Gene Therapy for Leukocyte Adhesion Deficiency,10384,NA,NA,NA,NA,24,NA,NA,152489,NA
11188724,ZIC,AR,1,N,NA,NA,NA,NA,ZICAR041169,NA,NA,1ZICAR041169-17,NIAMS:1051343\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,9691702 (contact),"GADINA, MASSIMO  (contact)",NA,NA,NA,"Acoustics;Aerosols;Area;assay development;ATAC-seq;atopy;Autoimmune Diseases;bench to bedside;Biological Sciences;Biology;bone;Bone Diseases;cell analyzer;Cell fusion;Cell Separation;Cells;ChIP-seq;Clinical;Clinical Investigator;Clinical Research;Color;color detection;Computer software;computerized;Consultations;Contractor;Core Facility;Cytometry;Data;data acquisition;Data Analyses;Data Science;Dedications;Deposition;design;Detection;detector;developmental disease;Dimensions;Discipline;Doctor of Philosophy;Electronics;Equipment;Equipment and supply inventories;experience;Fellowship;flexibility;Flow Cytometry;Functional disorder;Goals;high dimensionality;high resolution imaging;Human;Human Resources;Hypersensitivity;Image;Image Analysis;imaging capabilities;Imaging technology;Immune;Immune System Diseases;Immunology;Immunophenotyping;Instruction;instrument;instrumentation;Interest Group;International;Intramural Research Program;Laboratories;Lasers;Leadership;Learning;meetings;Mid-Atlantic Region;Mission;Modernization;Morphology;multiple omics;Muscle;Myopathy;National Heart, Lung, and Blood Institute;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;new technology;novel;operation;Optics;Patients;peer;Policies;Population;Postdoctoral Fellow;Proteins;Research;research and development;Research Personnel;Research Project Grants;Research Support;Safety;Sampling;Scanning;Scientist;Services;single-cell RNA sequencing;Skin;skin disorder;Societies;Sorting;Specimen;System;Techniques;Time;Training;Training Technics;transcriptome sequencing;Tube;United States National Institutes of Health;Vendor","Flow cytometry support to research in immune, skin, muscle and bone  diseases",41169,NA,NA,NA,NA,17,NA,NA,1051343,NA
11188725,ZIC,AR,1,N,NA,NA,NA,NA,ZICAR041173,NA,NA,1ZICAR041173-17,NIAMS:2442797\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,78871687 (contact),"SUN, HONG-WEI  (contact)",NA,NA,NA,"Active Sites;Address;Adult-Onset Still&apos;s Disease;Affect;age effect;Alternative Splicing;Amino Acids;Analysis of Variance;analysis pipeline;Apoptosis Promoter;Architecture;Area;Arteritis;Arthritis;Artificial Intelligence;ATAC-seq;Autoimmune Diseases;BCL2L1 gene;Benign;big biomedical data;Bioinformatics;Biological Assay;Biomedical Research;bisulfite sequencing;Blood;Blood coagulation;Bone Diseases;Calcinosis;CCL21 gene;CD3 Antigens;CD4 Positive T Lymphocytes;CDC2 gene;Cell Differentiation process;Cell Line;Cells;Cellular Indexing of Transcriptomes and Epitopes by Sequencing;Child;ChIP-seq;Chromatin;Cleavage Under Targets and Release Using Nuclease;Clinical;Clone Cells;cohesin;cohort;collaborative environment;Colon Carcinoma;comparison control;Complications of Diabetes Mellitus;Computational Biology;Computer Models;Consultations;coronavirus disease;COVID-19;COVID-19 vaccine;crosslinking and immunoprecipitation sequencing;Data;Data Analyses;Data Science;Data Set;data standards;data submission;data wrangling;Dedications;deep learning model;density;design;Detection;Development;Diabetic Foot Ulcer;Diabetic mouse;diabetic ulcer;Diagnosis;Disease;Disease remission;Disseminated eosinophilic collagen disease;DNA sequencing;DNA Sequencing Facility;Drug resistance;Ectopic Expression;empowerment;Enhancers;Ensure;Epidermis;Event;Exhibits;experience;Experimental Designs;Exposure to;Female;Flare;Fostering;gain of function;Gene Expression;Gene Expression Profile;Gene Expression Profiling;Genes;Genetic;Genetic Markers;Genetic Transcription;Genome;genome sequencing;genome-wide;genomic data;Genomics;Germ-Line Mutation;global run on sequencing;granulocyte;healing;high dimensionality;histone modification;Homeostasis;Immune;Immune System Diseases;Individual;Inflammation;inhibitor;Injury;innovation;Interferons;Intramural Research Program;Introns;Investigation;JAK1 gene;Joints;Junk DNA;keratinocyte;Knock-out;large cell Diffuse non-Hodgkin&apos;s lymphoma;Linear Models;Lupus;lymph nodes;Lymphocyte;male;Malignant Neoplasms;Manuscripts;Maps;Mentors;Merkel cell carcinoma;Methodology;Methods;microbiome;MicroRNAs;Mining;Modeling;mouse model;Multiomic Data;multiple omics;Mus;Muscle;muscle progenitor cell;Mutation Analysis;Myopathy;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;Natural History;neutrophil;next generation sequencing;novel;old mice;oral cavity epithelium;Pathogenicity;Pathway interactions;Patients;Peripheral Blood Mononuclear Cell;Pharmaceutical Preparations;Pharmacotherapy;Play;potential biomarker;Process;programs;promoter;Prospective Studies;protein function;Proteins;Quality Control;random forest;rare variant;Regulation;Relapsing polychondritis;Research;Research Personnel;Research Project Grants;response;Rheumatoid Arthritis;RNA Splicing;Role;Sampling;SARS-CoV-2 infection;Scientific Advances and Accomplishments;Scleroderma;single cell analysis;single cell ATAC-seq;single-cell RNA sequencing;Skin;Skin wound healing;Somatic Mutation;Spondylarthritis;Structure;success;systemic autoimmune disease;systemic juvenile idiopathic arthritis;Systemic Lupus Erythematosus;T cell differentiation;Techniques;Technology;Testing;three dimensional structure;Time;Tissue-Specific Gene Expression;tool;Training;transcription factor;Transcriptional Regulation;transcriptome;transcriptome sequencing;transcriptomics;Transgenic Mice;tumor progression;Vaccination;Variant;Vasculitis;Vision;whole genome;Wild Type Mouse;Withholding Treatment;wound;wound healing","Applying Bioinformatics to Research in Immune, Muscle, and Bone Diseases",41173,NA,NA,NA,NA,17,NA,NA,2442797,NA
11188726,ZIC,AR,1,N,NA,NA,NA,NA,ZICAR041207,NA,NA,1ZICAR041207-09,NIAMS:1772614\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,78875616 (contact),"DELL'ORSO, STEFANIA  (contact)",NA,NA,NA,"Adult;alpha ketoglutarate;Autoantibodies;Autoimmune Diseases;autoinflammatory diseases;Biological Assay;Bone Diseases;Cell Lineage;Cell Maintenance;Cells;CHD4 gene;Chromatin;Collaborations;Data Analyses;Data Collection;data sharing;derepression;Dermatomyositis;DNA sequencing;early onset;Embryonic Induction;embryonic stem cell;Enhancers;Ensure;Epigenetic Process;epigenomics;Experimental Designs;experimental study;Genes;genetic risk factor;Genetic Transcription;Genome;Genomic approach;Genomics;Glutamine;Idiopathic Inflammatory Myopathies;Immune checkpoint inhibitor;instrumentation;Libraries;Mentors;Merkel cell carcinoma;Mesoderm;Metabolism;MicroRNAs;Mining;Molecular;Molecular Biology;multidisciplinary;multiple omics;Mus;Muscle;Muscle Fibers;muscle progenitor cell;Myopathy;Myositis;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;Natural regeneration;neutrophil;notch protein;NuRD complex;Pathogenesis;pathogenic autoantibodies;Patients;Polycomb;Preparation;Process;Protocols documentation;Publications;Publishing;Quality Control;Regulation;Research;Research Personnel;Research Project Grants;Resolution;RNA;Role;Services;Signal Transduction;single cell sequencing;Skin;skin disorder;Somatic Mutation;Specific qualifier value;stem cells;syntax;Systemic Lupus Erythematosus;Technology;Training;transcriptome;transcriptome sequencing;transcriptomic profiling;transcriptomics;United States National Institutes of Health","High Throughput Next Generation Sequencing, Single-Cell Omics and Spatial Transcriptomic: supports genomics and epigenomics research in muscle, skin, bone and autoimmune diseases",41207,NA,NA,NA,NA,9,NA,NA,1772614,NA
11188727,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC009255,NA,NA,1ZICBC009255-50,NCI:1399485\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79355596 (contact),"CROSSMAN, ASSIATU  (contact)",NA,NA,NA,anti-cancer research;Antigen-Presenting Cells;Apoptosis;Area;B cell repertoire;B-Cell Activation;B-Lymphocytes;Basic Science;Biological Assay;Biology;Blood Cells;Cancer Research Project;Cell Cycle;Cell Death;Cell Lineage;Cell membrane;Cell Physiology;cell preparation;Cell Proliferation;Cell Separation;Cell surface;Cell Survival;Cells;Cellular biology;CISH gene;Computer software;Consultations;Core Facility;Cost efficiency;Cultured Cells;Custom;Cytokine Signaling;Data;Data Analyses;Defect;Development;Electronics;Epithelial Cells;Evaluation;Event;Experimental Autoimmune Encephalomyelitis;Experimental Designs;Flow Cytometry;FOXO1A gene;Gene Expression Regulation;Generations;Genetic Transcription;Genetically Modified Animals;Goals;Histocompatibility Antigens;Immune;Immunobiology;Immunology;In Vitro;in vivo;Individual;instrument;instrumentation;Interleukin 7 Receptor;intestinal barrier;intestinal epithelium;intraepithelial;Investigation;Lymphocyte Biology;lymphocyte proliferation;Manufacturer;Mediating;member;Membrane Microdomains;Metabolic;MHC Class I Genes;MHC Class II Genes;MicroRNAs;Mucosal Immune Responses;Multiparametric Analysis;National Cancer Institute;NCI Center for Cancer Research;Outcome;Pathogenesis;Phenotype;Phosphotransferases;Post-Transcriptional Regulation;proteostasis;Provider;Reagent;receptor;receptor expression;Regulation;Regulation of Exocytosis;Regulatory T-Lymphocyte;Research Personnel;Research Project Grants;Research Support;response;Role;Signal Transduction;Signaling Molecule;single cell analysis;Specific qualifier value;stem cells;Sterility;Stimulus;T cell differentiation;T-Cell Development;T-Cell Receptor;T-Lymphocyte;TAF7 gene;Techniques;Technology;thymocyte;Thymus Gland;Tissues;trafficking;Transcription Initiation,Application of Flow Cytometry to Cell Biology,9255,NA,NA,NA,NA,50,NA,NA,1399485,NA
11188728,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC010517,NA,NA,1ZICBC010517-22,NCI:158959\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8123119 (contact),"NICKLAUS, MARC  (contact)",NA,NA,NA,Algorithms;Anniversary;Area;Cactaceae;Catalogs;Chemical Structure;Chemicals;Collection;Computer Assisted;Computers;Data;database structure;Databases;design;Drug Design;drug development;Education;Generations;Goals;improved;Informatics;informatics tool;migration;Paper;Property;Publications;Readability;Records;Research Personnel;Resources;Running;Sampling;screening;Services;small molecule;Structure;tautomer;tool;tool development;United States National Institutes of Health;Update;Vendor;virtual;web server;web services;web site;web-based tool;Work,Large Databases of Small Molecules - Drug Development Tool and Public Resource,10517,NA,NA,NA,NA,22,NA,NA,158959,NA
11188729,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC010639,NA,NA,1ZICBC010639-21,NCI:158959\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8123119 (contact),"NICKLAUS, MARC  (contact)",NA,NA,NA,2019-nCoV;analog;Apoptotic;Binding Proteins;Biological Assay;CCR;Cell Death Induction;Cells;Chemistry;Clinical;cofactor;Collaborations;Computer software;conformer;Databases;design;Development;Docking;EP300 gene;Epithelial Cells;Generations;Genes;Goals;HIF1A gene;HIV-1;in silico;In Vitro;inhibitor;interest;Malignant Neoplasms;Molecular Target;N-terminal;neoplastic cell;novel;novel lead compound;novel therapeutics;Principal Investigator;programs;Property;Resources;screening;Screening for cancer;Signal Transduction;small molecule;STAT3 gene;tool;transcription factor;United States National Institutes of Health;virtual library;Work,In Silico Screening for Cancer Targets,10639,NA,NA,NA,NA,21,NA,NA,158959,NA
11188730,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC010685,NA,NA,1ZICBC010685-20,NCI:1180352\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,12499012 (contact),"KLEINER, DAVID ERWIN (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Autopsy;Brain;Cause of Death;Cessation of life;Chest;Clinical;clinical care;clinical center;clinical investigation;Clinical Investigator;Clinical Pathology;Clinical Protocols;Clinical Research;Collaborations;COVID-19 mortality;Cultured Tumor Cells;Databases;Demyelinating Diseases;Disease;Genetic;Goals;graft vs host disease;Hematologic Neoplasms;Hematopoietic Stem Cell Transplantation;Histology;Hospitals;Hour;Human;human tissue;immunodeficiency;Information Systems;Intramural Research Program;Investigation;Laboratories;Magnetic Resonance Imaging;Malignant Neoplasms;Mission;Multiple Sclerosis;National Institute of Mental Health;Nervous System Disorder;Non-Hematologic Malignancy;Normal tissue morphology;Pathologic;Pathology;Patient Care;Patients;Procedures;Process;programs;Protocols documentation;quality assurance;Reporting;Research;Research Personnel;Research Project Grants;Research Subjects;Research Support;Science;Services;Specimen;System;Text;Time;Tissues;tool;Training;treatment response;tumor;United States National Institutes of Health;urologic,Postmortem Pathology,10685,NA,NA,NA,NA,20,NA,NA,1180352,NA
11188731,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC010687,NA,NA,1ZICBC010687-20,NCI:2700456\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14732101 (contact),"CHINQUEE, JOSEPH  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Admission activity;Autopsy;Biopsy;Clinic;Clinical;clinical center;Consult;Consultations;COVID-19;Cytopathology;Data;Diagnosis;Diagnostic;Diagnostic Services;digital imaging;digital pathology;Dissection;Educational process of instructing;Evaluation;Growth;Hematopathology;Histology;Histopathology;human tissue;Immunohistochemistry;Infection;Laboratories;laboratory experience;laboratory experiment;Malignant Neoplasms;methylation testing;Microscope;Microscopic;Microscopy;Microtomy;Mission;molecular diagnostics;next generation sequencing;novel;Operative Surgical Procedures;Pathologist;Pathology;Patients;Preparation;Process;Protocols documentation;Reporting;Research;Research Activity;Research Personnel;Research Support;Rotation;Scanning;Slide;Specimen;Stains;Surgical Pathology;Techniques;tissue processing;Tissue Procurements;Tissues;Training;United States National Institutes of Health,Histology Core Laboratory,10687,NA,NA,NA,NA,20,NA,NA,2700456,NA
11188732,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC010858,NA,NA,1ZICBC010858-18,NCI:1219241\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692243 (contact),"KRUHLAK, MICHAEL  (contact)",NA,NA,NA,3-Dimensional;anti-cancer research;Architecture;cancer stem cell;CCR;Cell Differentiation process;Cells;Chromatin;Communities;Core Facility;DNA Damage;Educational process of instructing;Elements;Endothelial Cells;Ewings sarcoma;fluorescence lifetime imaging;Image;Image Analysis;image processing;imaging software;Imaging Techniques;in vivo imaging;instrument;Interest Group;Licensing;light microscopy;Methodology;Methods;Microscope;microscopic imaging;Microscopy;Mitochondria;Monitor;Morphology;neoplastic cell;outreach;Protein Dynamics;Proteins;Publications;Reporter;Research;Research Personnel;response;Services;Site;stem cell growth;superresolution imaging;Techniques;Thymus Gland;Time;Training;two-photon;ultra high resolution;United States National Institutes of Health;Visualization,CCR Microscopy Core,10858,NA,NA,NA,NA,18,NA,NA,1219241,NA
11188733,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC010905,NA,NA,1ZICBC010905-17,NCI:2119096\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355702 (contact),"HALAS, HYUNMI  (contact)",NA,NA,NA,Activated Lymphocyte;Address;Adoptive Cell Transfers;anti-cancer;Antigens;Area;Atypical lymphocyte;authority;Autologous;B lymphoid malignancy;Back;Biological Response Modifiers;Biopsy;Blood;Blood Component Removal;blood product;Blood specimen;cancer cell;Carcinoma;Cell Physiology;Cell Therapy;Cells;Characteristics;Cholangiocarcinoma;Clinical;clinical translation;Clinical Trials;Collection;Colorectal Cancer;Computer software;Core Facility;Cyclic GMP;Data;data curation;design;Development;Disseminated Malignant Neoplasm;Documentation;Effectiveness;Employee;Enrollment;Ensure;Environment;Equipment;Event;Excision;expiration;Extramural Activities;gene delivery system;Gene Modified;gene therapy;Generations;Genes;Goals;healthy volunteer;Human;Immunologics;Immunotherapy;improved;Industrialization;Industry;Infusion procedures;Institution;interest;Laboratories;Lymphocyte;Malignant Breast Neoplasm;Malignant neoplasm of cervix uteri;Malignant Neoplasms;manufacture;Manufactured Materials;Manufacturer;manufacturing facility;Melanoma;Mission;National Cancer Institute;neoantigens;Neoplasm Metastasis;novel therapeutics;operation;Operative Surgical Procedures;patient safety;Patients;Peripheral Blood Lymphocyte;Peripheral Blood Mononuclear Cell;Phase;prevent;Process;Production;programs;Protocols documentation;quality assurance;Quality Control;Quarantine;Reagent;receptor;Regulation;Reporting;Research;Research Personnel;Research Project Grants;Resected;Retroviral Vector;Sampling;screening;Serum;Services;Source;Specific qualifier value;success;Suspensions;synovial sarcoma;System;T cell therapy;T-Lymphocyte;targeted treatment;Testing;therapy development;Tissues;tool;Training;Translating;tumor;Tumor Antigens;tumor immunology;tumor infiltrating lymphocyte therapy;Tumor Tissue;Tumor-Associated Process;Tumor-Infiltrating Lymphocytes;United States National Institutes of Health;Update;vector;Work,Surgery Branch Cell Prep Core,10905,NA,NA,NA,NA,17,NA,NA,2119096,NA
11188734,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC010915,NA,NA,1ZICBC010915-17,NCI:370958\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162268 (contact),"WISNIEWSKI, JAN  (contact)",NA,NA,NA,Biological Assay;Cells;Computer software;Contract Services;Core Facility;cost;design;digital imaging;Equipment;Event;Image;Image Analysis;image processing;Imaging Techniques;Immune system;Immunohistochemistry;Immunology;instrument;Laser Scanning Confocal Microscopy;Lasers;Microscope;microscopic imaging;Microscopy;Mission;new technology;novel;Procedures;quantitative imaging;Reagent;Research Personnel;Resolution;Scanning;Standardization;superresolution microscopy;System;Work,EIB Microscopy Core Facility,10915,NA,NA,NA,NA,17,NA,NA,370958,NA
11188735,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC010936,NA,NA,1ZICBC010936-17,NCI:1605816\OD:452607\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692271 (contact),"MCKINNON, KATHERINE  (contact)",NA,NA,NA,biological research;CCR;Core Facility;Experimental Designs;Flow Cytometry;Goals;instrumentation;National Cancer Institute;NCI Center for Cancer Research;Research Project Grants;Techniques;Technology;Training;Vaccines,CCR Vaccine Branch FACS Core,10936,NA,NA,NA,NA,17,NA,NA,2058423,NA
11188736,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC010947,NA,NA,1ZICBC010947-17,NCI:390720\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14732110 (contact),"LAKE, ROSS  (contact)",NA,NA,NA,3-Dimensional;Adult;anti-cancer research;Basic Science;Brain;Brain region;Breast;Cancer Biology;cancer cell;cancer genetics;CCR;cell motility;Cells;Child;Circulation;Clinical Research;cohort;Colorectal;Communities;Confocal Microscopy;Core Facility;Differentiation Antigens;Distant;Embryo;empowerment;Epithelial Cells;Equipment;experimental study;fluorescence imaging;fluorescence microscope;gang;Genomics;Gleason Grade for Prostate Cancer;Glioblastoma;Goals;high resolution imaging;Human;Image;Image Analysis;imaging capabilities;Incubated;Indolent;instrument;interest;Label;Laboratories;Lasers;Lymph;Malignant neoplasm of prostate;Malignant neoplasm of thyroid;Malignant Neoplasms;Manuscripts;Measures;Microdissection;Microscope;Microscopy;Mission;Modeling;Molecular;Motor;Mus;Neoplasm Metastasis;novel therapeutic intervention;Optics;Organ;Ovarian;Postbaccalaureate;Postdoctoral Fellow;Preparation;Process;progression marker;Prostate;prostate cancer metastasis;Proteins;Radical Prostatectomy;real time model;Research;Research Personnel;residence;Resolution;Role;Scanning;Scientist;Signal Pathway;Signaling Molecule;Slide;Speed;Stains;stem-like cell;Stomach;Structure;summer student;Surveys;System;Techniques;three dimensional cell culture;Time;TNF gene;trafficking;transcriptomics;Tubular formation;tumor progression;Visualization;Xenograft Model;Zebrafish,Laboratory of Cancer Biology and Genetics Microscopy Core Facility,10947,NA,NA,NA,NA,17,NA,NA,390720,NA
11188737,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC010948,NA,NA,1ZICBC010948-17,NCI:1877132\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692295 (contact),"ROBBINS, PAUL  (contact)",NA,NA,NA,Adoptive Immunotherapy;Adoptive Transfer;Algorithms;Antigen Presentation Pathway;Antigens;Atypical lymphocyte;Autologous;Autologous Tumor Cell;Autologous Tumor-Infiltrating Lymphocyte;Binding;Bioinformatics;Biological Assay;Biological Models;Breast Cancer Patient;cancer cell;cancer type;candidate identification;Carcinoma;Cell Line;Cell Separation;Cell surface;Cells;Cellular immunotherapy;Characteristics;Cholangiocarcinoma;Chromium;Clinical;Clinical Trials;clinically significant;Color;Colorectal Cancer;Colorectal Neoplasms;Copy Number Polymorphism;Core Facility;Cytotoxic T-Lymphocytes;Data;Differentiation Antigens;Disseminated Malignant Neoplasm;DNA;DNA analysis;DNA sequencing;DNA Sequencing Facility;driver mutation;Elements;Epitopes;Evaluation;Event;exome sequencing;experimental study;Expression Library;Family;fluorophore;Future;gene cloning;Gene Expression;Gene Fusion;Genes;Genetic Transcription;Helper-Inducer T-Lymphocyte;High-Throughput Nucleotide Sequencing;Histology;Human;immune function;Immunotherapy;immunotherapy trials;In complete remission;In Vitro;Individual;instrument;instrumentation;Investigation;KRAS2 gene;Lesion;Libraries;Malignant Breast Neoplasm;Malignant neoplasm of gastrointestinal tract;Malignant neoplasm of lung;Malignant neoplasm of ovary;Malignant Neoplasms;Mammary Neoplasms;melanocyte;Melanoma;Metastatic breast cancer;Monophenol Monooxygenase;Mus;mutant;Mutate;Mutation;Nature;neoantigens;Neoplasm Metastasis;neoplastic cell;novel;Oncogenes;Operative Surgical Procedures;Organoids;overexpression;patient population;Patients;Peptides;peripheral blood;Phenotype;Population;Postdoctoral Fellow;Proteins;Quantitative Reverse Transcriptase PCR;Reagent;Recurrence;Renal Carcinoma;Research;Research Personnel;resistance mechanism;response;Reverse Transcriptase Polymerase Chain Reaction;RNA;robotic system;Sampling;screening;Screening Result;Series;service member;Services;SILV gene;Somatic Mutation;Suspension Culture;T cell therapy;T-Cell Receptor;T-Lymphocyte;Testing;therapy resistant;tissue culture;tissue/cell culture;TP53 gene;transcriptome;transcriptome sequencing;tumor;Tumor Antigens;Tumor Escape;tumor progression;Tumor-Infiltrating Lymphocytes;Xenograft procedure,DNA Sequencing and FACS Core Facilities,10948,NA,NA,NA,NA,17,NA,NA,1877132,NA
11188738,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC010953,NA,NA,1ZICBC010953-17,NCI:2053644\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692305 (contact),"SIMPSON, ROBERT  (contact)",NA,NA,NA,Adenocarcinoma;Agonist;androgen independent prostate cancer;Androgen Receptor;Animal Model;animal model development;anti-cancer research;Applied Research;Biological Markers;Biological Models;bioluminescence imaging;biomarker discovery;biomarker identification;Blood Vessels;cancer biomarkers;cancer cell;Cancer Model;cancer therapy;cancer type;carcinogenesis;Castration;cell behavior;Cells;Childhood;clinically relevant;Clonal Hematopoietic Stem Cell;Collection;Complex;Comprehension;design;Development;Diagnosis;Diagnostic;Diagnostic Neoplasm Staging;Disease;Dissociation;Endothelial Cells;Erythroid;Exhibits;Extracellular Signal Regulated Kinases;Focal Adhesions;genome editing;Genotype;Hematogenous;Hematopoietic stem cells;Heterogeneity;Histologic;Human;human disease;IL8 gene;Immunofluorescence Immunologic;Immunohistochemistry;improved;Informatics;Injections;insight;intravital microscopy;Invaded;Luciferases;Lung;lymph nodes;Lymphatic;lymphatic vessel;Malignant Neoplasms;Medical;Medicine;Metastatic malignant neoplasm to brain;Metastatic Neoplasm to the Bone;Metastatic Prostate Cancer;Methods;migration;Modeling;Molecular;molecular diagnostics;molecular pathology;Monitor;Mus;Muscle;Neoplasm Metastasis;Neuroendocrine Carcinoma;neutrophil;novel;novel therapeutics;Organ;Osteolytic;Pathogenesis;Pathologic;Pathology;patient derived xenograft model;PAX3 gene;personalized medicine;Phenotype;Phylogenetic Analysis;Population;preclinical trial;Prognosis;prostate cancer metastasis;prostate cancer model;protein expression;protein kinase C-delta;RB1 gene;Reagent;Relapse;Research;Residencies;Resistance;response;Rhabdomyosarcoma;RNA Splicing;Signal Transduction;Specific qualifier value;Stains;targeted treatment;Techniques;Technology;technology development;Testing;therapeutic development;Tissues;Tongue;tool;TP53 gene;Training;tumor;Tumor Cell Invasion;Validation;Variant;Xenograft procedure;Zebrafish,"Computational Pathology Research for Cancer Modeling, Diagnostics and Biomarkers",10953,NA,NA,NA,NA,17,NA,NA,2053644,NA
11188739,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC010965,NA,NA,1ZICBC010965-17,NCI:949444\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692329 (contact),"TARASOV, SERGEY  (contact)",NA,NA,NA,biomacromolecule;biophysical analysis;biophysical chemistry;Biophysics;Calorimetry;CCR;Circular Dichroism;Circular Dichroism Spectroscopy;Collaborations;Complex;computerized data processing;Consultations;cost effective;Data Analyses;design;Experimental Designs;experimental study;Fluorescence Spectroscopy;Fluorometry;Goals;HIV;Hour;instrument;instrumentation;Investigation;Laboratories;light scattering;liquid chromatography mass spectrometry;Maintenance;Malignant Neoplasms;Mass Spectrum Analysis;Modernization;NCI Center for Cancer Research;operation;Photometry;Property;Protocols documentation;Research;Research Personnel;Resolution;Resources;Running;Scanning;Services;Spectrometry;Spectrum Analysis;structural biology;Structure;System;Technology;Time;time interval;Titrations;Training;United States National Institutes of Health;Walking,CCR Biophysics Resource Core,10965,NA,NA,NA,NA,17,NA,NA,949444,NA
11188740,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC010978,NA,NA,1ZICBC010978-17,NCI:550977\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858546 (contact),"PALLIKKUTH, SANDEEP  (contact)",NA,NA,NA,Animals;Biochemical;Cancer Biology;cancer cell;Cells;Cellular biology;Chicago;clinical center;Color;Complex;confocal imaging;Confocal Microscopy;Core Facility;Data;Development;Experimental Designs;experimental study;Fluorescence;fluorescence imaging;fluorescence lifetime imaging;fluorescence microscope;Fluorescence Recovery After Photobleaching;Fluorescence Resonance Energy Transfer;Focal Adhesions;G Protein-Coupled Receptor Signaling;Goals;Human Resources;Image;Imaging Techniques;Imaging technology;instrument;intravital imaging;Kinetics;Laboratories;Laboratory Scientists;Lasers;Lateral;light microscopy;live cell imaging;Malignant Neoplasms;Medicine;meetings;member;Microscope;Microscopy;Molecular;Molecular and Cellular Biology;Molecular Biology;Morphogenesis;National Cancer Institute;new technology;Noise;Pathway interactions;Pattern;Pediatric Oncology;Photobleaching;Principal Investigator;Receptor Biology and Gene Expression;Regulation;Research;Research Personnel;Resolution;Resources;RNA;Role;Sampling;Scanning;Scientist;Signal Pathway;Signal Transduction;single molecule;Stains;stem cell fate;superresolution microscopy;System;T-Cell Activation;T-Lymphocyte;Techniques;Technology;Training;ultra high resolution;United States National Institutes of Health;Universities;Update;Work,Confocal Core for the Laboratory of Cellular and Molecular Biology,10978,NA,NA,NA,NA,17,NA,NA,550977,NA
11188741,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC010981,NA,NA,1ZICBC010981-17,NCI:150953\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79972406 (contact),"HESELMEYER, KERSTIN  (contact)",NA,NA,NA,Aneuploidy;assay development;Biological Assay;Biological Markers;biomarker identification;Cancer Gene Mutation;cell free DNA;Chromosomes;clinical development;clinical investigation;Clinical Management;Clinical Trials;Collaborations;Development;Disease;Evaluation;Germ-Line Mutation;Goals;Immune response;Immunologic Monitoring;Investigation;Investigational Therapies;Knowledge;Laboratories;Malignant Neoplasms;Methods;Monitor;Mutation Analysis;nanopore;National Institute of Child Health and Human Development;new technology;novel;Pathogenicity;Patient Monitoring;patient safety;Patient Selection;Patient-Focused Outcomes;Patients;Peripheral Blood Mononuclear Cell;Pharmaceutical Preparations;Pregnant Women;prenatal testing;Process;Publishing;response;Sampling;Screening for cancer;Somatic Mutation;specific biomarkers;Technology;technology development;Test Result;Therapeutic;tumor;tumor DNA;Tumor Markers;Validation;Work,Biomarker Investigations for Clinical Trials,10981,NA,NA,NA,NA,17,NA,NA,150953,NA
11188742,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC010989,NA,NA,1ZICBC010989-17,NCI:1131975\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687510 (contact),"BEYER, RACHEL  (contact)",NA,NA,NA,Air;antigen-specific T cells;Autologous;cancer cell;Categories;cell bank;Cell Separation;Cells;cellular transduction;Clinic;Clinical;clinical lot;Colon Carcinoma;Core Facility;cost;Cyclic GMP;Dedications;Ensure;Environmental Monitoring;Epithelial Cells;Gene Delivery;Gene Modified;gene therapy;gene therapy clinical trial;Generations;Goals;Health care facility;Humidity;improved;Individual;individualized medicine;Interruption;Lentivirus Vector;Malignant Breast Neoplasm;Malignant neoplasm of lung;manufacture;Mechanics;Mediating;meetings;Metastatic Melanoma;Mutation;neoantigens;novel;novel strategies;Oncogenes;operation;Operative Surgical Procedures;Patients;Peripheral Blood Lymphocyte;Peripheral Blood Mononuclear Cell;pressure;Production;programs;Reagent;Research;Retroviral Vector;Risk;Schedule;Solid Neoplasm;Specific qualifier value;T cell therapy;T-Cell Receptor;T-Cell Receptor Therapy;T-Lymphocyte;Temperature;Testing;Time;trend;tumor;Tumor-Infiltrating Lymphocytes;vector;Viral;Viral Vector;Virus,Clinical production of viral vectors for cancer gene therapy,10989,NA,NA,NA,NA,17,NA,NA,1131975,NA
11188743,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC010991,NA,NA,1ZICBC010991-17,NCI:931077\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692373 (contact),"CAMPHAUSEN, KEVIN  (contact)",NA,NA,NA,Advanced Technology Center;Bioinformatics;Computing Methodologies;Core Facility;Data;Data Analyses;Development;Dose;Extramural Activities;Gene Mutation;innovation;Internet;machine learning method;Malignant Neoplasms;Methods;MMP9 gene;novel;protein biomarkers;Publishing;Quality Control;Radiation exposure;Radiation Oncology;Radiation-Sensitizing Agents;Research Personnel;response;Role;Services;Statistical Methods;synthetic lethal interaction;tool development;Training;tumor progression,Radiation Oncology Branch - Microarray Facility,10991,NA,NA,NA,NA,17,NA,NA,931077,NA
11188744,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011021,NA,NA,1ZICBC011021-16,NCI:6592276\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8778166 (contact),"GULLEY, JAMES L. (contact)",NA,NA,NA,Acceleration;AIDS related cancer;anti-cancer research;Area;Basic Science;Bioinformatics;Biology;Budgets;Chemistry;Developmental Biology;Disease Progression;Disease susceptibility;drug discovery;Equipment;Genetic;Human Resources;Laboratories;Laboratory Research;Malignant Neoplasms;Molecular Target;NCI Center for Cancer Research;programs;Qualifying;Research;Research Personnel;Research Support;Resources;Retrovirology;RNA;Running;Scientist;structural biology;tool,Basic Research Support for the CCR,11021,NA,NA,NA,NA,16,NA,NA,6592276,NA
11188745,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011030,NA,NA,1ZICBC011030-17,NCI:699594\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692441 (contact),"PARKHURST, MARIA  (contact)",NA,NA,NA,Adoptive Cell Transfers;Adoptive Transfer;Antigen Targeting;Antigen-Presenting Cells;Antigens;Autoantigens;Autologous;Binding;cancer infiltrating T cells;Cell Separation;Cells;Clinical Protocols;Clinical Trials;Colon Carcinoma;Core Facility;Epitopes;exome sequencing;gene therapy clinical trial;genetically modified cells;Goals;Histology;Human;Immunology;Immunotherapy;In Vitro;individual patient;Lymphocyte Activation;Malignant Breast Neoplasm;Malignant neoplasm of lung;Malignant neoplasm of pancreas;Malignant Neoplasms;Melanoma;Methods;Mutate;Mutation;National Cancer Institute;neoplastic cell;novel;objective response rate;Operative Surgical Procedures;Patients;Peptides;Population;Protocols documentation;Renal Carcinoma;Research Personnel;RNA;T-Cell Receptor;T-Lymphocyte;Techniques;Technology;transcriptome sequencing;Transgenic Mice;tumor;Tumor Antigens;tumor immunology;Tumor-Infiltrating Lymphocytes,The Antigen Targeting Core,11030,NA,NA,NA,NA,17,NA,NA,699594,NA
11188746,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011044,NA,NA,1ZICBC011044-17,NCI:960311\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692469 (contact),"VOCKE, CATHY D (contact)",NA,NA,NA,accurate diagnosis;Adrenal Gland Neoplasms;Adrenal Mass;Affect;Aliquot;Ascites;Basic Science;bench to bedside;bevacizumab;Biological;Biopsy;Bladder;bladder surgery;Blood;Blood specimen;Body Fluids;cancer biomarkers;Cancer cell line;Cancer Gene Mutation;Cancer Patient;cancer type;Carbon Dioxide;Carcinoma;Caring;Cell Culture Techniques;cell immortalization;Cell Line;Cell Nucleus;Cellular Metabolic Process;central database;Chest;Clinical;clinical center;Clinical Research;Clinical Treatment;Clinical Trials;Collaborations;Collection;Communication;Cyst Fluid;Data;Databases;Detection;Disease;DNA;DNA analysis;DNA Sequence Rearrangement;DNA sequencing;Dose;Electron Microscopy;Elements;Ensure;epidemiology study;Equipment and supply inventories;Erlotinib;exome;exome sequencing;extracellular;Family;Fluorescent in Situ Hybridization;Formalin;Freezing;gene discovery;Gene Expression;Genes;Genetic study;Genitourinary system;Genome;Genomics;Germ Lines;Glutaral;Goals;Heart;Hereditary Leiomyomatosis and Renal Cell Cancer;House mice;Human;Immunohistochemistry;Immunoprecipitation;Immunotherapy;Incubators;Inherited;Karyotype;Karyotype determination procedure;Kidney;Kidney Neoplasms;kidney surgery;Laboratories;Light;Liquid substance;Malignant neoplasm of prostate;Malignant neoplasm of urinary bladder;Malignant Neoplasms;metabolomics;Metastatic Neoplasm to Lymph Nodes;Methods;Methylation;Mitochondrial DNA;Molecular;Molecular Epidemiology;Molecular Target;molecular targeted therapies;Mus;Mutation;Mutation Analysis;new therapeutic target;next generation;Nitrogen;Northern Blotting;novel;Nuclear;Operative Surgical Procedures;Organelles;Other Genetics;Oxygen;Oxygen Consumption;Paper;Papillary;Pathway interactions;Patient Selection;Patients;Pharmaceutical Preparations;Pharmacodynamics;pharmacokinetics and pharmacodynamics;Pheochromocytoma;Plasma;Polymorphism Analysis;Predisposition;preservation;Privacy;Procedures;Process;prospective;Prostate;protein expression;Proteins;Proteomics;PSA level;Publishing;Reactive Oxygen Species;Reagent;Recording of previous events;Renal Carcinoma;Renal Cell Carcinoma;Reporting;Research;Research Personnel;Resources;RNA;Saliva;Sampling;Scientist;Secure;Security;Serum;Single Nucleotide Polymorphism;Site;Specimen;Sterility;Succinate Dehydrogenase;Surgical Pathology;Syndrome;Techniques;Testing;Therapeutic Agents;Time;Tissue Banks;tissue fixing;tissue processing;Tissue Sample;Tissues;transcriptome sequencing;Tuberous Sclerosis;tumor;Tumor Tissue;tumorigenesis;United States National Institutes of Health;Urine;Urogenital Cancer;Urologic Cancer;Urologic Oncology;Uterine Fibroids;VHL gene;Western Blotting;Whole Blood;whole genome;Xenograft Model;Xenograft procedure,Tissue Processing-Sequencing Facility,11044,NA,NA,NA,NA,17,NA,NA,960311,NA
11188747,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011047,NA,NA,1ZICBC011047-17,NCI:1205384\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162291 (contact),"DU BOIS DE VROYLANDE, WENDY  (contact)",NA,NA,NA,Amendment;Animal Care and Use Committees;Animal Experimentation;Animal Genetics;Animal Model;Animals;anti-cancer research;B-Cell Lymphomas;Bioluminescence;Breeding;Cancer Biology;cancer genetics;cancer initiation;Cancer Model;Cell Line;Communities;Computer software;congenic;cost effective;design;DNA;Equipment;experimental study;Foundations;Genetic;Genetically Engineered Mouse;Genotype;Goals;imager;in vivo Model;Laboratories;Malignant Breast Neoplasm;Malignant neoplasm of pancreas;Malignant neoplasm of prostate;Melanoma;Monitor;mouse model;Multiple Myeloma;Mus;National Cancer Institute;Neoplasm Metastasis;new technology;Pharmaceutical Preparations;Plasma Cell Neoplasm;Plasma Cells;Preclinical Testing;Preparation;Research;Research Personnel;Research Support;Shipping;Skin Carcinogenesis;Techniques;Technology;tissue culture;tool;Transgenic Organisms;tumor;Tumor Bank;Tumor Cell Line;tumorigenesis;Writing,Animal Model and Genotyping Core Support Facility,11047,NA,NA,NA,NA,17,NA,NA,1205384,NA
11188748,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011052,NA,NA,1ZICBC011052-17,NCI:1837061\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692483 (contact),"FILIE, ARMANDO  (contact)",NA,NA,NA,Anatomy;Ancillary Study;Breast;Cell Count;Cell Line;Central Nervous System;Clinical;Clinical Protocols;Clinical Research;COVID-19;Cytology;Cytopathology;Diagnosis;Diagnostic;Diagnostic Services;Duct (organ) structure;Evaluation;experience;Fellowship;Fine needle aspiration biopsy;Flow Cytometry;Goals;Gynecologic;human disease;immunocytochemistry;immunosuppressed;Investigation;Lavage;Malignant Neoplasms;Molecular;Molecular Analysis;Morphology;Nature;neoplastic cell;Organ;Organism;Pathologic;Pathology;patient population;Patients;Pericardial cavity;Peritoneal;Pleural;Prognosis;prognostic;Protocols documentation;Research;research study;Research Technics;Residencies;Respiratory System;RNA;Sampling;Specimen;System;Techniques;Technology;Testing;Therapeutic;Training;Tumor-Infiltrating Lymphocytes;United States National Institutes of Health;urogenital tract,Cytopathology Core,11052,NA,NA,NA,NA,17,NA,NA,1837061,NA
11188749,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011075,NA,NA,1ZICBC011075-17,NCI:439117\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692529 (contact),"DURELL, STEWART  (contact)",NA,NA,NA,ABCB1 gene;Adenosine;Alanine;ATP phosphohydrolase;Binding;Binding Sites;Biochemical;cancer therapy;Carrier Proteins;Cell surface;Cells;chemotherapy;Chemotherapy-Oncologic Procedure;Communication;comparative;Cryoelectron Microscopy;Data;design;Drug Efflux;Drug Transport;Effectiveness;Experimental Designs;experimental study;Goals;Human;Hydrolysis;Individual;Integral Membrane Protein;Knowledge;Maps;member;Membrane;Modeling;Molecular Conformation;molecular dynamics;molecular modeling;Multi-Drug Resistance;mutant;Mutation;Mutation Analysis;Nucleotides;Pathway interactions;Pharmaceutical Preparations;Proteins;Pump;Recovery;rhodamine 6G;Role;Site;small molecule;small molecule inhibitor;Structure;Structure-Activity Relationship;Substrate Interaction;Substrate Specificity;Testing;Transmembrane Domain;Trefoil Motif;tripolyphosphate;Tyrosine;Verapamil,Molecular Modeling of the Human P-glycoprotein Transporter Protein,11075,NA,NA,NA,NA,17,NA,NA,439117,NA
11188750,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011077,NA,NA,1ZICBC011077-17,NCI:79839\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692529 (contact),"DURELL, STEWART  (contact)",NA,NA,NA,Apoptosis;Binding;Biochemical Pathway;Biotinylation;Cancer Biology;Carbon;Cell Cycle Arrest;Cells;Cellular Stress;Chemicals;DNA Damage;drug development;Enzymes;gain of function;high throughput screening;In Vitro;Metabolic;Metabolism;Modification;molecular dynamics;molecular modeling;molecular targeted therapies;mutant;Normal Cell;Pattern;Post-Translational Protein Processing;Proteins;Proteome;Reaction;response;Signal Transduction;small molecule;structural biology;Sulfhydryl Compounds;TP53 gene;transcription factor;tumor;Work,Molecular Modeling of Interactions Regulating the Activity of the p53 Protein,11077,NA,NA,NA,NA,17,NA,NA,79839,NA
11188751,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011079,NA,NA,1ZICBC011079-17,NCI:4488176\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162296 (contact),"XI, LIQIANG  (contact)",NA,NA,NA,"American;Archives;B-Lymphocytes;Biological Assay;Biological Markers;Blood;Bone Marrow;BRAF gene;Cancer Patient;cancer subtypes;Capillary Electrophoresis;CCR;cell free DNA;Cells;Certification;Classification;Clinical;clinical center;clinical diagnosis;Clinical Treatment;Clinical Trials;clinically relevant;Collaborations;college;Complex;Consult;cost;Detection;Diagnostic;digital;Disease;DNA;Early Diagnosis;Eligibility Determination;exome sequencing;Gene Expression;Gene Mutation;Genes;Genomics;Hematologic Neoplasms;Hematopathology;Histiocytic sarcoma;Human Herpesvirus 4;Human Herpesvirus 8;Human T-lymphotropic virus 1;instrument;Intramural Research Program;Laboratories;Liquid substance;Lymphoproliferative Disorders;Malignant neoplasm of lung;Malignant neoplasm of pancreas;Malignant neoplasm of urinary bladder;Malignant Neoplasms;Melanoma;Methylation;Modernization;Molecular;Molecular Biology;Molecular Diagnostic Testing;molecular diagnostics;molecular oncology;molecular pathology;molecular targeted therapies;multiplex assay;Mutation;Mutation Analysis;mutational status;National Cancer Institute;National Heart, Lung, and Blood Institute;National Human Genome Research Institute;National Institute of Allergy and Infectious Disease;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;National Institute of Child Health and Human Development;National Institute of Dental and Craniofacial Research;National Institute of Diabetes and Digestive and Kidney Diseases;National Institute of Environmental Health Sciences;National Institute of Mental Health;National Institute of Neurological Disorders and Stroke;Needle biopsy procedure;neoplastic cell;novel;Pathologic;Pathologist;Pathology;Patient Care Team;Patients;Pediatric Neoplasm;Performance;Play;Pleural;precision oncology;Process;prognostic;programs;Proteins;Quality Control;rare cancer;Reagent;Recurrence;Research;research clinical testing;Research Personnel;Rest;Reverse Transcriptase Polymerase Chain Reaction;RNA;Role;Rotation;Running;Saliva;Sampling;Site;Specimen;Specimen Handling;Structure;Subgroup;symposium;T cell clonality;Technology;Test Result;Testing;Therapeutic;Tissues;Training and Education;transcriptome sequencing;Translational Research;treatment response;tumor behavior;tumor DNA;United States National Institutes of Health;virus related cancer",Molecular Diagnostics Core Laboratory,11079,NA,NA,NA,NA,17,NA,NA,4488176,NA
11188752,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011093,NA,NA,1ZICBC011093-17,NCI:328295\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858560 (contact),"WANG, HAO-WEI  (contact)",NA,NA,NA,Biological Assay;Body Fluids;cancer cell;Cerebrospinal Fluid;Clinical;Detection;Diagnosis;Disease;Evaluation;Flow Cytometry;Goals;Hematopoietic Neoplasms;improved;leukemia/lymphoma;Liquid substance;Molecular Diagnosis;Morphology;Multicentric Angiofollicular Lymphoid Hyperplasia;Neoplasms;Patients;Pleural;primary effusion lymphoma;prognostic;Prognostic Factor;Protocols documentation;Techniques;Therapeutic;Therapeutic Intervention;Vitreous humor,Flow cytometric detection of malignant cells in body fluids,11093,NA,NA,NA,NA,17,NA,NA,328295,NA
11188753,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011104,NA,NA,1ZICBC011104-17,NCI:656590\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858560 (contact),"WANG, HAO-WEI  (contact)",NA,NA,NA,Antibodies;Antibody Therapy;Antigens;B-Cell Lymphomas;Benign;Binding;Biological Assay;Biological Markers;biomarker evaluation;cancer cell;CAR T cell therapy;CCR;cell determination;Cell Surface Proteins;Characteristics;chimeric antigen receptor T cells;Development;Diagnosis;Disease;Evaluation;Flow Cytometry;Goals;HIV/AIDS;Human Herpesvirus 8;improved;insight;Lymphoma;Lymphoproliferative Disorders;Malignant Neoplasms;Medical;Monitor;Neoplasms;neoplastic cell;novel therapeutics;Pathway interactions;Patients;Play;primary effusion lymphoma;prognostication;rapid test;Research;Research Personnel;Resources;response;Role;System;Techniques;Testing;Therapeutic;Therapeutic Agents;Therapeutic antibodies;therapeutic evaluation;therapeutic target;Time;treatment response,Flow cytometric evaluation of biomarkers,11104,NA,NA,NA,NA,17,NA,NA,656590,NA
11188754,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011138,NA,NA,1ZICBC011138-17,NCI:977921\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692635 (contact),"TELFORD, WILLIAM  (contact)",NA,NA,NA,Advisory Committees;Apoptosis;Azerbaijan;Biological Assay;CCR;Cell Separation;Cells;Core Facility;Cytometry;Data Analyses;Data Collection;design;Detection;Device or Instrument Development;Education;educational atmosphere;Educational workshop;experimental study;Faculty;Fiber;Flow Cytometry;Fluorescence-Activated Cell Sorting;Fluorescent Probes;high dimensionality;Home;Image Cytometry;Immunology;Immunophenotyping;indexing;Instruction;instrument;instrumentation;Interest Group;investigator training;Investments;Kazakhstan;Label;Laboratories;Lasers;lectures;Length;Malignant neoplasm of gastrointestinal tract;Malignant neoplasm of thorax;Measurement;Medicine;meetings;Meleagris gallopavo;member;Mission;new technology;novel;Optics;Pathology;Pediatric Oncology;Policies;Program Development;programs;Pump;research and development;Research Personnel;Research Project Grants;Resources;Running;Russia;Saudi Arabia;Schedule;Schools;Scientist;Services;Singapore;solid state;Sorting;stem cells;Students;Supervision;Techniques;Technology;telomere;Testing;theories;Time;Training;Transplantation;ultraviolet;United States National Institutes of Health;virtual;Visit;web site;Work,FACS Core Facility,11138,NA,NA,NA,NA,17,NA,NA,977921,NA
11188755,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011139,NA,NA,1ZICBC011139-17,NCI:108658\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692635 (contact),"TELFORD, WILLIAM  (contact)",NA,NA,NA,Automobile Driving;Biological;Biological Assay;CCR;Cells;design;Detection;Development;Exclusion;Fiber;Fiber Optics;Flow Cytometry;Fluorescence;Fluorescent Probes;Fluorochrome;Gases;Goals;high dimensionality;improved;Individual;instrument;instrumentation;interest;Lasers;Light;Measurement;member;Modernization;novel;Optics;Oranges;Peer Review;Performance;pressure;programs;prototype;Pump;Reporting;Research Personnel;Review Literature;Sampling;solid state;Source;Technology;ultraviolet;Validation;Viola;Visible Radiation;Work,Application of novel laser technology for flow cytometric analysis,11139,NA,NA,NA,NA,17,NA,NA,108658,NA
11188756,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011236,NA,NA,1ZICBC011236-16,NCI:503759\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857619 (contact),"CARRELL, JEFFREY  (contact)",NA,NA,NA,Adhesions;Aging;Agreement;assay development;Binding;Biological Sciences;Biology;Bioluminescence;Cancer Biology;cancer genetics;CCR;CD8-Positive T-Lymphocytes;Cell Separation;Cell Therapy;Cells;Chemicals;chimeric antigen receptor T cells;Clinical Research;Colon;Computer software;Data Collection;Development;Developmental Biology;Division of Cancer Treatment and Diagnosis;E-Cadherin;Epithelium;Epitopes;Equipment;Evaluation;Female;Flow Cytometry;Functional disorder;Generations;glycogen synthase kinase 3 beta;Growth Factor;Hour;Human;Individual;innovation;insight;Institution;instrument;Interferon Type II;Interferons;investigator training;Laboratories;Life Cycle Stages;Luciferases;Macrophage;Maintenance;Malignant Neoplasms;mammary;mesothelin;Metastatic breast cancer;Microfluidics;Mouse Embryonic Stem Cells;Mus;National Institute of Allergy and Infectious Disease;operation;Organoids;Pathway interactions;Price;programs;PTGS2 gene;Publications;quality assurance;Reagent;reproductive;Research Personnel;Resistance;RNA;Sampling;Science;Scientist;Secure;Services;Signal Transduction;Sorting;spatiotemporal;structural biology;Students;symposium;System;Technology;tool;Training;tumor;Urologic Oncology;webinar;Work,CCR-Frederick Flow Cytometry Core,11236,NA,NA,NA,NA,16,NA,NA,503759,NA
11188757,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011237,NA,NA,1ZICBC011237-16,NCI:2525817\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10274554 (contact),"OHUIGIN, COLM  (contact)",NA,NA,NA,Affect;Alleles;Anus;Area;Authorship;Autoimmune;Autoimmune Diseases;Autoimmunity;Bacteria;Bar Codes;Base Pairing;Base Sequence;Behavior;Binding;Bioinformatics;bioinformatics pipeline;bioinformatics tool;Biomass;cancer immunotherapy;Cancer Patient;cancer therapy;checkpoint inhibition;checkpoint therapy;Clinical;cloud platform;cohort;Cohort Studies;Communicable Diseases;Communication;Communities;comparative;Computer Analysis;Copy Number Polymorphism;cost effectiveness;Crohn&apos;s disease;Data;Data Storage and Retrieval;Disease;Disease Outcome;DNA;Drosophila genus;Epidemiology;fecal transplantation;Frequencies;fungus;Gene Amplification;Genes;Genetic;genetic analysis;Genetic Transcription;genome sequencing;Genomic approach;Genomics;Genotype;Goals;Graft Rejection;gut microbiota;Haplotypes;Health;Hepatitis C virus;Heterozygote;high throughput analysis;HIV;HLA Antigens;HLA-B Antigens;HLA-C Antigens;Human;Human Papillomavirus;Immune checkpoint inhibitor;Immunoglobulins;Immunologics;Infection;Inflammatory;Intestines;killer immunoglobulin-like receptor;Laboratories;Leukocytes;Libraries;Longitudinal Studies;Macaca;Malignant Neoplasms;Melanoma;Metabolic;Metabolic Pathway;metagenome;Metagenomics;Methodology;Methods;Microbe;microbial;microbial genome;Microbial Genome Sequencing;microbiome;microbiome analysis;microbiome components;microbiome research;microbiota;microbiota composition;Mission;Modification;Molecular Medicine;Mus;Nature;novel;Nucleic Acids;nutrition;Oral Characters;oral microbial community;Organism;Outcome;Paper;pathogen;Pathway Analysis;Pathway interactions;Patients;Pediatric Research;Peptides;Play;Population;Postbaccalaureate;Preparation;Process;Protocols documentation;Publications;Publishing;receptor;Reproducibility;Research;Research Personnel;response;Ribosomal RNA;Ribosomes;Risk;RNA;Robotics;Role;rRNA Genes;Running;Saliva;Sampling;Science;Scientist;Sequence Analysis;Shotguns;Source;Spectrum Analysis;Standardization;Statistical Data Interpretation;Students;Swab;System;Testing;Tissues;Transcript;transcriptomics;transplantation medicine;tumor;tumor immunology;United States National Institutes of Health;Vagina;Virus Diseases;whole genome;Work,LICI Microbiome and Genetics Core,11237,NA,NA,NA,NA,16,NA,NA,2525817,NA
11188758,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011265,NA,NA,1ZICBC011265-15,NCI:1089666\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692419 (contact),"TESSAROLLO, LINO  (contact)",NA,NA,NA,Alleles;Autopsy;Biopsy;Blood;Breeding;cancer genetics;CCR;Clip;Collection;Communities;Counseling;CRISPR/Cas technology;Derivation procedure;design;Development;DNA;Embryo;Engineering;Gene Targeting;Generations;Genes;Goals;human disease;Injections;mammary;Measurement;Microinjections;Molecular Biology;mouse model;Mus;Mutation;Palpation;Point Mutation;Pregnancy;Process;programs;Research Personnel;Services;Splenectomy;Tail;Technology;Transgenic Mice;tumor;Vasectomy;Weaning,Gene Targeting Facility,11265,NA,NA,NA,NA,15,NA,NA,1089666,NA
11188759,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011331,NA,NA,1ZICBC011331-15,NCI:6150767\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79972425 (contact),"MALIK, MARIAM  (contact)",NA,NA,NA,anti-cancer research;Automation;Base Pairing;Bioinformatics;Biological Sciences;Cell Line;Cells;Collaborations;Collection;Communities;Complex;Computer software;cost;Data;Data Analyses;data archive;DNA;Ensure;Funding;Generations;genome editing;High-Throughput Nucleotide Sequencing;In Situ;Individual;Informatics;Journals;Laboratories;Metadata;Methods;Mission;Molecular;nanopore;National Institute of Allergy and Infectious Disease;NCI Center for Cancer Research;next generation sequencing;open source;Peer Review;Policies;Principal Investigator;Process;Production;programs;Protocols documentation;Publications;Reagent;Research;Research Personnel;Research Project Grants;Resources;RNA;Role;Sampling;Science;sequencing platform;Services;single cell analysis;single molecule;Software Tools;Standardization;Stretching;System;Technology;Testing;Time;Tissues;Training;transcriptome sequencing;transcriptomics;Tumor Tissue;United States National Institutes of Health;Work,CCR Sequencing Facility,11331,NA,NA,NA,NA,15,NA,NA,6150767,NA
11188760,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011379,NA,NA,1ZICBC011379-14,NCI:199598\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692529 (contact),"DURELL, STEWART  (contact)",NA,NA,NA,Active Sites;Binding;Cancerous;Catalysis;Catalytic Domain;CCR;cell growth;cell transformation;Development;DNA Damage;Enzymes;experimental study;Family;Genetic Transcription;Goals;inhibitor;innovation;insight;Ions;Kinetics;Laboratories;Magnesium;Malignant Neoplasms;molecular dynamics;Nitrogen;Oxygen;p38 Mitogen Activated Protein Kinase;Phosphoric Monoester Hydrolases;Phosphotransferases;PPM1D gene;protein phosphatase 2C;Proteins;Regulation;Roentgen Rays;Serine;Structure;Sulfur;Threonine;TP53 gene;Work,Inhibitor Development Against the Wip1 Phosphatase,11379,NA,NA,NA,NA,14,NA,NA,199598,NA
11188761,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011428,NA,NA,1ZICBC011428-13,NCI:1450610\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14732145 (contact),"LIVAK, FERENC  (contact)",NA,NA,NA,15 year old;20 year old;Advanced Malignant Neoplasm;Aerosols;Agreement;analytical tool;anti-cancer research;Area;Biological Assay;Biological Products;Breast Cancer Model;cancer stem cell;Cell fusion;Cell Separation;Cells;Chronic;Client;Complex;Computer software;Consultations;Consumption;Containment;Contract Services;Contracts;cost;Custom;Data Analyses;Dedications;design;detector;Development;diagnostic strategy;DNA analysis;DNA Damage;Education;Ensure;Equity;experience;experimental study;flexibility;Flow Cytometry;Fluorescence-Activated Cell Sorting;Fluorochrome;follow-up;Freezing;Funding;Future;Genetic;genome integrity;Goals;Hour;Housing;Image;Immune response;Individual;innovation;instrument;instrumentation;investigator training;Laboratories;Laboratory Personnel;Laboratory Research;Lasers;Lead;Leadership;Left;Lymphocyte;Maintenance;Malignant neoplasm of lung;Manufacturer;member;Mission;Modernization;NCI Center for Cancer Research;Neurons;new technology;novel;Occupations;operation;Periodicals;Phagocytosis;Policies;Positioning Attribute;pressure;Price;Procedures;Research Personnel;Research Support;Resource Sharing;Resources;response;Sampling;Schedule;Services;single cell analysis;Site;Sorting;Students;Supporting Cell;Technical Expertise;Technology;technology development;Testing;Time;Training;tumor;tumor diagnostic;United States National Institutes of Health;Universities;Virginia;Visit;Work,"CCR, LGI, Flow Cytometry Core",11428,NA,NA,NA,NA,13,NA,NA,1450610,NA
11188762,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011430,NA,NA,1ZICBC011430-13,NCI:1295034\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11593641 (contact),"JENKINS, LISA  (contact)",NA,NA,NA,3&apos; Untranslated Regions;Acetylation;Algorithms;American;Basic Science;Binding;Biological;Biological Assay;Biotechnology;Captopril;CCR;CDC2 gene;Cell Cycle Progression;Cells;Cellular biology;cellular oncology;Chickens;Clinical;Co-Immunoprecipitations;Collaborations;Colorectal Cancer;Communication;Communities;Complex;Computer software;crosslink;Cysteine;Data;Data Analyses;Databases;design;Deubiquitinating Enzyme;Development;Developmental Therapeutics Program;DNA Damage;DNA replication fork;Dose;Embryo;enzyme activity;Experimental Designs;experimental study;follow-up;Follow-Up Studies;Gene Silencing;Genetic;Genetic Transcription;genome integrity;genome-wide;genomic data;Histone Deacetylase Inhibitor;HIV;HIV Infections;Homeodomain Proteins;Homologous Gene;Hydrogen Sulfide;Inductively Coupled Plasma Mass Spectrometry;inhibitor;interest;Isotope Labeling;Journals;knock-down;Label;Laboratories;loss of function;Lysine;Malignant Breast Neoplasm;Malignant neoplasm of prostate;Malignant Neoplasms;Manuscripts;Maps;Mass Spectrum Analysis;Measures;member;Messenger RNA;Metals;Methods;Methylation;Methyltransferase;microorganism;Mitosis;Molecular;Molecular and Cellular Biology;mRNA Expression;mRNA Stability;Mus;National Institute of Diabetes and Digestive and Kidney Diseases;Nature;Nuclear;Nucleic Acids;Oncogenes;Oral;Outcome;overexpression;Paper;paralogous gene;phosphoproteomics;Phosphorylation Site;Post-Translational Protein Processing;Preparation;prevent;programs;protein aggregation;Protein Conformation;protein expression;Proteins;Proteolysis;Proteomics;Publishing;Rattus;recruit;Regulation;replication stress;Reporting;Research;Research Personnel;Resistance;Resources;RNA;RNA Stability;Running;S phase;Sampling;Signal Transduction;Site-Directed Mutagenesis;small molecule;small molecule inhibitor;SN-38;Societies;Specificity;Sulfhydryl Compounds;Techniques;Technology;Testing;Therapeutic;thioester;Time;tool;Topoisomerase;Transcript;transcription factor;Translational Research;TRIM Gene;Tumor Suppressor Proteins;ubiquitin isopeptidase;Ubiquitination;United States National Institutes of Health;United States National Library of Medicine;Vaccines;web-based tool;Work;Zebrafish;Zinc,CPTR - Mass Spectrometry Unit,11430,NA,NA,NA,NA,13,NA,NA,1295034,NA
11188763,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011434,NA,NA,1ZICBC011434-13,NCI:1636160\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355738 (contact),"KEDEI, NOEMI  (contact)",NA,NA,NA,Antibodies;Apoptosis;Atlases;Bar Codes;Bioinformatics;Biological Assay;Biological Markers;Biological Sciences;biomarker validation;Blood capillaries;Cancer Detection;cancer therapy;Canis familiaris;Capillary Electrophoresis;Cardiovascular Diseases;CCR;Cell Cycle;Cell Death;Cell Proliferation;Cells;Clinical;clinical application;clinical practice;Clinical Protocols;Clinical Research;Clinical Trials;Collaborations;Colon Carcinoma;Communities;computerized data processing;Consumption;cost;cost estimate;cytokine;Data;Data Analyses;data infrastructure;data sharing;Data Storage and Retrieval;Detection;Development;digital;digital pathology;Drug Targeting;Enzyme-Linked Immunosorbent Assay;Evaluation;experience;experimental study;extracellular;Fibroblasts;Fluorescent Antibody Technique;Freezing;Genes;Genomics;Human;Image;Image Analysis;imager;imaging modality;Imaging technology;Immune;Immunoassay;Immunofluorescence Immunologic;Immunologic Monitoring;Immunology;Immunooncology;improved;indexing;Individual;Industry Collaboration;Inflammation;innovative technologies;instrument;interest;Laboratories;Liver neoplasms;Lymphoid Tissue;Macrophage;Malignant Breast Neoplasm;Malignant neoplasm of liver;Malignant neoplasm of lung;Malignant Neoplasms;Manuscripts;Measurement;Measures;Melanoma;Metabolic Diseases;Metastatic Neoplasm to the Lung;Methodology;Methods;Molecular;Molecular Profiling;Monitor;Morphology;multidisciplinary;Mus;Names;nanoimmunoassay;nanoscale;Neighborhoods;neoplastic cell;neurofibroma;Neurosciences;Optics;Organ;Osteosarcoma;ovarian neoplasm;Pathologist;Pathway interactions;Performance;Peripheral Blood Mononuclear Cell;Pharmaceutical Preparations;Pharmacodynamics;Phenotype;Plasma;Post-Translational Protein Processing;pre-clinical;preclinical study;Preparation;preservation;Program Development;Protein Analysis;protein biomarkers;Proteins;Protocols documentation;Publications;Publishing;Regulation;Reporting;Reproducibility;Research;Research Personnel;Research Project Grants;Resolution;Resources;response;RNA;Running;Sample Size;Sampling;Science;Serum;Services;Signal Transduction;Signaling Molecule;Site;Slide;Specialist;Specimen;Stains;System;Technology;technology platform;therapeutic target;Tissue imaging;Tissue Microarray;Tissues;tool;Transcript;transcriptome;treatment response;tumor;tumor microenvironment;Tumor Tissue;United States National Institutes of Health;Update;Validation;Vendor;Walking;Western Blotting;Work,Collaborative Protein Technology Resource - Nano-Scale Protein Analysis Section,11434,NA,NA,NA,NA,13,NA,NA,1636160,NA
11188764,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011475,NA,NA,1ZICBC011475-12,NCI:275153\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,12032348 (contact),"REINHOLD, WILLIAM  (contact)",NA,NA,NA,Antibodies;anticancer activity;Antineoplastic Agents;Area;Binding;Bioinformatics;Cancer cell line;Cancer Patient;cancer site;Cancerous;Cell Line;Chemicals;Computer software;Data;data integration;Data Set;Databases;design;Development;Developmental Therapeutics Program;digital repositories;Discipline;Disparate;distributed data;drug discovery;drug sensitivity;Drug usage;Encyclopedias;Extramural Activities;General Hospitals;Generations;Genes;genetic variant;genomic data;Genomics;Goals;Graph;Image;improved;Individual;Informatics;insight;interest;Laboratories;Linear Regressions;Machine Learning;Maintenance;Malignant Neoplasms;Mammalian Cell;Maps;Massachusetts;Metadata;Mining;Molecular;molecular scale;National Center for Advancing Translational Sciences;novel therapeutics;Output;Patients;Pattern;personalized cancer therapy;Persons;Pharmaceutical Preparations;Pharmacogenomics;pharmacologic;Pharmacology;Phenotype;Predictive Factor;Protein Isoforms;quality assurance;repository;Research;Research Personnel;Resources;response;Sarcoma;Scientist;Series;Site;small cell lung carcinoma;Solid;Structure;System;therapy outcome;Time;tool;Training;Update;Validation;Variant;web app;web site;web-based tool,Genomics and Bioinformatics Group web site development and maintenance,11475,NA,NA,NA,NA,12,NA,NA,275153,NA
11188765,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011497,NA,NA,1ZICBC011497-12,NCI:137576\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,12032348 (contact),"REINHOLD, WILLIAM  (contact)",NA,NA,NA,Adrenocortical Carcinoma;Almanacs;Area;bioinformatics resource;Cancer cell line;Cancerous;CCR;Cell Line;Cell Survival;Cells;Clustered Regularly Interspaced Short Palindromic Repeats;Collaborations;Data;Databases;Development;Developmental Therapeutics Program;Disease;DNA copy number;drug sensitivity;Encyclopedias;Extramural Activities;Future;General Hospitals;Genes;Genetic;Genetic Transcription;genetic variant;Genomics;Goals;interest;Knock-out;Malignant Neoplasms;Manuscripts;Massachusetts;MicroRNAs;Molecular;multiple data sources;National Cancer Institute;National Cancer Program;neuroendocrine cancer;Oncologist;Output;Patients;Pattern;Pharmaceutical Preparations;pharmacologic;Pharmacology;Phenotype;Protein Isoforms;Proteins;Publications;Publishing;Reporting;response;RNA;RNA Processing;RNA Splicing;Sampling;small cell lung carcinoma;Source;Standardization;The Cancer Genome Atlas;Tissues;tool;Transcript;treatment response;Variant;web app;Work,RNA data development of cancer cell lines and patients,11497,NA,NA,NA,NA,12,NA,NA,137576,NA
11188766,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011509,NA,NA,1ZICBC011509-12,NCI:137576\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,12032348 (contact),"REINHOLD, WILLIAM  (contact)",NA,NA,NA,Affective;Alkylating Agents;analytical method;Antineoplastic Agents;Biological;Bleomycin;Cancer Patient;cancer therapy;CDC2 gene;cell growth;Cell Line;Characteristics;Cladribine;Clinical;Clinical Data;Clinical Trials;Complex;Computational Technique;Computer software;Core-Binding Factor;Data;data integration;Databases;Disease;disorder subtype;DNA biosynthesis;DNA Damage;DNA Methylation;DNA Repair;DNA Repair Gene;DNA Synthesis Inhibitors;drug action;Drug Compounding;Drug Targeting;EGFR gene;Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Epigenetic Process;Erlotinib;Event;FDA approved;Gene Dosage;Genes;Genetic;genetic variant;genomic profiling;Genomics;Goals;infancy;inhibitor;Knowledge;Lead;leukemia;Linear Regressions;Machine Learning;Malignant Neoplasms;Manuscripts;mathematical learning;mathematical methods;Mathematics;MDM2 gene;Methodology;MicroRNAs;Molecular;Molecular Profiling;multiple datasets;mutational status;novel;Outcome;Output;Pathway interactions;Patients;Pattern;Pharmaceutical Preparations;pharmacologic;Pharmacology;Pharmacology Study;Protein Isoforms;PTEN gene;RAD52 gene;Ras/Raf;Resources;response;statistical learning;Structure;Subgroup;System;Techniques;Tissues;Topoisomerase;Topoisomerase-I Inhibitor;TP53 gene;Transcript;translational applications;Variant;Visualization;web app,Comparison of molecular factors to drug activities,11509,NA,NA,NA,NA,12,NA,NA,137576,NA
11188767,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011515,NA,NA,1ZICBC011515-12,NCI:303590\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11592582 (contact),"SCHNEIDER, JOEL  (contact)",NA,NA,NA,Address;Animals;Area;Biochemical Pathway;Biological;Biology;CCR;chemical synthesis;Chemicals;Chemistry;Communities;Consultations;Contracts;cost effective;Custom;experience;Goals;In Vitro;Laboratories;milligram;Nature;Outsourcing;Postdoctoral Fellow;programs;Research;Resources;Running;sabbatical;Synthesis Chemistry;Technology;tool,Chemical Synthesis Group,11515,NA,NA,NA,NA,12,NA,NA,303590,NA
11188768,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011532,NA,NA,1ZICBC011532-12,NCI:4286395\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79972425 (contact),"MALIK, MARIAM  (contact)",NA,NA,NA,Area;base;Bioinformatics;bioinformatics resource;Biological;biomedical informatics;CCR;Cloud Computing;Collaborations;Communities;comparative genomic hybridization;Computer software;Data Analyses;Data Correlations;data integration;data mining;Databases;Dedications;Ecosystem;experimental study;forging;Fostering;Goals;Hour;improved;Informatics;Information Technology;Infrastructure;Investments;Laboratories;Maps;mathematical analysis;member;Metadata;MicroRNAs;Modeling;next generation;next generation sequence data;operation;Outcome;Pathway interactions;Play;programs;Reporting;Reproducibility;Research;Research Personnel;Resources;Scientist;Sequence Analysis;Services;skills;Standardization;Statistical Data Interpretation;System;Time;Training;Training and Education;United States National Institutes of Health;Update;user-friendly;virtual,CCR Collaborative Bioinformatics Resource,11532,NA,NA,NA,NA,12,NA,NA,4286395,NA
11188769,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011535,NA,NA,1ZICBC011535-11,NCI:888622\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8777676 (contact),"WANG, YUN XING M (contact)",NA,NA,NA,beamline;Biological;CCR;Collaborations;Communities;Data;Data Analyses;doctoral student;Extramural Activities;Goals;International;Research;Research Personnel;Sampling;Science;Services;Technical Expertise;Training;tutoring;United States National Institutes of Health,SAXS Core,11535,NA,NA,NA,NA,11,NA,NA,888622,NA
11188770,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011567,NA,NA,1ZICBC011567-11,NCI:1984068\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,12448464 (contact),"PEGORARO, GIANLUCA  (contact)",NA,NA,NA,aging related disease;anti-cancer research;Area;Basic Science;Biological;Biological Assay;Biology;Cells;Chromosomal Instability;Collection;computerized tools;Core Facility;design;DNA;DNA Damage;Epigenetic Process;Event;Extramural Activities;Gene Expression Regulation;Goals;Hormones;Image;imaging facilities;instrument;Intramural Research;Malignant Neoplasms;Microscopy;novel;Nuclear Translocation;Oligonucleotides;Pathway interactions;Phenotype;Population;Premature aging syndrome;quantitative imaging;Research Personnel;Resources;response;RNA Splicing;Running;Scientist;screening;Small Interfering RNA;tumor progression;United States National Institutes of Health,HiTIF Microscopy Core Facility,11567,NA,NA,NA,NA,11,NA,NA,1984068,NA
11188771,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011569,NA,NA,1ZICBC011569-11,NCI:2119096\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355702 (contact),"HALAS, HYUNMI  (contact)",NA,NA,NA,Activated Lymphocyte;Adoptive Cell Transfers;Aftercare;anti-cancer;Area;Atypical lymphocyte;B-Lymphocytes;Back;biobank;Biocompatible Materials;Biological;Biopsy;Blood;blood product;Blood specimen;Carcinoma;Cell Physiology;Cell Therapy;Cells;Characteristics;Cholangiocarcinoma;Clinical;Clinical Protocols;Clinical Trials;Code;Colorectal Cancer;Competence;Core Facility;Cyclic GMP;Disseminated Malignant Neoplasm;Effectiveness;Enrollment;Ensure;Environmental Monitoring;Equipment;Equipment and supply inventories;Event;follow-up;Gene Modified;gene therapy;Goals;HPV positive;Human;Human Resources;Immunologics;Immunotherapy;Infusion procedures;Institution;Laboratories;Location;Lymphocyte;lymphocyte product;Malignant Breast Neoplasm;Malignant Neoplasms;manufacture;manufacturing process;manufacturing run;meetings;Melanoma;member;Mission;National Cancer Institute;neoantigens;Neoplasms;novel therapeutics;Operative Surgical Procedures;participant enrollment;Patients;Peripheral Blood Lymphocyte;Phase;Production;programs;Protocols documentation;quality assurance;Quality Control;Regulation;Report (document);Reporting;Research;Research Personnel;Resected;Sampling;Services;Site;Specific qualifier value;Sterility;synovial sarcoma;T-Lymphocyte;Testing;Training;Training Programs;Translating;tumor;Tumor Antigens;tumor immunology;Tumor-Infiltrating Lymphocytes;United States National Institutes of Health;Vendor,Cell Production Core Facility,11569,NA,NA,NA,NA,11,NA,NA,2119096,NA
11188772,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011571,NA,NA,1ZICBC011571-11,NCI:229165\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,12448468 (contact),"KARPOVA, TATIANA  (contact)",NA,NA,NA,Address;Bayesian Analysis;Binding;Binding Sites;CCR;Cells;Chromatin;Chromosomes;Collaborations;Dependence;Development;DNA;DNA Sequence;Evaluation;Gene Expression Regulation;Genes;Genetic Transcription;Germany;Image;Imaging technology;Individual;Kinetics;Methods;Microscopy;Modeling;Population;promoter;Research;residence;Scientist;single molecule;Site;stem;Stress;System;Techniques;Time;transcription factor;Transcriptional Regulation;ultra high resolution;Universities;Yeast Model System;Yeasts,Transcription factor mobility,11571,NA,NA,NA,NA,11,NA,NA,229165,NA
11188773,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011574,NA,NA,1ZICBC011574-11,NCI:916657\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,12448468 (contact),"KARPOVA, TATIANA  (contact)",NA,NA,NA,"biophysical properties;CCR;Cellular biology;Collaborations;Comb animal structure;Consultations;Country;Custom;Education;Educational process of instructing;Ensure;Fluorescence Resonance Energy Transfer;Head;Image;innovation;instrument;instrumentation;Interest Group;Laboratories;Light;light microscopy;Lighting;Malignant Neoplasms;Microscope;Microscopy;Mission;nano;National Heart, Lung, and Blood Institute;Optics;outreach;Paper;Publications;Research;Research Personnel;Resolution;Running;single molecule;Techniques;Training;ultra high resolution;United States National Institutes of Health;Universities",LRBGE Optical Microscopy Core,11574,NA,NA,NA,NA,11,NA,NA,916657,NA
11188774,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011596,NA,NA,1ZICBC011596-11,NCI:10639443\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162323 (contact),"WINKLER PICKETT, ROBIN  (contact)",NA,NA,NA,3-Dimensional;anti-cancer research;archive data;Automation;Bioinformatics;Biological Assay;Cells;Cellular Assay;cellular imaging;Chromatin;collaboratory;Collection;Cryo-electron tomography;Cryoelectron Microscopy;data archive;Dedications;Development;Electron Microscopy;exome;expression cloning;Fluorescence Microscopy;gene panel;Genomics;High-Throughput Nucleotide Sequencing;HIV Infections;Image;Immune;Interdisciplinary Study;Ions;Laboratories;Light;light microscopy;Malignant Neoplasms;Mass Spectrum Analysis;metabolomics;Metadata;Metals;Methods;microscopic imaging;Microscopy;Molecular;molecular imaging;NCI Center for Cancer Research;new technology;next generation sequencing;novel;nucleic acid detection;Optics;Pathway interactions;Phosphopeptides;programs;protein expression;protein purification;Proteins;Proteomics;Reporting;Research;research facility;Research Personnel;Resources;Sample Size;Sampling;Scanning Electron Microscopy;Science;screening;Services;single cell analysis;single cell sequencing;Speed;Standardization;Structure;T-Lymphocyte;Techniques;Technology;Tissue Stains;Tissues;transcriptome sequencing;Transposase;two-photon;ultra high resolution;Validation;Visualization;Work,CCR Dedicated Cores,11596,NA,NA,NA,NA,11,NA,NA,10639443,NA
11188775,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011623,NA,NA,1ZICBC011623-10,NCI:3160426\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14280419 (contact),"CONNER, ELIZABETH  (contact)",NA,NA,NA,"3-Dimensional;ATAC-seq;Atlases;Authorship;Award;bacterial genome sequencing;Biochemistry;Bioinformatics;bioinformatics resource;Biological;Biological Assay;Biological Sciences;Businesses;carcinogenesis;CCR;Cell Therapy;Cells;Cellular biology;cellular oncology;ChIP-seq;Cleavage Under Targets and Release Using Nuclease;clinical center;Collaborations;Communities;Computer software;Computers;Consultations;Core Facility;cost;cost effective;CRISPR screen;Custom;Data;Data Analyses;Data Reporting;Data Science;design;Developmental Therapeutics Program;Dideoxy Chain Termination DNA Sequencing;digital;DNA;DNA purification;DNA Sequencing Facility;Educational workshop;Elements;Enzymes;Experimental Designs;Gene Expression;Genetic;Genitourinary system;genome analysis;genome integrity;Genomics;Grant;Head;Hi-C;HIV/AIDS;Hour;Human;Imaging technology;immunodeficiency;Immunology;Immunooncology;Individual;innovation;instrument;instrumentation;Interest Group;Laboratories;Learning;lectures;Libraries;Malignant lymphoid neoplasm;Malignant neoplasm of gastrointestinal tract;Malignant neoplasm of thorax;Malignant Neoplasms;meetings;member;Messenger RNA;Methods;Mission;Molecular;Molecular Biology;molecular imaging;Molecular Profiling;Mus;nano-string;nanopore;National Heart, Lung, and Blood Institute;National Human Genome Research Institute;National Institute of Allergy and Infectious Disease;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;National Institute of Child Health and Human Development;National Institute of Diabetes and Digestive and Kidney Diseases;National Institute of Neurological Disorders and Stroke;Nature;neuro-oncology;next generation sequencing;oncology program;Operative Surgical Procedures;outreach;Paper;Pathology;Pediatric Oncology;Plasmids;Policies;Principal Investigator;Procedures;Process;Production;programs;Proteins;Proteomics;Provider;Quality Control;Radiation Oncology;Reaction;Receptor Biology and Gene Expression;Recovery;Reporting;Research;Research Personnel;Resources;Reverse Transcriptase Polymerase Chain Reaction;RNA;RNA library;Running;Sampling;Schedule;Science;Scientist;seal;Secure;sequencing platform;Services;single cell analysis;single cell sequencing;single-cell RNA sequencing;Slide;Summary Reports;Surgical Oncology;System;Systems Analysis;Techniques;Technology;Technology Transfer;Thoracic Surgical Procedures;Time;Training;Training and Education;transcriptome;transcriptome sequencing;tumor immunology;United States National Institutes of Health;Urologic Oncology;Vaccines;Vendor;webinar;Woman;Work;working group",CCR Genomics Core,11623,NA,NA,NA,NA,10,NA,NA,3160426,NA
11188776,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011638,NA,NA,1ZICBC011638-10,NCI:879776\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10274463 (contact),"HEWITT, STEPHEN  (contact)",NA,NA,NA,3D Print;Autopsy;biomarker validation;Collaborations;COVID-19;COVID-19 mortality;Disease;DNA;Experimental Pathology;Goals;Histology;Image Analysis;Immunohistochemistry;In Situ Hybridization;Laboratories;laser capture microdissection;Malignant Breast Neoplasm;Malignant neoplasm of liver;Malignant Neoplasms;member;Methodology;Pathologist;Pathology;Publications;Publishing;Research;Research Personnel;Research Support;RNA;SARS-CoV-2 infection;Science;Services;Skin Cancer;Tissue Microarray;tool;United States National Institutes of Health;whole slide imaging,Experimental Pathology Laboratory (EPL),11638,NA,NA,NA,NA,10,NA,NA,879776,NA
11188777,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011641,NA,NA,1ZICBC011641-10,NCI:2262089\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14280069 (contact),"GILBERT, MARK  (contact)",NA,NA,NA,angiogenesis;Animal Experiments;Animal Model;Animals;anti-tumor agent;anti-tumor drug;Area;Biological;Biological Markers;Biological Process;Biology;Biopsy;Biotechnology;blood-brain barrier disruption;Brain Neoplasms;Breeding;Camptothecin-11;Cancer cell line;cancer stem cell;Categories;Cell Line;Cells;Central Nervous System Neoplasms;Characteristics;Clinic;Clinical;clinical center;clinical development;Clinical Drug Development;Clinical Investigator;Clinical Trials;Clinical Trials Design;Collaborations;Communities;Convection;Cooperative Research and Development Agreement;Cytostatics;cytotoxic;Data;design;Development;Developmental Therapeutics Program;Diagnostic;Dose;Drug Delivery Systems;Drug Screening;Drug Targeting;early phase clinical trial;endothelial stem cell;Evaluation;expectation;experimental study;Extramural Activities;Future;Gene Expression Profile;Gene Expression Profiling;Generations;Genetic;Genomics;Glioma;glioma cell line;Growth;Human;human disease;Image;imaging science;Immunotherapeutic agent;In Vitro;in vivo;Institution;Intracarotid;Investigational Therapies;irinotecan;Label;Laboratories;Magnetic Resonance Imaging;Magnetism;Metabolic;Methods;Mission;Modeling;Molecular;mouse model;Mus;National Institute of Neurological Disorders and Stroke;neural;novel;novel therapeutics;Operative Surgical Procedures;Pathway interactions;Patients;Pattern;Pharmaceutical Preparations;Pharmacologic Substance;pre-clinical;precision medicine;preclinical development;Program Development;programs;Progression-Free Survivals;Property;Protective Agents;protein biomarkers;Radiation-Sensitizing Agents;Reagent;repository;Research;Research Design;research facility;Research Personnel;Resources;response;RNA;Sampling;Schedule;screening;screening program;Serum;Serum Markers;Services;Specimen;stem cell biology;stem cells;subcutaneous;Surrogate Markers;targeted treatment;Technology;Testing;Therapeutic;Tissues;Translational Research;translational study;tumor;Tumor Cell Line;tumor progression;Tumor Stem Cells;United States National Institutes of Health;vasculogenesis;Work;Xenograft procedure,Pre-clinical Translational Research Facility,11641,NA,NA,NA,NA,10,NA,NA,2262089,NA
11188778,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011731,NA,NA,1ZICBC011731-09,NCI:192890\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14732101 (contact),"CHINQUEE, JOSEPH  (contact)",NA,NA,NA,Accreditation;American;Anatomy;biobank;Cancer Center;Clinical;clinical center;Collaborations;Collection;college;Complex;Consult;data resource;Databases;demographics;Diagnosis;Diagnostic;Freezing;Frozen Sections;Genetic Materials;Goals;Histology;Human;Journals;Laboratories;laboratory facility;Medical center;meetings;Military Personnel;Operating Rooms;operation;Pathologist;Pathology;Patients;Peer Review;preservation;Primary Neoplasm;Process;programs;Protocols documentation;Publications;repository;Research;Research Personnel;Research Support;Services;Slide;Specimen;Stains;standard of care;Standardization;Surgical Pathology;System;Time;Tissue Banks;Tissue Preservation;tissue processing;Tissue Procurements;tissue resource;Tissues;Training;United States National Institutes of Health;Work,"Tissue Procurement, Processing Facility and Biorepository",11731,NA,NA,NA,NA,9,NA,NA,192890,NA
11188779,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011820,NA,NA,1ZICBC011820-07,NCI:137576\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,12032348 (contact),"REINHOLD, WILLIAM  (contact)",NA,NA,NA,Adrenocortical Carcinoma;Almanacs;Area;bioinformatics resource;Cancer cell line;Cancerous;CCR;Cell Line;Cell Survival;Clustered Regularly Interspaced Short Palindromic Repeats;Data;Databases;Development;Developmental Therapeutics Program;Disease;DNA;DNA copy number;DNA Methylation;DNA Sequence Alteration;drug sensitivity;Electronic Mail;Encyclopedias;Extramural Activities;Future;General Hospitals;Genes;Genetic;Genetic Transcription;genetic variant;Genomics;Goals;interest;Knock-out;Malignant Neoplasms;Manuscripts;Massachusetts;Methylation;MicroRNAs;Molecular;multiple data sources;Mutation;National Cancer Institute;National Cancer Program;neuroendocrine cancer;Oncologist;Output;Patients;Pattern;Pharmaceutical Preparations;pharmacologic;Pharmacology;Phenotype;Proteins;Publications;Publishing;Reporting;response;Sampling;Site;small cell lung carcinoma;Source;Standardization;System;The Cancer Genome Atlas;Tissues;tool development;Transcript;treatment response;web app;whole genome;Work,DNA data development for cancer cell lines and patients,11820,NA,NA,NA,NA,7,NA,NA,137576,NA
11188780,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011849,NA,NA,1ZICBC011849-07,NCI:1090420\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14732013 (contact),"MATSUO, HIROSHI  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;antagonist;APOCEC3G gene;Biochemical;cancer cell;Complex;Cryoelectron Microscopy;Development;DNA;Genes;Goals;HIV Genome;HIV-1;HIV/AIDS;Human;Infection;inhibitor;insight;Macromolecular Complexes;Malignant Neoplasms;Mutate;Mutation;novel therapeutics;Nuclear Magnetic Resonance;Oligonucleotides;protein structure;Proteins;Research Project Grants;RNA;Structure;Techniques;vif Gene Products;X-Ray Crystallography,Structural studies of biomolecules related to cancer and HIV-AIDS,11849,NA,NA,NA,NA,7,NA,NA,1090420,NA
11188781,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011891,NA,NA,1ZICBC011891-06,NCI:755102\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692203 (contact),"HO, MITCHELL  (contact)",NA,NA,NA,Address;Africa;anti-cancer research;Antibodies;antibody engineering;Antibody Formation;antibody libraries;Antibody Therapy;Antibody-drug conjugates;Antigen Targeting;Antigens;Apical;Area;Award;Bacteriophages;Binding;Binding Proteins;biothreat;Bispecific Antibodies;Camels;cancer cell;cancer therapy;Cell Surface Receptors;Cells;Cellular biology;checkpoint inhibition;chimeric antigen receptor T cells;clinical application;Collaborations;Communicable Diseases;Communication;Communities;Complex;Cryoelectron Microscopy;cytotoxic;design;Development;Epitopes;Eukaryotic Cell;Exhibits;Glycoproteins;Glypican;GP2 gene;GPC3 gene;GTPBP1 gene;Hepatology;Human;human disease;Immunoglobulin G;Immunotoxins;improved;inhibiting antibody;innovation;insight;Intramural Research;Intramural Research Program;Ion Channel;Laboratories;Laboratory Research;Lassa virus;Libraries;Ligand Binding;Malignant Neoplasms;member;mesothelin;Molecular Biology;Mus;Names;nanobodies;National Cancer Institute;Nature;NCI Center for Cancer Research;neutralizing antibody;new technology;Normal Cell;novel;pandemic disease;Paper;Patients;Phage Display;Play;programs;Prokaryotic Cells;Property;Proteins;Protomer;Publishing;Research;Research Personnel;Resources;response;Role;Scientist;Services;Shark;Signal Transduction;Site;Specificity;T-Cell Activation;T-Lymphocyte;targeted treatment;Technology;technology development;Therapeutic;Therapeutic antibodies;Therapeutic Index;Therapeutic Uses;Toxic effect;Training;United States National Institutes of Health;Virus;Virus Diseases,Antibody Engineering Program,11891,NA,NA,NA,NA,6,NA,NA,755102,NA
11188782,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011931,NA,NA,1ZICBC011931-05,NCI:1111984\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162371 (contact),"CALZONE, KATHLEEN  (contact)",NA,NA,NA,Address;Administrator;Adopted;Affect;Agreement;Annual Reports;CCR;Cell Line;Certification;Charge;Clinical;Clinical Investigator;Clinical Protocols;Code;Complex;Computer software;Computers;Cooperative Research and Development Agreement;Data;data handling;data integration;data management;data portal;data preservation;data sharing;data sharing networks;data standards;data submission;database of Genotypes and Phenotypes;Development;Disease;Electronic Mail;Elements;Ensure;experience;Feedback;Funding;Future;genomic data;Genomics;Hand;Home;Human;Individual;Informed Consent;Infrastructure;Institution;Intramural Research Program;Laboratory Scientists;Language;Lead;Learning;Link;Malignant Neoplasms;Manuals;Mediation;meetings;Modification;Names;Notification;Online Systems;Organism;Participant;payment;Performance;Persons;Policies;Policy Developments;Positioning Attribute;Procedures;Process;programs;Protocols documentation;Rare Diseases;Recommendation;Records;Reporting;Research;Research Personnel;Resources;Review Committee;Science Policy;Services;Source;Specific qualifier value;statistics;Supervision;System;Time;Time Study;timeline;tool;Transfer Agreement;United States;United States National Institutes of Health;Update;waiver;web site;wiki;Work;working group,Genomic Data Sharing,11931,NA,NA,NA,NA,5,NA,NA,1111984,NA
11188783,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011932,NA,NA,1ZICBC011932-05,NCI:2228085\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857650 (contact),"CROOKS, DANIEL  (contact)",NA,NA,NA,3-Dimensional;Bacteria;Biochemical;Biological;Biological Assay;Biological Markers;Blood;Brain Neoplasms;cancer biomarkers;Cancer Detection;cancer diagnosis;Cancer Model;cancer prevention;cancer recurrence;cancer therapy;Carbon;Carcinogenesis Mechanism;Cell Line;Cells;Chemicals;chimeric antigen receptor T cells;Citric Acid Cycle;clinically relevant;cohort;Collaborations;Custom;Data Analyses;Detection;Development;Glioma;Goals;Human;Immune system;Infusion procedures;inhibitor;Investments;Ions;Magnetic Resonance Spectroscopy;Malignant neoplasm of ovary;Mammals;Manuscripts;Mass Chromatography;Mass Spectrum Analysis;Measures;member;Mentors;Metabolic;Metabolism;metabolome;metabolomics;Methods;Modification;Monitor;mutant;NADH;NADP;neoplastic cell;Neuroblastoma;neuroblastoma cell;new therapeutic target;Nicotinamide adenine dinucleotide;NMR Spectroscopy;novel;novel strategies;novel therapeutics;Nuclear;Operative Surgical Procedures;Organoids;Pathway interactions;Patients;Physiologic pulse;Plants;pre-clinical;Preparation;Procedures;Proliferating;pyridine nucleotide;Resolution;Sampling;small molecule;spectroscopic imaging;stable isotope;Therapeutic Agents;Therapeutic Intervention;Time;Tissues;Toxic effect;Tracer;tumor;Tumor Cell Line;tumor metabolism;Tumor Tissue;Tumor-Derived;Urine,Metabolomics Core,11932,NA,NA,NA,NA,5,NA,NA,2228085,NA
11188784,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011933,NA,NA,1ZICBC011933-05,NCI:2251020\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8778166 (contact),"GULLEY, JAMES L. (contact)",NA,NA,NA,Basic Science;cancer therapy;CCR;Clinical Research;Hematopoietic Neoplasms;HIV vaccine;Immune system;Immunotherapy;Laboratory Research;Malignant neoplasm of lung;Malignant neoplasm of prostate;Malignant Neoplasms;Metastatic Neoplasm to the Bone;Metastatic Neoplasm to the Lung;Mission;Modeling;Mus;Neoplasm Metastasis;Neuroblastoma;Osteosarcoma;Pediatric Neoplasm;Pharmaceutical Preparations;Pharmacology Study;Principal Investigator;Resources;Solid Neoplasm;Testing;Therapeutic;Translating;Translations,Office of Translational Resources,11933,NA,NA,NA,NA,5,NA,NA,2251020,NA
11188785,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011956,NA,NA,1ZICBC011956-05,NCI:880054\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857653 (contact),"KETTENHOFEN, CHRISTINE  (contact)",NA,NA,NA,Acceleration;Address;AGFG1 gene;anti-cancer research;antibody conjugate;Antibody-drug conjugates;Antineoplastic Agents;Artificial Intelligence;Award;Behavior;Biochemical;Biological;Biological Assay;Biological Models;Biology;biomarker identification;BRAF gene;Breeding;cancer cell;Cardiac Edema;CCR;cell motility;Cell Survival;Cells;Cellular Structures;Chemicals;Chemistry;Childhood Melanoma;Cilia;ciliopathy;cilium biogenesis;Clinical;Clustered Regularly Interspaced Short Palindromic Repeats;cohort;Collaborations;Collection;Color;Communication;convergent extension;Costello syndrome;CRISPR/Cas technology;Defect;design;Development;developmental disease;Disease;disease model;Division of Cancer Epidemiology and Genetics;DUSP6 protein;Effectiveness;egg;Embryo;Equipment;Evaluation;Event;experimental study;Extramural Activities;Failure;fluorophore;Funding;Future;Gene Transfer Techniques;Generations;Genes;Genetic;genetic approach;genetic manipulation;Germ Lines;Germ-Line Mutation;Goals;Human;human disease;Hypertrophic Cardiomyopathy;Image;imaging capabilities;improved;in vivo;in vivo imaging;in vivo optical imaging;Injections;insight;Investigation;knock-down;knockout gene;Label;Laboratories;Link;Malignant Breast Neoplasm;Malignant Childhood Neoplasm;Malignant Neoplasms;Manuscripts;MAP Kinase Gene;Measurement;Mechanics;Medical Genetics;Melanoma;Membrane;Membrane Fusion;Methods;Mission;model organism;Modeling;Molecular;Monitor;Monoclonal Antibodies;mutant;Mutation;Nature;neoplastic cell;Neurodegenerative Disorders;novel;novel therapeutics;optical imaging;Orthologous Gene;Outcome;overexpression;Pathway interactions;Patients;Pediatric Oncology;Pharmacotherapy;Phenotype;Preparation;Process;Productivity;Property;protein expression;Protein Overexpression;Proteins;Publishing;Ras/Raf;Regulation;Reporter;Reporting;Research;Research Personnel;Resources;reverse genetics;RNA;Role;Severities;Signal Pathway;Signal Transduction;Structure;Subcellular structure;System;targeted agent;targeted treatment;Technical Expertise;Technology;Testing;Therapeutic;Therapeutic Agents;Time;timeline;tool;Toxic effect;trafficking;Training;transgene expression;Transgenic Organisms;tumor;tumor microenvironment;tumor progression;United States National Institutes of Health;Universities;uptake;Variant;variant of interest;variant of unknown significance;Vertebrates;Visualization;Work;Xenograft procedure;Zebrafish;zebrafish development,Zebrafish core,11956,NA,NA,NA,NA,5,NA,NA,880054,NA
11188786,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC011958,NA,NA,1ZICBC011958-05,NCI:2364210\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11592683 (contact),"SCHNEEKLOTH, JOHN  (contact)",NA,NA,NA,Acceleration;Animals;anti-cancer;Antineoplastic Agents;Basic Science;Biology;biophysical analysis;CCR;Chemicals;Data Analyses;drug candidate;Goals;In Vitro;in vivo;interest;Laboratories;Lead;lead optimization;lead series;Legal patent;Mission;novel;Organic Chemistry;Pharmaceutical Chemistry;pharmacokinetics and pharmacodynamics;pre-clinical;preclinical development;Research Personnel;Resources;Risk;screening;screening panel;small molecule;Source;structural biology;Technology;Toxic effect;Translations,Medicinal Chemistry Accelerator,11958,NA,NA,NA,NA,5,NA,NA,2364210,NA
11188787,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC012029,NA,NA,1ZICBC012029-04,NCI:561301\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355765 (contact),"LASSOUED, WIEM  (contact)",NA,NA,NA,Aftercare;androgen independent prostate cancer;anti-PD-1;Antibodies;Autopsy;B-Lymphocytes;Benign;Biology;Biopsy;Brachyury protein;Brain;cancer cell;cancer immunotherapy;Cancer Patient;Castrate sensitive prostate cancer;CD19 gene;CD8-Positive T-Lymphocytes;CD8B1 gene;Cell Density;Cell Line;Cells;chemotherapy;Chordoma;Cisplatin;Clinical;Collaborations;Combination immunotherapy;Complex;Comprehensive Cancer Center;Cooperative Research and Development Agreement;CT26;CXCL13 gene;cytokine;Cytoplasm;cytotoxic;cytotoxic CD8 T cells;Dendritic Cells;Development;Disease Outcome;Drops;Enrollment;Equilibrium;FCGR3B gene;first-in-human;Fluorescent Antibody Technique;Foundations;FOXP3 gene;Frequencies;Funding;Gene Modified;Genetic Transcription;Grant;Granzyme;HLA-DR Antigens;Hospitals;Immune;immune cell infiltrate;Immune checkpoint inhibitor;Immunofluorescence Immunologic;Immunologics;Immunooncology;Immunotherapeutic agent;indexing;insight;Institution;interest;Interleukin-12;ITGAM gene;ITGAX gene;Laboratories;London;Lymphocyte;machine learning method;Macrophage;malignant mouth neoplasm;Malignant neoplasm of prostate;Malignant Neoplasms;Manuscripts;mast cell;Mediating;medical schools;Medical Students;meetings;Metastatic Neoplasm to the Bone;Metastatic Prostate Cancer;Molecular;Mus;Myeloid-derived suppressor cells;Natural Killer Cells;Nature;NCAM1 gene;neoplasm immunotherapy;neoplastic cell;Nivolumab;Normal tissue morphology;novel;Olfactory Neuroblastoma;Pathology;patient response;Patients;pericardial sac;Phase II Clinical Trials;Pituitary Gland;Play;posters;pre-clinical;Preparation;Process;programmed cell death ligand 1;programmed cell death protein 1;programs;protein expression;Proto-Oncogene Protein c-kit;Protocols documentation;PTPRC gene;Publishing;Quality of life;Radical Prostatectomy;Regulatory T-Lymphocyte;Research;Resistance;response;RNA;Role;Safety;Sampling;Sampling Studies;Scanning;Signal Transduction;Site;Source;Spinal Cord;Stains;stem;Students;Synaptophysin;T-Cell Receptor;T-Cell Receptor Therapy;T-Lymphocyte;targeted treatment;tertiary lymphoid organ;Testing;therapeutic vaccine;Tissue Sample;Tissues;Training;translational study;Tryptase;tumor;tumor growth;tumor progression;Tumor Tissue;tumor-immune system interactions;Tumor-Infiltrating Lymphocytes;Universities;Validation;vector;Woman;Work,Tumor Immune MicroEnvironment Facility (Scientific Core),12029,NA,NA,NA,NA,4,NA,NA,561301,NA
11188788,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC012030,NA,NA,1ZICBC012030-04,NCI:306070\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14731980 (contact),"WEIGERT, ROBERTO  (contact)",NA,NA,NA,"Adolescent;Anaphase;Animal Model;Animals;Apoptosis;Area;B-Lymphocytes;CCR;Cell Cycle;Cell Line;Cell membrane;Cell Physiology;Cells;Child;Childhood Soft Tissue Sarcoma;Clinic;Collagen Fiber;cytokine;Data Analyses;Development;Disease;Disease Progression;drug efficacy;Ear;efficacy testing;Embryo;Experimental Designs;Extracellular Matrix;Genetically Engineered Mouse;Glycogen;Glycogen storage disease type II;high resolution imaging;Human;Image;imaging approach;Immune system;In Situ;in vivo;Induction of Apoptosis;Injections;intravital imaging;intravital microscopy;Invaded;Investigation;Label;Ligands;lung cancer cell;Malignant Breast Neoplasm;Malignant Neoplasms;Measures;mechanical properties;melanoblast;Melanoma;Membrane Glycoproteins;Methods;Microscopy;migration;Mission;Modeling;Molecular;Monitor;mouse model;multimodality;Mus;Muscle;Muscular Atrophy;NADH;National Heart, Lung, and Blood Institute;Neoplasm Metastasis;neoplastic cell;Neutrophil Infiltration;novel;Nuclear;Organ;Pathologic;Patients;Pharmaceutical Preparations;Physiological;Procedures;Reporter;Research Personnel;response;Rhabdomyosarcoma;Rodent Model;Role;Signal Transduction;Skin;Squamous cell carcinoma;System;Therapeutic Intervention;Time;Tissues;TNF gene;Tongue;tool;Transgenic Animals;Translating;triple-negative invasive breast carcinoma;tumor;tumor growth;tumor initiation;tumor microenvironment;tumor progression;Visualization",Intravital Microscopy Core,12030,NA,NA,NA,NA,4,NA,NA,306070,NA
11188789,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC012031,NA,NA,1ZICBC012031-04,NCI:2868110\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79972406 (contact),"HESELMEYER, KERSTIN  (contact)",NA,NA,NA,Adopted;Algorithms;Alternative Splicing;analysis pipeline;Aneuploidy;Antibodies;archive data;Area;assay development;Bioinformatics;bioinformatics resource;Biological;Biological Assay;Biology;biomarker development;CCR;Cells;ChIP-seq;Classification;Clinical;clinical biomarkers;collaborative approach;Communities;Complex;Computational Biology;convolutional neural network;Data;data acquisition;Data Analyses;data archive;data management;Detection;differential expression;diverse data;DNA;DNA analysis;DNA sequencing;Enhancers;Epigenetic Process;epigenetic regulation;exome;exome sequencing;Gene Rearrangement;Genes;Genetic;Genome;genome sequencing;Goals;Hi-C;immune cell infiltrate;Immunogenomics;innovation;Intention;Laboratories;Machine Learning;Malignant Neoplasms;Maps;mass spectrometric imaging;Mediating;member;Methods;Micrococcal Nuclease;Molecular Profiling;Molecular Target;multimodality;Mutation Detection;nanopore;new technology;next generation sequence data;next generation sequencing;Oncogenes;Process;Proteomics;Protocols documentation;Research;Research Personnel;Resources;response;RNA;RNA Editing;screening;Sequence Analysis;single cell analysis;single cell ATAC-seq;single-cell RNA sequencing;Spectral Karyotyping;Structure;T-Lymphocyte;targeted sequencing;Technology;technology development;tool;Training;transcriptome sequencing;transcriptomics;tumor;Tumor Antigens;tumor heterogeneity;Validation;Work,Omics Technology facility,12031,NA,NA,NA,NA,4,NA,NA,2868110,NA
11188790,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC012048,NA,NA,1ZICBC012048-04,NCI:838170\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79355662 (contact),"WANG, LIMIN  (contact)",NA,NA,NA,Affect;Bacteriophages;CCR;Chronic Disease;Communities;COVID-19;data acquisition;Data Analyses;data pipeline;Development;Disease;Epitopes;Extramural Activities;Health;HIV;Human;Human Resources;human virome;Immune response;Immunity;Immunoprecipitation;Individual;Infection;Leadership;Malignant neoplasm of liver;Malignant neoplasm of lung;Malignant neoplasm of prostate;Malignant Neoplasms;Methodology;Molecular;neuroinflammation;Pathogenesis;Pathogenicity;Patients;Procedures;Research Personnel;Research Project Grants;Research Support;response;Screening for Hepatocellular Cancer;Serology;Services;Technology;Viral;Virus,Identification of viral exposure signatures for early detection of liver cancer,12048,NA,NA,NA,NA,4,NA,NA,838170,NA
11188791,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC012049,NA,NA,1ZICBC012049-04,NCI:880425\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687510 (contact),"BEYER, RACHEL  (contact)",NA,NA,NA,Allogenic;Annual Reports;antigen test;Antigen-Presenting Cells;Autologous;B-Lymphocytes;Biological Assay;Cells;cellular transduction;Clinical;Clinical Trials;Coculture Techniques;Complex;Contracts;Cooperative Research and Development Agreement;Data;Dendritic Cells;Detection;Development;Disease Progression;endonuclease;Endotoxins;Ensure;Epitopes;expectation;Failure;gene therapy;Generations;Good Manufacturing Process;Individual;individualized medicine;Infusion procedures;Interferon Type II;Interferons;Lead;manufacture;Manufactured Materials;manufacturing organization;meetings;Microbiology;mutant;Mycoplasma;neoantigens;novel;Operative Surgical Procedures;patient safety;Patient Schedules;Patients;Peptides;Performance;personalized medicine;Physiologic pulse;Plasmids;Production;Qualifying;Quality Control;Reagent;Reporting;Research;Residual state;Resources;Retroviridae;Safety;Signal Transduction;Specific qualifier value;Specificity;Sterility;System;T-Lymphocyte;Testing;Time;timeline;transduction efficiency;Treatment Protocols;vector;Viral;Virus;Work,QC and Release Testing of Vector and Cell Clinical Gene Therapy Products,12049,NA,NA,NA,NA,4,NA,NA,880425,NA
11188792,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC012051,NA,NA,1ZICBC012051-04,NCI:503100\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687510 (contact),"BEYER, RACHEL  (contact)",NA,NA,NA,Autologous;Blood Component Removal;Buffers;Cell Count;Cells;Centrifugation;Clinical;Clinical Trials;Custom;Data;Development;Ensure;equipment acquisition;exhaust;experimental study;Filtration;Formulation;Gammaretrovirus;gene therapy;Germ Cells;Goals;improved;Individual;Infection;Lentivirus;manufacture;manufacturing process;meetings;Methods;Mutation;Older Population;Operative Surgical Procedures;Patients;Phenotype;Population;precision medicine;preservation;Procedures;Process;Production;Proliferating;Protocols documentation;Recording of previous events;Retroviral Vector;Retroviridae;Safety;Specific qualifier value;stem;Sterility;System;T-Cell Receptor;T-Lymphocyte;T-Lymphocyte Subsets;Testing;Therapeutic;Time;tool;Transfection;tumor;Tumor-Infiltrating Lymphocytes;vector;Viral Vector;Virus;Work,Use of lentivirus in individualized cell-gene therapy,12051,NA,NA,NA,NA,4,NA,NA,503100,NA
11188793,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC012081,NA,NA,1ZICBC012081-03,NCI:1250899\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858603 (contact),"VALKOV, ANNA  (contact)",NA,NA,NA,Binding Proteins;biophysical properties;CCR;Cells;Development;experience;Human Resources;Immunization;Membrane Proteins;Methodology;nanobodies;Production;programs;Proteins;protocol development;Protocols documentation;Research;Resources;RNA-Binding Proteins;screening;structural biology;Technology;tissue culture;tool;Work,Protein Technology Core,12081,NA,NA,NA,NA,3,NA,NA,1250899,NA
11188794,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC012084,NA,NA,1ZICBC012084-03,NCI:79839\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692529 (contact),"DURELL, STEWART  (contact)",NA,NA,NA,Alzheimer&apos;s Disease;Amyloid beta-Protein;amyloid structure;aqueous;Atomic Force Microscopy;beta barrel;Binding;Cholesterol;Data;drug development;Electrons;Ganglioside GM1;Goals;Grouping;Ion Channel;Lipids;Liposomes;Membrane;Modeling;Neurons;Penetration;Peptides;Periodicals;Structure;Toxic effect;Update;Variant,Modeling Oligomeric Structures of Amyloid forming Peptides,12084,NA,NA,NA,NA,3,NA,NA,79839,NA
11188795,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC012115,NA,NA,1ZICBC012115-03,NCI:1904916\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858605 (contact),"WLOKA, KASKA  (contact)",NA,NA,NA,Acute Myelocytic Leukemia;Allogenic;anti-cancer research;artificial intelligence method;assay development;Autologous;Biological Assay;Cancer Patient;Cell Therapy;Cells;Childhood;chimeric antigen receptor T cells;Clinical;Clinical Investigator;Clinical Protocols;Clinical Research;Clinical Trials;Collaborations;Custom;Data;Data Analyses;design;Development;Disease Progression;DOCK8 deficiency;Ensure;Evaluation;Experimental Designs;fighting;Flow Cytometry;Goals;graft vs host disease;Hematopoietic Stem Cell Transplantation;high dimensionality;HIV/AIDS;Human Herpesvirus 8;immune reconstitution;Immune system;immunodeficiency;Immunology;Immunooncology;Immunophenotyping;Immunotherapy;improved;Infusion procedures;Injections;interest;Interleukin-15;International;keratinocyte growth factor;Laboratories;Lymphocyte;Lymphoma;Malignant lymphoid neoplasm;Malignant Neoplasms;Mature T-Lymphocyte;Measures;Medicine;meetings;Methods;Mission;Modernization;Monitor;Multicentric Angiofollicular Lymphoid Hyperplasia;Multiple Myeloma;National Cancer Institute;Natural Killer Cells;NCI Center for Cancer Research;novel;Patients;Pediatric Oncology;pediatric patients;Phenotype;Plasma Cells;Pleural effusion disorder;Preparation;Procedures;Productivity;prognostic;programs;recruit;Research Personnel;Resources;Sampling;Series;Services;Stem cell transplant;T-Lymphocyte;Technology;Testing;Therapeutic;Therapeutic Effect;therapeutically effective;therapy outcome;Training;Wiskott-Aldrich Syndrome;young adult,Clinical Research Correlatives Core,12115,NA,NA,NA,NA,3,NA,NA,1904916,NA
11188796,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC012123,NA,NA,1ZICBC012123-03,NCI:1717697\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858607 (contact),"KELLY, MICHAEL  (contact)",NA,NA,NA,Animal Model;Basic Science;Bioinformatics;Biological;Biological Assay;cancer type;Cell Lineage;Cell Surface Proteins;Cells;Chromatin;Clinical Research;Communities;Complex;Dedications;Detection;experience;Gene Expression Profiling;Gene Expression Regulation;Genetic;Genomics;Goals;Human;Immune;in situ sequencing;insight;Interest Group;Laboratories;Molecular;multimodality;NCI Center for Cancer Research;Peer Review;Population;Publications;Receptor Cell;Research Personnel;Research Project Grants;Resolution;RNA Sequences;Sampling;single cell analysis;Technology;Transcript;transcriptomics;tumor microenvironment;United States National Institutes of Health;Update,Single Cell Analysis Facility,12123,NA,NA,NA,NA,3,NA,NA,1717697,NA
11188797,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC012129,NA,NA,1ZICBC012129-02,NCI:1816449\NIDCD:488935\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79355671 (contact),"LONDON, NYALL  (contact)",NA,NA,NA,Area;cancer type;Chemotherapy and/or radiation;Clinical Trials;Development;Enrollment;Genes;Goals;Head and Neck Cancer;Immunotherapeutic agent;improved;In Vitro;in vivo;interest;Laboratories;Malignant Neoplasms;Metastatic/Recurrent;mouse model;mutant;Nasal cavity;Nose;Olfactory Epithelium;Olfactory Neuroblastoma;Operative Surgical Procedures;Patients;programs;Research Personnel;Series;Sinus;skull base;Skull Base Neoplasms;Smell Perception;therapeutic target;Translating;Treatment Effectiveness;tumor;tumorigenesis,Mechanisms of olfactory neuroblastoma tumorigenesis,12129,NA,NA,NA,NA,2,NA,NA,2305384,NA
11188798,ZIC,CA,1,N,NA,NA,NA,NA,ZICBC012174,NA,NA,1ZICBC012174-01,NCI:813203\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15687345 (contact),"THOMAS, ANISH  (contact)",NA,NA,NA,Aneuploid Cells;Aneuploidy;anti-cancer research;Antibody-drug conjugates;assay development;Automobile Driving;biobank;Biological Assay;Biological Markers;Biological Models;biomarker identification;Blood;Bone Marrow;Cancer Diagnostics;CCR;Cells;Cellular biology;Centromere;Chromosomal Instability;Clinical;Clinical Trials;Clustered Regularly Interspaced Short Palindromic Repeats;Collaborations;Cultured Tumor Cells;diagnostic tool;digital;Diploidy;DNA Damage;drug development;Drug resistance;Epigenetic Process;Evolution;FDA approved;Flow Cytometry;Genome;Genomics;Heterogeneity;Immune;Immunohistochemistry;Immunologic Monitoring;Immunophenotyping;improved;In Vitro;indexing;industry partner;innovation;Invaded;Investigation;Kinetochores;Laboratories;Libraries;liquid biopsy;loss of function;Malignant Neoplasms;Measures;Microtubules;Modeling;Modification;Molecular;molecular marker;molecular phenotype;Molecular Profiling;Monitor;Nature;Neoplasm Circulating Cells;Neoplasm Metastasis;noninvasive diagnosis;Organoids;Outsourcing;Pathway interactions;Patient-Focused Outcomes;Patients;peripheral blood;personalized medicine;Pharmaceutical Preparations;pharmacodynamic biomarker;Pharmacodynamics;Physiological;Pleural effusion disorder;Poison;Postbaccalaureate;Postdoctoral Fellow;Principal Investigator;Process;Prognosis;prognosis biomarker;prognostic tool;Proliferating;Proteins;Proteomics;Recurrence;Research;Research Personnel;Sampling;screening;Services;single-cell RNA sequencing;small molecule inhibitor;Solid Neoplasm;Techniques;technology development;Testing;Therapeutic;therapeutic development;therapeutic target;therapy resistant;Tissues;tool;transcriptomics;translational goal;translational medicine;translational therapeutics;treatment effect;treatment strategy;tumor;tumor heterogeneity;tumor microenvironment;Tumor Tissue,Development Therapeutics Branch-Translational Medicine and Therapeutics Group,12174,NA,NA,NA,NA,1,NA,NA,813203,NA
11188799,ZIC,DK,1,N,NA,NA,NA,NA,ZICDK070002,NA,NA,1ZICDK070002-20,NIDDK:1142985\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,8498846 (contact),"GAVRILOVA, OKSANA  (contact)",NA,NA,NA,Adipose tissue;Affect;Animals;Ascorbic Acid;Biochemistry;Body Composition;Body Temperature;bombesin receptor subtype 3;Brain region;Brown Fat;CCR;cell growth;Cell Physiology;Complex;Deoxyglucose;Development;Diabetes Mellitus;Diabetic mouse;Disease;drug action;drug development;Eating;endoplasmic reticulum stress;energy balance;Energy Metabolism;epigenomics;Focal and Segmental Glomerulosclerosis;Food Energy;G-Protein-Coupled Receptors;Genetic;genetic approach;Glucose;glucose metabolism;glucose tolerance;Glycogen;glycosylation;GNAS gene;Growth;GTP-Binding Proteins;Hepatic;Homeostasis;Hormones;Immune response;Insulin;Insulin Resistance;insulin secretion;Islets of Langerhans;Laboratories;lipid biosynthesis;Measures;Metabolic;metabolic abnormality assessment;Metabolism;Molecular;Molecular Biology;Morphology;mouse model;Mus;National Institute of Child Health and Human Development;National Institute of Dental and Craniofacial Research;National Institute of Diabetes and Digestive and Kidney Diseases;Nervous System;neural circuit;neurotrophic factor;nonalcoholic steatohepatitis;Obesity;obesity genetics;Operative Surgical Procedures;organ growth;Pathogenesis;Pharmacology;Phase;Phenotype;Physiological;Physiology;Prevalence;Principal Investigator;programs;Protein Biosynthesis;protein kinase D;Psychology;Purinergic P1 Receptors;Regulation;Research Personnel;Resistance;RGS Proteins;Role;Satiation;Serum;Services;Signal Transduction;Societies;Standardization;Testing;Tissues;Triglycerides;Tubular formation;uptake,Metabolic Studies of Mouse Models of Obesity and Diabetes,70002,NA,NA,NA,NA,20,NA,NA,1142985,NA
11188800,ZIC,DK,1,N,NA,NA,NA,NA,ZICDK071006,NA,NA,1ZICDK071006-17,NIDDK:1913203\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,9693524 (contact),"WALTER, MARY  (contact)",NA,NA,NA,Accounting;adipokines;adiponectin;Aliquot;Bar Codes;biobank;Biological;Biological Assay;Biological Markers;Biological Specimen database;Blood;Clinical;Clinical Research;Collaborations;Collection;cytokine;Data;Databases;des-n-octanoyl ghrelin;Diabetes Mellitus;Endocrine;Ensure;Enteroglucagon;genetic testing;Genomic DNA;ghrelin;glucagon-like peptide 1;Hormones;Hour;Human;Instruction;International;Label;Leptin;Liquid substance;Measurement;Measures;Metabolic;Methods;National Institute of Diabetes and Digestive and Kidney Diseases;Online Systems;Oxidative Stress;Plasma;Preparation;preservation;Principal Investigator;Process;programs;Protocols documentation;Reproducibility;Research;Research Personnel;Sampling;Services;Ships;Site;Specimen;Statutes and Laws;System;Technology;Testing;Tube;web platform;Whole Blood,Clinical Research and Assay Support,71006,NA,NA,NA,NA,17,NA,NA,1913203,NA
11188801,ZIC,DK,1,N,NA,NA,NA,NA,ZICDK075039,NA,NA,1ZICDK075039-16,NIDDK:1436995\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,10274599 (contact),"WALTER, PETER  (contact)",NA,NA,NA,Area;Basic Science;Bile Acids;Biological Assay;Carbon;Clinical;Clinical Research;Cocaine;Collaborations;Communities;Deuterium;doubly-labeled water;Fructose;Galactose;Glucose;Glycerol;Human;Human Milk;instrument;Investigation;Isotopes;Label;Lactose;Lactulose;Levamisole;long chain fatty acid;Mannitol;Mass Fragmentography;mass spectrometer;Mass Spectrum Analysis;Measures;Metabolic;metabolic abnormality assessment;Methods;National Institute of Diabetes and Digestive and Kidney Diseases;Nitrogen;Nonesterified Fatty Acids;novel;Palmitates;Pharmaceutical Preparations;Plasma;Positioning Attribute;programs;Protocols documentation;Research;Research Personnel;Research Project Grants;Resolution;small molecule;Source;stable isotope;Sucrose;Sweetening Agents;total energy expenditure;Tracer;United States National Institutes of Health;Urine;Very Long Chain Fatty Acid;Volatile Fatty Acids,Clinical Mass Spectrometry Core,75039,NA,NA,NA,NA,16,NA,NA,1436995,NA
11188802,ZIC,DK,1,N,NA,NA,NA,NA,ZICDK075152,NA,NA,1ZICDK075152-05,NIDDK:498613\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,77844230 (contact),"REECE, JEFFREY  (contact)",NA,NA,NA,2019-nCoV;3-Dimensional;absorption;ACE2;ADRBK1 gene;Alpha Cell;Area;Arizona;astrogliosis;Behavior;Biological Assay;Biomedical Research;blood glucose regulation;Bone Diseases;Budgets;Categories;Cells;Cellular Morphology;chemokine;Chromosome Segregation;Clinical;clinical center;Color;Complement;Computer software;Computers;Darkness;Development;Diabetes Mellitus;Digestive System Disorders;disability;Distal convoluted renal tubule structure;DNA;Endocrine System Diseases;Endotoxins;Equipment;equipment acquisition;Event;experience;finesse;Fluorescence;Fluorescence Microscopy;Fluorescent Dyes;Fluorescent Probes;Genetic;Giant Cells;Glucagon;Health;Hematological Disease;Heparitin Sulfate;Hepatic;Hepatitis C;Image;Image Analysis;Immune response;Immunohistochemistry;improved;Individual;Inflammatory;Inherited;instrument;Integrins;interest;Intramural Research;Intramural Research Program;islet;Journals;Kidney Diseases;Kinetics;Knowledge;Laboratories;Lasers;Licensing;Life;light microscopy;light transmission;Lighting;Lilium;Liver;Liver diseases;Maryland;meetings;Metabolic;Metabolic Diseases;Methods;Microscope;Microscopy;Midbrain structure;Mission;Modeling;Monitor;Moths;Mus;National Institute of Diabetes and Digestive and Kidney Diseases;Nature;Nutrition Disorders;Organism;Organoids;Pathology;PIK3CG gene;Preparation;Printing;Proteins;Proto-Oncogene Proteins c-akt;Publications;Qi;Renal tubule structure;Research;Research Personnel;Research Project Grants;Resources;Retinal Cone;rosin;Sampling;Scanning;service providers;Side;Signal Transduction;single nucleus RNA-sequencing;Slide;Spermatogenesis;Structure;Structure of retinal pigment epithelium;Subcategory;synucleinopathy;System;tau Proteins;Techniques;Technology;technology/technique;Thyroid Hormones;Time;Tissues;tool;Training;Transgenic Mice;ultra high resolution;United States National Institutes of Health;Urologic Diseases;vpr Gene Products,Light Microscopy core for NIDDK,75152,NA,NA,NA,NA,5,NA,NA,498613,NA
11188803,ZIC,CA,1,N,NA,NA,NA,NA,ZICSC006536,NA,NA,1ZICSC006536-31,NCI:1674018\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,9979589 (contact),"FIGG, WILLIAM DOUGLAS (contact)",NA,NA,NA,Ascites;aspirate;Bar Codes;biobank;Biological;Biological Specimen Banks;Blood;Bone Marrow Aspiration;CCR;Cerebrospinal Fluid;Clinic;Clinical;Clinical Management;Clinical Protocols;Clinical Research;Clinical Trials;Data;Data Collection;Databases;Development;DNA;Ensure;Extramural Activities;Human;Laboratories;Life Cycle Stages;Methods;Mission;pharmacokinetics and pharmacodynamics;Pleural effusion disorder;Procedures;Process;Protocols documentation;repository;Research Design;Resources;Saliva;sample collection;Sampling;Services;software systems;Specimen;Specimen Handling;Time;Urine;Validation,Biospecimen Processing and Biorepository,6536,NA,NA,NA,NA,31,NA,NA,1674018,NA
11188804,ZIC,CA,1,N,NA,NA,NA,NA,ZICSC006537,NA,NA,1ZICSC006537-31,NCI:1674018\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,9979589 (contact),"FIGG, WILLIAM DOUGLAS (contact)",NA,NA,NA,ABCB1 gene;abiraterone;absorption;Agonist;analytical method;antagonist;Antineoplastic Agents;aurora kinase A;Azacitidine;BAY 54-9085;bevacizumab;Binding Proteins;Biological;Biological Assay;Biological Availability;Bortezomib;Camptothecin;cancer therapy;canine model;Carboplatin;CCR;Cells;Childhood Rhabdomyosarcoma;Cisplatin;Clinical;clinical center;Clinical Pharmacology;Clinical Research;Clinical Trials;Clinical Trials Design;clopidogrel;Collaborations;Combined Modality Therapy;Communities;Complex;Concentration measurement;Conduct Clinical Trials;cost;Coupled;Cyclophosphamide;cytotoxicity;Data;Depsipeptides;Detection;detector;Development;diffuse midline glioma;Disseminated Malignant Neoplasm;docetaxel;Dose;drug clearance;drug development;drug disposition;Drug Formulations;Drug Interactions;Drug Kinetics;drug metabolism;Drug Monitoring;Equation;Erlotinib;Etoposide;Excretory function;Extramural Activities;Finasteride;first-in-human;flavopiridol;Fluorescence;Frequencies;Future;Goals;Guidelines;High Pressure Liquid Chromatography;Imatinib;Immune checkpoint inhibitor;Immunotoxins;in silico;inhibitor;Institution;instrument;Interleukin-15;intraperitoneal;irinotecan;Ketoconazole;kinase inhibitor;lapatinib;large cell Diffuse non-Hodgkin&apos;s lymphoma;lenalidomide;Liquid substance;Locally Advanced Malignant Neoplasm;Malignant Neoplasms;mass spectrometer;Mathematics;Measures;MEKs;Melphalan;mesothelin;Metabolism;method development;Microdialysis;Midazolam;Modeling;Modification;Monoclonal Antibodies;MS-275;mucosal melanoma;Mus;Mutate;nanoparticle;nanoparticle drug;Nelfinavir;Nivolumab;nonhuman primate;novel anticancer drug;novel therapeutics;Paclitaxel;Patients;pembrolizumab;personalized approach;Pharmaceutical Preparations;pharmacodynamic model;Pharmacodynamics;pharmacokinetic model;pharmacokinetics and pharmacodynamics;Pharmacology;Phase;Phase I/II Trial;Phenylacetates;Phenylbutyrates;Physiological Processes;Plicamycin;pomalidomide;Population;pre-clinical;Pre-Clinical Model;Prodrugs;Program Development;programs;Randomized;Recombinants;Regimen;Relapse;Reproducibility;Research Personnel;response;Rhabdoid Tumor;Rhabdomyosarcoma;Route;Sampling;Scheme;simulation;Stress;SU 5416;Suramin;Tamoxifen;Tariquidar;temozolomide;Testing;Thalidomide;Therapeutic;Therapeutic Uses;Time;Tissues;TNP470;Topoisomerase-I Inhibitor;Topotecan;Toxic effect;tumor;United States National Institutes of Health;Valproic Acid;virtual patient;Xenograft Model,Using Clinical Pharmacology Principles to Develop New Anticancer Therapies,6537,NA,NA,NA,NA,31,NA,NA,1674018,NA
11188805,ZIC,CA,1,N,NA,NA,NA,NA,ZICSC009372,NA,NA,1ZICSC009372-33,NCI:2298067\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,78858560 (contact),"WANG, HAO-WEI  (contact)",NA,NA,NA,AIDS related cancer;B-Cell Lymphomas;Benign;Biological Assay;Biopsy;Blood;Body Fluids;Bone Marrow;cancer cell;CCR;cell determination;Cell Surface Proteins;Characteristics;Clinical;Clinical Protocols;Communities;Detection;Detection of Minimal Residual Disease;Diagnosis;Diagnostic tests;Disease;Education;Eligibility Determination;Enrollment;Evaluation;Event;Fine needle aspiration biopsy;Flow Cytometry;Goals;Hematology;HIV/AIDS;Human Herpesvirus 8;Immunophenotyping;improved;Institution;Laboratories;leukemia/lymphoma;Lymphoproliferative Disorders;Malignant - descriptor;Malignant Neoplasms;Measurement;Medical;Monitor;Neoplasms;neoplastic cell;Patients;Play;primary effusion lymphoma;prognostication;Protocols documentation;Research;Residual state;response;Role;Selection for Treatments;System;targeted treatment;Techniques;Testing;therapeutic evaluation;Tissues;treatment response;Tumor Antigens;United States National Institutes of Health,Flow cytometric analysis of benign and malignant tumors,9372,NA,NA,NA,NA,33,NA,NA,2298067,NA
11188806,ZID,AR,1,N,NA,NA,NA,NA,ZIDAR041180,NA,NA,1ZIDAR041180-17,NIAMS:5422612\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES,NA,NA,NA,10269396 (contact),"COLBERT, ROBERT  (contact)",NA,NA,NA,"Alopecia;Ankylosing spondylitis;Appointments and Schedules;Clinical;clinical center;Clinical Protocols;Clinical Research;Clinical Trials;Consult;Contracts;cost;COVID-19;Data Analyses;Databases;Dermatology;Educational process of instructing;Fellowship;Genetic Determinism;Genomics;Glucocorticoids;healthy volunteer;Hospitalists;Infrastructure;Inpatients;Institutional Review Boards;Interferons;Intramural Research Program;Lupus;Lupus Nephritis;Medical;Medicare;Melorheostosis;Merkel cell carcinoma;Merkel Cells;microbiome;Muscle;Myositis;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;Natural History;Neighborhood Health Center;novel;Nurse Practitioners;Nursing Research;operation;Orthopedic Procedures;Orthopedics;Outpatients;Patient Admission;Patient Care;Patients;Peroxisome Proliferator-Activated Receptors;Phototoxicity;Physician Assistants;Physicians;Preparation;programs;Protocols documentation;Research;Research Activity;Research Infrastructure;Research Personnel;Research Support;Rheumatology;sarcopenia;Services;Specialist;Specimen;Spinal Fusion;Spondylarthritis;systemic juvenile idiopathic arthritis;Systemic Lupus Erythematosus;Testing;tissue biomarkers;TNF gene;Training Programs;Translational Research;Travel;treatment effect;United States National Institutes of Health;Vasculitis;Washington",Clinical Support Services for the NIAMS Intramural Research Program,41180,NA,NA,NA,NA,17,NA,NA,5422612,NA
11188807,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC010686,NA,NA,1ZIDBC010686-20,NCI:964449\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14732101 (contact),"CHINQUEE, JOSEPH  (contact)",NA,NA,NA,Accreditation;Adherence;Anatomy;Archives;Autopsy;Biocompatible Materials;Biopsy;CCR;Clinical;Clinical Pathology;Clinical Services;Diagnosis;Diagnostic;digital;Ensure;Goals;Histopathology;Image;imaging program;Institutional Review Boards;Laboratories;Mission;operation;Operative Surgical Procedures;Pathologist;Pathology;Pathology Report;Patients;Process;Protocols documentation;remote grading;Research;Research Personnel;Research Support;Services;Slide;Stains;Surgical Pathology;surgical research;Testing;Tissue Procurements;Tissues;tool;United States National Institutes of Health;whole slide imaging,Clinical Operations for Laboratory of Pathology,10686,NA,NA,NA,NA,20,NA,NA,964449,NA
11188808,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC010882,NA,NA,1ZIDBC010882-17,NCI:34675895\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79972475 (contact),"KARZAI, FATIMA  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;AIDS related cancer;Benchmarking;Biometry;Cancer Patient;CCR;Clinical;Clinical Investigator;Clinical Research;Clinical Research Protocols;clinical training;Clinical Trials;Continuing Education;Data Collection;data management;Data Storage and Retrieval;design;Development;diagnostic strategy;Ensure;Environment;Goals;HIV/AIDS;Human Subject Research;improved;Individual;Informatics;Infrastructure;Institution;Life;Malignant Neoplasms;Measurement;Monitor;NCI Center for Cancer Research;novel diagnostics;novel therapeutics;Nursing Research;Outcome Measure;outreach;Patient Care;Patient Compliance;Patient Recruitments;patient safety;Patients;Performance;Phase;Policies;Procedures;Process;programs;Protocols documentation;Public Health;Quality of life;Regulation;Research;Research Activity;Research Personnel;Research Training;Resources;Services;Structure;tool;Training and Education;Translational Research;trial design,Center for Cancer Research Clinical Trials Support,10882,NA,NA,NA,NA,17,NA,NA,34675895,NA
11188809,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC010987,NA,NA,1ZIDBC010987-17,NCI:10483410\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79972475 (contact),"KARZAI, FATIMA  (contact)",NA,NA,NA,AIDS related cancer;Cancer Intervention;cancer prevention;CCR;Clinical;clinical center;Clinical Research;Clinical Research Protocols;Clinical Trials;cost;Detection;Development;Diagnosis;Disease;Funding;Goals;HIV;Incidence;Malignant Neoplasms;Maryland;Methods;Mission;Molecular;Monitor;NCI Center for Cancer Research;new technology;novel;novel strategies;novel therapeutic intervention;Participant;participant enrollment;Patients;Pre-Clinical Model;Prognosis;Screening for cancer;Services;Special Population;translational clinical trial;Transportation;Travel;United States National Institutes of Health,Center for Cancer Research Patient Travel,10987,NA,NA,NA,NA,17,NA,NA,10483410,NA
11188810,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC010990,NA,NA,1ZIDBC010990-17,NCI:9414220\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692373 (contact),"CAMPHAUSEN, KEVIN  (contact)",NA,NA,NA,Articulation;bench to bedside;Brain Neoplasms;Breast;cancer care;Cancer Patient;Clinic;Clinical;clinical center;Clinical Research;clinical training;Collaborations;Consultations;design;Genitourinary system;Head and neck structure;Histologic;Intramural Research Program;Journals;lectures;Lung;Lymphoma;Malignant lymphoid neoplasm;Malignant Neoplasms;Medical;Medical Oncology;Mission;neuro-oncology;New Agents;next generation;Nursing Faculty;Oncology;oncology program;Operative Surgical Procedures;Patient Admission;Patient Care Management;Patients;Pediatric Oncology;Pediatrics;Physicians;Physics;pre-clinical research;Prostate;Protocols documentation;Radiation;Radiation Oncologist;Radiation Oncology;Radiation therapy;Radiobiology;Research;Scientist;Subgroup;Talents;Training;Translational Research;United States National Institutes of Health;Urologic Oncology;Writing,Radiation Oncology Branch - Radiation Clinic,10990,NA,NA,NA,NA,17,NA,NA,9414220,NA
11188811,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC011022,NA,NA,1ZIDBC011022-16,NCI:7074637\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8778166 (contact),"GULLEY, JAMES L. (contact)",NA,NA,NA,Antigens;Biological Assay;Biological Markers;CCR;Clinical;clinical investigation;Clinical Research;Collaborations;cytotoxicity;Data Analyses;Dedications;Development;enzyme linked immunospot assay;Enzyme-Linked Immunosorbent Assay;Freezing;Immunologic Tests;Laboratories;Mitogens;Patients;Peripheral Blood Mononuclear Cell;Phase I Clinical Trials;Proliferating;Research Support;response;Safety;sample collection;Sampling;Services;Technology;Testing;Validation,Clinical Research Support for the CCR,11022,NA,NA,NA,NA,16,NA,NA,7074637,NA
11188812,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC011089,NA,NA,1ZIDBC011089-17,NCI:459892\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,2093160 (contact),"LINEHAN, WILLIAM MARSTON (contact)",NA,NA,NA,Admission activity;Affect;Amendment;Appointment;Appointments and Schedules;Archives;Bilateral;Blood;bone imaging;Businesses;Cancer-Predisposing Gene;Cardiology;Clinical;clinical center;Clinical Data;Clinical Management;Clinical Nursing;Clinical Nursing Research;Clinical Oncology;Clinical Research;Clinical Trials;Collaborations;Communication;Communities;Complement 3d;Complex;Conduct Clinical Trials;Consent;Consult;Consultations;continuing nursing education;Contracts;Counseling;COVID-19;Data;data integrity;data management;Databases;demographics;Dermatology;Diagnosis;diaries;Discharge Plannings;Discipline of Nursing;Disease;DNA;Education;Educational Materials;Educational process of instructing;Eligibility Determination;Endocrine;Enrollment;Ethics;Evaluation;Family;Family Study;Film;follow-up;Generations;Genetic;genetic counselor;genetic pedigree;Genetic Predisposition to Disease;Genetic Risk;genetic testing;Genotype;Goals;Good Clinical Practice;Growth;Guidelines;Health Promotion;Heart;Hereditary Disease;Hereditary Leiomyomatosis and Renal Cell Cancer;Heritability;HIV;human model;Human Resources;human subject protection;Humanities;Image;imaging study;Informed Consent;Inherited;Inpatients;Institutional Review Boards;Intake;Internal Medicine;Kidney Neoplasms;Knowledge;Letters;Location;Magnetic Resonance Imaging;Malignant - descriptor;Malignant neoplasm of prostate;Malignant neoplasm of urinary bladder;Malignant Neoplasms;Measurement;Medical;Medical History;Medical Records;meetings;member;Mentors;Mentorship;Methods;Modality;Natural History;nephrogenesis;Neurology;neurosurgery;novel;Nursing Research;Operating Rooms;operation;Operative Surgical Procedures;Paper;Papillary;participant enrollment;Patient Appointment;Patient Care;Patient Compliance;Patient Education;patient expectation;Patient Recruitments;Patient Schedules;Patients;Persons;PET/CT scan;Physician Assistants;Physicians;Policies;Postoperative Period;Practice Guidelines;Predisposition;Principles of law and justice;Probability;Procedures;Process;Professional Practice;programs;Protocols documentation;psychosocial;Quality of life;Questionnaires;Recommendation;recruit;Renal Carcinoma;Renal Cell Carcinoma;Reporting;Research;Research Support;Resources;Risk;Schedule;Scientist;Services;Slide;Social Work;Societies;Specialist;success;Support Groups;Surgeon;Surgical Management;surveillance strategy;Syndrome;System;Telephone;Test Result;text searching;Time;Tissue Procurements;Tissues;Travel;tumor;United States National Institutes of Health;Urine;Urologic Cancer;Urologic Oncology;Urology;Visit;Work;Writing;X-Ray Computed Tomography,Clinical Nursing and Data Management Core,11089,NA,NA,NA,NA,17,NA,NA,459892,NA
11188813,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC011092,NA,NA,1ZIDBC011092-17,NCI:3679130\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,2093160 (contact),"LINEHAN, WILLIAM MARSTON (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Adult;Affect;Childhood;Clinical;clinical center;Collaborations;Consult;Consultations;COVID-19;design;Emergency Situation;Goals;HIV;Hospitals;Hour;National Cancer Institute;Operative Surgical Procedures;Patients;Play;Research Personnel;Role;surgical service;Tissue Procurements;Tissues;United States National Institutes of Health;Urologic Oncology;Urologic Surgeon;Urologic Surgical Procedures;Urology,Urologic Oncology Branch Consult Core,11092,NA,NA,NA,NA,17,NA,NA,3679130,NA
11188814,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC011242,NA,NA,1ZIDBC011242-16,NCI:1086388\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10274731 (contact),"WOOD, BRADFORD J (contact)",NA,NA,NA,3-Dimensional;Ablation;Acceleration;Address;Animals;Annual Reports;Antigen Presentation;Antineoplastic Agents;Artificial Intelligence;Atmosphere;Augmented Reality;automated segmentation;Automation;Award;Basic Science;bench to bedside;Biological Markers;Biomedical Engineering;Biopsy;cancer classification;cancer clinical trial;Cancer Patient;cancer therapy;Catheters;CCR;Cellular Phone;checkpoint inhibition;chemotherapy;Clinic;Clinical;clinical center;Clinical Protocols;Clinical Research;Clinical Trials;Clip;Collaborations;collaborative environment;combination cancer therapy;Communities;Computer software;Computers;Cooperative Research and Development Agreement;cost;cost effective;Data;Data Science;Data Scientist;Databases;deep learning;deep learning model;Detection;Development;Devices;Diagnosis;digital pathology;Discipline;Disease;Doctor of Philosophy;Dose;Down-Regulation;Drug Combinations;Drug Delivery Systems;drug discovery;Drug Modelings;Drug Targeting;Ecosystem;Education;education pathway;Electroporation;Emerging Technologies;Energy-Generating Resources;Engineering;Environment;Exposure to;Faculty;Family suidae;Fine needle aspiration biopsy;first-in-human;Fluoroscopy;Focused Ultrasound Therapy;Freezing;Gel;Goals;Goggles;Hepatitis;Human;Image;image guided;Image Guided Biopsy;image guided therapy;image processing;image-guided drug delivery;Imaging Device;imaging modality;imaging scientist;imaging system;Imaging technology;Immune;Immune checkpoint inhibitor;immune modulating agents;immune resistance;immunoregulation;Infusion procedures;Injections;innovation;Intervention;Interventional radiology;Intramural Research Program;Investigation;Kidney;Lasers;Light;Liposomes;Liver;Local Therapy;Localized Malignant Neoplasm;Location;lymph nodes;Magnetic Resonance Imaging;Malignant neoplasm of liver;Malignant neoplasm of prostate;Malignant neoplasm of urinary bladder;Malignant Neoplasms;Mechanics;Medical;Medical Oncology;Medicine;Mentors;Methods;Microspheres;microwave electromagnetic radiation;minimally invasive;Modeling;Molecular;Molecular Target;multidisciplinary;Multimodal Imaging;multimodality;nanoparticle;nanoscale;National Institute of Biomedical Imaging and Bioengineering;Needle biopsy procedure;Needles;new technology;novel;Oncologist;Oncology;Operative Surgical Procedures;Organ;Paint;pandemic disease;Pathology;Pathway interactions;Patient Care;Patients;Pharmaceutical Preparations;Physicians;Population;post-COVID-19;pre-clinical;precision drugs;Procedures;prognostication;programs;Prostate;prostate biopsy;Protocols documentation;Radiation;Radiation Oncology;radio frequency;radiologist;Radiology Specialty;Rectum;Reporting;Research;Research Personnel;Resources;Robotics;Saline;Scientist;Screening for cancer;Signal Transduction;small molecule;software development;sound;Standardization;Structure of base of prostate;Students;Surgical Oncology;System;targeted treatment;Techniques;Technology;technology/technique;Testing;Therapeutic Embolization;Thermal Ablation Therapy;Thinness;Time;tool;Training;Training and Education;Translating;translational model;Translational Research;treatment planning;trial planning;tumor;tumor ablation;ultrasound;United States National Institutes of Health;Urethra;urologic;Urologic Oncology;vector;Vision;Visit;Visualization;Voice;web app;Woodchuck,Center for Interventional Oncology,11242,NA,NA,NA,NA,16,NA,NA,1086388,NA
11188815,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC011291,NA,NA,1ZIDBC011291-15,NCI:2636986\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11592663 (contact),"MIETTINEN, MARKKU  (contact)",NA,NA,NA,Accreditation;Adrenal Gland Carcinoma;aging process;ALK gene;Anatomy;Antibodies;Benign;Biopsy;Carcinoma;Cardiovascular system;Clinical;clinical center;Clinical Investigator;Clinical Research Protocols;Colon Carcinoma;Communicable Diseases;Communities;Consultations;Degenerative Disorder;developmental disease;Diagnosis;Diagnostic;diagnostic biomarker;Diagnostic Services;Disease;Excision;Fluorescent in Situ Hybridization;General Population;Genetic;Genetic Diseases;Genetic study;Goals;Heart Diseases;Hematoxylin and Eosin Staining Method;Histology;Hybrids;Immunohistochemistry;interleukin-13 receptor;Laboratories;Malignant Neoplasms;Mesothelioma;Methylation;Modality;Molecular Genetics;Mutation;Neurilemmoma;neurosurgery;Non-Cutaneous Melanoma;novel diagnostics;Operative Surgical Procedures;Pathology;patient population;Patients;preferentially expressed antigen in melanoma;Process;programmed cell death ligand 1;receptor expression;Research;Research Project Grants;Resources;Sarcoma;Services;Soft Tissue Neoplasms;Specimen;Surgical Pathology;synovial sarcoma;Tissues;Training;Training Programs;tumor;United States National Institutes of Health;Xenograft procedure,General Surgical Pathology,11291,NA,NA,NA,NA,15,NA,NA,2636986,NA
11188816,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC011517,NA,NA,1ZIDBC011517-12,NCI:1369278\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14732189 (contact),"GLOD, JOHN  (contact)",NA,NA,NA,Adult;behavioral health;Behavioral Sciences;Cancer Patient;Caring;CCR;Cell Therapy;Child;Child health care;child services;Childhood;Chronic Disease;Clinical;clinical center;Clinical Protocols;Clinical Trials;coping;Discipline;Education;Enrollment;Evaluation;Family;Illness impact;improved;innovation;Intervention;Leadership;Malignant Neoplasms;Measures;Medical;mindfulness intervention;neurobehavioral;Neurofibromatosis 1;NF1 gene;Outcome Measure;Palliative Care;Patient Care;Patient Outcomes Assessments;Patient Participation;Patients;Pediatric Oncology;psychologic;psychosocial;Quality of Life Assessment;Research;Research Activity;research study;Research Support;Services;student training;Supportive care;Technical Expertise;United States National Institutes of Health;Work;young adult,Pediatric Oncology Branch Behavioral Science Core,11517,NA,NA,NA,NA,12,NA,NA,1369278,NA
11188817,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC011540,NA,NA,1ZIDBC011540-11,NCI:1197024\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6189074 (contact),"HASSAN, RAFFIT  (contact)",NA,NA,NA,CCR;Chest;Clinical;Clinical Research;Clinical Trials;Conduct Clinical Trials;drug development;Drug Targeting;gastrointestinal;Goals;Immune checkpoint inhibitor;Immunotherapeutic agent;innovation;Malignant mesothelioma;Malignant neoplasm of gastrointestinal tract;Malignant neoplasm of liver;Malignant neoplasm of pancreas;Malignant neoplasm of thorax;Malignant neoplasm of thymus;Malignant Neoplasms;mesothelin;novel;Patients;preclinical study;Radiation therapy;Research Personnel;Scientist;standard care;treatment program;Tumor Antigens,Thoracic and Gastrointestinal Malignancies Branch Clinical Core,11540,NA,NA,NA,NA,11,NA,NA,1197024,NA
11188818,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC011543,NA,NA,1ZIDBC011543-11,NCI:2885087\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162141 (contact),"RAJAN, ARUN  (contact)",NA,NA,NA,Address;Annual Reports;Caring;CCR;Clinic;Clinical;clinical care;Clinical Oncology;Clinical Research;Clinical Services;Clinical Trials;Community Clinical Oncology Program;Credentialing;Education;falls;Feedback;Fellowship;Goals;Hospitalists;Human Resources;Immunotherapy;Information Dissemination;Infusion procedures;inpatient service;Internal Medicine;Laboratories;Learning;Length of Stay;Licensing;Lymphoma;Medical Oncology;meetings;Nurse Practitioners;Nursing Research;oncology service;operation;outpatient programs;Patients;Physician Assistants;Policies;Procedures;programs;Quality of Care;Research Personnel;Resource Sharing;Rotation;Schedule;Science;Services;Solid Neoplasm;Students;Training;Visit;volunteer;Walking;Work,Medical Oncology Service Clinical Core,11543,NA,NA,NA,NA,11,NA,NA,2885087,NA
11188819,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC011642,NA,NA,1ZIDBC011642-10,NCI:2120708\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14280069 (contact),"GILBERT, MARK  (contact)",NA,NA,NA,"Adult;American Society of Clinical Oncology;Angiogenesis Inhibitors;anti-cancer research;anti-CTLA4;anti-PD-1;Antineoplastic Agents;Basic Science;Belief;bevacizumab;Biological Response Modifiers;Biology;Biotechnology;Brain;Brain Neoplasms;cancer care;Cancer Center;Cardiology;Central Nervous System;Central Nervous System Neoplasms;Characteristics;Child;Clinic;Clinical;clinical care;clinical center;clinical investigation;Clinical Research;Clinical Trials;cognitive function;Communities;Complex;Consultations;Dana-Farber Cancer Institute;design;Disease;Doctor of Medicine;Double-Blind Method;drug development;effective therapy;Endocrinology;Ensure;Environment;Fellowship;Freedom;Genetic;Glioblastoma;Glioma;Group Practice;Health;Health system;Healthcare;Hospitals;Immune checkpoint inhibitor;Immune response;Immunocompetence;Immunologic Monitoring;improved;Individual;individual patient;individualized medicine;Infrastructure;innovation;Institution;Intramural Research Program;ipilimumab;Isocitrate Dehydrogenase;Journals;Kansas;Laboratories;Leadership;Malignant Glioma;Malignant neoplasm of central nervous system;Malignant Neoplasms;Measures;Medical;Medical center;Medical Oncology;medical schools;Medicine;meetings;member;Methodist Church;Microscopic;Mission;Molecular;Monitor;Morphology;multidisciplinary;Mutation;MYCN gene;National Cancer Institute;National Heart, Lung, and Blood Institute;National Institute of Mental Health;National Institute of Neurological Disorders and Stroke;neuro-oncology;Neurocognitive Deficit;Neurology;Neurosurgeon;neurosurgery;New England;Newly Diagnosed;Nivolumab;North Carolina;novel;novel diagnostics;novel therapeutics;Ohio;Oncology;Ophthalmology;Pain;palliation;Pathology;Patient Agents;Patient-Focused Outcomes;Patients;Peripheral;Peripheral Blood Mononuclear Cell;personalized medicine;Pharmacologic Substance;phase III trial;Physical Medicine;Physicians;Placebo Control;Primary Brain Neoplasms;Privatization;programs;prototype;Psychiatry;Publishing;Quality of life;Radiation;Radiation Oncologist;Radiation Oncology;Radiation Therapy Oncology Group;Randomized;rare cancer;Recurrence;Research;Research Personnel;Research Project Grants;Resources;Role;Running;safety testing;Second Opinions;Services;Site;Social Work;South Carolina;Specimen;Spinal Cord Neoplasms;standard care;Stratification;survival outcome;Symptom Burden;Testing;Texas;Therapeutic;Tissues;tool;Training Programs;Translational Research;translational research program;treatment arm;Treatment Efficacy;tumor;Tumor Tissue;United States National Institutes of Health;Universities;Utah;virtual;Washington",Brain Tumor Clinical and Clinical Research Program,11642,NA,NA,NA,NA,10,NA,NA,2120708,NA
11188820,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC011683,NA,NA,1ZIDBC011683-09,NCI:509133\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162141 (contact),"RAJAN, ARUN  (contact)",NA,NA,NA,Address;AIDS related cancer;Annual Reports;Caring;CCR;Clinic;Clinical;clinical care;Clinical Research;Clinical Services;Clinical Trials;Communities;Community Clinical Oncology Program;Credentialing;Feedback;Fellowship;Goals;HIV/AIDS;Hospitalists;Human Resources;Information Dissemination;Infusion procedures;inpatient service;Inpatients;Internal Medicine;Laboratories;Learning;Length of Stay;Licensing;Lymphoma;Malignant Neoplasms;Medical Oncology;meetings;Nurse Practitioners;Nursing Research;oncology service;operation;outpatient programs;Patients;Physician Assistants;Policies;Procedures;programs;Quality of Care;Research Personnel;Resource Sharing;Running;Schedule;Science;Services;Solid Neoplasm;Training;volunteer;Walking;Work,Medical Oncology HIV-AIDS Clinical Research,11683,NA,NA,NA,NA,9,NA,NA,509133,NA
11188821,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC011716,NA,NA,1ZIDBC011716-09,NCI:35482310\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79972475 (contact),"KARZAI, FATIMA  (contact)",NA,NA,NA,Adherence;Adverse event;AIDS related cancer;Area;Basic Science;Behavior;Budgets;Cancer Burden;cancer type;CCR;Clinic;Clinical;Clinical Investigator;Clinical Nursing Research;Clinical Research;Clinical Treatment;clinical trial implementation;Clinical Trials;Code;Collaborations;Collection;Competence;Complex;Continuing Education;Country;Critical Thinking;Data;data management;Data Management Resources;Development;Discipline of Nursing;Documentation;Education;electronic data;Ensure;Ethics;HIV/AIDS;human subject;Individual;Information Technology;Informed Consent;innovation;Knowledge;Licensing;Maintenance;Maryland;Measurement;Medical;Mentorship;Mission;Monitor;novel therapeutics;Nurse&apos;s Role;Nurses;Nursing Models;Nursing Research;Nursing Societies;Nursing Specialties;Oncology;Oncology Nurse;Patient Care;Patient Recruitments;patient retention;Patients;Performance;Persons;Phase;Physicians;Play;Prevention strategy;programs;Protocol Compliance;Protocols documentation;quality assurance;Records;recruit;Reporting;Research;Role;Safety;Secure;Serious Adverse Event;skills;Specialist;System;Training;Translating;Translational Research;Translations,CCR Research Nursing,11716,NA,NA,NA,NA,9,NA,NA,35482310,NA
11188822,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC011792,NA,NA,1ZIDBC011792-08,NCI:606510\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162296 (contact),"XI, LIQIANG  (contact)",NA,NA,NA,American;Basic Science;bench to bedside;Biological Assay;Biomedical Research;cancer genomics;cancer therapy;CCR;Certification;chemotherapy;Chromosomal Duplication;Chromosomal translocation;Clinical;clinical diagnostics;Clinical Protocols;Clinical Research;Clinical Trials;clinically significant;Collaborations;college;Communities;cost;design;Detection;detection test;Development;Diagnostic;Diagnostic Services;Eligibility Determination;Event;Fluorescent in Situ Hybridization;Formalin;Funding;Gene Rearrangement;genomic profiling;Glioma;Goals;Hematologic Neoplasms;Human Resources;Immunology;improved;Knowledge;Laboratories;Lung;Lymphoma;Malignant Breast Neoplasm;Malignant neoplasm of gastrointestinal tract;Malignant neoplasm of thorax;Malignant Neoplasms;Modernization;Molecular;molecular diagnostics;molecular pathology;neuro-oncology;novel diagnostics;Oncogenes;Operative Surgical Procedures;Paraffin Embedding;Pathology;Patients;Pediatric Oncology;personalized diagnostics;Pharmaceutical Preparations;precision medicine;prognostic;Protocols documentation;Research;research clinical testing;Research Personnel;Resources;Solid Neoplasm;standard of care;Surgical Pathology;targeted treatment;Technology;Testing;Therapeutic;Transplantation;United States National Institutes of Health;Update;Urologic Oncology;Vaccines,Development of FISH Molecular Diagnostics to support Clinical Trials at NCI,11792,NA,NA,NA,NA,8,NA,NA,606510,NA
11188823,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC011875,NA,NA,1ZIDBC011875-06,NCI:23136159\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162369 (contact),"SHORER, SHY  (contact)",NA,NA,NA,Adverse event;Adverse reactions;Agreement;CCR;Clinical;clinical research site;clinical trial protocol;Communication;Medical;Monitor;Pharmacologic Substance;Procedures;Process;Protocols documentation;Reporting;Safety;Serious Adverse Event;Structure;System;Writing,Office of Sponsor and Regulatory Oversight,11875,NA,NA,NA,NA,6,NA,NA,23136159,NA
11188824,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC011908,NA,NA,1ZIDBC011908-06,NCI:1853306\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162371 (contact),"CALZONE, KATHLEEN  (contact)",NA,NA,NA,active duty;Advertising;Advisory Committees;Affect;Agreement;Appointment;Back;Bioethics;Blood specimen;Budgets;cancer genetics;cancer genomics;CCR;CDH1 gene;Charge;Classification;Clinic;Clinical;clinical center;clinical infrastructure;Clinical Services;clinical training;clinically relevant;cohort;Collaborations;Collection;Communities;Consent;Consult;Consultations;Continuing Education;cost;Counseling;Data;Development;Disclosure;Doctor of Philosophy;Education;Education Gap;Educational Curriculum;Educational process of instructing;Eligibility Determination;empowerment;Enrollment;evidence base;exome;exome sequencing;experience;Extramural Activities;Faculty;falls;Family;Fellowship;Funding;Genes;Genetic;Genetic Counseling;genetic counselor;genetic pedigree;Genetic Research;Genetic Services;genetic testing;genetic variant;Genomics;Germ Lines;Germ-Line Mutation;Goals;Healthcare;Hematology;Historically Black Colleges and Universities;Hybrids;Individual;Infrastructure;Inherited;Institutional Review Boards;instructor;interest;Kidney;Label;Laboratories;Lead;Leadership;Learning;Length;Longterm Follow-up;Lung;Malignant Neoplasms;malignant stomach neoplasm;Manuals;Mediation;Medical;Medicine;meetings;member;Mentors;Mesothelioma;Modeling;multidisciplinary;National Human Genome Research Institute;National Institute of Allergy and Infectious Disease;neuro-oncology;novel;Pathology;Patient Care;Patient Preferences;Patients;Pediatric Oncology;Persons;Positioning Attribute;Price;programs;Prostate;protocol development;Protocols documentation;Provider;Recording of previous events;Records;Renal Carcinoma;Reporting;Research;Research Personnel;research study;Resources;Role;Rotation;sabbatical;Saliva;Sampling;Schedule;Services;simulation;Somatic Mutation;Source;Standardization;Students;Swab;systematic review;Telemedicine;Testing;Thinking;Time;Training;Training Programs;tumor;Tumor Pathology;United States National Institutes of Health;Universities;university student;Variant;variant of unknown significance;Venous blood sampling;Vocational Guidance;Wages;Work;working group,Clinical Cancer Genomics Program,11908,NA,NA,NA,NA,6,NA,NA,1853306,NA
11188825,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC011911,NA,NA,1ZIDBC011911-06,NCI:415831\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6572356 (contact),"SCHRUMP, DAVID  (contact)",NA,NA,NA,"Blood Vessels;Cerebral Decortication;Cessation of life;Chest wall structure;Clinical;clinical center;Complex;Consult;Esophagectomy;Excision;Exposure to;Fellowship Program;Immunocompromised Host;indexing;Innovative Therapy;Investigational Therapies;Laboratory Research;Lung;Lung nodule;Malignant neoplasm of lung;Malignant neoplasm of thorax;Malignant Neoplasms;Mediastinal;meetings;Metastatic Neoplasm to the Lung;Mission;Morbidity - disease rate;mortality;Multi-Drug Resistance;Mycobacterium Infections;Mycoses;National Heart, Lung, and Blood Institute;National Institute of Allergy and Infectious Disease;neoplasm therapy;next generation;oncology program;operation;Operative Surgical Procedures;Patient Care;Patients;Pediatric Oncology;Pleural;Pneumonectomy;Pneumothorax;Procedures;reconstruction;Regimen;Resistance;Rotation;Scientist;screening;Second Opinions;Services;standard of care;Surgeon;Surgical Oncology;surgical service;symposium;Therapeutic;Thoracic Surgeon;Thoracic Surgical Procedures;Thoracoplasty;Training;Training Support;Translational Research;Treatment Protocols;United States;United States National Institutes of Health",Thoracic Surgery Consultative Services,11911,NA,NA,NA,NA,6,NA,NA,415831,NA
11188826,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC011959,NA,NA,1ZIDBC011959-05,NCI:7035519\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162296 (contact),"XI, LIQIANG  (contact)",NA,NA,NA,"American;Biological Assay;Cancer Patient;CCR;cell free DNA;Cells;Certification;Charge;Classification;Clinic;Clinical;clinical center;Clinical Protocols;clinically relevant;college;Complex;Continuing Education;Copy Number Polymorphism;Development;Diagnosis;Diagnostic;Diagnostic Services;Eligibility Determination;Evaluation;exome sequencing;Funding;gene panel;Genes;genome sequencing;Genomics;Guidelines;insertion/deletion mutation;insight;Internet;Intramural Research Program;Laboratories;Malignant neoplasm of liver;Malignant neoplasm of prostate;Malignant Neoplasms;Microsatellite Instability;Mission;Modernization;Molecular;Molecular Diagnostic Testing;molecular diagnostics;molecular oncology;molecular pathology;molecular targeted therapies;Mutation;National Cancer Institute;National Human Genome Research Institute;National Institute of Allergy and Infectious Disease;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;National Institute of Diabetes and Digestive and Kidney Diseases;neuro-oncology;next generation;next generation sequencing;novel;Oncology;Pathogenicity;Pathologic;Pathologist;Pathology;Patients;Pediatric Oncology;Phase;Physicians;Play;pre-clinical;precision medicine;precision oncology;Principal Investigator;Process;prognostic;Proteins;Protocols documentation;rare cancer;Reagent;Reflex action;Reporting;Research;RNA;RNA Splicing;Role;Running;Sampling;Scientist;screening;service programs;Services;Single Nucleotide Polymorphism;Solid Neoplasm;Specimen;Structure;symposium;Testing;Therapeutic;Time;Training and Education;training opportunity;transcriptome sequencing;tumor;tumor behavior;tumor DNA;Tumor Markers;United States National Institutes of Health;Validation;Variant;whole genome",NCI COMPASS-Comprehensive Oncologic Molecular Pathology and Sequencing Service,11959,NA,NA,NA,NA,5,NA,NA,7035519,NA
11188827,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC012026,NA,NA,1ZIDBC012026-04,NCI:2939106\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78355624 (contact),"PAI, SUNG-YUN  (contact)",NA,NA,NA,Acceleration;Acute;Adolescent and Young Adult;Allogenic;Autologous;Cell Therapy;Cells;Child;chronic graft versus host disease;Clinical;Clinical Research;Clinical Trials;Collaborations;conditioning;congenital immunodeficiency;Development;Disease;DOCK8 deficiency;GATA2 deficiency;Gene Mutation;gene therapy;Genetic Diseases;Germ Lines;Germ-Line Mutation;Goals;Hematological Disease;Hematopoietic Stem Cell Transplantation;Homologous Transplantation;Imatinib;Immune;immune function;immune reconstitution;Immune System Diseases;Immunity;immunodeficiency;improved;medical specialties;member;Molecular;Mutation;Myeloproliferative disease;Natural History;novel;Nurse Practitioners;Other Genetics;participant enrollment;Patient-Focused Outcomes;Patients;Physician Assistants;Physicians;programs;Protocols documentation;reconstitution;research clinical testing;Research Personnel;RUNX1 gene;Stem cell transplant;Syndrome;synergism;System;T-Lymphocyte;Techniques;Testing;Transplant Recipients;Transplantation;transplantation therapy;treatment and outcome;Tyrosine Kinase Inhibitor;Variant;Virus;Work,ID-CTP Clinical Core,12026,NA,NA,NA,NA,4,NA,NA,2939106,NA
11188828,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC012078,NA,NA,1ZIDBC012078-03,NCI:1252890\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,15201740 (contact),"ARMSTRONG, TERRI S. (contact)",NA,NA,NA,cancer therapy;Clinical;clinical outcome assessment;Clinical Trials;Communication;Development;Disease;early phase trial;Educational workshop;Extramural Activities;Foundations;Malignant Neoplasms;meetings;Mission;Monitor;NCI Center for Cancer Research;Outcome;Outcomes Research;patient oriented;Patient-Focused Outcomes;Publications;Recruitment Activity;Reporting;Research Personnel;symptomatic improvement;Symptoms;virtual reality;wearable device;Work,Office of Patient-Centered Outcomes Research (OPCORe),12078,NA,NA,NA,NA,3,NA,NA,1252890,NA
11188829,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC012090,NA,NA,1ZIDBC012090-03,NCI:931749\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858639 (contact),"ABDULLAEV, ZIED  (contact)",NA,NA,NA,Brain Neoplasms;Central Nervous System Neoplasms;Classification;Clinical;Clinical Management;Clinical Pathology;clinical practice;Development;Diagnosis;Diagnostic;diagnostic accuracy;diagnostic criteria;DNA Integration;DNA Methylation;DNA methylation profiling;DNA Sequence Alteration;DNA sequencing;Gene Fusion;Histopathology;improved;individual patient;insight;Methods;Methylation;Modality;Molecular;molecular diagnostics;Mutation;next generation sequencing;Patient Care;Patients;personalized care;personalized diagnostics;programs;Publishing;RNA;Series;standard of care;tumor;Update;whole genome,Classification of tumors using whole-genome methylation profiling,12090,NA,NA,NA,NA,3,NA,NA,931749,NA
11188830,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC012137,NA,NA,1ZIDBC012137-02,NCI:917161\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8108820 (contact),"THIELE, CAROL J (contact)",NA,NA,NA,3-Dimensional;Adrenal Glands;Adrenocortical Carcinoma;Adult;Androgens;Architecture;Atlases;Cancer Therapy Evaluation Program;CCR;cell free DNA;Cells;Childhood;Childhood Brain Neoplasm;Childhood Melanoma;Childhood Solid Neoplasm;Clinical;Clinical Trials;Combined Modality Therapy;computerized tools;Computing Methodologies;Core Facility;cytokine;Data;Data Analyses;data integration;data modeling;Data Set;data tools;data visualization;Development;Disease;effectiveness evaluation;epigenomics;Evaluation;extracellular vesicles;feasibility testing;Funding;Gene Expression Profiling;Generations;Genetic;Genetic Transcription;Genomics;Germ Lines;Goals;gut microbiome;High-Risk Cancer;Histology;Human;Hydrocortisone;Image;Immunology;Immunophenotyping;Infrastructure;Intramural Research Program;Knowledge;Link;Liver;Lung;Malignant Bone Neoplasm;Malignant Childhood Neoplasm;Malignant neoplasm of adrenal cortex;Malignant Neoplasms;Manuscripts;Maps;medullary thyroid carcinoma;Metabolism;metabolomics;Metastatic Neoplasm to the Lung;Modeling;Molecular;Morphology;multiple omics;Natural History;Neoplasm Metastasis;Osteosarcoma;Outcome;Pathology;Patient advocacy;patient engagement;Patient Outcomes Assessments;Patients;Pediatric Neoplasm;Pediatric Oncology;pediatric patients;pre-clinical;Pre-Clinical Model;precision medicine;precision medicine clinical trials;Precision therapeutics;preclinical development;Preclinical Testing;programs;Proteomics;Protocols documentation;rare cancer;Reaction;recruit;refractory cancer;Relapse;Research;Research Personnel;response;Rhabdomyosarcoma;single cell analysis;single cell genomics;single cell sequencing;Solid Neoplasm;steroid hormone;Structure of parenchyma of lung;Testing;Therapeutic;Therapeutic Trials;Tissue Sample;Tissues;transcriptome sequencing;transcriptomics;Translating;Translational Research;tumor;tumor heterogeneity;tumor microenvironment;Visualization software;whole body imaging;young adult,Childhood Cancer Data Initiative,12137,NA,NA,NA,NA,2,NA,NA,917161,NA
11188831,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC012159,NA,NA,1ZIDBC012159-01,NCI:714032\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79972499 (contact),"DAVIS, JEREMY  (contact)",NA,NA,NA,Affect;Automobile Driving;Characteristics;Clinical;Defect;Diffuse gastric cancer;Disease;disease phenotype;Genomics;Genotype;Goals;Individual;Inherited;Invaded;Malignant Neoplasms;malignant stomach neoplasm;Molecular;Natural History;Neoplasm Metastasis;Operative Surgical Procedures;Pathologic;Patients;Phenotype;Recording of previous events;Risk;Risk Reduction;Syndrome;tumor;tumor initiation,Molecular Mechanisms Driving Hereditary Diffuse Gastric Cancer Syndrome,12159,NA,NA,NA,NA,1,NA,NA,714032,NA
11188832,ZID,CA,1,N,NA,NA,NA,NA,ZIDBC012190,NA,NA,1ZIDBC012190-01,NCI:769154\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79972501 (contact),"ADJEI, BRENDA  (contact)",NA,NA,NA,Accountability;Address;Advocate;Area;Awareness;cancer care;care systems;Catchment Area;CCR;Clinical;Clinical Research;Clinical Trials;Communities;community partners;Data;data tools;design;Development;Equity;evidence base;experience;Focus Groups;health assessment;health care delivery;Health Personnel;improved;Institution;lens;Monitor;outreach;participant enrollment;patient oriented;Patients;Population;Provider;Research;Resources;Survey Methodology;Surveys;tool;Underrepresented Populations;United States Agency for Healthcare Research and Quality;Visualization software,Office of Healthcare Delivery and Equity Research,12190,NA,NA,NA,NA,1,NA,NA,769154,NA
11188833,ZID,CL,1,N,NA,NA,NA,NA,ZIDCL002107,NA,NA,1ZIDCL002107-25,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,79959606 (contact),"WEST-MITCHELL, KAMILLE  (contact)",NA,NA,NA,Affect;Age;Allogenic;Amino Acid Substitution;Ankle;Arrhythmia;Arthritis;Biochemical;Blood;Blood Donations;Blood donor;Blood Transfusion;Cardiology;Cardiomyopathies;Caucasians;Cell Nucleus;Cell surface;Cells;Charge;Chronic;Clinical;clinical center;clinical phenotype;cohort;Comprehensive Health Care;Control Groups;cost;Costs and Benefits;Cysteine;Cytoplasm;Data;Data Collection;Deposition;Development;Diabetes Mellitus;Diagnosis;Diet Habits;Disclosure;Discrimination;Disease;Duodenum;Eligibility Determination;Enrollment;Environment;Epigenetic Process;Erythrocytes;European;Evaluation;Excision;Exercise;Fatigue;Female;Ferritin;Frequencies;Gastrointestinal tract structure;Gender;Genes;Genetic Diseases;Genetic Screening;Genetic Transcription;Gonadal structure;Health Services Accessibility;Heart;Heart Atrium;Hemochromatosis;Hemoglobin;Hepatocyte;hepcidin;Hereditary Disease;Hereditary hemochromatosis;HFE gene;Hip region structure;Homozygote;Hormones;Hypogonadism;Hypothyroidism;Improve Access;Incentives;Incidence;Insulin;Insurance;Iron;iron absorption;Iron Overload;Joints;Knee;Left;Life;Liver;Liver Cirrhosis;Maintenance;Maintenance Therapy;male;Malignant neoplasm of liver;mean corpuscular volume observed;meetings;Membrane;Monitor;Morbidity - disease rate;mortality;Mutation;Nucleotides;Organ;Organ failure;Other Genetics;Oxidative Stress;Pancreas;Participant;participant enrollment;Pathway interactions;Patients;Penetrance;Persons;Phase;Physicians;prevent;programs;Prospective Studies;Protocols documentation;Public Health;Recommendation;recruit;Replacement Arthroplasty;Research;Research Personnel;Resources;response;Reticuloendothelial System;Risk;Safety;screening;Series;seroconversion;Serum Markers;Services;Signal Transduction;Skin;social stigma;Source;Stress;success;Symptoms;Therapeutic;Thyroid Function Tests;Thyroid Gland;Total Hip Replacement;Transfusion;Treatment Cost;treatment program;Tyrosine;United States National Institutes of Health;Up-Regulation;Vascular blood supply;Venous blood sampling;Ventricular;women subjects;young adult,Prospective Studies Of Phlebotomy Therapy In Hereditary Hemochromatosis,2107,NA,NA,NA,NA,25,NA,NA,0,NA
11188834,ZID,CL,1,N,NA,NA,NA,NA,ZIDCL002124,NA,NA,1ZIDCL002124-13,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,79959606 (contact),"WEST-MITCHELL, KAMILLE  (contact)",NA,NA,NA,Acute;Adverse effects;Age;Allogenic;Alloimmunization;anti-microbial drug;Blood Component Removal;Blood Donations;Blood donor;Bone Pain;Cataract;Chills;Collection;Communities;Consent;CSF3 gene;Dexamethasone;Diagnosis;Disease;Dose;efficacy study;Eligibility Determination;Enrollment;experience;Fatigue;Fever;Filgrastim;Frequencies;granulocyte;health assessment;healthy volunteer;hospital discharge rate;Infection;Informed Consent;Institutional Review Boards;interest;Leukapheresis;Life;member;Monitor;Nausea;Neutropenia;neutrophil;ophthalmic examination;Outcome Measure;Participant;Patients;Pharmaceutical Preparations;Plateletpheresis;Policies;Primary Care Physician;Procedures;Process;programs;prospective;Protocols documentation;recruit;Regimen;Registries;Reporting;retention rate;Schedule;Severities;Symptoms;Testing;Therapeutic;Time;Toxic effect;Transfusion;transfusion medicine;United States Food and Drug Administration;Venous;volunteer,Granulocyte Donation with GCSF,2124,NA,NA,NA,NA,13,NA,NA,0,NA
11188835,ZID,DC,1,N,NA,NA,NA,NA,ZIDDC000075,NA,NA,1ZIDDC000075-17,NIDCD:3399659\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,79350266 (contact),"LEVY, JOSHUA  (contact)",NA,NA,NA,adeno-associated viral vector;Administrator;Admission activity;Adult;Ambulatory Care Facilities;Appointment;AQP1 gene;Area;atorvastatin;Audiology;bevacizumab;Care given by nurses;career development;Caring;CCR;Child;Chromosome Mapping;Cisplatin;cisplatin induced hearing loss;Clinical;clinical care;Clinical Clerkship;Clinical Data;clinical implementation;Clinical Investigator;Clinical Research;Clinical Services;Clinical Trials;Clinics and Hospitals;Communication impairment;Complex;Congresses;Consult;Consultations;Continuing Education;Credentialing;Data;Data Collection;data management;Databases;Development;Disease;Dose;Emergency Situation;Endoscopy;Equilibrium;Equipment and Supplies;Evaluation;Fellowship;Fostering;Genes;genetic analysis;genetic deafness;Genetic study;genome editing;Head and Neck Disorder;Head and Neck Squamous Cell Carcinoma;Head and Neck Surgeon;Hearing;hearing impairment;Hearing problem;hearing restoration;Hereditary Disease;hereditary hearing loss;Hospital Administration;Hospitals;Hour;Human;human papilloma virus oropharyngeal squamous cell carcinoma;Human Resources;human subject;Image;India;inpatient service;Inpatients;Institutional Review Boards;Intervention;Intervention Studies;Intramural Research Program;irradiation;Laboratories;Labyrinth;Maintenance;Medical;Medical Students;meetings;Mentors;Mission;Molecular;Molecular Analysis;Monitor;National Institute on Deafness and Other Communication Disorders;Natural History;Neoadjuvant Therapy;Nurse Practitioners;Nursing Research;Olfactory Neuroblastoma;Operative Surgical Procedures;Otolaryngologist;Otolaryngology;ototoxicity;outpatient programs;Outpatients;Pakistan;Parotid Gland;Pathogenesis;Patient Care;Patient Education;patient screening;Patients;Phase;phase 2 study;Phenotype;photoimmunotherapy;Physicians;Program Development;programs;protocol development;Protocols documentation;Provider;quality assurance;Records;recruit;Recurrent respiratory papillomatosis;Research;Research Support;Resources;response;Safety;Salivary;Scientist;Services;Specimen;Speech;Supervision;Surgeon;symposium;Testing;Time;Training;Travel;United States National Institutes of Health;Vestibular Aqueduct;Visit;Voice;volunteer;Work,NIDCD Core for Clinical Research and Care,75,NA,NA,NA,NA,17,NA,NA,3399659,NA
11188836,ZID,DK,1,N,NA,NA,NA,NA,ZIDDK070013,NA,NA,1ZIDDK070013-16,NIDDK:4377749\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,16147217 (contact),"KOH, CHRISTOPHER  (contact)",NA,NA,NA,Adverse event;Area;Bar Codes;biobank;Biometry;Blood Glucose;Clinical;clinical database;clinical investigation;Clinical Investigator;Clinical Protocols;Clinical Research;Clinical Research Protocols;Clinical Services;Collection;Conflict of Interest;Consent Forms;Consultations;Credentialing;Cystic Fibrosis;Data;data sharing;Databases;Development;Diabetes Mellitus;Diagnosis;Disease;disease natural history;Documentation;Dose;Electronics;Endocrinology;Ethics;Functional disorder;Gastroenterology;glucose monitor;Good Clinical Practice;Hematology;Hepatology;Human;human subject;Human Subject Research;indexing;Institutional Review Boards;Insulin;Insulin deficiency;Insulin Infusion Systems;Insulin Resistance;Intramural Research Program;Laboratory Research;Lead;Maintenance;Medical;medical specialties;member;Metabolism;Mission;Monitor;multidisciplinary;National Institute of Diabetes and Digestive and Kidney Diseases;Nephrology;novel strategies;Obesity;Pathogenesis;Patient Care;Patients;Principal Investigator;programs;protocol development;Protocols documentation;Reporting;Research;Research Personnel;Research Support;Research Training;Safety;Sampling;Services;Site;Technology;Testing;Training;United States National Institutes of Health,"Multidisciplinary Collaborative Clinical Research, Protocol Navigation, Monitoring Compliance, and Other Clinical Services in NIDDK Program Area Diseases",70013,NA,NA,NA,NA,16,NA,NA,4377749,NA
11188837,ZID,CA,1,N,NA,NA,NA,NA,ZIDSC006329,NA,NA,1ZIDSC006329-44,NCI:336024\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,7937849 (contact),"MILLER, ROBERT  (contact)",NA,NA,NA,3D Print;Acceleration;Anatomy;Anesthesia procedures;Body Surface;Brachytherapy;Calcium;Calibration;cancer imaging;Cephalic;Clinical;clinical implementation;Clinical Protocols;Clinical Research;clinically relevant;Collimator;Communication;Consultations;data centers;Dedications;Detection;Devices;Diameter;Directories;Dose Rate;Elements;Environment;Equipment;fabrication;Facility Designs;Farm;flexibility;Fractionation;Freedom;Functional Imaging;Guidelines;Image;image reconstruction;imaging capabilities;Immobilization;Implant;improved;in vivo;Interruption;interstitial;Iodine;Lateral;Maintenance;Measurement;Methodology;Mission;Monitor;Motion;Motor;Needles;Optics;Patients;Periodicals;Physics;Plant Leaves;Positioning Attribute;Process;Prostate;prostate radiotherapy;Protocols documentation;quality assurance;Radiation;Radiation Oncology;Radiation Physics;Radiation therapy;Radiation Tolerance;radio frequency;Radiosurgery;Research Project Grants;Scanning;Schedule;Security;Series;Services;Source;Speed;Surface;System;Testing;Thinness;Time;Tracer;Transducers;treatment planning;ultrasound;United States National Institutes of Health;Vertebral column;virtual;Visual;Water;Width;X-Ray Computed Tomography,Clinical Radiation Physics Service,6329,NA,NA,NA,NA,44,NA,NA,336024,NA
11188838,ZID,CA,1,N,NA,NA,NA,NA,ZIDSC007202,NA,NA,1ZIDSC007202-41,NCI:1292531\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,79972508 (contact),"YEE, LAURA  (contact)",NA,NA,NA,Acquired Immunodeficiency Syndrome;Biometry;cancer therapy;Clinical Treatment;Clinical Trials;Collaborations;Component of the Center for Cancer Research;Consultations;Data Analyses;design;Development;Diagnostic Procedure;drug testing;Evaluation;Growth;improved;In Vitro;Laboratories;Leadership;Malignant Neoplasms;Methods;Monitor;Multi-Institutional Clinical Trial;nonhuman primate;prognostic;Research;Research Personnel;Selection for Treatments;Services;Staging System;Statistical Data Interpretation,Office of Collaborative Biostatistics,7202,NA,NA,NA,NA,41,NA,NA,1292531,NA
11188839,ZIE,CA,1,N,NA,NA,NA,NA,ZIEBC010843,NA,NA,1ZIEBC010843-18,NCI:8041234\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858344 (contact),"KANAKRY, JENNIFER  (contact)",NA,NA,NA,"Acquired Immunodeficiency Syndrome;Adult;AIDS related cancer;Ambulatory Care;American Cancer Society;American Society of Clinical Oncology;anti-cancer research;Anti-Retroviral Agents;Appointment;Area;Basic Science;Board Certification;Bone Marrow Examination;Cancer Control;cancer therapy;career;Centers for Disease Control and Prevention (U.S.);chemotherapy;Chronic Leukemia;Clinic;Clinical;clinical care;clinical center;clinical diagnostics;Clinical Oncology;Clinical Research;Clinical Sciences;clinical training;Communities;Comprehensive Cancer Center;design;Development;Diagnostic Procedure;Disease;Division of Cancer Prevention;Drug Industry;drug testing;Educational Curriculum;Educational process of instructing;Ensure;experience;experimental study;Fellowship;Fellowship Program;First Year Experience;Goals;Hematological Disease;Hematologist;Hematology;Hodgkin Disease;Hospitals;Human;Industry;inpatient service;interest;Intramural Research;Investigation;Journals;Laboratories;Laboratory Research;Leadership;lectures;Lymphoma;Malignant neoplasm of ovary;Malignant neoplasm of prostate;Malignant Neoplasms;Maryland;Medical;Medical Oncology;Medicine;meetings;member;National Cancer Institute;National Heart, Lung, and Blood Institute;NCI Center for Cancer Research;neoplastic;next generation;novel strategies;novel therapeutics;Oncologist;Oncology;Outpatients;Paracentesis;patient oriented;patient population;Patients;Peer Review;Physicians;Positioning Attribute;programs;Publications;recruit;Renal Cell Carcinoma;Research;Research Activity;Research Personnel;Research Project Grants;Rotation;Scientist;Series;skill acquisition;Stem cell transplant;symposium;Thoracentesis;Time;Training;Translational Research;United States;United States National Institutes of Health;Universities;Washington;Work",NIH Hematology Oncology Fellowship Program,10843,NA,NA,NA,NA,18,NA,NA,8041234,NA
11188840,ZIE,CA,1,N,NA,NA,NA,NA,ZIEBC011023,NA,NA,1ZIEBC011023-17,NCI:23635\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692537 (contact),"PINTO, PETER  (contact)",NA,NA,NA,Accreditation;Basic Science;cancer genetics;Cancer Patient;career;Clinical;Clinical Research;Clinical Trials;Complex;Continuity of Patient Care;Data;design;Diagnosis;Educational Curriculum;experience;Fellowship;Fellowship Program;Goals;Immunotherapy;improved;Individual;Industry;Journals;Laboratory Research;Laboratory Scientists;Learning;lectures;Malignant neoplasm of penis;Malignant neoplasm of prostate;Malignant neoplasm of testis;Malignant neoplasm of ureter;Malignant neoplasm of urinary bladder;Malignant Neoplasms;Medicine;Methods;minimally invasive;Mission;Modality;Molecular;Molecular Biology;multidisciplinary;National Cancer Institute;Oncologist;Operative Surgical Procedures;Patients;Physicians;programs;Quality of life;Renal Carcinoma;Research;Research Personnel;Research Project Grants;Research Training;Residencies;Scientist;Societies;Solid;Surgeon;symposium;Systemic Therapy;Techniques;Therapeutic;therapy development;Training;Training Programs;Translational Research;United States;United States National Institutes of Health;urologic;Urologic Cancer;Urologic Oncology;Urologic Surgeon;Urology;Work,Clinical Fellowship Training Program,11023,NA,NA,NA,NA,17,NA,NA,23635,NA
11188841,ZIE,CA,1,N,NA,NA,NA,NA,ZIEBC011241,NA,NA,1ZIEBC011241-16,NCI:749091\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692515 (contact),"JAFFE, ELAINE  (contact)",NA,NA,NA,Academy;Accreditation;American;Appointment;career;Career Choice;Caring;Certification;Child;Clinical;clinical center;Clinical Research;clinical training;Communication;Communities;Consultations;Country;Credentialing;Data;Dedications;Diagnosis;Diagnostic;Diagnostic Services;Disease;District of Columbia;Education;Educational Curriculum;Environment;experience;Exposure to;Faculty;Fellowship;Fellowship Program;Flow Cytometry;Functional disorder;Future;Goals;Head;Hematology;Hematopathology;Home;Hospitals;Immune System Diseases;improved;individual patient;International;Journals;Laboratories;Literature;Lymphoma;Medical;Medical center;medical specialties;Medicine;meetings;member;Mentors;molecular diagnostics;neoplastic;Occupations;Paper;Pathology;Patient Admission;Patients;Peer Review;Philosophy;Positioning Attribute;Procedures;programs;Publishing;Research;Research Project Grants;Review Literature;Rotation;Services;skills;success;symposium;Techniques;Time;Training;Training Programs;Translational Research;United States;United States National Institutes of Health;University Hospitals;Visit;Washington,Hematopathology Fellowship,11241,NA,NA,NA,NA,16,NA,NA,749091,NA
11188842,ZIE,CA,1,N,NA,NA,NA,NA,ZIEBC011384,NA,NA,1ZIEBC011384-14,NCI:2055605\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,11142369 (contact),"BARR, FREDERIC  (contact)",NA,NA,NA,Accreditation;Anatomy;Area;Autopsy;Biological Assay;cancer therapy;Case Study;Child;Clinical;clinical center;Clinical Pathology;Clinical Research;Clinical Services;Clinical Trials;Clonality;Communicable Diseases;Consultations;Cytopathology;Diagnosis;Diagnostic;Digestive System Disorders;Disease;disease diagnosis;Disease Management;DNA analysis;DNA Methylation;Education;Educational process of instructing;epidemiology study;Etiology;experience;Exposure to;Extramural Activities;Flow Cytometry;Fluorescent in Situ Hybridization;Functional disorder;Gene Fusion;Gene Mutation;Genes;Genetic;Genetic study;Hematopathology;Hospitals;improved;insight;Institution;Kidney Diseases;Laboratories;Learning;Lymphoid;Malignant Neoplasms;Medical Examiners;Medicine;Mission;molecular diagnostics;Molecular Genetics;molecular pathology;Mutation;neoplastic;Nervous System Disorder;neuropathology;next generation sequencing;novel;Oncology;Outcome;participant enrollment;Pathogenesis;Pathologic;Pathology;Patient Care;Patients;Philosophy;Play;programs;Protocols documentation;Publications;recruit;Research;Research Activity;research clinical testing;Residencies;Role;Rotation;Services;soft tissue;Surgical Pathology;Techniques;Tissue Procurements;Training;Training Programs;United States National Institutes of Health;University Hospitals;urologic;Washington,Anatomic Pathology Residency Program,11384,NA,NA,NA,NA,14,NA,NA,2055605,NA
11188843,ZIE,CA,1,N,NA,NA,NA,NA,ZIEBC011516,NA,NA,1ZIEBC011516-12,NCI:7103136\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14732189 (contact),"GLOD, JOHN  (contact)",NA,NA,NA,Accreditation;Adolescent and Young Adult;Adult;Cause of Death;Cell Therapy;Central Nervous System Melanoma;Central Nervous System Neoplasms;Child;Childhood;Clinical;clinical care;clinical center;Clinical Research;Clinical Services;Disease;Education;Endocrine Gland Neoplasms;Enrollment;Ewings sarcoma;Fellowship;graduate medical education;improved;Institution;irinotecan;Joints;Late Effects;Lead;leukemia;Lymphoma;Malignant Childhood Neoplasm;Malignant Neoplasms;Medical;Mentors;Minor;Mission;Neuroblastoma;Nurse Practitioners;Osteosarcoma;Patient Care;Patients;Pediatric Oncology;pediatric patients;physician-scientist training program;Play;Quality of life;rare cancer;Recurrence;Role;Soft tissue sarcoma;Survivors;synovial sarcoma;therapy development;Training;Training Programs;Translating;Translational Research;tumor;United States National Institutes of Health;Unresectable,Pediatric Oncology Branch Clinical Care and Education,11516,NA,NA,NA,NA,12,NA,NA,7103136,NA
11188844,ZIE,CA,1,N,NA,NA,NA,NA,ZIEBC011653,NA,NA,1ZIEBC011653-10,NCI:15841\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14280079 (contact),"ALEWINE, CHRISTINE  (contact)",NA,NA,NA,Caring;Clinical;Clinical Skills;Consult;Educational process of instructing;Gastrointestinal Neoplasms;Goals;improved outcome;Interest Group;Journals;Malignant neoplasm of gastrointestinal tract;Malignant neoplasm of pancreas;Malignant neoplasm of thorax;Medical Oncologist;Medical Oncology;multidisciplinary;oncology program;Outcome;pancreatic cancer patients;Patients;Primitive foregut structure;Protocols documentation;Publications;Publishing;Seminal;Surgical Oncology;Training;tumor;Work,Clinical Support,11653,NA,NA,NA,NA,10,NA,NA,15841,NA
11188845,ZIE,CA,1,N,NA,NA,NA,NA,ZIEBC011912,NA,NA,1ZIEBC011912-06,NCI:123553\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,16162371 (contact),"CALZONE, KATHLEEN  (contact)",NA,NA,NA,academic preparation;Acceleration;Address;Advanced Practice Nurse;Africa;American Nurses&apos; Association;Area;Boston;Brazil;cancer genomics;Categories;Certification;Clinical;clinical practice;Collaborations;college;Communication;Community of Practice;Competence;Country;Cross-Sectional Studies;design;Developing Countries;Development;Discipline of Nursing;Doctor of Philosophy;doctoral student;Education;education planning;education resources;Educational Curriculum;Educational process of instructing;Faculty;faculty support;Funding;Genetic;Genomics;Goals;Graduate Degree;Grant;Guidelines;Health Personnel;Health Professional;Healthcare;Hearing;hospital care;Hospital Planning;Hospitals;implementation study;improved;Indiana;innovation;Institution;Institutional Review Boards;international partnership;Intervention;Interview;Ireland;Israel;Japan;Knowledge;Leadership;Learning;Licensure;Literature;Malignant Neoplasms;medical specialties;Mentors;Methodology;Methods;Midwife;Modeling;Nature;next generation;Nurses;Nursing Assessment;Nursing Education;Nursing Faculty;Nursing Models;Nursing Schools;Nursing Societies;Oncology;Oncology Nurse;Outcome;Outpatients;Participant;Patients;pedagogy;Pharmacogenomics;Phase;Policies;Postdoctoral Fellow;Precision Health;Process;programs;Protocols documentation;Publications;Publishing;Registered nurse;Regulatory Element;Reporting;Research;Research Project Grants;Resources;Role;Scheme;Science;Site;skills;Strategic Planning;Students;Surveys;systematic review;Teacher Professional Development;Technology;Testing;text searching;tool;translational genomics;undergraduate student;United States National Institutes of Health;Universities;Update;Wales;web site;webinar;Work;Workforce Development;Writing,Genomic Competency Initiative,11912,NA,NA,NA,NA,6,NA,NA,123553,NA
11188846,ZIE,CA,1,N,NA,NA,NA,NA,ZIEBC011992,NA,NA,1ZIEBC011992-05,NCI:154003\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857694 (contact),"ZEIGER, MARTHA  (contact)",NA,NA,NA,"Academic Medical Centers;Administrative Supplement;Advanced Malignant Neoplasm;anti-cancer research;Applications Grants;Budgets;Cancer Center Support Grant;Cancer health equity;career;cohort;Collaborations;Communities;cost;Development;Direct Costs;Disease;Education;Educational Curriculum;Eligibility Determination;equity, diversity, and inclusion;Evaluation;Extramural Activities;Funding;Goals;Grant;health disparity populations;improved;Institution;Journals;Malignant Neoplasms;Manuscripts;meetings;Mentors;Methods;NCI-Designated Cancer Center;NIH Program Announcements;Operative Surgical Procedures;Outcome;Participant;participant interview;Persons;Physicians;Population;Process;programs;Progress Reports;recruit;Research Personnel;Research Support;Scientist;Societies;Surgeon;Surveys;symposium;timeline;Training;Training Activity;Translational Research;Travel;Underrepresented Minority;Underrepresented Students;United States;United States National Institutes of Health;Writing",Training and Development of Outstanding Surgeon Scientists,11992,NA,NA,NA,NA,5,NA,NA,154003,NA
11188847,ZIE,CA,1,N,NA,NA,NA,NA,ZIEBC012097,NA,NA,1ZIEBC012097-03,NCI:4479209\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858651 (contact),"BLAKELY, ANDREW  (contact)",NA,NA,NA,Adrenocortical Carcinoma;Basic Science;Cancer Biology;cancer therapy;Clinical;Clinical Oncology;Clinical Research;Dermatology;design;Disease;disease heterogeneity;Educational process of instructing;Etiology;Fellowship;Funding;Future;Gastrointestinal Stromal Tumors;Journals;Laboratories;Malignant Neoplasms;malignant stomach neoplasm;Mesothelioma;Modernization;Molecular;National Cancer Institute;NCI Center for Cancer Research;Neuroendocrine Tumors;next generation;oncology program;Operative Surgical Procedures;Outcome;Output;Patient Care;Patients;Positioning Attribute;Process;programs;Publications;Publishing;Rare Diseases;Research;Rotation;Scientist;Surgeon;Surgical Oncology;Tissues;Training;Training Programs;Translational Research;translational study,Surgical Oncology Program Training Program,12097,NA,NA,NA,NA,3,NA,NA,4479209,NA
11188848,ZIE,DK,1,N,NA,NA,NA,NA,ZIEDK075100,NA,NA,1ZIEDK075100-17,NIDDK:1537194\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,NA,NA,15187433 (contact),"MUNIYAPPA, RANGANATH  (contact)",NA,NA,NA,"Academia;Academic Medical Centers;Accreditation;Admission activity;Adult;Ambulatory Care;Basic Science;Beds;career;Childhood;Clinic;Clinical;clinical center;Clinical Endocrinology;Clinical Investigator;clinical practice;Clinical Research;Clinical Sciences;clinical training;Complex;Consultations;Dedications;Development;Diabetes Mellitus;Education;Educational process of instructing;Endocrine;Endocrinology;experience;Faculty;Fellowship;Fellowship Program;flyer;Foreign Medical Graduates;graduate medical education;Hospitals;inpatient service;Inpatients;Internal Medicine;Internship and Residency;Laboratory Research;Lead;Manuscripts;medical schools;Metabolism;Mission;National Heart, Lung, and Blood Institute;National Institute of Allergy and Infectious Disease;National Institute of Child Health and Human Development;National Institute of Dental and Craniofacial Research;National Institute of Diabetes and Digestive and Kidney Diseases;Outpatients;Patient Care;Pharmacologic Substance;Physicians;Positioning Attribute;Primary Care;Procedures;programs;Publishing;Regulation;Research;research facility;Research Personnel;Research Project Grants;Rotation;Scientist;Supervision;Talents;Time;Training;Training Programs;trend;United States;United States National Institutes of Health;Universities;University Hospitals;Washington;Work","The NIH Inter-Institute Training Program in Endocrinology, Diabetes & Metabolism",75100,NA,NA,NA,NA,17,NA,NA,1537194,NA
11188849,ZIE,CA,1,N,NA,NA,NA,NA,ZIESC000853,NA,NA,1ZIESC000853-71,NCI:153418\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF CLINICAL SCIENCES - NCI,NA,NA,NA,10686755 (contact),"MERINO, MARIA  (contact)",NA,NA,NA,Anatomy;Area;clinical center;clinical conference;Collaborations;Development;Diagnosis;Educational process of instructing;Evaluation;human tissue;Kidney;Medical Oncology;member;Molecular;Molecular Target;Mutation;Pathology;Patient Admission;Patients;Prostate;Research;Research Personnel;Role;Surgical Pathology;Testing;Tissues;tool;Training;translational goal;Translational Research;tumor;United States National Institutes of Health;urinary;Urinary system;Urologic Diseases;Urologic Oncology;Visit,Translational Surgical Pathology,853,NA,NA,NA,NA,71,NA,NA,153418,NA
11188850,ZIG,CA,1,N,NA,NA,NA,NA,ZIGBC010856,NA,NA,1ZIGBC010856-18,NCI:24794995\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9414522 (contact),"CUSTER, MARY  (contact)",NA,NA,NA,Animal Experimentation;Animal Model;animal resource;Animals;anti-cancer research;Basal Cell;Basic Science;Biomedical Research;Brain;Breast;Cervical;Clinical;Colon;Communities;Development;Fostering;Future;Genetically Engineered Mouse;Head and neck structure;Hematopoietic Neoplasms;HIV/AIDS;Image;Intramural Research Program;Kidney;Liver;Lung;Malignant Neoplasms;Melanoma;Molecular Target;National Cancer Institute;NCI Center for Cancer Research;nonhuman primate;novel;Ovarian;Pancreas;pre-clinical;Pre-Clinical Model;pre-clinical research;Preclinical Testing;Principal Investigator;programs;Prostate;Rana;Rattus;Research;Research Personnel;Skin Neoplasms;Squamous cell carcinoma;technology development;Thyroid Gland;Training and Education;Validation;Zebrafish,Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research,10856,NA,NA,NA,NA,18,NA,NA,24794995,NA
11188851,ZIG,CA,1,N,NA,NA,NA,NA,ZIGBC010931,NA,NA,1ZIGBC010931-17,NCI:1613577\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692305 (contact),"SIMPSON, ROBERT  (contact)",NA,NA,NA,"Academia;Address;Animal Model;Animals;Annual Reports;Basic Science;Biological Models;Biomedical Research;biomedical scientist;Body System;cancer cell;Clinic;clinical training;Collaborations;college;Colorado;comparative;Coupled;Development;Diagnostic;Disease;disease model;Doctor of Philosophy;Doctor of Veterinary Medicine;Drug Industry;Education;Educational Curriculum;Extramural Activities;Faculty;Future;Goals;Government;Health;health goals;Human;human disease;human model;inter-institutional;Internships;Intramural Research;investigator training;Laboratory Research;Light;Malignant Neoplasms;Medical Education;medical specialties;Medicine;member;model organism;molecular pathology;National Heart, Lung, and Blood Institute;National Institute of Allergy and Infectious Disease;National Institute of Neurological Disorders and Stroke;NCI Center for Cancer Research;novel therapeutics;Pathology;Pennsylvania;Policy Maker;Positioning Attribute;programs;Public Health;recruit;Research;Research Contracts;Research Personnel;Research Training;Scientist;summer research;summer student;Training;Training Programs;Translating;translational scientist;Translations;United States;United States National Institutes of Health;Universities;Veterinarians;Veterinary Medicine;Visit",Comparative Biomedical Scientist Training Program,10931,NA,NA,NA,NA,17,NA,NA,1613577,NA
11188852,ZIG,CA,1,N,NA,NA,NA,NA,ZIGBC011689,NA,NA,1ZIGBC011689-09,NCI:108763\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14280471 (contact),"LEBLANC, AMY  (contact)",NA,NA,NA,Amputation;anti-CTLA-4 therapy;Antineoplastic Agents;antiviral immunity;Biological;Biotechnology;bridge program;Cancer Biology;cancer clinical trial;Canis familiaris;catalyst;Clinical;Clinical Trials;Collaborations;comparative;Complement;Conceptions;Contracts;cost;Data;data management;demethylation;design;Development;Development Plans;drug development;Drug Industry;Enrollment;Genomics;Goals;Human;Immunologics;Immunotherapy;Infrastructure;Institution;Leadership;Lymphoma;Malignant Neoplasms;member;Multi-Institutional Clinical Trial;Natural History;North America;novel;novel anticancer drug;novel therapeutics;Oncologist;Oncology;oncology program;oncology trial;Osteosarcoma;pet animal;Pharmaceutical Preparations;pharmacokinetics and pharmacodynamics;Pharmacologic Substance;Phase;Positioning Attribute;Process;Property;Protocols documentation;Publishing;Research Personnel;Resources;Role;Solid Neoplasm;Therapeutic;Therapeutic Agents;Translation Process;Veterinary Schools,Comparative Oncology Trials Consortium,11689,NA,NA,NA,NA,9,NA,NA,108763,NA
11188853,ZIG,CA,1,N,NA,NA,NA,NA,ZIGBC011735,NA,NA,1ZIGBC011735-09,NCI:340244\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,6809564 (contact),"SHARAN, SHYAM  (contact)",NA,NA,NA,Acinar Cell;Acinar Cell Carcinoma;Acute Myelocytic Leukemia;Adopted;Alleles;anaplastic thyroid cancer;Animal Model;Animals;anti-cancer;Antibody-drug conjugates;APC gene;Area;Behavioral;behavioral phenotyping;Biological;Biopsy;Brain;Cancer Model;CCR;Cell Therapy;Characteristics;chimeric antigen receptor T cells;Clinical;clinically relevant;Code;Collaborations;Collection;Communities;Correlative Study;Costello syndrome;Development;disease model;DNA Polymerase II;drug development;efficacy study;Enterobacteria phage P1 Cre recombinase;Ewings sarcoma;experimental study;FLT3 gene;Formulation;Future;Gastrointestinal Neoplasms;Gastrointestinal Neuroendocrine Neoplasm;Gastrointestinal Stromal Tumors;Gastrointestinal tract structure;Gene Expression;Genetic Engineering;Genetically Engineered Mouse;Goals;Hematopoietic Neoplasms;Histopathology;Human;immunodeficiency;Implant;improved;in vivo;in vivo Model;inhibitor;Joints;Kaposi Sarcoma;Laboratories;Lead;Malignant neoplasm of pancreas;Malignant Neoplasms;Methods;Mission;Modeling;Molecular;molecular drug target;mouse model;Mus;Mutation;novel;Oncogenes;Oncogenic;Oncology;Organogenesis;Pancreas;pancreatic ductal adenocarcinoma model;pancreatic tumorigenesis;Papillary thyroid carcinoma;Pathology;patient derived xenograft model;Patients;pre-clinical;pre-clinical research;Preclinical Drug Development;preclinical evaluation;Productivity;programs;rare cancer;Reagent;Recommendation;Reproducibility;Research Design;Research Infrastructure;Research Personnel;Resources;RNA;Scientist;Site Visit;Skin;small cell lung carcinoma;Specialist;Therapeutic;therapeutic development;Time;tool;Transgenic Animals;Transgenic Organisms;Translational Research;treatment response;tumor;Tumor Suppressor Genes;Work,Development of Novel Informative Preclinical Animal Models - CAPR Infrastructure,11735,NA,NA,NA,NA,9,NA,NA,340244,NA
11188854,ZIH,CA,1,N,NA,NA,NA,NA,ZIHBC011235,NA,NA,1ZIHBC011235-16,NCI:5642848\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14732217 (contact),"LEVINE, JASON  (contact)",NA,NA,NA,Animals;anti-cancer research;Bioinformatics;Budgets;cancer type;clinical center;Clinical Research;clinical trial participant;clinical trial protocol;Clinical Trials;Collaborations;Collection;Computer software;Data;Data Analyses;Data Collection;Data Storage and Retrieval;Databases;design;Development;Disease;Division of Cancer Epidemiology and Genetics;Documentation;Engineering;Equipment and supply inventories;Funding;Future;Goals;Human;Human Resources;Information Technology;Institutional Review Boards;Iris;lectures;Life Cycle Stages;Medical;Methods;NCI Center for Cancer Research;Online Systems;Postdoctoral Fellow;prevent;Principal Investigator;Process;programs;Protocols documentation;Qualifying;Research;Research Personnel;Series;Site;Standardization;Study Subject;symposium;System;Systems Analysis;Technology;Time;Tissues;United States National Institutes of Health;Validation;web app;web site;website development;wiki,Support of NCI CCR Clinical Research and Bioinformatics,11235,NA,NA,NA,NA,16,NA,NA,5642848,NA
11188855,ZIH,CA,1,N,NA,NA,NA,NA,ZIHBC011703,NA,NA,1ZIHBC011703-09,NCI:1417383\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,9692363 (contact),"LEE, MAXWELL  (contact)",NA,NA,NA,Bioinformatics;bisulfite sequencing;Breast Cancer Model;Cancer Etiology;ChIP-seq;Chromatin Interaction Analysis by Paired-End Tag Sequencing;Collaborations;Complex;Computing Methodologies;Data;Data Analyses;Data Set;deep learning;dynamic system;empowerment;Epigenetic Process;exome sequencing;Gene Expression;Genetic;genetic analysis;Genome;genome sequencing;genomic data;Germ-Line Mutation;Goals;Image;improved;insight;interest;Machine Learning;mathematical model;Melanoma;metabolomics;Metastatic Neoplasm to the Lung;Methylation;Modeling;Molecular;Mus;Neoplasm Metastasis;Patients;Post-Transcriptional Regulation;Primary Neoplasm;Proteomics;Public Domains;Research;Research Personnel;RNA immunoprecipitation sequencing;Series;Somatic Mutation;The Cancer Genome Atlas;Tissues;transcriptome sequencing;treatment response;tumor progression;Variant;whole genome;Work,"Integrated analyses of genetics, epigenetics, and gene expression",11703,NA,NA,NA,NA,9,NA,NA,1417383,NA
11188856,ZIH,CA,1,N,NA,NA,NA,NA,ZIHBC012005,NA,NA,1ZIHBC012005-05,NCI:171251\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,77857449 (contact),"YOUKHARIBACHE, PHILIPPE  (contact)",NA,NA,NA,3-Dimensional;Algorithms;Amino Acid Transporter;Animals;Anti-viral Agents;Anti-viral Therapy;Antibodies;Antibody Binding Sites;antibody engineering;Antigens;betacoronavirus;Big Data;Binding;Biology;CCL21 gene;CD28 gene;CD8B1 gene;Cell membrane;Cell Surface Proteins;Cell Surface Receptors;Cells;chimeric antigen receptor;chimeric antigen receptor T cells;Clinical Trials;Code;Collaborations;Communities;computational platform;Computer software;CTLA4 gene;Data;data repository;Data Science;data sharing;data streams;data visualization;Databases;design;Development;diverse data;Ecosystem;Education;Engineering;Epitopes;extracellular;Extramural Activities;frontier;Funding;gene product;Genes;Goals;Grant;Group Structure;Grouping;Heart;Human;Human Genome;Immune system;Immunoglobulin Domain;immunological synapse;Immunooncology;Immunotherapeutic agent;Immunotherapy;improved;in silico;In Vitro;in vivo;Individual;inhibitor;innovation;Knowledge;Ligands;Light;Link;Machine Learning;meetings;Methods;Mining;Molecular;nanobodies;novel strategies;Nutrient;open source;Pathway interactions;Pattern;Printing;programmed cell death ligand 1;programmed cell death protein 1;programs;Property;Protein Conformation;protein data bank;Protein Databases;protein protein interaction;protein structure prediction;Proteins;Proteome;Protocols documentation;receptor;Reproducibility;Research;Retroviridae;Route;SARS-CoV-2 antibody;Schedule;Scheme;scientific computing;Signal Transduction;software development;structural biology;Structure;Surveys;System;T-Lymphocyte;Techniques;Tertiary Protein Structure;Therapeutic;Time;tool;Trust;United States National Institutes of Health;United States National Library of Medicine;Viral Proteins;Visualization;web based software;web platform,Structural data science methods and software to study immunotherapeutic proteins,12005,NA,NA,NA,NA,5,NA,NA,171251,NA
11188857,ZIH,CA,1,N,NA,NA,NA,NA,ZIHBC012032,NA,NA,1ZIHBC012032-04,NCI:1958200\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,78858342 (contact),"TURKBEY, BARIS  (contact)",NA,NA,NA,anti-cancer research;Artificial Intelligence;artificial intelligence algorithm;artificial intelligence model;Bladder;cancer imaging;CCR;Clinical Data;Clinical Informatics;Computers;Data;Data Set;Development;digital;digital pathology;Endoscopy;Environment;experience;high end computer;High Performance Computing;Histology;Image;imaging biomarker;instrument;interest;Laboratories;Lead;Leadership;Malignant neoplasm of lung;Malignant neoplasm of prostate;Medical Imaging;Methods;Multimodal Imaging;NCI Center for Cancer Research;novel;Osteosarcoma;Pathologist;Pathology;Postbaccalaureate;Postdoctoral Fellow;pre-clinical;Prostate;Radiology Specialty;recruit;Research;Research Personnel;Resources;Scanning;Science;Scientist;Slide;supercomputer;Surface;System;touchscreen;Training;tumor microenvironment;United States National Institutes of Health;virtual,CCR Artificial Intelligence Resource,12032,NA,NA,NA,NA,4,NA,NA,1958200,NA
11188858,ZIH,LM,1,N,NA,NA,NA,NA,ZIHLM200888,NA,NA,1ZIHLM200888-16,NLM:366260951\,INTRAMURAL RESEARCH,2024,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL LIBRARY OF MEDICINE,NA,NA,NA,79356308 (contact),"HUERTA, MICHAEL  (contact)",NA,NA,NA,2019-nCoV;Acceleration;Adoption;African American;Alaska Native population;American Indians;analytical tool;Antimicrobial Resistance;Archival Collection;archive data;Archives;Artificial Intelligence;Asian Americans;automated analysis;Automated Indexing;Awareness;Behavioral;Bioinformatics;Biological;Biomedical Computing;Biomedical Engineering;biomedical informatics;Biomedical Research;Biotechnology;Black American;Books;Catalogs;catalyst;Chemicals;Classification;Clinical;Clinical Data;Clinical Research;clinical trial recruitment;Clinical Trials;ClinVar;cloud based;cloud platform;Code;Collection;Common Core;Common Data Element;Communities;community engagement;comparative;Comparative Genomic Analysis;comparative genomics;Computational Science;computerized data processing;COVID-19;COVID-19 pandemic;Data;Data Analyses;data management;Data Science;Data Set;data standards;Data Storage and Retrieval;data submission;Databases;Development;digital;digital medicine;Discipline;disorder prevention;diverse data;DNA Sequence;Drug Labeling;Early Intervention;Economics;Ecosystem;Electronic Health Record;electronic health record system;Electronics;Emergency response;Ensure;Environmental Health;Epidemiology;Escherichia coli;exhibitions;experience;Family;Food Safety;foodborne illness;foodborne pathogen;Frequencies;Funding;Genbank;gender minority health;generative artificial intelligence;Genetic;Genome;genome annotation;genome resource;genome sequencing;genomic data;Genomics;Global Awareness;Goals;Government;Health;health data;health disparity;health equity;health management;Health Professional;Health Promotion;Health Services;Health Services Research;Health Technology;Healthcare;Hispanic;History of Medicine;Human;Human Genetics;Human Genome;Image;improved;indexing;Individual;Information Dissemination;Information Services;Information Systems;Infrastructure;innovation;Institution;Interlibrary Loans;International;Internet;interoperability;Intramural Research Program;journal article;Journals;knowledgebase;Latino;Leadership;lectures;Libraries;Listeria;Literature;Logical Observation Identifiers Names and Codes;Machine Learning;machine learning algorithm;Malignant Neoplasms;Manuscripts;Maps;Medical;Medical Device;Medical Informatics;Medical Libraries;Medicine;MEDLINE;MedlinePlus;MeSH Thesaurus;Metadata;Methods;Modeling;Modernization;Molecular Biology;Molecular Genetics;Mutation;online resource;open data;operation;Organism;outreach;Pacific Islander;pathogen;Pathogen detection;Patients;Performance;Persons;Pharmaceutical Preparations;Phenotype;Pilot Projects;Play;Policies;Population;Positioning Attribute;preservation;Prevention Measures;Printing;Process;programs;Proteins;Protocols documentation;Provider;Public Health;public health emergency;Publishing;PubMed;quality assurance;Readability;Recording of previous events;Records;Reduce health disparities;Reporting;repository;Research;research and development;Research Personnel;research study;Research Support;Resources;Retrieval;Role;Route;Salmonella;Sampling;Science;Scientific Advances and Accomplishments;scientific computing;Security;Sequence Read Archive;Services;Sexual and Gender Minorities;social;Source;Strategic Planning;System;Systematized Nomenclature of Medicine;Techniques;Technology;Terminology;Text;Time;tool;Training;training data;Transcript;Translating;Travel;Trust;Underrepresented Populations;United States National Institutes of Health;United States National Library of Medicine;Update;Vaccines;Variant;Visualization;web services;web site;Women&apos;s Health,National Biomedical Information Services,200888,NA,NA,NA,NA,16,NA,NA,366260951,NA
11188859,ZII,CA,1,N,NA,NA,NA,NA,ZIIBC011234,NA,NA,1ZIIBC011234-16,NCI:2282940\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,10274929 (contact),"HENDERSON, DARREN  (contact)",NA,NA,NA,Animals;Architecture;Biological;CCR;Chemistry;design;Goals;Leadership;Outsourcing;Procedures;Recommendation;Research Personnel;Resources;Services;Strategic Planning,CCR New Space Activation,11234,NA,NA,NA,NA,16,NA,NA,2282940,NA
11188860,ZII,DC,1,N,NA,NA,NA,NA,ZIIDC000099,NA,NA,1ZIIDC000099-01,NIDCD:980353\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,NA,NA,79350266 (contact),"LEVY, JOSHUA  (contact)",NA,NA,NA,Address;Affect;Ambulatory Care Facilities;Attention;Awareness;Behavior;Biological;Chemicals;Clinic;Clinical;clinical center;clinical practice;Collaborations;Communication;Communities;Comprehensive Health Care;Consultations;COVID-19 pandemic;Dedications;Diagnostic;Disease;Education;Education and Outreach;Evaluation;Event;evidence base;Fostering;Goals;Health;Health Professional;Hospitals;Human;improved;Individual;innovation;insight;Interdisciplinary Study;Intervention;Knowledge;Laboratory Research;Magnetic Resonance Imaging;Mission;Molecular;National Institute on Deafness and Other Communication Disorders;Natural History;news;nutrition;Olfaction Disorders;Outcome Measure;outpatient facility;outreach;Patient Care;patient oriented;Patient Outcomes Assessments;Patients;Personal Satisfaction;Preventive measure;Protocols documentation;Quality of life;Rehabilitation therapy;Research;Research Personnel;Resources;Science;Sensory;Sensory Disorders;Services;Smell Perception;Taste Disorders;Taste Perception;Therapeutic;Training Programs;United States National Institutes of Health;Work,Space Activation - Clinical Director - National Taste & Smell,99,NA,NA,NA,NA,1,NA,NA,980353,NA
11188861,ZIJ,CA,1,N,NA,NA,NA,NA,ZIJBC011133,NA,NA,1ZIJBC011133-16,NCI:160787\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,8778166 (contact),"GULLEY, JAMES L. (contact)",NA,NA,NA,Acceleration;anti-cancer research;Basic Science;Biomedical Research;career;Clinical Research;Disparity population;Environment;experience;graduate student;Institution;interest;Laboratories;Laboratory Research;Malignant Neoplasms;Mentors;NCI Center for Cancer Research;next generation;Population;Postbaccalaureate;programs;Quality of life;Reporting;Research;Research Personnel;Scholars Program;Science;skills;Students;summer internship;summer program;Talents;Technology;Training;Training and Education;training opportunity;Training Programs;Translational Research;undergraduate student;Underrepresented Minority;Underrepresented Populations;United States National Institutes of Health;Universities;virtual,CCR Office of Training and Education,11133,NA,NA,NA,NA,16,NA,NA,160787,NA
11188862,ZIJ,CA,1,N,NA,NA,NA,NA,ZIJBC011285,NA,NA,1ZIJBC011285-15,NCI:830384\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,14732225 (contact),"BRONEZ, MELISSA  (contact)",NA,NA,NA,Advocate;Awareness;career;CCR;clinical center;Clinical Research;clinical training;Clinical Trials;Communication;Communities;Congresses;Development;Division of Cancer Epidemiology and Genetics;Division of Cancer Treatment and Diagnosis;Education and Outreach;Employee;Ensure;Facebook;Government;Instagram;interest;Internet;Interview;Intramural Research;Journals;LinkedIn;Malignant Neoplasms;Medical;Mission;Multimedia;news;Paper;Peer Review;Press Releases;Printing;Production;programs;Publications;recruit;Research;research faculty;Research Personnel;Research Training;Scientific Advances and Accomplishments;social media;Taxes;Twitter;United States National Institutes of Health;Visit;web site;Work;Writing,CCR Education and Outreach,11285,NA,NA,NA,NA,15,NA,NA,830384,NA
11188863,ZIJ,CA,1,N,NA,NA,NA,NA,ZIJBC012189,NA,NA,1ZIJBC012189-01,NCI:584594\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79972534 (contact),"CLARK, SHAUNA  (contact)",NA,NA,NA,Affinity;Amaze;American Association of Cancer Research;anti-cancer research;Area;Asian Americans;Award;Awareness;Biomedical Research;career;CCR;Clinical Trials;Collaborations;Communication;community building;Data;Development;disability;Discipline;Educational workshop;Effectiveness;Equity;Event;experience;Faculty;Faculty Recruitment;Feedback;Fostering;Funding;Goals;Health Disparities Research;health disparity;Heme;improved;Institution;interest;Interest Group;Intervention;Interview;Learning;Lived experience;Measures;meetings;Mentors;Minority;Modeling;news;Newsletter;outreach;Policies;Population;Procedures;Process;programs;Published Comment;recruit;Research;Research Personnel;Resources;Science;Scientist;screening;Series;Standardization;Surveys;symposium;Talents;Time;Training;Travel;Universities;Vision;Visit;web site;Work,Office of Equity and Inclusion,12189,NA,NA,NA,NA,1,NA,NA,584594,NA
11188864,ZIJ,CL,1,N,NA,NA,NA,NA,ZIJCL090044,NA,NA,1ZIJCL090044-08,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,15187036 (contact),"SEAM, NITIN  (contact)",NA,NA,NA,Agreement;Baltimore;Caring;cohort;Critical Care;Data;Databases;Dedications;Development;District of Columbia;Education;Educational Curriculum;Educational process of instructing;effectiveness evaluation;Enrollment;Fellowship;Fellowship Program;follow-up;Funding;Goals;Health;Hospitals;improved;Institution;Journals;Knowledge;Learning;Lung;Manuscripts;Maryland;Mechanical ventilation;Modeling;Paper;Participant;patient safety;Patients;Peer Review;Performance;performance tests;Persons;Physiology;Procedures;programs;Publications;Publishing;Research;respiratory;Respiratory physiology;simulation;Statistical Data Interpretation;Surveys;Testing;Time;Training;Training Programs;United States National Institutes of Health;Universities;ventilation;Ventilator;Virginia;virtual;Washington,Master Level Learning,90044,NA,NA,NA,NA,8,NA,NA,0,NA
11188865,ZIK,CA,1,N,NA,NA,NA,NA,ZIKBC010857,NA,NA,1ZIKBC010857-18,NCI:4640052\,INTRAMURAL RESEARCH,2024,NATIONAL CANCER INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,DIVISION OF BASIC SCIENCES - NCI,NA,NA,NA,79972425 (contact),"MALIK, MARIAM  (contact)",NA,NA,NA,Acceleration;Agreement;anti-cancer research;Area;assay development;Bioinformatics;bioinformatics tool;Biological;Biological Assay;biomarker development;biomarker identification;Biomedical Research;Biotechnology;Budgets;CCR;clinical application;Clinical Research;Collaborations;Communities;Complex;Computer software;Contracts;cost;Cost Savings;Data;Data Analyses;Databases;Dedications;Dideoxy Chain Termination DNA Sequencing;digital;Dissection;E-learning;Educational Curriculum;Educational process of instructing;Educational workshop;Emerging Technologies;Event;experimental study;Funding;Funding Mechanisms;Future;Gene Expression Profiling;Genomics;Growth;high throughput analysis;high throughput technology;Human Resources;Image;Imaging technology;Individual;Informatics;insight;Investments;Journals;Laboratories;Licensing;Mammalian Cell;Mediation;metabolomics;Modeling;nano-string;nanoscale;new technology;next generation sequencing;Pathway interactions;preservation;Principal Investigator;Private Sector;programs;Protein Analysis;protein expression;Proteins;Proteomics;Provider;Publications;Quality Control;Reporting;Research;Research Personnel;Resources;response;Sampling;Science;Scientific Advances and Accomplishments;Scientist;Services;Signal Transduction;single cell analysis;single cell genomics;skills;Software Tools;Statistical Data Interpretation;Strategic Planning;success;System;Technology;Technology Transfer;therapeutic target;Time;timeline;Training and Education;training opportunity;Training Programs;transcriptomics;Transfer Agreement;Translational Research;tumor heterogeneity;tumor microenvironment;United States National Institutes of Health;Visualization;Work,Science and Technology Resources,10857,NA,NA,NA,NA,18,NA,NA,4640052,NA
11188936,N02,CA,NA,N,NA,NA,NA,NA,75N91021D00017,NA,NA,75N91021D00017-P00002-759102200006-1,NCI:4601249\,NON SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,CALVERTON,UNITED STATES,NA,04,083656892,US,1069201,"INFORMATION MANAGEMENT SERVICES, INC.",MD,207053407,NA,78865936 (contact),"RILEY, THOMAS  (contact)",NA,2022-09-22,2025-09-21,Data Reporting;Databases;Division of Cancer Prevention;Informatics;Information Technology,INFORMATION TECHNOLOGY AND INFORMATICS SUPPORT TO THE DIVISION OF CANCER PREVENTION.,0,NA,NA,NA,NA,NA,NA,NA,4601249,NA
11188937,N02,DA,NA,N,NA,NA,NA,NA,75N95023P00850,NA,NA,75N95023P00850-P00001-0-1,NINDS:3820\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,WALTHAM,UNITED STATES,NA,NA,NA,US,NA,NA,MA,02451,Regulatory affairs support for the development of biologics therapies for central nervous system disorders.,79371732 (contact),"BRADEL, ROMAN  (contact)",NA,2023-09-19,2025-09-18,Biological Response Modifier Therapy;Central Nervous System Diseases;Development;Regulatory Affairs;Services,REGULATORY AFFAIRS CONSULTANT SUPPORT SERVICES,0,NA,NA,NA,NA,NA,NA,NA,3820,NA
11188939,N01,CA,NA,N,NA,NA,NA,NA,261201700012I,NA,NA,261201700012I-P00009-26100002-2,NCI:3125784\,NON SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,SAN JOSE,COSTA RICA,NA,NA,853088008,CS,10011285,FUNDACION INCIENSA,NA,10108,NA,78846463 (contact),"PORRAS, CAROLINA  (contact)",NA,2018-04-06,2025-09-15,Area;Cervical;cervical cancer prevention;Contracts;cost;Costa Rica;Dose;follow-up;Funding;girls;Human papilloma virus infection;Human Papilloma Virus Vaccination;Human Papilloma Virus Vaccine;Human Papilloma Virus-Related Malignant Neoplasm;Human papillomavirus 16;Immunization;Lesion;Malignant neoplasm of cervix uteri;mortality;Participant;Phase;premalignant;prevent;prophylactic;Recommendation;Regimen;Risk;Running;Safety;Schedule;Vaccinated;vaccine acceptance;vaccine evaluation;vaccine trial,FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS_ Cures funded,0,NA,NA,NA,NA,NA,NA,NA,3125784,NA
11189039,P50,MD,3,N,2024-09-17,2024-07-01,2025-06-30,NA,P50MD017366,NA,PA-23-189,3P50MD017366-04S1,NIMHD:26797\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,LOS ANGELES,UNITED STATES,NA,36,092530369,US,577505,UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,900952000,NA,7754727;2436979 (contact),"BODEN-ALBALA, BERNADETTE MARIE;BROWN, ARLEEN F. (contact)","STINSON, NATHANIEL",2021-09-24,2026-06-30,Address;Affect;Area;Award;California;Cardiometabolic Disease;cardiometabolism;career;Caring;catalyst;Chronic Disease;Chronic Kidney Failure;Collaborations;Communication;Communities;community engagement;community partners;County;Data Collection;data harmonization;data sharing;data standards;Development;Diabetes Mellitus;disease disparity;Disparity;disparity elimination;Ensure;Equipment;Equity;Ethnic Population;Evaluation;Funding;Grant;health equity;Hypertension;Infrastructure;Institution;interest;Intervention;Lead;Leadership;Los Angeles;Measurement;medically underserved;meetings;Mentors;Monitor;multi-ethnic;multiple chronic conditions;National Institute on Minority Health and Health Disparities;Oranges;Patients;Pilot Projects;Prevention;Procedures;programs;Protocols documentation;Recommendation;recruit;Research;Research Personnel;Resources;Risk Factors;safety net;Secure;social health determinants;Stroke;Structure;Training;United States National Institutes of Health;Vulnerable Populations,Admin Core,17366,ZMD1,ZMD1,8337,S1,4,21267,5530,NA,26797
11189040,P50,MD,3,N,2024-09-17,2024-07-01,2025-06-30,NA,P50MD017366,NA,PA-23-189,3P50MD017366-04S1,NIMHD:26797\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,LOS ANGELES,UNITED STATES,NA,36,092530369,US,577505,UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,900952000,NA,6842791;9443546 (contact),"SORKIN, DARA H.;WASHINGTON, DONNA  (contact)","STINSON, NATHANIEL",2021-09-24,2026-06-30,Acceleration;Active Learning;Affect;analytical method;Annual Reports;Behavioral;Behavioral Sciences;Biological;built environment;California;Cardiometabolic Disease;cardiometabolism;career;career development;Chronic Disease;cognitive interview;Communities;Community Health;Community Participation;Complex;Data;Development;Disadvantaged;disease disparity;Disparity;Early identification;Elements;Environment;Equity;ethnic minority;Ethnic Population;Evolution;experience;Exposure to;Faculty;Focus Groups;Funding;Goals;Group Interviews;Health Disparities Research;health disparity;Healthcare Systems;improved;Individual;innovation;Intervention;Leadership;Learning;learning community;low socioeconomic status;Measurement;Measures;Mentors;Mentorship;Methodology;Methods;Minority Health Research;Modification;Motivation;multi-ethnic;National Institute on Minority Health and Health Disparities;Nature;next generation;Personality;Pilot Projects;Population Heterogeneity;Populations at Risk;Postdoctoral Fellow;Procedures;Process;Program Research Project Grants;programs;racial minority;Research;Research Personnel;Research Project Grants;Resources;Risk Factors;Role;Science;Scientist;secondary analysis;Shapes;social;social cognitive theory;social culture;Structure;success;Talents;theories;tool;Training;Training Programs;Underrepresented Populations;United States National Institutes of Health;Work,Investigator Development Core,17366,ZMD1,ZMD1,8338,S1,4,21267,5530,NA,26797
11189041,P50,MD,3,N,2024-09-17,2024-07-01,2025-06-30,NA,P50MD017366,NA,PA-23-189,3P50MD017366-04S1,NIMHD:26796\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,LOS ANGELES,UNITED STATES,NA,36,092530369,US,577505,UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,900952000,NA,8070940 (contact);8062971,"NORRIS, KEITH C (contact);TANJASIRI, SORA P","STINSON, NATHANIEL",2021-09-24,2026-06-30,Address;Advocacy;Award;Awareness;Behavioral;Behavioral trial;Biological;Cardiometabolic Disease;cardiometabolism;catalyst;Chronic;Clinical;Clinical Trials;Collaborations;Communication;Communities;community academic partnership;Community Actions;community based participatory approach;Community Developments;community engaged approach;community engaged research;community engagement;Community Health;community organizations;community partnership;community planning;County;Development;Diabetes Mellitus;Disparity;disparity reduction;Enrollment;Environment;Equity;Ethnic Origin;Ethnic Population;experience;Feedback;Foundations;Goals;health disparity;health equity;Health Promotion and Education;Health system;Hypertension;improved;Individual;Inequity;Infrastructure;innovation;Institution;Intervention;Knowledge;leadership development;Lived experience;Los Angeles;Mediating;member;Methods;Morbidity - disease rate;mortality;multi-ethnic;National Institute on Minority Health and Health Disparities;next generation;novel;novel strategies;Oranges;Outcome;Participant;Patients;peer;Pilot Projects;Policies;Policy Maker;Policy Making;policy recommendation;Prevention;Prevention approach;Process;Recommendation;recruit;Reduce health disparities;Research;Research Personnel;Research Project Grants;Resources;Risk Factors;Risk Reduction;social;social culture;social determinants;Solid;Stroke;structural health determinants;Structure;System;Techniques;Training;Translations;Trust;Voice;Vulnerable Populations;Work,Community Engagement Core,17366,ZMD1,ZMD1,8339,S1,4,21267,5529,NA,26796
11189042,P50,MD,3,N,2024-09-17,2024-07-01,2025-06-30,NA,P50MD017366,NA,PA-23-189,3P50MD017366-04S1,NIMHD:26796\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,LOS ANGELES,UNITED STATES,NA,36,092530369,US,577505,UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,900952000,NA,10327925 (contact);10328590,"CASILLAS, ALEJANDRA  (contact);TOWFIGHI, AMYTIS","STINSON, NATHANIEL",2021-09-24,2026-06-30,"Accounting;Address;Adult;African American;Ambulatory Care;Asian Americans;Asian population;Awareness;Black Populations;Black race;Blood Pressure;blood pressure control;Blood Pressure Monitors;blood pressure reduction;cardiology service;cardiometabolism;cardiovascular health;cardiovascular risk factor;Cardiovascular system;Caring;chronic care model;Chronic Disease;Clinic;Clinical;Communities;Community Health Aides;community partnership;community-level factor;Complex;County;COVID-19 pandemic;Data;design;diet and exercise;digital health;Disease;Disparity;disparity reduction;Education;Education and Outreach;Educational Materials;Equity;ethnic disparity;ethnic diversity;ethnic minority population;Ethnic Origin;Ethnic Population;Event;experience;federal poverty level;Filipino American;Health;Health behavior;health care availability;health disparity;health equity;health literacy;Health Services;Health system;Healthcare Systems;High Prevalence;Hispanic;Home Blood Pressure Monitoring;Hospitals;Hypertension;improved;improved outcome;Income;Individual;innovation;Institutional Racism;Intervention;Latino;Latino Population;Limited English Proficiency;Linguistics;literacy;Los Angeles;Low income;low socioeconomic status;Mediator;medical specialties;medication compliance;Medication Management;Mexican Americans;mortality;multi-ethnic;multi-racial;Municipalities;Myocardial Infarction;Myocardial Ischemia;National Heart, Lung, and Blood Institute;Neurology;novel;operation;Participant;patient level intervention;patient portal;Patients;Pharmaceutical Preparations;Pharmacists;Population;post stroke;preventable death;Prevention trial;primary outcome;Primary Prevention;Public Health;Race;racial disparity;racial diversity;racial minority population;Randomized;randomized trial;Randomized, Controlled Trials;Recording of previous events;Recurrence;Research Personnel;Risk;Risk Reduction;safety net;Self Management;skills;social health determinants;socioeconomic disparity;Stroke;System;team-based care;Technology;telehealth;Testing;traditional care;treatment as usual;United States;video visit;vulnerable community;wireless fidelity","BP REACH: Blood Pressure disparities Reduction, Equity, and Access among safety net patients with Cardiovascular Health risk",17366,ZMD1,ZMD1,8340,S1,4,21267,5529,NA,26796
11189043,P50,MD,3,N,2024-09-17,2024-07-01,2025-06-30,NA,P50MD017366,NA,PA-23-189,3P50MD017366-04S1,NIMHD:26795\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,LOS ANGELES,UNITED STATES,NA,36,092530369,US,577505,UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,900952000,NA,7754727 (contact),"BODEN-ALBALA, BERNADETTE MARIE (contact)","STINSON, NATHANIEL",2021-09-24,2026-06-30,"Achievement;Address;Adult;Advocacy;Affect;American Heart Association;Area;behavior change;Behavior Therapy;Behavioral;Biological Process;Black Populations;Blood Pressure;Blood Pressure Monitors;blood pressure reduction;Blood Vessels;California;cardiometabolism;Cardiovascular Diseases;cardiovascular disorder prevention;cardiovascular disorder risk;cardiovascular health;cardiovascular risk factor;Cause of Death;Cessation of life;Child;clinically significant;Color;Communication;Communities;community based participatory research;community engagement;Community Health;Community Health Aides;community intervention;Cost Savings;County;Data;Development;disability;Disparity;disparity gap;Economics;Education;Effectiveness;efficacy evaluation;efficacy testing;empowerment;Equity;ethnic disparity;Ethnic Population;Event;Family;family structure;Growth;Health;health equity;heart disease risk;Heart Diseases;Household;Hypertension;hypertension prevention;improved;Individual;Intervention;Latino;Latino Population;Learning;Life;Life Style;Link;Measures;Modeling;mortality;multi-ethnic;Multilingualism;Myocardial Infarction;novel;Oranges;Participant;Patients;Physical environment;Population;Population Heterogeneity;prevent;Prevention;prevention effectiveness;Prevention strategy;Primary Prevention;programs;Provider;provider communication;Psychological reinforcement;Race;racial disparity;Randomized, Controlled Trials;reinforced behavior;Research;residential segregation;Risk;Risk Factors;risk perception;Risk Reduction;Self Efficacy;Shapes;skills;social;social capital;social determinants;social movement;Social Network;Social Processes;social structure;socioeconomic disparity;socioeconomics;Stroke;support network;technological innovation;Testing;Translating;treatment adherence;treatment as usual;Underserved Population;Vascular Diseases;Vietnamese;web portal;Work;young adult;Youth",UCLA-UCI Center for Eliminating Cardio-Metabolic Disparities in Multi-Ethnic Populations,17366,ZMD1,ZMD1,8341,S1,4,21266,5529,NA,26795
11189075,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000069,NA,NA,1ZIADA000069-09,NIDA:2428804\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,14747538 (contact),"MICHAELIDES, MICHAEL  (contact)",NA,NA,NA,abuse liability;addiction;Address;Agonist;Animal Model;Animals;Area;Autopsy;Behavior;Behavioral;Binding;biobehavior;Bioinformatics;Biological;Brain;Clinical Research;Clinical Treatment;clinically relevant;Cocaine;comorbidity;designer receptors exclusively activated by designer drugs;Development;Disease;Dopamine;dopamine transporter;drug of abuse;Economic Burden;enantiomer;Environment;FDA approved;Genetic;genetic technology;Goals;Human;Image;imaging approach;imaging modality;Imaging technology;in vivo;innovation;Investigational Drugs;Ketamine;Knowledge;Ligands;Methadone;Methods;Molecular;molecular dynamics;molecular imaging;Molecular Neurobiology;mu opioid receptors;neurobiological mechanism;Neurobiology;neuropsychopharmacology;neuroregulation;neurotransmission;novel;Opioid;Opioid agonist;Opioid Receptor;optical imaging;optogenetics;Pathologic;pharmacologic;Pharmacology;Pharmacotherapy;Positron-Emission Tomography;programs;Psychological reinforcement;Role;Substance abuse problem;Substance Use Disorder;substance use treatment;Synapses;System;Technology;theranostics;Therapeutic;Tissues;Tracer;Transgenic Organisms;Translating;Translational Research;United States National Institutes of Health;Zinc,Biobehavioral Imaging and Molecular Neuropsychopharmacology of Substance Abuse Mechanisms,69,NA,NA,NA,NA,9,NA,NA,2428804,NA
11189076,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000550,NA,NA,1ZIADA000550-16,NIDA:2580126\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,8183590 (contact),"IKEMOTO, SATOSHI  (contact)",NA,NA,NA,Amygdaloid structure;Anterior;anterior commissure;Behavior;Behavioral;Brain region;Calcitonin Gene-Related Peptide;Calcitonin-Gene Related Peptide Receptor;Cell Nucleus;Data;designer receptors exclusively activated by designer drugs;Dose;drug seeking behavior;drug withdrawal;Electrophysiology (science);emotional symptom;Emotions;fear memory;Fiber;FOS gene;Genetic;Glutamates;Hour;Injections;interstitial;Lateral;Limb structure;Minor;Morphine;morphine administration;motivated behavior;Motivation;Motor Activity;mu opioid receptors;Mus;Naloxone;negative affect;neural;neuromechanism;Neurons;Neurophysiology - biologic function;opioid withdrawal;optogenetics;Pain;parabrachial nucleus;Photometry;Play;Population;preference;Procedures;Rewards;Role;subcutaneous;Subgroup;Symptoms;Withdrawal;Withdrawal Symptom,Correlates of motivation and reward,550,NA,NA,NA,NA,16,NA,NA,2580126,NA
11189077,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000552,NA,NA,1ZIADA000552-16,NIDA:3629955\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,79972952 (contact),"CADET, JEAN LUD  (contact)",NA,NA,NA,Abstinence;Adult;Animals;Behavior;Behavioral;Brain;Brain region;Cell Adhesion Molecules;Chronic;Corpus striatum structure;craving;Development;diagnostic criteria;Disease susceptibility;Dopamine;Dopamine D1 Receptor;Dopamine Receptor;Dorsal;Dose;Gene Expression;Genetic Transcription;HDAC2 gene;High Pressure Liquid Chromatography;High Prevalence;Histone Deacetylase;Incubated;Individual;inhibitor;Intake;Legal;Medical;Messenger RNA;Methamphetamine;methamphetamine exposure;methamphetamine use;Methamphetamine use disorder;methamphetamine user;Modeling;Names;neurotoxicity;Pharmaceutical Preparations;Polyadenylation;psychostimulant;Punishment;Rattus;Relapse;Resistance;Self Administration;sex;Shock;social;Substance Use Disorder;transcriptome sequencing,Neurotoxicity in the adult rat following chronic exposure to methamphetamine,552,NA,NA,NA,NA,16,NA,NA,3629955,NA
11189078,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000566,NA,NA,1ZIADA000566-15,NIDA:879029\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,8183696 (contact),"KIYATKIN, EUGENE A (contact)",NA,NA,NA,Analgesics;Attenuated;awake;Brain;Coupled;Dose;Drug Contamination;Electrophysiology (science);Exposure to;extracellular;Fentanyl;Heroin;Hyperoxia;Hypoxia;Intravenous;Naloxone;Opioid;Oxygen;Pattern;Pharmaceutical Preparations;Phase;Rattus;response;sensor;Speed;Testing;Therapeutic;Xylazine,Electrophysiological and electrochemical studies of addictive drugs,566,NA,NA,NA,NA,15,NA,NA,879029,NA
11189079,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000587,NA,NA,1ZIADA000587-13,NIDA:4996144\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,11592808 (contact),"SCHOENBAUM, GEOFFREY  (contact)",NA,NA,NA,addiction;Address;Affect;Animal Model;antagonist;Area;Association Learning;Behavior;Behavioral;Brain;cocaine use;Collaborations;comorbidity;cue reactivity;Data;Decision Making;Dependence;Dopamine;dopamine system;dopaminergic neuron;drug of abuse;Educational process of instructing;expectation;Goals;graduate school;Human;insight;Intervention;Learning;Left;Link;Mediating;medical schools;meetings;Modeling;multithreading;neural;neural circuit;Neurons;neuropsychiatric disorder;Opiate Addiction;Paper;Pharmaceutical Preparations;Positioning Attribute;Postdoctoral Fellow;predictive modeling;Process;programs;Publishing;Rattus;Research;Rodent;Role;Sensory;Signal Transduction;Substance Use Disorder;System;tenure track;Work,"Associative learning, decision-making, and addiction",587,NA,NA,NA,NA,13,NA,NA,4996144,NA
11189080,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000595,NA,NA,1ZIADA000595-12,NIDA:2621754\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,78379856 (contact),"APONTE, YEKA  (contact)",NA,NA,NA,Action Potentials;addiction;Affect;Anorexia;Anterior;Appetitive Behavior;Attention;Attenuated;awake;Behavior;Behavioral Assay;Behavioral Paradigm;Biological Models;Body Weight decreased;Bulimia;Calcium-Binding Proteins;Cell Physiology;cell type;Collection;Diabetes Mellitus;Disease;Drug abuse;drug of abuse;Eating;Eating Disorders;Electrophysiology (science);experimental study;feeding;Feeding behaviors;Feeling;Fluorescence;Food;Genetic;Glutamates;Hunger;Hyperphagia;Hypothalamic structure;Individual;interest;Laboratories;Lateral;Learning;leptin receptor;microendoscopy;Midbrain structure;Motivation;Mus;Nature;neuronal circuitry;Neurons;Nociception;Obesity;Opiate Addiction;Opioid;optogenetics;pain behavior;Parvalbumins;Pattern;Peptides;Population;Property;Regulation;Rewards;Satiation;Stimulus;Structure of nucleus infundibularis hypothalami;Synapses;therapeutic target;Weight Gain;Work,Hypothalamic neuronal circuits controlling survival behaviors,595,NA,NA,NA,NA,12,NA,NA,2621754,NA
11189081,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000602,NA,NA,1ZIADA000602-10,NIAAA:2823151\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,14282527 (contact),"KOOB, GEORGE  (contact)",NA,NA,NA,addiction;Adrenergic Agonists;Adrenergic Antagonists;Agonist;Amygdaloid structure;Analgesics;Animals;antagonist;Anti-Anxiety Agents;anti-depressive agents;anti-fungal agents;Anti-Inflammatory Agents;Antioxidants;Anxiety;Anxiety Disorders;anxiety-like behavior;Attenuated;basal forebrain;base;Behavior;beta-2 Adrenergic Receptors;Biological Assay;Brain;Brain Diseases;Brown Fat;Buprenorphine;burden of illness;Castor Oil;Cell Nucleus;Chlordiazepoxide;Chronic;Clinical;clinical development;Clinical Trials;Cocaine;cocaine exposure;cocaine self-administration;Cocaine use disorder;CRF receptor type 1;cysteinyltyrosine;Data;Diet;diet-induced obesity;disability;Dose;Drug Addiction;Drug Targeting;Drug usage;Eating;Elements;emotion regulation;Emotional;Emotions;endogenous opioids;Fatty acid glycerol esters;Feeding behaviors;Female;Gene Deletion;Gene Expression;ghrelin;ghrelin receptor;glucose metabolism;glucose uptake;Glutamates;Goals;heat stimulus;Heroin;Heroin Dependence;Hormones;Hour;Human;Hyperalgesia;Hypothalamic structure;intraperitoneal;Intravenous;kappa opioid receptors;Ketamine;Laboratories;Ligands;Locomotion;lofexidine;male;Measures;mechanical stimulus;Mechanics;Mental Depression;Mental disorders;Metabotropic Glutamate Receptors;Methadone;MK801;Molecular;Mood Disorders;Motivation;mu opioid receptors;Mus;N-Methyl-D-Aspartate Receptors;Naloxone;Naltrexone;negative emotional state;neural circuit;neuroadaptation;Neurobiology;neuron development;Neuropeptides;Neurotransmitters;new therapeutic target;Nociception;nociceptive response;non-opioid analgesic;norbinaltorphimine;novel;Nucleus Accumbens;Obesity;Ondansetron;Opioid;Opioid agonist;Opioid Antagonist;Opioid Peptide;Opioid Receptor;opioid use;opioid withdrawal;Oral;Output;oxidation;Oxytocin;Pain;Pain Measurement;pain relief;pain sensitivity;Pharmaceutical Preparations;pharmacologic;Pharmacological Treatment;Physiological;Play;Positron-Emission Tomography;Pre-Clinical Model;preclinical study;Process;Property;Protocols documentation;Rattus;receptor;Receptor Activation;Recording of previous events;Research;response;Ricinoleic Acids;Role;Saline;Serotonin Receptors 5-HT-3;sex;Stimulus;Stomach;Stress;Structure of terminal stria nuclei of preoptic region;Synaptic plasticity;System;Tail Suspension;Temperature;Testing;Therapeutic;Thermogenesis;Time;transcriptome sequencing;United States Food and Drug Administration;Withdrawal,Neurobiology of Addiction,602,NA,NA,NA,NA,10,NA,NA,2823151,NA
11189082,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000603,NA,NA,1ZIADA000603-10,NIDA:2955121\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,14282518 (contact),"LIN, DA-TING  (contact)",NA,NA,NA,Acute;addiction;Animal Behavior;Animal Model;Animals;Behavior;Behavioral;Brain;Brain region;Calcium;Cocaine;Code;Color;Complex;Computer Analysis;Corpus striatum structure;Custom;Data;design;Development;Dorsal;Drug Addiction;drug relapse;Drug usage;Engineering;Event;Exploratory Behavior;fluorescence microscope;Food;Functional disorder;Generations;Goals;Grain;Hallucinogens;hippocampal pyramidal neuron;Image;imaging system;Imaging Techniques;Imaging technology;Implant;in vivo;in vivo calcium imaging;in vivo imaging;indexing;Interneurons;learned behavior;learning strategy;lens;Liquid substance;Locomotion;machine learning algorithm;Maps;Medial;Methods;Microscope;microscopic imaging;Mission;Mus;National Institute of Drug Abuse;Nature;neural;neural circuit;Neuroglia;neuroimaging;neuronal circuitry;Neurons;Nucleus Accumbens;optical imaging;optogenetics;Pathway interactions;Phencyclidine;Population;Prefrontal Cortex;Rattus;Rewards;Rodent;Science;self supervised learning;social;Strategic Planning;System;Time;tool,Illuminating neural coding mechanisms using in vivo calcium imaging in freely behaving rodents,603,NA,NA,NA,NA,10,NA,NA,2955121,NA
11189083,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000606,NA,NA,1ZIADA000606-10,NIDA:2628749\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,14282522 (contact),"SHI, LEI  (contact)",NA,NA,NA,addiction;Adenylate Cyclase;Adverse effects;Affinity;Agonist;Allosteric Site;Amphetamines;Analgesics;analog;anti-depressive agents;beta-arrestin;Binding;Binding Sites;Biological Assay;Brain;Characteristics;Chemicals;Cocaine;conformational conversion;Cyclic AMP;Data;design;Development;Dissociation;Dopamine Receptor;dopamine transporter;dosage;drug discovery;drug market;drug of abuse;Drug Targeting;Effectiveness;extracellular;Fentanyl;fentanyl analog;Free Energy;G-Protein-Coupled Receptors;Goals;GTP-Binding Proteins;Heroin;high risk;Homologous Gene;Human;Illicit Drugs;Imipramine;In Vitro;Indoles;Infiltration;inhibitor;insight;Intoxication;Lead;Ligand Binding;Ligands;Location;Modeling;Molecular Conformation;molecular dynamics;mu opioid receptors;Nervous System;Nervous System Disorder;Neurons;Neurotransmitters;novel;Opioid;Overdose;overdose death;Pathway interactions;Pharmaceutical Preparations;pharmacologic;Pharmacotherapy;Play;Production;Property;Proteins;Public Health;receptor;recruit;Reporting;Research;Research Subjects;response;Role;scaffold;Series;Serotonin;serotonin transporter;side effect;sigma-1 receptor;Signal Transduction;Signaling Protein;Site;Site-Directed Mutagenesis;small molecule;Structure-Activity Relationship;Substance Use Disorder;Synapses;synergism;synthetic cannabinoid;synthetic opioid;Therapeutic;therapeutic development;therapy development;Toxic effect,"Structural basis for the functions of dopamine receptors, neurotransmitter transporters, and sigma 1 receptor",606,NA,NA,NA,NA,10,NA,NA,2628749,NA
11189084,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000618,NA,NA,1ZIADA000618-08,NIDA:2765624\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,9693010 (contact),"HARVEY, BRANDON  (contact)",NA,NA,NA,addiction;analog;Attenuated;Biological;Bromocriptine;Calcium;Cells;Cellular biology;Cocaine;Coin;Collaborations;Diabetes Mellitus;Dopamine D2 Receptor;ecstasy;Endoplasmic Reticulum;endoplasmic reticulum stress;Enterobacteria phage P1 Cre recombinase;excitotoxicity;FDA approved;Functional disorder;Genes;Glutamates;Goals;high-throughput drug screening;Homeostasis;improved outcome;Journals;KDEL receptor;Laboratories;Liver;Methamphetamine;Modeling;Monitor;mu opioid receptors;Mus;Muscle;National Institute of Drug Abuse;Nerve Degeneration;Neurodegenerative Disorders;Neuronal Dysfunction;Neurons;Neurosciences;novel;Pancreas;Paper;Parkinson Disease;Pharmaceutical Preparations;prevent;Production;Property;Proteins;Publishing;Rat Transgene;Rattus;receptor expression;Reporter;Reporting;Research;response;Role;Stroke;stroke model;Substance abuse problem;Substance of Abuse;Substance Use Disorder;System;Therapeutic;Tissues;tool;Transgenic Mice;Transgenic Organisms;Work,Cellular mechanisms of neuronal dysfunction in addiction and neurodegeneration,618,NA,NA,NA,NA,8,NA,NA,2765624,NA
11189085,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000622,NA,NA,1ZIADA000622-08,NIDA:3360330\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,15265851 (contact),"BRADBERRY, CHARLES  (contact)",NA,NA,NA,addiction;Anatomy;Animals;Area;awake;Bilateral;Brain;Cerebrum;Clinic;Collaborations;contingency management;design;Economics;fluorodeoxyglucose;Focused Ultrasound;Genetic;Goals;imaging approach;imaging study;Impulsivity;Investigation;Manuscripts;Measures;Metabolic Activation;metabolic rate;Milk;Modeling;multimodality;Nature;neural;Neurosciences;non-drug;nonhuman primate;Paper;Pharmaceutical Preparations;pharmacologic;Photic Stimulation;Positron-Emission Tomography;preclinical imaging;Preparation;Primates;programs;remifentanil;Research;Resolution;response;Rewards;Saline;Satiation;Specific qualifier value;Stimulus;System;Technology;Tissues;touchscreen;uptake;visual processing,Multimodal preclinical  imaging studies of decisional determinants of drug vs non-drug choice,622,NA,NA,NA,NA,8,NA,NA,3360330,NA
11189086,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000624,NA,NA,1ZIADA000624-07,NIDA:1066680\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,15666314 (contact),"EPSTEIN, DAVID  (contact)",NA,NA,NA,abuse liability;adaptive intervention;addiction;Address;Agonist;alcohol cue;Annual Reports;antiretroviral therapy;Arousal;Attention;Behavior Control;Behavioral;behavioral and social science;Boredom;Bypass;chronic pain;Collaborations;Collection;comparative;Constipation;craving;Data;Dose;drinking;drug craving;Drug usage;Effectiveness;Environment;Exposure to;Feeling;Goals;HIV;HIV risk;Human;Iatrogenesis;Illicit Drugs;Intervention;Intervention Studies;Laboratories;Laboratory Study;Leadership;Leisures;Life;Link;Measures;medical schools;Memory;mental state;Methadone;Methodology;neighborhood safety;Neighborhoods;Neurobiology;Neurosciences;novel strategies;opioid abuse;Opioid replacement therapy;opioid withdrawal;Outcome;Outcome Assessment;Outcome Measure;Participant;Patients;Persons;Pharmaceutical Preparations;Pharmacologic Substance;Phase;Physiological;Placebos;Predictive Analytics;Prevention;Probability;Procedures;Property;Protocols documentation;Psychiatry;psychologic;psychosocial;Psychosocial Stress;Publishing;Research;Research Design;Research Personnel;respiratory;response;Risk;Risk Behaviors;Risk Factors;Running;Safety;safety testing;Science;Sedation procedure;side effect;Site;Sleep disturbances;social;Social Sciences;Stress;Substance Use Disorder;substance use treatment;Technology;Testing;Therapeutic;therapy adherence;Time;translational study;treatment research;Universities;Vendor;Virginia;wearable device;Work,New approaches to addiction treatment,624,NA,NA,NA,NA,7,NA,NA,1066680,NA
11189087,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000628,NA,NA,1ZIADA000628-06,NIDA:2513285\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,16135727 (contact),"CURTIS, BRENDA  (contact)",NA,NA,NA,addiction;Address;Anxiety;Area;automated intervention;Behavior;behavior observation;Behavioral;Cellular Phone;clinical practice;Clinical Research;Communications Media;Communities;County;Cues;Data;Data Analytics;Data Collection;Data Reporting;Development;Devices;digital;Digital biomarker;digital data;Dimensions;Dropout;drug craving;Epidemic;Event;Exhibits;Feedback;Foundations;Goals;Harvest;health care availability;Health Personnel;imprint;Individual;innovation;insight;Interview;Language;Life;Linguistics;Literature;long term recovery;Machine Learning;Measurement;Measures;Methodology;Methods;Modeling;Monitor;mortality;multimodal data;multimodality;natural language;Natural Language Processing;Nature;novel;opioid overdose;Output;Participant;Patient Self-Report;Patients;Pattern;Pharmaceutical Preparations;predictive modeling;Prevention strategy;prospective;psychologic;Psychometrics;Public Health;public health research;Publications;Recovery;Relapse;relapse prediction;relapse prevention;relapse risk;Reporting;Research;Risk;Role;Self Efficacy;sensor;social media;Social support;sociodemographics;Source;Stress;substance use treatment;Surveys;System;Techniques;Testing;theories;Time;tool;Treatment outcome;treatment program;Twitter;Variant;wearable device;Work,Digital Markers in Relapse and Recovery,628,NA,NA,NA,NA,6,NA,NA,2513285,NA
11189088,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000635,NA,NA,1ZIADA000635-05,NIDA:2465296\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,77869872 (contact),"LEGGIO, LORENZO  (contact)",NA,NA,NA,acamprosate;Acylation;Acyltransferase;addiction;Addictive Behavior;Address;Adverse event;Agonist;Alcohol consumption;alcohol craving;alcohol cue;Alcohol dependence;alcohol misuse;alcohol seeking behavior;alcohol use disorder;Alcoholic Liver Diseases;Alcohols;Aldosterone;Amino Acid Substitution;Amygdaloid structure;analog;Animal Model;antagonist;Ataxia;Attention;Autopsy;bariatric surgery;base;Behavioral;behavioral pharmacology;beta diversity;biobehavior;Biological;Biological Factors;Blood alcohol level measurement;Brain;brain based;Brain imaging;brain tissue;California;Calories;Case/Control Studies;Cells;Charge;Clinical;clinical practice;Clinical Trials;Cohort Studies;comparison control;Complex;Control Groups;cue reactivity;Cues;Data;Data Analyses;Dependence;Development;Dipeptidyl Peptidases;Disease;Disulfiram;Dopamine;Dose;Double-Blind Method;double-blind placebo controlled trial;drinking;drinking behavior;Drug Kinetics;drug seeking behavior;Eating;Electronic Health Record;Electrophysiology (science);Elements;Endorphins;Environmental Risk Factor;Enzymes;Etiology;experimental study;feeding;Feeling;Female;fibroblast growth factor 21;Frequencies;Functional Magnetic Resonance Imaging;gamma-Aminobutyric Acid;Gene Expression;genetic variant;ghrelin;ghrelin receptor;GLP-I receptor;glucagon-like peptide 1;glucose metabolism;Glutamates;gut microbiome;gut microbiota;gut-brain axis;Health;Heart;Heavy Drinking;Heterogeneity;Hippocampus;Homeostasis;Human;improved;Individual;inhibitor;innovation;Inpatients;insight;Intake;interest;Intramuscular;Investigation;Laboratories;Laboratory Study;Link;Lipids;liraglutide;Liver;male;Measures;Medicine;metabolome;Methods;microbial;Mineralocorticoid Receptor;Modality;Motor;Mus;Naltrexone;Nature;Neurobiology;Neurons;neuropsychopharmacology;Neurosecretory Systems;Neurotransmitters;Non-Insulin-Dependent Diabetes Mellitus;novel;novel therapeutics;Nucleus Accumbens;Obesity;Oral;Outcome;Outpatients;Pathway interactions;patient oriented;patient response;Patients;peptide hormone;Peripheral;Pharmaceutical Preparations;Pharmacoepidemiology;pharmacologic;Pharmacological Treatment;Pharmacotherapy;Phase;Phase Ib Clinical Trial;Physiological;Placebo Control;Play;pleasure;Population Study;Pre-Clinical Model;preclinical study;preference;Prefrontal Cortex;Preparation;primary care setting;Procedures;prototype;Psychiatry;Psychoneuroendocrinology;psychosocial;Randomized;Rattus;Receptor Gene;Recording of previous events;recruit;Reducing Agents;Research;Rewards;Role;Route;Safety;safety testing;Self Administration;Serotonin;Serum;Severities;Side;Signal Transduction;Speed;Spironolactone;Subcutaneous Injections;substance use;Substance Use Disorder;Surveys;System;Techniques;Testing;transmission process;United States Department of Veterans Affairs;United States Food and Drug Administration;virtual;Water consumption;Wistar Rats;Work,Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN),635,NA,NA,NA,NA,5,NA,NA,2465296,NA
11189090,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000638,NA,NA,1ZIADA000638-04,NIDA:2565601\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,8017433 (contact),"YANG, YIHONG  (contact)",NA,NA,NA,Abstinence;activity marker;adverse outcome;Agonist;antagonist;Area;Auditory;Automobile Driving;Autoradiography;awake;Axon;Baclofen;Biological Assay;Brain;Brain region;Cells;cerebral blood volume;Characteristics;Corpus striatum structure;craving;Data;Data Set;Decision Making;Dendrites;design;discounting;Disease;Distant;Dopamine;dopamine D3 receptor;Dorsal;Drug Addiction;drug craving;electric field;Elements;Exhibits;experimental study;Exposure to;Fluorescence-Activated Cell Sorting;Food;Frequencies;Functional Magnetic Resonance Imaging;Gene Expression;Human;imaging modality;Impulse Control Disorders;Impulsive Behavior;Impulsivity;In Situ Hybridization;Incubated;Intervention;Link;male;Medial;Membrane Potentials;Mental disorders;Modeling;Motor;Muscimol;Nervous System Disorder;neural;neuroimaging;neuromechanism;Neurons;Neuropharmacology;neuroregulation;next generation;Nucleus Accumbens;Opiate Addiction;Opioid;Output;Oxycodone;oxycodone seeking;oxycodone self-administration;Pharmaceutical Preparations;pharmacologic;Physiologic pulse;Polymerase Chain Reaction;Positron-Emission Tomography;Pre-Clinical Model;preference;Rattus;receptor;receptor expression;Receptor Gene;Relapse;repetitive transcranial magnetic stimulation;response;Rewards;Role;Science;Self Administration;Signal Transduction;Structure;Substance Use Disorder;System;Testing;Therapeutic;Time;Training;Transcranial magnetic stimulation;Width,Neuroimaging and neuromodulation of preclinical models of substance use disorders,638,NA,NA,NA,NA,4,NA,NA,2565601,NA
11189091,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000641,NA,NA,1ZIADA000641-03,NIDA:2662876\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,78851388 (contact),"JANES, AMY  (contact)",NA,NA,NA,Acceleration;addiction;Adolescent;Adoption;Adult;Alexithymias;Arousal;Awareness;Behavior;Biological;Biological Markers;biomarker development;Blood flow;Brain;brain based;Brain region;Cerebrovascular Circulation;Child;Chronic;Cigarette;cigarette smoke;Clinical;clinical predictors;clinically relevant;Cognition;cognitive control;Collaborations;Communication;comorbidity;craving;cue reactivity;Cues;Data;Data Collection;denoising;depressive symptoms;design;Development;Diagnostic;Disease;Disease remission;Drug Addiction;Economics;Electronic cigarette;elementary school;Elements;Emerging Tobacco Products;emotion dysregulation;Emotional;Evaluation;experience;Frequencies;Functional Magnetic Resonance Imaging;functional MRI scan;Goals;Health;Heart Rate;Heterogeneity;Human;Human Characteristics;Impaired cognition;improved;Individual;innovation;insight;Investigation;Judgment;Link;Literature;Major Depressive Disorder;Maps;Measures;meetings;Mental disorders;Mental Health;Modeling;Morphologic artifacts;National Institute of Drug Abuse;neural correlate;neuroadaptation;Neurobiology;neuropsychopharmacology;Neurosciences;Nicotine;Nicotine Dependence;nicotine use;Nicotinic Agonists;Nicotinic Antagonists;non-smoker;novel;Outcome;Participant;Pathway interactions;Pattern;pediatric trauma;Persons;Pharmaceutical Preparations;Phase;Policies;Population;potential biomarker;preadolescence;preventable death;Preventive;Procedures;prognostic;Property;Protocols documentation;Psychiatry;Public Health;Publishing;Qualifying;Quam;rate of change;Recommendation;Recovery;recruit;relapse risk;Reporting;Respiration;Rest;reward anticipation;Rewards;Risk;Risk Factors;Role;Scanning;School-Age Population;sex;Signal Transduction;Smoke;Smoking;smoking cessation;Smoking Cessation Intervention;Subgroup;Substance of Abuse;substance use;Substance Use Disorder;suicidal behavior;Suicide attempt;systematic review;Testing;therapy development;Time;Tobacco smoking behavior;Tobacco use;tool;Trauma;Treatment outcome;Validation;vaping;Work,Defining neurobiological links between substance use and mental illness,641,NA,NA,NA,NA,3,NA,NA,2662876,NA
11189092,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000642,NA,NA,1ZIADA000642-03,NIDA:2307010\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,78851390 (contact),"KAHNT, THORSTEN  (contact)",NA,NA,NA,Adaptive Behaviors;addiction;Alzheimer&apos;s Disease;amnestic mild cognitive impairment;Anatomy;Area;Behavior;Behavioral;Blood;Body mass index;Brain;Chemical Structure;Code;Cognition;cognitive function;Cues;Decision Making;Dementia;design;Desire for food;Event;Food Intake Regulation;Functional Magnetic Resonance Imaging;Goals;Hormones;Human;Hypothalamic structure;Lateral;learned behavior;Learning;Magnetic Resonance Imaging;Metabolic hormone;midbrain central gray substance;Midbrain structure;mild cognitive impairment;Modeling;motivated behavior;neural;neuropsychiatric disorder;neuropsychiatry;neuroregulation;novel;Odors;Olfactory tract;Olfactory tubercle;Outcome;Participant;patient population;Population;Process;Publishing;Research;Research Project Grants;Resolution;response;Rewards;Role;Smell Perception;Structure;Substance Use Disorder;Techniques;Testing;tractography;Training;Transcranial magnetic stimulation;United States National Institutes of Health,Neurocomputational mechanisms of learning and decision-making and their disruption in addiction,642,NA,NA,NA,NA,3,NA,NA,2307010,NA
11189093,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000644,NA,NA,1ZIADA000644-02,NIDA:1279517\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,14282520 (contact),"VENDRUSCOLO, LEANDRO  (contact)",NA,NA,NA,Acids;Acute;addiction;Adrenergic Agonists;Adrenergic Antagonists;Agonist;alcohol abuse therapy;Alcohol consumption;alcohol craving;alcohol effect;alcohol exposure;alcohol response;alcohol sensitivity;Alcohol withdrawal syndrome;Alcohols;Analgesics;antagonist;Anti-Anxiety Agents;anti-depressive agents;Anxiety;Anxiety Disorders;anxiety-like behavior;base;Behavior;beta-2 Adrenergic Receptors;Biological Assay;biological systems;Blood alcohol level measurement;Brain;Brain Diseases;breath alcohol measurement;Buprenorphine;burden of illness;Butylene Glycols;Chronic;Clinical;clinical development;Clinical Trials;Cocaine;cocaine exposure;cocaine self-administration;Cocaine use disorder;Communication;CRF receptor type 1;Cross-Over Studies;cysteinyltyrosine;Data;Development;Diagnosis;disability;Dose;Drug Targeting;Drug usage;emotion regulation;endogenous opioids;Fatty acid glycerol esters;Female;Glutamates;Goals;heat stimulus;Heroin;Heroin Dependence;Hour;Human;Hyperalgesia;Infusion procedures;Intake;interdisciplinary approach;Interoception;Intoxication;intraperitoneal;Intravenous;kappa opioid receptors;Ketamine;ketogenic diet;Ketones;Link;Locomotion;lofexidine;male;Measures;mechanical stimulus;Mechanics;men;Mental Depression;Mental disorders;Metabotropic Glutamate Receptors;Methadone;Mission;MK801;Molecular;Monitor;Mood Disorders;Motivation;mu opioid receptors;Mus;N-Methyl-D-Aspartate Receptors;Naloxone;Naltrexone;National Institute of Drug Abuse;neural circuit;neuroadaptation;Neurobiology;neuron development;Neurons;Neuropeptides;Neurosciences;Neurotransmitters;Nociception;nociceptive response;non-opioid analgesic;norbinaltorphimine;Ondansetron;Opioid;Opioid agonist;Opioid Antagonist;Opioid Peptide;Opioid Receptor;opioid use;opioid withdrawal;Oral;Oral Administration;Oxytocin;Pain;Pain Measurement;pain sensitivity;Participant;Pharmaceutical Preparations;pharmacologic;Pharmacological Treatment;Physiological;Placebos;Play;Pre-Clinical Model;preclinical study;Prevention strategy;Protocols documentation;Questionnaires;Ramp;Rattus;receptor;Receptor Activation;Recording of previous events;Research;response;Role;Self Administration;Serotonin Receptors 5-HT-3;sex;Single-Blind Study;Stimulus;Stress;Substance Use Disorder;Sweetening Agents;Synaptic plasticity;System;Tail Suspension;Temperature;Testing;Therapeutic;United States Food and Drug Administration;Water;Wistar Rats;Withdrawal;Woman,Stress and Addiction Neuroscience Unit,644,NA,NA,NA,NA,2,NA,NA,1279517,NA
11189094,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000645,NA,NA,1ZIADA000645-02,NIDA:418000\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,11592808 (contact),"SCHOENBAUM, GEOFFREY  (contact)",NA,NA,NA,Address;Affect;Animal Model;Autopsy;Behavior;behavior test;Behavioral;Brain;Cells;Cognitive;cognitive testing;Corpus striatum structure;Data;Dimensions;Equipment;experimental study;Funding;Future;Genes;Hand;Hippocampus;HIV;HIV-associated neurocognitive disorder;Human;Impaired cognition;Impairment;improved;indexing;Individual;Individual Differences;Infection;Learning;Manuscripts;Measures;Microglia;Midbrain structure;Modeling;Molecular;National Institute of Drug Abuse;neural circuit;neural information processing;neural patterning;neuroinflammation;neurotoxicity;novel;patient population;Performance;pharmacologic;Population;Positioning Attribute;preconditioning;promoter;Proviruses;Rattus;Rodent Model;Sensory;Structure;Testing;Update;Work,CHARACTERIZATION OF COGNITIVE INFERENCE IN A RODENT MODEL OF HIV-ASSOCIATED NEUROCOGNITIVE DISORDER,645,NA,NA,NA,NA,2,NA,NA,418000,NA
11189095,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000646,NA,NA,1ZIADA000646-02,NIDA:1337600\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,16135727 (contact),"CURTIS, BRENDA  (contact)",NA,NA,NA,Address;Adherence;Affect;algorithm training;Algorithms;Artificial Intelligence;Attitude;Awareness;Behavior;Behavior monitoring;Behavioral;Behavioral Paradigm;Big Data;binge drinking;Biological Markers;Black race;Cannabis;cannabis craving;Cellular Phone;Classification;Clinical;clinical practice;Communication;Communities;comparative;Complex;Computational algorithm;Consumption;Data;Data Collection;Data Set;dating behavior;deep learning;demographics;Devices;digital;digital phenotyping;Ecological momentary assessment;effective intervention;Epidemic;Event;Face;feature selection;Formulation;gender minority;Goals;Gravitation;Health;health record;high risk behavior;high risk sexual behavior;HIV;HIV risk;HIV Seropositivity;Incidence;Individual;innovation;insight;Intervention;Language;Legal;Location;machine learning algorithm;marijuana legalization;marijuana use;marijuana user;Measures;men;Methodology;Modernization;Monitor;Moods;Oral;Outcome;Participant;Pattern;phenotypic data;Policies;pre-exposure prophylaxis;Prevalence;Research;Risk;Risk Behaviors;sex;Sex Behavior;Sexual and Gender Minorities;sexual encounter;sexual minority men;Sexual Partners;social media;Social support;substance use;Surveys;tailored messaging;Techniques;Technology;Time;tool;transmission process;United States;Unsafe Sex,Digital Phenotyping & Deep Learning: Substance Use Impact on PrEP Adherence among Black Sexual and Gender Minorities,646,NA,NA,NA,NA,2,NA,NA,1337600,NA
11189096,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000647,NA,NA,1ZIADA000647-02,NIDA:405983\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,77869872 (contact),"LEGGIO, LORENZO  (contact)",NA,NA,NA,"addiction;Address;Aging;Agonist;Albumins;alcohol comorbidity;Alcohol consumption;alcohol craving;alcohol effect;alcohol seeking behavior;alcohol use disorder;Alcoholic Liver Diseases;Alcohols;Aldosterone;Alkaline Phosphatase;antagonist;antiretroviral therapy;Anxiety;Area;Baclofen;behavioral and social science;Bilirubin;Biological Markers;Biomedical Research;Blood;Cardiovascular system;CD4 Lymphocyte Count;Chronic Disease;Clinical;clinical practice;Clinical Research;clinically relevant;co-infection;Cohort Studies;comorbidity;Consensus;Consumption;cost;cost effective;Country;Data;Data Science;Decision Making;Diagnosis;Dose;Drug Prescriptions;Drug usage;Early identification;Edema;Electronic Health Record;Environmental Risk Factor;Essential Hypertension;experience;experimental study;FDA approved;Female;Fentanyl;frailty;France;GABA-B Receptor;Goals;Health Benefit;health disparity;Heart failure;Hepatitis C co-infection;Hepatology;Hepatotoxicity;high risk sexual behavior;HIV;Hospitalization;Human;Hypokalemia;Impairment;improved;indexing;Individual;Intake;interest;International;Investigation;Literature;Liver Cirrhosis;Liver diseases;liver function;liver injury;male;Measures;Medical;Mental disorders;Meta-Analysis;Methods;Mineralocorticoid Receptor;Morbidity - disease rate;mortality;Motivation;Mus;Neurologic;novel;off-label use;Opioid;opioid misuse;opioid use;opioid use disorder;opioid withdrawal;Outcome;Pain;Patient Self-Report;Patients;Persons;Pharmaceutical Preparations;Pharmacoepidemiology;Pharmacotherapy;physical conditioning;Physiological;Polypharmacy;Population;preclinical study;Primary Hyperaldosteronism;prospective;Prothrombin time assay;Psychiatry;Psychological reinforcement;Public Health;Publishing;randomized, clinical trials;Randomized, Controlled Trials;Rattus;Regulation;Reinforcement Schedule;Research;Research Priority;Risk;Risk Factors;RNA;Role;Safety;Self Administration;Series;Severities;Signal Transduction;social factors;Spironolactone;substance use;Substance Use Disorder;Symptoms;Testing;therapy adherence;Traction;transmission process;United States National Institutes of Health;vapor;Work;Workload",Investigating the effects of novel medications for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV.,647,NA,NA,NA,NA,2,NA,NA,405983,NA
11189097,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000648,NA,NA,1ZIADA000648-02,NIDA:585200\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,14747538 (contact),"MICHAELIDES, MICHAEL  (contact)",NA,NA,NA,Brain;Cocaine;comorbidity;Dopamine;Drug Exposure;drug of abuse;experimental study;Exposure to;Gene Expression;Generations;Goals;Heroin;HIV;Human;Knowledge;Mediating;Metabolic Marker;molecular imaging;Monitor;Neuroimmune;neuroinflammation;neurotransmission;novel;Positron-Emission Tomography;Proteins;radioligand;Rat Transgene;Rattus;Reporter;Research;response;Rodent;therapeutic development;Therapeutic Intervention,Longitudinal and noninvasive characterization of brain function and HIV expression in a novel HIV transgenic rat,648,NA,NA,NA,NA,2,NA,NA,585200,NA
11189098,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000649,NA,NA,1ZIADA000649-02,NIDA:585200\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,8017433 (contact),"YANG, YIHONG  (contact)",NA,NA,NA,Acceleration;addiction;Age;age related;Aging;aging brain;Alcohols;antiretroviral therapy;Brain;cerebral atrophy;Chronic;Chronology;cocaine use;Cognition;Cognitive;cognitive performance;cohort;comorbidity;conditioning;connectome;Control Groups;Data;Drug usage;Education;executive function;frontal lobe;Functional Magnetic Resonance Imaging;gray matter;Habits;Head;High Prevalence;high school;HIV;HIV Infections;HIV Seronegativity;HIV Seropositivity;HIV-associated neurocognitive disorder;Human;Image;Impaired cognition;improved;Individual;Investigation;Left;Magnetic Resonance Imaging;Manuscripts;Maps;Masks;Medial;men;Metabolism;mild cognitive impairment;Modeling;Motion;Motivation;MRI Scans;Neurobiology;Neurocognitive Deficit;neuroimaging;Nodal;Participant;patient subsets;Patients;Pattern;Persons;Population;Pre-Clinical Model;predictive modeling;Predisposing Factor;Preparation;Process;Regression Analysis;Research Project Grants;Rest;Rewards;risk mitigation;sex;Standardization;Statistical Data Interpretation;Structure;Structure of superior frontal gyrus;substance use;Substance Use Disorder;Sum;Testing;United States National Institutes of Health;Variant;Women&apos;s prevalence,Impact of comorbidity of HIV infection and substance use disorder on brain aging and cognitive impairment,649,NA,NA,NA,NA,2,NA,NA,585200,NA
11189099,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000650,NA,NA,1ZIADA000650-02,NIDA:292600\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,8017433 (contact),"YANG, YIHONG  (contact)",NA,NA,NA,Amendment;Behavior;Behavioral;Brain;Brain region;Chicago;Cocaine;Cocaine use disorder;cohort;Collaborations;community organizations;contingency management;Data;Decision Making;Drug usage;Functional Magnetic Resonance Imaging;Gambling;HIV;HIV Infections;HIV risk;Illinois;Impairment;Individual;Intervention;Iowa;Left;Maryland;Needle-Exchange Programs;Neuropsychology;neuroregulation;outreach;Pattern;Phase;Population;Prefrontal Cortex;protocol development;Protocols documentation;Punishment;recruit;Research Project Grants;response;Rewards;Risk;Risk Assessment;Risk Behaviors;Risk Taking;Sex Behavior;Substance Use Disorder;Testing;Time;Transcranial magnetic stimulation;treatment center;Universities;Visit;Work,Reduction of HIV risk behavior with transcranial magnetic stimulation,650,NA,NA,NA,NA,2,NA,NA,292600,NA
11189100,ZIA,DA,1,N,NA,NA,NA,NA,ZIADA000651,NA,NA,1ZIADA000651-02,NIDA:418000\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NA,NA,9693010 (contact),"HARVEY, BRANDON  (contact)",NA,NA,NA,Affect;Animals;antiretroviral therapy;Behavior;Behavior assessment;Brain;Brain region;Cell Nucleus;cell type;Cells;Central Nervous System;Clinical Research;Cocaine;cognitive testing;Collaborations;comorbidity;constitutive expression;cytokine;Development;differential expression;Disease;drug of abuse;Effectiveness;Elements;Embryonic Development;Enterobacteria phage P1 Cre recombinase;Evolution;Exposure to;falls;Gene Expression;Gene Expression Profile;Genes;Genetic Recombination;Genetic Transcription;Genome;glial activation;Glutamates;Goals;HIV;HIV Genome;HIV therapy;HIV-1;HIV-associated neurocognitive disorder;Homeostasis;Human;improved;Inflammation;Inflammatory;Inherited;Learning;Ligands;Location;Mediating;Metabolic;Methamphetamine;Methods;Microglia;Midbrain structure;Modeling;Molecular;Molecular Profiling;Monitor;nanoparticle;National Institute of Drug Abuse;Neurocognitive Deficit;Neuroglia;neuroinflammation;Neurons;Neuropathogenesis;neurotoxicity;NF-kappa B;novel;novel therapeutic intervention;Pathogenesis;Pathology;Pathway interactions;Physiological;Population;Positioning Attribute;Positron-Emission Tomography;Post-Transcriptional RNA Processing;preclinical study;Prefrontal Cortex;Production;Productivity;promoter;Proviruses;psychostimulant;rat genome;Rat Transgene;Rattus;receptor;Reporter;Reporting;response;RNA;RNA Processing;RNA Splicing;Signal Transduction;single nucleus RNA-sequencing;single-cell RNA sequencing;Site;Sorting;stimulant exposure;Stimulus;Study models;Substance of Abuse;T-Lymphocyte;Testing;Time;Tissues;transcription termination;transcriptome;Transgenes;Transgenic Organisms;Viral;Viral Proteins;Viral reservoir;Virus;Virus Replication;Work,Developing rat models of HIV-associated neurotoxicity and neuroinflammation,651,NA,NA,NA,NA,2,NA,NA,418000,NA
11189101,ZIA,EB,1,N,NA,NA,NA,NA,ZIAEB000015,NA,NA,1ZIAEB000015-18,NIBIB:427054\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,9693598 (contact),"JIN, ALBERT J (contact)",NA,NA,NA,anti-cancer;Antineoplastic Agents;Area;Atomic Force Microscopy;bioimaging;Biological;Biological Sciences;Biomedical Research;biophysical techniques;Biophysics;Brain;Cell Line;Cells;cellular imaging;circumsporozoite protein;Clathrin;Collaborations;Collagen;Communication;Complex;Cytoskeleton;Development;DNA;efficacy study;Extracellular Matrix;Extramural Activities;Fiber;gang;Gel;Generations;genetic variant;glycosylation;HepG2;Image;Immune response;Immunologics;Immunotherapy;improved;In Vitro;insight;instrumentation;Investigation;macromolecule;Malaria;Malaria Vaccines;Malignant Neoplasms;Manuscripts;Mass Spectrum Analysis;mathematical analysis;mathematical model;mechanical properties;Medical;Membrane;Methodology;Methods;microscopic imaging;Microscopy;Microtubules;Molecular Structure;Morphology;Motility;multidisciplinary;nano;nanomechanics;nanomedicine;nanoparticle;nanoscale;Nanostructures;Nanotechnology;National Institute of Allergy and Infectious Disease;National Institute of Biomedical Imaging and Bioengineering;National Institute of Child Health and Human Development;National Institute of Neurological Disorders and Stroke;Neurons;Nitric Oxide;novel;novel vaccines;Optics;Organ;Parasites;Pathogenesis;peer;Peer Review;Photosensitizing Agents;Physiological;Plasmodium falciparum;Plasmodium vivax;preclinical efficacy;Property;protein crosslink;Proteins;Public Health;Publications;Publishing;Raman Spectrum Analysis;Reactive Oxygen Species;receptor mediated endocytosis;Recombinants;Research;research study;Sampling;Scientist;single molecule;Spectrum Analysis;Sporozoites;Synaptic Transmission;System;theranostics;Therapeutic;Tissues;trafficking;transmission-blocking vaccine;United States National Institutes of Health;vaccine candidate;Vaccines,Biomedical Studies and Cellular Imaging via Atomic Force Microscopy,15,NA,NA,NA,NA,18,NA,NA,427054,NA
11189102,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000184,NA,NA,1ZIAEY000184-42,NEI:4190009\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,9693896 (contact),"CASPI, RACHEL R. (contact)",NA,NA,NA,Actinobacteria class;Active Immunization;Adopted;Adoptive Transfer;Affect;Agonist;Animal Model;Anti-Inflammatory Agents;Antibiotic Therapy;Antibodies;Antibody-drug conjugates;Antigen Presentation;Antigens;Arrestins;Aryl Hydrocarbon Receptor;Autoimmune Responses;autoimmune uveitis;Autoimmunity;Automobile Driving;Bioinformatics;Biological Markers;birdshot chorioretinitis;Cataract;CD6 antigen;Cell Differentiation process;Cells;Characteristics;Clinic;Clinical;clinical material;Collaborations;commensal microbes;Corynebacterium;cytokine;cytotoxic;Data;Dendritic Cells;Development;Disease;Ebola;Ebola Hemorrhagic Fever;engineered T cells;Engineering;Equilibrium;experience;Experimental Models;Eye;Eye diseases;fatty acid oxidation;FCGR3B gene;Firmicutes;Flow Cytometry;FOXP3 gene;Fusobacteria;gain of function mutation;Genes;Genetic;Germ-Free;Glycoproteins;Goals;gut microbes;gut microbiome;gut microbiota;Haplotypes;high dimensionality;Homeostasis;Host Defense;Human;human microbiota;IL17 gene;Immune;Immune response;Immune Tolerance;Immunity;Immunization;Immunologics;Immunology;Immunotherapy;improved;In Situ;In Vitro;in vivo;Individual;Inflammasome;Inflammation;Inflammatory;Inflammatory Response;inhibitor;insight;Interleukin-1;interstitial retinol-binding protein;Intervention;Intestines;intraepithelial;Knock-in Mouse;Laboratories;Legal patent;lens;lens capsule;Lymphocyte;Lymphocyte Depletion;Macrophage;Manuscripts;Measurable;Mediating;Metabolic;Microbe;microbial;microbiome;microbiota;Modeling;Molecular;Molecular Mimicry;Monoclonal Antibodies;mouse model;Mucosal Immune Responses;mucosal site;Mucous Membrane;multiple omics;Mus;Mutation;Myeloid Cells;Nasopharynx;National Institute of Allergy and Infectious Disease;ocular surface;Oral cavity;Organism;pathobiont;Pathogenesis;Pathogenicity;Pathway interactions;Patients;Peptides;Peripheral Blood Mononuclear Cell;Phenotype;Population;Preparation;preservation;Process;Production;protective effect;receptor;reconstitution;Recovery;recruit;Regulatory T-Lymphocyte;response;Retina;retinal damage;RNA;Role;sensor;Signal Transduction;single-cell RNA sequencing;success;Surface;Survivors;T cell response;T-Cell Receptor;T-Lymphocyte;Therapeutic;Tissues;TLR2 gene;transcription factor;transcriptome;transcriptomics;Transgenic Mice;Uveitis;Vagina;Viral Load result;Viremia;Vision;Volatile Fatty Acids;γδ T cells,"Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina",184,NA,NA,NA,NA,42,NA,NA,4190009,NA
11189103,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000255,NA,NA,1ZIAEY000255-36,NEI:162719\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,8476359 (contact),"WISTOW, GRAEME J (contact)",NA,NA,NA,age related;age-related disease;Aging;amyloid formation;Animal Model;Binding Proteins;biophysical properties;Blindness;Cataract;Cell Maturation;Collaborations;Cryoelectron Microscopy;Crystallins;Cytoskeleton;Defect;Degenerative Disorder;Deposition;Development;Enzymes;Eye;Failure;Family;gamma-Crystallins;Genes;Human;human model;Inflammatory Response;Intermediate Filaments;intermolecular interaction;lens;Lens Fiber;Molecular Structure;Mus;Mutate;Pathway interactions;Process;Processed Genes;Proteins;recruit;Refractive Indices;Retina;Role;Stress;Swelling;Tissues;Work,Molecular Structure and Function of Crystallins,255,NA,NA,NA,NA,36,NA,NA,162719,NA
11189104,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000260,NA,NA,1ZIAEY000260-35,NEI:1505149\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,79365502 (contact),"REDMOND, T. MICHAEL  (contact)",NA,NA,NA,3&apos; Untranslated Regions;Affect;All-Trans-Retinol;Animal Model;Antioxidants;autosome;Belgium;Beta Carotene;Binding;Biochemical;biophysical analysis;Blindness;Carotenoids;Catalysis;Cell Culture System;Cell Culture Techniques;Cell Line;Cell model;Cell Nucleus;Cells;Chemistry;chromophore;Codon Nucleotides;Collaborations;Complement;Cultured Cells;Cysteine;Databases;Development;Dioxygenases;Disease;Dissection;Endoplasmic Reticulum;Enzymes;experimental study;FDA approved;Gene Modified;gene replacement therapy;Genes;Genetic;Genetic Transcription;Goals;Green Fluorescent Proteins;Health;Human;in vivo;induced pluripotent stem cell;Inherited;interest;Internal Ribosome Entry Site;Isomerase;Isomerism;Knock-in Mouse;Knock-out;Learning;Lutein;Mammals;man;Manuscripts;Mass Spectrum Analysis;Membrane;Messenger RNA;Metabolic;Metabolic Pathway;Metabolism;Methods;Modeling;Molecular;Molecular Biology;Molecular Genetics;mouse model;Mus;Mutate;Mutation;National Center for Advancing Translational Sciences;Niacinamide;North America;novel;Open Reading Frames;operation;Oxygenases;palmitoylation;Pathogenicity;Pathway interactions;patient derived induced pluripotent stem cells;Patients;pattern dystrophies;Peptides;Phenotype;photoprotection;Photoreceptors;Physiology;Play;Point Mutation;Process;promoter;Protein Biochemistry;protein expression;Proteins;Pyruvate;Regulation;Reporting;Research;response;Retina;Retinal Dystrophy;Retinal Pigments;Retinitis Pigmentosa;Retinoic Acid Receptor;Retinoids;retinol isomerase;RNA Splicing;Role;RPE65 protein;sensor;small molecule;small molecule inhibitor;structural biology;Structure;Structure of retinal pigment epithelium;Therapeutic;Transcriptional Regulation;Transfection;Translational Regulation;Translations;Variant;vector;Vision;visual cycle;Vitamin A;Work;Xanthophylls,Molecular Biology Of Outer Retina-specific Proteins,260,NA,NA,NA,NA,35,NA,NA,1505149,NA
11189105,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000262,NA,NA,1ZIAEY000262-29,NEI:345777\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,2058079 (contact),"EGWUAGU, CHARLES E (contact)",NA,NA,NA,Adoptive Transfer;Adverse effects;Autoimmune Diseases;autoimmune uveitis;B-Lymphocytes;Binding;Blood-Retinal Barrier;Cell secretion;Cells;chronic inflammatory disease;CNS autoimmune disease;CTLA4 gene;cytokine;Dimerization;exhaustion;exosome;Family;Growth;Immune;Immunosuppression;in vivo;Inflammatory;Interleukin-10;Interleukin-12;interleukin-23;Lymphocyte Function;Mediating;member;Membrane;mouse model;Multiple Sclerosis;Mus;neuroinflammation;Pathogenesis;Physiological;Play;Population;programmed cell death protein 1;Protein Secretion;receptor;Regulatory T-Lymphocyte;Role;T-Lymphocyte;Therapeutic;Uveitis,Role of IL-12 family cytokines in autoimmune Uveitis,262,NA,NA,NA,NA,29,NA,NA,345777,NA
11189106,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000272,NA,NA,1ZIAEY000272-34,NEI:1871266\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,2069643 (contact),"HEJTMANCIK, JAMES F. (contact)",NA,NA,NA,Affect;Complex;Corneal dystrophy;Data Set;database of Genotypes and Phenotypes;Diabetic Retinopathy;Diagnosis;Disease;Eye diseases;Family;Functional disorder;gene product;Genes;Genetic;genetic linkage analysis;Glaucoma;Goals;Hereditary Disease;Human;human disease;improved;Inherited;insight;interest;Laboratories;Lead;Leber&apos;s amaurosis;Molecular;Mutation;Myopia;Patient Care;Physiology;positional cloning;Prevention;recruit;Retinal Dystrophy;Retinitis Pigmentosa;snowflake vitreoretinal degeneration;Structure-Activity Relationship;Visual;visual processing;Visual System,Inherited Ocular Diseases,272,NA,NA,NA,NA,34,NA,NA,1871266,NA
11189107,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000280,NA,NA,1ZIAEY000280-33,NEI:244078\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,2058079 (contact),"EGWUAGU, CHARLES E (contact)",NA,NA,NA,Animal Model;Apoptosis;autoimmune uveitis;B-Lymphocyte Subsets;B-Lymphocytes;Cell Proliferation;Cells;Cellular Metabolic Process;Cessation of life;CISH gene;cytokine;Cytoplasm;Data;Disease;Embryonic Development;Eye;Genetic Transcription;human model;Immunity;Immunosuppression;Inflammation;Inflammatory;Inflammatory Response;Insecta;Interferons;Interleukin-10;IRF4 gene;Lymphocyte;Lymphoid;Lymphoid Cell;Lymphoid Tissue;Mammals;Mediating;Metabolic;Metabolism;Mus;neuroprotection;Pathogenicity;Pathologic;Pathway interactions;Patients;Physarum polycephalum;Physiological Processes;Proteins;PTPN6 gene;Rattus;Research;Resistance;response;Retina;Role;Scleritis;Signal Transduction;STAT3 gene;T-Lymphocyte;transcription factor;Transgenic Mice;Uveitis;Zinc Fingers,Suppressors of Cytokine Signalling (SOCS) have Neuroprotective  Roles in Retina,280,NA,NA,NA,NA,33,NA,NA,244078,NA
11189108,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000281,NA,NA,1ZIAEY000281-32,NEI:1789907\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,2069643 (contact),"HEJTMANCIK, JAMES F. (contact)",NA,NA,NA,age related;Aging;Apoptosis;arm;Bacteria;Biological;Biological Models;C-Peptide;Candidate Disease Gene;Cataract;Characteristics;Clinical;Code;Complex;congenital cataract;Crystalline Lens;Crystallins;design;Development;Diagnosis;Disease;disease-causing mutation;eye formation;Family;Functional disorder;gamma-Crystallins;gene function;gene product;Gene Structure;Genes;Genetic;genetic linkage analysis;Goals;Greek;In Vitro;Inherited;insight;interest;Investigation;lens;Lens development;Lens Opacities;lens transparency;Lesion;Modification;Molecular;Molecular Biology;Molecular Genetics;mutant;Mutate;Mutation;mutation screening;Pathologic;Pathway interactions;physical mapping;Physiology;Prevention;protein function;protein structure;Proteins;RNA;Stress;Structure;System;Systems Development;Technology;Transgenic Mice;Vision;Work,Clinical/molecular Studies In Families With Congenital Or Hereditary Cataracts,281,NA,NA,NA,NA,32,NA,NA,1789907,NA
11189109,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000306,NA,NA,1ZIAEY000306-30,NEI:1342430\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,79365508 (contact),"BECERRA, S. PATRICIA  (contact)",NA,NA,NA,Acetylation;Affinity;Affinity Chromatography;Age Months;Age related macular degeneration;Aging;Amino Acid Substitution;Amino Acids;Ammonium Sulfate;Angiogenesis Inhibitors;Angiography;Animal Model;Anions;arrestin3;BCL2 gene;Binding;Biochemical;Biochemistry;Biological Assay;BODIPY;Buffers;C-terminal;Cations;Cell Aging;Cell Death;Cell Line;Cell Survival;Cells;cellular transduction;Complementary DNA;complex R;Confocal Microscopy;Corneal Neovascularization;Crossbreeding;CRX protein;cytokine;Deposition;design;Detergents;Development;Electroretinography;Escherichia coli;Evaluation;Exclusion;Exhibits;expression vector;Eye;Eyedrops;Family;Freezing;Gel;Gene Expression;Genes;Genetic Engineering;Genetic Transcription;Genotype;Histology;Histones;Hour;Human;Hydrolysis;IL6 gene;Immunofluorescence Immunologic;Immunofluorescence Microscopy;In Situ Nick-End Labeling;in vitro Assay;in vivo;Inflammation;Inflammatory;Inherited;inhibitor;Interest Group;Interferon Type II;Interleukin-6;Knockout Mice;Lactones;life span;Light;Link;Lipase;lipid metabolism;Lipids;Magnesium Chloride;Maintenance;Mammals;Measures;Mediating;member;Membrane;milligram;Modification;Molecular;Molecular Sieve Chromatography;molecular size;Monitor;Morphology;mouse model;Mus;Mutagenesis;mutant;N-terminal;Neoplasm Metastasis;Neuronal Differentiation;neuronal survival;neuroprotection;Nuclear;Opsin;overexpression;Oxidative Stress;peptide chemical synthesis;Peptides;Phospholipase;Phospholipase A1;Phospholipase A2;Phospholipids;Photoreceptors;pigment epithelium-derived factor;pigment epithelium-derived factor receptor;Play;Polyacrylamide Gel Electrophoresis;postnatal;Precipitation;prevent;PRKCA gene;Process;Production;protective effect;protein purification;protein structure;Proteins;Quantitative Reverse Transcriptase PCR;Recombinants;Research;Retina;Retinal Cone;retinal damage;Retinal Degeneration;retinal ischemia;Retinal Photoreceptors;Reverse Transcriptase Polymerase Chain Reaction;rho;Rhodopsin;Role;Sampling;screening;Serpin Superfamily;sex;Shock;Signal Transduction;Solubility;Stains;Structure of retinal pigment epithelium;Synaptophysin;Testing;Thick;TNF gene;Transcript;transcription factor;Transmission Electron Microscopy;Triglycerides;tumorigenesis;Variant;Vision;Work;zaprinast,Role of Protein Interactions in Retina Development and Function,306,NA,NA,NA,NA,30,NA,NA,1342430,NA
11189110,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000311,NA,NA,1ZIAEY000311-29,NEI:1139032\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,6570952 (contact),"TOMAREV, STANISLAV I (contact)",NA,NA,NA,Adult;Affect;Alzheimer&apos;s Disease;Amacrine Cells;AMPA Receptors;Amyotrophic Lateral Sclerosis;Binding;Binding Proteins;Biological;Biological Assay;Brain;Cell Physiology;cell type;Cells;Chronic;Communication;comparative;Complex;Data;Defect;Dependovirus;Development;differential expression;Dimerization;Docking;Electroretinography;Epilepsy;Excision;extracellular;Extracellular Matrix;Extracellular Protein;Eye;Eye Development;Gene Expression;Gene Expression Profile;Gene Expression Profiling;Gene set enrichment analysis;Genes;Genetic Transcription;Glaucoma;Glutamate Receptor;Glutamates;Glycoproteins;Goals;Huntington Disease;Immunoprecipitation;In Vitro;in vivo;Kinetics;Knock-out;Knockout Mice;Maps;Measures;Mediating;Modeling;Modification;Molecular;Molecular Genetics;Molecular Mechanisms of Action;monomer;Mus;Mutation;Nervous System Disorder;olfactomedin;overexpression;Parkinson Disease;Pathologic;Pathology;Pathway interactions;pathway tools;Pattern;Photoreceptors;Physiology;Play;Population;Process;protein folding;protein function;protein protein interaction;Proteins;Retina;Retinal Ganglion Cells;Role;Sampling;Synapses;Testing;Tissue-Specific Gene Expression;Tissues;Transcription Process;transcriptome sequencing;Transfection;Wild Type Mouse,Molecular Genetics Of Early Eye Development,311,NA,NA,NA,NA,29,NA,NA,1139032,NA
11189111,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000315,NA,NA,1ZIAEY000315-33,NEI:345777\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,2058079 (contact),"EGWUAGU, CHARLES E (contact)",NA,NA,NA,Adoptive Transfer;Adverse effects;Autoimmunity;Brain;Cells;Cerebellar Ataxia;CNS autoimmune disease;cytokine;Development;Disease;Encephalomyelitis;Experimental Autoimmune Encephalomyelitis;experimental study;extracellular;Eye;Growth Factor;Homologous Gene;IL17 gene;Immune response;Immunosuppression;Immunotherapy;Inflammatory;Interferon Type II;Lymphocyte;Mediating;mouse model;Multiple Sclerosis;Mus;nanobodies;Paralysed;Pathogenicity;Pathway interactions;pharmacologic;recruit;Regulation;Signal Transduction;Spinal Cord;STAT protein;STAT1 gene;STAT3 gene;T-Lymphocyte;Th1 Cells;Therapeutic,Regulation of JAK/STAT  pathways in the eye,315,NA,NA,NA,NA,33,NA,NA,345777,NA
11189112,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000318,NA,NA,1ZIAEY000318-27,NEI:1301750\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,6570952 (contact),"TOMAREV, STANISLAV I (contact)",NA,NA,NA,3-Dimensional;Aftercare;Animal Model;Axon;Biological Process;Blindness;bone marrow mesenchymal stem cell;Cell Culture Techniques;Cell Death;Cell Line;Cell Proliferation;Cell Survival;cell type;Cells;Chromosome Mapping;Code;comparative;comparison control;Conditioned Culture Media;Cytoprotection;Data;Data Set;density;Dermal;differential expression;Engineering;exosome;extracellular vesicles;Fibroblasts;Fractionation;Gene set enrichment analysis;Glaucoma;Growth Factor;Hour;Human;human embryonic stem cell line;improved;In Vitro;in vivo;induced pluripotent stem cell;intravitreal injection;Investigation;Mammals;Messenger RNA;Methods;MicroRNAs;microvesicles;miRNA expression profiling;Molecular;morphometry;mouse model;Mus;Natural regeneration;Neurites;neuroprotection;Ontology;Pathway Analysis;Pathway interactions;Play;Population Heterogeneity;Property;Proteins;restoration;Retina;Retinal Ganglion Cells;RNA;Role;Sampling;Signal Transduction;Source;Stains;Testing;therapeutic candidate;therapeutic target;three dimensional cell culture;transcriptome sequencing;Trees;Tubulin;Ultracentrifugation;Undifferentiated,Molecular Mechanisms Of Glaucoma,318,NA,NA,NA,NA,27,NA,NA,1301750,NA
11189113,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000350,NA,NA,1ZIAEY000350-25,NEI:630535\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,2058079 (contact),"EGWUAGU, CHARLES E (contact)",NA,NA,NA,Adrenal Cortex Hormones;Adverse effects;Allogenic;B-Lymphocytes;Cells;chronic graft versus host disease;CNS autoimmune disease;cytokine;Development;Disease;Dose;effective therapy;Family;graft vs host disease;Hematologic Neoplasms;Hematopoietic Stem Cell Transplantation;Homologous Transplantation;Immune;Immunity;Immunotherapy;Inflammatory;Interleukin-10;Interleukin-12;Interleukins;member;mortality;Mus;Population;Regulatory T-Lymphocyte;Risk;Severities;standard of care;Steroids;T-Lymphocyte;Therapeutic;Uveitis,Development of Immunologic therapies against uveitis,350,NA,NA,NA,NA,25,NA,NA,630535,NA
11189114,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000372,NA,NA,1ZIAEY000372-24,NEI:345777\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,2058079 (contact),"EGWUAGU, CHARLES E (contact)",NA,NA,NA,Adoptive Transfer;Allogenic;Autoimmune Diseases;B-Lymphocytes;Cells;Cellular immunotherapy;CNS autoimmune disease;cytokine;Development;Disease;exosome;Hematologic Neoplasms;Hematopoietic Stem Cell Transplantation;Homeostasis;Homologous Transplantation;Immune;Immunosuppression;Immunotherapy;Inflammation;Inflammatory;Interleukin-10;Lymphocyte;mortality;Mus;nanobodies;Patients;Regulation;Signal Pathway,Mechanisms of immune homeostasis and regulation of intraocular inflammation,372,NA,NA,NA,NA,24,NA,NA,345777,NA
11189115,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000410,NA,NA,1ZIAEY000410-19,NEI:40680\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,8157480 (contact),"CHEW, EMILY Y (contact)",NA,NA,NA,"Blood Glucose;Blood Pressure;blood pressure control;British;Cardiovascular Diseases;cardiovascular risk factor;Cardiovascular system;Cataract Extraction;Cessation of life;clinical effect;Clinical Treatment;Confidence Intervals;Congestive Heart Failure;conventional therapy;Coronary Arteriosclerosis;Coronary heart disease;cytokine;Data;design;Diabetes Mellitus;Diabetic Retinopathy;Dietary intake;Dyslipidemias;Early treatment;Eye;Fenofibrate;follow-up;Fundus;Fundus photography;glycemic control;Glycosylated hemoglobin A;Goals;High Density Lipoprotein Cholesterol;High Density Lipoproteins;Hospitalization;hypertension control;Journals;LDL Cholesterol Lipoproteins;Lipids;Low-Density Lipoproteins;Manuscripts;Masks;Measurement;Medical;Microvascular Dysfunction;mortality;Myocardial Infarction;Newly Diagnosed;Non-Insulin-Dependent Diabetes Mellitus;Odds Ratio;ophthalmic examination;Ophthalmology;Outcome;Outcome Measure;Paper;Participant;participant enrollment;Patients;Persons;Phase;Placebos;posters;primary endpoint;primary outcome;progression risk;Protocols documentation;Publishing;Randomized;Randomized Controlled Clinical Trials;randomized, clinical trials;recruit;revascularization;Sample Size;Schedule;secondary analysis;secondary outcome;Serum;Severities;Simvastatin;stereoscopic;Stroke;Time Study;treatment arm;Triglycerides;Update;Visual Acuity;Writing",ACCORD (Action to Control Cardiovascular Risk in Diabetes),410,NA,NA,NA,NA,19,NA,NA,40680,NA
11189116,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000415,NA,NA,1ZIAEY000415-22,NEI:3254376\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,7873679 (contact),"HIKOSAKA, OKIHIDE  (contact)",NA,NA,NA,addiction;Anatomy;Animals;Anterior;Association Learning;Basal Ganglia;Basal Ganglia Diseases;Behavior;Behavior Control;Behavioral inhibition;Behavioral Mechanisms;Brain;Brain Diseases;Caring;Cerebral cortex;Cluster Analysis;cognitive control;Corpus striatum structure;Dedications;Dopamine;dopaminergic neuron;Eye Movements;Face;Familiarity;flexibility;Functional disorder;Goals;Habenula;Human;Image;Impairment;improved;information processing;Involuntary Movements;Lateral;Link;long term memory;Macaca;Medial;Mediating;Mental Depression;Methods;Monkeys;Motivation;motor control;Motor output;Motor Skills;Movement;neural;Neurons;nonhuman primate;Output;Parkinson Disease;pars compacta;Pathway interactions;Patients;Pattern;Persons;Play;Primates;Proactive Inhibition;Process;Reactive Inhibition;Recording of previous events;Research;reward processing;Rewards;Role;sample fixation;Sensory;Short-Term Memory;Signal Transduction;social;Social Behavior;Speed;Stimulus;Substantia nigra structure;Tail;Visual;visual stimulus;Work;Writing,Neuronal networks for control of eye movement,415,NA,NA,NA,NA,22,NA,NA,3254376,NA
11189117,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000433,NA,NA,1ZIAEY000433-20,NEI:1464469\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,8476359 (contact),"WISTOW, GRAEME J (contact)",NA,NA,NA,access restrictions;Age related macular degeneration;Aging;Animal Model;Antibodies;Bibliography;biological adaptation to stress;Blindness;Bruch&apos;s basal membrane structure;calcification;Calcium;capillary bed;Cell Culture System;Cell Culture Techniques;Cell model;Cells;Cholesterol;Collaborations;Deposition;deprivation;Development;Drusen;experimental study;Eye;Eye Development;FDA approved;functional genomics;Gene Expression Profiling;Genes;geographic atrophy;Health Personnel;Human;Hydroxyapatites;knock-down;Knockout Mice;Laser injury;Lesion;mineralization;Modeling;Morphology;mouse model;Mus;Nonexudative age-related macular degeneration;novel;Pathway interactions;patient population;Pharmaceutical Preparations;Printing;Process;Proteins;Publishing;release of sequestered calcium ion into cytoplasm;Retina;Role;RPE65 protein;Serum;Small Interfering RNA;Structure of retinal pigment epithelium;Techniques;Testing;therapeutic evaluation;Therapeutic Intervention;Time;transcriptome sequencing;Transgenes;Transgenic Mice;Up-Regulation;Validation;Vision;Work;wound;wound healing,Functional Analysis of Novel Genes in Eye Development and Vision,433,NA,NA,NA,NA,20,NA,NA,1464469,NA
11189118,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000438,NA,NA,1ZIAEY000438-15,NEI:833934\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,79365508 (contact),"BECERRA, S. PATRICIA  (contact)",NA,NA,NA,"adenovirus mediated delivery;Affinity;Agarose Chromatography;Age;age group;Age Months;Aging;Albumins;Amino Acid Substitution;Amino Acids;Animal Model;beta-Galactosidase;Binding;Blood specimen;C-terminal;Cell Death;Cell Nucleus;Cessation of life;chemical synthesis;Choroid;Collaborations;Cornea;Cryoultramicrotomy;diagnostic assay;diagnostic tool;Disease;DNA Damage;Dose;Drusen;efficacy evaluation;Electroretinography;Engineering;Enzyme-Linked Immunosorbent Assay;Evaluation;Exhibits;extracellular;Eye;Eyedrops;Family suidae;Fundus photography;Genes;Goals;Heterozygote;Histologic;Histology;Human;Immunofluorescence Immunologic;improved;In Situ;in vivo;in vivo Model;in vivo monitoring;Internal Ribosome Entry Site;Knockout Mice;Lipids;Measures;Membrane;Modification;Monitor;Morphology;mouse model;Mus;Mutation;N-terminal;National Heart, Lung, and Blood Institute;novel therapeutics;Nuclear;Organoids;Oxidative Stress Induction;Pathway interactions;Patients;Penetration;Peptides;Phosphatidylserines;Phospholipase;Phospholipids;Phosphorylation;photoreceptor degeneration;Photoreceptors;pigment epithelium-derived factor;pigment epithelium-derived factor receptor;Plasma;prevent;receptor;Regulation;Retina;Retinal Diseases;Retinitis Pigmentosa;rho;Rhodopsin;RNA;Role;Safety;Sampling;senescence;Serpins;Stains;Structure of retinal pigment epithelium;Therapeutic;Thick;Tight Junctions;Time;Tissues;vector;Visual;Western Blotting;Wild Type Mouse;Zinc",Therapeutics for the chorioretina,438,NA,NA,NA,NA,15,NA,NA,833934,NA
11189119,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000444,NA,NA,1ZIAEY000444-18,NEI:1891606\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,79365502 (contact),"REDMOND, T. MICHAEL  (contact)",NA,NA,NA,accurate diagnosis;Affect;Age related macular degeneration;amino acid metabolism;Area;Biochemistry;Biogenesis;Bioinformatics;Biological Assay;Biological Markers;Biology;biomarker identification;Blood Circulation;Catalogs;Cell Culture Techniques;Cell Line;Cell Physiology;Cell Therapy;Cells;Cellular biology;Characteristics;Citric Acid Cycle;cohort;Collaborations;Crista ampullaris;Cultured Cells;Darkness;Data;Diagnosis;differential expression;Differentiation Antigens;Disease;Early Diagnosis;Electron Transport;Enzyme-Linked Immunosorbent Assay;Etiology;experimental study;Extramural Activities;Eye;Functional disorder;functional genomics;Future;Gene Expression;Gene Expression Profiling;Gene Expression Regulation;Genes;Genetic Transcription;Goals;Heterogeneous-Nuclear Ribonucleoprotein L;High Pressure Liquid Chromatography;Human;Immunoassay;Immunology;Immunoprecipitation;In Situ Hybridization;in vivo;Inflammation;Inflammatory;interest;Isomerism;knock-down;Laboratories;Lead;Lipids;Lysosomes;Mass Spectrum Analysis;Melanosomes;MERTK gene;Messenger RNA;Metabolic Pathway;Methods;MicroRNAs;Mitochondria;Modeling;Modernization;Molecular Biology;Molecular Structure;Monitor;Nerve Degeneration;Neurobiology;Niacinamide;Nucleic Acids;overexpression;Oxidative Phosphorylation;Pathologic;Pathology;Pathway interactions;Pattern;Peptides;Phenotype;Physiology;Pigmentation physiologic function;Plasma;Plasma Proteins;Play;Probability;Process;Proliferative Vitreoretinopathy;protein biomarkers;protein expression;Protein Secretion;Proteins;Proteome;Proteomics;Protocols documentation;Publications;Pyruvate;Pyruvate Metabolism Pathway;Reaction;Regulator Genes;repaired;Research;Research Personnel;Resolution;respiratory;response;Retina;Retinal Degeneration;Retinoids;Retinol Binding Proteins;Risk;RNA;Role;RPE65 protein;Sampling;Signal Pathway;Signal Transduction;Smooth Endoplasmic Reticulum;stoichiometry;Stress;Structure of retinal pigment epithelium;Supplementation;Testing;Transcript;transcriptome sequencing;TRPM1 gene;Untranslated RNA;Up-Regulation;Validation;visual cycle;Western Blotting;WNT Signaling Pathway;Writing,Signaling in the retina and retinal pigment epithelium,444,NA,NA,NA,NA,18,NA,NA,1891606,NA
11189120,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000450,NA,NA,1ZIAEY000450-17,NEI:6826053\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,1863448 (contact),"SWAROOP, ANAND  (contact)",NA,NA,NA,3-Dimensional;Affect;Age;Age Months;age related changes;age related decline;Age related macular degeneration;Aging;aging related;Amino Acids;Animals;ATAC-seq;Autopsy;BACH1 gene;beta-Chemokines;Biology;Birds;Birth;Blindness;Brain;Cell Communication;cell type;Cells;Central Nervous System;Cessation of life;Chordata;Chromatin;Chromatin Loop;Co-Immunoprecipitations;Data;Data Set;Defect;design;Development;Diet;Dimerization;Disease;disorder of macula of retina;DNA;Elderly;Enhancers;Epigenetic Process;epigenetic regulation;epigenome;epigenomics;Evolution;Exhibits;experimental study;Eye;Fatty acid glycerol esters;Functional disorder;Gene Expression;Gene Expression Regulation;gene regulatory network;Gene Targeting;Genes;Genetic;genetic signature;Genetic Transcription;Genetic Variation;Genome;genome wide association study;Genomics;Genotype;Glaucoma;glucose metabolism;Glycemic Index;Glycolysis;Goals;Hi-C;Histones;Homeostasis;Homologous Gene;Human;Individual;induced pluripotent stem cell;Inherited;insight;Investigation;Knockout Mice;Life;Ligands;Lighting;Link;Lysine;Maintenance;Maps;Mediating;Mediterranean Diet;Metabolism;Methods;Molds;Molecular;mouse model;Mus;Natural regeneration;Neurons;novel;Nutritional;Organoids;Pathogenesis;Pathway interactions;Patients;Peripheral Nervous System;Phenotype;Photoreceptors;Physiological;Post-Translational Protein Processing;postmitotic;Predisposition;Primary Open Angle Glaucoma;Production;promoter;Promoter Regions;Protein Isoforms;Proteins;Regulation;Regulatory Element;Regulatory Pathway;Reporting;Resolution;response;Retina;Retinal Cone;Retinal Diseases;retinal neuron;Retinal Photoreceptors;retinal rods;RNA Splicing;RNA-Binding Proteins;Rod;Role;Sampling;sex;Signal Pathway;single-cell RNA sequencing;spatiotemporal;Specific qualifier value;stem cell organoids;subretinal injection;Synaptic Potentials;synaptogenesis;Testing;therapy design;Time;tool;Trabecular meshwork structure;Transcriptional Regulation;transcriptome;transcriptome sequencing;transmission process;Variant;Vision;Visual Acuity;visual information;Vitamin B Complex;yeast two hybrid system;Yeasts,"Genetic and epigenetic regulation of retinal development, aging and evolution",450,NA,NA,NA,NA,17,NA,NA,6826053,NA
11189121,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000469,NA,NA,1ZIAEY000469-16,NEI:1846858\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,10272888 (contact),"BROOKS, BRIAN  (contact)",NA,NA,NA,Affect;Alleles;Anophthalmos;Biological Assay;Blindness;Candidate Disease Gene;candidate identification;Cells;Child;Chromosome 13;Clinical;clinical care;Clinical Data;cohort;Coloboma;Congenital Abnormality;CRISPR screen;CRISPR/Cas technology;Data;Defect;Development;Developmental Gene;Developmental Process;DNA Sequence Rearrangement;dosage;Embryology;Enrollment;Exhibits;exome;experimental study;Eye;Eye Development;Failure;Family;Family history of;FAT gene;First Pregnancy Trimester;Funding;Gene Expression;Genes;Genetic;Genetic Counseling;genetic disorder diagnosis;genetic epidemiology;genetic testing;genome editing;genome sequencing;Genomics;Genotype;Goals;Habits;Health;Heterozygote;Human;human disease;In Vitro;in vivo;Individual;Inherited;inhibitor;Institutional Review Boards;integration site;Iris;Junk DNA;Knowledge;Laboratory Study;Life Style;malformation;Mediating;Methods;Microphthalmos;Molecular;Molecular Diagnostic Testing;Mothers;mouse model;Mus;mutant;Mutation;novel;Nuclear;ophthalmic examination;optic stalk;Optics;Parents;Participant;Pathway interactions;Patient Care;Patients;Phenotype;population based;Pregnancy;Prevention;Protocols documentation;Publishing;Questionnaires;recruit;Registries;Reporting;Repression;Research;Retina;Role;screening;Signal Pathway;Signal Transduction;Signaling Protein;Site;Surface;Syndrome;Telephone;Test Result;Texas;transcriptome sequencing;Transgenes;Transgenic Organisms;United States National Institutes of Health;Variant;Vascular Endothelial Growth Factors;whole genome;Work;Zebrafish,The Genetics of Uveal Coloboma,469,NA,NA,NA,NA,16,NA,NA,1846858,NA
11189122,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000470,NA,NA,1ZIAEY000470-16,NEI:1175643\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,10272888 (contact),"BROOKS, BRIAN  (contact)",NA,NA,NA,adenovirus mediated delivery;Adult;Albinism;Amblyopia;Autophagocytosis;autosome;Axon;Biology;Blindness;Cells;Characteristics;Child;Clustered Regularly Interspaced Short Palindromic Repeats;Collaborations;Collection;Defect;Development;differentiation protocol;disease-in-a-dish;Dose;Early treatment;experience;Eye;FDA approved;Fibroblasts;ganglion cell;gene replacement;gene replacement therapy;gene therapy;Genes;Glare;Goals;Hair;High Pressure Liquid Chromatography;high-throughput drug screening;Human;Hypopigmentation;improved;In Vitro;in vitro Model;in vivo;induced pluripotent stem cell;induced pluripotent stem cell technology;inhibitor;Length;Libraries;macula;Measures;Mediating;Melanins;Melanosomes;Modeling;Monophenol Monooxygenase;Morphology;mouse model;Mus;National Center for Advancing Translational Sciences;Natural Products;Oculocutaneous Albinism;Oculocutaneous albinism type 1;Operative Surgical Procedures;Optic Chiasm;Oral;orbit muscle;Pathogenesis;Pathologic Nystagmus;Patients;Pharmaceutical Preparations;Pharmacologic Substance;Pharmacotherapy;Phenotype;Photophobia;Physiology;Pigmentation physiologic function;Pilot Projects;postnatal;Proteins;Rattus;Refractive Errors;Research;response;Role;Skin;small molecule;Structure of retinal pigment epithelium;Testing;Tissues;Validation;Vision;vision aid;visual cycle;Visual impairment;Work;Zebrafish,Understanding the pathogenesis of and identifying treatments for albinism,470,NA,NA,NA,NA,16,NA,NA,1175643,NA
11189123,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000476,NA,NA,1ZIAEY000476-16,NEI:1342430\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,10272899 (contact),"SERGEEV, YURI  (contact)",NA,NA,NA,3-Dimensional;Achievement;Active Sites;Affect;age-related disease;Aging;AKT2 gene;Alleles;Amino Acid Sequence;Amino Acids;Anabolism;Anterior;Behavior;Binding;Biochemical;Biochemical Reaction;Biochemistry;Biophysics;Carboxylic Acids;Cells;Clinical;Clinical Research;Co-Immunoprecipitations;Compensation;Complex;Computer Models;Computer Simulation;Cysteine;Cytosolic Phospholipase A2;Data;Databases;dimer;Disease;disease phenotype;DNA Sequence Alteration;Docking;dopaquinone;Elements;Engineering;enzyme activity;enzyme substrate;Enzymes;Exhibits;experimental study;Eye;Eye diseases;flexibility;Free Energy;Functional disorder;Gait abnormality;Genes;Genetic;Genetic Annotation;genetic variant;Genotype;genus Solanum;Goals;Hair;Hereditary Eye Diseases;high-throughput drug screening;Homology Modeling;Human;Hydrolase;Hydroxylation;Hypopituitarism;improved;in silico;In Vitro;in vitro activity;Indolequinones;Indoles;Inherited;insight;interest;Investigation;Knowledge;Ligand Binding;Ligands;Light;Link;Lipids;Melanins;Metabolic Pathway;Methods;Missense Mutation;Modeling;models and simulation;Molecular;Molecular Chaperones;Molecular Conformation;molecular dynamics;molecular modeling;Monophenol Monooxygenase;Mutagenesis;mutant;Mutation;neuropathy target esterase;next generation sequencing;overexpression;oxidation;Pathogenicity;Pathway interactions;Patients;Pharmaceutical Preparations;Phenotype;Play;preference;Preventive therapy;Process;Production;programs;protein expression;protein misfolding;protein protein interaction;protein structure;protein structure function;Proteins;Pseudomonas aeruginosa;Reaction;Recombinant Proteins;Recombinants;Research;Role;Sequence Homologs;Severities;Severity of illness;simulation;small molecule;Standardization;Structure;Substrate Interaction;Sum;Technology;theories;therapeutic target;Thermodynamics;Tissues;tool;Tyrosine;Variant;Visual impairment;Visual System;Water;web site;Work,Proteins From Hereditary Eye Diseases: In silico and Experimental Studies,476,NA,NA,NA,NA,16,NA,NA,1342430,NA
11189124,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000488,NA,NA,1ZIAEY000488-16,NEI:1789907\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,9693880 (contact),"LI, WEI  (contact)",NA,NA,NA,Animal Model;Animals;Carrier Proteins;Cells;Chromatin;coping;Cornea;experience;experimental study;exportin 1 protein;Genetic Transcription;Genomics;Health;Hibernation;Human;human stem cells;Impairment;Importins;improved;in vivo;induced pluripotent stem cell;insight;interest;Intervention;islet;Larva;Life;Metabolic;Metabolic stress;Metabolism;Modeling;Modification;Mus;natural hypothermia;novel strategies;Nuclear;Nuclear Pore Complex Proteins;Obese Mice;Organ Preservation;Outcome;Pancreas;Pathologic;Play;practical application;Prediabetes syndrome;preservation;Preservation Technique;Proteomics;Retina;Retinal Diseases;Role;severe injury;Spermophilus;stem cell model;Sumoylation Pathway;Surveys;System;Temperature;Temperature Sense;Therapeutic;therapeutic target;Tissues;transcription factor;transcriptome sequencing;Work;Zebrafish,Adaptive changes of the ground squirrel retina during hibernation,488,NA,NA,NA,NA,16,NA,NA,1789907,NA
11189125,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000489,NA,NA,1ZIAEY000489-16,NEI:40680\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,8157480 (contact),"CHEW, EMILY Y (contact)",NA,NA,NA,"Adverse effects;Age;age related;Age related macular degeneration;Antioxidants;Artificial Intelligence;Ascorbic Acid;Beta Carotene;Blindness;Blood specimen;Case Study;Cataract;Categories;Clinical;clinical center;Clinical Trials;cohort;Copper;Data;deep learning;design;Development;Disease;Disease Progression;Documentation;Dose;Elderly;Enrollment;Evaluation;Event;Eye diseases;follow-up;Follow-Up Studies;Formulation;Fundus;Fundus photography;Goals;Individual;Intake;lens;Literature;logarithm;Lutein;macula;Manuscripts;Multicenter Trials;Natural History;Nutritional;Omega-3 Fatty Acids;ophthalmic examination;oral supplementation;Participant;Peer Review;Persons;Phase;Photography;Polyunsaturated Fatty Acids;Population;population based;Prognosis;Protocols documentation;Publishing;randomized, clinical trials;Recommendation;Reporting;Risk;Risk Factors;Sampling;Telephone;Visit;Visual Acuity;Vitamins;Xanthophylls;zeaxanthin;Zinc",Age-Related Eye Disease Follow-up Study (AREDS) Follow-up Study,489,NA,NA,NA,NA,16,NA,NA,40680,NA
11189126,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000490,NA,NA,1ZIAEY000490-15,NEI:2481462\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,10672755 (contact),"LI, TIANSEN  (contact)",NA,NA,NA,3D Print;Address;Adopted;Affect;Age;Ally;Animal Model;Animal Welfare;Apical;Area;Atmosphere;Attention;Axon;axon regeneration;axonal pathfinding;Biocompatible Materials;Biological;Biological Models;Bioreactors;Blindness;Cell Communication;Cell Culture Techniques;Cell Death;Cell Line;Cell Polarity;Cells;Cellular biology;Childhood;Cilia;Clarin-1;Complex;cost;Culture Media;deafness;design;Development;Diffuse;Discipline;Disease;disease model;effective therapy;Electrophysiology (science);Embryoid bodies;Engineering;Environment;experience;Exposure to;gene function;gene therapy;Generations;Genes;genetic analysis;genome editing;Harvest;human disease;Hydrogels;Hypoxia;improved;Incubated;induced pluripotent stem cell;interest;Investigation;Knowledge;Learning;Link;Liquid substance;Magnetism;Manuscripts;Measurement;Methods;Modeling;Molecular;Morphogenesis;mouse model;Muller&apos;s cell;Mutation;Neck;neural;Neural Retina;neurotrophic factor;novel;Nutrient;Nutrient availability;Optic vesicle;optical sensor;Organoids;Outcome;Oxygen;Oxygen Consumption;Partial Pressure;Pathogenicity;Pathway interactions;Phase;Phenotype;Photoreceptors;Pigment Epithelium;Preparation;Process;Production;protein transport;Proteins;Protocols documentation;Reproducibility;Research;Resources;Retina;Retinal Degeneration;Rodent Model;Role;RPGR gene;Side;Signaling Molecule;small molecule;Spottings;Stains;Starvation;Stem cell transplant;stem cells;Structure;Survival Rate;Synapses;Syndrome;Therapeutic;Therapeutic Studies;three dimensional structure;Tissues;USH1C gene;Usher Syndrome;Usher Syndrome Type 1;Vision,Disease mechanism and therapies for retinal degeneration,490,NA,NA,NA,NA,15,NA,NA,2481462,NA
11189127,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000498,NA,NA,1ZIAEY000498-15,NEI:223738\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,11127200 (contact),"CUKRAS, CATHERINE  (contact)",NA,NA,NA,Affect;Blood specimen;Caring;Chloroquine;Clinical;clinical center;Congresses;Data;Development;DNA Sequence Alteration;Family;field study;Fundus;Genes;Genetic;genetic analysis;Genetic Screening;Genotype;Hydroxychloroquine;Individual;Knowledge;Medical;Mutation;Observational Study;Operative Surgical Procedures;ophthalmic examination;Ophthalmologist;Other Genetics;Outpatients;Participant;participant enrollment;Patients;personalized medicine;Pharmaceutical Preparations;Phenotype;Physical Examination;Publishing;Recording of previous events;recruit;Retina;retinal toxicity;Testing;Time;Toxic effect;United States National Institutes of Health;Visit;Visual;Visual Fields,"Genotype - phenotype Study of Patients with Plaquenil-induced Retinal Toxicity,",498,NA,NA,NA,NA,15,NA,NA,223738,NA
11189128,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000502,NA,NA,1ZIAEY000502-15,NEI:1220391\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,9693880 (contact),"LI, WEI  (contact)",NA,NA,NA,Accounting;Anatomy;Axon;BCL9 gene;Cells;Color;Color Visions;Cone;Development;Electron Microscopy;Face;Foundations;ganglion cell;interest;Light;Mammals;Pattern;Physiological;preservation;Primates;Resolution;Retina;Retinal Cone;Signal Transduction;Spermophilus;Stimulus;System;Variant,Organization and development of the S-cone system,502,NA,NA,NA,NA,15,NA,NA,1220391,NA
11189129,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000509,NA,NA,1ZIAEY000509-14,NEI:313234\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,11127200 (contact),"CUKRAS, CATHERINE  (contact)",NA,NA,NA,Affect;Age related macular degeneration;Blindness;Categories;Clinical;Clinical assessments;Clinical Trials;Dark Adaptation;Darkness;Data;design;Detection;Disease;Disease Progression;Elderly;Eye;functional outcomes;Fundus photography;Impairment;Investigation;Late-Onset Disorder;Measures;Mediating;Monitor;Neurodegenerative Disorders;Nonexudative age-related macular degeneration;novel;novel therapeutics;Outcome Measure;Participant;participant enrollment;Pathology;Patient Self-Report;Patients;Persons;Protocols documentation;retinal rods;Rod;Schedule;Severities;Severity of illness;Time;Vision;Vision Screening;Visual;Visual Acuity;Visual impairment,Longitudinal Investigation of Dark Adaptation in Participants with AMD,509,NA,NA,NA,NA,14,NA,NA,313234,NA
11189130,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000511,NA,NA,1ZIAEY000511-13,NEI:3144541\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,11599184 (contact),"KRAUZLIS, RICHARD  (contact)",NA,NA,NA,Age;Anatomy;Animal Model;Animals;Area;Attention;Attention deficit hyperactivity disorder;autism spectrum disorder;Axon;Basal Ganglia;Behavior;Brain;Brain region;Cells;Cerebral cortex;cholinergic;Complement;Complex;Computer Models;Contralateral;Corpus striatum structure;Detection;Disease;Dopamine;Dorsal;Event;expectation;Face;Face Processing;Fiber;fovea centralis;frontal lobe;Genetic;Goals;Human;Image;in vivo;Individual;interest;Interneurons;Lateral Geniculate Body;Learning;Macaca;Methods;Midbrain structure;Modeling;Molecular Target;Monkeys;Motor;motor control;Mus;neuronal circuitry;Neurons;neurophysiology;nonhuman primate;novel;object recognition;operation;optogenetics;Output;Pathway interactions;Perception;Performance;Peripheral;Photometry;Phylogenetic Analysis;Play;Population;preference;Primates;Probability;Process;Property;Publishing;rapid detection;Recovery;Recovery of Function;recruit;response;Retina;Rewards;Rodent;Role;Route;Scientist;segregation;selective attention;Sensory;sensory cortex;Sensory Disorders;Signal Transduction;skills;Slice;somatosensory;Stimulus;Structure;superior colliculus Corpora quadrigemina;Synapses;System;Techniques;Testing;Thalamic structure;Therapeutic Intervention;Time;transmission process;virtual;Vision;Visual;Visual attention;visual control;Visual Cortex;Visual Fields;visual learning;visual motor;visual object processing;Visual Pathways;visual processing;Visual System;Work,Visual Circuits,511,NA,NA,NA,NA,13,NA,NA,3144541,NA
11189131,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000514,NA,NA,1ZIAEY000514-13,NEI:414933\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,77868117 (contact),"KEENAN, TIARNAN  (contact)",NA,NA,NA,Age related macular degeneration;biobank;Biological Markers;Biological Specimen Banks;biomarker identification;Clinical Data;clinical database;Collection;Data Collection;Data Set;design;Diabetic Retinopathy;Disease;Enrollment;Experimental Models;Eye;Genetic;genetic variant;Health;minimal risk;novel;ocular imaging;Outcome Measure;Participant;Pathogenesis;Phenotype;prospective;Protocols documentation;Reporting;Research;Retina;Retinal Diseases;Sampling;Schedule;Specific qualifier value;Standardization;study population;Testing;treatment response;Visual Acuity,NEI Intramural Biorepository for Retinal Diseases (12-EI-0042),514,NA,NA,NA,NA,13,NA,NA,414933,NA
11189132,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000522,NA,NA,1ZIAEY000522-13,NEI:101699\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,11127200 (contact),"CUKRAS, CATHERINE  (contact)",NA,NA,NA,Adverse event;Affect;Age Years;Anti-Inflammatory Agents;bevacizumab;Blindness;cellular targeting;central retinal vein occlusion;Chronic;Clinical Research;Data;design;Dose;Effectiveness;Eligibility Determination;Exhibits;Extravasation;Eye;Fluorescein Angiography;Generations;histological studies;Human;improved;Inflammation;Inflammatory;inhibitor;Injections;Injury;Length;Letters;Liquid substance;macula;macular edema;Masks;Measures;Mediation;Microglia;migration;Minocycline;Multicenter Studies;Natural History;Neurons;Oral;Participant;Perimetry;Persons;Pharmaceutical Preparations;placebo group;Placebos;primary outcome;Process;Property;Randomized;response;Retina;retinal toxicity;Retinal Vein Occlusion;Safety;safety outcomes;secondary outcome;Severities;Site;Source;Structure;systemic toxicity;Testing;Tetracyclines;Thick;Time;Treatment Factor;Vascular Endothelial Growth Factors;vein occlusion;Visit;Visual Acuity;Withdrawal,Eval. of Minocycline as a Microglia Inhibitor in Tx of CRVO and BRVO,522,NA,NA,NA,NA,13,NA,NA,101699,NA
11189133,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000528,NA,NA,1ZIAEY000528-13,NEI:40680\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,11599204 (contact),"ZEIN, WADIH  (contact)",NA,NA,NA,10q;11p;11q;17q;Affect;Air;Audiology;Auditory;autosome;Blood specimen;Bone Conduction;caloric stimulation;Categories;CDH23 gene;chromosome 5q loss;Chromosomes;Cities;Classification;Clinical;college;computerized;deaf;Disease;disease natural history;DNA;ear muscle;early childhood;Electroretinography;Enrollment;Equilibrium;Evaluation;Eye Movements;Fluorescein Angiography;Fundus photography;Genes;genetic deafness;Genetic study;genetic testing;Genotype;hearing impairment;Inherited;Knowledge;Lens Opacities;Life;Link;macula;macular edema;middle ear;Molecular;Molecular Genetics;Mutation;MYO7A gene;Natural History;Nature;New York;Night Blindness;Noise;oculomotor;Optic Nerve;otoacoustic emission;Participant;participant enrollment;Patients;PCDH15 gene;Phenotype;Phenylephrine;Photography;Positioning Attribute;Procedures;Protocols documentation;Reflex action;Rehabilitation therapy;Reporting;Retina;Retinitis Pigmentosa;Severities;Site;Speech Intelligibility;speech recognition;Syndrome;Testing;tomography;tool;Tropicamide;Tympanometry;United States National Institutes of Health;Universities;USH1C gene;USH2A gene;Usher Syndrome;Usher Syndrome Type 1;Usher Syndrome Type 2;Vestibular dysfunction;Vestibular function;Vestibular Function Tests;vestibular system;Vision;Visit;Visual Acuity;Visual Fields;VLGR1 gene;WHRN gene,Natural History and Genetic Studies of Usher Syndrome,528,NA,NA,NA,NA,13,NA,NA,40680,NA
11189134,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000530,NA,NA,1ZIAEY000530-12,NEI:337641\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,11127208 (contact),"QIAN, HAOHUA  (contact)",NA,NA,NA,adeno-associated viral vector;Anatomy;Animal Model;Animals;behavior test;Code;Darkness;Databases;early detection biomarkers;effectiveness evaluation;Electrophysiology (science);Evaluation;Fundus;Gene Expression;gene replacement therapy;Genes;Goals;Health;Human;Image;in vivo;inherited retinal degeneration;interest;intravitreal injection;Manuals;Methods;mouse model;Mus;novel;Optical Coherence Tomography;Patients;Pattern;restoration;Retina;retinal imaging;Severities;Signal Pathway;Signal Transduction;Subgroup;Techniques;Testing;therapeutic gene;Time;tool;Transgenic Organisms;Vision;Visual;visual performance,Evaluation of Visual Function in Animal Models,530,NA,NA,NA,NA,12,NA,NA,337641,NA
11189135,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000534,NA,NA,1ZIAEY000534-12,NEI:756642\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,10272888 (contact),"BROOKS, BRIAN  (contact)",NA,NA,NA,Address;Age;Biological Assay;Blood specimen;Cell Differentiation Induction;Cells;Cellular biology;Child;Clinic;Clinical;clinical outcome measures;Clinical Trials;cohort;Consent;Darkness;Data;Data Analyses;deep learning;Diagnostic Imaging;Disease;disease model;Disease Progression;DNA;Dose;efficacy testing;Electrophysiology (science);Electroretinography;Eligibility Determination;Enrollment;Evaluation;Eye;Family;FDA approved;Fibroblasts;Five-Year Plans;Flecks;follow-up;Formulation;functional outcomes;Future;Generations;genetic testing;Genotype;Goals;high-throughput drug screening;Image;In Vitro;induced pluripotent stem cell;Institutional Review Boards;Investigation;Measures;Medical;Medical Genetics;Medical Records;membrane-associated placental tissue protein 1;Metformin;Molecular;Monitor;Natural History;Neural Retina;novel;Nuclear;open label;ophthalmic examination;Optical Coherence Tomography;Oral cavity;Outcome;Outcome Measure;Outcome Study;Participant;participant enrollment;Pathogenesis;Patients;Perimetry;Pharmaceutical Preparations;Phase II Clinical Trials;Phenotype;Plasma;Population Study;primary outcome;Protocols documentation;Psychophysiology;Questionnaires;Recording of previous events;recruit;repository;Research;Research Personnel;Retina;Retinal Diseases;Safety;Sampling;Scanning;secondary outcome;Serum;Skin;skin biopsy;Standardization;Structure of retinal pigment epithelium;Techniques;Therapeutic;Thinness;Time;time use;Titrations;treatment trial;United States National Institutes of Health;Vision;Vision Tests;Visit,Natural History of ABCA4-Related Retinopathies,534,NA,NA,NA,NA,12,NA,NA,756642,NA
11189136,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000536,NA,NA,1ZIAEY000536-11,NEI:40680\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,8157480 (contact),"CHEW, EMILY Y (contact)",NA,NA,NA,Affect;Area;Blindness;Ciliary Neurotrophic Factor;Degenerative Disorder;Devices;Disease;Enrollment;Eye;follow-up;Goals;Implant;implantable device;implantation;macula;Manuscripts;Measures;Multicenter Studies;Nerve Degeneration;Participant;Phase;Phase II Clinical Trials;phase II trial;Phase III Clinical Trials;Photoreceptors;Placebos;primary endpoint;Protocols documentation;Publications;Reporting;Retina;Safety;sham surgery;Site;Telangiectasis;Testing;United States National Institutes of Health;Visit,"Phase 2 Clinical Trial of Ciliary Neurotrophic Factor (CNTF) for Macular Telangiectasia Type 2 (MacTel) (14-EI-0078, 17-EI-0136)",536,NA,NA,NA,NA,11,NA,NA,40680,NA
11189137,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000543,NA,NA,1ZIAEY000543-11,NEI:24408\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,11127200 (contact),"CUKRAS, CATHERINE  (contact)",NA,NA,NA,Adverse event;Affect;Animal Model;Antibiotics;Bilateral;Blindness;Categories;Cell Death;Cells;clinical trial enrollment;constriction;Contralateral;Cystoid Macular Edema;Development;Disease;Etiology;Eye;FDA approved;Genetic Diseases;glial activation;Immune;Inflammatory;Intervention;Label;Letters;macula;macular edema;Measurement;Measures;Microglia;Minocycline;neuroinflammation;neuroprotection;open label;Optical Coherence Tomography;Oral;Oral Administration;Outcome;Participant;Patients;Perimetry;Peripheral;Pharmaceutical Preparations;Phase I/II Clinical Trial;Pilot Projects;Process;Production;prospective;response;Retina;Retinitis Pigmentosa;Safety;Thick;Time;Vision;Visual Acuity;Visual Fields,Pilot Study to Evaluate Oral Minocycline in the Treatment of Cystoid Macular Edema Associated with Retinitis Pigmentosa,543,NA,NA,NA,NA,11,NA,NA,24408,NA
11189138,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000544,NA,NA,1ZIAEY000544-10,NEI:3762872\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,14282336 (contact),"TAM, JOHNNY  (contact)",NA,NA,NA,adaptive optics;Aging;Area;Artificial Intelligence;Cells;cellular imaging;Cellular Structures;Clinic;clinical application;clinical center;clinical imaging;Cloud Computing;Collaborations;Custom;Data;Data Science;Data Set;design;Detection;Development;Diagnosis;Disease;Disease Progression;Extramural Activities;Eye;Eye diseases;Female;Functional disorder;generative artificial intelligence;Goals;healthy volunteer;Human;human imaging;Image;Image Enhancement;imaging approach;Imaging Device;imaging modality;imaging platform;imaging program;Imaging technology;improved;instrumentation;Light;live cell imaging;male;Measures;Microscopic;National Eye Institute;National Institute of Biomedical Imaging and Bioengineering;Nature;Neurodegenerative Disorders;next generation;Noise;Onset of illness;Ophthalmoscopes;Optical Coherence Tomography;optical imaging;Optical Instrument;Optical Methods;Optics;Patients;Pilot Projects;programs;Research;Resolution;Retina;Retinal Diseases;retinal imaging;Role;Scanning;sex;Signal Transduction;Speed;Stream;Structure;Structure of retinal pigment epithelium;Techniques;Technology;Time;United States National Institutes of Health;Universities;Visualization,Adaptive Optics Retinal Imaging,544,NA,NA,NA,NA,10,NA,NA,3762872,NA
11189139,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000546,NA,NA,1ZIAEY000546-10,NEI:3937795\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,1863448 (contact),"SWAROOP, ANAND  (contact)",NA,NA,NA,Affect;age effect;Age related macular degeneration;Aging;Autopsy;autosome;base;Basic Science;case control;Cell Death;Cells;Clinical;cohort;Collaborations;Complement;complement pathway;Complex;CRISPR/Cas technology;Data;Defect;Development;Dexamethasone;Diet;Disease;disease phenotype;Disease Progression;disease-causing mutation;DNA Methylation;DNA methylation profiling;drug candidate;drug discovery;Effectiveness;Environment;Environmental Risk Factor;epigenetic regulation;epigenome;Exhibits;exome;Family;Fluorescence;Functional disorder;Gene Expression;gene regulatory network;Genes;genetic association;Genetic Counseling;Genetic Determinism;Genetic study;Genetic Variation;Genome;genome sequencing;genome wide association study;Genotype;Glaucoma;Goals;Human;Immune;Immune response;induced pluripotent stem cell;Inherited;insight;Intervention;Knockout Mice;lead candidate;Leber&apos;s amaurosis;Literature;macula;Macular degeneration;Manuscripts;Metabolic Pathway;Methods;Methylation;Modality;Modeling;Molecular;mouse model;Mus;Mutation;Nerve Degeneration;novel;novel therapeutics;Organoids;Pathogenesis;Pathology;Pathway interactions;Patients;Phenotype;Photoreceptors;Phototransduction;Preparation;Promoter Regions;protein expression;Publishing;Quantitative Trait Loci;rare variant;Rattus;Reporter Genes;Reporting;Research;Reserpine;Retina;Retinal Degeneration;Retinal Diseases;Retinitis Pigmentosa;Rhodopsin;RNA Editing;RNA Splicing;Rod;Role;segregation;Services;Signal Pathway;Site;small molecule;Testing;Therapeutic;therapeutic candidate;therapeutic development;Therapeutic Intervention;TIMP3 gene;Trabecular meshwork structure;trait;transcriptome;transcriptome sequencing;Untranslated RNA;Variant;Visual impairment;whole genome;Work,"Mechanisms, modeling and therapies of retinal and macular neurodegeneration",546,NA,NA,NA,NA,10,NA,NA,3937795,NA
11189140,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000552,NA,NA,1ZIAEY000552-09,NEI:378321\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,11984467 (contact),"JEFFREY, BRETT  (contact)",NA,NA,NA,Age related macular degeneration;Amendment;Area;Australia;Cessation of life;Cladribine;Clinical;Clinical Trials;Collaborations;Color;Cone;Custom;Dark Adaptation;Darkness;Discrimination;Disease;Early Diagnosis;Enrollment;Family;FDA approved;Functional disorder;Fundus;healthy volunteer;instrument;Kinetics;late-onset retinal degeneration;Light;macula;Measures;Mediating;member;Methods;Modification;Monitor;Normal Range;novel;Outcome Measure;Participant;Patients;Pattern;Perimetry;Process;Protocols documentation;Psychophysics;Publishing;recruit;Retina;Retinal Cone;Retinal Degeneration;Retinal Diseases;Rod;Schedule;Shapes;Stimulus;systems research;Telangiectasis;Testing;Vertebrate Photoreceptors;Visual Fields,Rod and Cone Mediated Function in Retinal Disease,552,NA,NA,NA,NA,9,NA,NA,378321,NA
11189141,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000553,NA,NA,1ZIAEY000553-09,NEI:390525\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,16173245 (contact),"HURYN, LARYSSA  (contact)",NA,NA,NA,Affect;Anatomy;Ataxia;Atrophic;autosome;Blindness;CAG repeat;Case Series;Case Study;Characteristics;Clinical;clinical outcome measures;Clinical Trials;Code;cohort;comorbidity;Data Analyses;DNA;Enrollment;Fibroblasts;Future;Genes;Genetic Anticipation;Individual;information gathering;Life Style Modification;Molecular;Natural History;Nerve Degeneration;Neurodegenerative Disorders;neuroimaging;Participant;Patients;Plasma;Population;prospective;Quality of life;Reporting;repository;Retina;Retinal Degeneration;Sampling;Skin;Spinocerebellar Ataxias;Time;Type 7 Spinocerebellar Ataxia,Natural History of Spinocerebellar Ataxia Type 7 (SCA7),553,NA,NA,NA,NA,9,NA,NA,390525,NA
11189142,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000554,NA,NA,1ZIAEY000554-09,NEI:126107\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,77868117 (contact),"KEENAN, TIARNAN  (contact)",NA,NA,NA,Adverse event;Affect;Age related macular degeneration;Aging;Area;arm;Atrophic;Blindness;Cells;Choroidal Neovascularization;Cicatrix;Clinical;Development;Dose;Dryness;Etiology;Evaluation;Eye;Fundus;Fundus photography;geographic atrophy;Geographic Locations;human old age (65+);Image;Immune;Impairment;Inflammation;Inflammatory;luminance;macula;Macular degeneration;Measures;Microglia;Minocycline;neovascular;ocular surface;Oral;Participant;Patient Recruitments;Patients;Perimetry;Persons;Phase;phase 2 study;Photoreceptors;prevent;primary outcome;Process;prospective;rate of change;Reading;recruit;Retina;Retinal Degeneration;Running;Safety;safety outcomes;secondary outcome;Severities;Structure of retinal pigment epithelium;Study Subject;United States;Visit;Visual Acuity,Evaluation of Oral Minocycline in Treating Geographic Atrophy Associated with Age-Related Macular Degeneration,554,NA,NA,NA,NA,9,NA,NA,126107,NA
11189143,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000555,NA,NA,1ZIAEY000555-09,NEI:40680\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,8157480 (contact),"CHEW, EMILY Y (contact)",NA,NA,NA,Adrenal Glands;Adverse event;Affect;aggressive therapy;angiogenesis;antagonist;Appearance;autosome;Benign;Blindness;Brain;Broad Ligament;Cell Line;cell type;Cyst;design;Disease;Electronics;eligible participant;Epididymis;experience;Exudate;Eye;Fibrosis;Fluorescein Angiography;Fundus photography;Hereditary Disease;Histopathology;Individual;intravitreal injection;Investigational Therapies;Kidney;Labyrinth;Letters;Malignant Neoplasms;Manuscripts;Measures;Mediator;open label;Operative Surgical Procedures;Optical Coherence Tomography;Outcome Measure;Outcome Study;Pancreas;Paper;Participant;PDGFA gene;Phase;phase 1 study;Phase I/II Trial;Platelet-Derived Growth Factor;primary outcome;Proliferating;prospective;Publications;Publishing;ranibizumab;Reporting;Retina;Role;Safety;secondary outcome;Spider nevus;Spinal Cord;standard care;study population;Testing;Traction;tumor;United States;Vascular Endothelial Growth Factors;Vascular Permeabilities;VEGFA gene;VHL protein;Vision;Visual Acuity;Von Hippel-Lindau Syndrome,A Phase I/II Trial for Intravitreous Treatment of Severe Ocular von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab (16-EI-0159),555,NA,NA,NA,NA,9,NA,NA,40680,NA
11189144,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000556,NA,NA,1ZIAEY000556-08,NEI:488156\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,9693896 (contact),"CASPI, RACHEL R. (contact)",NA,NA,NA,active method;Adrenal Cortex Hormones;Affect;age related;Anatomy;Animal Model;Anterior;arm;Basic Science;biobank;Biological;Biological Assay;Blindness;Categories;Cells;Clinical;Clinical Markers;Clinical Research;clinical subtypes;Clinical Trials;cohort;commensal microbes;design;Diagnostic;Disease;Disease remission;Enrollment;epigenomics;Failure;Flare;Flow Cytometry;Gene Expression Profiling;Goals;gut dysbiosis;gut microbiome;gut microbiota;healthy volunteer;high dimensionality;high risk;Human;human disease;Immune;immune function;immune modulating agents;Immune system;Immunologics;improved;Individual;Inflammation;Inflammatory;innovation;Intermediate Uveitis;Intervention;Laboratories;Location;Manuscripts;Mediating;microbial;microbiome;Molecular;Molecular Immunology;Molecular Profiling;Panuveitis;Participant;Pathogenesis;patient oriented;patient subsets;Patients;Peripheral Blood Mononuclear Cell;personalized medicine;Pharmaceutical Preparations;Phenotype;Pilot Projects;Posterior Uveitis;Prediction of Response to Therapy;Preparation;Prognosis;prognosis biomarker;programs;prospective;Proteomics;Role;Sampling;single cell sequencing;standard of care;stool sample;systemic autoimmune disease;Techniques;Therapeutic;Tissues;transcriptome sequencing;transcriptomics;translational approach;Translational Research;Treatment Protocols;treatment responders;treatment response;Undifferentiated;unnecessary treatment;Uveitis;Vision,Studies of Ocular inflammation: Clinical & Translational Research,556,NA,NA,NA,NA,8,NA,NA,488156,NA
11189145,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000558,NA,NA,1ZIAEY000558-08,NEI:4312048\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,15200456 (contact),"CONWAY, BEVIL  (contact)",NA,NA,NA,Anatomy;Animals;Anterior;Area;Auditory;Banana;Behavior;Behavioral;Biological Models;Brain;Brain imaging;Categories;Cells;Cerebral cortex;Characteristics;Child;Cognition;Cognitive;cognitive process;Cognitive Science;Color;color category;comparative;comparison group;Complex;Computer Models;Concept Formation;Cone;Consensus;convolutional neural network;Cues;Data;Data Set;Ear;Emotions;experience;experimental study;extrastriate visual cortex;Eye;fovea centralis;Frequencies;Functional Magnetic Resonance Imaging;gaze;Goals;Heart;Human;Image;Individual;Inferior;information processing;Investments;Journals;Knowledge;Language;large datasets;Learning;Likelihood Functions;Macaca;Magnetic Resonance Imaging;Maps;Measures;meetings;Memory;Methods;Microelectrodes;microstimulation;Mind;Modeling;Monkeys;movie;neural;neuroethology;neuroimaging;Neurons;neurophysiology;Neurosciences;Noise;non-verbal;nonhuman primate;object shape;Paper;Pattern;Perception;Persons;pharmacologic;Photoreceptors;Physiological;Play;Population;Positioning Attribute;Primates;Process;programs;psychologic;Psychophysics;Publications;Publishing;receptive field;Redness;Research;Research Personnel;Research Technics;Resolution;response;Retina;retinotopic;Reverse engineering;Role;Sampling;Scanning;Science;science and society;Sensory;Shapes;Signal Transduction;social cognition;Societies;Source;spatiotemporal;Stimulus;Strawberries;Structure;Temporal Lobe;Testing;Thinking;tool;trend;ventral visual stream;Vision;vision science;Visual;Visual Cortex;Visual Fields;Visual Pathways;visual processing;visual search;visual stimulus;visual tracking;Visualization;Work,"Using Color as a Model System for studying Perception, Thoughts, and Action",558,NA,NA,NA,NA,8,NA,NA,4312048,NA
11189146,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000560,NA,NA,1ZIAEY000560-07,NEI:44748\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,8157480 (contact),"CHEW, EMILY Y (contact)",NA,NA,NA,Addendum;Age related macular degeneration;Biological Markers;Biological Specimen Banks;biomarker identification;Blindness;British;Certification;Classification;Classification Scheme;Clinic;clinical research site;Data;Data Analyses;Derivation procedure;Development;Elderly;Eligibility Determination;Equipment;Future;Genetic Determinism;genetic information;Genotype;Human Resources;Image;Imaging technology;Institutional Review Boards;international center;Leadership;Longitudinal Studies;Measurement;Multicenter Studies;Natural History;operation;oral supplementation;Outcome;Participant;Patient Recruitments;Patients;Phase II Clinical Trials;Phenotype;Reading;recruit;Research Personnel;Resources;Retina;serial imaging;Site;Standardization;System;Therapeutic;United States;United States National Institutes of Health;Vision;vision development,AMD Ryan Initiative Study (ARIS),560,NA,NA,NA,NA,7,NA,NA,44748,NA
11189147,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000562,NA,NA,1ZIAEY000562-06,NEI:101699\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,11127200 (contact),"CUKRAS, CATHERINE  (contact)",NA,NA,NA,Agreement;Clinical;clinical outcome measures;Clinical Trials;design;Diagnosis;Disease Progression;Electroretinography;Enrollment;Evaluation;Functional disorder;functional outcomes;Future;Goals;imaging modality;Intervention;Kinetics;Length;macula;Maps;Measures;Nature;neuroinflammation;novel;Optical Coherence Tomography;Outcome Measure;Participant;Patients;Perimetry;photoreceptor degeneration;Photoreceptors;primary outcome;Process;Psychophysics;Quantitative Evaluations;Retina;Retinitis Pigmentosa;scaffold;secondary outcome;Severities;study population;Surveys;Testing;Therapeutic Intervention;Thick;Time;Transplantation;Visual Acuity;Visualization,A Survey study of Retinitis Pigmentosa (RP) clinical measures and repeatability testing of potential outcome measures,562,NA,NA,NA,NA,6,NA,NA,101699,NA
11189148,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000564,NA,NA,1ZIAEY000564-06,NEI:1383110\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,79973024 (contact),"GUAN, BIN  (contact)",NA,NA,NA,achromatopsia;Albinism;Aniridia;Anophthalmos;Autosomal Dominant Optic Atrophy;Axenfeld-Rieger syndrome;bioinformatics pipeline;Blood;blue cone monochromacy;causal variant;Cell Line;Choroideremia;Classification;CLIA certified;Clinic;Clinical;clinical care;clinical center;clinical phenotype;Clinical Protocols;Clinical Services;cohort;Collaborations;Coloboma;cone-rod dystrophy;Corneal dystrophy;Data;Data Set;design;Development;Diagnostic tests;Dideoxy Chain Termination DNA Sequencing;digital;Disease;DNA;epigenomics;exome;exome sequencing;Extramural Activities;Frequencies;functional genomics;Genes;Genetic;genetic testing;Genome;genome sequencing;Genomics;Goals;Heritability;Human;improved;in silico;Individual;insertion/deletion mutation;Laboratories;Leber&apos;s Hereditary Optic Neuropathy;malformation;meetings;Microphthalmos;Mitochondrial DNA;Molecular;molecular diagnostics;Molecular Genetics;next generation sequencing;Night Blindness;novel;Outsourcing;Patients;pattern dystrophies;programs;Protocols documentation;Publishing;recruit;Reporting;Research;Retinal Degeneration;Retinitis Pigmentosa;Sampling;segregation;Single Nucleotide Polymorphism;Site;Skin;Sorsby&apos;s fundus dystrophy;Stargardt&apos;s disease;Stickler syndrome;Testing;tool;Usher Syndrome;Variant;variant of unknown significance;Vision Disorders;Vitelliform macular dystrophy;X-Linked Retinoschisis,Clinical ophthalmic molecular diagnostics and discovery,564,NA,NA,NA,NA,6,NA,NA,1383110,NA
11189149,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000565,NA,NA,1ZIAEY000565-06,NEI:2359423\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,15200443 (contact),"HUFNAGEL, ROBERT  (contact)",NA,NA,NA,Address;Affect;Animal Model;Area;ATAC-seq;Bibliography;Biological Models;Birds;Blindness;BMPR1A gene;candidate validation;causal variant;Cell Line;Cell model;Cells;Cellular biology;Child;Childhood;Code;Collaborations;congenital vision disorder;CRISPR/Cas technology;Data;Development;Developmental Biology;Diagnostic;Disease;Dysplasia;Education;Employment;epigenomics;Eye;Eye diseases;fovea centralis;Frequencies;functional genomics;gene therapy;Generations;Genes;Genetic;Genetic Screening;genetic testing;genetic variant;Genetic Variation;Genome;genomic locus;genomic platform;genomic variation;Genomics;Goals;Hereditary Disease;Heritability;Hi-C;Human;human disease;human model;In Vitro;induced pluripotent stem cell;Investigation;Knowledge;Laboratories;Live Birth;Lizards;Machine Learning;macula;malformation;Maps;Medical Genetics;Medicine;Modeling;Molecular;Molecular Biology;Molecular Diagnosis;molecular diagnostics;Morbidity - disease rate;Morphology;Mus;Neural Retina;novel;novel strategies;Pathogenicity;Patients;Population;Population Study;preclinical study;prevent;Primates;programs;Proteins;public database;Replacement Therapy;Research;Retinal Degeneration;RNA-Binding Proteins;Science;Shock;single cell sequencing;Sumoylation Pathway;Syndrome;Techniques;Technology;Tissues;transcriptome sequencing;transcriptomics;Untranslated RNA;Variant;Vision;Work;Zebrafish,Genomic and epigenomic mechanisms of pediatric ocular disorders,565,NA,NA,NA,NA,6,NA,NA,2359423,NA
11189150,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000566,NA,NA,1ZIAEY000566-06,NEI:20340\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,8157480 (contact),"CHEW, EMILY Y (contact)",NA,NA,NA,Affect;Anatomy;Area;Blindness;Cells;Ciliary Neurotrophic Factor;Clinic;Clinical Trials;Controlled Clinical Trials;Degenerative Disorder;design;Deterioration;Diabetic Retinopathy;Diagnosis;Disease;Disease Progression;Early treatment;effective therapy;efficacy evaluation;Eligibility Determination;Encapsulated;Enrollment;Exclusion Criteria;Eye;follow-up;Goals;Image;Implant;Intervention;Intervention Studies;Letters;macula;Masks;Measures;Multicenter Studies;Multicenter Trials;Operative Surgical Procedures;Ophthalmologist;Outcome Measure;Participant;Perimetry;Persons;Pharmacologic Substance;Phase;phase 3 study;Phase I Clinical Trials;Phase II Clinical Trials;phase II trial;Phase III Clinical Trials;phase III trial;Photoreceptors;placebo group;Placebos;primary endpoint;primary outcome;Questionnaires;Randomized;rate of change;Reading;Reporting;Retina;Safety;safety testing;screening;secondary outcome;Serious Adverse Event;sham surgery;sham-controlled study;Signal Transduction;Site;Speed;study population;Surgeon;Surgical complication;Telangiectasis;Telephone;Testing;Thick;treatment group;Vision;Visual Acuity,"A Phase 3 Multicenter, Randomized, Sham-Controlled Study to Determine the Safety and Efficacy of Renexus in Macular Telangiectasia Type 2",566,NA,NA,NA,NA,6,NA,NA,20340,NA
11189151,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000568,NA,NA,1ZIAEY000568-06,NEI:44748\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,11127200 (contact),"CUKRAS, CATHERINE  (contact)",NA,NA,NA,Adverse reactions;Dark Adaptation;design;Eligibility Determination;Enrollment;Event;improved;Investigation;Kinetics;luminance;Measurement;Measures;Outcome Measure;Participant;Patient Outcomes Assessments;Patients;primary outcome;prospective;Questionnaires;retinyl palmitate;secondary outcome;study population;Supplementation;Visual Acuity,An Investigation of Vitamin A Palmitate Supplementation in Patients withAMD and/or Reticular Pseudodrusen (RPD) and Delayed Dark Adaptation,568,NA,NA,NA,NA,6,NA,NA,44748,NA
11189152,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000569,NA,NA,1ZIAEY000569-05,NEI:2074665\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,77868128 (contact),"SHIH, HAN-YU  (contact)",NA,NA,NA,3-Dimensional;Alzheimer&apos;s Disease;Amyloidosis;Architecture;Autoimmunity;Binding;Binding Sites;Biological;brain parenchyma;CD8-Positive T-Lymphocytes;Cells;Chromatin;Chromatin Loop;cytokine;Cytokine Gene;Development;Dimensions;Disease;disorder prevention;DNA;DNA Methylation;Elements;Engineering;Epigenetic Process;Exhibits;Flow Cytometry;Gene Expression Regulation;Genes;Genome;Genomics;Glaucoma;Helper-Inducer T-Lymphocyte;histone modification;Homeostasis;Host Defense;Human;Immune;Immune response;Immunity;Immunology;immunoregulation;Impairment;Infiltration;insight;Interferon Type I;Interferon Type II;interleukin-22;Knowledge;Lymphocyte;Lymphoid Cell;Mediating;Molecular;mouse model;Mus;Nerve Degeneration;Neurodegenerative Disorders;neuroinflammation;Nucleic Acid Regulatory Sequences;Phenotype;Play;Positioning Attribute;Predisposition;Production;Regulation;Regulatory Element;Research;Role;Science;Signaling Molecule;single-cell RNA sequencing;Site;Specific qualifier value;Stimulus;Synteny;Techniques;Th1 Cells;Tissues;Toxoplasmosis;transcription factor;Variant,Genomic regulation of immune response in neurodegeneration in mice,569,NA,NA,NA,NA,5,NA,NA,2074665,NA
11189153,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000570,NA,NA,1ZIAEY000570-05,NEI:1859062\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,77868130 (contact),"NIENBORG, HENDRIKJE  (contact)",NA,NA,NA,Acoustics;Address;Affect;Anatomy;Animal Behavior;Animals;Area;area striata;Attention;Behavior;behavior influence;behavior prediction;Behavioral;Biological;Brain;Brain region;Cerebral cortex;Characteristics;Cognitive;Collaborations;Communication;Complex;cost;Data;Data Set;Decision Making;Desire for food;Development;dimension reduction;discrimination task;dorsal raphe nucleus;Electrophysiology (science);extrastriate visual cortex;Eye;Eye Movements;Face;Feedback;flexibility;follow-up;Funding;Hand;Hibernation;high dimensionality;Human;improved;Individual;information processing;Knowledge;Learning;learning strategy;Light;Macaca;Machine Learning;Mammals;Measurement;Mental disorders;Modeling;Monkeys;Motion;Motor Activity;Movement;Mus;Nervous System Disorder;neural;Neurobiology;Neuromodulator;Neurons;neurophysiology;neuroregulation;Neurosciences;neurotransmission;optogenetics;Organism;Performance;pharmacologic;Physiological;Primates;Property;Publications;Reporting;Research;response;retinal imaging;Robotics;Rodent;Role;Saccades;sample fixation;Science;selective attention;Sensory;Sensory Process;Serotonergic System;Serotonin;serotonin receptor;Signal Transduction;Spermophilus;statistics;Stimulus;Structure;System;Techniques;Testing;tool;Training;training project;unsupervised learning;vigilance;Vision;Visual;Visual Cortex;visual discrimination;Visual Fields;visual information;visual processing;visual stimulus;vocalization;Work,Neural Substrates for Visual Decision Making in the Visual Cortex,570,NA,NA,NA,NA,5,NA,NA,1859062,NA
11189154,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000571,NA,NA,1ZIAEY000571-05,NEI:256282\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,11984467 (contact),"JEFFREY, BRETT  (contact)",NA,NA,NA,Affect;Assessment tool;Biological Markers;Clinical;clinical outcome measures;Clinical Trials;Clinical Trials Design;Color Visions;Consumption;Contrast Sensitivity;Cross-Sectional Studies;Data;disability;experience;Floor;functional outcomes;Goals;healthy volunteer;Measures;Normal Range;novel;Outcome Measure;Patient Recruitments;Patients;Performance;Perimetry;Photosensitivity;Protocols documentation;Reality Testing;recruit;Retinal Diseases;Testing;Time;Training;virtual;virtual reality;Vision;Visual Acuity;Visual Fields;Visual impairment;walking speed,An Observational Cross-Sectional Study of Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease,571,NA,NA,NA,NA,5,NA,NA,256282,NA
11189155,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000572,NA,NA,1ZIAEY000572-05,NEI:40680\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,8157480 (contact),"CHEW, EMILY Y (contact)",NA,NA,NA,Adolescent;Adverse event;Affect;Antibodies;Blindness;Data;design;Dose;efficacy evaluation;Electroretinography;Enrollment;Eye;first-in-human;follow-up;Gene Transfer;Genes;Genetic;Injections;intravitreal injection;Laboratories;Link;Macular degeneration;male;Measurement;Monitor;Optical Coherence Tomography;Outcome Measure;Participant;Phase;Phase I/II Clinical Trial;primary outcome;prospective;Publishing;response;Retina;Retinal Diseases;retinal imaging;Safety;Sample Size;Scheme;secondary outcome;statistics;Structure;study population;Testing;Transgenes;vector;Vision;Visual Fields;X-Linked Retinoschisis;young man,A Phase I/IIa Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis,572,NA,NA,NA,NA,5,NA,NA,40680,NA
11189156,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000574,NA,NA,1ZIAEY000574-04,NEI:20340\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,11127200 (contact),"CUKRAS, CATHERINE  (contact)",NA,NA,NA,adaptive optics;Affect;Basement membrane;Biological Markers;Cellular Morphology;Cellular Structures;Clinical;cohort;design;Development;Diagnostic Procedure;Disease;Enrollment;Eye diseases;healthy volunteer;human subject;Image;imaging system;instrument;Investigation;Lasers;Location;Longitudinal Studies;multimodality;novel diagnostics;novel therapeutics;Ophthalmoscopy;Optical Coherence Tomography;optical imaging;Outcome Measure;Participant;Pathology;Photoreceptors;primary outcome;protocol development;Protocols documentation;Resolution;Retina;Retinal Diseases;retinal imaging;Scanning;Structure of retinal pigment epithelium;study population,Adaptive Optics Imaging of Outer Retinal Diseases,574,NA,NA,NA,NA,4,NA,NA,20340,NA
11189157,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000576,NA,NA,1ZIAEY000576-04,NEI:130175\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,11984467 (contact),"JEFFREY, BRETT  (contact)",NA,NA,NA,Atrophic;Canada;Collaborations;Cross-Sectional Studies;Data;disorder of macula of retina;Enrollment;Family;follow-up;Funding;Funding Agency;Funding Mechanisms;Goals;Institution;macula;member;Mutation;Natural History;Participant;Patient Recruitments;Patients;Phase;Prevalence;prospective;Protocols documentation;Rare Diseases;recruit;Secondary to;Stargardt&apos;s disease;Switzerland;Therapeutic;Time;Travel;United States National Institutes of Health;Universities;Visit;Work,An Observational Prospective Natural History Study of Stargardt-like Macular Dystrophy (STDG3) Secondary to Mutations in ELOVL4,576,NA,NA,NA,NA,4,NA,NA,130175,NA
11189158,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000577,NA,NA,1ZIAEY000577-04,NEI:386457\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,79365502 (contact),"REDMOND, T. MICHAEL  (contact)",NA,NA,NA,2019-nCoV;ACE2;Amino Acids;Antibodies;Antibody Therapy;Appearance;base;Biochemical;Biochemistry;Blocking Antibodies;Caveolae;caveolin 1;Cell Line;Cell Survival;Cells;Child;China;Cholesterol;Codon Nucleotides;Conjunctivitis;Coronavirus;COVID-19;COVID-19 pandemic;Data;Disease;Dynamin;Dynamin I;economic impact;Endocytosis;Evolution;experimental study;extracellular;Eye;Glycoproteins;Goals;Human;Infection;interest;Knowledge;Lung;Mediating;Membrane;Membrane Microdomains;Morbidity - disease rate;mortality;Mutagenesis;mutant;Mutation;Nonsense Codon;novel;novel coronavirus;ocular surface;Organ;Organoids;particle;Pathway interactions;Peptide Hydrolases;Play;Posterior Uveitis;Process;Property;Protein Biochemistry;protein expression;Proteins;Public Health;Publications;Publishing;receptor;Regulation;Reporting;Rest;Ribosomes;RNA Biochemistry;RNA Sequences;Role;SARS coronavirus;SARS-CoV-2 B.1.1.529;SARS-CoV-2 B.1.617.2;SARS-CoV-2 spike protein;SARS-CoV-2 variant;Site;skills;Small Interfering RNA;Structure;Tertiary Protein Structure;Toxic effect;Transfection;Translations;Variant;Vimentin;Viral Conjunctivitis;Virulence;Virulence Factors;Virus;Vision research;weapons,Biochemistry of SARS-CoV-2 Spike Protein and its Ocular Surface Membrane Receptor,577,NA,NA,NA,NA,4,NA,NA,386457,NA
11189159,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000578,NA,NA,1ZIAEY000578-01,NEI:101699\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,79973036 (contact),"MAGONE, M. TERESA  (contact)",NA,NA,NA,Address;Affect;Autoimmune;Biological Assay;Biological Markers;Blood Tests;Calibration;chemokine;Clinic Visits;Clinical;clinical care;clinical examination;Clinical Management;Clinical Research;Collection;Cornea;Custom;cytokine;Diagnosis;Diagnostic;Disease;Dry Eye Syndromes;Enzyme-Linked Immunosorbent Assay;Evaluation;Film;Functional disorder;Growth Factor;healthy volunteer;Hour;Individual;individual patient;Inflammation;Inflammatory;innovation;insight;Lacrimal gland structure;Measurement;Measures;Methods;migration;millimeter;Modification;Monitor;ocular surface;ocular surface disease;Outcome Measure;Paper;Patients;personalized diagnostics;Property;Proteins;Sampling;Sjogren&apos;s Syndrome;Standardization;Structure;Syndrome;Systemic Therapy;Testing;tool;Variant,Tear film biomarker testing from Schirmer strips as a clinical tool in autoimmune ocular surface disease,578,NA,NA,NA,NA,1,NA,NA,101699,NA
11189160,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000579,NA,NA,1ZIAEY000579-02,NEI:134243\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,79365561 (contact),"MCGAUGHEY, DAVID  (contact)",NA,NA,NA,Atlases;Bioconductor;Computer software;Data;data curation;Development;dimension reduction;flexibility;Gene Expression;improved;Knowledge;Learning;Literature;Machine Learning;Metadata;open source;Paper;Publications;Resources;Sampling;tool;Update;Visualization;web app,Data Curation and Projection,579,NA,NA,NA,NA,2,NA,NA,134243,NA
11189161,ZIA,EY,1,N,NA,NA,NA,NA,ZIAEY000580,NA,NA,1ZIAEY000580-01,NEI:248146\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,79973036 (contact),"MAGONE, M. TERESA  (contact)",NA,NA,NA,Adverse event;Age related macular degeneration;Area;Autologous;Autologous Transplantation;Blindness;Cell Therapy;Cells;Clinical Trials;cohort;Data;Elderly;Enrollment;Eye;Fingers;Future;Generations;geographic atrophy;Glycolates;In Vitro;induced pluripotent stem cell;macula;Methods;monolayer;neurosensory;Nonexudative age-related macular degeneration;Operative Surgical Procedures;Outcome Measure;Participant;Patient Recruitments;Phase;phase I/IIa trial;primary outcome;Procedures;Reporting;Retina;Safety;safety and feasibility;scaffold;secondary outcome;Site;stem cell biology;Structure of retinal pigment epithelium;Transplantation;Universities;Visual Acuity;Work,A Phase I/IIa Trial for Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated with Age-Related Macular Degeneration,580,NA,NA,NA,NA,1,NA,NA,248146,NA
11189162,ZIC,EB,1,N,NA,NA,NA,NA,ZICEB000012,NA,NA,1ZICEB000012-18,NIBIB:1510844\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,8484769 (contact),"MORGAN, NICOLE Y (contact)",NA,NA,NA,"3-Dimensional;Adoption;Antibodies;Award;Axon;Back;base;bench to bedside;Biochemical;biological systems;biomaterial development;Biomaterials Research;Biomedical Research;CCR;cell motility;Cells;chemokine;Chills;Clinical;Coculture Techniques;Collaborations;Companions;Complement;Consumption;Dedications;density;design;Development;Device Designs;Device or Instrument Development;Devices;Dimensions;Discipline;Elements;Emulsions;Encapsulated;Endothelium;Equipment;exosome;experimental study;Extracellular Matrix;fabrication;Fibroblasts;Fluorescence;Fluorescence Resonance Energy Transfer;Foreign Bodies;Gel;Geometry;Glass;Harvest;Height;high throughput screening;Human Resources;Hydrogels;Hypoxia;Image;Imaging Device;in vitro Model;in vivo;instrument;instrumentation;interest;Intramural Research Program;Knowledge;Laboratories;Length;liposomal formulation;Liquid substance;Macrophage;manufacturing cost;matrigel;Measurement;Mechanics;Membrane;meter;Microfabrication;Microfluidic Microchips;Microfluidics;millimeter;Modeling;Modification;Molds;National Center for Advancing Translational Sciences;National Heart, Lung, and Blood Institute;National Institute of Allergy and Infectious Disease;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;National Institute of Biomedical Imaging and Bioengineering;National Institute of Child Health and Human Development;National Institute of Diabetes and Digestive and Kidney Diseases;National Institute of Neurological Disorders and Stroke;National Institute on Deafness and Other Communication Disorders;Neoplasm Metastasis;Neurons;operation;Operative Surgical Procedures;Oxygen;Patients;Pattern;Pluronics;poly(ethylene glycol)diacrylate;Polymers;pressure;Printing;Process;Protocols documentation;prototype;pulmonary arterial hypertension;Pump;real-time images;Research;Research Personnel;Resected;Resolution;Resource Sharing;response;Robotics;Sampling;SARS-CoV-2 infection;senescence;Sepharose;Sickle Cell Anemia;simulation;Spatial Distribution;stem cells;Structure;Surface;Syringes;System;Techniques;Temperature;Thinness;three dimensional cell culture;Time;tissue culture;Tissues;tool;Training;transcriptomics;United States National Institutes of Health;UV Radiation Exposure;viscoelasticity;With laterality;Work;Zebrafish",Microfabrication for Biomedical Research,12,NA,NA,NA,NA,18,NA,NA,1510844,NA
11189163,ZIC,EB,1,N,NA,NA,NA,NA,ZICEB000076,NA,NA,1ZICEB000076-14,NIBIB:892557\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,11129599 (contact),"KALISH, HEATHER  (contact)",NA,NA,NA,"2019-nCoV;acrylic acid;Address;Aedes;Aftercare;Antibodies;Automation;Autopsy;B-Lymphocytes;Binding;Biological;Biological Assay;Blood specimen;Calcium;Chlorine;Clinical Research Protocols;Collaborations;Communities;community transmission;Contrast Media;Coupled;COVID-19 mortality;Culicidae;Detection;Development;Diagnosis;Disease;Dose;Enrollment;Enzyme-Linked Immunosorbent Assay;Evaluation;Exhibits;experience;experimental study;Exposure to;Eye;Gel;glycosylated IgG;glycosylation;Goals;Health;Health Personnel;healthy volunteer;Hepatitis C;high throughput analysis;histological stains;HIV;HIV Infections;Human;IgG3;IL7 gene;Image;Immune;Immune response;Immunochemistry;immunodeficiency;immunoengineering;Immunoglobulin A;Immunoglobulin G;Immunoglobulin M;Immunology;immunoregulation;Individual;Inductively Coupled Plasma Mass Spectrometry;Infection;Inflammatory Response;Inherited;instrumentation;interest;Label;Laboratories;Lipids;Manganese;manganese oxide;Manuals;Mass Spectrum Analysis;Measurement;Measures;Metals;Mission;Mitochondrial Diseases;Modality;Molecular;Molecular Profiling;mouse model;Mus;nanoparticle;National Institute of Allergy and Infectious Disease;National Institute of Biomedical Imaging and Bioengineering;novel;Participant;participant enrollment;particle;Patients;Pattern;Paxlovid;pediatric patients;Peptides;Persons;Pharmaceutical Preparations;Plasma;Potassium;Procedures;Process;Proteins;Protocols documentation;Reaction;Regulation;Research;Research Personnel;Resolution;Retinal Diseases;Role;saliva analysis;saliva sample;Sampling;SARS-CoV-2 antibody;SARS-CoV-2 exposure;seropositive;serosurvey;Serum;Serum Proteins;small molecule;Sodium;Spatial Distribution;Specimen;Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization;Spectrophotometry;Syndrome;System;Techniques;Time;Tissue imaging;Tissue Sample;Tissue Stains;Tissues;tool;Trace metal;Trauma patient;tumor;ultrasound;uptake;Vaccination;vaccine immunogenicity;vaccine response;Work;Xerostomia",Micro Analytical Immunochemistry,76,NA,NA,NA,NA,14,NA,NA,892557,NA
11189164,ZIC,EB,1,N,NA,NA,NA,NA,ZICEB000080,NA,NA,1ZICEB000080-14,NIBIB:1427823\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,11129605 (contact),"ZHANG, GUOFENG  (contact)",NA,NA,NA,"Actins;Autophagocytosis;Biological;Biological Process;Cell Line;Cells;chemical fixation;Collaborations;Cryopreservation;Cytoskeleton;Dehydration;Development;digital;Drosophila genus;Drug Delivery Systems;Electron Microscopy;Exposure to;Freeze Substitution;Freezing;gastrointestinal system;glycosylation;Link;medical schools;Membrane Fusion;Methods;Mitochondria;Molecular;Morphology;Motility;Mucins;nanoparticle;National Heart, Lung, and Blood Institute;National Institute of Biomedical Imaging and Bioengineering;National Institute of Dental and Craniofacial Research;National Institute of Diabetes and Digestive and Kidney Diseases;National Institute of Neurological Disorders and Stroke;Negative Staining;Neurons;neuroprotection;Organelles;Oxidative Stress;pressure;Procedures;Process;Publishing;Research Personnel;sample fixation;Sampling;Stains;Structure;System;Techniques;Transmission Electron Microscopy;United States National Institutes of Health;Universities",Electron Microscopy,80,NA,NA,NA,NA,14,NA,NA,1427823,NA
11189165,ZIC,EB,1,N,NA,NA,NA,NA,ZICEB000085,NA,NA,1ZICEB000085-12,NIBIB:6060040\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,1972928 (contact),"DIMITRIADIS, EMILIOS K (contact)",NA,NA,NA,"3-Dimensional;Address;Adhesions;Affect;Aftercare;Air;Albinism;alpha synuclein;Amino Acid Sequence;Amino Acids;Apoptosis;Appearance;Atomic Force Microscopy;Attention;Automobile Driving;Behavior;Binding Sites;Biochemical;Biogenesis;Biological;biological systems;Biomedical Engineering;Biomedical Research;Blood capillaries;Blood Vessels;Cell membrane;Cell Nucleolus;Cell Nucleus;Cells;Characteristics;Chemicals;Collaborations;Collagen;Communities;Complex;Computer Models;Computing Methodologies;crosslink;Cysteine;Cytoplasmic Granules;Data Analyses;Development;Disease;DNA;Drosophila genus;Elasticity;Electron Microscopy;Environment;Epithelium;eumelanin;Evolution;Exhibits;Exocytosis;experimental study;Extracellular Matrix;Fiber;Fluorescence Microscopy;Gel;Geometry;Goals;Growth;Hair Color;Human;Image;Image Analysis;imaging study;In Vitro;Individual;insight;interest;Intramural Research;Knock-out;Length;mathematical methods;Measures;mechanical properties;Mechanics;Melanins;melanocyte;member;Membrane;Methods;microscopic imaging;Microscopy;Modulus;molecular dynamics;monomer;Monophenol Monooxygenase;Morphology;Mucins;Mucous body substance;mutant;nanofluidic;nanoscale;Nanotopography;National Heart, Lung, and Blood Institute;National Institute of Dental and Craniofacial Research;Neurodegenerative Disorders;novel;novel anticancer drug;Organism;Osmosis;oxidation;Paper;Parkinson Disease;Pathway interactions;Patients;Pattern;Peptides;Pericytes;Periodicity;Pharmaceutical Preparations;Phase;physical science;Physiological;Pigments;Polymers;Positioning Attribute;Probability;Process;Production;Property;protein expression;Protein Glycosylation;Proteins;Protocols documentation;Publishing;Reaction;Recombinants;Research;Resistance;Resolution;Resources;Ribosomes;RNA;Role;Salivary Glands;Sampling;scaffold;Scanning;Scanning Probe Microscopy;single molecule;skin color;small molecule;Spectrum Analysis;Stress;Structure;Supporting Cell;Surface;Swelling;synuclein;System;Techniques;Technology;Temperature;Time;Tissues;tool;Training;Tyrosine;United States National Institutes of Health;Variant;Vesicle;viscoelasticity;Work",Scanning Probe Microscopy for the Intramural Research Community,85,NA,NA,NA,NA,12,NA,NA,6060040,NA
11189166,ZIC,EB,1,N,NA,NA,NA,NA,ZICEB000087,NA,NA,1ZICEB000087-08,NIBIB:1397287\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,8193737 (contact),"KIESEWETTER, DALE O (contact)",NA,NA,NA,Albumins;American;Analytical Chemistry;Animal Model;Animals;Annual Reports;Binding;Biomedical Engineering;cancer therapy;chemical synthesis;Chemicals;Chemistry;Collaborations;Communicable Diseases;Computer software;Consumption;Core Facility;Data;data acquisition;Data Analyses;Data Files;Development;Diagnostic;Diagnostic Imaging;Disease;Employee;Enzymes;Equipment;Evaluation;falls;Fluorine;Goals;High Pressure Liquid Chromatography;Human Resources;Image;Imaging Device;imaging study;imaging system;Immunochemistry;instrument;interest;Intramural Research Program;intravital imaging;invention;Label;Laboratories;Legal patent;Longitudinal Studies;Mass Chromatography;Mass Fragmentography;Mass Spectrum Analysis;meetings;Mentorship;Microscope;Modeling;Molecular;multi-photon;Mus;nanomaterials;National Institute of Biomedical Imaging and Bioengineering;National Institute of Diabetes and Digestive and Kidney Diseases;National Institute of Neurological Disorders and Stroke;Neurosciences Research;NMR Spectroscopy;novel;Oligonucleotides;optical imaging;Organic Chemistry;Peptides;PET/CT scan;physical science;Positron-Emission Tomography;Postdoctoral Fellow;posters;Principal Investigator;Procedures;Process;programs;Prosthesis;protein crosslink;Proteins;Proteomics;Radioactivity;radiochemical;Radioisotopes;Radiolabeled;Radionuclide Imaging;Radionuclide therapy;radiotracer;Reporting;Research;Research Personnel;Resolution;Resource Sharing;Sampling;Scientist;Services;single photon emission computed tomography;small molecule;Societies;System;Therapeutic;Therapeutic Studies;thyroid neoplasm;Time;Tracer;Treatment Efficacy;tumor;validation studies;Water;Work;X-Ray Computed Tomography,Molecular Tracer and Imaging Core Facility,87,NA,NA,NA,NA,8,NA,NA,1397287,NA
11189167,ZIC,EB,1,N,NA,NA,NA,NA,ZICEB000103,NA,NA,1ZICEB000103-01,NIBIB:732263\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,79973045 (contact),"POHIDA, THOMAS  (contact)",NA,NA,NA,3-Dimensional;3D Print;adaptive optics;Aedes;Air;Alcohols;analog;analytical ultracentrifugation;Animal Behavior;Animal Feed;Atomic Force Microscopy;Automation;Behavior;Behavior monitoring;Behavioral;Behavioral Assay;bioimaging;Biomechanics;Biophysics;Bioreactors;Biosensor;Blood flow;Blood Vessels;Bone Growth;Brain;brain tissue;Calcium;cancer cell;cancer therapy;Cannulas;Cardiac Electrophysiologic Techniques;Cardiovascular system;Cartilage;Cell Culture Techniques;cell fixing;cell growth;Cell Separation;Cells;Cerebrum;Childhood;Clinic;Clinical;Clinical Research;Collaborations;collaborative environment;Communication;Complex;Computer software;Computers;cost;Coupling;COVID-19 monitoring;COVID-19 patient;COVID-19 test;cranium;crosslink;Culicidae;Custom;data acquisition;data visualization;Dengue Infection;design;Detection;Development;Devices;Diffusion;digital;Disinfectants;Dissection;Documentation;Drosophila genus;drug efficacy;early detection biomarkers;elastography;Electronics;Engineering;engineering design;Epiphysial cartilage;Equipment;Evaluation;Evoked Potentials;Exhibits;exoskeleton;experience;experimental study;Extracellular Matrix;fabrication;Fostering;Freezing;Fresh Tissue;Functional Magnetic Resonance Imaging;Generations;Genomics;Glioblastoma;glymphatic system;Growth;Head;Hela Cells;hemodynamics;Hibernation;high reward;high risk;histological studies;Histology;histone-binding proteins;Histopathology;HIV;Home;Housing;Hydrogels;Image;imager;imaging system;Immunological Models;Impairment;improved;in vivo;Incubated;Incubators;Individual;Infrastructure;Injections;innovation;instrument;instrumentation;Intellectual functioning disability;Intervention;Intramural Research Program;Intubation;Knowledge;Laboratories;Laboratory Research;Larva;Lasers;Learning;Light;Lighting;Liver;Lower Extremity;Macaca;Machine Learning;machine vision;magnetic field;Magnetic Resonance;Magnetic Resonance Elastography;Magnetic Resonance Imaging;Malignant Neoplasms;Maps;Measurement;Mechanics;Memory;Methodology;Methods;Microfluidics;Microscopy;mimetics;mirror neuron;Mobile Health Application;Molds;Monitor;monitoring device;Motor Neurons;Movement;Mus;Myography;Near-Infrared Spectroscopy;neoplastic cell;network dysfunction;Neurodevelopmental Disorder;neuroimaging;neuronal circuitry;Neurosciences;Nociception;novel;novel strategies;open source;Optics;optogenetics;Organ;Organoids;otoacoustic emission;Ovary;Oxygen;Oxygen saturation measurement;Pain;Patients;Pattern;pediatric patients;Perfusion;Peritoneum;PET/CT scan;Phase;Phenotype;Placenta;Polymers;portability;Positron-Emission Tomography;precision medicine;preservation;pressure;Principal Investigator;printed circuit board;Process;Production;Prostate;Prostatic Neoplasms;prosthetic hand;Proteins;Proteomics;prototype;pup;pyrethroid;Quantitative Evaluations;radio frequency;radiological imaging;Reader;recruit;Rehabilitation therapy;Research;research and development;Research Personnel;research study;Resected;resistance mechanism;Resource Sharing;Resources;response;Retinal Dystrophy;retinal imaging;RNA-Protein Interaction;Robotics;Running;Sampling;Science;Scientist;Sensory;Sepharose;serial imaging;Shoes;Signal Transduction;single cell analysis;software development;Software Engineering;Specific qualifier value;spectrograph;Spectrum Analysis;Spermophilus;spheroids;Spinal;Surface;System;Systems Analysis;Systems Biology;systems research;Techniques;Technology;technology development;temporal measurement;Testing;theories;Therapeutic;tick feeding;Time;tissue culture;Tissue Sample;Tissues;Traction Force Microscopy;Training;Transfection;tumor;ultrasound;United States National Institutes of Health;Validation;vapor;vestibular system;Vibrissae;Virus;Vision;Visual;visual tracking;water treatment;wearable device;Zebrafish,Instrumentation Development and Engineering Application Solutions (IDEAS) Shared Resource,103,NA,NA,NA,NA,1,NA,NA,732263,NA
11189168,ZIC,EB,1,N,NA,NA,NA,NA,ZICEB000104,NA,NA,1ZICEB000104-01,NIBIB:436868\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,79973047 (contact),"VISHWASRAO, HARSHAD  (contact)",NA,NA,NA,"3-Dimensional;American;Artificial Intelligence;artificial intelligence model;Award;base;Bibliography;Biological;Biological Markers;biological systems;Black race;Brain;Canis familiaris;carcinogenesis;Cells;Cellular biology;Child;Collaborations;Comb animal structure;Communities;Complex;computer infrastructure;Computer software;Country;Custom;Data;Data Analyses;Data Scientist;Data Set;design;Development;Doctor of Philosophy;Education;Educational workshop;Emerging Technologies;Engineering;Event;First Independent Research Support and Transition Awards;Fluorescence;Funding;Geometry;High Performance Computing;Home;Human;human data;human disease;Image;Image Analysis;image processing;imaging capabilities;imaging scientist;imaging Segmentation;imaging system;Imaging technology;Immune;Immune system;improved;in vivo;in vivo imaging;innovation;insight;instrumentation;International;Investments;Legal patent;Light;Malignant Neoplasms;Manuscripts;Measurement;Metastatic Osteosarcoma;Methods;Microscope;microscopic imaging;Microscopy;model organism;Molecular;Monitor;multiplexed imaging;Mus;National Center for Advancing Translational Sciences;National Heart, Lung, and Blood Institute;National Institute of Biomedical Imaging and Bioengineering;National Institute of Diabetes and Digestive and Kidney Diseases;National Institute of Neurological Disorders and Stroke;Neoplasm Metastasis;new technology;next generation;novel;operation;optical imaging;Optics;Organoids;Osteosarcoma;Pattern;Preparation;Principal Investigator;Process;prototype;Publishing;Research;research and development;Research Personnel;Resolution;Resource Development;Resource Sharing;Resources;Sampling;Scanning Probe Microscopes;Scientist;second harmonic;Services;Signal Transduction;Societies;software infrastructure;Speed;submicron;Survival Rate;System;Techniques;Technology;terabyte;Testing;theories;Therapeutic;therapeutic candidate;therapy development;Time;Tissue Sample;Tissues;tool;Training;Transgenic Mice;tumor;tumor microenvironment;two-photon;ultra high resolution;Underrepresented Minority;United States National Institutes of Health;user-friendly",Advanced Imaging and Microscopy Shared Resource,104,NA,NA,NA,NA,1,NA,NA,436868,NA
11189169,ZIC,EY,1,N,NA,NA,NA,NA,ZICEY000443,NA,NA,1ZICEY000443-17,NEI:396078\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,10672755 (contact),"LI, TIANSEN  (contact)",NA,NA,NA,adeno-associated viral vector;Animal Model;Biological Models;Books;Capsid;cell type;cesium chloride;Client;Clinical;Collaborations;Complement;CRISPR/Cas technology;Cytomegalovirus;Dependovirus;Disease;DNA Sequence Alteration;efficacy evaluation;Endotoxins;Engineering;Eye diseases;Gene Delivery;Gene Expression;gene therapy;Gene Transduction Agent;Gene Transfer;Genes;Genome;genome editing;GNRH1 gene;Human;human induced pluripotent stem cells;human subject;in vivo;Inherited;Laboratories;Leber&apos;s amaurosis;Link;Mediating;Mutation;Names;National Institute of Neurological Disorders and Stroke;Organoids;Pathology;pharmacologic;PHluorin;Plasmid Cloning Vector;Plasmids;Production;promoter;recessive genetic trait;Research;Research Personnel;Research Project Grants;Retina;Retinal Degeneration;Retinitis Pigmentosa;RNA;RPGR gene;Serotyping;Services;Simian virus 40;Techniques;Testing;Therapeutic;therapeutic gene;Tomatoes;United States National Institutes of Health;Usher Syndrome;vector;Viral Packaging,Ocular Gene Therapy,443,NA,NA,NA,NA,17,NA,NA,396078,NA
11189170,ZIC,EY,1,N,NA,NA,NA,NA,ZICEY000457,NA,NA,1ZICEY000457-17,NEI:429679\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,9693896 (contact),"CASPI, RACHEL R. (contact)",NA,NA,NA,7 year old;Adopted;Age;analytical method;Apoptosis;bioinformatics resource;Blood;Budgets;Cells;Collaborations;Communities;Computer software;cytate;cytokine;data acquisition;Data Analyses;Detection;DNA;Education;Equipment;equipment acquisition;Eye;Flow Cytometry;Foundations;Gene Expression;Genetic Transcription;Genotype;Grant;Hour;Human;human tissue;Individual;Information Technology;instrument;instrumentation;Intramural N.I.H. Research Support;Investments;Laboratories;Leukocytes;Liquid substance;Measurement;Membrane;Methods;Monitor;National Eye Institute;operation;Peripheral Blood Mononuclear Cell;Phenotype;Ploidies;Postdoctoral Fellow;Preparation;Principal Investigator;Procedures;Production;Proliferating;Proteins;Protocols documentation;Publications;Recommendation;recruit;Reporter Genes;Research;Research Personnel;Research Project Grants;Sampling;Science;Services;Sorting;Source;Specimen;square foot;Stains;Students;Techniques;Tissues;Training;United States National Institutes of Health;volunteer;Work,Flow Cytometry CORE,457,NA,NA,NA,NA,17,NA,NA,429679,NA
11189171,ZIC,EY,1,N,NA,NA,NA,NA,ZICEY000458,NA,NA,1ZICEY000458-17,NEI:1871680\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,9693898 (contact),"DONG, LIJIN  (contact)",NA,NA,NA,"Alleles;Animal Model;Area;assisted reproduction;Biomedical Research;Biopsy Specimen;Brain;cell type;Cells;Clone Cells;Clustered Regularly Interspaced Short Palindromic Repeats;Collaborations;Complex;Cone;CRISPR/Cas technology;Cryopreservation;Derivation procedure;design;disease model;DNA;Electroporation;Embryo;embryo cryopreservation;embryonic stem cell;Engineering;Etiology;Eye diseases;Female;Fibroblasts;Gene Expression Regulation;Gene Modified;Gene Targeting;Genes;Genetic Engineering;Genetic Induction;Genome;genome editing;Genomic DNA;Genotype;Growth;Guide RNA;Human;human disease;human induced pluripotent stem cells;Human Pathology;induced pluripotent stem cell;inducible Cre;Intramural Research Program;Knock-in;Knock-out;Laboratories;Leber&apos;s amaurosis;Mediating;Mission;Mitochondria;molecular pathology;mouse model;Mus;Mutagenesis;mutant;Mutation;National Institute of Arthritis, and Musculoskeletal, and Skin Diseases;National Institute of Child Health and Human Development;National Institute of Diabetes and Digestive and Kidney Diseases;National Institute of Neurological Disorders and Stroke;National Institute on Deafness and Other Communication Disorders;Oligonucleotides;operation;Opsin;Ovum;pathogen;Patients;Peripheral Blood Mononuclear Cell;Point Mutation;Population;preimplantation;programs;Proteins;Reaction;Research Personnel;Research Project Grants;Retina;Retinal Degeneration;RNA;Rodent;Role;RPE65 protein;Sampling;Sequence Deletion;Series;Services;sperm cell;Syndrome;System;Tail;Technology;technology development;transcription factor;Transgenes;Transgenic Founder Mouse;United States National Institutes of Health;Usher Syndrome;Viral;Vision;Work",NEI Genetic Engineering Core,458,NA,NA,NA,NA,17,NA,NA,1871680,NA
11189172,ZIC,EY,1,N,NA,NA,NA,NA,ZICEY000459,NA,NA,1ZICEY000459-17,NEI:1576067\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,9693900 (contact),"FARISS, ROBERT  (contact)",NA,NA,NA,Aging;Agreement;Biological;Cilia;clinical application;Confocal Microscopy;Cryoelectron Microscopy;Crystallization;Custom;Data;denoising;Development;ex vivo imaging;fluorescence imaging;fluorescence lifetime imaging;fluorophore;Freezing;Future;Goals;high resolution imaging;Histology;human model;Image;imaging approach;imaging study;Imaging Techniques;improved;in vivo;insight;instrumentation;Lasers;Methodology;Methylmethacrylate;Microscope;novel;ocular imaging;Organelles;Organoids;Paraffin;particle;Pathologic;Physics;Preparation;Process;protein purification;protein structure;Proteins;Research Personnel;Resolution;Resources;Retina;Retinal Degeneration;Sampling;Scanning;Scientist;Services;Slide;Structure;Structure-Activity Relationship;superresolution imaging;Synapses;Synchrotrons;System;Techniques;Technology;Time;Tissue Sample;tissue/cell culture;Tissues;Training;Transgenic Mice;Transmission Electron Microscopy;United States National Institutes of Health;X ray diffraction analysis;X-Ray Crystallography,Imaging Core Unit,459,NA,NA,NA,NA,17,NA,NA,1576067,NA
11189173,ZIC,EY,1,N,NA,NA,NA,NA,ZICEY000478,NA,NA,1ZICEY000478-16,NEI:1009929\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,16173238 (contact),"GOETZ, KERRY  (contact)",NA,NA,NA,achromatopsia;Albinism;American;Aniridia;Anophthalmos;Ataxia;Autosomal Dominant Optic Atrophy;Axenfeld-Rieger syndrome;Biomedical Research;Blood;Blood specimen;Cephalic;Choroideremia;Chronic progressive external ophthalmoplegia;CLIA certified;Clinic;Clinical;Clinical Data;Clinical Research;Clinical Trials;Collaborations;Communities;Community Health;community partnership;cone-rod dystrophy;Consultations;Corneal dystrophy;Data;Data Set;Databases;Deposition;design;Development;diagnosis evaluation;Diagnostic;Disease;DNA;Eligibility Determination;Enrollment;Environment;Epilepsy;Ethics;Extramural Activities;Eye;Eye diseases;Future;Genes;Genetic;Genetic Counseling;genetic information;genetic testing;Genotype;Glaucoma;Goals;Government;Health Personnel;Hermanski-Pudlak Syndrome;Human Genetics;Individual;individual patient;Industry;Informed Consent;interest;Kearns-Sayre syndrome;Leber&apos;s Hereditary Optic Neuropathy;Medical Genetics;MELAS Syndrome;Microphthalmos;Mission;Modeling;Molecular;Molecular Diagnostic Testing;molecular diagnostics;Molecular Genetics;molecular phenotype;Neuropathy;news;Night Blindness;Notification;Oculocerebrorenal Syndrome;Online Systems;Pantothenate kinase;Participant;participant enrollment;Pathway interactions;Patients;pattern dystrophies;personalized health care;Persons;Phenotype;phenotypic data;precision medicine;Private Practice;Privatization;Rare Diseases;recruit;Red Fiber;Registries;Reporting;repository;Research;Research Personnel;Research Project Grants;research study;Resources;Retinal Degeneration;Retinal Diseases;Retinal Dystrophy;Retinitis Pigmentosa;Retinoblastoma;Role;Sampling;Scientist;Secure;Seitelberger&apos;s Disease;Services;Sorsby&apos;s fundus dystrophy;Stargardt&apos;s disease;Stickler syndrome;Test Result;tool;treatment trial;United States Dept. of Health and Human Services;United States National Institutes of Health;Usher Syndrome;Vision;Vision research;Vitelliform macular dystrophy;web site;X-Linked Retinoschisis,National Ophthalmic Disease Genotyping and Phenotyping Network - eyeGENE,478,NA,NA,NA,NA,16,NA,NA,1009929,NA
11189174,ZIC,EY,1,N,NA,NA,NA,NA,ZICEY000503,NA,NA,1ZICEY000503-14,NEI:681334\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,11127208 (contact),"QIAN, HAOHUA  (contact)",NA,NA,NA,Adopted;Animal Model;automated segmentation;Behavior;behavior test;Collaborations;Communication;Communities;Computer software;Computers;Consultations;Data;Data Analyses;design;Disinfection;Electrophysiology (science);Ensure;Environment;Equipment;experience;Extramural Activities;Eye;Goals;Human Resources;Image;imaging Segmentation;innovation;Instruction;instrument;Machine Learning;Maintenance;Measures;Methods;Monitor;Mus;Performance;Periodicals;Physiology;Procedures;programs;Protocols documentation;Reporting;Research;Research Design;Research Personnel;Research Project Grants;Resources;response;Retina;retinal imaging;Scientist;Services;Supervision;Techniques;tool;Training;United States National Institutes of Health;virtual;Vision;Vision research,Visual Function Core,503,NA,NA,NA,NA,14,NA,NA,681334,NA
11189175,ZID,EY,1,N,NA,NA,NA,NA,ZIDEY000472,NA,NA,1ZIDEY000472-16,NEI:10194940\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,10274752 (contact),"O'DONNELL, WILLIAM  (contact)",NA,NA,NA,"Age related macular degeneration;Autoimmune;Blood Vessels;Cataract;Clinic;Clinical;clinical application;clinical care;clinical center;Clinical Data;Clinical Informatics;Clinical Investigator;Clinical Protocols;Clinical Research;Clinical Research Protocols;Clinical Trials;Collaborations;Communities;Consult;Consultations;Credentialing;data management;design;Development;diabetic;Diagnosis;Diagnostic;Diagnostic Services;Disease;Education;Ensure;Eye;Eye diseases;Fellowship;Fostering;Funding;Genetic;graft vs host disease;Grant;Health Personnel;high risk;Image;imager;Inflammation;Infrastructure;Inherited;innovation;Institutional Review Boards;Intramural Research Program;Investigation;Laboratory Research;Lasers;Lead;macular edema;Maryland;Metastatic Melanoma;Methodology;Monitor;motor disorder;multidisciplinary;National Eye Institute;National Heart, Lung, and Blood Institute;National Institute of Allergy and Infectious Disease;neovascularization;Neurocysticercosis;Nutritional;off-label drug;Office Management;Ophthalmology;outpatient facility;Pathology;Patient Care;patient safety;Patients;pharmacologic;Phase;Physicians;Prevention;Process;programs;Protocols documentation;quality assurance;Research Personnel;Research Training;Resources;Retinal gene therapy;Safety Management;Services;skills;Source;Students;System;Testing;testing services;Time;Training;Translations;Travel;United States National Institutes of Health;Vision;Visual System;Wegener&apos;s Granulomatosis",Clinical Research and Protocol Support Services,472,NA,NA,NA,NA,16,NA,NA,10194940,NA
11189176,ZIE,EY,1,N,NA,NA,NA,NA,ZIEEY000477,NA,NA,1ZIEEY000477-16,NEI:325438\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,16173245 (contact),"HURYN, LARYSSA  (contact)",NA,NA,NA,achromatopsia;Affect;Albinism;Aniridia;Anophthalmos;Bardet-Biedl Syndrome;Basic Science;Caring;Child;Clinic;Clinical;Clinical Protocols;Clinical Research;Clinical Sciences;Coloboma;Cystinosis;Dark Adaptation;Electrophysiology (science);Environment;Evaluation;experience;Exposure to;Eye;Eye diseases;Family;Fellowship;Generations;Genetic;Genetic Counseling;genetic counselor;Genetic Diseases;genetic pedigree;Grant;Holoprosencephaly;Individual;Inherited;inherited retinal degeneration;interest;Investigation;Journals;Knowledge;Laboratories;Laboratory Research;Learning;Leber&apos;s amaurosis;malformation;Manuscripts;Medical;Medical Genetics;Metabolic Diseases;Methods;Microphthalmos;Molecular Diagnosis;molecular diagnostics;Molecular Genetics;multidisciplinary;Neurofibromatosis 2;ophthalmic examination;Ophthalmological Diagnostic Techniques;Patients;Perimetry;Physicians;Preparation;programs;Psychophysics;Publications;Recording of previous events;Research;Research Project Grants;Retinitis Pigmentosa;Review Literature;Series;Stargardt&apos;s disease;symposium;Syndrome;Testing;Training;Trichothiodystrophy;Usher Syndrome;Vision;Visual;Work;Writing;WT1 gene;Xeroderma Pigmentosum;Zein,Ophthalmic Genetics Fellowship,477,NA,NA,NA,NA,16,NA,NA,325438,NA
11189177,ZIE,EY,1,N,NA,NA,NA,NA,ZIEEY000487,NA,NA,1ZIEEY000487-16,NEI:663079\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,77868117 (contact),"KEENAN, TIARNAN  (contact)",NA,NA,NA,age related;Age related macular degeneration;biobank;Blood;Clinical;clinical application;clinical care;clinical epidemiology;Clinical Research;clinical training;clinical trial participant;Collaborations;Collection;Dark Adaptation;Diabetic Retinopathy;Disease;DNA;Epidemiology;epidemiology study;experience;Eye diseases;Faculty;Fellowship;follow-up;gene therapy;Genotype;geographic atrophy;high standard;HIV;Hydroxychloroquine;Individual;Inherited;inhibitor;Intervention Studies;macula;Medical;National Cancer Institute;National Eye Institute;National Human Genome Research Institute;Natural History;Nerve Degeneration;neuroprotection;novel;Nursing Faculty;Participant;Patient Care;Patients;Phase;Phenotype;Protocols documentation;recruit;Resources;Retina;Retinal Diseases;retinal toxicity;Retinal Vein Occlusion;screening;Serous;Telangiectasis;Testing;Translational Research;Von Hippel-Lindau Syndrome;X-Linked Retinoschisis,Medical Retina Fellowship,487,NA,NA,NA,NA,16,NA,NA,663079,NA
11189178,ZIG,EY,1,N,NA,NA,NA,NA,ZIGEY000460,NA,NA,1ZIGEY000460-17,NEI:1156760\,INTRAMURAL RESEARCH,2024,NATIONAL EYE INSTITUTE,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL EYE INSTITUTE,NA,NA,NA,79365622 (contact),"ALLEN-WORTHINGTON, KRYSTAL  (contact)",NA,NA,NA,"Accreditation;Administrative Personnel;Anesthesia procedures;Angiography;animal care;Animal Experimentation;animal facility;Animal Husbandry;animal imaging;Animals;Area;Bite;Breeding;Budgets;Callithrix;Caring;Communities;comparative;Contracts;Derivation procedure;Development;Disease;Employee;environmental enrichment for laboratory animals;Euthanasia;Family suidae;Gnotobiotic;Government;Guidelines;Habitats;Healthcare;Hemorrhage;Hour;Housing;Injections;International;Intramural Research Program;Laboratory Animal Science;Laboratory Animals;Laws;Lead;Leadership;Macaca;Magnetic Resonance Imaging;Maryland;Medical;Medicine;Mission;model development;Movement;Mus;National Center for Complementary and Integrative Health;National Heart, Lung, and Blood Institute;National Human Genome Research Institute;National Institute of Allergy and Infectious Disease;National Institute of Child Health and Human Development;National Institute of Mental Health;National Institute of Neurological Disorders and Stroke;National Institute on Alcohol Abuse and Alcoholism;National Institute on Deafness and Other Communication Disorders;nonhuman primate;operation;Operative Surgical Procedures;Participant;pathology imaging;Phenotype;Photography;Play;Policies;policy recommendation;Positioning Attribute;Positron-Emission Tomography;Preparation;Prevention;Principal Investigator;Procedures;programs;Protocols documentation;radiological imaging;Rattus;Regulation;Research;Research Activity;Research Personnel;Research Support;Resources;restraint;Retina;Rodent;Role;Running;sample collection;Services;Specialist;Spermophilus;Techniques;Training;United States National Institutes of Health;Veterinarians;Weaning;Zebrafish",Veterinary Research and Resources Section,460,NA,NA,NA,NA,17,NA,NA,1156760,NA
11189179,ZIJ,MD,1,N,NA,NA,NA,NA,ZIJMD000023,NA,NA,1ZIJMD000023-02,NIMHD:9150\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,NA,NA,79350271 (contact),"JOHNSON, ANTHONY  (contact)",NA,NA,NA,"Academy;Acclimatization;African American;American Indians;American Public Health Association;Asian;Award;Awareness;Bangladesh;Behavioral Sciences;Biomedical Research;Caliber;career;Charge;China;Clinical;Collaborations;college;Communication;Communities;community collaboration;community research;community science;Complex;Data;Data Analyses;Dedications;design;Development;Development Plans;disparity reduction;Doctor of Philosophy;Domiciles;Education;Educational Status;Educational workshop;Effectiveness;Ensure;Environment;Epidemiology;epidemiology study;equity, diversity, and inclusion;ethnic diversity;Evaluation;Event;Evidence based practice;experience;Feedback;Fellowship;Female;first responder;Fostering;Funding Opportunities;Gender;Genetic;Genomics;Ghana;Goals;graduate student;Grant;Health;Health behavior and outcomes;Health Disparities Research;health disparity;Health Promotion;high reward;high risk;Hispanic Americans;HIV Vaccine Trials Network;Human;Individual;infrastructure development;insight;Institution;International;Internships;Intervention;Interview;Intramural Research;Intramural Research Program;Knowledge acquisition;Latino;Leadership;leadership development;Learning;lectures;Life;Location;male;Maryland;Medical;Medical Students;meetings;Mentors;Mexican Americans;minority health disparity;Minority Health Research;minority scientist;Minority-Serving Institution;Mission;Monitor;National Institute of Nursing Research;National Institute on Minority Health and Health Disparities;Native Americans;Needs Assessment;Nervous System Disorder;New Zealand;operation;Operations Research;Outcome;outreach;Patient Care;Personal Satisfaction;Persons;Policies;population health;Population Heterogeneity;Population Research;Population Sciences;Postbaccalaureate;Postdoctoral Fellow;posters;practical application;pre-doctoral;Principal Investigator;Problem Solving;Procedures;Professional counselor;Professional Organizations;professional students;Program Development;Program Effectiveness;Program Efficiency;Program Evaluation;programs;Public Health;Readiness;recruit;Recruitment Activity;Reduce health disparities;Research;Research Personnel;Research Training;resource guides;Resources;Role;Science;Science Policy;Scientist;Series;Site;skill acquisition;skills;skills training;Social Behavior;Social Sciences;Societies;Stroke;Student recruitment;Students;success;summer internship;symposium;Training;Training and Education;training opportunity;Training Programs;trend;tribal community;Underrepresented Populations;United States;United States National Institutes of Health;United States Public Health Service;Universities;virtual;Visit;Vocational Guidance;Vulnerable Populations;Water;Work;Writing",Intramural Training and Scientific Workforce Outreach Operations,23,NA,NA,NA,NA,2,NA,NA,9150,NA
11189217,N01,AI,NA,N,NA,NA,NA,NA,272201800007I,NA,NA,272201800007I-P00005-759302200001-1,NIAID:216610\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,SAINT CHARLES,UNITED STATES,NA,02,078652667,US,10089014,"EUROFINS PANLABS, INC.",MO,633045685,NA,79977785 (contact),"ZHAO, YOUNG  (contact)",NA,2021-12-15,2025-04-30,Biological;Biological Assay;Chemistry;Communicable Diseases;Development;Development Plans;Drug Kinetics;Evaluation;In Vitro;in vivo;Interventional Agent Development;Lead;lead optimization;manufacture;pandemic preparedness;pathogen;pre-clinical;product development;programs;Property;Rodent;Safety;screening;Services;Therapeutic;therapeutic development;Toxicology;Toxin;viral pandemic,"Task E11: Lead Optimization Screening Assays for ADMET, Safety Profiling, and Rodent Pharmacokinetics for the Antiviral Pandemic Preparedness Program (APP)",0,NA,NA,NA,NA,NA,NA,NA,216610,NA
11189218,Y01,ES,NA,N,NA,NA,NA,NA,AES22010001,NA,NA,AES22010001-1-0-1,NIEHS:1060000\,INTERAGENCY AGREEMENTS,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,NA,NA,78886806 (contact),"WALLQVIST, ANDERS  (contact)",NA,NA,NA,Acceleration;Accounting;Acute;Address;Adoption;Affect;Agreement;assessment application;Biochemical Pathway;Biological;Biological Models;biological systems;Biology;Cardiovascular system;Chronic;Communication;Computer Models;data modeling;Development;Disease;Environment;environmental chemical;Evaluation;evidence base;Exposure to;genome-wide;hazard;Health;Human;improved;Individual;innovation;Link;mathematical model;Mathematics;Metabolic;Mission;Modeling;Molecular;multi-scale modeling;National Institute of Environmental Health Sciences;Organ;Outcome;Persons;Population;Predisposition;Preventive;reproductive;Research;research and development;response;Rodent;safety assessment;Science;sex;sex as a biological variable;System;tool;tool development;Toxicology;Translating,Developing Computational Models to Understand and Predict Adverse Human Health Effects Associated with Exposure to Environmental Chemicals,220100,NA,NA,NA,NA,NA,NA,NA,1060000,NA
11189219,N01,AI,NA,N,NA,NA,NA,NA,75N93021C00003,NA,NA,75N93021C00003-P00005-9999-1,NIAID:4149452\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,FREDERICK,UNITED STATES,NA,06,078706021,US,10034768,"PRECISION BIOSERVICES, INC.",MD,217014765,NA,78320451 (contact),"PHIPPARD, DEBORAH  (contact)",NA,2024-09-30,2025-09-29,Autopsy;Biological;Biological Specimen Banks;Biopsy;Body Fluids;cervicovaginal;Clinical Research;Clinical Trials;Cohort Studies;Contracts;Cryopreservation;Dryness;Feces;HIV;HIV Vaccine Trials Network;Institution;International;Laboratories;Lavage;National Institute of Allergy and Infectious Disease;observational cohort study;Paper;Peripheral Blood Mononuclear Cell;Plasma;repository;Saliva;Seminal fluid;Serum;Site;Specimen;Spottings;The Multicenter AIDS Cohort Study;Tissues;Urine;Whole Blood;Women&apos;s Interagency HIV Study,NIAID Specimen Repository,0,NA,NA,NA,NA,NA,NA,NA,4149452,NA
11189220,N01,DA,NA,N,NA,NA,NA,NA,271201800001I,NA,NA,271201800001I-P00001-759502300003-1,NINDS:1319807\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,ALBANY,UNITED STATES,NA,20,787793900,US,3294801,"ALBANY MOLECULAR RESEARCH, INC.",NY,122035121,This study is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to understand the basis of pain and enhance clinical pain management.,79330166 (contact),"SURMAN, MATTHEW  (contact)",NA,2023-08-18,2026-03-04,absorption;analog;Animal Model;Area;Biological Assay;cancer pain;chemical synthesis;Chemistry;clinical pain;Communication;computational chemistry;Computer Assisted;Contracts;Data;design;Development;direct application;Drug Compounding;drug discovery;Enzymes;Evaluation;Excretory function;Goals;Helping to End Addiction Long-term;In Vitro;indexing;inhibitor;Investigational Drugs;Investigational New Drug Application;Lead;lead optimization;Ligands;Logistics;malignant mouth neoplasm;Metabolic;Metabolism;milligram;Nervous System Disorder;novel;novel therapeutics;Pain;Pain management;Performance;Pharmaceutical Chemistry;Phase;pre-clinical;Preparation;programs;Property;Research Personnel;scaffold;scale up;Services;Shipping;small molecule;Speed;Stroke;Structure-Activity Relationship;Substance Use Disorder;success;System;Teleconferences;Testing;Therapeutic;therapeutically effective;Toxicology;United States National Institutes of Health;Update;Writing,SPIGELMAN (UCLA) - MCSP- EXPLORATORY CHEMISTRY (EC),0,NA,NA,NA,NA,NA,NA,NA,1319807,NA
11189221,N02,CA,NA,N,NA,NA,NA,NA,91021A00291021F00001,NA,NA,91021A00291021F00001-P00006-0-1,NCI:1116093\OD:150000\,NON SBIR/STTR CONTRACTS,2024,NATIONAL CANCER INSTITUTE,NA,FAIRFAX,UNITED STATES,NA,11,072648579,US,1644201,"ICF, INC., LLC",VA,220316050,NA,78283990 (contact),"SCHWARZ, MARY  (contact)",NA,2021-09-15,2025-09-14,behavioral health;Cancer Control;Contractor;Data;design;Development;Effectiveness;Focus Groups;General Population;Health behavior;Health behavior change;high risk;implementation efforts;interactive tool;Internet;Language;Maintenance;Malignant Neoplasms;Marketing;mHealth;Monitor;Online Systems;programs;Reporting;Resources;Services;Site;smartphone application;smoking cessation;Spanish;Surveys;Text;Tobacco;tool;Underserved Population;Work,"DEVELOPMENT, MAINTENANCE, AND PROMOTION OF NCI SPONSORED BEHAVIORAL AND MOBILE HEALTH INITIATIVES.",0,NA,NA,NA,NA,NA,NA,NA,1266093,NA
11189223,N02,DA,NA,N,NA,NA,NA,NA,75N95022C00035,NA,NA,75N95022C00035-P00002-9999-1,NIMH:416786\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,DALLAS,UNITED STATES,NA,30,800771545,US,578404,UT SOUTHWESTERN MEDICAL CENTER,TX,753909105,NA,78877488 (contact),"ROATEN, KIMBERLY  (contact)",NA,2024-09-26,2025-09-25,Health system;Injury;insight;Outcome Assessment;patient screening;screening program;suicidal risk;Suicide;Suicide prevention;suicide rate,ASSESSING OUTCOMES OF HEALTH SYSTEM SUICIDE RISK SCREENING PROGRAMS,0,NA,NA,NA,NA,NA,NA,NA,416786,NA
11189264,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000058,NA,NA,1ZIAAI000058-50,NIAID:544242\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413516 (contact),"COHEN, JEFFREY  (contact)",NA,NA,NA,Acute;adaptive immune response;arm;Astrocytes;Astrovirus;Automobile Driving;B-Lymphocytes;Brain;brain tissue;Cells;chemotherapy;Child;Chronic;Chronic diarrhea;Defect;defense response;Diarrhea;Disease;effective therapy;Encephalitis;Excitatory Synapse;Gastroenteritis;Goals;Herpesviridae;Homeostasis;Host Defense;Human;human disease;Immune;Immunocompromised Host;immunodeficiency;Impairment;improved;improved outcome;Infection;Infusion procedures;Inhibitory Synapse;Macrophage;Microglia;Neurons;neurotropic virus;Norovirus;Organ;Outcome;Pathogenesis;Patients;Peripheral;Persons;Phagocytosis;Process;repaired;response;System;T-Lymphocyte;Viral;Virus;Virus Diseases,Pathogenesis and Chemotherapy of Human Virus Infections,58,NA,NA,NA,NA,50,NA,NA,544242,NA
11189265,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000197,NA,NA,1ZIAAI000197-45,NIAID:1210409\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691541 (contact),"NUTMAN, THOMAS  (contact)",NA,NA,NA,Affect;Allergic;Allergic Disease;Anthelmintics;Antibodies;Antigen-Presenting Cells;Antigens;Automobile Driving;Binding;CD4 Positive T Lymphocytes;Cells;Chronic;Clinical;cohort;Dendritic Cells;Development;Disease;Effector Cell;Enterovirus;Environment;Epitopes;Exhibits;Exposure to;extracellular vesicles;Filarial Elephantiases;Filariasis;Flow Cytometry;FRAP1 gene;Functional disorder;Genetic;Goals;helminth infection;Herpesviridae;Heterogeneity;HHV-6A;Human;human virome;Immune;Immune response;Immunity;Immunoglobulin G;Immunologic Memory;Immunologics;immunoregulation;Individual;Infection;Interleukin-13;Interleukin-4;Interleukin-5;Loa loa;Loiasis;Lymphatic;Memory;MicroRNAs;Molecular;monocyte;multiple omics;Onchocerciasis;Outcome;Parasites;Parasitic infection;Pathogenesis;Pathogenicity;Peptides;Phosphorylation;Production;programs;Proteins;Recording of previous events;Regulation;response;Rhinovirus;RNA;Role;Serology;seropositive;Sorting;Specificity;Strongyloidiasis;T cell response;T-Lymphocyte Subsets;Th2 Cells;transcriptome sequencing;Viral;Viral Antigens;Virus;Work,Immunoregulation /Immune Recognition In Filarial/Nonfilarial Parasitic Infection,197,NA,NA,NA,NA,45,NA,NA,1210409,NA
11189266,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000224,NA,NA,1ZIAAI000224-43,NIAID:647218\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691503 (contact),"SHEVACH, ETHAN  (contact)",NA,NA,NA,Address;Adult;Alloantigen;allograft rejection;Animals;Antigen Presentation;Antigen Targeting;Antigen-Presenting Cells;Antigens;Area;Autoantigens;Autoimmune;Autoimmune Diseases;Autoimmunity;Avidity;Breeding;Bystander Suppression;CD28 gene;CD44 gene;CD8-Positive T-Lymphocytes;CD80 gene;CD86 gene;CD8B1 gene;Cell surface;cell type;Cells;Clinic;Complex;Dendritic Cells;Development;diphtheria toxin receptor;Disease;Effector Cell;Event;Excision;FOXP3 gene;Germ Cells;Goals;Graft Rejection;graft vs host disease;Homeostasis;Human;IL2RA gene;immune activation;Immune response;Immunologics;Immunosuppression;Immunosuppressive Agents;In Vitro;in vivo;Infection;Inflammatory;Interferon Type II;Interferons;Interleukin-2;Kidney Transplantation;Lymphoid Tissue;Mediating;Modeling;Mus;Organ;partial response;Pathway interactions;Patients;Peptide/MHC Complex;Peptides;Peripheral;Physiologic pulse;Population;prevent;Prevention;promoter;Regulation;Regulatory T-Lymphocyte;response;Role;Signal Transduction;Specificity;Stem cell transplant;Suppressor-Effector T-Lymphocytes;Surface;Synapses;Syndrome;System;T cell response;T memory cell;T-Cell Activation;T-Lymphocyte;Therapeutic;Thymus Gland;Transgenic Mice;tumor;Up-Regulation;uptake,Control of Autoimmunity by Regulatory T Cells,224,NA,NA,NA,NA,43,NA,NA,647218,NA
11189267,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000241,NA,NA,1ZIAAI000241-43,NIAID:1111301\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413747 (contact),"MILLER, LOUIS  (contact)",NA,NA,NA,African;Aotus primate;Binding Proteins;Blood;blood group;Blood typing procedure;Cerebral Malaria;Complement Receptor;erythrocyte receptor;Erythrocytes;Human;improved;Invaded;Ligands;Malaria;Malawi;Molecular;Parasites;Plasmodium falciparum;Plasmodium vivax;Proteins;Receptor Cell;Role;Saimiri;Testing;vaccine development;Vaccines;Work,Malaria Parasite Ligands And Host Cell Receptors,241,NA,NA,NA,NA,43,NA,NA,1111301,NA
11189268,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000249,NA,NA,1ZIAAI000249-43,NIAID:1048126\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,8588565 (contact),"KOMAROW, HIRSH D (contact)",NA,NA,NA,Adult;Age;Alleles;Allergic Disease;anti-IgE;Antibodies;Austria;Autoantibodies;Autoimmune Diseases;Basophils;Binding;Biological Assay;Biological Markers;Biological Products;Blinded;Bone Marrow;Bone Marrow Aspiration;candidate marker;Case/Control Studies;Cell Count;Cell Degranulation;Cell division;Cell Proliferation;Cells;Cellular biology;Characteristics;Child Care;Childhood;China;Clinical;Clinical Immunology;Clinical Trials;cohort;Collaborations;Cutaneous Mastocytosis;Cytometry;Data;Databases;Diagnosis;Disease;Disease stratification;Disseminated eosinophilic collagen disease;eosinophil;Event;Evolution;Exhibits;Fc Receptor;Flow Cytometry;FPR2 gene;France;Future;genetic association;Genetic Polymorphism;Genome;Germany;healthy volunteer;Hematological Disease;Hematopoietic;Heterozygote;Histopathology;Human;Hypersensitivity;Idiopathic anaphylaxis;IL-6 inhibitor;Immunophenotyping;Individual;Indolent Systemic Mastocytosis;Inflammatory;Interferon alpha;Interferon Type I;Interferon-beta;Interferons;Interleukin 6 Receptor;Interleukin-6;Interleukins;Investigation;Israel;Journals;Laboratories;leucyl-phenylalanine;Manuscripts;mast cell;mastocytosis;Measurement;Mediator;Molecular Abnormality;Mutation;novel;novel therapeutics;particle;Pathogenesis;Patients;Pattern;pediatric patients;peripheral blood;Pharmaceutical Preparations;Placebos;Preparation;Prevalence;Production;Proliferating;Publications;Publishing;Quality of life;Randomized;receptor;receptor expression;Recommendation;reduce symptoms;Reporting;Research;response;Retirement;Role;Safety;Sampling;Serum;Severities;Signal Transduction;STAT1 gene;Surrogate Markers;symposium;symptomatology;Symptoms;Systemic Mastocytosis;Training;Tryptase;Tyrosine Kinase Inhibitor;Variant,"The Pathogenesis, Diagnosis, and Treatment of Systemic Mast Cell Disorders",249,NA,NA,NA,NA,43,NA,NA,1048126,NA
11189269,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000256,NA,NA,1ZIAAI000256-43,NIAID:1086843\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6479341 (contact),"SACKS, DAVID  (contact)",NA,NA,NA,Area;arm;Bilateral;Biological;Biology;biomarker validation;Bite;Blood;Cell fusion;Cell hybridization;Cells;Chromosome Mapping;Clinical;Communities;Competence;Cutaneous Leishmaniasis;Development;Disease;Dose;Drug resistance;Early Diagnosis;Early treatment;Exposure to;fly;Generations;Genes;Genetic;Genetic Recombination;Genetic Transcription;Genome;genome analysis;Geographic Locations;Goals;Haplotypes;HIV;Homologous Protein;Human;Huntingtin-Associated protein 1;Hybrids;Immune response;In Vitro;in vivo;India;Infection;Inflammatory Response;Island;Laboratories;Leg;Leishmania;Leishmania donovani;Leishmaniasis;Life Cycle Stages;Mammals;Mediating;Meiosis;microbiota;Microscopy;Midgut;Modeling;molecular marker;Motility;Mus;novel;Nuclear;paralogous gene;parasite genome;Parasites;Parents;Partner in relationship;pathogen;Pathogenesis;Pathology;Patient Isolation;Patients;Phlebotominae;Phlebotomus;Population;programs;Relapse;Reporting;Saliva;segregation;Series;Sexual Reproduction;single cell analysis;single-cell RNA sequencing;Source;Sri Lanka;Testing;trait;transcriptomics;transmission process;Vaccines;vector;Visceral;Visceral Leishmaniasis;whole genome;Xenodiagnosis,Vector Biological  Studies in Leishmaniasis,256,NA,NA,NA,NA,43,NA,NA,1086843,NA
11189270,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000300,NA,NA,1ZIAAI000300-43,NIAID:1557829\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6568367 (contact),"KOZAK, CHRISTINE  (contact)",NA,NA,NA,Adenosine;Alleles;Anti-Retroviral Agents;Anti-viral Response;arms race;Base Pairing;Biology;Breeding;Cell Nucleus;Cell Surface Receptors;Chromosomes;Complementary DNA;Cytidine;Cytidine Deaminase;Data;Deamination;Derivation procedure;Development;Direct Repeats;Disease;DNA;Endogenous Retroviruses;Evolution;Exhibits;Family;Frequencies;Fv-1 protein;gag Gene Products;Gammaretrovirus;Generations;Genes;Genetic;Genetic Polymorphism;Genetic Recombination;Genetic Variation;Genome;genome analysis;genome editing;genome integrity;genome-wide;Geographic Distribution;Geography;Germ Lines;Goals;Guanosine;Haplotypes;HIV;homologous recombination;House mice;Human;Inbred Strain;Inbred Strains Mice;Inbreeding;Individual;Infection;Infection prevention;Inherited;insight;Integration Host Factors;Introns;Laboratory mice;Length;Life Cycle Stages;Long Terminal Repeats;Mammals;mammary tumor virus;mouse genome;Mouse Mammary Tumor Virus;Mouse Strains;Murine leukemia virus;Mus;Mutagenesis;Mutagens;Mutation;novel;Open Reading Frames;Orthologous Gene;pathogen;Pathogenicity;Pattern;Point Mutation;Population;preference;Process;Production;Proviruses;receptor;Recording of previous events;Recurrence;Resistance;resistance factors;resistance gene;Retroviridae;Reverse Transcription;RNA Splicing;Rodent;Role;Sequence Analysis;Site;Source;Southeastern Asia;Specificity;Superantigens;T-Lymphocyte;Time;TRIM5 gene;tumorigenesis;Uracil;usability;Variant;Viral;Viral Genes;viral resistance;Virion;Virus;virus envelope;Virus Replication;Work,Genetic Aspects Of Viral Oncogenesis In Inbred Strains and Wild Mouse Species,300,NA,NA,NA,NA,43,NA,NA,1557829,NA
11189271,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000307,NA,NA,1ZIAAI000307-43,NIAID:1617431\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691561 (contact),"MOSS, BERNARD  (contact)",NA,NA,NA,Biology;Cells;Chimeric Proteins;Data;DNA-Binding Proteins;Drosophila spi protein;Gene Expression;Genome;Goals;Host Defense;membrane assembly;Modeling;Poxviridae;Proteins;prototype;Reagent;Role;tissue culture;Vaccinia virus;Viral;viral DNA;Viral Proteins;Virion,Poxvirus Biology,307,NA,NA,NA,NA,43,NA,NA,1617431,NA
11189272,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000326,NA,NA,1ZIAAI000326-43,NIAID:1306400\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77880414 (contact),"BUCHHOLZ, URSULA  (contact)",NA,NA,NA,2 year old;5 year old;Active immunity;Active Immunization;Acute;Adolescence;Adult;age group;Age Months;Amino Acids;Anti-viral Agents;Antibody Response;Antigens;Apoptosis;Asthma;Attenuated;Attenuated Vaccines;attenuation;Blinded;Cattle;Cessation of life;Child;Childhood;Chimeric Proteins;Clinical;Clinical Research;Clinical Trials;Codon Nucleotides;Collaborations;Complementary DNA;Complication;Conduct Clinical Trials;Cooperative Research and Development Agreement;Data Analyses;Deletion Mutation;design;Development;Dose;effectiveness evaluation;efficacy study;Elements;Evaluation;Experimental Models;follow-up;Genes;Genetic;Genetic Transcription;Genome;Goals;Half-Life;Head;Health;Hemagglutinin;Hospitalization;Human;Human Metapneumovirus;Immune response;Immunity;Immunization;immunogenic;immunogenicity;improved;infancy;Infant;Infection;Interferons;Kansas;Laboratories;Laboratory Study;lead candidate;Lower Respiratory Tract Infection;Manuscripts;Maryland;maternal vaccination;Medical;Missense Mutation;Modeling;Monoclonal Antibodies;mucosal site;Mutation;Neuraminidase;Open Reading Frames;Para-Influenza Virus Type 1;Para-Influenza Virus Type 3;parainfluenza virus;Participant;particle;Passive Immunity;passive immunoprophylaxis;pathogen;Phase;phase 1 study;Phase I Clinical Trials;phase I trial;Phenotype;Pneumovirus;Polymerase;Population;Positioning Attribute;preclinical development;preclinical study;Preparation;Proteins;Publications;randomized placebo controlled study;recombinant virus;Reporting;Research;research clinical testing;respiratory;Respiratory Disease;Respiratory Mucosa;Respiratory syncytial virus;Respiratory Syncytial Virus Infections;Respiratory Syncytial Virus Vaccines;response;reverse genetics;RNA chemical synthesis;RNA replication;Safety;Seasons;seropositive;Serotyping;Side;Subunit Vaccines;System;therapeutic candidate;Toddler;Universities;Up-Regulation;vaccine candidate;Vaccine Clinical Trial;Vaccine Design;vaccine evaluation;vaccine strategy;Vaccines;vector;vector vaccine;Viral;Viral Antigens;Viral Genes;Viral Pathogenesis;viral RNA;virology;Virus;Virus Diseases;volunteer,Clinical Trials of  Vaccines for Respiratory Syncytial Virus and Related Viruses,326,NA,NA,NA,NA,43,NA,NA,1306400,NA
11189273,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000327,NA,NA,1ZIAAI000327-43,NIAID:1702601\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77880414 (contact),"BUCHHOLZ, URSULA  (contact)",NA,NA,NA,A549;Active Immunization;Affect;Age;Animal Experiments;Anti-viral Agents;Antibodies;Antigens;attachment protein G;Attenuated;Attenuated Vaccines;attenuation;Cattle;Cell Culture Techniques;Cells;Child;Childhood;Chimeric Proteins;Clinical Research;Clinical Trials;Code;Codon Nucleotides;Collaborations;Complement;Cooperative Research and Development Agreement;Cytoplasmic Tail;Development;Disease;disulfide bond;Engineering;Epithelium;Genes;Glycoproteins;Growth;Hamsters;Hemagglutinin;Human;Human Parainfluenza Virus 2;Immunization;immunogenic;immunogenicity;immunoprophylaxis;In Vitro;in vivo;Infant;Infection;Interferons;Intranasal Administration;Laboratory Study;Lead;lead candidate;Life;Lung;manufacture;Membrane;Missense Mutation;Modification;Molecular Biology;Molecular Conformation;Molecular Virology;Mutation;Nasal turbinate bone structure;Neuraminidase;neutralizing antibody;NIH Vaccine Research Center;nonhuman primate;Nose;NPM1 gene;Nucleoproteins;Open Reading Frames;Para-Influenza Virus Type 1;Para-Influenza Virus Type 3;parainfluenza virus;particle;Phase;phase 1 study;Phase I Clinical Trials;Phenotype;Phosphoproteins;Pneumovirus;Polymerase;preclinical study;programs;Protein Conformation;Proteins;Reporting;research clinical testing;respiratory;respiratory pathogen;Respiratory syncytial virus;Respiratory Syncytial Virus Vaccines;response;reverse genetics;Serotyping;Serum;Site;System;vaccine candidate;Vaccine Clinical Trial;Vaccines;vector;Vero Cells;Vertebral column;Viral;Viral Antigens;Viral Proteins;Virion;Virus;Virus Replication;Work,Laboratory And Pre-clinical Studies Of Parainfluenza Viruses,327,NA,NA,NA,NA,43,NA,NA,1702601,NA
11189274,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000354,NA,NA,1ZIAAI000354-42,NIAID:295297\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691353 (contact),"STROBER, WARREN  (contact)",NA,NA,NA,Acetylmuramyl-Alanyl-Isoglutamine;Alleles;autosome;Blau syndrome;Cells;Clinical;Colonic inflammation;comparison control;Crohn&apos;s disease;Defect;Deubiquitinating Enzyme;Deubiquitination;Development;dextran sulfate sodium induced colitis;Disease;Dominant-Negative Mutation;Etiology;Exhibits;Eye;Functional disorder;Gastrointestinal tract structure;Gene Abnormality;Gene Expression;gene function;Genes;Genetic;Genetic Polymorphism;Genetic Transcription;genome wide association study;gut inflammation;gut microbiota;Heterozygote;Human;IL17 gene;Immunologics;immunoregulation;In Vitro;in vivo;Inflammation;Inflammatory;Inflammatory Bowel Diseases;Innate Immune Response;Interferon alpha;IRF3 gene;IRF4 gene;joint inflammation;Joints;Knock-in;Knock-in Mouse;Lamina Propria;Lead;Learning;lentivirally transduced;Ligands;Link;Lymphoid Cell;Mediating;Mesentery;Molecular;Molecular Abnormality;monocyte;Mus;Mutate;Mutation;NF-kappa B;Organism;overexpression;Patients;peripheral blood;Phosphorylation;Predisposition;Production;Regulation;Reporting;Research;response;RIPK2 gene;sensor;Series;Signal Transduction;Site;Skin;Spleen;Statistical Study;Sterility;Stimulus;T-Lymphocyte;theories;Tissues;TNF receptor-associated factor 3;transcription factor;trinitrobenzene sulfonic acid induced colitis;ubiquitin isopeptidase;Ubiquitination;Ulcerative Colitis;Work,Immunoregulatory Defects In Inflammatory Bowel Disease,354,NA,NA,NA,NA,42,NA,NA,295297,NA
11189275,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000361,NA,NA,1ZIAAI000361-42,NIAID:929964\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,79330076 (contact),"REDD, ANDREW  (contact)",NA,NA,NA,Accident and Emergency department;Acquired Immunodeficiency Syndrome;administrative database;Africa;Age;Algorithms;American;Anosmia;Anti-Retroviral Agents;Antibodies;Antibody Response;Asia;Behavioral;Biological;Biological Assay;CD4 Positive T Lymphocytes;Cells;chemokine;Classification;Clinical;Clinical Trials;Clonality;co-infection;cohort;Collaborations;Communicable Diseases;convalescent plasma;Country;COVID-19;COVID-19 impact;cross reactivity;cytokine;Data;Developing Countries;Development;Disease;Disease Progression;Down-Regulation;efficacy evaluation;Emergency Department patient;Epidemiology;Fatigue;Female;Goals;Health;Health Sciences;High Prevalence;HIV;HIV Infections;HIV Seropositivity;HIV-1;HIV/STD;human old age (65+);Immune response;Immunoassay;Immunologics;Immunology;Individual;Infection;Inflammation;Interleukin-6;International;Intervention;Journals;Kidney;Kidney Diseases;Kidney Transplantation;Kinetics;Laboratories;Latin America;Long COVID;longitudinal analysis;low and middle-income countries;Maintenance;male;Male Circumcision;Measures;Mediating;Medicine;men;microbicide;Molecular;Morbidity - disease rate;Mutation;New England;novel;Odds Ratio;organ transplant recipient;Organ Transplantation;Outcome;pandemic disease;Participant;Patient Self-Report;Patients;Perinatal;Persons;Pharmaceutical Preparations;Plasma;Population;post-COVID conditions;pre-pandemic;prevent;Primary Care Physician;programs;Publications;randomized trial;Reporting;reproductive;response;Rest;Role;Sampling;SARS-CoV-2 infection;screening;Serum;sex;sociodemographic variables;Solid;South Africa;superinfection;Symptoms;Syphilis;T cell response;Testing;transcriptomics;transmission process;Transplantation;Uganda;Universities;Vaccination;Vaccines;Validation;Viral;Viral reservoir;virology;Virus Diseases;Virus Latency;whole genome;Woman;Work,International Studies of the Acquired Immune Deficiency Syndrome (AIDS),361,NA,NA,NA,NA,42,NA,NA,929964,NA
11189276,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000372,NA,NA,1ZIAAI000372-42,NIAID:1306400\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,77880414 (contact),"BUCHHOLZ, URSULA  (contact)",NA,NA,NA,Age;Amino Acids;Animal Model;Attenuated;Attenuated Vaccines;attenuation;Basic Science;Biological Assay;Cardiopulmonary;Characteristics;Childhood;clinical candidate;clinical development;Clinical Research;Code;Codon Nucleotides;Computational algorithm;Cooperative Research and Development Agreement;Cytoplasm;design;Development;Elderly;Evaluation;experimental study;Family member;Gene Mutation;Gene Proteins;gene synthesis;Genes;Genetic;Genome;genome-wide;glycoprotein G;Glycoproteins;Goals;Human;Human Metapneumovirus;Hydrophobicity;Immunobiology;immunodeficiency;improved;Individual;Laboratory Study;lead candidate;Licensing;Marketing;member;Messenger RNA;Molecular Biology;Molecular Genetics;Molecular Virology;Morbidity - disease rate;mortality;multiple myeloma M Protein;Murine pneumonia virus;mutant;Mutation;Nonstructural Protein;Nucleoproteins;Open Reading Frames;pathogen;Phase;Phosphoproteins;Play;Pneumovirus;Point Mutation;Polymerase;Population;preclinical development;preclinical study;programs;Proteins;Reagent;Refractory;Reporting;research clinical testing;Respiratory syncytial virus;Respiratory Syncytial Virus Vaccines;Respiratory Tract Diseases;reverse genetics;RNA;RNA Viruses;Rodent;Role;Route;Serology test;System;Temperature;vaccine candidate;Vaccine Clinical Trial;vaccine development;Vaccines;Variant;Viral;viral fitness;Viral Proteins;Virus,Laboratory Studies of Human Respiratory Syncytial Virus and Other Pneumoviruses,372,NA,NA,NA,NA,42,NA,NA,1306400,NA
11189277,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000394,NA,NA,1ZIAAI000394-41,NIAID:839085\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,8620541 (contact),"MARGULIES, DAVID  (contact)",NA,NA,NA,Address;Affinity;Antibodies;Antigen-Presenting Cells;Antigens;Area;Autoimmunity;Bacterial Infections;Biochemical;Biological;Cancerous;Cell surface;Cells;Collaborations;Communicable Diseases;Complex;Computational algorithm;Computational Technique;Cryoelectron Microscopy;Docking;Engineering;Epitopes;Family;Generations;genetic analysis;Goals;Histocompatibility;Human;humanized mouse;immune activation;Immune response;Immune system;immune system function;in vitro Model;in vivo;interest;Lymphocyte Function;Malignant Neoplasms;Molecular;Molecular Biology;Molecular Genetics;Monoclonal Antibodies;Monoclonal Antibody Therapy;mouse model;Mus;Myeloid Cells;Natural Killer Cells;Nature;NK Cell Activation;Parasitic infection;Pathologic;Peptide/MHC Complex;Peptides;prediction algorithm;Predisposition;Process;protein complex;Proteins;Publications;Reaction;receptor;Receptor Cell;Recombinants;Regulation;response;Roentgen Rays;Role;Site;Stress;Structure;T-Cell Receptor;three dimensional structure;trafficking;tumor;Viral Physiology;Virus Diseases,Molecular Genetic Analysis Of Lymphocyte Function,394,NA,NA,NA,NA,41,NA,NA,839085,NA
11189278,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000416,NA,NA,1ZIAAI000416-41,NIAID:1617431\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691561 (contact),"MOSS, BERNARD  (contact)",NA,NA,NA,Animal Model;Antibodies;Cellular Immunity;Collaborations;Disease;Encapsulated;Immune response;improved;Infection;Infectious Skin Diseases;Licensing;Lipids;Messenger RNA;Monkeypox;Monkeypox virus;Mucous Membrane;nanoparticle;Orthopoxvirus;particle;Proteins;Recombinant Proteins;recombinant virus vaccine;Research;RNA vaccine;Role;side effect;Testing;vaccine candidate;Vaccines;vector;Viral Antigens;Viral Proteins,Recombinant Virus Vaccines,416,NA,NA,NA,NA,41,NA,NA,1617431,NA
11189279,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000430,NA,NA,1ZIAAI000430-40,NIAID:125596\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413516 (contact),"COHEN, JEFFREY  (contact)",NA,NA,NA,"afferent nerve;Attenuated;Cells;Chickenpox;Chickenpox Vaccine;Collaborations;Cranial Nerves;Ganglia;Goals;Hematologic Neoplasms;Herpes zoster disease;Herpesvirus Type 3;Human;Immunocompromised Host;Licensing;Molecular Biology;National Heart, Lung, and Blood Institute;Pathogenesis;patient response;Persons;Primary Infection;response;Subunit Vaccines;United States;Vaccines;Virus;Virus Diseases;Zoster Vaccine",Molecular Biology Of Varicella Zoster Virus Infection,430,NA,NA,NA,NA,40,NA,NA,125596,NA
11189280,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000432,NA,NA,1ZIAAI000432-40,NIAID:689024\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691353 (contact),"STROBER, WARREN  (contact)",NA,NA,NA,Affect;Albumins;analog;Animal Experiments;Anti-Inflammatory Agents;Autophagocytosis;Binding;Blood;Caspase;Cell Line;Cell Survival;Cells;Characteristics;Chemicals;Circulation;Colitis;Collaborations;Coupled;Crohn&apos;s disease;cytokine;Data;dectin 1;Dendritic Cells;Disease;enhancing factor;Epithelial Cells;Evaluation;Event;Exhibits;Flagellin;Gastrointestinal tract structure;Genes;Genetic;Genetic Polymorphism;Genetic Processes;genome wide association study;gut inflammation;gut microbiome;gut microbiota;Hand;Human;IL18 gene;Immune;immune activation;immune function;Immune response;immunoregulation;Impairment;Individual;Inflammasome;Inflammation;Inflammatory;Inflammatory Bowel Diseases;inhibition of autophagy;inhibitor;Interleukin-10;Intestinal permeability;Intestines;Intraperitoneal Injections;Kidney;kinase inhibitor;knock-down;Lamina Propria;Legionella pneumophila;lethal factor;Ligands;LRRK2 gene;Lung;Macrophage;Measures;Mediating;Medical center;medical schools;Messenger RNA;Methods;microbial;Molecular;Molecular Abnormality;Mucosal Immune Responses;Mus;Needles;New York City;NF-kappa B;Nuclear Translocation;Organism;Parents;Parkinson Disease;Patients;Peripheral;Phosphorylation;Phosphorylation Inhibition;Phosphotransferases;Play;Production;promoter;Property;Proteins;Protocols documentation;Qi;Research Personnel;response;RIPK2 gene;Risk;Role;Series;Serine;side effect;Specificity;Stimulus;Time;Tissues;Toxic effect;transcription factor;Transgenes;Ulcerative Colitis,Regulation Of Immune Responses In Humans and in Experimental Animals,432,NA,NA,NA,NA,40,NA,NA,689024,NA
11189281,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000439,NA,NA,1ZIAAI000439-40,NIAID:2490071\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691541 (contact),"NUTMAN, THOMAS  (contact)",NA,NA,NA,Angiostrongylus;Antibodies;Antigens;Autoantibodies;Autoantibody binding;autoreactivity;Bioinformatics;Biological Assay;cell free DNA;Clinical;Clinical Research;commercialization;cross reactivity;Data;Detection;Development;Diagnosis;Diagnostic;Disease;DNA;eosinophil;Eosinophilia;Family Study;Filarial Elephantiases;Filariasis;Gnathostoma;Goals;helminth infection;Human;Infection;insight;Intestinal Volvulus;kindred;Leishmania;Loa;Loiasis;Mediating;Meningitis;Methodology;Methods;Molecular;neurotoxic;Onchocerciasis;Parasites;Parasitic infection;PARK7 gene;Patients;Plasma;Polymerase;Prevention;Publishing;Recombinants;recombinase;response;Services;Strongyloides;Syndrome;Therapeutic Studies;Toxocara;Trypanosoma cruzi;United States National Institutes of Health;Urine;Work,Clinical And Therapeutic Studies Of Human Filariasis and Related Diseases,439,NA,NA,NA,NA,40,NA,NA,2490071,NA
11189282,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000483,NA,NA,1ZIAAI000483-39,NIAID:2269751\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6479429 (contact),"WELLEMS, THOMAS E (contact)",NA,NA,NA,Aedes;Affect;Africa;Aftercare;Anopheles Genus;Anti-malarials;Antimicrobial Resistance;Apoptosis;Area;artesunate;asexual;Attention;biological adaptation to stress;Blood;Blood specimen;Cells;Cellular Stress;Chloroplasts;Collaborations;Communication;Culicidae;Deterioration;Development;Diagnostic Procedure;diagnostic tool;Disease;disease transmission;Drug resistance;Erythrocytes;Eukaryotic Cell;experimental study;Failure;field study;Funding;Genotype;Glutathione;Goals;Hemolysis;Human;Individual;Infection;innovation;insight;Investigation;Knowledge;Label;Laboratories;Light;Malaria;malaria infection;Malaysia;Maryland;Metabolism;Microscopy;Mitochondria;Modeling;Monkeys;Morphology;multidisciplinary;National Institute of Allergy and Infectious Disease;Nature;new therapeutic target;nonhuman primate;novel strategies;Organelles;Oxidative Stress;Parasitemia;Parasites;Pathway interactions;Pharmaceutical Preparations;Pharmacotherapy;Plants;Plasmodium;Plasmodium falciparum;Plasmodium knowlesi;Plasmodium vivax;Plastids;Play;Population;Preparation;Prevention;Primates;Production;Publications;Recrudescences;Recurrence;Regulation;Reporting;Research;Research Project Grants;response;Riboflavin;RNA;Role;Saimiri;Scientific Advances and Accomplishments;Sepsis;Severity of illness;Sex Differentiation;Shapes;Signal Transduction;single cell analysis;single-cell RNA sequencing;sound;Sporozoites;stressor;Swelling;tissue culture;Tissue-Specific Gene Expression;Toxoplasma;transcriptome;transmission process;treatment strategy;ultra high resolution;Universities;vaccine candidate;Vaccines;vector mosquito;Virulence;Work,Malaria Drug Resistance and Disease Virulence,483,NA,NA,NA,NA,39,NA,NA,2269751,NA
11189283,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000494,NA,NA,1ZIAAI000494-38,NIAID:724563\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6479341 (contact),"SACKS, DAVID  (contact)",NA,NA,NA,Ablation;CCL24 gene;Cells;Cessation of life;chemokine;Chronic;Clinical Research;confocal imaging;Cutaneous;Cutaneous Leishmaniasis;cytokine;Dermis;Development;Discontinuous Capillary;Disease;Environment;eosinophil;experimental study;Generations;Goals;Granuloma;Growth;Hamsters;healing;Hepatic;Heterogeneity;Homeostasis;Human;Immunity;Immunologics;immunoregulation;India;Infection;Infectious Skin Diseases;Inflammatory;Interleukin-4;Interleukin-5;interstitial;Kupffer Cells;Label;Leishmania infantum;Leishmania major;Leishmaniasis;Lesion;Liver;Lymphoid Cell;Macrophage;Mediating;Mediator;migration;Modeling;Molecular;monocyte;mouse model;Mus;Organ;Parasite Control;Parasites;Persons;Preventive vaccine;Property;rational design;recruit;repaired;Resistance;response;Signal Pathway;Signal Transduction;single-cell RNA sequencing;Source;therapeutic vaccine;Tissues;TSLP gene;vaccine development;Vaccines;Visceral;Visceral Leishmaniasis,IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS,494,NA,NA,NA,NA,38,NA,NA,724563,NA
11189284,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000512,NA,NA,1ZIAAI000512-37,NIAID:592329\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9691541 (contact),"NUTMAN, THOMAS  (contact)",NA,NA,NA,Angiostrongylus cantonensis;Antigens;Ascaris;Biological Assay;Biological Process;Biology;Cameroon;Chromosomes;Clinical;Clustered Regularly Interspaced Short Palindromic Repeats;Collaborations;commercialization;Country;Data;Detection;detection limit;Diagnosis;diagnostic strategy;DNA;Dracunculus medinensis;Fluorescence;fluorophore;Genes;Genome;genome annotation;Genomics;Gnathostoma;Goals;Helminths;IgG4;Immunoassay;improved;Individual;Infection;insight;Intestinal Volvulus;Knowledge;Laboratories;Leishmania;Life Cycle Stages;Loa;Loiasis;Meningitis;Microscope;Molecular;molecular diagnostics;Molecular Target;Monitor;Monoclonal Antibodies;multiplex assay;Nature;neglected tropical diseases;Nematoda;Onchocerciasis;Parasites;parasitism;Pathogenicity;Patients;Plasma;polyclonal antibody;programs;Proteins;Proteomics;Recrudescences;Research Personnel;Sampling;Schistosoma;Schistosoma mansoni;Strongyloides stercoralis;Taenia solium;telomere;Testing;Therapeutic Intervention;tool;Toxocara;Toxocara canis;transmission process;Treatment Efficacy;Trichinella;Trichocephalus trichiura;Update;Validation;Visit,Molecular Definition Of Filarial And Related Nonfilarial Genes And Proteins,512,NA,NA,NA,NA,37,NA,NA,592329,NA
11189285,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000525,NA,NA,1ZIAAI000525-37,NIAID:166575\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,6479748 (contact),"LONG, ERIC O (contact)",NA,NA,NA,Abnormal Cell;Affinity;Alleles;Antigens;Autoimmune Diseases;B lymphoid malignancy;B-Lymphocytes;Binding;Binding Sites;cancer cell;cancer immunotherapy;CD58 gene;CD94 Antigen;Cell Count;Cell Line;Cell surface;Cells;chimeric antigen receptor;Chronic Lymphocytic Leukemia;chronic myeloid leukemia cell;Clustered Regularly Interspaced Short Palindromic Repeats;Complex;CRISPR screen;Cytolysis;Data;Detection;Disease;Down-Regulation;Genes;Genetic study;genome-wide;Germ Lines;glycoproteomics;glycosylation;glycosyltransferase;Golgi Apparatus;HLA-C Antigens;Human;human disease;Immune Evasion;Immune system;Immunoglobulins;Immunotherapy;Infection;K-562;Killer Cells;Knock-out;large cell Diffuse non-Hodgkin&apos;s lymphoma;leukemia/lymphoma;Ligands;Lymphocyte Function;Lymphoid Cell;Malignant Neoplasms;Mediating;Modification;MS4A1 gene;Mutation;N-acetyllactosamine;Natural Killer Cells;neoplastic cell;Non-Hodgkin&apos;s Lymphoma;Pathway interactions;Patients;Peptide Hydrolases;Peptides;Play;Polysaccharides;predicting response;preference;protein aminoacid sequence;receptor;Receptor Activation;receptor binding;Recombinant Antibody;Regulation;Resistance;response;rituximab;Role;Shapes;Specificity;Surface;Testing;Transferase,Regulation of innate lymphocyte function,525,NA,NA,NA,NA,37,NA,NA,166575,NA
11189286,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000545,NA,NA,1ZIAAI000545-36,NIAID:1389263\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,11242108 (contact),"GERMAIN, RONALD N (contact)",NA,NA,NA,adaptive immune response;Adjuvant;Afferent Neurons;Affinity;analytical method;Animals;Anti-CD40;Antigen Presentation;Antigen-Presenting Cells;Antigens;Area;Atlases;autoreactivity;B-Cell Activation;B-Lymphocytes;Behavior;Blood Vessels;Breast;Cancer Model;CD209 gene;CD4 Positive T Lymphocytes;CD8-Positive T-Lymphocytes;cell motility;Cell Physiology;cell type;Cells;Cessation of life;checkpoint inhibition;checkpoint therapy;Collection;Color;Communities;complex data;Computer software;Cytometry;Data;Dendritic Cells;Detection;detection method;Development;Dimensions;Disease;Effector Cell;Elements;Endothelial Cells;Event;Excision;Experimental Models;experimental study;Flow Cytometry;Follicular Lymphoma;Freezing;Generations;Germ-Free;Goals;Hand;high dimensionality;Host Defense;Human;Image;imaging modality;imaging study;Imaging technology;Immune;immune checkpoint blockade;Immune response;Immune system;immune system function;Immunohistochemistry;Immunologics;Immunosuppression;Immunotherapeutic agent;Immunotherapy;implantation;improved;in vivo;innate immune function;insight;Interferons;Intervention;Intestines;intravital microscopy;Laboratories;Lectin;Lung;Lung Adenocarcinoma;lymph nodes;Lymphocyte;Lymphocyte Subset;Lymphoid;Lymphoid Tissue;Macrophage;Malignant - descriptor;Malignant neoplasm of ovary;Malignant Neoplasms;Maps;Mediating;Memory;Methods;microbial products;Microscopy;microwave electromagnetic radiation;Modeling;multiplexed imaging;Mus;Mutation;Myelogenous;Myeloid Cells;National Institute of Allergy and Infectious Disease;neoplastic cell;neutrophil;new technology;novel;Oligosaccharides;Ontology;optical imaging;Organ;Outcome;Pancreas;PARP inhibition;Pathology;Patients;Pattern;PD-1 pathway;Pericytes;Phenotype;Photons;Poison;Poisoning;Population;Positioning Attribute;Production;Productivity;programmed cell death protein 1;Proliferating;Property;protein protein interaction;Proteins;Publishing;Regulatory T-Lymphocyte;Reporting;Research;Resolution;responders and non-responders;response;Retina;RNA;Role;Sampling;Signal Transduction;Site;Specific qualifier value;Speed;Spleen;Stains;stem;Structure;Surface Immunoglobulins;System;T-Cell Activation;T-Cell Receptor;T-Lymphocyte;T-Lymphocyte Subsets;technology development;Testing;Thick;Thymus Gland;Tissue imaging;Tissues;TNF gene;transcriptome sequencing;transcriptomics;Transgenic Animals;tumor;Tumor Antigens;tumor growth;tumor immunology;tumor microenvironment;Vagotomy;Variant;Visualization;Work;XCR1 gene,Multiscale Analysis of Immune Responses,545,NA,NA,NA,NA,36,NA,NA,1389263,NA
11189287,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000548,NA,NA,1ZIAAI000548-36,NIAID:753566\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,9413516 (contact),"COHEN, JEFFREY  (contact)",NA,NA,NA,Acute Disease;Animal Model;Animals;Antibodies;Antibody Response;Cavia;CD8-Positive T-Lymphocytes;clinical center;Disease;DNA;efficacy evaluation;Fibroblasts;genital herpes;genital infection;Goals;Growth;Herpes Simplex Infections;Herpes Simplex Virus Vaccines;HIV;Human;human disease;Human Herpesvirus 2;Immunity;In Vitro;Infection;Lesion;Licensing;Macaca mulatta;Modeling;Monkeys;Monoclonal Antibodies;mortality;Mus;Natural Immunity;Neurologic Symptoms;neutralizing antibody;Phase I Clinical Trials;Prevention;Preventive vaccine;Primary Infection;Primates;Recurrence;Risk;Sapajus apella;Swab;T cell response;Testing;transmission process;United States National Institutes of Health;vaccine candidate;vaccine development;vaccine effectiveness;vaccine-induced antibodies;Vaccines;Vagina;Virus;Virus Shedding;Vulva,Development Of Vaccines For Genital Herpes Simplex Infection,548,NA,NA,NA,NA,36,NA,NA,753566,NA
11189288,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000566,NA,NA,1ZIAAI000566-28,NIAID:1221285\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,10526060 (contact),"SU, HELEN  (contact)",NA,NA,NA,Affect;anergy;Antigens;Apoptosis;Atherosclerosis;Autoimmune Diseases;Autoimmune Process;autoinflammatory diseases;Body System;Cardiomegaly;Cardiovascular system;CD8-Positive T-Lymphocytes;Cell Culture Techniques;Cells;Characteristics;chemokine receptor;Citrobacter rodentium;Colitis;Colon;Complex;congenital immunodeficiency;Data;Development;Disease;disease model;early onset;Endothelial Cells;Epithelium;Event;gastrointestinal;Genes;Goals;GPR15 gene;Guanosine Triphosphate Phosphohydrolases;Homeostasis;Homing;Human;Immune;Immune system;Immune Tolerance;Immunologics;immunoregulation;Inflammatory;Inflammatory Bowel Diseases;intestinal barrier;Investigation;Knockout Mice;Ligands;Lipids;Location;loss of function;Macrophage;Mature T-Lymphocyte;Mediating;Metabolism;Molecular;Morbidity - disease rate;mortality;Mus;Mutation;novel therapeutic intervention;Organ;Pathogenesis;Pathogenicity;Patients;Physiological;Play;Predisposition;prevent;Process;Protein Family;Regulation;Regulatory T-Lymphocyte;Reporting;Research;Role;Signal Pathway;single-cell RNA sequencing;System;T-Lymphocyte;T-Lymphocyte Subsets;targeted treatment;Work,Gene Regulatory Events in Establishing Mature T Cell Tolerance,566,NA,NA,NA,NA,28,NA,NA,1221285,NA
11189289,ZIA,AI,1,N,NA,NA,NA,NA,ZIAAI000567,NA,NA,1ZIAAI000567-34,NIAID:193786\,INTRAMURAL RESEARCH,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NA,NA,15700778 (contact),"HACKSTADT, TED  (contact)",NA,NA,NA,Affect;Agriculture;Amino Acids;Apoptotic;Area;Bacteria;Bacterial Proteins;Basic Science;Binding;Blindness;Calcineurin;Calcium;calcium indicator;Calcium Signaling;Cell membrane;Cell Physiology;Cell secretion;Cells;Cellular biology;chemokine;Chlamydia;Chlamydia Infections;Chlamydia trachomatis;Chlamydophila pneumoniae;Chlamydophila psittaci;Cholesterol;Chronic;Chronic Disease;community acquired pneumonia;cytokine;Cytoplasm;Cytosol;Data;Defense Mechanisms;Development;Disease;Domestic Fowls;Down-Regulation;Economics;Ectopic Expression;Endosomes;Environment;Epithelium;Eukaryotic Cell;Event;Face;Genes;Genetic;genetic manipulation;Genetic Transcription;Genome;Golgi Apparatus;Growth;Hela Cells;Homeostasis;Human;human disease;human pathogen;Hydrophobicity;immunological intervention;immunoregulation;Impairment;improved;Industry;Infection;Inflammation;Inguinal lymph node group;inorganic phosphate;Inositol;Integral Membrane Protein;interest;ITPR1 gene;Knock-out;Length;Life Style;Livestock;Lymphogranuloma Venereum;Mass Spectrum Analysis;Mediating;Medical;member;Membrane;Membrane Proteins;Metabolic;Metabolism;Microtubule-Organizing Center;Microtubules;Mitochondria;Mitochondrial Proteins;Modification;Molecular Biology;Mucous Membrane;novel;nuclear factors of activated T-cells;Nutrient;obligate intracellular parasite;Organelles;Parasites;pathogen;Pathogenesis;pathogenic bacteria;Pathway interactions;Pelvic Inflammatory Disease;Probability;Process;Production;Protein Analysis;Protein Biosynthesis;protein protein interaction;Proteins;Proteomics;receptor;recruit;Recycling;Regulation;release of sequestered calcium ion into cytoplasm;response;Serology;Sexually Transmitted Diseases;Signal Pathway;Signal Transduction;Specificity;Sphingomyelins;STIM1 gene;Study Section;Systemic infection;Therapeutic Intervention;Trachoma;trafficking;Transferrin;Translating;Translations;transmission process;Type III Secretion System Pathway;United States;Vacuole;Vesicle;virtual;Zoonoses,Cellular Biology Of Host/parasite Interactions,567,NA,NA,NA,NA,34,NA,NA,193786,NA
